
(IN-PACKAGE :SP)
(DEFPARAMETER SPARSER::*NS-RD-PHASE3-16201-16500*
  '(".1100delC" ".1798_1799GT" ".1799_1800TG" ".319+43dupA" ".444+1G"
    ".945_946" "4eBP1-S240" "4eBP1-T37" "70S6K" "A+C" "A-498" "A-bomb" "A-loop"
    "A-rich" "A1" "A1096V" "A146T" "A167T" "A23187-induced" "A30P" "A5" "A533D"
    "A549-miR-622" "A549-pLKO" "A549-shDR5" "A550V" "A572V" "A573V" "A628S5"
    "A769662+rapamycin-treated" "A91Cα-T109Cα" "AA+GA" "AADC" "AARSs"
    "AATAAACA" "ABI-3730" "AC-220" "ACCTCGCCCCCCAGCTCCGGGG" "ACO1" "ACSL"
    "ACSL4" "ACSL4-functional" "ACTR2" "ADAMTS" "ADDIT" "ADIPOQ-null"
    "ADP-ribosylases" "ADP-ribosyltransferases" "ADPR" "ADR-treatment" "ADRs"
    "AFMA070WD1" "AG-014699" "AG-221" "AG16146" "AG22056" "AGAGC" "AGC" "AGERA"
    "AGGAU" "AGGGT" "AID-DIvA" "AIIIa" "AIRN" "AJCC" "AKI–CKD" "AKT-dependent"
    "AKT-in" "AKT-mTOR-p70S6K" "AKT8055" "AKTS1" "ALLGGEN" "ALLs" "ALST" "AMA"
    "AMGIO2" "AMIGO1" "AMIS" "AMPK-Ser486" "AMPKα-null" "AMPKβ1" "AMPKβ2"
    "AMPKγ" "AMPKγ1" "ANASTASIOU" "ANDOR" "ANGPLT2" "ANKRD13A" "ANL" "ANLm"
    "ANLmp" "ANLmp21" "ANLp" "ANOSIM" "ANR" "AOC" "AOLT" "AP" "AP-1-dependent"
    "AP-1-mediated" "AP1-dependent" "APACHE" "APACHE-II" "APCmin"
    "APPL1-TGFβRI-ICD" "APPL1-TβRI-ICD" "AR-FL" "AR-FL-overexpressing" "AR-V"
    "AR-V-targeted" "AR-V2" "AR-V3" "AR-V4" "AR-V9" "AR-Vs" "AR-positive"
    "AR-status" "AR45" "ARC239" "ARE-RNA" "ARE1~4" "ARE3" "ARE4" "AREsite"
    "ARMS-qPCR" "ARR" "ARRP19" "AS-NMD" "ASC-J9" "ASCL4" "ASCO" "ASDs"
    "ASF-ESE" "ASO-miR-346" "ASO-miR-346-treated" "ASPIRE" "AT7867" "ATB-737"
    "ATCC" "ATG12-Atg5-Atg16L" "ATGTAAACAAS" "ATGTAAACAS" "ATM-S1981"
    "ATM-Ser1981" "ATM-dependence" "ATMIN-null" "ATMi" "ATP-competitive"
    "ATR-Substrate" "AUBPs" "AUG" "AUKB" "AUUUA" "AW" "AZD" "AZD-2281"
    "AZD6378" "AbbVie" "Abcam" "Abcodia" "Abdel" "Abdel-Ghany" "Acat3"
    "Acat3-1" "Acat3-2" "Acat3-3" "Achilles" "Actinobacteria" "Ad-LacZ" "Adda"
    "Affymetrix" "Africa" "African" "African-American" "Africans" "Afrikaans"
    "Afrikaner" "Ahr" "Aims" "Aki1" "Akt-PS473" "Akt-S473" "Akt-Ser473"
    "Akt-pathways" "Akti1" "Al-Khobar" "Albiges" "Aldrich" "Aleve" "Alexa"
    "Alhazzazi" "Alk" "All-in-all" "AlmarBlue" "Alpers" "Alpha-MEM-GlutaMax"
    "Alzheimer" "Alzheimer's" "Alzheimer’s" "America" "American" "Americans"
    "Amgen" "AmpliSeg" "Amyloid-β" "Anderson" "Andreotti"
    "Androgen-deprivation" "Angelini" "Anhui" "Annexin-FITC" "Annxin" "Api"
    "Arcy" "Arg-1" "Arg194Trp" "Arg399Gln" "Arg399glutanine" "Arg→Gln"
    "Arg→Trp" "Aristolactam" "ArrayScan" "Ashkenazi" "Asi" "AsiSI-DSBs"
    "AsiSI-ER" "Asian" "Asians" "Asp167del" "Astra" "AstraZeneca" "Astragali"
    "Astragalus" "Atg12-Atg5-Atg16L1" "Au-rich" "Aukema" "Aurora-A-Borealis"
    "Avalos" "Aviel" "Aviel-Ronen" "Avinash" "AzadC" "Azami" "Aβ" "A–3E" "A–5C"
    "A–S2C" "A–S3E" "A–S4C" "B-LMP1" "B-LMP1and" "B-SLL" "B-form" "B-like"
    "B-lymphoid" "B-malignancies" "B-miR-346" "B-regulated" "B1"
    "B16-GFP-MAGE-C2" "B2" "B3" "B4" "B55α" "B55β" "B55γ" "BALB" "BAPTA-AM"
    "BCAR4" "BCL" "BCL-xl" "BCSCs" "BD" "BG-12" "BG-647-SiR" "BGJ398"
    "BH3-chimaeras" "BH3-domains" "BH3-mimetic" "BH3-mimetics" "BH3-only"
    "BIDUS" "BIMEL" "BJ" "BL-like" "BL1" "BMI" "BMMR" "BMMs" "BMN" "BMN-673"
    "BODIPY-GTP-binding" "BRAFV600" "BRCA1-immunoreactive" "BRCT-WGR"
    "BRL44408" "BRRM" "BSA-Au" "BT168" "BT275" "BTBD19" "BTC27" "BTC29" "BTCs"
    "BTZ-resistnat" "BTZ-susceptibility" "BV-176-treated" "BY719" "Ba"
    "Bacteroidetes" "Baggott" "Bak-DKO-MEFs" "Balb" "Baldock" "Baltimore"
    "Bankoff" "Bao" "Bardoxolone" "Bardoxolone-methyl" "Barr" "Barretina"
    "Bartel" "Baseler" "Baskaran" "Baumdick" "Baumer" "Bax" "Bay11-7802"
    "Bay11–7802" "Bayer" "Bayes" "Baynam" "Bcl-2-function" "Bcl-2-system"
    "Bcl-xl" "Beaven" "Begg" "Bel" "Bel-7704" "Belarus" "Bem1p" "Bergethon"
    "Bergfors" "Berlin" "Bernatchez" "Bernier" "Bernier-Villamor" "Bernoux"
    "Bethesda" "Bid" "Bild" "Bim" "Bio" "Bio-Rad's" "BioMarin" "Biosystems"
    "Bis" "Bitplane" "Blenkiron" "Blood" "Boehringer" "Bonferroni" "Bordone"
    "Borealis" "Boren" "Boston" "Bouwman" "Boyden" "Braak" "Brachmann"
    "Branched-chain" "Brattain" "BrdUrd" "Bre1" "Breitenbach" "Brevibacterium"
    "Brien" "British" "Bromoadenosine" "Brzozowska" "Brüggemann" "Bueno"
    "Bunda" "Burguete" "Burguete-Garcia" "Burk" "Burkitt" "Burkitt's" "Burnett"
    "Buzzai" "Bylebyl" "Bültmann" "B–S7D" "C-124T" "C-146T" "C-PARP1"
    "C-labeled" "C-lobe" "C-lobes" "C-methyl-Met" "C-phosphate-G" "C-pocket"
    "C-rich" "C-site" "C-terminally" "C0" "C1" "C2" "C2-TRIM28" "C2089" "C28"
    "C2BBel" "C3" "C3H" "C3H10T1" "C3HC4-Type" "C4" "C4-type" "C57B" "C57BL6"
    "C6" "C62S" "C7ORF60" "CA19-9" "CA19–9" "CAAX" "CACNA2D" "CAECs" "CAGGTG"
    "CAL-101" "CAMCs" "CAPIRI" "CAPOX" "CARD16" "CASMCs" "CAV1-interaction"
    "CAV1-interactions" "CBP-mediated" "CBRH" "CBRH-7919" "CC-chemokine"
    "CCAAT" "CCAAT-box" "CCAAT-boxes" "CCAAT-enhancer-binding" "CCAT2" "CCCH"
    "CCD-19" "CCD-19Lu" "CCD66" "CCDC66" "CCID" "CCIDs" "CCL227"
    "CCR4-NOT-deadenylase" "CCVs" "CCinsG" "CD" "CD-transfected"
    "CD133-integrin-Par" "CD133WT" "CD133ΔC11" "CD133ΔC3" "CD133ΔC3-7"
    "CD133ΔC7" "CD133ΔE5" "CD168" "CD28null" "CD28nullCD8 + " "CD28 + "
    "CD44+CD24" "CD44 + " "CD4Cre" "CD52" "CD66" "CD8 + " "CD90" "CDDO-Im"
    "CDE" "CDK6-Del" "CDK6-Del-directed" "CDKNA2A" "CDNK1" "CDNK1A" "CEE"
    "CEE " "CELSR1" "CENP-1" "CENPJ" "CEP131-F1" "CEP7" "CEU" "CEW"
    "CGA-arginine" "CGG " "CHASM" "CHEK2*1100delC" "CHGA" "CHGB" "CHI3L1"
    "CHIC35" "CHILD-PUGH" "CHIR" "CHOP-like" "CHR" "CHR-dependent" "CI1040"
    "CI=1.09–1.24" "CICAMS" "CID2950007" "CIMP" "CIMs" "CIV" "CJ" "CKD" "CKLF"
    "CKLF-like" "CLDs" "CLIPseq" "CLOVES" "CLPTM1Lhas" "CLS-439" "CMTM1-8"
    "CMTMRos" "CMTMs" "CMV6-Klotho" "CNKI" "CNS2" "CNS2-deficient"
    "CNS2-mediated" "CNVs" "COADREAD" "COIN" "COMET" "CONDEL" "CONSORT" "COON"
    "COON-terminal" "COX-2–1195" "CPG" "CR-0560" "CR0004" "CR0010" "CR1515"
    "CR1744" "CREBA" "CREBB2" "CRISPR" "CRISPR-Cas9" "CRISPR-Cas9-based"
    "CRISPR-Cas9-mediated" "CRL-1848" "CS-resident" "CSC-like" "CSDC2" "CSDE1"
    "CTC" "CTCs" "CU" "CU-element" "CUGCG" "CUL4-DDB1ligase" "CVAD" "CVs"
    "CWR22rv1" "CXB1" "CXCL14" "CYP27C1" "CYT38" "CYT387" "CaM-KIIN" "CaP8"
    "CaP8 " "Cajal-Retzius" "Caki2" "Cal12T" "Calcusyn" "Calothrix" "Cambrex"
    "Canada" "Cang" "Cap-dependent" "Capsaspora" "Carboplatin" "Cardoso"
    "Carlo" "Carney" "Carney-Stratakis" "Caron" "Case" "Case1" "Case6"
    "Catlett" "Catlett-Falcone" "Caucasian" "Caucasians" "Cav-1" "Cdc2"
    "Cdc42-effector" "Cdc42-like" "Cdc42Q61L" "Cdkn1acip" "Cdkna1" "CellSearch"
    "CellTiter" "Celther" "Cephalotaxus" "ChIP-PCR" "ChIP-based" "ChIP-qPCR"
    "ChIP-quantitative-PCR" "ChIP–quantitative" "ChT" "ChT-L" "Chaffer" "Chan"
    "Chang" "Chaoshan" "Charcot" "Charcot–Leyden" "Charles" "Charlson"
    "Cheminformatics-based" "Cheng" "Chernobyl" "CherryLacR" "Chi-square"
    "Chi-squared" "Chikh" "Child-Pugh" "Child–Pugh" "Chiu" "Chk1" "Chmielecki"
    "Cholesterol-rich" "Chou" "Chou-Talalay" "Chromagranin" "Chuang" "Chung"
    "Chuprin" "Cip" "Clara" "Clark" "Clinico-epidemiological"
    "Clinico-pathological" "Cnaan" "CoQ" "Cochran–Mantel–Haenszel" "Cohen"
    "Col1A" "Collagen-II" "Collagen1a1" "Colo" "Colo-206" "Colombia" "Colomer"
    "Cometriq" "Compendia" "Complex-II" "Complex-IV" "Complex-V"
    "Computer-based" "Con-injected" "Con-treated" "Connell" "Contreras"
    "Control-shRNA" "Coomassie" "Corp" "Correa" "Cortot" "Corynebacterium"
    "Costollo" "Cowden" "Cox-regression" "CpSCRP" "Cpeb" "Cpeb4-mediated" "Cr"
    "Cre-models" "CreERT2" "Crohn" "Crohn’s" "Cross-seeding" "Crossno" "Ct"
    "Cu" "Cul-DDB1" "Cul3" "Cullin1-myc-ΔC" "Curtis" "Cyanobacteria" "Cybulski"
    "CycLex" "Cyclacel" "Cyclapolin1" "Cyp450" "Cys-Sec" "Cys-pair" "CytoScan"
    "Czech" "Cα" "C→T" "D--F" "D-hexose" "D-type" "D10A" "D10Y" "D17S945" "D2"
    "D2-class" "D283-effLuc" "D3" "D3H2LN" "D3H2LN-LUC-shRNA" "D54" "D6" "DAA"
    "DAAs" "DAB21P" "DAP-81" "DAP2IP" "DARPins" "DAVID" "DAZAP" "DAck" "DBA1"
    "DC-3" "DC-C" "DCAF11" "DCAFs" "DCHF" "DCHF-DA" "DDA1" "DDB1-deficiect"
    "DDB1-deficinet" "DDPIV" "DDSBR" "DEmiRs" "DGE" "DGKa" "DHPLC" "DIANA-miR"
    "DIANA-miRPath" "DIANA-microT" "DIANA-mirPath" "DIMSCAN" "DIO1" "DKC"
    "DLD1" "DLG-motif" "DNA-DNA" "DNA-RNA" "DNA-binding" "DNA-damage-induced"
    "DNA-damage-responsive" "DNA-protein" "DNAH7" "DNAJC10" "DNAPKi"
    "DNA‐damaging" "DNMT-1between" "DONGQI" "DPL" "DPP3" "DR1044" "DR1120"
    "DR1123" "DR1124" "DR1127" "DR158" "DR189" "DR5-KO" "DR5-mediated" "DR663"
    "DRB5" "DREAM-CDE" "DRIP-qPCR" "DSAPGS" "DSB-3" "DSB-III" "DSB-resection"
    "DSGIS" "DTX" "DZNep" "Dacheva" "Daiichi" "Dapi" "Darby" "Dasso" "Davies"
    "Davis" "Dbb1" "Dbs" "Ddda1" "De-conjugation" "Dead" "Deftereos" "Delahunt"
    "Denk" "Denuc" "DerSimonian–Laird" "Deven" "Dex"
    "Dexmedetomidine-pretreatment" "Dey" "Diacerine" "Dianamt" "Dictostylium"
    "Dictyostelium" "Disch" "Discriminant" "Dnd1" "Dohmen" "Dong" "Doppler"
    "Double-hit" "Double-strand" "Dovizio" "Doyle" "Dravet" "Drozd"
    "DsRed-Rab5-positive" "Dsred-Keap1" "Du" "Duan" "Duchenne" "Duclos"
    "Dufresne" "Dulbecco" "Dulbecco's" "Dunn" "Dunnett" "DupA" "Durand"
    "Durante" "Dutch" "E-FRET" "E-MTAB-2204" "E-MTAB-2701" "E-MTAB-3687"
    "E-MTAB-3695" "E-MTAB-3763" "E-box" "E-boxes" "E-cadherin-like"
    "E-regulated" "E1-like" "E1308X" "E169del" "E1978X" "E1b" "E2-like"
    "E2-ubiqitination" "E2419" "E258K" "E260A" "E2F1-Eco132" "E2F1-His" "E2F3a"
    "E2F3b" "E3-ligase" "E3-like" "E3-ubiquitin" "E3-ubiqutin" "E380A" "E545G"
    "E7" "E7-dependent" "E7449-dose" "E746–A750" "E7directly" "E9-pSPL3" "E9.5"
    "EADC" "EAV" "EAV1" "EAV1-exressiong" "EAV3" "EAp53" "EBNA" "EBNA1itself"
    "EBPε" "EBarrays" "EC109" "EC109-miR-101" "EC50" "EC9706-miR-101"
    "ECM-receptor" "ECOG-PS" "EEA1-containing" "EEs" "EF-24" "EG" "EGA"
    "EGAS00001001302" "EGD" "EGF-Src-β4" "EGF-like" "EGF-r" "EGF-stimulus"
    "EGFP" "EGFP-RhoA" "EGFR-NSCLC" "EGFR-TKIs-naïve" "EGFR-TKIs-resistance"
    "EGFR-TKIs-resistant" "EGFR-Y1045F" "EGFR-Y1045F-mCitrine" "EGFR-mCitrine"
    "EGFR-paGFP" "EGFRT790M" "EGFR‐TKI" "EGR" "EGanimals" "EIIaCre" "EJ-1"
    "EKR1" "ELISAs" "EMG" "EML" "EML4-ALK-driven" "EML4-ALK-induced"
    "EML4-ALK-mediated" "EML4-ALK-rearranged" "EMQA" "EMQA-paclitaxel"
    "EMT-like" "ENSA-PP2AB55" "ENSA-dependent" "EORTC" "ER+" "ER-element"
    "ER-negativity" "ER-positive" "ER-siIGF1R" "ERE-luciferase" "ERK-dependent"
    "ERS" "ERas-treated" "ERα-negative" "ES7" "ES8" "ESC-like" "ESMO"
    "ESRSearch" "ESSRA" "ETF" "ETF-ubiquinone" "ETFs" "ETGE" "ETO-treatment"
    "EU" "EURTAC" "EUS" "EWSC" "EWSCs" "EX243" "EYA-SIX" "EZN3046" "EZN3920"
    "EZN4150" "Eap" "Eble" "Ecb" "EdU-incorporation" "Edu" "Edward" "Efb-C"
    "Efb-N" "Efb-N-interacting" "Efb-N-loaded" "Efb-P-selectin" "Efb-platelet"
    "Egger" "Egger’s" "Egypt" "Ehp" "EiJ" "Eighty-four" "Eisai" "El" "Elecsys"
    "Ell-OE" "Ell3-OE" "Elongin–Cullin–SOCS" "Endothelial-specific" "Engel"
    "English" "EpRE" "EpREs" "EpY" "Epcam" "Epigenome" "Epithelial-mesenchymal"
    "Epithelial-to-mesenchymal" "Epstein-Barr" "ErbB-family" "ErbB-receptors"
    "ErbB3-directed" "Eriksson" "Erker" "Estrogen" "Etoposide" "Eu-Myc-driven"
    "Europe" "European" "Eustermann" "Evans" "Ewing’s" "ExAC" "Exelixis"
    "Eμ-MYC" "E–1G" "F-FDG" "F-SNP" "F-actin" "F1" "F1-F2" "F12" "F191-N197"
    "F1F2" "F1F2F3-SSB" "F2" "F2-F3" "F263A" "F26IIB" "F3-DNA" "F3-F1" "F9"
    "F9-derived" "FAD" "FADH" "FAF2" "FAK-mediated" "FAM212a" "FAM212b"
    "FASTKD5" "FAT10-conjugation" "FBJ" "FBOX5" "FBXW" "FDG-PET" "FERMTs"
    "FEV1" "FEZF1" "FGF2-dependentstimulation" "FGF2R" "FGF2Rα" "FHs" "FIGO"
    "FITC-BSA" "FITC-Dextran" "FITC-Efb" "FITC-fibrinogen" "FL2" "FL3" "FLAG"
    "FLAG-Difopein" "FLAG-LoxP-SNAP" "FLAG-SNAP-tag" "FLAG-SNAP-tagged"
    "FLIM-FRET" "FLIPI" "FLT3-ITD" "FLT3-ITD-D835Y" "FLT3-ITD-dependent"
    "FLT3-ITD-positive" "FLT3-wt" "FLuc-only" "FMCDs" "FNIII" "FO" "FOLFIRI"
    "FOX-like" "FOXC-2" "FOXJ3" "FOXK2-Sso7d" "FOXM1and" "FOXO3a-miR-622" "FP7"
    "FTLD" "FTLD-TDP" "FUCCI" "FUSIP" "FV" "FVB-MMTV-ErbB2" "FXpSXP" "Fa-CI"
    "Facebook" "Fachiroh" "Fahad" "Fahr" "Fahr’s" "Falcone" "Fanpan" "FaraAMP"
    "FaraATP" "Farnesyl-transferase" "Faustino" "Fb" "Fbxl" "Fbxl5-mediated"
    "Fe" "Feldman" "Fenugreek" "Fig.S6C" "Figue" "Figueiredo" "FileMaker"
    "Filho" "Fine-mapping" "Finlay" "Finnin" "Finnish" "Firsanov"
    "First-in-human" "First-line" "Fischer" "Flag" "Flag-Omomyc"
    "Flag-p62T352A" "Flag-tag" "Flag–PIAS4-C335F" "Flag–PIAS4-C335F-expressing"
    "Flag–PIAS4-WT" "Flag–PIAS4-transfected" "Flag–iBox–PAK4cat" "Fluc" "Fm"
    "Fms-like" "FokI" "Folch" "Folkman" "Follow-up" "Forbes" "Forman" "Forrest"
    "Forty-eight" "Forty-five" "Forty-four" "Forty-nine" "Forty-one"
    "Forty-seven" "Forty-three" "Forty-two" "Fos-B" "Fos-L1" "Fos-L2" "Fosl1"
    "Foundation-7" "Four-two" "Fourteen-Three-Three-Peptide" "Foxa" "Fragile–X"
    "Francisco" "French" "Fresno" "Freud" "Freud1" "Frew" "Friedlander"
    "Frumento" "FtH" "Fu" "Fukushima" "Funauchi" "Function" "Fyn" "Fyn-EV"
    "Fyn-SIL" "Förster" "F–S6J" "G-actin" "G-allele" "G-quadruplexes"
    "G-quartet" "G-rich" "G-strand" "G-to-A" "G-trap" "G0" "G007-LK" "G1"
    "G1-S" "G1-arrest" "G1-dependant" "G12C" "G13D" "G13R" "G1–S" "G2-and"
    "G220X" "G2M" "G60–T75" "G6p" "GA" "GABA)–the" "GADD45α" "GADD45β" "GAR"
    "GAS5-plasmid" "GAS7A" "GAS7B" "GAS7C" "GAS9" "GBC" "GBD" "GBR12909"
    "GC-MS" "GCB" "GCD-0941" "GC–MS" "GEF-GTPase" "GEF-mediated" "GEMMs" "GENT"
    "GFP-CEP131-positive" "GFP-CL1" "GFP-E-cadherin-expressing" "GFP-LXRα"
    "GFP-TβRI-ICD" "GFP-cODC" "GFP-lentiviral" "GFPHTT72Q" "GFPu" "GG" "GG+GA"
    "GGCC" "GGTCANNNTGACC3" "GG " "GIST-like" "GIST_11" "GIST_124" "GIST_131"
    "GIST_150" "GIST_174" "GIST_178" "GIST_188" "GK-GKRP" "GK-GKRP-H187Y"
    "GKRP-K5R" "GLE" "GLE2p-binding" "GLISA" "GLOBOCAN" "GM00731" "GOSlim"
    "GP900" "GPIZ" "GPIZ-shDAB2IP" "GPLD1" "GR-CDH1" "GR-null" "GR-siIGF1R"
    "GR1" "GRO-seq" "GSC-like" "GSE12803" "GSE14520" "GSE18842" "GSE19804"
    "GSE2034" "GSE20712" "GSE22058" "GSE24-2" "GSE24.2" "GSE24.2-NLS1.3"
    "GSE24.2-NLS2.3" "GSE24759" "GSE26375" "GSE30285" "GSE31210" "GSE3141"
    "GSE34184" "GSE37745" "GSE37754" "GSE38332" "GSE4-NLS1" "GSE4-NLS1-DA"
    "GSE41313" "GSE50081" "GSE5846" "GSE61967" "GSE8894" "GSEAs" "GSK3-by"
    "GSK3β-S9" "GST-ARE-Luciferase" "GST-LC" "GST-R5BD" "GST-SC" "GST-chimeras"
    "GST-iBox" "GST-pull" "GST–AMPKα1-K118R" "GST–AMPKα1-WT" "GST–AMPKα2"
    "GTAAACA" "GTCCTG" "GTEx" "GTPBP" "GTPBP3-defective" "GTPBP3-substrates"
    "GVGD" "Gac" "Gaedcke" "Gain-of-function" "Gal" "Gal-3C" "GalNAc" "Galardi"
    "Gallen" "Gansu" "Ganzinelli" "Garcia" "Garcinia" "Gb" "Gefiinib" "Geiss"
    "Geiss-Friedlander" "Geltrex" "GeneGo" "GeneOntology" "Geng" "Genome-wide"
    "Genome–phenome" "Genotype-phenotype" "Genotype–phenotype" "Geoffroy"
    "Gerlinger" "German" "Germany" "Gertz" "Gfap" "Ghahramani" "Ghahramani’s"
    "Ghany" "Giemsa" "GigaDB" "Giordano" "Glasgow" "Glaxo" "Gleason" "Gli1"
    "Gln54Lysfs" "GlnArg" "GlnGln" "GlnGln+GlnArg" "Glu-rich" "Glu643del"
    "GlutaMax" "GmbH" "Godinho" "Gomori" "Gonçalves" "Goosecoid" "GppCp"
    "GppNp" "Gpxs" "Grabiner" "Grandis" "Granta" "Granta519" "Grb2"
    "Grb2-p85-TGF-RII" "Greek" "Grosshans" "Grote" "Growth-arrest-specific"
    "Grünwald" "Gsr" "Gu" "Guangdong" "Guangxi" "Guerra" "Gupta" "Gy" "Gő6983"
    "GαS" "Gαs" "Gβ" "G→A" "H&E" "H-L-H" "H-RasY64A" "H-RasY64A·GTPγS"
    "H-RasY64A·GppNp" "H-Ras·GDP" "H-Ras·GTP" "H-Ras·GTPγS" "H-Scores"
    "H-score" "H-scores" "H1" "H1650ER" "H1975" "H1993" "H2AK13"
    "H2AX-pS139-Gly" "H2DIDS" "H3" "H3122CR1" "H3Ac" "H3K18" "H3K18ac" "H3K27"
    "H3K9" "H3K9Ac" "H3R2" "H3R8" "H4" "H4Ac" "H4K20" "H4R3" "H9-hESC-derived"
    "HA-NLS-PKM2" "HA-SUMO3" "HA-tag" "HAHBD" "HAT + " "HA–Strep-Tactin" "HB-2"
    "HBPs" "HBSS" "HBVX" "HBcAg" "HBx-Cherry" "HBx-GFP-stimulated"
    "HBx-Myc-transfected" "HCC1195" "HCC1833" "HCT" "HCT116-DR5KO" "HCT116-KD2"
    "HCT116-KD3" "HCmel" "HCmel10" "HCmel3" "HCmel3-R" "HCmel3-R-2514"
    "HCmel3-R-2515" "HCmel3-R-3037" "HCmel3-Rs" "HD-DH-PH-Cat"
    "HDAC9-positivity" "HDF" "HEC-50" "HELLP" "HEMa" "HEMa-LP" "HER2-negative"
    "HER2-targeting" "HERPUD2" "HFD-induced" "HGF-induced" "HGSCs" "HIAP"
    "HIF-hydroxylase" "HIF-α" "HIF1-α" "HIFα" "HK" "HKC-2" "HK‐2" "HL-7702"
    "HME" "HMG1L10" "HMLE" "HMN" "HMN-176" "HMN-214" "HMR-1275" "HNSCCs"
    "HOIL1L" "HOMA" "HOMA‐IR" "HOMA‐β" "HPF-a" "HPRT" "HPVE6" "HR-HPV"
    "HR-HPV16" "HR-PFS" "HR-machinery-dependent" "HR-prone" "HR=3.981"
    "HRG-β1-HER2" "HRMEC" "HRMECs" "HRasV12" "HSC72" "HSP90α" "HT1080"
    "HT29-KD6" "HT29-lucD6" "HT29-lucD6-COX2" "HT29-lucD6-EV" "HTB-177"
    "HULC-107-mut" "HZ" "Haenszel" "Hahn" "Haider" "Hainan" "Half-life"
    "Haller" "Hampton" "Hanahan" "Hannon" "HapMap" "HaploReg" "Hardy-Weinberg"
    "Hardy–Weinberg" "HeLa204" "Hebei" "Hedgehog-GLI1" "Hedghod" "Heinrich"
    "Helfer" "Helga" "Helgason" "HemECs" "HemSC" "HemSCs" "Henan" "Henley"
    "Henríquez-Hernández" "Hep3B-ERα" "Hep3B-miR-214" "HepG2-shERα" "Hernández"
    "Herrmann" "Hi-Q" "Hickey" "Higgins" "High-grade" "High-level"
    "High-resolution" "Hippo" "Hippo-YAP" "Hippo-dependent" "Hirschey"
    "His-PDK1" "His-Select" "His-p300" "His2240Leufs*4" "His2261Leufs"
    "Hispanic" "Hodgkin" "Hodgkin's" "Hodgkin’s" "Hoechst" "Holm"
    "Holm–Sidak's" "Honda" "Hong" "Hooper" "Houde" "Howitz" "Hsp90α" "Htra2-β1"
    "Hu" "HuH" "HuProt" "Huang" "Hui" "HumanPhospho" "HumanPhospho-kinase"
    "Hunan" "Huntington's" "Husain" "Huxley" "Hydroxyl" "HyperCVAD" "Hébrant"
    "I-IV" "I-PpoI" "I-Sce1" "I-binding" "I157T" "I2" "I272A" "I83-E95" "IAPH"
    "IARC" "IC-50" "IC-NOTCH-GFP" "IC50" "IC50s" "ICGC" "ICI-118,551" "IFVγ"
    "IG20" "IGF1-treatment" "II-1" "II-2" "II-3" "II-4" "II-5" "II-7" "II-B08"
    "II-B08-treated" "II-III" "II-IV" "III-1" "III-2" "III-7" "III-8" "IIIa"
    "IIIc" "IIRC" "IIa" "IIa1" "IIb" "IIb-IIIa" "II–III" "IJJ" "IKBα" "IKF3"
    "IKKs" "IKQ" "IL-1βwere" "IL-36" "IL-36-mediated" "IL-36α" "IL-36β"
    "IL-36γ" "IL-36γsecretion" "IL-6Rα" "IL-6–STAT3–Twist" "IL-6–or" "IL1-β"
    "IL20R" "IL20R2" "IL213" "IL218" "IL22R1" "ILP2" "ILs" "IMRT" "IPASS"
    "IPHA" "IRC" "IRC-083864" "IRES-like" "IRESs" "IRIFs" "ISE" "ISET" "IST-9"
    "IScerette" "ITAF" "ITAF-like" "ITAFs" "ITC" "ITG4A" "ITGA10-11" "ITGA2-4"
    "ITGAVB3" "ITGB1s" "ITGB2s" "IVIS" "IVIS-SPECTRUM" "IVS" "IVS2+1G"
    "IVS3–24" "Ibrahim" "Identifier" "Ig-like" "IgA" "IgG-like" "Igκ" "Ik"
    "Ik-Ba" "Il" "Il-B08" "Iliopoulos" "Illumina" "ImageJ" "ImageStream"
    "Imaris" "ImmuneMap" "In-cell" "In-vitro" "In-vivo" "InDdb1" "Index"
    "Indian" "Indians" "Individual-specific" "Infinium" "Inge" "Ingelheim"
    "Ingham" "InhibitingPLK2" "Inka" "Inka1–GFP" "Inka2" "Inoue" "Int"
    "IntERactome" "Inter-cellular" "Intplex" "Intron1" "Ireton" "Ishida"
    "Isotype-matched" "Iurlo" "IκBKγ" "I–IV" "J-aggregates" "J3" "J3-bound"
    "J9" "JAK-STAT3" "JAK-STAT3-VEGF" "JAK1-2" "JAK1-3" "JEC" "JEKO1"
    "JFH1-infected" "JPN" "JQ1" "JSL1" "JVM-13" "Jagged-1" "Japanese" "Jaspla"
    "Jed4" "Jeghers" "Jeko" "Jeko1" "Jewish" "Ji" "Jiang" "Jiangsu" "Jiangxi"
    "Jie" "Jilin" "Jitschin" "Johannesburg" "Juan" "Judah" "Jukat" "Jung"
    "Justin" "Juvet" "K-RasG12V" "K-RasG12V·GTPγS" "K-Ras·GTPγS" "K-rat"
    "K09E9.4" "K18" "K381A" "K45R" "K54R" "K5Q" "K63-only" "K632S5" "K8" "K9"
    "KAP1-pS824" "KATO3" "KD2" "KD3" "KD6" "KDTs" "KGM" "KIIN" "KIZ"
    "KKEKKKSKK" "KNS-62" "KO-AA" "KO-DD" "KPS" "KRAS-12" "KRAS-G12G12C"
    "KRAS-G13D" "KRAS-LCS" "KRAS-LCS6" "KRAS-mt" "KRKR" "KRasV12" "KT-MT"
    "KT–MT" "KU" "Kai" "Kanai" "Kang" "Kaplan" "Kaplan-Meier" "Kaplan–Meier"
    "Kaposi" "Kaposi's" "Kaposi’s" "Karachaliou" "Karkhanis" "Karnofsky"
    "Kastan" "Katherine" "Katy" "Kaufman" "Kcal" "Kd" "Keap" "Keap1-Cul3E3"
    "Keap1-sulfenic" "Kelch" "Kelch-like" "KeratinoSens" "Keratinosens"
    "Keshava" "Khella" "Ki-67" "Ki67" "Kiel" "Killer" "Kim" "Kimura" "Kinexus"
    "Kip" "Kirsten" "Kit-8" "Kline" "Klinghoffer" "Knauf" "Knock-down"
    "Knocking-down" "Knudsen" "Kolmogorov" "Kolmogorov-Smirnov" "Kong" "Korea"
    "Korean" "Korkaya" "Kossa" "Kostourou" "Koulich" "Kowalsk" "Krahl" "Krebs"
    "Kroeber" "Kronecker" "Kronke" "Kruppel-like" "Kruskal-Wallis"
    "Kruskal-Willis" "Kruskal–Wallis" "Kudlow" "Kulkarni" "Kurek" "Kusabira"
    "Kyoto" "L-Ala-Gln" "L-Gln" "L-Myc" "L-TAG" "L-alanyl-glutamine"
    "L-integrin" "L1" "L2" "L242A" "L261A" "L52R" "L9R" "LAMTOR-2" "LC-3II"
    "LC3-I" "LC3I" "LC3II" "LCLs" "LDL-cholesterol" "LE" "LETL" "LEfSe" "LIGlV"
    "LIM" "LINC00273" "LLL12" "LLT" "LMP1transcription" "LNA-ASO" "LNA-ASOs"
    "LOH" "LOVD" "LPARs" "LPC-Mig" "LPHN2" "LPS" "LR-hTERT" "LREA" "LRT" "LRTs"
    "LS-102" "LSKs" "LSSLPKRLCLV" "LTT" "LUMIER" "LUMinescence-based"
    "LV-miR-26a" "LVLGD" "LXR-null" "LXRKO" "LXRαβ" "LY3023414" "LY5" "LY6161"
    "Labelle" "Labute" "Lac" "LacO" "Lallemand" "Lallemand-Breitenbach"
    "Lamaze" "Laminin" "Lamp1-mCherry" "Lan" "Lancelot" "Lane1-2" "Lang"
    "Langerhans" "Lap" "Lap#12" "Lap#6" "Lap#6-CM" "Latin" "Latino" "Lats1"
    "Lauren" "Le" "Leav" "Lef1" "Lehmann" "Leiden" "Leigh" "Leontieva" "Let-7b"
    "Leu-to-Ile" "Leu132-Cys133-Arg134" "Leu→Leu" "Levene" "Lewy" "Leyden"
    "Lgl" "Lhermitte" "Lhermitte-Duclos" "Li" "Liechty" "LifeTechnologies"
    "Lineweaver" "Lineweaver–Burk" "Litchfield" "Liu" "Liu's" "Live"
    "Llamazares" "LncRNA-GAS5" "Lo" "LoD" "Loewe" "Log-rank" "Lombard" "Lonza"
    "Lou" "Low-level" "LoxP" "LoxP-sites" "Ltd" "Lu" "LuCaP" "LuCaP35"
    "Lubbock" "Luc" "Luc-GFP" "Luc-P1" "Luc-P1-MT" "Luc-P1-WT" "Luis" "Lund"
    "Lux-Lung" "Ly6E" "Lynparza" "Lys-9trimethylation" "Lys120" "Lys54Argfs"
    "Löhr" "M-MSP" "MAD-MB-231" "MAP1S-deficiency-triggered" "MAP1Smediated"
    "MAP1Sregulated" "MAP1Sspecific" "MAPK-T185" "MAPKAP" "MAR" "MAVER1" "MBA"
    "MBA-MB-231" "MBP‐QP" "MCDs" "MCE" "MCE-7" "MCF10a-normal" "MCF7shp53"
    "MCF7vector" "MCL-1expression" "MDA-MB-23" "MDA-MB-231-D3H2LN"
    "MDA-MB-231cells" "MDA-MBN-231cells" "MDA-MD-453" "MDA_MB231" "MDBs" "MDSC"
    "MDSCCs" "MDSCs" "MDV" "MDV-R" "ME1007" "ME4405" "MEAF" "MEAF6-SEPSEC"
    "MED8A" "MEK-ERK" "MELAS" "MEV" "MHD" "MICoA" "MIP-1-α" "MIP-1αand"
    "MIP-DILI" "MK2-dependent" "MK2-mediated" "MKKK" "ML-141" "ML141" "MM15"
    "MM27" "MM54a" "MM65" "MM85" "MMC-treatment" "MMTV-ErbB2" "MMTV-PyMT"
    "MMTV-Wnt1" "MNA" "MNC" "MOIs" "MPM-p3" "MPS" "MQSpTPL" "MREs" "MS"
    "MSC-irrelevant" "MST1–2" "MST2-promoted" "MSigDB" "MTMR8" "MTO1-family"
    "MTS" "MTU1" "MV-4" "MV-4–11" "MVID-like" "MVIH" "MVP1" "MXD" "MYCBNP2"
    "MYO3B" "MZ" "MZ7" "MZB1" "Ma-Mel-102" "Ma-Mel-15" "Ma-Mel-27" "Ma-Mel-48"
    "Ma-Mel-54a" "Ma-Mel-85" "Maarabouni" "Madin" "Madin–Darby" "Malays"
    "Malaysia" "Mallory-Denk" "Mannheim" "Mantel-Cox" "Mantel–Haenszel"
    "Marburg" "Marfany" "Mariani" "Marino" "Marquart" "Marshall" "Masson"
    "Masson's" "Material" "Matic" "Matsuda" "Matsui" "Matsushima"
    "Matsushima-Nishiu" "Mattew" "Maucksch" "Maughan" "Mavers" "Maxi"
    "Maxi-EBV" "May-Grünwald" "May-Grünwald-Giemsa" "McKay" "McKenzie"
    "McLaughlin" "McNamara" "Mecom" "Meff" "Mehenni" "Meier" "Mel-RM" "Merck"
    "Merkel" "Mesenchymal-epithelial" "Meso-Scale-Discovery" "MetaCore"
    "Methods" "Methyl-Met" "Methyl-β-cyclodextrin" "Methylosome" "Mexican"
    "Mi2" "MiR-101" "MiR-103" "MiR-1247-5p" "MiR-18a" "MiR-208b" "MiR-494"
    "MiR-519d" "Michael" "Michigan" "Micocci" "Micro-CT" "MicroRNA-7"
    "Miettinen" "Mig" "Migration" "Migtrigel" "Milano" "Millipore" "Milne"
    "Minamide" "Minneapolis" "Minsky" "Mitelman" "MitoTracker" "Mitsutake" "Mn"
    "MnmG" "Moch" "Momelotinub" "Mongiardi" "Monig" "Moniot" "Monocyte-derived"
    "Monte" "Morfouace" "Morgillo" "Morris" "Morrison" "Morvaridi" "Mourtada"
    "Mourtada-Maarabouni" "Moyal" "Msp" "Mukhopadhyay" "Munc18-2–dependent"
    "Munc18-like" "Murai" "Muranen" "Mutationtaster2" "Mutect" "MuvB" "Mx1Cre"
    "MxCre" "Myb-MuvB" "Myc-POT1ΔOB" "MycER" "Myo5B-GTD" "Myo5B-LC" "Myr-Akt"
    "Mø" "MβCD" "M–O" "N-LMP1" "N-RAS-G12V" "N-SH2" "N-acetyl"
    "N-acetylgalactosamine-specific" "N-acetylglucosaminyl-transferases"
    "N-domain" "N-glycosylated" "N-labeled" "N-lobe" "N-lobes" "N-stage" "N0"
    "N1+N2" "N375" "N400" "N9" "NALM" "NALM-19" "NB-4" "NCBI" "NCI-60"
    "NCI-H1819" "NCI-H1915" "NCI-H660" "NCT01858168" "NEHJ" "NEMO–pIKK-β"
    "NEPCs" "NEXT-2" "NF-κB-inflammatory" "NF-κB1" "NF1-associated" "NFE"
    "NFKB" "NFκB-CXCR4" "NGR-A2" "NK-κB" "NKT-cells" "NKT-like" "NKTCL" "NLRC"
    "NLRC5-D3" "NLS2" "NMS-P937" "NM_004322.3" "NM_00525.3" "NNPredict"
    "NOD-SCID" "NOD-like" "NOTCH" "NPOS" "NQO" "NRF2-triggerd" "NSAFs"
    "NSC-95397" "NSCLS" "NSLCL" "NSa1" "NSa5" "NT-proBNP" "NV012" "NVP"
    "NVP-AUY922-AG" "NVP-BGJ398" "NXRN" "NXRN1" "NXRN3" "Na-treated" "Nagel"
    "Najafi" "Najafi-Shoushtari" "Nanda" "NanoLuc" "Napper" "Naprosyn" "Nathoo"
    "Natio" "Nebraska" "Neh" "Neh3–5" "Neh4" "Neh5" "Neh6" "Neh7" "Nelson"
    "Nerviano" "Netherlands" "Neu" "Neural-Wiskott" "NeuronJ" "Neve"
    "Next-Generation" "Next-Generation-Sequencing" "Next-generation" "Nguyen"
    "Nhe4–5" "Nippon" "Nishiu" "Nissl" "Nkx2" "Nonaka" "Noonan" "North-Central"
    "Norton" "Norton-Simon" "Notch" "Notch-mediated" "Notch-overexpressing"
    "Nrf" "Nrf2-100" "Nrf2-100-FLuc2" "Nrf2-100-Fluc" "Nrf2-100-Fluc2"
    "Nrf2-100-Luc2" "Nrf2-100-Luciferase" "Nrf2-ARE" "Nrf2-FLuc2"
    "Nrf2-activator" "Nrf2-activators" "Nrf2-regulatory" "Nrf2-response"
    "Nrf2–ARE" "Nu" "NuRD" "Nueva" "Nultin-3a" "Nutullin-3" "Nε" "O-linked"
    "O3" "OARSI" "OA + " "OC" "OCI-AML5" "OCI-LY18" "OD490" "ODNs" "OECD" "OFC"
    "OGTT" "OH" "OHTAM" "OKD" "OKD48-Luc" "OL" "OLAR5" "OLT-AKI" "OMIM" "ONNO"
    "OP449" "OPB-31121" "OPCs" "OPHN" "OPSCC" "OR=1.20" "OR=1.21" "OR=1.26"
    "ORR" "ORs" "OVCA533" "OX" "OX-refractory" "Obispo" "Obmolova" "Octamer-4"
    "Oerlemans" "Offterdinger" "Ogino" "Oligo1" "Oligo3" "OmniExpressExome"
    "OmniExpressExome-8v1" "On-TARGETplus" "OncoMine" "One-third" "Oorschot"
    "Oren" "Origene" "Osanto" "Oshiro" "OspE" "Outeiro" "Ouyang" "Overhauser"
    "Ozcan" "Oε2" "P1" "P2" "P26–114,113" "P28–12,591" "P53" "P6" "P7"
    "P943_946" "P9–13" "PA-JEB" "PAIL" "PAK4-like" "PAK4-null" "PAK4r" "PAK4–6"
    "PAK5cat" "PAKcat" "PALB-2" "PAM50" "PANTHER" "PAQR8" "PARP-DNA" "PARP1-4"
    "PARP1-DNA" "PARP5a" "PARP9" "PARPi" "PARsylate" "PBD-phosphopeptide"
    "PBIP1-p-T78" "PCC" "PCCs" "PCDHGA11" "PCR-RFLP" "PCR-Sanger" "PD20" "PDBj"
    "PDGF-Rα" "PDGFRα-mutant" "PDSCCs" "PEB" "PEC" "PEST" "PESX" "PET-CT"
    "PF-03758309" "PF-04691502" "PF-0477736" "PFBC-like" "PFBs" "PFGC" "PFK"
    "PFT-α" "PG-pathway" "PGDF-B" "PGE2-mediated" "PGL" "PHA" "PHA-680626"
    "PHA666762" "PHLPP–S" "PHT-427" "PI-3-phosphate" "PI3K-AKT1" "PI3K-CA"
    "PI3K-like" "PI3KC2G" "PI3KCA" "PI3P" "PI45P2" "PICRUSt" "PIK3CA-E545G"
    "PIK3CA-E545K" "PIK3KCA" "PIKKs" "PKAc" "PKCS" "PKCɛ" "PKCβII" "PKCη"
    "PKD-S744" "PKD-S916" "PKD1-S744" "PKD1-S916" "PKH67" "PKIγ" "PKM1"
    "PKM2-NLS" "PKM2-NLS-mutant" "PLHS" "PLHS-Pmab" "PLHSpT" "PLHSpT-Pmab"
    "PLINK" "PLK-1to" "PLK-1with" "PLK-5" "PLK1-R136G&T210D"
    "PLK1-R136G-overexpressing" "PLK2‐dependent" "PLK‐binding" "PLV" "PNAS"
    "POF1B" "POOLA" "POTΔOB" "PP2AA" "PP2AB" "PP2AB55α" "PP2AB56" "PP2AC"
    "PPXY" "PR-negative" "PRCC-009" "PRMT5-MEP50-containing"
    "PRMT5-Methylosome" "PRMTs" "PROVEAN" "PSCC" "PT1B" "PTB-1B" "PTCLnos"
    "PTD-A2" "PTD-A2–injected" "PTD-A2–treated" "PTEN-deficiency-induced"
    "PTEN-loss-induced" "PTEN-null" "PTEN-proficient" "PTMC" "PTMCs" "PTP2B"
    "PTTG-shRNA1" "PTTG-shRNA2" "PV-treatment" "PaC" "PaTu899S" "PacBio"
    "PacMetUT1" "Pailler" "Pan-CDK" "Pan-Cancer" "Parkinson" "Parkinsonism"
    "Parkinson’s" "Partition-defective" "Paso" "Pasquinelli" "PatternCNV"
    "Pax7nGFP" "Peak-like" "Pearson" "Pearson's" "Pemphigoid" "Penicillium"
    "PeproTech" "Peptidimer-c" "Peptoniphilus" "Perou" "Petillo" "Peutz"
    "Pfizer" "Pfizer's" "PgR-showed" "Pgd" "Ph" "Ph-treatment" "Pharma"
    "PhastCons" "Philadelphia" "Philipsen" "PhosphoNet" "PhosphoS"
    "PhosphoSite" "PhosphoT" "Phosphoinositide-3" "Pias1–4" "Pillai" "Plessl"
    "Pluripotency-associated" "Pmab" "Poisson" "PolII" "Polimeno" "Polo-box"
    "Poloboxtide" "Poloxipan" "Polo‐like" "Polska" "Poly-L-Ornithine"
    "PolyPhen2" "Polymerase1" "Polyphen2" "Post-activation" "Post-mortem"
    "Post-transcriptional" "Post-translationally" "PottersWheel" "Poulsen" "Pp"
    "Prabhu" "Praefcke" "Prasad" "Prestwick" "PrimePCR" "Principal-Component"
    "Pro-inflammation" "Pro-inflammatory" "Pro-to-Gly" "ProA-FLAG-tag" "ProSAP"
    "Proline-Rich" "Promega" "Propionium" "Protein-RNA" "ProteinPilot"
    "Protodioscin" "Prusac" "Pseudo-hypoxic" "Puerto" "Pugh" "Pull-down"
    "Puma-knockout" "Purdue" "Puthier" "PvuII" "PyMT" "PyroMark" "Q-FISH"
    "Q220X" "Q382A" "Q546L" "Q61R" "QD" "QGY-7703-miR-214" "Qiagen" "Qian"
    "QuickChange" "R&D" "R-4" "R-CHOP" "R-Hyper" "R-MA" "R-based"
    "R-enantiomer" "R-enantiomer-selective" "R-enantiomers" "R-etodolac"
    "R-forms" "R-ketorolac" "R-loop" "R-loops" "R-naproxen" "R172H" "R175H"
    "R1905" "R1–R4" "R23X" "R248Q" "R251X" "R273H" "R299Q" "R3" "R385A" "R579X"
    "R653-Q855" "R=0.599" "RANK-ligand" "RAS-association" "RASSF1-1α" "RASSF1C"
    "RASSIF1A" "RASSSF1A" "RB-like" "RB05" "RB45" "RBVI" "RE-biogenesis"
    "RE-dissociation" "RFLP" "RFP-CAAX" "RFPcassette" "RFTN1" "RFs" "RGLs"
    "RH-SENP3" "RHIM" "RHT1" "RHT2" "RHZ" "RIG-I–like" "RII" "RIII" "RIKEN"
    "RIPchip" "RIPseq" "RJ" "RMS-1" "RNA" "RNA-130a" "RNA-ChIP" "RNA-DNA"
    "RNA-PolII" "RNA-like" "RNA-protein" "RNA-protein-protein" "RNA22"
    "RNAhybrid" "RNAi-HIF-1α" "RNAseq" "RNU48" "RNaseP" "RO3280"
    "ROCK-regulatory" "ROP" "RPI-Pred" "RPI-prediction" "RPISeq" "RPISeq-RF"
    "RPISeq-SMV" "RPISeq-SVM" "RPKM" "RPKPLVDP" "RPMI-1640" "RPRR" "RPRR-X"
    "RPRRX" "RPRRX-S" "RPTP" "RPTPA" "RPTPJ" "RRGA" "RRSO" "RRx" "RRx-001"
    "RSK1–4" "RSRQ" "RSRQPlvl" "RSXpSXP" "RTA-408" "RTOG" "RUNX" "RUNX1T1"
    "RVVFLEPLKD" "RXXpS" "RXY" "RYAAAYA" "Rab11" "Rab40" "Rab5" "Rab5-CA"
    "Rab5-DN" "Rab5-GTP" "Rab5-mCherry-positive" "Rab5S34N" "Rab8" "RacGAP"
    "Rad3" "Rad9p" "Radix" "Raf-1" "Raf1-driven" "Raheja" "Rajal" "Rakha"
    "Ramachandran" "Ramona" "RanBP" "Rap-plus-Spa" "Ras-Sos" "Ras-homologous"
    "Ras-like" "RasB8" "RasB8p0" "RasB8p3" "RasY64A" "RasY64A·GTPγS" "Ras·GDP"
    "Ras·GTP" "Ras·GTPγS" "Rayner" "Rb" "Rb-null" "Rbx1-Cullin1-Skp1-F-box"
    "Rbx1-mediated" "Re-analysis" "Re-evaluation" "Re-expression" "Re-growth"
    "Re-introduction" "ReNcell" "Real‐time" "Reduction-oxidation" "Redux"
    "Rela" "Renilla" "Renmin" "Ret" "Rett" "Reverse-phase" "Reverter"
    "Re‐biopsy" "Re‐examination" "Rhex-1" "Rho-family" "RhoG" "RhoUr" "RhoV"
    "Ribo-seq" "Rican" "Ricarte-Filho" "Richmond" "Rico" "Rieger" "Riesenberg"
    "Ringner" "Ripley" "Roadmap" "Roche" "Rockefeller" "Ronen" "Roseomonas"
    "Rossmann" "Rossmann-fold" "Roux" "Ruan" "Ruegger" "Rumpf" "Russia"
    "RxRxxS" "Rxrα" "RxxS" "S-H" "S-HDF" "S-enantiomer" "S-enantiomers"
    "S-forms" "S-ibuprofen" "S-ketorolac" "S-methionine" "S-naproxen"
    "S-phase-expressed1" "S-transferases" "S1" "S127" "S12A" "S12C" "S12E"
    "S12F" "S143A" "S143D" "S143E" "S1C" "S1D" "S1E" "S1G" "S1H" "S202" "S204"
    "S21" "S235" "S2A–C" "S2C" "S2D" "S2E" "S2F" "S2G" "S2a" "S2a–c" "S2b" "S3"
    "S3-B" "S307D" "S317" "S345" "S363" "S386A" "S3C" "S3E" "S4-B" "S432"
    "S432A" "S432D" "S432E" "S473" "S47A" "S47E" "S48A" "S4A" "S4B" "S4D" "S4E"
    "S5A" "S5C" "S5E" "S5G" "S5H" "S6" "S6A" "S6C" "S6G" "S7" "S744" "S78A"
    "S78E" "S7A–C" "S7D" "S7E" "S8" "S8-A" "S8-B" "S8-C" "S8A" "S8B" "S8C"
    "S8b" "S9" "S9A" "S9d" "SA-β-Gal" "SA-β-Gal-positive" "SA-β-gal" "SAR405"
    "SAβGal" "SB3" "SBE13" "SCF-like" "SCF-βTrCP-dependent" "SCG2" "SCIN"
    "SCPC" "SCS" "SCV000255937" "SCV000255938" "SCV000255939" "SCV000255940"
    "SCV000255941" "SCaBER" "SCr" "SDH-intact" "SDHA-D" "SDHX" "SDK2" "SDX"
    "SDX-301" "SDX-308" "SDs" "SENP" "SENPs" "SEPSEC" "SET-FUCRW" "SET-PEB-1"
    "SET-RW" "SET-immunoprecipitant" "SFRS15" "SFTB" "SGGKKATQApSQEY" "SGKs"
    "SHANK" "SHH-medulloblastoma" "SIFT" "SILEC10" "SIM" "SIMs" "SIRTs" "SITS"
    "SK-Mel-37" "SKP1-Cullin-Fbox-βTrCP" "SL13" "SLC16A14" "SLFN" "SLFN11"
    "SLFNs" "SLPGAGLSpSQELSGG" "SM" "SMV" "SMiNS-like" "SMiNSc-like" "SN12PM6"
    "SNAKA" "SNAKA-51" "SNAP-tag" "SNF2-family" "SNORD12" "SNORD12b" "SNORD12c"
    "SNPase-ARMS" "SNPbrowser" "SNPs" "SNU" "SNU-2535" "SNV" "SNVs" "SNX-7018"
    "SNX-7081" "SNX-7081+2-FaraA" "SNX-7081-induced" "SNX-7081-mediated"
    "SNX-7081-treated" "SOFA" "SOX" "SOX2-MYC-directly" "SPIN4" "SPSS" "SQSTM"
    "SR" "SRE2" "SREBP-mediated" "SRPKs" "SRSF" "SSBR" "SSPNN" "SSX2IP" "SSXS"
    "ST-HSC" "STA-7346" "STA7346" "STAT3-mediated" "STAT3-null" "STAT3WT"
    "STGE" "STIL" "STIMA-1" "STRBP" "STS-2" "STUbL" "STUbLs" "SU3-5R" "SU3-RFP"
    "SUPB" "SUPB-15" "SV40-miR-S1-5p" "SV40Tag" "SVEC4-10" "SVM" "SW-1353"
    "SW-1990" "SW-620" "SW-837" "SW480-D2" "SW480-D2-scram" "SW480-D2-scramble"
    "SW480-D2-si-IκB" "SW480-D2-si-IκB-α" "SW480-D4" "SW480-con"
    "SW480-con-scramble" "SW480ADH" "SWE" "SYF-c-Src-TrkB" "SYF-cSrc-TrkB"
    "SYTO" "SYTOX" "Safranin-O" "Saharan" "Sahiwals" "Saitama" "Salvesen"
    "Sampson" "Samuels" "Sanchez" "Sanchez-Contreras" "Sanchez-Tillo" "Sanger"
    "Sarcomatoid" "Sarit" "Sato" "Saudi" "Saudis" "Sayin" "Sbi" "Scansite"
    "Schafer" "Schekman" "Schemies" "Schiff" "Schimmel" "Schizosaccharomyces"
    "Schlafen" "Schlieffen" "Schmick" "Schmid" "Schnerch" "Schwann" "ScrTAT"
    "Sean" "Sec1" "Seckel" "Sedelnikova" "Self-renewal" "Seligson" "Sellheyer"
    "Semi-quantification" "Sequence-specific" "Ser-4" "Ser127YAP1" "Ser1981"
    "Ser21" "Ser235" "Ser307" "Ser398Profs" "Ser432-specific" "Ser474"
    "Ser518Leufs" "Ser518Leufs*32" "Serenex" "SerpinB3a" "Serpinb3a" "Serpine"
    "Serrano" "Sertoli" "Setoodeh" "Seventy-seven" "Shanxi" "Sharpin" "Shaw"
    "Shea" "Shen" "Shinyaku" "Shoushtari" "Shp1" "Shrm" "Shroom" "Shuji"
    "SiNS-like" "SiNSc-like" "Sichuan" "Sigismund" "Silybum" "Simpson"
    "Single-Strand" "Single-cell" "Single-nucleotide" "Sip2" "SirReal2"
    "Sirius" "Sironi" "Sirt" "Sirt-6" "Sirt1–indole" "Sirt2" "Sirt2–ADPR"
    "Sirt2–ADPR–CHIC35" "Sirt2–ADPR–EX243" "Sirt2–ADPR–indole" "Sirt2–Real2"
    "Sirt3–ADPR–EX243" "Sirt3–indole" "Sixty-six" "Sixty-two" "Skp1-Cullin1-F"
    "Skp1-Cullin1-Rbx1-F" "Skrzypczak" "Sloan" "Slovak" "Slp4a–Stx3" "Slpa4"
    "Smad" "Smads" "Smirnov" "Smuc" "Snap23a" "Sofi" "Solomon" "Songyang"
    "Sorlie" "Southmead" "SpD" "SpT" "Spain" "Spanish" "Spearman" "Spengler"
    "Squalene" "Src" "Src-PY418" "Src-dependent" "Src-family" "Src-mediated"
    "Src-signaling" "Sriramachandran" "Starke" "StemPro" "Stoddard" "Storz"
    "Strain-specific" "Stratakis" "Strep" "Strep-Tactin" "Structure-based"
    "Studentship" "Stura" "Sub-G1" "SubG1" "Suberbielle" "Sudol"
    "Super-resolution" "Suspitsin" "Sv" "Sweden" "Swiss" "Switch" "Switzerland"
    "Syc" "SykPTK" "Syns" "Szczepankiewicz" "Szczurek" "Süssmuth" "T+C" "T-77C"
    "T-AOC" "T-LGL" "T-PLL" "T-allele" "T-cell" "T-circle" "T-circles"
    "T-helper" "T-lymphoid" "T-precursor-stage" "T-stage" "T0" "T1" "T1989"
    "T2" "T202" "T210-loop" "T2D" "T2DM" "T2N0M0" "T2weightd" "T3" "T306"
    "T306D" "T359" "T3–T4" "T4" "T4A" "TA-RRBS" "TAAACA" "TAK-960"
    "TAK-960-mediated" "TAK-960-treated" "TAK1-TAB1" "TALEN" "TALINs" "TAOS1"
    "TARGETplus" "TAT-A2" "TAT-peptide" "TAp73S" "TAp73‐KD" "TAp73‐dependent"
    "TBC1D30" "TBX-YAP" "TCAAGGTCA3" "TD19" "TDZD" "TEADs" "TG-BRAFV600E"
    "TGACnnnGC" "TGCA" "TGE" "TGF-R" "TGF-RI" "TGF-RII" "TGF-RIII" "TGFb"
    "TGFβ3" "THO" "TIRF" "TK-10" "TK10" "TKD" "TKM" "TKM-080301" "TL" "TL-118"
    "TMA-1005" "TMEM51" "TMPO" "TMR-Dextran" "TMR-dextran" "TMRM" "TNBCs"
    "TNF-1α" "TNF-β" "TOP-like" "TOP2A-expressor" "TOPflash" "TORCH"
    "TORopathies" "TP53p" "TPA-induced" "TPF" "TPF-regents" "TRA-1-81"
    "TRAF2-mediated" "TRAMPC" "TRAMPC2-RANKL" "TRANSFAC" "TRAP-C1" "TRF-1"
    "TRIM66" "TRIM67" "TRIM7" "TRIM70" "TRIM76" "TROSY" "TRUB" "TSCCs" "TSVC"
    "TTAGGG" "TVC" "TWIST1" "TWN" "TXNRD3" "Tactin" "Tai" "Taihang" "Taipale"
    "Taiwan" "Talalay" "Tango6" "Taqman" "TargetScanHuman" "Targetscan"
    "Tasigna" "Tatham" "Taxon" "Tc1-associated" "Tcf" "Tekmira"
    "Temporal-spatial" "Teng" "Tesaro" "Tet-Off" "Tet-On" "Tet-off" "Tetraodon"
    "Texas" "Th17" "Th2" "Th2-cyotkine" "Th2-effector" "ThPOK" "Thailand"
    "Theileria" "Therad3" "Thirty-eight" "Thirty-five" "Thirty-six" "Thomas"
    "Thompson" "Thr-kinase" "Thr14" "Thr306" "Thr308" "Thr37" "Thr4" "Tibialis"
    "Tillo" "Tilson" "Tilve" "Time-lapse" "Timofeeva" "Tiwari" "Tm"
    "ToleratedDose" "Toll-like" "Tollenaere" "Topo-1" "Toulouse" "ToxCast"
    "Tra-1-60" "Tra-1-81" "Trans-Lentiviral" "Treg-like" "Trevigen" "Tricin"
    "Trigonella" "Triple-knockout" "Triple-negative" "TrkB-shRNAs" "Trp53"
    "TrpArg" "TrpArg+ArgArg" "TrpTrp" "TrpTrp+TrpArg" "Truebestein"
    "TrxR1-null" "Tuj1" "Tukey" "Tumor-suppressive" "Tunisia" "Turato"
    "TurboGFP" "Turkish" "Tweenty-one" "Twenty-five" "Twenty-four"
    "Twenty-nine" "Twenty-seven" "Twenty-six" "Twenty-three" "Tyr1007" "Tyr15"
    "TβRI-ICD" "TβRI-ICD-APPL" "TβRI-ICD-induced" "U-2973" "U-MSP" "U-rich"
    "U-type" "U0216" "U118" "U133" "U2" "U251" "U2AF2-bound" "U2AF2-centered"
    "U2AF2-dependent" "U2AF2-interactome" "U2AF2s" "U2OS-3xFLAG-FOXJ3"
    "U2OS-3xFLAG-FOXO3" "U2OS-FOXK2-HF" "U87-viii" "UCL" "UCSC" "UCSF"
    "UDP-glucuronosyl" "UFB" "UFBs" "UGAA" "UGSM" "UICC" "ULK" "ULM" "UMSCC23"
    "UO31" "UPCI" "UPPs" "UPSs" "URL" "URRs" "US" "USA" "USP35" "UTRs"
    "UUAUUUA" "UUAUUUAUU" "UVA" "Ub-AMC" "Ub-K63R" "Ub-aldehyde" "Ubal" "UfSP1"
    "Ufm1" "Ukraine" "Ulrich" "Ultraviolet-induced" "UniFrac" "Urso" "Uzunova"
    "V-shape" "V-shaped" "V12Ras" "V2-V3" "V2.0" "V240A" "V341fs" "V5-tagged"
    "VAPAHCS" "VCA" "VE821" "VEGF-1" "VIB-VIII" "VIL1" "VNN2" "VP16-LXR-alpha"
    "Val-to-Cys" "Val1951" "Valencia" "Vaquero" "VarScan" "Vara" "VarioWatch"
    "Vasireddy" "Vav1Cre" "VavCre" "Vazquez-Martin" "Vb" "Vectibix"
    "Vehicle-treated" "Venn" "Vgll4" "Vida" "Vieira" "Vij" "Vipera" "Vivanco"
    "Vogelstein" "Volinia" "Vps9" "Vs" "W3" "WAR" "WBC" "WBCs" "WDSCCs"
    "WGR-CAT" "WGS" "WHI" "WHI-P154" "WHIP" "WHIP-154" "WI" "WMM" "WP"
    "WP-1066" "WRNIP" "WST-1" "WT-MEFs" "Waby" "Wach" "Wahlberg" "Wald"
    "Walkersville" "Wallis" "Waltham" "Warburg" "Warburg's" "Weibull"
    "Weichert" "Weil" "Weinberg" "Weissella" "Wellcome" "Weng" "Westerberg"
    "Whitney" "Whole-exome" "Wilcoxon" "Willis" "Wilmott" "Wilson" "Wiskott"
    "Wnt-C59-treated" "Wnt1" "Wolff" "Written" "Wu" "X-axes" "X-axis"
    "X-irradiation" "X-positive" "X-ray" "X-rays" "XC" "XC-302" "XDC-1787-C"
    "XI" "XPR1" "XRab40" "XT" "XTT" "Xa" "XbaI" "Xeno-transplantation" "Xhosa"
    "Xinchang" "Xouri" "Xq12" "Xu" "Xx" "Y-intercept" "Y1068F"
    "Y1086F-mCitrine" "Y1203fs" "Y204" "Y32–Y40" "Y357YAP1" "YAP1-dependent"
    "YB-1–and" "YES" "YP" "YU" "Yamagata" "Yamanaka" "Yamao" "Yang" "Yao" "Yat"
    "Yat-sen" "Yeh" "Yes" "Yes-associated" "Yi" "Yoon" "York" "Young-Ok"
    "Youssef" "Yrich" "Yudushkin" "Z-stacking" "Z-stacks" "ZC3H7A" "ZD"
    "ZD-1839" "ZFAND5" "ZFAS1-miRNA" "ZFNs" "ZFP36L3" "ZNF592" "ZPFM1" "ZPFM2"
    "ZR75.1" "ZZ" "Zeitlin" "Zellweger" "Zeneca" "Zhang" "Zhao" "Zhejiang"
    "Zheng" "Zhou" "Zhu" "Zn" "Zn-FokI" "Zn-finger" "ZnF1" "a2A" "aK" "aTA"
    "aa181–310" "aa1–200" "aa201–437" "aa36-345" "aberrancies"
    "above-discussed" "abscissa" "abscissa-intercept" "absorbance"
    "acetyl-mimic" "acetylcholine" "acetyltransferase-deacetylase"
    "acid-induced" "acid-susceptible" "acid–Schiff" "acinar-to-ductal"
    "acro-renal-ocular" "acrospiromas" "acryloylamino" "activator-like"
    "activators" "active-site" "activityof" "acyl" "acyl-carnitine"
    "acyl-lysine" "adduct" "adduct-repair" "adducts" "adenine-to-cytosine"
    "adeno" "adenocarcimomas" "adenoid" "adenomas" "adenosyl" "adenylyl"
    "adolapin" "adult-onset" "advanced-stage" "aeruginosa" "agar"
    "age-of-initial" "age-of-onset" "age-related" "agomir" "agomirs" "agonism"
    "agonists" "algorithm" "algorithms" "alia" "alignScore" "alkyl"
    "alkylimidate" "allDdb1" "allele-specifically" "alleles" "allograft"
    "allostery" "alpha-helical" "alternative-spliced" "amino-acid"
    "amino-terminal" "amino-terminus" "aminoacids" "aminophosphonate"
    "amplicon" "amplicons" "analyser" "analysis–transposition" "andATMIN"
    "andBRAF" "andGli1" "andMDM2" "andPTB" "andand" "andnPTB"
    "androgen-deprivation" "aneuploidy" "angio" "angio-kinase" "angiocrine"
    "angiogenesis-associated" "angiography" "anions" "anisotropy" "anlage"
    "annulata" "anoikis-like" "anoikis-sensitivity" "anokis" "anorexia"
    "anorexia-cachexia" "antagomir" "antagomirs" "anterograde" "anthraquinone"
    "anticodon" "anticodons" "antigen" "antigens" "antioxidant-chemotherapy"
    "antiplatelet" "antiprogestogens" "antiubiquitin" "anti‐cancer"
    "anti‐hyperglycaemic" "anti‐tumourigenic" "antrum" "anxiety-like" "apamin"
    "apical-basal" "apico" "apico-basal" "apicomplexan" "aplasia" "apocrine"
    "apoptosis-like" "apoptotic-like" "apoptotic-related" "appropriateness"
    "arginine-rich" "argonauta" "arisen" "arrest-specific" "arsenic-mediated"
    "artic" "asaccharolyticus" "aspartatecarbamoyltransferase-dihydroorotase"
    "astel1" "asynchronously-growing" "atPD" "atenolol" "ation" "atipamezole"
    "atomic-force" "attenuats" "aureus" "auto-PARylation" "auto-activate"
    "auto-activates" "auto-activating" "auto-activation" "auto-correlation"
    "autophagy-intact" "autophagy-lysosome" "autoradiography" "autoreceptors"
    "autosomal-dominant" "autosomal-recessive" "axial" "axilla" "axon" "a–S4c"
    "a–c" "a–d" "a–e" "b-actin" "back-and-forth" "back-calculated" "basal-like"
    "basal-luminal" "basal-type" "basaloid" "base-call" "base-extension"
    "base-pair" "base-pairs" "base-specificity" "bealwayslower" "beamline"
    "beforePD" "begun" "benzo" "benzoquinoneimine" "benzthiazole-N-oxide"
    "benzyl" "between-study" "bi" "bi-allelic" "bi-functional" "biase"
    "biliverdin" "bio-availability" "bioactivities" "biocomplexes" "biofluids"
    "biofunctions" "bioinformatics-based" "biomakers" "biomarker-studies"
    "biomass" "biomolecules" "biosource" "biosources" "biostat" "biotin"
    "biotin-GA" "biotin-miR-346" "biotinylated-ganetespib"
    "biotinylated-geldanamycin" "biphosphate" "birth-and-death" "birthdate"
    "bisphosphate" "blast-like" "blockade-mediated" "blocker" "blockers"
    "blood-based" "blood-brain" "blood-brain-barrier" "blood-derived"
    "blood–brain" "blue-dead" "bodyweight" "bonafide" "bootstrap" "bottom-up"
    "box-containing" "box1" "brachytherapy" "bradycardia" "brake-point"
    "branched-chain" "break-apart" "break-induced" "breakage-fusion-bridge"
    "breakpoint" "breakpoints" "bresat" "broader" "browser" "btween"
    "bucladesine" "butane-2,3-diol" "bvFTD" "by-product" "by-products" "by100"
    "c-Cbl-binding-impaired" "c-MycER" "c-Src-JAK2" "c-Src-deficient"
    "c-Src-induced" "c-Src-mediated" "c-Src-shRNA" "c-Src-shRNAs" "c-neu"
    "c397het_delG" "cATP" "cNO" "cODC" "cPARP" "cadaverine" "cadaverine-Alexa"
    "calcification-prone" "calcium-phosphate" "caliper" "callosum"
    "calorimetry" "calvaria" "cancer-relevant" "candidate-gene" "cap-dependent"
    "cap-independent" "cap-n-collar" "capase-3" "capase-8" "capillary-like"
    "capsid" "carbamoyl-phosphate" "carbonyl" "carbonyls" "carboxyl"
    "carboxylesterases" "carboxymethyluridine" "carcinogenesisi"
    "cardiomyopathies" "cargo-selective" "cargos" "carnitine" "carotid"
    "carriers" "carryingEGFRL858R" "cartilage–bone" "case-by-case"
    "case-control" "case-only" "case–control" "caspas-3" "caspase-3-like"
    "caspase-8-null" "cassette-insertion" "castration-induced"
    "castration-sensitive" "cas­pase" "catalyse" "cateninaxis" "caveloae"
    "caveolae-dependent" "caveolin-mediated" "cavum" "ccRCC" "ccRCCs" "ceRNAs"
    "cell-autonomous" "cell-intrinsic" "cell-of-origin" "cell-of-origins"
    "cell-permeable" "cell-permeable3" "cell-to-cell" "cellcycle" "celllines"
    "cells" "cellular-binding" "cellulo" "cell‐type" "centiles" "centresome"
    "centriole" "centromere" "cerebellar-specific" "cerebellum" "cerevisiae"
    "cftDNA" "chairperson" "changess" "chaperone-like" "chem" "chemo"
    "chemo-preventive" "chemo-radio" "chemo-radio-sensitive"
    "chemo-radio-sensitize" "chemo-radiotherapy" "chemo-reagent"
    "chemo-reagents" "chemo-repellent" "chemo-sensitivities"
    "chemo-sensitivity" "chemo-therapy" "chemoattractant" "chemoimmunotherapy"
    "chemoradiotherapy" "chemoresistance" "chemoresistant"
    "chemotherapy-resistance" "chemotypes" "chi-square" "chi-squared"
    "child-parent" "chimericDdb1" "chlorophenylhydrazone"
    "cholangiopancreatography" "cholangiopathies" "cholangiopathy"
    "cholestasis-associated" "cholesterol-containing" "cholesterol-depleting"
    "cholesterol-rich" "chondroid" "choroid" "chosen" "chr12p" "chr4" "chr9"
    "chromatid" "chromatids" "chromatin-remodeling" "chromatograms"
    "chromosomally-inserted" "chromosome-microtubule" "chromosome-positive"
    "chromosome14q" "cibaria" "cicloheximide" "cinnamaldeyde" "cinnamate"
    "circuitry" "cis-element" "cis-regulatory" "cisplatin-gemcitabine"
    "cisplatin-resistance-related" "cisplatin‐dependent" "cisplatin‐treated"
    "cistrome" "clade" "classifier" "classifiers" "clear-cell" "clear-evidence"
    "clearer" "clearers" "clearest" "clinic-pathological" "clinicaltrials"
    "clinical–pathological" "clinicians" "clinico" "clinico-pathological"
    "coactivator-1" "coactivator-1α" "coagulase-like" "cobas"
    "cobblestone-like" "coculture" "codeis" "codon" "codon-12" "codon-13"
    "codon-anticodon" "codons" "cofounders" "coiled-coil" "coiled-coils"
    "cold-shock" "coli" "collagen-II" "collagens" "colleagn" "colonosphere"
    "colony-formation" "colony-forming" "color-coded" "comedo-like"
    "commonalities" "commonest" "complex-2" "compounds-induced"
    "computation-based" "conc" "concentration-dependently" "condictions"
    "conditional-null" "condons" "congenita" "contact-inhibited" "continuum"
    "control-treated" "coplayers" "copy-containing" "copy-number"
    "coregulators" "corneum" "correlatedwithmiR" "correlatedwithmiR-29b"
    "cortico" "cortico-striatal" "corticosteroid" "corticosteroids"
    "cost-effective" "cost-effectiveness" "cost-to-benefit" "cosubstrate"
    "coumestans" "counter-balance" "counter-intuitive" "covalently-modified"
    "covariance" "covariate" "covariates" "coworkers" "coxibs" "co‐IP" "cpDNA"
    "cpdm" "cresyl" "cribriform" "cribriform-morular" "cribriform–morular"
    "cross-cellular" "cross-compared" "cross-contamination" "cross-reactivity"
    "cross-regulation" "cross-regulatory" "cross-resistance" "cross-section"
    "cross-sectional" "cross-sensitivity" "cross-species" "crossover"
    "cryoloops" "crystallization-competent" "crystallization-condition"
    "crystallo" "crystallo­graphic" "crystals" "ctDNA" "custom-prepared"
    "cut-off" "cut-offs" "cutanea" "cutis" "cyclapolin1" "cycle-related"
    "cyclohexamide" "cylclosporin" "cyotkine" "cysteinylglycine" "cystonsines"
    "cyto" "cytoband" "cytochome" "cytodomain" "cytomemetry" "cytometer"
    "cytopenia" "cytopenias" "cytoskeletal-associated" "cytosol-like" "c–e"
    "d-f" "dCSK" "dL" "dRASSF8" "damage-associated" "damage-induced"
    "damage-inducible" "damage-inducing" "damage-transducing"
    "damage–inducible" "danger-associated" "dark-side" "dasatinb"
    "dasatinib+CYT387" "dasatinib-CYT387" "databasethat" "dataset" "datasets"
    "day14" "day5" "day7" "days" "dbGAP" "dbSNP" "dbSNP131" "dbSNP137" "ddPCR"
    "ddb1-deficient" "ddrb1" "de-conjugated" "de-conjugation" "de-regulated"
    "de-repressed" "de-repression" "de-stabilization" "deacetyl"
    "deacetyl-mimic" "death-risk" "deazaneplanocin" "decoctions" "deeper"
    "deficiect" "deficinet" "degron" "degrons" "del11q" "del17p" "del17p13"
    "del5395" "delE746-A750" "demarcations" "dendrite" "dense-band"
    "dense-membrane" "deoxynucleotidyl" "deoxyuridine" "dependet" "derepresses"
    "derivate" "derived-bioactive" "dermal-epidermal" "desaturade-1" "desmoid"
    "desmoplasia" "detection-method" "dextran-treated" "de‐regulated"
    "di-methylate" "di-methylation" "diamino" "diamino-pyrimidine"
    "diarylthiazole" "dichlorofluorescin" "dideoxy" "dien-28-imidazolide"
    "diet-induced" "diffraction-quality" "dihydro" "dihydroethidium"
    "dihydropteridinone" "dimerizer" "dimethyl-fumarate" "dimethylpyrimidine"
    "dinucleotides" "dione" "dioxooleana-1,9" "dipeptidyl" "diphosphates"
    "diploid" "dis" "discrepant" "displasia" "disposal-like" "disrupted--in"
    "disrupter" "disruptors" "disulfide-based" "dithiocarbamate" "doi"
    "domain-domain" "doman" "dominant-negative" "dominant-negative-mediated"
    "donor-derived" "dormancy" "dose-dependence" "dose-dependently"
    "dose-escalation" "dose-increasingly" "dose-independent"
    "dose-intensification" "dose-limiting" "dose-response" "dose-survival"
    "dose‐dependent" "dose–response" "double-helical" "double-hit"
    "double-knockdown" "double-membrane" "double-minute"
    "double-point-mutation" "double-strand" "doublings" "down-modulate"
    "down-modulated" "down-modulation" "down-stream" "downregulators"
    "downstream-regulator" "down‐regulated" "doxcycyline"
    "doxycycline-regulatable" "drawn" "droplet" "droplets" "drug-combination"
    "drug-dependency" "drug-discovery" "drug-drug" "drug-like" "drugs"
    "dual-functional" "dual-labeled" "dual-labeling" "dual-labelled"
    "dual-regulating" "duct-specific" "ductulo" "ductulo-lobular" "duplexes"
    "dural" "dye-based" "dynamin-like" "dysglycaemia" "dyslipidaemia"
    "dyslipidemia" "dysphagia" "dysplasia" "dysthymia" "d–S2k" "d–f" "e-3"
    "eIF4E-binding-protein" "eIFs" "eLife" "eQTL" "eYFP" "early-mid"
    "early-onset" "early-stage" "eaten" "ebiNS" "ebiNSc" "eccrine" "ectoderm"
    "ectopia" "edema" "edgeR" "effLuc" "effecter" "effectuates"
    "efficacy-of-standard" "eightfold" "eldest" "electro" "electron-dense"
    "electropherograms" "electrophoresis-single" "electrophysiology"
    "element-binding" "eleven-nineteen" "elomeres" "eluates" "emboli"
    "embryoid" "embryonic-lethal" "empts" "enantiomer" "enantiomers"
    "enantiopure" "encephalomyopathy" "end-organ" "end-product" "end-stage"
    "end-to-end" "endocarditis" "endoderm" "endometrium" "endoscopies"
    "endoscopy" "endotoxemia" "endpoint" "endpoint-convergence" "endpoints"
    "energy-efficient" "enface" "enhancer" "enhancer-binding" "enopus"
    "enroute" "enteropathy" "enterotoxin-like" "entropy" "enzyme-substrate"
    "eosin" "eosinophils" "epidermoid" "epileptiform" "epithelia"
    "epithelial-like" "epithelial-mesenchymal" "epithelial-mesenchymal-like"
    "epithelial-specification" "epithelial-stroma" "epithelial-to-mesenchymal"
    "epithelial–mesenchymal" "epithelioid" "epithelioid-like" "epithelium"
    "epitopes" "equi" "equi-molar" "erbB2-driven" "erlotinb" "erytheroid"
    "erytheroid-derived-2-like" "estrogen-receptor-α" "et" "eta" "euclidean"
    "evaginations" "ever-changing" "evidenceofmiR" "evidenceofmiR-29b's" "ex"
    "ex-smoker" "ex-vivo" "ex12" "ex2" "ex3" "exercise-induced" "exocrine"
    "exome-level" "exon11-mutated" "exon3" "exon4" "exon5" "exons" "exosome"
    "exploration-induced" "expresser" "expressers" "expressionslevels"
    "exressiong" "extra-hepatic" "extra-nuclear" "extra-thymic"
    "extracellularly-delivered" "extramaze" "extrinsic–death" "eyrthoplakia"
    "e–S2g" "fEPSPs" "fMSCs" "facilitated-tumor" "factor-1" "factor-2"
    "factor-kappa-B" "factor-кB" "factors" "factors-α" "fallen"
    "false-discovery-rate-corrected" "farnesyl" "fasciculations"
    "fast-migrating" "fat-pads" "fatostain" "fatter" "feed-back" "feedforward"
    "feedings" "female-type" "femtosecond" "fenoprofen" "ferredoxin"
    "ferrozine" "fiber-type-specific" "fibro" "fibro-muscular"
    "fibroblast-like" "fibroblast-to-neuron" "fibroblastoid"
    "fibroblastoid-like" "fibrofatty" "fibromyxoid" "fibrosis-associated"
    "field-of-view" "fine-needle" "fine-tune" "fine-tuned" "fine-tuning"
    "finger-like" "first-generation" "first-in-class" "first-line"
    "fission-fusion" "five-drug" "five-subunit" "five-transmembrane"
    "five-weeks" "five-year" "fixed-dose" "flag‐PIK3CA" "flash-frozen"
    "flatworms" "flavanoids" "flavonoid" "flavonoids" "flavonolignan" "flexure"
    "flora" "flow-activated" "flow-cytometric" "flow-mediated"
    "fluorescein-SGGKKATQApSQEY" "fluorescently-labelled" "fluorodeoxyglucose"
    "fluorophores" "fly-casting" "focus-array" "foenum" "foenum-graecum"
    "fold-coverage" "fold-increase" "folic" "follicles" "follow-up" "follow‐up"
    "forebrain" "forestomach" "formalin-fixation" "formaton" "formulae"
    "four-stranded" "fpkm" "frame-shift" "frame-shifts" "free-electron"
    "free-survival" "fresh-frozen" "front-line" "frozen" "fructose-1-phosphate"
    "fructose-2,6-bisphosphate" "fructose-6-phosphate" "full-body" "full-lenth"
    "full-term" "full-text" "fully‐automated" "fumarate" "fundus" "funiculosum"
    "fusion-activated" "futher" "g-p" "gDNA" "gain-and-loss-of-function"
    "gain-of-function" "galactomannans" "gallbladder" "gammaherpesvirus"
    "garicinol" "gasotransmitter" "gasotransmitters" "gastrectomy" "gastro"
    "gastro-esophageal" "gastro-intestinal" "gastrulate" "gate-keepers"
    "gatekeeper" "gavage" "geldanamycin-derivative" "gemciatbine" "gene-level"
    "generatedDdb1" "generatedTrp53" "genes" "genetically-engineered"
    "gene–environment" "gene–gene" "genome" "genome-wide" "genomes"
    "genome‐wide" "geranylgeranyl" "geranylgeranyl-transferase" "germ-line"
    "germline" "glia" "glia-like" "glomeruli" "glucose-6" "glycaemia"
    "glycemia" "glycerophosphate" "glycinamide" "glycophosphatidylinositol"
    "glycosaminoclycans" "goes" "gondii" "gotten" "grad" "graecum" "grainy"
    "gram-negative" "granulo" "granulo-monocyte" "granulo-monocytic"
    "granulocyte-monocyte" "greater" "greatest" "grip-like" "group11"
    "growth-arrest-specific" "growth-dependency" "growth-signaling"
    "growth-suppressive" "guanine-mimetic" "guanine-to-thymidine" "hESCs"
    "hMSC" "hMSCs" "hMps1-MDM2-ubH2B" "hMps1with" "hNPCs" "hNQO1-ARE-Luc"
    "hRBM4" "hT" "hTR" "hTR-telomere" "haeme" "half-ERE" "half-identical"
    "half-inhibitory" "half-life" "half-lives" "half-siblings" "half-sisters"
    "half-site" "half-sites" "half‐life" "hapatocytes" "haplo"
    "haplo-insufficiency" "haplotype" "haplotypes" "happenstance" "hara-kiri"
    "hard-to-find" "harringtonia" "has-miR-142-5p" "has-miR-202" "has-miR-98"
    "head-to-head" "head-to-tail" "heat-shock" "heatmap" "heatmaps" "helices"
    "helix" "helix-loop-helix" "hematocrit" "hematuria" "hemeoxygenase-1"
    "hemispherectomy" "hemoclips" "hemocytometer" "hepatectomy"
    "hepatoblastomas" "hepatocyte-like" "hepatotoxins" "hetero"
    "hetero-dimeric" "hetero-dimers" "hetero-oligomerization" "heterodimers"
    "heteroduplexes" "heteronucleotide" "heterotopias" "heterozygote"
    "hexahistidine" "hexamer" "hexanucleotide" "hexokinases" "hexokinasse"
    "hidden" "hidden-platform" "hidradenocarcinomas" "hidradenomas"
    "hidroxitamoxifen" "high-LOH" "high-TIL" "high-ab" "high-affinity"
    "high-affinity-binding" "high-cellularity" "high-concentration"
    "high-confidence" "high-content" "high-copy" "high-density" "high-dose"
    "high-expresser" "high-fat-diet" "high-frequency" "high-grade" "high-iron"
    "high-level" "high-mobility-group" "high-molecular-weight" "high-order"
    "high-penetrant" "high-performance" "high-quality" "high-resolution"
    "high-risk" "higher-affinity" "higher-grade" "higher-order"
    "highly-conserved" "hippo-mediated" "histologies" "histology"
    "histopathology" "histostains" "histotype" "histotypes" "hnRNPA1-ESS"
    "hnRNPA1-ISS" "hnRNPLL" "hnRNPs" "hoc" "holocomplexes" "holoenzymes"
    "home-brew" "homeodomain" "homo-FRET" "homo-dimers" "homolog" "homologies"
    "homologs" "homology-2" "homology-based" "homonucleotide" "homozygote"
    "homozygotes" "honoraria" "hormonal-dependent" "hormone-naïve"
    "hormone-receptor" "host-intrinsic" "host-microbe" "hot-miR-138" "hot-spot"
    "hotpot" "hotspot" "hotspots" "hr" "hsCRP" "hsa-miR-101" "hsp-miR-98"
    "http" "huRANKL" "hyaloid" "hyaloplasm" "hydride" "hydrogels"
    "hydrogen-bonds" "hydrogen-exchanger" "hydrolysates" "hydroxybutyrate"
    "hydroxycholesterol" "hydroxyisoleucine" "hydroxymethylcytosine"
    "hygroscopicus" "hyper" "hyper-activation" "hyper-dissemination"
    "hyper-invasive" "hyper-γ-H2A" "hyperinsulinemia" "hyperoxia"
    "hyperpentaploid" "hyperphosphatemia" "hyperpolarization-activated"
    "hyperresponsiveness" "hypo-cellularity" "hypo-methylation" "hypocalcemia"
    "hypoglycemia" "hypomorphs" "hypothermia" "h~48" "h~48 " "i-GSEA4GWAS"
    "iBox-C" "iBox38" "iBox–PAK4cat" "iCOGs" "iFGFR" "iFGFR1" "iGSEA4GWAS"
    "iNOS+p53" "iNSCs" "iNSCs-like" "iNSc-like" "iNc" "iPALM" "iRegulon"
    "identifiers" "ie" "ihBTC" "ihBTC1" "ihBTC2" "ihBTC2-radiation" "ihCTC"
    "ihHTC" "ihSTC" "ii" "iii" "ill-defined" "imidodiphosphate"
    "immune-associated" "immune-cell-poor" "immune-cell-rich"
    "immune-depressed" "immune-driven" "immune-regulatory" "immune-related"
    "immune-suppressive" "immuno" "immuno-precipitated" "immunoassay"
    "immunoassays" "immunoconjugates" "immunocytochemistry"
    "immunocytochemisty" "immunoglobulin" "immunohistiochemistry"
    "immunohistochemistry" "immunohystochemistry" "immunophenotype"
    "immunophenotypes" "immunoprecipitant" "immunoreactions"
    "immunosurveillance" "immunotherapies" "immunotherapy" "impedance"
    "in-cellulo" "in-depth" "in-frame" "in-house" "in-line" "in-nucleus"
    "in-situ" "in-stent" "in-vitro" "in-vivo" "inATMIN" "inAtaxia" "inBTC2"
    "inDdb1" "inNestin" "inNrf2" "inPten" "inTAp73" "inTrp53" "incompleteness"
    "indel" "indels" "indica" "indicus" "indocyanine" "induced-apoptosis"
    "induced-pluripotent" "inducibleNestin" "infection-induced"
    "inflammation-associated" "inflammation-induced" "inflammation-promoting"
    "inhibitis" "inhibiton" "inhibitor-1" "inhibitor-treated" "inhibitors"
    "inhibitsTAp73" "injectedDdb1" "innervate" "inspite" "instates"
    "insulin-AKT-mTOR" "insulin-activated" "insulin-induced" "insulin-like"
    "insulinoma-glucagonoma" "integrin-cytoskeleton" "integrin-evoked"
    "intensity-modulated" "inter-cellular" "inter-chain" "inter-day"
    "inter-domain" "inter-individual" "inter-malignancy" "inter-observer"
    "inter-regulatory" "inter-strand" "inter-study" "inter-subset"
    "interactiong" "interactomes" "interassay" "interconvert"
    "intermediate-risk" "intermembrane" "interquartile" "interstitium"
    "interstrand" "intra" "intra-abdominal" "intra-epithelial" "intra-oral"
    "intra-peritoneum" "intra-tissue" "intra-tumor" "intra-tumour"
    "intracardiac" "intracellular-domain" "intractableEML"
    "intractableEML4-ALK" "intramembrane" "intrastrand" "intratibia"
    "intra‐thoracic" "intrinsic–mitochondrial" "intron" "introns"
    "invaginations" "invariant" "invasion-associated" "invasion-inducing"
    "invasion-inhibition" "invasion-metastasis" "invasion-promoting"
    "invasison" "ionic" "ischaemia" "ischemia-reperfusion"
    "ischemia–reperfusion" "islet-derived" "isoenzyme" "isoflux"
    "isoform-specificity" "isograft" "isoindolin" "isoindolin-2-ylmethyl"
    "isolectin" "isomer" "isothiocyanatostilbene" "isothiocyanatostilbenes"
    "isotype" "isotypes" "isozymes" "iv" "jam-l" "jeikeium"
    "kappa-light-chain-enhancer" "karyotype" "karyotypes" "kbp" "ketoprofen"
    "ketorolac" "kg" "kilobases" "kinase-neutral" "kinase-null"
    "kinase–substrate" "kinetochore-mitotic" "kinome" "kiri" "kit-8"
    "knock-down" "knock-in" "knocked-down" "knockin" "knocking-down" "knowdown"
    "kruppel-like" "l19insTT" "lHSP72" "lactone" "lactose" "laevis" "lambda"
    "lamina" "laminin-332" "laminin-triggered" "laparotomies" "laparotomy"
    "large-cell" "large-diameter" "large-scale" "larger-sized" "laser-based"
    "laser-induced" "late-onset" "late-stage" "lavage" "layer-specific"
    "learnt" "lebetina" "left-side" "lenth" "lenti-ZFP36L1-infected"
    "lenti-ctrl" "lenti-ctrl-infected" "lenti-miR-27b" "lenti-shZFP36L1"
    "less-than-perfect" "let-7b" "let-7f" "let-7f-5p" "let-7i" "leucemia"
    "leucin" "leukocoria" "library-infected" "life-long" "lifespan" "ligand-1"
    "ligand-receptor" "light-chain" "light-tone" "liker" "line-to-line"
    "lineage-specific" "lineage-survival" "lipocytes" "lipofectamine"
    "lipopolysaccharide" "liquid-ordered" "littermate" "littermates"
    "live-cell" "liver-carcinogenic" "lncPro" "lncRNA-ATB" "lncRNA-GAS5" "loCP"
    "lobar" "localizations" "loco-regional" "log-additive" "log-normal" "log2"
    "long-chain" "long-lasting" "long-lived" "long-period" "long-range"
    "long-standing" "look-up" "loop-like" "loss-of-ATM-function"
    "loss-of-function" "loss-of-heterozygosity" "low-MPS" "low-TIL"
    "low-abundance" "low-affinity" "low-density" "low-dose" "low-frequency"
    "low-grade" "low-level" "low-quality" "low-resolution" "low-risk"
    "low-to-null" "lower-grade" "lpha" "luciferase-reporter" "luminometry"
    "luteal-phase" "lympendothelium" "lymphadenectomy" "lymphendothelium"
    "lymphoblastoid" "lymphoepithelioid" "lymphoma-2" "lymphoma-extra" "lysis"
    "m3p" "m5p" "mAG1" "mCP" "mCRPC" "mCherry-PTP1B-D181A" "mGFP" "mHSP72"
    "mHTT" "mKO2" "mMSC" "mMSCs" "mRNA" "mRNA-level" "mRNA-like"
    "mRNA-stability" "mROS" "mSin3A" "mT-mG" "mTOR-inhibitor" "mTOR-pathway"
    "mTOR1" "mTORC1-S6" "mTORC1-S6K-S6" "mTORC1-S6K1-S6" "mTORopathies" "mTORs"
    "macro-metastasis" "macrophage-like" "macroscopicK" "main-chain" "make-up"
    "malignances" "malonyl-coA" "mammography" "mammosphere" "mammospheres"
    "mant" "mantGDP" "mantGTP" "mapback" "margenta" "marianum" "mass-action"
    "mastectomy" "mature-B-cell" "mdx" "mdx-βgeo" "mean±SD" "measuredK"
    "mechanisms" "mediated-ADCC" "mediatedcontrolof" "medically-intractable"
    "medications" "medium-to-large" "medulla" "medullary-like" "mega-analysis"
    "megabase-wide" "megalencephaly-polymicrogyria-polydactyly-hydrocephalus"
    "melanin" "melanogaster" "melittin-Sepharose" "mellitus" "membranaceus"
    "membrane-potential" "mesencephalon" "mesenchymal-epithelial"
    "mesenchymal-like" "mesenchymal-to-epithelial" "mesenchyme"
    "mesenchyme-like" "mesoderm" "mesothelium" "mesylate" "metagenome"
    "metal-stress" "metalloproteinase-1" "metastasis-repressive"
    "metastasis-suppressive" "metastatic-repressive" "metenkephalin"
    "metformin-p53-dependent" "methanesulfonate" "methionine–choline-deficient"
    "methoxy" "methyl-DNA" "methyl-Ile" "methyl-Met" "methyl-β-cyclodextrin"
    "methyladenine" "methylaminomethyluridine" "methylcytosine"
    "methylsulfinyl" "methyluridine" "metoprolol" "mevalonate" "mg3" "miR-101"
    "miR-101-transfected" "miR-103" "miR-107" "miR-10a" "miR-1181" "miR-122"
    "miR-122-mediated" "miR-124" "miR-124-1" "miR-126a-3p" "miR-127"
    "miR-127-5p" "miR-130a" "miR-130b-ZEB1" "miR-133b" "miR-135" "miR-135a"
    "miR-138" "miR-138-mediated" "miR-138-suppressed" "miR-139-3p" "miR-141"
    "miR-141-3p" "miR-142-3p" "miR-142-5p" "miR-143" "miR-144" "miR-146-5p"
    "miR-146b-3p" "miR-148b" "miR-150" "miR-155" "miR-155-3p" "miR-155-5p"
    "miR-155-treated" "miR-15a" "miR-17" "miR-17-92" "miR-18" "miR-182"
    "miR-18a" "miR-190" "miR-192" "miR-192-mediated" "miR-192-transfected"
    "miR-192-treated" "miR-193a-3p" "miR-195" "miR-196a-5p" "miR-199"
    "miR-199a" "miR-199b" "miR-199b-5p" "miR-200" "miR-200s" "miR-202-3p"
    "miR-202-5p" "miR-203" "miR-204" "miR-205" "miR-208b" "miR-20a" "miR-210"
    "miR-210-3p" "miR-211" "miR-214" "miR-214-based" "miR-214-induced"
    "miR-214-inhibited" "miR-214-overexpressing" "miR-214–overexpressing"
    "miR-215" "miR-219" "miR-219-1-3p" "miR-22" "miR-223" "miR-224" "miR-24"
    "miR-24-Bim" "miR-24-mediated" "miR-24-overexpressing" "miR-26a"
    "miR-26a-1" "miR-26a-2" "miR-296" "miR-29b-AKT" "miR-29b-AKT-HK2"
    "miR-29b-mediatedcontrolof" "miR-29bmay" "miR-3" "miR-301b" "miR-302a"
    "miR-302c" "miR-30a" "miR-3151" "miR-32" "miR-326" "miR-328" "miR-329"
    "miR-330-5p" "miR-33b" "miR-34" "miR-342-5p" "miR-346" "miR-346-activated"
    "miR-346-dependent" "miR-346-facilitated" "miR-346-induced" "miR-346-loop"
    "miR-346-mediated" "miR-34b" "miR-34c" "miR-361" "miR-367" "miR-369-3p"
    "miR-369–3p" "miR-370" "miR-371-3p" "miR-372" "miR-373" "miR-376b"
    "miR-378a-3p" "miR-380-3p" "miR-382" "miR-410" "miR-424" "miR-433"
    "miR-450a" "miR-451" "miR-451-induced" "miR-455" "miR-455-3p" "miR-484"
    "miR-485-3p" "miR-486" "miR-487a" "miR-487b" "miR-490-3p" "miR-491-3p"
    "miR-494" "miR-499a-5p" "miR-502" "miR-505" "miR-506" "miR-508"
    "miR-508-5p" "miR-508-p" "miR-510" "miR-511" "miR-512-3p" "miR-517a"
    "miR-517c" "miR-518b" "miR-518d" "miR-518f" "miR-519c" "miR-519d"
    "miR-519e" "miR-520b" "miR-520d-5p" "miR-522" "miR-523" "miR-545"
    "miR-548a" "miR-548a-5p" "miR-548b-5p" "miR-548c" "miR-548d" "miR-548d-5p"
    "miR-556-3p" "miR-561" "miR-570" "miR-576-3p" "miR-576-5p" "miR-589"
    "miR-590-3p" "miR-597" "miR-598" "miR-599" "miR-615-5p" "miR-618" "miR-622"
    "miR-622-associated" "miR-622-mediated" "miR-622-overexpressing"
    "miR-622-transfected" "miR-627" "miR-652" "miR-654-3p" "miR-655" "miR-672"
    "miR-708" "miR-885-5p" "miR-888" "miR-889" "miR-891a" "miR-9" "miR-9-2"
    "miR-9-3" "miR-92a-1" "miR-92a-2" "miR-92a-2-3p" "miR-92a-2-5p"
    "miR-92a-3p" "miR-98" "miR-98-5p" "miR103" "miR200c" "miR423-5p"
    "miR92a-2-3p" "miR92a-2-3p-overexpressing" "miRDB" "miRNA-130a" "miRNA-15a"
    "miRNA-16-1" "miRNA-192" "miRNA-200" "miRNA-29" "miRNA-372" "miRNA-451"
    "miRNA-9" "miRNA124" "miRWalk" "miRanda" "miR‐490" "miR‐490‐3p"
    "miR‐490‐5p" "miR‐490‐5p's" "micro-CT" "micro-compartments"
    "micro-disection" "micro-dissected" "micro-environment" "micro-injected"
    "micro-irradiation" "micro-molar" "microRNA-200" "microRNA-451"
    "microRNA-494" "microRNA-7" "microautophagy" "microbeam" "microbiota"
    "microbiotas" "microcrystals" "microdeletions" "microdomains"
    "microenvironment-induced" "microenvironment-niches" "microfocus"
    "micrograph" "micrographs" "microhomology" "micron-sized" "microparticles"
    "microplate" "microplates" "microsatellite" "microsatellite-unstable"
    "microscopicK" "microseeds" "microspheres" "microtiter" "microvasculature"
    "microvessel" "microvessels" "micro‐RNAs" "mid-deep" "mid-follicular"
    "mid-twenties" "midbrain" "midzone" "migration-and" "mild-regenerating"
    "millisecond" "mimicker" "mineralization-inducing" "mini-review"
    "miniprotein" "mir" "mir-214" "missense" "missingness"
    "mitochondria-nucleus" "mitochondrial-dependent" "mitochondrial-encoded"
    "mitochondrial-mediated" "mitochondrial-nuclear" "mitochondrial-related"
    "mitochondrial-targeting" "mitogen-activated" "mitoribosomes" "mitoses"
    "mitosis-regulatory" "mitotic-phase" "mixed-lineage" "mnm5s2UUU"
    "mobility–group" "mock-treated" "moderate-penetrance" "moderate-risk"
    "moderate-to-elevated" "moderate-to-high" "moderately-increased"
    "modes-of-action" "modest-to-weak" "molecular-weight" "mono-adducts"
    "mono-bound" "mono-methylate" "monobodies" "monocyte-derived"
    "monocytic-like" "monocytic-specific" "monolayer" "monomethylarginine"
    "monopartite" "monophosphate" "monopolar-phenotypic" "monotherapy"
    "monotheray" "month-old" "mortem" "moth-eaten" "mother-twins"
    "motif-containing" "motif-dependent" "motif-specific" "motile" "mp53BS"
    "mucosa" "multi-cancer" "multi-chemotherapy" "multi-component" "multi-drug"
    "multi-focal" "multi-kinase" "multi-lineage" "multi-organ" "multi-protein"
    "multi-stage" "multi-step" "multi-subunit" "multi-systemic" "multi-to-one"
    "multi-vesicular" "multicenter" "multicentre" "multiexon" "multigene"
    "multilineage" "multiphoton" "multiple-center" "multiple-hit"
    "multiple-target" "multiprotein" "multisubunit" "multitype" "multivariate"
    "muscle-resident" "muscularis" "mutant-NLS" "mutant-like" "mutations"
    "mutation–its" "mutp53" "myc-POTΔOB" "myelencephalon" "myeloid-cell-rich"
    "myocytes" "myofiber" "myofibers" "myofibloblasts" "myofibroblast-like"
    "myofibroblastlike" "myoid" "myonuclei" "myristate" "n-collar" "n=6"
    "nCounter" "nRTKs" "nabumetone" "nano" "nano-Gln" "nano-molar"
    "nanomedicine" "nanosecond" "nascent-RNA" "naso" "naso-pharyngeal"
    "nation-wide" "naïve" "ncomms10029" "ncomms10068" "ncomms10075"
    "ncomms10100" "ncomms9528" "ncomms9681" "ncomms9690" "ncomms9704"
    "ncomms9755" "ncomms9859" "ncomms9897" "ncomms9979" "near-cognate"
    "near-complete" "near-fatal" "near-infrared" "near-physiological" "nearest"
    "necropsy" "necrosome" "neg" "negative-control" "nematoda" "neo-adjuvant"
    "neo-vascular" "neoadjuvant" "neointima" "neoplasias" "neoplasm-like"
    "nephrectomy" "nephron" "nephropathies" "nephropathy" "nephrotoxins"
    "nestin-positive" "neural-crest" "neurite" "neuro" "neuro-degenerative"
    "neuro-developmental" "neuro-hormones" "neurobiology" "neuroendocrine"
    "neuron-like" "neuropathology" "neurosphere" "neurospheres" "neutropenia"
    "never-smokers" "newer" "newly-synthesized" "next-generation"
    "next-generation-sequencing" "ngTMA" "nick-end" "nitro" "no-combination"
    "node-negative" "nomifensine" "noncarriers" "noncaveolae" "nonmalignant"
    "nonobese" "nonperfect" "nonredundant" "nonresponders" "nonresponse"
    "nonsense-mediated" "nonsevere" "nonsignificant" "nonsurvivors" "non‐PD"
    "non‐small" "non‐tumour" "normal-large" "normal-sized" "normally-reacting"
    "not-commonly" "novelPLK2" "novo" "nucleases" "nucleates" "nucleo"
    "nucleo-cytoplasmatic" "nucleophilc" "nucleosomal-like" "nutgall"
    "nutrient-complete" "nystagmus" "n = 6" "ob" "observedK" "occludins"
    "occurrences" "oestrogen" "oestrogen-dominant" "oestrogens" "ofATMin"
    "ofDdb1" "ofEGFR" "ofK" "ofPDcases" "ofPIK3CA" "ofTAp73" "off-target"
    "offs" "ofnPTB" "oftel1" "old-style" "oligodendrocyte-like"
    "oligodendroglioma-like" "oligodeoxynucleotides" "oligodeoxynucleotidesve"
    "oligomycin" "oligos" "oligosaccharide-binding" "omega-N" "omentum" "omic"
    "on-going" "on-target" "once-daily" "onco" "onco-properties" "oncologists"
    "oncology" "oncomiR" "oncotarget" "one-base" "one-month" "one-period"
    "one-site" "one-step" "one-tailed" "one-tenth" "one-third" "one-to-one"
    "oocyst" "oocytes" "oophorectomy" "open-channel" "open-to-closed" "opioids"
    "orNestin" "organelle" "organelles" "organoids" "oropharynx" "ortholog"
    "orthologue" "orthologues" "osteo" "osteoblast-like" "osteoblasts"
    "osteogenesis-inducing" "osteomimicry" "osteomyelitis" "ound" "ouse"
    "out-compete" "out-of-control" "out-of-expectation" "out-of-frame"
    "outer-membrane" "ovalbumin-serine" "ovariectomy" "over-accumulate"
    "over-activating" "over-activation" "over-interpreting" "over-presence"
    "over-representation" "over-simplistic" "over-treated" "over-treatment"
    "over-winding" "overdose" "overexpressed–Huh7" "overexpressingTAp73"
    "overridden" "overseen" "overuse" "overview" "over‐expression" "owczarzaki"
    "oxalacetate" "oxalipatin" "oxoG" "oxoguanine" "oxygenase-1" "p18IN4"
    "p18INK4c" "p21CIP" "p38-MK2-14-3-3-dependent" "p38MAPK" "p38β"
    "p53-competent" "p53-defective" "p53-depedent" "p53-dependet" "p53-null"
    "p53-p21-DREAM-CDE" "p53-wildtype" "p53BR" "p53BRmt" "p53BS" "p53ER"
    "p53R175H" "p53s" "p53shRNA" "p62ΔPB1" "p62ΔUBA" "p62ΔZZ"
    "p70S6K-dependent" "p85α" "p95HER2" "pAKT2" "pBOB" "pCMV-Klotho"
    "pCMV-Klotho-transfected" "pCMV6" "pCMV6-Klotho" "pCdc2" "pChk1" "pDNAs"
    "pEGFR" "pEZX" "pEZX-PG04" "pGATA" "pGL3-1172" "pGL3-1733" "pGL3-202"
    "pGL3-320" "pGL3-320-mut" "pGL3-502" "pGL3-581" "pGL3-702" "pGSK3β1130"
    "pH2AX" "pHER2" "pHH3" "pLEX-PTPN6" "pLKO" "pLL3.7" "pLPCX" "pLYN"
    "pLasts1" "pLats1" "pMXs" "pMet" "pMst1" "pRRL-CMV-IRES-GFP" "pRuF"
    "pRuF-empty" "pS127-YAP" "pS127-YAP1" "pSPL3" "pSTAT3" "pSXN" "pSiCHECK"
    "pSiCHECK2" "pSmad2" "pSmad2C" "pSmad3C" "pT306" "pT4" "pTNM" "pY1045"
    "pY1221" "pY1234" "pY357-YAP1" "pY416-SRC" "pY527-SRC" "pYAP" "pYAP-S127"
    "pYB1" "pack-years" "paired-cell" "paired-end" "paired-pulse" "pairwise"
    "palmitoylcarnitine" "pan-HER-TKI" "pan-PI3K" "pan-cytopenia"
    "pan-regulated" "pan-specific" "pan-upregulation" "pan-βAR" "pancreata"
    "pancreatitis" "pancreatitis-like" "papillae" "papilliferum" "para-medial"
    "para-medially" "paracrine" "paralog" "parenchyma" "parent-child" "parents"
    "parthanatos" "parthenium" "parvum" "pase" "pathobiology"
    "pathogen-associated" "pathogenesy" "pathomechanism" "pathophysiology"
    "pathway-of-cancer" "pattern-recognition" "pcDNA" "pcDNA3-myc"
    "pcDNA3.1-HULC" "peak-like" "pedicle" "peg-IFN" "pellucidum" "penetrance"
    "penetrant" "penicilline" "peptidases" "peptide-6" "peptides" "peptidimer"
    "peptidimer-c" "perforant" "perhaps" "peri-operative" "peri-tumoral"
    "peritoneum" "peroxinitrate" "peroxiredoxin-5" "person-years" "phagophore"
    "pharmaco" "pharmaco-mimetic" "pharmacotherapy" "phase-II" "phase-III"
    "phase-contrast" "phasecontrast" "phenome" "phenotype-like" "phenyl"
    "phenylarsine" "phenylketonuria" "phonetype" "phosphatidylinositol-3-OH"
    "phosphatidylinositol-3-phosphate" "phosphodegron" "phosphoenolypyruvate"
    "phosphogluconolactone" "phosphoinoside" "phosphoinositide-3-OH"
    "phosphoinositides" "phosphoinosotide" "phosphopeptide"
    "phosphopeptide-PBD" "phosphopeptides" "phosphoribosyl"
    "phosphorylatesTAp73" "phosphorylation-consensus"
    "phosphorylation-defective" "phosphotransfer" "phos‐Tag" "phos‐tag"
    "photo-activated" "photomicrograph" "phs000424" "phsopho" "phsopho-S6"
    "phyla" "phytocompounds" "phytohemagglutinine" "pick-up" "pifithrin-α"
    "placebo-treated" "plasmaDNA" "plasmaDNAamong" "plasmaDNAin"
    "plasmaDNAreflects" "plasmaDNAto" "plasmaDNAusingMBP" "plasmaDNAwas"
    "plasmon" "plasticity-inducing" "platelet-monocyte" "platelet-tumour"
    "platins" "platins-pemetrexed" "platinum-resistant" "platyzoa" "plexiform"
    "pll3.7" "ploidy" "plug-in" "plugin" "pluripotency-associated" "pmel-1"
    "point-mutants" "polarization-based" "polarography" "polo‐like" "poly-A"
    "poly-L-lysine" "poly-SUMOylation" "poly-T" "polyI" "polySUMO" "polySUMO2"
    "polycytidine" "polyinosine" "polyinosine-polycytidine" "polymerase1"
    "polymorphism" "polymorphisms" "polypectomy" "polypirimidine" "polyploid"
    "polypoid" "polypyrimidine" "polysomy" "pombe" "pons"
    "poor-differentiation" "poor-switching" "poorer" "poorest"
    "poorly-differentiated" "pore-forming" "porphyria" "porphyrin"
    "positive-feedback" "positive-stain" "positron" "positron-emission"
    "post-Chernobyl" "post-RRSO" "post-TPF" "post-Tukey" "post-activation"
    "post-carboplatin" "post-dose" "post-hoc" "post-implantation"
    "post-infection" "post-injury" "post-irradiation" "post-menopausal"
    "post-mitotic" "post-mortem" "post-natal" "post-progestin" "post-radiation"
    "post-reimplantation" "post-release" "post-replication" "post-replicative"
    "post-stimulation" "post-stimulus" "post-synaptic" "post-tamoxifen"
    "post-tetanic" "post-thaw" "post-transcription" "post-transcriptional"
    "post-transcriptionally" "post-transduction" "post-transfection"
    "post-translation" "post-translational" "post-translationally"
    "post-transplantation" "post-treatment" "post-wash" "postmenopause"
    "posttransplant" "potassium-dependent" "pre" "precancer" "precancers"
    "precipitant" "premenopause" "preplate" "preventsTAp73" "pri" "pri-miR-138"
    "pri-miR-26a-1" "pri-miR-346" "pri-miR-622" "primary-response"
    "primer-alignment" "primer-pair" "priori" "pro-IL-1β" "pro-adhesive"
    "pro-angiogenesis" "pro-angiogenic" "pro-autophagic" "pro-cancer"
    "pro-caspase-8" "pro-differentiation" "pro-fibrogenesis" "pro-fibrotic"
    "pro-fibrotic-related" "pro-inflammatory" "pro-invasive" "pro-luc"
    "pro-lymphoid" "pro-metastasis" "pro-metastatic" "pro-migratory"
    "pro-oestrous" "pro-osteogenic" "pro-peptide" "pro-senescence"
    "pro-survival" "pro-thrombotic" "pro-tumor" "pro-tumoral" "pro-tumorigenic"
    "proband" "probands" "probe-sets" "probrain" "procaspase-3" "procollagen"
    "profiler" "progeny" "progestin" "progression-free-survival"
    "proliferator-activated" "proline-glutamate-serine-threonine" "promots"
    "proof-of-concept" "proof-of-principle" "propiophenone"
    "prospectively-collected" "prostaglandins" "prostasphere" "prostaspheres"
    "prostatectomy" "protease-14" "proteasome-mediated" "protein-1c"
    "protein-72" "protein-DNA" "protein-level" "protein-members"
    "protein-sulfenic" "proteinopathy" "protein–RNA" "protein–ligand"
    "proteome" "proteosome" "proto" "proven" "pseudo-merohedrally"
    "pseudo-phosphorylation" "pseudo-substrate" "pseudoinclusions"
    "pseudosubstrate" "pseudosubstrates" "psiCheck‐2" "pufferfish" "pull-down"
    "pull-downs" "pulldown" "pulled-down" "pulse-chase" "punctae" "puquitinib"
    "purmorphamine" "pyrazole" "pyrazolines" "pyrazolo" "pyrimidodiazepines"
    "pyrograms" "pyrrolo" "pyrrolo-pyrazole" "q3dx4" "qChIP" "qPCR-HRM"
    "quadruplexes" "quinazolin-3-one" "rKlotho" "radiation-associated"
    "radiation-induced" "radiation-resistance" "radiation-sensitive"
    "radio-chemoresistance" "radio-resistance" "radio-therapy"
    "radioactively-labelled" "radioimmunoassays" "radioiodine"
    "radioisotope-based" "radioresistance" "radioresistant"
    "radiotherapy-induced" "ragged-red" "random-effects" "rank-sum" "rapalogs"
    "re-analyzed" "re-appearance" "re-assessed" "re-cleave" "re-confirmed"
    "re-differentiated" "re-distribution" "re-endothelialization"
    "re-endothelialize" "re-enter" "re-entry" "re-establish" "re-established"
    "re-establishment" "re-evaluated" "re-evaluation" "re-examination"
    "re-examine" "re-examined" "re-examining" "re-expressed" "re-expressing"
    "re-expression" "re-fed" "re-growth" "re-induce" "re-induced" "re-infected"
    "re-infection" "re-initiate" "re-introduction" "re-joining"
    "re-localization" "re-oxygenation" "re-phosphorylated" "re-polymerization"
    "re-proliferative" "re-route" "re-routing" "re-seeded" "re-seeding"
    "re-sensitizes" "re-sequencing" "re-stained" "re-stimulated" "re-testing"
    "re-transferring" "re-transplantation" "reaction-restriction" "reactions–a"
    "read-out" "readout" "readouts" "real‐time" "reboot" "receptor-gamma"
    "receptor-ligand" "receptor-membrane" "receptor-repressor" "rectosigmoid"
    "recurrence-free" "redeye" "reduction-oxidation" "reenter" "refractoriness"
    "regrow" "regrowth" "regulators" "regulatory-binding" "relativeness"
    "releasate" "relocalise" "repamycin" "reperfusion-induced"
    "rephosphorylate" "replication-blocking" "replication-dependent"
    "replication-impaired" "replicon" "repopulate" "reporter-positive"
    "repressingnPTB" "repressors" "repurpose" "reroute" "reroutes"
    "research-outcomes" "residue-long" "residuum" "resistnat" "resorb" "resp"
    "respective-length" "responder" "responders" "retro" "retrovirus"
    "revacept" "reverse-phase" "re‐biopsy" "rfu" "rhAPO2L" "rhApo2L" "rhabdo"
    "rhabdoid" "ribofuranoside" "ribosylases" "ring-finger" "risk-benefit"
    "risk-factor" "risk-factors" "risk-reducing" "risk-reduction" "rosaceae"
    "rostate" "round-shaped" "rowth" "rs10073340" "rs1048315" "rs1061581"
    "rs11212617" "rs11237477" "rs11705932" "rs1256030" "rs12597021"
    "rs12699477" "rs13167280" "rs1421896" "rs149330805" "rs1748" "rs1799782"
    "rs1801132G" "rs2018199" "rs2066827" "rs2075158" "rs2228480" "rs223469"
    "rs2234693" "rs2273773" "rs2450140" "rs2510044" "rs2511156" "rs2530223"
    "rs2547547" "rs25487" "rs25489" "rs2735845" "rs2736098" "rs2736100"
    "rs2736118" "rs2853668" "rs2853669" "rs2853691" "rs3213239" "rs3213245"
    "rs32954" "rs3758391" "rs3798577" "rs3859027" "rs401681" "rs402710"
    "rs41282930" "rs41290601" "rs4561483" "rs4635969" "rs4986938" "rs5215"
    "rs5216" "rs5219" "rs55637647" "rs55870064" "rs61764370" "rs6457452"
    "rs689466" "rs6996321" "rs7107174" "run-away" "run-on" "s12864-015-2131-y"
    "s12881-015-0240-8" "s12885-015-1763-2" "s12885-015-1779-7"
    "s12885-015-1817-5" "s12885-015-1872-y" "s12885-015-1880-y"
    "s12885-015-1890-9" "s12885-015-1913-6" "s12885-015-1940-3"
    "s12967-015-0721-8" "s13045-015-0206-5" "s13058-015-0649-1"
    "s13058-015-0656-2" "s13059-015-0791-1" "s13075-015-0828-6"
    "s13742-015-0088-z" "sIL-6R" "sMaf" "sMafG" "sMafK" "sOPG" "sPNET"
    "saliva-derived" "salpingo" "salpingo-oophorectomy" "sarcomatoid" "sashimi"
    "scramble-shRNA-treated" "screenings" "sd" "sebocytes" "sebum"
    "second-degree" "second-generation" "second-line" "second-order"
    "secretome" "seemd" "seizure-freedom" "selectin-Fc"
    "selectin-PSGL-1-dependent" "selenocysteine" "selenol–thiol"
    "selenomethionine" "selenosulfide" "self-activating" "self-activation"
    "self-amplifying" "self-assembly" "self-associated" "self-association"
    "self-defense" "self-defensive" "self-digestion" "self-oligomerization"
    "self-phosphorylation" "self-protective" "self-reactive" "self-renew"
    "self-renewal" "self-report" "self-sustaining" "selisistat" "semi"
    "semi-conductor" "semi-conservative" "semi-quantify" "semi-quantitative"
    "semi-rigid" "semi-solid" "sen" "senescence-like" "senescent-specific"
    "sensitiveness" "sensitizer" "sensitizers" "sequelae" "sequence-divergent"
    "sequence-independent" "sequence-specific" "sequence-specifically"
    "serine-9" "serum-treated" "sessile" "set-up" "sgRNA" "sh-POH1-Tet-on"
    "sh-miR-33a" "sh386" "sh848" "shACSL4" "shAPRT" "shATM" "shBub" "shBub1"
    "shCOPR5" "shCTRL" "shCon" "shDR5" "shER" "shERK" "shERK1" "shERβ"
    "shERβ-reduced" "shFOXO" "shFOXO3-treated" "shFOXO3a" "shGTPBP3"
    "shGTPBP3-1" "shGTPBP3-2" "shHIF-1α" "shLuc" "shNT" "shPIAS" "shPIAS-8"
    "shPIAS4-5" "shPIAS4-8" "shPTEN" "shared-environmental" "short-axis"
    "short-chain" "short-hairpin" "short-term" "short-time" "shp53" "shrunken"
    "shut-down" "sh‐PIK3CA" "si-2" "si-GAS5" "si-HULC-1" "si-HULC-2" "si38"
    "siALK" "siATM" "siCTL" "siEGFP" "siFANCD2" "siGFP" "siGSK3β" "siIGF1R"
    "siISCU" "siISCU1" "siISCU2" "siMITF" "siNQO1" "siNT" "siPIAS4" "siPias4"
    "siR-R" "siRASSF1" "siRASSF1A" "siRNA-1" "siRNA-2" "siRNA-transfection"
    "siRNA1" "siRNA2" "siRNAas" "siTAp73" "siUBC9" "siUbc9-1" "siUbc9-2"
    "sibship" "side-chain" "side-effect" "side-effects" "side-population"
    "sigmoid" "signal-to-noise" "silencers" "silencin" "silica-induced"
    "silico" "sillico" "simpler" "simplest" "simvistatin" "single-base"
    "single-cell" "single-center" "single-chain" "single-channel" "single-dose"
    "single-drug" "single-letter" "single-nucleotide" "single-plex"
    "single-site" "single-strand" "sip53-treated" "sirtuin" "sirtuin-like"
    "sirtuin–indole" "site-specifically" "situ" "six-cycle" "six-oncogenic"
    "slow-growing" "slowed-down" "smMIPs" "small-GTP" "small-angle"
    "small-bowel" "small-cell" "small-molecule" "small-molecules"
    "small-nucleolar-RNA" "small-sized" "small-vessel" "smear-like" "smokers"
    "sodium-hydrogen" "sodium-induced" "soft-agar" "solenoid" "sotrastaurin"
    "spacer" "spacers" "spatial-temporal" "spatial–temporal" "spatio"
    "spatio-temporal" "specifier" "sphere-forming" "spheroid-induced"
    "sphingosine" "spike-in" "spiked-in" "spindle-cell" "spindle-like"
    "spindle-type" "spindlin" "splice-acceptor" "splice-related" "spline"
    "squamoid" "squamous-cell" "square-root" "srep15182" "srep15494"
    "srep15666" "srep15688" "srep15701" "srep15793" "srep15798" "srep15821"
    "srep15993" "srep16082" "srep16229" "srep16262" "srep16331" "srep16355"
    "srep16408" "srep16482" "srep16497" "srep16524" "srep16555" "srep16578"
    "srep16759" "srep16811" "srep16849" "srep16889" "srep16900" "srep16976"
    "srep17395" "srep17499" "srep17527" "srep17550" "srep17602" "srep17621"
    "srep17663" "srep17701" "ss" "ssDNA" "stability-conserving"
    "stably-infected" "stainings" "stand-alone" "standard-fat-diet"
    "standard-of-care" "state-of-the-art" "stategies" "stategy" "steady-state"
    "stellate" "stem-cell" "stem-like" "stem-loop" "stemloid" "stemness"
    "step-by-step" "step-up" "step-wise" "stepwise"
    "sterol-response-element-binding" "stilbene" "strand-breaks"
    "stress-activated" "stress-associated" "stress-induced" "stress-inducible"
    "stress-mediated" "stress-responses" "stress-responsive"
    "stress-stimulated" "stresses-induced" "stressful" "stressors"
    "stroke-like" "stromal-derived" "stromal-epithelial" "structure-activity"
    "structure-based" "structure-function" "structure–activity" "study-entry"
    "styryl" "sub-G" "sub-G1" "sub-Saharan" "sub-cellular" "sub-class"
    "sub-classes" "sub-classification" "sub-clones" "sub-diploid"
    "sub-fractionation" "sub-group" "sub-groups" "sub-lethal" "sub-lineage"
    "sub-maximal" "sub-nanosecond" "sub-optimal" "sub-pathway" "sub-pathways"
    "sub-population" "sub-populations" "sub-region" "sub-retinal" "sub-select"
    "sub-stoichiometric" "sub-strain" "sub-telomeric" "subG1" "subarachnoid"
    "subcomplex" "subdomain" "subfamilies" "subgroupings" "sublineage"
    "sublineages" "sublines" "subplate" "subsequent-line" "subset" "subsets"
    "subsites" "substituents" "substrate-like" "subtype" "successfull"
    "succinate-dehydrogenase" "succinyl" "succinyl-CoA" "sulfide"
    "sulfoxythiocarbamate" "sulfur-based" "sulpiride" "superantigen-like"
    "supercomplexes" "superfold" "supernatant" "supernatants" "superscripts"
    "supplementals" "supra-maximal" "surfacesof" "surgies" "survivors"
    "switch-like" "switched-off" "synapse" "synaptophsin" "synergism" "synon"
    "synonimous-synonimous" "synoptophysin" "synovia" "synthases-PG"
    "synthesis-independent" "synthetases" "t-SNARE" "t-circles" "tATP"
    "tBHQ-treatment" "tNSAIDs" "take-rate" "tamoxifen-inducibleGli1"
    "tamoxifen-inducibleNestin" "target-DNA" "target-capture-based"
    "target-gene" "taurinomethyl" "taurinomethyluridine" "telencephalon"
    "telomerase-mediated" "telomerase-positive" "telomere-proximal"
    "telomere-telomerase" "telomeropathies" "telorette" "teltail" "ten-eleven"
    "tens-of-minutes" "tetrachloride" "tetraploid" "tetrazine-TAMRA" "thalamus"
    "thatDdb1" "thatPLK2" "thatS6k1" "the16-week-old" "theAKT3" "theCd4Cre"
    "theCul4" "theK" "thePTB" "theTAdomain" "thenPTB" "therapy-induced"
    "thermo" "thiadiazolidinone" "thio" "thiophene" "thoraco" "thoraco-lumbar"
    "three-dimensional" "three-stage" "three-step" "three-tube" "three-way"
    "threonine-specific" "thrombocythemia" "thrombus" "thymidine-to-guanine"
    "thyroidectomy" "tightly-regulated" "time-average" "time-course"
    "time-dependently" "time-invariant" "time-lapse" "time-point" "time-points"
    "time-scale" "time-series" "time-space" "time-tendency" "timeline"
    "timepoint" "time‐dependent" "titer" "to-date" "to150" "toDdb1"
    "toEGFRtyrosine" "toH2AX" "tobacco-smoking" "toll-like" "toolbox"
    "top-down" "topologies" "topology" "toremifene" "total-STAT3" "totel1"
    "toxicants" "tract-binding" "tradeoff" "tranfectants" "trans-activator"
    "trans-cellular" "trans-cyclo-octene" "trans-regulatory" "trans-tail"
    "transcript-1" "transcript-specific" "transcription-quantitative"
    "transcription–PCR" "transcription–quantitative" "transcriptome"
    "transcriptomes" "transdifferentiate" "transducer" "transfectoin"
    "transferase-1" "transgenes" "transit-time" "transmembrane-4"
    "transmigrate" "transmodulate" "transplantation-induced" "transwell"
    "transwell-invasion" "transwells" "trasuzumab" "treated-cells"
    "treatment-naïve" "tri-helical" "tri-lineage" "tri-potency"
    "tri-potentiality" "trial-by-trial" "trichrome" "triggerd" "trinucleotide"
    "triphosphate" "triple-hit" "triple-knockout" "triple-negative"
    "triple-point-mutation" "triple-staining" "triptans" "trisomy"
    "trisphosphate" "trogen" "tromethamine" "tropolone" "tube-like" "tubule"
    "tubules" "tug-of-war" "tumor-cytokine-miRNA" "tumor-driver"
    "tumor-intrinsic" "tumor-like" "tumor-specificity" "tumor-sphere"
    "tumor-spheres" "tumor-suppressive" "tumor-surveillance" "tumorosphere"
    "tumorospheres" "tumorspheres" "tumour-initiating" "tumour-mediated"
    "tumour-promoting" "tumour-suppressive" "tumour-suppressor" "turanica"
    "turn-over" "tussues" "twenty-first" "twenty-five" "twenty-six"
    "two-and-two" "two-base" "two-binding" "two-carbon" "two-class"
    "two-compartment" "two-domain" "two-gene" "two-hit" "two-hybrid"
    "two-layer" "two-pronged" "two-side" "two-site" "two-step" "two-tailed"
    "two-thirds" "two-times" "two-week" "type-1" "type-2" "typhimurium"
    "tyrosine-protein" "tyrosyl" "ubiquitin-7-amido-4-methylcoumarin"
    "ubiquitin-HA" "ubiquitin-proteasome-mediated" "ubiquitome"
    "ubiquitously-expressed" "ubiqutin" "ufm" "ufm1-conjugation" "ulnar"
    "ultra-centrifugation" "ultra-deep" "ultra-low" "ultrafine"
    "ultrastructure" "ultraviolet-induced" "ultraviolet-inducible"
    "ultraviolet-irradiated" "un" "und" "under-expressed" "under-participation"
    "under-replicated" "under-researched" "under-treatment" "undergoes"
    "undergone" "underpinnings" "undertaken" "underwritten" "uni" "univariate"
    "unmet" "unresponsiveness" "up-regulator" "up-stream" "up-to-date"
    "up‐regulated" "up‐regulation" "urea" "ureter" "utero" "uveal"
    "v-SNARE–like" "vacuole" "vacuoles" "value=0.03" "variance-covariance"
    "vasculatures" "vedotin" "vehicle-treated" "vena" "ventriculostomy" "vera"
    "vergae" "vesicle-coat" "vesico" "vesico-ureteral" "vessel-associated"
    "vessel-specific" "vestigial-like" "vi" "villi" "villus" "viremia"
    "viscera" "vitro" "viverrini" "vivo" "viz" "vol" "voltage-gradients" "vs.1"
    "vs.10.0" "vs.12.0" "vs.14.0" "vulgaris" "water-soluble" "wave-like"
    "web-based" "website" "websites" "weeks" "well-accepted" "well-conserved"
    "well-defined" "well-designed" "well-developed" "well-differentiated"
    "well-differentiation" "well-documented" "well-measured" "well-studied"
    "well-suited" "well-tolerated" "well-vascularized" "werenPTB"
    "western-style" "whenTAp73" "whole-blood" "whole-cell" "whole-exome"
    "whole-genome" "whole-tumour" "whole‐body" "wide-scale" "wide-spread"
    "widefield" "widely-expressed" "wild‐type" "withDdb1f" "withEGFR"
    "withEGFR‐TKI" "withdrawn" "wk" "wks" "woodchucks" "workers" "workflow"
    "workhorses" "workup" "world-wide" "wound‐healing" "wtih" "wtp53" "www"
    "x-ray" "x10" "xeno" "xeno-estrogens" "xeno-transplantation"
    "xenograft-transplantation" "xl" "year-to-year" "ylmethyl" "z-score"
    "z-scores" "zeroes" "zinc-induced" "×10" "×S" "× 10" "× 10" "× 10" "÷14"
    "ʹend" "Δ148–314" "Δ169" "Δ245–373" "Δ3" "Δ31–147" "Δ5" "Δ5 " "Δ60" "ΔC"
    "ΔC-terminal" "ΔC11" "ΔC3-7" "ΔC7" "ΔCD" "ΔCt" "ΔE5" "ΔE9" "ΔGBD" "ΔIgG"
    "ΔKD-2" "ΔKD2" "ΔLRR" "ΔM" "ΔN" "ΔOB" "ΔPB1" "ΔROCK2" "ΔUBA" "ΔZZ" "Δcells"
    "Δkinase" "Δmec1" "ΔΨm" "Δψ" "ΙΚΚ-β" "α-8-oxoguanine" "α-CD28" "α-CD3"
    "α-EF" "α-G" "α-IL23" "α-Me-COOH" "α-Thr172" "α-aminophosphonate"
    "α-carbon" "α-carboxyl" "α-chains" "α-granule" "α-helical" "α-helix"
    "α-integrin" "α-integrins" "α-level" "α-methyl" "α-methylated" "α-motif"
    "α-myc" "α-particles" "α-subunit" "α-tail" "α-tails" "α-β" "α1-TAT" "α10"
    "α11" "α2-adrenergic" "α2β1" "α3" "α4" "α4β1" "α5" "α6" "α6β4-plectin" "αC"
    "αIIb" "αv" "α–integrin" "β-adrenergic" "β-carbon" "β-catenin-YAP"
    "β-cateninaxis" "β-chain" "β-glycerophosphate" "β-hydroxybutyrate"
    "β-integrin" "β-lactose" "β-oxidation" "β-sheet" "β-sheet-like" "β-sheets"
    "β-subunit" "β1AR" "β2-MG" "β3-tubulin" "β4-S1356" "β4-S1364" "β4-T1736"
    "β4-keratinocytes" "β5-subunit" "β6" "β8" "β‐cell" "γ-H2A" "γ-aminobutyric"
    "γ-glutamyltransferase" "γ-irradiation" "γ-phosphate" "γ1" "γ2" "γ3" "γH2A"
    "γH2Ax" "κB" "κt" "μM–30" "μW" "μg" "μg " "μl" "μm-wide" "μmol" "τm"
    "ϕH2AX" "кB" "‘ETGE’" "‘Oncomine’" "‘antagomirs’" "‘pLYN’" "‘responder’"
    "‘sensitizer'" "‘teltail’" "∆Np73" "∆Ψ" "∊-amino" "−0.1" "△CT" "、p53"))

(DEFPARAMETER SPARSER::*BIO-ENTITY-HEADS-PHASE3-16201-16500*
  '("succinyl" "supercomplexes" "mitoribosomes" "argonauta"
    "near-cognate codons" "•U34" "anticodon" "U-type" "codon:anticodon"
    "anticodons" "taurinomethyluridine" "methylaminomethyluridine"
    "carboxymethyluridine" "methyluridine" "GTPBP3-" "GTPBP" "isoenzyme"
    "oxalacetate"
    "5-aminoimidazole-4-carboxamide-1- β -D-ribofuranoside (AICAR)"
    "stability/assembly" "subcomplex" "cicloheximide" "subunit A6"
    "polarography" "hydrolysates" "mnm5s2UUU" "thio" "APM" "phenyl"
    "-acryloylamino" "acryloylamino" "non-substrate" "shGTPBP3-1" "τm"
    "taurinomethyl" "MnmG" "UUR" "cardiomyopathies" "encephalomyopathy" "MELAS"
    "cytochome" "ETF-ubiquinone" "ETF" "ETFs" "TCAC" "CIV" "CoQ" "shGTPBP3"
    "pathomechanism" "5-aminoimidazole-4-carboxamide-1- β -" "hnRNPLL"
    "exon/junction" "SRPKs" "member U2AF2" "RIPchip" "U2AF2/U2AF1"
    "protein/RNA" "organizational topology" "ELISAs" "PhosphoS" "PhosphoT"
    "ProteinPilot" "eluates" "Interactome" "the proteomic datasets" "NFKB"
    "fpkm" "ImmuneMap" "GOSlim" "expressed/alternatively" "sashimi" "ASPIRE"
    "edgeR" "a unique protein interactome" "RIPseq" "CLIPseq" "UHM" "ULM"
    "JSL1" "interactomes" "SYNCRIP" "CIMs" "~80%" "40x" "villi" "Plessl"
    "Haider" "HELLP" "Prusac" "Simpson" "± SD" "10.1038/srep17621" "Tiwari"
    "Bernatchez" "Matsui" "siRNAas" "STIL" "ESSRA" "#63" "#213" "#188" "#184"
    "15/25" "6/25" "#199" "#194" "2/17" "15/17" "2/25" "19/25" "LSSLPKRLCLV"
    "monopartite" "11q13.1" "lpha" "trogen-" "trogen" "es" "GLOBOCAN" "subG1"
    "10.1038/srep17499" "Karachaliou" "DGKa" "LREA" "low/intermediate"
    "1.83–2.96" "0.91–1.97" "Colombia" "EURTAC" "H1975"
    "extracellular signal–regulated kinase 1/2" "10.1038/ncomms10100"
    "GBR12909" "nomifensine" "sulpiride" "autoreceptors" "HBSS"
    "dopaminergic markers AADC" "AADC" "p53 shRNA" "AG22056" "AG16146"
    "GM00731" "LU" "TGFβ3" "purmorphamine" "CHIR" "5.5±0.4%" "8.9±0.7%"
    "Dulbecco's" "Dulbecco" "-deoxyuridine-positive" "ANLp" "ANLmp21" "ANLm"
    "plugin" "NeuronJ" "ImageJ" "/DAPI" "ANLmp" "miRNA124" "ANL" "epigenome"
    "Jiang" "=7" "co-stained" "day 7" "5-ethynyl-2" "Tuj1" "10.1038/srep17602"
    "deacetylating H3K9" "IPS" "IPF" "OA + " "OA+" "Ba" "Ik" "colleagn"
    "SA-β-gal" "Safranin-O" "10 ng/ml" "2 mg/mL" "R&D" "IL-1β were"
    "formation/flux" "BY719" "only modest anti-proliferative" "SAR405"
    "GFP-LC3+" "h" "GFP+" "p110α-targeting using EZN4150" "LC3I" "EZN3046"
    "EZN4150" "caspase3/7" "LC3II" "~25 %" "Vogelstein" "Yrich"
    "the roughly 5 kb intron" "exon 4/5" "hexanucleotide" "TAII" "TAI" "Engel"
    "Perou" "5/6" "polysomy" "CEP7" "Albiges" "papillae" "Eble" "Delahunt"
    "CRCC" "≥6" "non-random" "the autophagic vacuoles" "Leontieva"
    "mTORC1-S6K-S6" "microautophagy" "pase" "Gomori"
    "significantly extended autophagic vacuoles" "TMRM" "incompleteness"
    "only sporadic vacuoles" "Thr37/46" "70S6 kinase"
    "single membrane-bound autophagic vacuoles" "p62/SQSTM" "и" "rapalogs"
    "pp242-" "pp" "10.1038/srep17701" "Turato" "onco" "displasia" "HepG2/SB3"
    "lipofectamine" "PUGH" "SerpinB3a" "Serpinb3a" "hepatoblastomas" "N = 6"
    "10.1038/srep17527" "Yamao" "Dictyostelium" "auto-correlation"
    "the spatiotemporal auto-correlation" "V-shaped" "a characteristic V-shape"
    "Kronecker" "/2" "−k" "j  " "protrusion/retraction" "Förster" "+  1"
    "subsequent thyroidectomy" "aggressive PTMC" "PTMCs"
    "fluorodeoxyglucose (FDG)" "Positron" "tomography/computed" "PTMC"
    "thyroidectomy" "g/mL" "± SD" "= 150" "= 0" "10.1038/ncomms10068" "Duan"
    "co-occupied" "5hmC" "5mC" "hydroxymethylcytosine" "RRBS" "SA-β-Gal"
    "vasculatures" "TALEN" "neural precursor/stem cells" "instates" "C/C"
    "GC/MS" "GC–MS" "anti-Human" "non-neural" "precursor/" "=1.000"
    "non-smoking" "Kirsten rat sarcoma viral oncogene homolog (KRAS)"
    "homolog (KRAS)" "mean±SD" "10.1038/srep17663"
    "form four-stranded potassium-dependent intramolecular G-quartet"
    "G-quartet" "Gefiinib" "harringtonia" "Cephalotaxus" "flavonolignan"
    "a natural polyphenolic flavonoid" "marianum" "Silybum" "LY5" "stategy"
    "bresat" "Timofeeva" "Lys-9trimethylation" "activityof" "ODNs"
    "oligodeoxynucleotidesve" "RacGAP" "nRTKs" "non-peptide" "co-repressors"
    "2B" "MiR-519d" "YP" "Abcodia" "honoraria" "CEW" "IJJ" "DGE" "ANR"
    "P-mediated" "premenopause" "postmenopause" "ductal ( xref c) epithelia"
    "oestrogen/progestin" "CEE " "CEE" "Dunnett" "covariance" "zeroes"
    "centiles" "bootstrap" "LRT" "LRTs" "restricted cubic spline" "spline"
    "74F1" "pg/ml" "Waltham" "PeproTech" "Amgen" "soluble recombinant huRANKL"
    "&D" "huRANKL" "microplates" "microplate" "Minneapolis" "sOPG" "CVs"
    "interassay" "CV" "Mannheim" "GmbH" "Roche" "analyser" "Elecsys"
    "tissue/serum relation" "oestrogens" "antiprogestogens" "≥ 3" "= 0.009"
    "= 0.003" "= 0" "= 150" "= 88" "IRIFs" "Rad9p" "-53BP1-BRCT 2" "eYFP"
    "ionic" "bis" "-SLPGAGLSpSQELSGG" "SLPGAGLSpSQELSGG" "∼3.5-fold"
    "SGGKKATQApSQEY" "H4K20" "H2AK13" "Baldock" "non-linear" "Ser1981"
    "surface/extracellular" "/CD38 +" "CD66" "rfu" "Pulldown" "unit/ml"
    "superantigen-like" "SEIX" "thrombus" "Ecb" "Ehp"
    "the aforementioned coagulase-like" "Sbi" "SCIN" "Eap" "osteomyelitis"
    "endocarditis" "ligand-1" "Efb" "CD38 +" "noncaveolae" "Smads" "2T3"
    "C3H10T1/2" "calvaria" "Live/Dead" "non-caveolar" "glycerophosphate"
    "these cholesterol-rich membrane microdomains" "C3H" "+ 2" "+ 10 " "+ 10 "
    "spatio" "SSBR" "F1F2F3" "HXMS" "subdomain" "AP" "and 2B" "SAXS" "k"
    "Overhauser" "isothermal calorimetry (ITC)" "ITC" "calorimetry" "F1F2"
    "Eustermann" "co-operative" "apurinic/apyrimidinic" "and 2E" "indocyanine"
    "Cardoso" "Monig" "Pathological T-stage" "T-stage" "preoperative histology"
    "postoperative histology" "preoperative and postoperative histology"
    "2= 0.110" "EUS" "EGD" "more limited lymphadenectomy"
    "underwent gastrectomy" "lymphadenectomy" "≥10 " "= 9" "= 0.009"
    "‐negative" "DNA‐damaging" "Mattew" "‐damaging" "Jie" "centrioles" "∆Np73"
    "up‐regulation" "‐abnormal" "‐treated" "TAp73‐KD" "‐healing" "‐KD"
    "half‐life" "autoradiography" "‐life" "siTAp73" "phos‐Tag" "‐TAp73" "‐tag"
    "co‐IP" "‐IP" "Songyang" "‐polo" "databasethat" "PhosphoSite" "Llamazares"
    "overexpressingTAp73" "inTAp73" "‐phosphorylatedTAp73" "theTAdomain"
    "phosphorylatesTAp73" "thatPLK2" "ofTAp73" "wild‐type" "‐dependent" "Δ Ct"
    "Real‐time" "TAp73 S" "48A" "TAp73S" "Tap73" "‐binding" "‐like" "TAp73"
    "CI1040" "CD38+" "MCL-1expression" "the very strong synergism"
    "MEKI/ABT-263" "CD123+" "MNC" "cleavage/activation" "MEKI" "100 ng/mL"
    "BEV" "kd" "HRG-β1" "Tyr 1221/1222" "coculture" "TCM" "progestin"
    "derivate" "Folkman" "Judah" "-β1" "tumor paracrine" "re-establishment"
    "-β1-induced" "Anti-angiogenesis" "phosphorylating Y357YAP1" "Ser127YAP1"
    "CYT 387" "p-Ser127YAP1" "TK10" "heatmaps" "Momelotinub" "reboot" "CYT387"
    "pStat3" "Szczepankiewicz" "Labute" "Clark" "crystallo" "Sirt" "SirReal2"
    "alkyl" "DMP" "dimethylpyrimidine" "–CHIC35" "C-site" "§" "EX243"
    "C-site (ECS)" "C-pocket" "Westerberg" "Süssmuth" "Solomon" "selisistat"
    "CHIC35" "Napper" "EX" "CHIC35  " "just 1 d" "Moniot" "and 3:1" "Hampton"
    "cosubstrate" "ribose  " "Avalos" "codeis" "Obmolova" "Ireton" "microseeds"
    "Stoddard" "Arcy" "Bergfors" "Stura" "Rumpf" "Yamagata" "Schafer" "Nguyen"
    "Gertz" "Disch" "-acetyl-ADPR" "alkylimidate" "Rossmann" "Zhao" "Finnin"
    "Lombard" "Lancelot" "Alhazzazi" "Kim" "Outeiro" "Milne" "Chuprin"
    "Hirschey" "Serrano" "Vaquero" "Schemies" "Bordone" "Howitz" "ribosylases"
    "Teng" "Bao" "Du" "Feldman" "Brachmann" "∊-amino" "ribose (ADPR)" "ADPR"
    "Sirtuins" "isotypes" "S -enantiomer" "C α" "v / v" "Durante" "alia" "DIO1"
    "Giordano" "Durand" "Hébrant" "Knauf"
    "sessile serrated colorectal adenomas and sessile serrated adenomas dysplasia"
    "sessile" "the cribriform–morular PTC subtype" "Histopathology"
    "normal/benign" "TDS" "pseudoinclusions" "BRAFV600E" "Guerra" "Faustino"
    "Cohen" "Davies" "BRAFV600" "homing/adhesion" "mesothelium" "SNAKA-51"
    "SNAKA" "TurboGFP" "shCTRL" "transcription/translation" "LPARs" "omentum"
    "1/7" "7/7" "cytopenias" "NEPC/SCPC" "an aggressive subtype" "SIL"
    "TRAMPC2" "intracardiac" "four public datasets" "QD" "bonafide" "innervate"
    "CHGB" "NEPCs" "antigen (PSA)" "TRAMPC" "CHGA" "NEPC" "non- targeting"
    "/mL" "MDB-forming hapatocytes" "hapatocytes" "form active holoenzymes"
    "FASTKD5" "photomicrograph" "UfSP1" "Ufm" "≥2" "PCA"
    "A representative AH biopsy" "ufm" "re-fed" "MDBs" "Denk" "D-type" "CXCL14"
    "re-evaluated" "Cip/Kip" "dasatinb" "Titer" "CCLE" "GDSC" "pLats1/2" "U133"
    "Cal12T" "pCDC2" "pChk1" "pMST1" "pLats1" "LATS1/2" "MST1/2" "p-70S6K"
    "1.06–3.14" "viscera" "≥ 30%" "21-day" "mg/m 2" "loss/mutations" "= 0.038"
    "Δ3" "SGC7901/VCR" "miR-27b" "miR-508-5p" "Thailand" "Fachiroh"
    "two independently associated polymorphisms" "rs2736100"
    "a synonymous coding SNP" "another associated polymorphism" "McKay"
    "CLPTM1Lhas" "fMSCs" "HapMap" "= 1.12–1.35" "1.04–1.37" "Meff" "SpD"
    "rs402710" "rs2736098" "5p15.33" "normal nasopharyngeal epithelium"
    "celllines" "1-like" "person-years" "rs401681" "rs2735845"
    "the associated polymorphism" "Guangdong" "Guangxi" "at 5p15" "U/mL"
    "= 0.91" "= 0.78" "= 1.12" "non-carriers" "ß-cell" "a Chi-squared p =0"
    "Garcia" "Burguete" "mellitus (DM)" "Fahad" "Eastern Saudi" "Saudi"
    "Saudis" "re-analyzed" "male/female" "10x" "Type-2" "Rela"
    "NLRC5-bound IKKs" "IKKs" "active TRAF2/6" "nonredundant" "IKK-α/-β" "NLRC"
    "toolbox" "PottersWheel" "pIKK-β" "andand" "-β"
    "TNF receptor–associated factor (TRAF) 2/6" "2/6" "BMMs" "TRAF2/6"
    "Anti-Flag" "anti–HA" "/ml" "S5 H" "S4 C" "NOD-like" "switch-like"
    "10.1038/srep17395" "db / db" "phosphoenolypyruvate" "SIRTs" "glycemia"
    "dyslipidemia" "K5Q" "K5R" "deacetyl" "PAIL" "db/db"
    "sterol regulatory element-binding protein-1c" "T2DM" "GKRP"
    "co-overexpression" "type-2" "10.1038/ncomms10029" "Truebestein" "iPALM"
    "Shrm" "Shroom" "spacers" "the unicellular eukaryote Capsaspora owczarzaki"
    "owczarzaki" "Capsaspora" "platyzoa" "flatworms" "nematoda"
    "phosphotransfer" "107-nm" "Dbs" "Folch" "FSEC" "ΔROCK2" "Darby" "Madin"
    "RMLC" "spacer" "0–1 " "Δ5 " "considering 8-oxo-dG" "mimicker" "siGSK3β"
    "siCTL" "some characteristic nuclear mitotracker" "mitotracker" "CMTMRos"
    "DCHF" "growth arrest and DNA damage–inducible protein 45β" "45β"
    "dyslipidaemia" "8-oxo-dG" "nonobese" "GADD45β" "-dichlorofluorescin"
    "dichlorofluorescin" "Mitotracker" "8-oxo-deoxyguanosine" "gene/protein"
    "= 9" "= 0" "10.1038/srep17550" "Sironi" "NPOS" "AML5" "non-regulators"
    "anti-leukemic" "Fms" "LIC" "= 0" "10.1038/ncomms9859" "Bunda"
    "II-B08-treated" "acetylcholine" "EpY" "FV" "Tukey" "viii" "Raf:RBD"
    "RasB8p0" "RasB8p3" "RasB8" "monobodies" "tyrosyl" "Noonan" "condons" "8 p"
    "c-Src-mediated" "10.1038/ncomms10075" "Tollenaere" "co-purified"
    "S47A/S78A" "SSX2IP" "Difopein" "RSXpSXP" "to 14-3-3" "RXXpS/T" "SILAC"
    "MAPKAP" "6 p" "Z-Stacks" "a 10:1" "Inge" "Rajal" "=1.698–9.336" "HR=3.981"
    "hematuria" "pathogenesy" "non-small cell lung carcinomas" "19p 13.3"
    "10.1038/ncomms9979" "AMP/ADP" "Houde" "shPIAS" "shPIAS4-5" "AMPKβ1"
    "siPIAS4" "6His–SUMO3" "NEM+" "SUMO2/3-" "+AICAR" "Pias1–4" "AMPKγ1"
    "AMPKα2" "Sip2" "AMPKγ" "-ribofuranoside" "ribofuranoside" "45-μm" "by 100"
    "HDF" "10.1038/ncomms9897" "Suberbielle" "microhomology"
    "non-neuronal cell" "Aβ-" "perforant" "metenkephalin"
    "2H3(K9) immunoreactive punctae" "fEPSPs" "scr-" "Scr" "extramaze" "hidden"
    "MWM" "Morris" "pH" "scr" "hAPP/Aβ" "punctae" "Braak" "γH2A" "Aβ"
    "the neuronal genome" "Alzheimer's" "Z-stacks" "p–ERK1/2" "1:50,000"
    "month-old" "=9" "non-dividing" "=0" "≥3" "5G-I" "Dbb1" "::MxCre"
    "stainings" "toH2AX" "MxCre" "Littermate" "day 5" "CD150+CD48-" "Lin+"
    "VavCre +" "Ddda1" "Dcaf11" "Dda1" "ddrb1" "Cang" "EIIaCre" "#11"
    "Regarding Essential Revision point #7" "dcaf11" "dda1"
    "Regarding Essential Revision point #6"
    "Regarding Essential Revision point #5" "ddb1-deficient" "WBCs" "VavCre"
    "interactome" "Avinash" "Hui" "Morrison" "Sean" "Kronke" "CUL4A/B"
    "DDB1-associated DCAFs" "neg" "retroviruses" "DCAF11" "DDA1" "endoderm"
    "Gfap" "deficiect" "γH2Ax" "deficinet" "AnnexinV/7AAD" "cKit +"
    "non-polyI:C" "repopulate" "littermate" "injectedDdb1" "inDdb1" "day7"
    "::Mx1Cre" "polycytidine" "polyinosine" "Mx1Cre" "InDdb1" "::Vav1Cre"
    "Mecom" "ofDdb1" "Vav1Cre" "cytopenia" "LSKs" "CUL4-DDB1 ligase"
    "CUL4-DDB1ligase" "CUL" "DCAFs" "=5" "f/  f"
    "cyclin-dependent kinase inhibitor 1A" "CD3 +" "polyI:C" "Gr1 +" "B220 +"
    "S202/S204" "Coomassie" "formation/progression" "GENT" "ICGC" "S9/S21"
    "PP2AB56" "non-tumour (NT)" "SKP1-Cullin-Fbox-βTrCP" "shLUC" "PP2AB"
    "HumanPhospho" "D3H2LN-" "overexpression/hyperactivation" "D3H2LN"
    "MDA-MB-231-D3H2LN" "V12Ras" "pMXs" "B55β" "B55α" "holocomplexes"
    "holoenzymes" "PP2AB55" "T202/Y204" "/well" "migration/invasion"
    "MDA-MB-231 cells " "auto-activating" "auto-activate" "retro"
    "auto-activates" "‘sensitizer'" "kiri" "~60%" "non-transformed"
    "Non-malignant" "PNAS" "Sigismund" "RE-biogenesis" "D/A" "micrograph"
    "Cyclohexamide" "widefield" "pY1045" "Yudushkin" "Offterdinger"
    "rephosphorylate" "reroutes" "Shp1/2" "RPTPs" "RPTP" "non-cbl" "auto-"
    "non-EGFR" "non-liganded" "X-axes" "actual co-localization"
    "an ER-associated phosphotyrosine phosphatase PTB-1B" "PTB-1B" "Schmid"
    "Lamaze" "Vieira" "reroute" "PT1B" "overseen" "LE" "RPTPA" "RPTPJ"
    "unresponsiveness" "anterograde" "EE" "TIRF" "Rab5-mCherry-positive EEs"
    "128TCOK" "TCOK" "~7.6min" "paGFP" "tyrosines 1148/1086" "anisotropy"
    "eightfold" "abscissa" "mCitrine" "EEs" "CCVs" "Xouri" "Schmick"
    "Brüggemann" "Baumdick" "transit-time" "re-routing"
    "The inevitable tradeoff" "tradeoff" "# 2" "non-intuitive" "=0.001" "2 +"
    "3 +" "1 +" "19Del" "EFGR" "crossover" "or 2nd-line" "in 1st" "TORCH"
    "IPASS" "to 2nd-line" "chemotherapy/2nd" "TKIs/2nd" "and 2nd-line" "Yang"
    "Rs1048315" "Xx" "Pp" "XbaI" "PvuII" "cholangiopathies" "cholangiopathy"
    "Pugh" "Valencia" "Qiagen" "PyroMark" "Obispo" "Luis" "rs1048315"
    "rs223469" "synon" "Intron" "SNPbrowser" "TBIL" "underwent liver biopsy"
    "endoscopic retrograde cholangiopancreatography" "cholangiopancreatography"
    "immunoassays" "AMA" "Haplotypes" "rs3798577" "rs2228480" "rs2234693"
    "rs1256030" "Jilin" "U/L" "10.1038/ncomms9681" "femtosecond" "microbeam"
    "autophagic cargos" "paraxial mesoderm" "the cephalic mesenchyme" "Inka2"
    "KIIN" "K09E9.4" "PKAc" "DAck" "Minamide" "PF-03758309" "SIM" "CAAX"
    "co-crystals" "PAKcat" "RPKPLVDP" "Å-diameter" "helices" "RSRQPlvl" "+3"
    "Cα" "IKQ" "RRGA" "Ramachandran" "LVLGD" "RSRQ" "24mer" "A-loop" "αC"
    "beamline" "microfocus" "cryoloops" "iBox38" "active PAK4cat" "2/3rd" "PLV"
    "PAK4cat" "iBox" "Inka" "microcrystals" "Leyden" "Charcot"
    "pseudosubstrates" "Baskaran" "Inka1" "gastrointestinal endoscopy"
    "endoscopic hemoclips" "hemoclips" "Mehenni"
    "gastrointestinal polyp dysplasia" "XI" "more endoscopic screenings"
    "Case 6’s" "481het" "+ 1 G " "C/G" "_139del19insTT" "_del" "_804 het"
    "_delGT" "_349het" "CCinsG" "_944 het" "laparotomy" "flexure" "polypectomy"
    "sigmoid" "antrum" "underwent three laparotomies" "underwent laparotomies"
    "endoscopies" "Gansu" "Hainan" "Jiangsu" "Jiangxi" "Anhui" "19p13.3"
    "Jeghers" "Peutz" "G/A" "l19insTT" "+ 1G " "_delG" "_delCCinsG" "_dupA"
    "laparotomies" "screenings" "mucocutaneous melanin" "non-catalytic" "+ 1 "
    "Case 6" "Case 1" "μmol/l" "C/T" "+ 1" "the postprandial dysglycaemia"
    "dysglycaemia" "‐reactivity" "radioimmunoassays" "‐hyperglycaemic" "‐body"
    "‐cell" "‐IR" "HOMA" "‐β" "pmol/l/min" "mmol/l/min" "2‐h" "pmol/l" "‐h"
    "mmol/l" "‐wide" "rs11212617" "ofATMin" "glycaemia" "inAtaxia" "Matsuda"
    "mg/dl" "= 0.03" "cellular miR423-5p" "posttransplant" "coplayers"
    "Non-Hodgkin's" "ASR" "LI" "3/85" "1/5" "co-ordinator" "ARR" "ScrTAT"
    "cpdm" "L261A/F263A" "E260A/L261A" "V240A/L242A" "RanBP" "superfold"
    "ITGB2s" "ITGB1s" "FERMTs" "TALINs" "microvessels" "PDGF-B/PDGF-Rβ"
    "heterozygotes" "a benign polymorphism" "XPR1" "A1096V" "Contreras"
    "Sanchez" "myelencephalon" "non -prone" "mesencephalon" "cadaverine"
    "the dorsal pons" "pons" "+/0" "histostains" "redeye/+" "redeye/redeye"
    "+2" "redeye" "hypomorphs" "HBPs" "*242Yext*89" "*242Yext"
    "a major ≈14-kDa" "L9R" "*89" "PDGF-B/" "PFGC" "Fahr’s" "Parkinsonism"
    "IBGC" "Fahr" "learnt" "IMF" "BBB" "non-calcification-prone" "ret/ret"
    "PFBC" "x 10" "TRIM7" "ATCC" "403aa" "MEV" "TRIM76" "TRIM67" "TRIM70"
    "TRIM66" "Raheja" "±0.9%" "Buzzai" "HCT116 p53 +/+" "the proneural subtype"
    "10/10" "ihHTC" "ihSTC" "ihCTC" "ihBTC" "David" "±0.16"
    "oligodendroglioma-like" "IhBTC2" "hyperpentaploid" "blocker" "SU3-5R"
    "SU3" "ihBTC2" "Caspase 3/7" "X10" "2 Gy" "cellulo" "Bild" "Neve" "XRab40"
    "multisubunit" "RhoUr" "ΔGBD" "Sharpin" "SHANK" "supplementals" "HuProt"
    "ubiquitome" "topologies" "GBD" "RhoV" "RhoG" "PAK4r" "V2.0" "U/ml" "1 E"
    "significantly faster tumor regrowth" "loss/mutation" "10-day-old"
    "vehicle-treated littermates" "cresyl" "SABG" "p53ER" "reenter" "sPNET"
    "15/20" "17p13.1" "H3K9" "10.1038/srep16889" "Qian"
    "other known clinical pathological covariates"
    "the most significant (lowest P -value) covariate" "Canada" "SWE" "Sweden"
    "JPN" "NFE2L2-" "NFE" "TWN" "Taiwan" "Kyoto" "diagnosis/prognosis"
    "Nuclear factor, erythroid 2-like" "enhancer/promoter" "QTL"
    "asaccharolyticus" "Peptoniphilus" "Discriminant" "hoc" "Willis" "LEfSe"
    "corneum" "vulgaris" "rs6996321" "cibaria" "Weissella" "Propionium" "flora"
    "Brevibacterium" "Roseomonas" "ANOSIM" "microbiotas" "UniFrac" "NTSI"
    "Taxon" "Nearest" "metagenome" "PICRUSt" "Bacteroidetes" "Actinobacteria"
    "sebum" "DZ" "jeikeium" "Corynebacterium" "microbiota" "2  + "
    "hidradenocarcinomas" "Nonaka" "Higgins" "Tilson" "acrospiromas" "basaloid"
    "reactive epidermal squamous epithelium" "Deftereos" "Kurek" "Krahl"
    "Sellheyer" "Chikh" "Henley" "Huxley" "Kaufman" "1+"
    "sebaceous adenomas and 3+" "and 3+" "3+" "some mature sebocytes"
    "sebocytes" "adenoid" "eccrine" "chondroid" "papilliferum" "colonosphere"
    "Prabhu" "Ly6E" "Mammospheres" "non-adherent" "anti-human" "10 ng/ml"
    "CD44+" "non-stem" "p53-p21-DREAM-CDE/CHR" "Löhr" "McKenzie" "Zhu" "Gac"
    "E1b" "dependet" "CDE/CHR" "browser" "PhastCons" "p53-p21-DREAM-CDE" "KIZ"
    "centriole" "CDE" "CHR" "MuvB" "μg / ml" "G 1 /S" "APC/C" "Beaven" "Juvet"
    "vehicle-treated hMSCs" "22OH-C-" "22OH-C" "hydroxycholesterol" "10b"
    "anti-adipogenic" "Walkersville" "Cambrex"
    "differentiated adipocytes exhibited lipid droplets" "droplets"
    "3-isobutyl-1-methyl-xanthine (IBMX)" "penicilline" "GlutaMax" "LXRKO"
    "Crossno" "Liechty" "mMSC/GFP" "mMSC" "mMSCs" "LXRα" "ob/ob" "= 12"
    "support/fees" "Baggott" "Katy" "Dravet" "FP7" "Eisai" "Weil" "Studentship"
    "UCL" "Wellcome" "categorise" "‘responder’" "chairperson" "Southmead"
    "Katherine" "stringent genotype" "KDTs" "rs5216" "_004322.3:c" "responder"
    "rs41282930" "SIFT" "pufferfish" "Tetraodon" "_00525.3:c" "≥50%"
    "missingness" "PLINK" "176/303" "22/303" "Boston" "hydroxybutyrate"
    "Cochran–Mantel–Haenszel" "KDT" "= 0.002" "n  = 6" "= 5"
    "prophylactic controlateral mastectomy" "HRT" "sequelae" "Carlo" "Monte"
    "surgies" "BMMR" "ovarian cancer OC" "bilateral mastectomy (BRRM)" "BRRM"
    "RRSO" "salpingo" "BRCA 1/2" "BRCA 1 / 2" "doman (DBD)" "doman"
    "deazaneplanocin" "DZNep" "mortem" "formaton" "anti-miR-26a" "HEC-50"
    "miR-26a-2" "miR-26a-1" "FIGO" "Mutp53" "pri-miR-26a-1" "pri" "mutp53"
    "1~2" "Let-7b" "miR- 26a" "co-injection" "/FOXP3+" "CD4+/CD25" "Polimeno"
    "T cells/RCC" "lentiviral shERβ" "shER" "interactiong" "HKC-2"
    "curative nephrectomy" "2 mg/ml" "re-seeded" "± 0.1" "IIa" "GEMMs" "GEMM"
    "angio" "NXRN" "NXRN3" "NXRN1" "GPLD1" "SCG2" "TL" "angiocrine" "GSEAs"
    "34/54" "Lo" "∼13%" "∼47%" "∼18%" "microvasculature"
    "intense tumor desmoplasia" "desmoplasia" "∼12%" "≥ 1" "JAK1-3" "∼63%"
    "= 1.17" "∼55%" "∼35%" "PIKKs" "pombe" "Schizosaccharomyces"
    "doublings (PD)" "doublings" "POT1ΔOB" "PIKK" "ΔOB" "Co-localizations"
    "~25%" "~95%" "~85%" "mTR +" "yet bulk telomere lengths oftel1 ATM Δcells"
    "Δcells" "=0.03" "VE821" "siATM" "SL13" "‘teltail’" "PacBio" "mTR+"
    "IScerette" "teltail" "telorette" "STELA" "chr4" "elomeres" "novo" "Adda"
    "just 48 hr" "ADDIT" "ng/" "polymerase 1" "G:C" "IRIF" "the Ripley’s"
    "Ripley" "re-joining" "non-HR-prone" "DNAPKi" "ATMi" "degron (AID)" "AsiSI"
    "FokI" "PGFE" "Ku" "Seckel" "Caron" "Asi" "DIvA" "10.1038/srep16849"
    "concept/conclusion" "α 2C" "α 2B" "Frumento" "cardiac IRI"
    "the peritubular interstitium" "glomeruli" "allogenic OLT" "AOLT" "SVC"
    "intestinal endotoxemia" "IVC" "vena" "-subtype" "attenuats"
    "underwent OALT" "normal tubular histology" "ARC239" "BRL44408" "/Nuclear"
    "IRI" "OLT" "α 2A" "atipamezole" "SCr" "BUN" "OALT" "Dex" "кB"
    "ischemia/reperfusion" "10.1038/srep16482" "biases" "Swiss" "Greek" "biase"
    "G→A" "C→T" "predictive or prognostic biomakers" "biomakers" "intrastrand"
    "399ArgArg" "194Arg" "the Egger’s" "the Begg’s" "Egger’s"
    "the unfavorable 399Gln allele, GlnGln, and GlnArg genotypes" "Arg399Gln"
    "399Arg" "0.75–1.75" "399Gln" "Arg194Trp" "194Trp" "GlnGln+GlnArg"
    "the favorable 399ArgArg genotype" "the unfavorable ORR" "+GlnArg"
    "the favorable 194Trp allele, TrpTrp, and TrpArg genotypes" "TrpArg+ArgArg"
    "1.66–2.45" "TrpTrp+TrpArg" "QS" "rs3213245" "rs25489"
    "Only two XRCC1 genetic polymorphisms" "rs25487" "rs1799782"
    "Arg399glutanine" "rs3213239" "GGCC" "19q13.2" "DDSBR" "hotpot" "GlnArg"
    "GlnGln" "the unfavorable ArgArg genotype"
    "the favorable TrpTrp and TrpArg genotypes" "TrpArg" "TrpTrp" "= 0.86"
    "= 0.91" "Cdnk1a" "TGCA" "a specific ovarian cancer subtype"
    "the heterozygous ovarian cancer subtype" "p53 R172H" "CDNK1A" "CDNK1"
    "Nultin-3a" "ALST" "TP53p" "/R273C" "Smirnov" "Kolmogorov"
    "the homozygous tumor subtypes" "this heterozygous subtype"
    "a distinct ovarian cancer subtype" "HGSCs" "HGSC" "state-of-the-art"
    "WST-1" "WTp53" "10.1038/srep16976" "Mitsutake" "Ricarte-Filho" "Filho"
    "non-radiogenic" "Korea" "papillary subtype" "polymorphism (RFLP)"
    "gene/genetic" "radioiodine" "Russia" "Ukraine" "Belarus" "Chernobyl"
    "cribriform" "Daiichi" "Fukushima" "RFs" "RNase H1" "B220+" "Acat3-2"
    "Acat3-1" "AIRN" "siFANCD2" "PD20" "FANCD2-/-" "BTBD19" "HSC72" "NV012"
    "FANCA-/-" "R-loop" "SRSF" "THO" "the eukaryotic genome" "R-loops"
    "interstrand" "co-transcriptional" "2  +" "phosphoinositides" "PI3P" "SSXS"
    "intramembrane" "co-regulator" "MDA-MB-231 cells" "C-terminally" "ΔUBA"
    "ΔPB1" "ΔZZ" "ZZ" "non-bleached" "HBV/HBx" "p62T352A"
    "a strong co-precipitation" "co-precipitation" "2A5" "HBcAg" "HBVX"
    "phosphogluconolactone" "μ l" "on/off" "10.1038/srep16811" "Gupta" "Natio"
    "Mariani" "equi" "40/50" "−ve" "fresh tongue tissue biopsies" "UPCI:SCC090"
    "PDSCCs" "MDSCCs" "WDSCCs" "only 14 (28%) HPV +ve" "+ve" "RLB" "TSCCs"
    "HNSCCs" "subsites" "precancer" "TSCC" "6/40" "~40%" "cpDNA"
    "traditional diagnostic biopsies" "synoptophysin"
    "standard diagnostic algorithms" "synaptophsin" "Chromagranin"
    "had historical IHC" "immunohistiochemistry" "His postoperative histology"
    "ng/µ" "AW" "Cooperative Oncology Group (ECOG) PS 0–2"
    "the SCLC diagnostic algorithm" "begun" "ED"
    "an aggressive neuroendocrine subtype" "squamoid" "cobas"
    "routine diagnostic biopsies" "PI3KCA" "procollagen" "anti-S100A8"
    "Wnt1/iFGFR1" "Trichrome" "10-day" "iFGFR1" "dimerizer" "NVP" "iFGFR"
    "Wnt1/ inducible" "erbB" "mammography" "MDSC" "MDSCs" "S7D" "S5A" "S5C"
    "S4A" "S2D" "p-p70S6K" "continuum" "nearly 2 SDs" "SDs" "≥70" "DR1044"
    "6/629" "e-3" "5/147" "1/22" "5/460" "11/629" "Nissl" "thoraco" "*32"
    "Ser518Leufs" "proteinopathy" "neurites" "_Thr331del" "DR189"
    "possible FTLD" "EMG" "DR1124" "DR1123" "muscular fasciculations"
    "fasciculations" "DR663" "bvFTD" "Asp167del"
    "a premature termination codon" "FTLD" "lobar" "Glu643del"
    "an extended Belgian FTD-ALS family DR158" "DR158" "II-3" "III-1" "CPG"
    "MNK1/2" "PhosphoNet" "Kinexus" "Storz" "PKCɛ" "T359/S363" "PKCη"
    "anti-PKD1/2" "PKCβII" "S744/748" "RSK1/2" "Gő6983" "JEB" "KGM" "RSK-1/2"
    "FnIII" "Bullous Pemphigoid" "Pemphigoid" "α6β4" "100 ng/ml"
    "this special subtype" "Bernoux" "Cnaan" "Colomer" "Rakha" "Gallen" "HER2−"
    "PgR+" "= 0.001" "= 0.005" "1E" "this nonsynonymous polymorphism"
    "Figueiredo" "nonsynonymous SNPs" "Egger  " "Begg  " "Begg" "Francisco"
    "GG " "RFLP" "Africans" "LMW" "Haenszel" "rs2066827" "= 3" "= 4"
    "an alternative strong consensus motif AATAAACA" "AATAAACA" "Sso7d"
    "co-depletion" "FOXK2/O3/J3" "co-association" "a strong co-association"
    "H3K18ac" "TAAACA" "FOXK2/J3" "co-bound" "CYP27C1" "ATGTAAACAAS" "∼1%"
    "ATGTAAACAS" "GTAAACA" "FOXK2/O3" "U2OS-3xFLAG-FOXO3" "hexahistidine"
    "RYAAAYA" "RUNX" "FOXJ3" "S8B" "S6C" "S6A" "A / C" "‐tumor" "‐thoracic"
    "‐up" "non‐PD" "re‐biopsy" "‐PD" "‐examination" "‐measurable" "MBP‐QP"
    "‐QP" "‐automated" "‐invasive" "anti‐cancer" "‐1686" "non‐small" "‐cancer"
    "2b/3" "EGFR‐TKI" "plasmaDNAreflects" "ofPDcases" "plasmaDNAwas"
    "‐QPreflects" "withEGFR‐TKI" "atPD" "beforePD" "plasmaDNA" "plasmaDNAamong"
    "‐small" "‐biasedPCRand" "plasmaDNAin" "treated withEGFR‐TKI" "withEGFR"
    "‐TKI" "‐biopsy" "‐TKIhas" "toEGFRtyrosine" "plasmaDNAto" "Nanda"
    "Johannesburg" "7/30" "breakpoints" "_1954insA" "Afrikaner" "Younger"
    "Xhosa" "Afrikaans" "Jewish" "Ashkenazi" "is 1/53" "black/African"
    "white/Caucasian" "Indian/Asian" "ancestry/coloured" "= 6" "2/5" "= 7"
    ".1100delC" "10.1038/srep16900" "FPCM" "Msp" "PFBs" "= 1.5 " "= 12 " "a 2D"
    "British" "co-regulatory" "macroscopically normal gastric epithelium"
    "co-upregulation"
    "paired normal tissues (Fig.  xref b) (Paired T test p = 0.001) IHC"
    "gastrectomy" "FOXM1 and" "oesophageal adeno-" "cellcycle"
    "upper gastrointestinal endoscopy" "endoscopy" "5/8" "co-regulation"
    "= 0.001" "Thompson" "ATG12-Atg5-Atg16L" "ULK" "phsopho"
    "oncogenic Ras-driven PDA" "ULK1/2" "S235/236" "DKO" "PDA" "Balb/c"
    "N-Ethyl-" "Non-essential" "N-ethyl-" "hepatocellular adenomas (HCA)"
    "adenomas" "rs13167280" "IVS" "RJ" "KU" "rs2853669" "G-quadruplexes"
    "= 0.0009" "FGF2R" "MMP-2/9" "Migtrigel" "CycLex" "artic"
    "contemporary pharmacotherapy" "pharmacotherapy" "mixed herbal decoctions"
    "decoctions" "Astragali" "Radix" "membranaceus" "Astragalus" "PIGF"
    "kappa-light-chain-enhancer" "Bankoff" "hMSCs" "intratibia" "hMSC"
    "osteomimicry" "estrogen/ERα" "Estrogen/ERα" "PacMetUT1" "LuCaP" "Leav"
    "Zellweger" "the predominant subtype" "Toremifene" "+ 1" "24 h"
    "osteoblast-like" "Co-culture" "Liu's"
    "mediating secondary chemoresistance" "the synergistic anti-cancer"
    "The in vivo synergistic anti-cancer" "plasmon" "immunoprecipitant"
    "anti-NSCLC" "almost certain eventual chemoresistance" "NSLCL" "Bueno"
    "sphingosine" "protein phosphatase 2A" "EMQA" "30-days"
    "effectively target HemSCs" "GαS" "1/12" "metoprolol" "atenolol"
    "proliferation—2.64-fold" "DIMSCAN" "Gαs" "CD31+" "CD133+" "ICI"
    "bucladesine" "HemECs" "symptomatic bradycardia" "bradycardia" "residuum"
    "fibrofatty" "Doppler" "β1AR" "≥10" "HemSCs" "HemSC" "pSmad2/3" "pMst1"
    "pYAP/total" "PPXY" "/K +" "Vgll4" "TEADs" "severe I/R AKI" "mild I/R AKI"
    "mild ischaemia" "severe AKI"
    "successfully induced largely reversible mild and moderate AKI" "pedicle"
    "Masson's" "trichrome" "Masson" "interstitium" "the transverse tubule"
    "medulla" "severe ischaemia" "Sudol" "ischaemia/reperfusion"
    "complete/incomplete" "Lats1/2" "ischaemia" "progressive fibrotic CKD"
    "CKD" "AKI" "Δ  C" "5SA" "+++" "++" "anti-YAP" "24 h" "co-ordinate"
    "10.1038/srep16331" "Ganzinelli" "Nelson" "0.60–2.67" "0.61–2.74"
    "0.54–1.41" "0.55–1.57" "0.37-1.15" "0.67-2.07" "0.49–1.58" "0.55–1.86"
    "erlotinb" "0.52-1.01" "0.27-1.24" "0.53-1.09" "0.55–1.22" "0.65–1.43"
    "1.37–2.34" "0.54–1.26" "0.64–1.47" "covariates" "1.60–2.85" "IQR" "TG/GG"
    "CONSORT" "G-allele" "rs61764370" "aminoacids" "0.52–1.01" "LCS6"
    "de-regulated" "95% CIs" "= 1.18" "= 0.88" "Pillai" "chemoradiotherapy"
    "TMPO" "STRBP" "BCL2 + /BCL6 +" "MYC + /BCL2 +" "≥70%" "diagnostic workup"
    "workup" "B cell-like" "DPL" "a generally favorable prognostic subtype"
    "the germinal center B cell-like (GCB) subtype" "COO" "GCB" "10/12"
    "= 0.87" "MYC /8q24" "8q24" "8q22.2" "ME1007" "co-introduced" "nu/nu"
    "co-introduction" "ME4405" "HEMa" "trisphosphate" "bisphosphate" "RNU48"
    "chromosome 14q" "Optic nerve or disc dysplasia" "nystagmus" "VUR" "Case6"
    "Case1" "cortical nephrogenic zone mesenchyme" "Cr" "frameshifts"
    "ACCTCGCCCCCCAGCTCCGGGG" "ex3" "224-225insAC" "57-58insGTGAACC" "ex2"
    "119-120delGC" "dbSNP137" "nephron" "choroid" "RCS" "non-polar"
    "GSE24.2-NLS1.3" "the nucleolar localization signal NLS2"
    "the longer peptide GSE24.2" "foci/cell"
    "the lentiviral vector pRRL-CMV-IRES-GFP" "γ H2AX-associated foci/cell"
    "GSE24.2-NLS2.3" "pcDNA3" "NLS2" "SYTO" "immunohystochemistry" "KKEKKKSKK"
    "KRKR" "GSE24-2" "DC-3" "Mn" "Zn-" "Cu" "dihydroethidium"
    "pRRL-CMV-IRES-GFP" "F26IIB" "TRUB" "DKLD" "telomeropathies" "DKC" "GAR"
    "GSE4" "GSE24.2" "congenita" "3/12" "cutanea" "porphyria" "DAA"
    "residual viremia" "viremia" "resp" "nonsevere" "VAPAHCS"
    "significantly younger" "Charlson" "Newer" "nonresponse (NR)" "DAAs"
    "sustained virologic responders" "SVR" "nCounter" "clearers"
    "COX-2 rs689466 polymorphism’s" "Asians" "=1.01–1.43" "=1.01–1.45"
    "=1.01–1.57" "=1.20" "GG+GA" "=1.21" "OR=1.26" "LSCC" "PSCC" "OPSCC"
    "oropharynx" "=0.97–1.09" "rs689466" "=1.26" "95%CI" "Material/Methods"
    "10.1038/srep16759" "Morvaridi" "orthologue" "transdifferentiate" "edema"
    "acute or chronic pancreatitis" "pancreata"
    "experimental acute and chronic pancreatitis" "Mst1/2" "myofibroblastlike"
    "the terminal ductal epithelium" "acute and chronic pancreatitis"
    "Langerhans" "stellate" "C57BL/6 J" "YAP/TAZ" "H & E" "five-year" "priori"
    "demarcations" "the mature T-cell lymphoma subtypes" "cyotkine" "STS-2"
    "synapse" "SMV" "SVM" "Forrest" "RPISeq" "lncPro" "x10" "LINC00273"
    "non-lymphocyte" "6/8" "13/14" "stromal/non-lymphoid" "PANTHER" "_at" "TME"
    "classifier" "the five different mature T-cell lymphoma subtypes"
    "mature T-cell lymphoma subtypes" "all non-Hodgkin’s"
    "mature T-cell lymphoma biopsies" "all mature T-cell lymphoma subtypes"
    "five different mature T-cell lymphoma subtypes" "5/14" "7/8"
    "co-stimulation" "leukemia/lymphoma" "proto" "eaten" "2/38" "WHI" "pLEX"
    "WHIP" "A550V" "re-evaluation" "mantGDP" "∼500-fold" "non-activated"
    "fluorophores" "theK" "macroscopicK" "microscopicK" "K-Ras·GTPγS" "ofK"
    "non-assigned" "H-Ras·GDP:Sos" "superscripts" "uniformly 13 C-labeled"
    "C-labeled" "TROSY" "N-labeled" "Ras·GTPγS" "simpler" "heteronucleotide"
    "aK" "·GppNp" "RasY64A·GTPγS" "H-RasY64A·GTPγS" "observedK" "H-Ras·GDP"
    "H-Ras·GTPγS" "K-RasG12V·GTPγS" "·GppCp" "GppCp" "GppNp"
    "the bulky mant adduct" "mant" "mantGTP" "millisecond" "measuredK"
    "Ras·GTP" "P-loop" "Ras·GDP" "·GDP" "homonucleotide" "·GTP" "Sos"
    "non-optimal" "non-labeled" "10.1038/srep16578" "almost all normal mucosa"
    "Zeb1/2" "benign epithelium" "phonetype" "/CD44 +" "Epcam" "KD2" "KD3"
    "shcon" "KD6" "FOXC-2" "GPIZ" "Hedghod" "24 h" "10.1038/srep15494"
    "Mongiardi" "Galardi" "PRMT5-mediated symmetric di-methylation"
    "H3R8 symmetric di-methylation" "symmetrical H4R3 di-methylation"
    "Karkhanis" "PRMT5 methylase complex and H4R3 symmetric di-methylation"
    "shCOPR5" "HEK293T/FO" "BT168" "BT168/FO" "U87MG/FO"
    "Symmetric di-methylation" "regulating H4R3 symmetric di-methylation" "FO"
    "symmetric di-methylation" "Methylosome"
    "PRMT5-dependent symmetric di-methylation" "H4R3" "di-methylation" "Wolff"
    "H4R3 symmetric di-methylation" "miniprotein" "Omomyc" "Co-localization"
    "E-boxes" "10.1038/srep15182" "wk" "allograft" "CaP8" "CaP8 " "22RV1 "
    "Charles" "PEB-" "PEB" "PEB-1" "wks" "urogenital mesenchyme (UGSM)" "vol"
    "UGSM" "titer" "FUCRW" "MSKCC" "Origene" "Protein Phosphatase 2A" "OP449"
    "NHT" "240/244" "day 14" "IC50s" "IC 50s" "n = 6" "IL-36γ secretion"
    "colonic myofibloblasts" "myofibloblasts" "U0216" "24h" "IL-36α" "IL-36β"
    "UC" "IL-36γ" "p38 MAPKs" "anti-sense" "Generally all SNVs" "Intplex"
    "around $0.97" "covers almost all possible SNVs" "non-target"
    "interquartile" "pairwise" "A167T" "Y-intercept" "non-mutated" "Jukat"
    "turanica" "lebetina" "Vipera" "Bis" "indica" "Garcinia" "Garicinol"
    "btween" "phenylarsine" "C62S" "inhibiton" "phasecontrast" "adolapin"
    "apamin" "garicinol" "electro" "BV" "BALB/C" "10.1038/srep16497" "Funauchi"
    "ferredoxin" "47/92" "Fbxl" "ferrozine" "IREs" "siEGFP" "siISCU" "mp53BS"
    "pGL3/p53BR" "p53BS" "12q24.1" "HCT116 p53  +/+" "Tango6" "co-recruited"
    "expressers" "expresser" "cleavage/ligation" "topology" "10.1038/srep16555"
    "gemciatbine" "TDZD" "thiadiazolidinone" "silencin" "E6/E7directly"
    "proteosome" "the tumor suppressor adenomatous polyposis coli (APC)"
    "coli (APC)" "1P" "pLL3.7" "factor/lymphoid" "ORs" "Turkish" "4G/4G"
    "the heterozygous genotype" "using Egger's" "Egger" "0.80–1.01"
    "= 0.86–1.01" "0.83–1.11" "0.84–1.02" "4G5G" "4G4G+4G5G" "5G5G+4G5G"
    "0.75–1.03" "CNKI" "5G5G" "4G4G" "4G/5G" "clade" "insertion/deletion"
    "= 0.86" "= 0.87" "Lang" "Samuels" "Vara" "Fresno" "Over‐expression"
    "‐miRNAs" "Grosshans" "Ruegger" "Pasquinelli" "Kai" "‐regulation" "‐Fos"
    "Lan" "cell‐type" "anti‐tumourigenic" "up‐regulated" "Gu" "miR‐490‐3p"
    "sh‐PIK3CA" "‐tumourigenic" "‐LacZ" "Vivanco" "‐PIK3CA" "and 3C" "‐fold"
    "786‐O" "over‐expression" "‐time" "wild‐type (WT)" "psiCheck" "‐type" "‐2"
    "‐O" "‐tumour" "‐3p" "de‐regulated" "miR‐490‐5p's" "3‐kinase" "‐expression"
    "down‐regulated" "‐185" "‐34a" "Khella" "Wach" "Osanto" "Youssef" "Weng"
    "Juan" "Petillo" "Jung" "Hannon" "Bartel" "micro‐RNAs" "3p" "Gerlinger"
    "Purdue" "Shen" "ccRCC" "Sato" "Dey" "ccRCCs" "Moch" "Frew" "‐kinase"
    "‐RNAs" "miR‐490‐5p" "miR‐490" "‐regulated" "‐5p" "‐490"
    "Dysregulated micro‐RNAs" "psiCHECK2" "∼22 nt" "10.1038/srep16524" "Tilve"
    "laevis" "enopus" "the Dunn’s" "S3E" "UVA" "nanosecond" "Jaspla"
    "chemoattractant" "The chemotaxis Dunn’s" "monophosphate" "Bromoadenosine"
    "Dunn" "ROI" "soluble extracellular Syns" "Syns" "A30P" "LRRK"
    "inactivation/phosphorylation" "Axon" "Lewy" "neurite" "axons" "axon"
    "+ 10" "+ 1 " "C57BL/6S" "~35%" "enantiopure" "Racemic ketorolac"
    "tromethamine" "Farnesyl" "Alexa" "microspheres" "co-ordination" "isomer"
    "R-etodolac" "SDX" "R-forms" "bioactivities" "S-forms" "non-COX"
    "pyrazolines" "Ketorolac" "entropy" "RhoA" "occludes" "Kulkarni" "isotype"
    "non-inhibitory" "racemic ketorolac" "R/S" "Naprosyn" "Aleve" "+/-EGF"
    "6 MNA" "6MNA" "GLISA" "Enantiomer" "-α-methyl" "larger substituents"
    "S-naproxen" "CID2950007/ML141" "6-methoxy-2-naphthalene" "MNA" "sulfide"
    "S-ibuprofen" "fenoprofen" "ketoprofen" "Cdc42Q61L" "plex" "S-enantiomers"
    "R-naproxen" "S-enantiomer" "nabumetone" "enantiomer" "R-enantiomers"
    "ketorolac" "enantiomers" "Prestwick" "drug-like" "non-steroidal" "Tricin"
    "1,2,3-trimethyl-trans" "the naturally occurring selenomethionine"
    "selenomethionine" "antigen (PCNA)" "phytocompounds" "flavanoids" "GC-MS"
    "shrunken" "100~500 " "h~48 " "Protodioscin" "hydroxyisoleucine"
    "galactomannans" "graecum" "Trigonella" "Egypt" "Africa" "Saharan"
    "Squalene" "Flavonoids" "FCE" "Fenugreek" "foenum" "kinome"
    "the phosphatase-resistant pThr mimetic (2S, 3R)-2-amino-3-methyl-4-phosphonobutyric"
    "PLHS" "Pmab-" "Pmab" "This optimal phosphopeptide" "grip-like" "MQSpTPL"
    "Poloboxtide" "HCT-8/V" "AIIIa" "Aristolactam" "SAR" "Saitama" "RIKEN"
    "nutgall" "tropolone" "SpT" "Poloxipan" "Pro-Leu-His-Ser-p-Thr-" "PLHSpT-"
    "PLHSpT" "phosphopeptides" "phosphopeptide" "paralogs" "Kowalsk"
    "TKM-080301" "Tekmira" "TKM" "PLK-1 with" "PLK-1with" "PLK-2/3"
    "2-amino-isoxazolopyridine" "mg/kg/week" "RO3280" "pyrimidodiazepines"
    "SBE13" "pyrazole" "pyrrolo" "Berlin" "Pharma" "Bayer" "Rockefeller"
    "diamino" "Cyclapolin1" "Ltd" "Cyclacel" "nM/L" "rhabdo" "osteo-" "osteo"
    "febrile neutropenia" "ADME" "Ingelheim" "mg/cycle" "Boehringer"
    "dihydropteridinone" "non-Hodgkin's" "Kline" "Glaxo" "thiophene" "bio"
    "Milano" "Nerviano" "pyrazolo" "HMN-176" "Shinyaku" "Nippon" "HMN"
    "funiculosum" "Penicillium" "styryl" "benzyl" "Calothrix" "Cyanobacteria"
    "methoxy"
    "termed nonhydrolyzable ATP analog adenylyl imidodiphosphate (AMPPNP)"
    "imidodiphosphate (AMPPNP)" "imidodiphosphate" "DARPins" "residue/s"
    "Achilles" "S-phase-expressed1" "Borealis" "neurobiology"
    "Polo-like kinase-1" "neutropenia" "mg/Kg" "EC 50" "non-ATP" "mg/m2"
    "± 0.1 " "nanomedicine" "oligodeoxynucleotides" "non-CSCs" "2cKO" "Grandis"
    "DTX" "Annxin" "UMSCC23" "OKC" "Dataset" "stemloid" "regrowth" "oncotarget"
    "TPF" "Annexin V +" "miR-142-3p" "MiR-202-5p" "miR-517c" "miR-517a"
    "prognostic classifiers" "classifiers" "normal glandular epithelium"
    "about possible let-7f-5p" "HCT116 p53−/−" "2Gy" "chem" "Cyto-" "Cyto"
    "miRPath" "let-7f-5p" "miR-202-5p" "miR-520b" "miR-548b-5p" "miR-548a-5p"
    "miR-518d" "miR-371-3p" "miR-302c" "miR-302a" "miR-155-5p" "miR-548d"
    "miR-142-5p" "miR-127-5p" "miR-450a" "miR-202-3p" "miR-193a-3p" "d"
    "miR-455-3p" "miR-512-3p" "miR-518f" "f" "EBarrays" "Bayes" "euclidean"
    "HCT116 p53+/+" "carboxylesterases" "Il" "cyto-" "cyto" "let-7 is" "RNA 22"
    "RNA22" "Quantitative label-free shotgun LC-MS/MS" "NSAFs" "FAF2"
    "the sub-cellular proteome" "SNX-7081+2-FaraA" "AARSs"
    "amino acyl tRNA synthetases (AARS)" "synthetases (AARS)" "LC-MS/MS"
    "Jitschin" "2-FaraA + SNX-7081" "the dual treatment dataset" "Proteome"
    "York" "Serenex" "FaraATP" "FaraAMP" "ϕH2AX" "17 p" "non-significant"
    "non-redundant" "∼92.9%" "KPS" "electropherograms" "pyrograms" "OL" "RTL"
    "2-year" "= 0.005" "1q25.2-q25.3" "surfacesof" "EC109" "expressionslevels"
    "miR-26a" "Dianamt" "MiRwalk" "MiRanda" "non-specificity" "cells / mouse"
    "μg / mL" "cells / well" "mg / mL" "G0 / G1" "effectuates"
    "mucinous histology" "adenocarcimomas" "amplification/overexpression"
    "≥25%" "-omic" "omic" "HCC1833" "CACTY" "SFTB" "RPKM" "Transcriptomes"
    "TARGETplus" "HCC1195" "Clara" "14q13" "cytoband" "histologies"
    "non-smokers" "OspE" "Kaposi’s" "enteropathogenic Escherichia coli" "ABD"
    "CpSCRP" "apicomplexan" "the parasitophorous vacuole" "microtiter"
    "homology-2" "a parasitophorous vacuole" "vacuole" "oocyst" "Int" "FHs"
    "parvum" "margenta" "p38β" "Diacerine" "aminophosphonate"
    "glycosaminoclycans" "anthraquinone" "SW-1353" "profiler" "SYSADOA"
    "= 0.002" "p38 MAPK" "flavonoid" "triggerd" "pDNAs" "ARE1~4" "orthologues"
    "kbp" "Forkhead box O3a" "nuclear factor (erythroid-derived 2)-like" "Neh5"
    "Neh4" "S -transferases" "BGJ398" "the other histological subtype"
    "non-amplified" "dysplastic squamous epithelium"
    "80% (4 of 5) FGFR1 -amplified EADC" "situ" "8p11" "esophageal neoplasias"
    "URL" "neoplasias" "EADC" "adeno-" "= 7" "SPIN4" "10/78" "chromosome14q"
    "MXD" "hereditary PCC/PGL" "identifying NF1-mutated PCC" "sporadic PCC"
    "PCCs" "spindlin" "Missense" "CCDC66" "Visual re-examination" "H-scores"
    "H-score" "0–3" "PCC" "*10" "Leiden" "_6782insTT" "SDHX" "PGL" "Stratakis"
    "Carney" "myoid" "*31" "*4" "~30 %" "Chemoresistance" "CD90" "vs"
    "Oncology" "Fu" "CSC-Like" "Isotype-matched" "5 × 10" "× 10"
    "anti-metastatic" "the AR-V7-driven transcriptome" "the PAM50" "repurpose"
    "agonism" "PAM50" "Ringner" "a unique AR-V7-driven transcriptome" "27/28"
    "43/47" "Abcam" "6–9" "1a-2"
    "gonadotropin-releasing hormone (GnRH) agonists/antagonists"
    "agonists/antagonists" "cistrome" "LBD" "Vs" "co-regulators" "NSCLS"
    "Vazquez-Martin" "Cortot" "Morgillo" "EGFR-TKIs-resistant sublines"
    "sublines" "PC9/GR" "siIGF1R" "H460/ER" "non-overlapping"
    "mesenchymal-like" "spindle-like" "AMIGO1" "homologies" "PHT-427"
    "capillary-like" "PyMT"
    "PTD-A2–treated ECs revealed severely impaired tube-like" "tube-like" "NGR"
    "TAT" "PTD" "RVVFLEPLKD" "491 aa" "457aa" "491aa" "ΔCD" "ΔLRR" "hyaloid"
    "Amigo" "AMIGO" "IgG-like" "-triphosphate" "glycophosphatidylinositol"
    "DDPIV" "micrographs" "TBC1D30" "cerevisiae" "v-" "v" "SM"
    "Sec1/Munc18-like" "_ER" "_LC" "GTD" "identity/compartmentalization" "AMIS"
    "active Rab8a/11a" "_Q70L" "_Q67L" "Tactin" "Strep" "Rab11/8"
    "exocytic/secretory" "late endosomes/lysosomes" "ultrastructure"
    "the premature stop codon" "ZFNs" "knockin" "synaptotagmin-like protein 4a"
    "Rab8/11" "Schiff" "villus" "a rare autosomal-recessive enteropathy"
    "Epithelia" "a lethal hereditary enteropathy" "enteropathy" "MVID" "Vb"
    "Slp4a" "23a" "non-essential" "LOH/loss" "15q" "CENPJ" "Nagel" "Suspitsin"
    "16q" "8p" "16p" "Muranen" "CHEK2*1100delC" "CHEK2* 1100delC"
    "CHEK2 *1100delC" "Dutch" "* 1100delC" "y" "*1100delC" "BRCA1 / 2" "6/14"
    "Log2" "clustered telomeres showed detectable telomerase co-localization"
    "quadruplexes" "precise genome" "–e" "e" "–b"
    "around three co-localizations" "LoxP" "SCaBER"
    "CRISPR-Cas9-mediated genome" "2 mg/ml" "~40 %" "co-localizations" "3/17"
    "McNamara" "anti-androgenic" "the ductulo-lobular histological subtype"
    "ductulo" "5/117" "8/12" "4/35" "307/353" "ClinicalTrials" "apocrine"
    "re-testing" "≥1" "ngTMA" "re-assessed" "= 5" "8/10" "= 17" "MPs/exosomes"
    "coxibs" "tNSAIDs" "releasate" "blockers" "Tcf" "MREs" "Dovizio" "Labelle"
    "Exosomes" "IIIa" "Revacept" "Fc" "revacept" "anti-platelet" "IIb/IIIa"
    "Fb" "microparticles" "- UTR" "22 nt" "bardoxolone" "diabetic nephropathy"
    "Bardoxolone" "cinnamaldeyde" "littermates" "K-rat" "STGE" "dipeptidyl"
    "E/S" "TGE" "DSGIS" "DSAPGS" "phosphodegron" "degron" "un" "UPSs"
    "erytheroid-derived-2-like" "erytheroid" "non-small cell lung carcinoma"
    "RNA-like" "non-stress" "synthesis/conjugation" "aureus" "co-evolved" "FtH"
    "gasotransmitter" "gasotransmitters" "aeruginosa" "typhimurium" "Kaposi's"
    "Kaposi" "Kelch" "Marburg" "Cul" "anions" "ONNO" "peroxinitrate" "●−"
    "transcription/expression" "Mø" "Neh6" "non-toxic"
    "alongside other physiological readouts" "readouts" "empts" "KeratinoSens"
    "OECD" "ToxCast" "EU" "ADRs" "accessible biofluids" "biofluids" "overdose"
    "OKD" "clearer" "Keratinosens" "many electrophilic skin sensitizers"
    "sensitizers" "nephrotoxins" "tetrachloride" "hepatotoxins"
    "-benzoquinoneimine (NAPQI)" "-benzoquinoneimine" "benzoquinoneimine"
    "N -acetyl-" "AKR" "catalyses" "Pgd" "Overview" "pharmaco"
    "4-nitroquinoline-1-oxide" "forestomach" "benzo"
    "end-stage diabetic nephropathy" "fumarate" "nephropathy"
    "electrophilic or oxidative stressors" "factor 2-like" "2-cyano-3,12"
    "Eriksson" "Sofi" "nucleophilc" "Gpxs" "catalyse" "hyaloplasm" "carbonyls"
    "EpREs" "Edward" "McLaughlin" "Michael" "Justin" "Transcriptome" "2GSH"
    "Gsr" "phyla" "gastrulate" "-cysteinylglycine" "cysteinylglycine"
    "diphosphates" "selenosulfide" "reversible thiol/disulfide"
    "selenocysteine" "EpRE" "hetero-" "2-like-2" "thioredoxin reductase-1"
    "Kelch-like" "cinnamate" "IKBα" "Yu" "2+" "biliverdin" "Fe" "porphyrin"
    "haeme" "Pre" "SFP" "cell/tissue" "bacterial lipopolysaccharide (LPS)"
    "sMaf" "oxygenase-1" "Nuclear factor (erythroid-derived 2)-like"
    "co-activator" "GSK3β axis" "1-methyl-4-phenyl-1,2" "-carnitine" "acyl"
    "carnitine" "palmitoylcarnitine" "FAD" "hydride" "Δψ" "nearly ~50%"
    "succinate" "production/availability" "∆Ψ" "midbrain" "Bcl"
    "transcription factors nuclear respiratory factor 1 and peroxisome proliferator-activated receptor γ coactivator-1α"
    "coactivator-1α" "x" "sulfoxythiocarbamate" "methylsulfinyl" "‘ETGE’"
    "multiphoton" "FADH" "=12" "ΔΨ m" "coactivator-1" "Alpers" "Leigh" "ZFAND5"
    "ZNF592" "GSE37754" "GSE20712" "the previous dataset" "PR+" "MPS"
    "the Pearson's" "Wilcoxon" "cystonsines" "Infinium" "basal-like" "mHsp72"
    "N-acetylglucosaminyl-transferases" "biocomplexes" "intercalate"
    "biomolecules" "Marino" "Krebs" "polymorphic HSP72 SNPs" "endotoxemia"
    "hypothermia" "denaturation/aggregation"
    "the previously shown IFN- γ or IL-17 nonresponse" "nonresponse" "SOFA"
    "nonsurvivors" "commonest" "G/G" "the polymorphic rs6457452 HSP72 SNP"
    "Whitney" "formulae" "multicentre" "factor-1" "chaperone-like"
    "various external and internal stressors" "ICU" "l/mHSP72" "mHSP72"
    "lHSP72" "ILs" "°HS" "lipopolysaccharide (LPS)" "SIRS" "HSP90 α" "μ g/mL"
    "10.1038/srep16408" "Tai" "a Spearman’s" "p38MAPK" "FAK/25aa-" "FAK/25aa"
    "FNIII" "R385A/S386A" "-Ala-Asn-Asn-Glu-Lys-Gln-Gly-Val-Arg-Ser 386"
    "FAK/N375" "FAK/N400" "Ghany" "Abdel" "the triple-negative subtype"
    "cytodomain" "β4" "non-receptor" "α6" "HER2 +" "ER +" "10.1038/srep15701"
    "Kimura" "LC3II/LC3I" "STAT3WT" "STAT3Y705F" "WP" "anti-autophagic"
    "the accessory transmembrane protein IL-6Rα" "IL-6Rα"
    "destructive organelles" "phagophore" "10.1038/srep16355" "ThPOK" "Fanpan"
    "CNS2" "Ahr" "Crohn’s" "Crohn" "Th17" "non-histone"
    "more-aggressive mammospheres" "dCSK" "RASSF1C-associated mammospheres"
    "ANASTASIOU" "BIDUS" "POOLA" "pY357-YAP1" "mSigDB" "YAP/TEAD1" "BCL-xl"
    "xl" "BCL" "homologs" "ANDOR" "Bitplane" "indeed found RASSF1C" "pY416-SRC"
    "active pY416-SRC" "dRASSF8" "pYAP" "siRASSF1A" "siRASSF1" "RASSF1-1α"
    "activation/inactivation" "re-localization" "pS127-YAP1"
    "a transcriptional co-activator" "Hahn" "pS127-YAP" "CGI" "kinase/MST"
    "uveal" "pY527-SRC" "SRC/YES" "RASSF1C" "derepresses" "5 × 10" "= 1.09"
    "S1C" "WAR" "Kastan" "UFB" "UFBs" "Ultrafine" "Lehmann" "WRNIP" "UBZ"
    "CherryLacR" "Lac" "LacO" "inATMIN" "andATMIN" "relocalise" "ultrafine"
    "MRN" "/5" "5-Ethynyl-2" "Rad3" "10.1038/srep16262" "Ji" "Baseler"
    "16-week-old" "16-week" "miR-126a-3p" "miR-378a-3p" "miR-210-3p"
    "miR-196a-5p" "miR-499a-5p" "MiR-141-3p" "AOC" "lipocytes" "OGTT" "fatter"
    "its own circular genome" "the unique intracellular organelle" "organelle"
    "miR-141-3p" "HFD" "2/4 " "g/kg" "1/3" "Mavers" "Immunohistochemistry"
    "OARSI" "midzone" "-to-S phase" "κB" "ADAMTS" "95 % CIs" "-1β"
    "non-cranial" "TNFSF" "30-day" "Nathoo" "APACHE" "non-survivors"
    "non-surviving" "Marshall" "caspas-3" "GCS" "Glasgow" "severe TBI"
    "multicenter" "TBI" "=  0.003" "95 % CI " "= 3" "anti-aging" "Baumer"
    "association/interaction" "Merck" "non-transfected"
    "interaction/association" "co-immunprecipitation" "co-localize" "MDA_MB231"
    "_MB231" "ʹend" "LRP/LR" "anti-Telomerase" "Non-tumorigenic" "shAPRT"
    "shNT" "XTT" "phosphoribosyl" "adenosyl" "Husain" "histotype" "histotypes"
    "rhAPO2L/TRAIL" "EORTC" "sarcomatoid/biphasic" "histologic subtype" "ECOG"
    "Urso" "BRCA1-associated protein-1" "refractoriness" "Sarcomatoid/biphasic"
    "non-epithelioid" "Diagnostic biopsies" "Sarcomatoid" "0.001 and"
    "rhabdoid" "Duchenne" "exon 11-mutated" "7p12" "12p13" "CDKN2A/B"
    "fibromyxoid" "SEPSEC" "MEAF" "CDKN2A/2B" "GIST_178" "GIST_131" "GIST_11"
    "_131" "GIST_124" "_178" "_11" "GIST_174" "GIST_188" "_174" "_188" "22q"
    "1p" "GIST_150" "_150" "_124" "INDELs" "SNV" "INDEL" "sarcomatoid"
    "1000 Genomes" "H 3 K 27" "12q22-q24.1" "TRANSFAC" "−391" "+26"
    "dinucleotides" "5-aza-2" "a valid and competitive biosource" "biosource"
    "Pailler" "alongside other promising biosources" "biosources"
    "non-invasively" "non-smoker" "EML4-ALK−" "0-1" "exosomes" "exosome"
    "PKH67" "EML4-ALK+" "ORR" "Spain" "Netherlands" "EML"
    "serial tumor biopsies" "95% CIs" "re-appearance" "re-establish"
    "Non-small-cell" "Costollo" "endometrium" "AKT8055" "Synergism"
    "AZD6244 / MEK162" "AZD6244/MEK162" "4–5nM" "166–258nM" "EC50"
    "Typical hotspots" "IUP" "6005delT" "GigaDB" "$100" "Mexican" "E1308X"
    "Southwestern USA" "Rico" "Dacheva" "cost/sample" "approximately $50"
    "collection/shipping" "Paso" "El" "Lubbock" "Texas" "Latino" "Richmond"
    "Baltimore" "Vida" "Nueva" "clinicaltrials" "Facebook" "Forman" "TVC"
    "GVGD" "manual Sanger" "AmpliSeg" "100X" "466X" "identifiers" "HER2+"
    "ER/PR+" "$25" "English" "Spanish" "screened/100,000" "US"
    "Western European" "FileMaker" "#0000058963" "LOVD" "calling indels" "GATK"
    "TSVC" "samples/chip" "amplicons" "Thermo" "Hispanic/Latin" "Rican"
    "Puerto" "z" "Latin" "Caucasians" "Americans" "oophorectomy" "mastectomy"
    "500X" "Deven" "Yi" "PHA666762" "Eastern Europe" "America" "v/v" "to 150"
    "Wilson" "isothiocyanatostilbene" "anti-tumorigenic" "Starke" "Bültmann"
    "necropsy" "caliper" "pMet" "H1993" "stilbenes" "grainy" "precipitant"
    "motile" "dihydro" "nitro" "substituents" "stilbene" "happenstance"
    "Isothiocyanatostilbenes" "Exelixis" "Cometriq" "H2DIDS" "DNDS" "SITS"
    "isothiocyanatostilbenes" "type-1" "IC 50 s"
    "aggressive breast cancer subtypes" "underpinnings" "ErbB" "WI" "Promega"
    "NanoLuc" "dione" "5,5-Dimethylcyclohexane-1,3-dione" "Ramona" "Curtis"
    "Sorlie" "Korean" "intron/exon" "PESX" "ESRSearch" "VarioWatch" "covariate"
    "GG" "eta" "days/month" "medications/month" "HWE" "UCSC" "NCBI" "Rs32954"
    "rs32954" "rs1421896" "five intronic single-nucleotide polymorphisms (SNP)"
    "polymorphisms (SNP)" "rs2530223" "positron" "fluorodeoxyglucose" "opioids"
    "acute medications/month" "triptans" "MOH" "overuse" "3-month" "6-day"
    "= 4" "10.1038/srep16082" "co-functions" "TUNEL" "deoxynucleotidyl"
    "mg/kg/day" "the bilateral axilla" "axilla" "immunocomplexes" "pulldown"
    "activation/phosphorylation" "Semi" "Bethesda" "C2BBel" "HNSCC" "ZD-1839"
    "ZD" "Phospho-STAT3" "inflammation/" "lateral hemispherectomy" "dbSNP"
    "Ghahramani’s" "Ghahramani" "solenoid" "Rieger" "arisen" "Baynam"
    "automated fluorescent dideoxy" "chromatograms" "OPHN1-" "OPHN" "VUS"
    "Stepwise" "Gb" "parents/mother" "trisomy" "Karyotype" "lactose"
    "The proband’s" "feedings" "hyperinsulinemia" "the proband’s"
    "Diagnostic Exome" "Grabiner" "TORopathies--for example" "TORopathies"
    "1p36" "phenylketonuria" "ASDs" "co-segregated"
    "family-trio Diagnostic Exome" "Exome" "non-mosaic" "10.1038/srep16229"
    "AUBPs" "U/A" "UUAUUUA" "AUUUA" "Monocyte/macrophages" "effecter"
    "UUAUUUAUU" "AREsite" "Giemsa" "Grünwald" "May-Grünwald-Giemsa"
    "monocyte/macrophages" "lenti-shZFP36L1" "lenti" "UCB" "myristate"
    "DataSets" "Cpeb" "hematocrit" "CCCH" "RBPDB" "monocyte/macrophage"
    "re-infection" "non–cell" "22nt" "activating protein-1"
    "FBJ murine osteosarcoma viral oncogene homolog" "FBJ" "FBXW" "GeneGo"
    "MetaCore" "pCdc2" "S3c" "BV-176-treated" "X-positive" "SUPB" "NALM-19"
    "follicles" "40/59" "51/54" "55/57" "57/57" "45/56" "38/55" "15/55" "ALLs"
    "the available leukemia datasets" "The web-based public database Oncomine"
    "B/T-ALL" "NALM" "Chk1/2" "PF-0477736" "transducers" "cells/mouse"
    "Kruppel-like" "IC 50  " "I/II" "monomethylarginine (MMA)"
    "monomethylarginine" "a symmetrical sulfonated urea" "Cheng"
    "apoptosis/death" "HL-7702" "CBRH" "Bel" "PRMTs" "Sedelnikova" "Firsanov"
    "grad" "Kroeber" "Oorschot" "Vasireddy" "non-irradiated" "und" "0–2"
    "bealwayslower" "UICC" "withdrawn" "0–1" "RTOG" "foci/nucleus" "Hernández"
    "cytometer" "Brzozowska" "preoperative chemo-" "rectosigmoid" "Germany"
    "± 0.1" "doi:10.1186" "= 12" "MVIH" "mg3" "MiR-208b" "website" "+20"
    "+1/+202" "−300" "−1531" "+202" "pcDNA3.1-HULC" "si-HULC-1" "biostat"
    "miRNA-9" "HULC" "ER+" "Pfizer's" "Pfizer" "occludins" "anti-metastasis"
    "fludarabine/bendamustine" "anti-apoptotic/pro-apoptotic" "Co-culturing"
    "anti-β2" "anti-α4" "α4β1" "epithelioid" "fibroblastoid" "successfull"
    "sotrastaurin" "phospho-ERK1/2" "fibroblastoid-like" "co-culturing"
    "co-cultures" "del17p" "PARsylate" "PARP+/FOXO3A+" "FOXO3A+" "PARP1+"
    "discrepant" "Lauren" "Clinico" "polymerase1" "Non-targeting" "CA 19–9"
    "= 6" "melanin" "Figue" "tranfectants" "MHD" "ΔM" "ΔN" "carboxyl"
    "the most immunogenic cancer-testis antigen" "Doyle" "5-bromo-2" "simplest"
    "cyclohexamide" "public microarray datasets" "Co-immunoprecipitation"
    "hT-shZ-HCT116 cells" "XAV" "hT" "Sanchez-Tillo" "Tillo" "promots"
    "co-localized" "heterozygote" "haplo" "no exonic SNPs" "phs000424" "dbGAP"
    "region synonymous SNP rs1748" "rs1748" "GTEx" "exonic SNPs"
    "_3611-34delinsCC" "LCLs" "Lymphoblastoid" "976-15G" "_4537delTGGCGACG"
    "_81delCT" "16p13" "9q34" "= 17" "-9" "co-precipitated" "immuno" "4G1"
    "AGERA" "GFPHTT72Q" "us" "autophagosomal cargos" "cargos" "cortico"
    "trinucleotide" "neuro" "Huntington's" "Huntington" "mHTT" "Non-histone"
    "CRISPR/Cas9" "dox" "Luc-P1-MT" "Luc-P1-WT" "Foundation-7" "Michigan" "μ g"
    "μ g/ml" "Stem cell-like" "CD34 +" "IPHA" "hsCRP" "non-PAH"
    "50–100 nm vesicular invaginations" "invaginations" "probrain"
    "Annual incidence is 1-2" "is 1-2" "IAPH" "immunoassay" "= 0.047" "= 0.002"
    "n = 6" "RB45" "RB05" "Mutationtaster2" "IIRC" "Indians" "Malays"
    "leukocoria" "probands" "Malaysia" "13q14" "Connell" "Kong"
    "retinal pigment epithelium" "HRMEC" "B/C" "isolectin" "17.31±1.2%"
    "29.74±1.5%" "=6" "non-perfused" "the VEGF-treated HRMECs"
    "significantly fewer anti-miR-155-treated HRMECs" "ROP"
    "VEGF-treated HRMECs" "Anti-miR-155" "angiography" "fundus" "C57BL/6J"
    "OIR" "HRMECs" "co-workers" "5×10" "in fact much broader" "iRegulon"
    "collagens" "PolII" "RNAPII" "feedforward" "seq" "Ribo" "synthetases"
    "transcriptomes" "specifier" "β 3" "α V" "phospho-p70S6K" "Dictostylium"
    "extracellular-signal-regulated kinase 1/2" "Phospho-p70S6K" "clearest"
    "OHTAM" "hidroxitamoxifen" "downregulators" "GSK3αβ" "Ser21/9" "Ser235/236"
    "biofunctions" "ACSL4-" "ACSL" "KEGG" "AKTS1" "ERbB"
    "the bioinformatic program DAVID" "mTORC1/2" "non-aggressive" "non-small"
    "TSC1/2" "non-homogeneous" "Chmielecki" "ToleratedDose" "150mg/day"
    "100mg/day" "1600mg/week" "u" "κt" "invariant" "Sloan" "Norton" "Tasigna"
    "non-genetic" "vitro" "Sayin" "drug/antioxidant"
    "the combinational treatment application timeline" "timeline"
    "drug/antioxidants" "sensitizer" "4±2" "cisplatin/EGCG" "co-treating" "RRx"
    "luminometry" "Nrf2-" "Nrf" "FLuc" "FLuc2" "ETGE" "degrons" "Neh" "Keap"
    "toxicants" "activators/inhibitors" "chemo-" "PatternCNV" "CNVs" "ribose"
    "at least 5 subtypes" "indel" "NKTCL" "1/64" "1/4" "7/21" "TMEM51"
    "E169del" "PCDHGA11" "DNAH7" "FEZF1" "MTMR8" "SDK2" "SLC16A14" "CACNA2D"
    "RUNX1T1" "T-LGL" "PolyPhen2" "Polyphen2" "transition/transversion"
    "indels" "SNVs" "VarScan" "Mutect" "leukemia/lymphoma (ATLL)" "PTCLnos"
    "LETL" "lymphoepithelioid" "HSTL" "Syc" "vedotin" "immunoconjugates"
    "newer" "at least 20 different subtypes" "Non-Hodgkin’s" "PROVEAN" "CHASM"
    "Non-synonymous" "Schnerch" "directly reprogrammed iNSCs" "Switzerland"
    "Lonza" "transgenes" "SFM" "StemPro" "ReNcell" "fully reprogrammed iNSCs"
    "reprogrammed iNSCs" "NSC/ebiNSc" "bi-" "uni-" "uni" "dendrites"
    "subsequent re-transferring" "ebiNS" "nearly all ebiNSc" "BJ/SMiNSc-like"
    "SiNSc-like/BJ" "BJ/ebiNSc" "Drozd" "Polska" "Celther" "ectoderm"
    "embryoid" "multilineage" "Geltrex" "Yamanaka" "BJ" "hESCs"
    "electrophysiology" "Maucksch" "SMiNSc-like" "SiNSc-like" "iNSCs-like"
    "ebiNSc" "iNc" "iNSCs" "4/5" "= 0.86" "= 5" "co-staining" "andMDM2" "UV"
    "ssDNA" "S3C" "chromosome/chromatid" "Oren" "Minsky" "Moyal" "Barretina"
    "HPRT" "or 2KR" "oxoG" "oxoguanine" "S5G" "pT306" "pT4" "and 3A"
    "Lys120/125" "Thr306/Ser307" "Bre1" "diploid" "tetraploid" "centresome"
    "–9" "S2B" "S2A" "anti-TNF-1α" "miR-130A" "replicon" "synovia" "OA"
    "TNF-1α" "miR-130a" "-1α" "miRNA-130a" "micro (mi)RNA-130a" "T-helper"
    "Correa" "cellular/environmental" "Immunocytochemistry" "LC-3II"
    "CellTiter" "peptidases" "inhibitor-1" "nucleates" "Annexin V/propidium"
    "10.1038/ncomms9755" "interconvert" "Gr-1+" "re-differentiated"
    "conditional re-expression" "HCmel10" "HCmel3" "HCmel" "Lund" "R-based"
    "peak-like" "Peak-like" "siNT" "sgRNA" "anti-correlated" "MSigDB"
    "Ma-Mel-54a" "Dox" "MZ7" "siMITF" "hyperresponsiveness" "Heatmap"
    "senescence-like" "heatmap" "a representative subset" "immunotherapies"
    "pmel-1" "Schwann" "Riesenberg" "co-occurrences" "E-box" "log 2"
    "smoking and alcohol history and chronic GI" "COIN" "Maughan"
    "microsatellite" "CIMP" "andBRAF" "Ogino" "Shuji" "mellitus" "pTNM"
    "antigen (CEA)" "CA19–9" "CA19-9" "G:p" "a premature stop codon" "PEST"
    "A: p" "non-lymph node" "our previously published cohort #3" "oncology"
    "#5" "A:p" "three other previously published NGS datasets" "WGS" "CICAMS"
    "Chaoshan" "Hebei" "Henan" "Shanxi" "Szczurek" "Taihang" "95% CI" "#3" "#1"
    "shFOXO" "shERK1/2" "shERK" "shFOXO3a" "−376" "-Basic-Luc" "+1" "−845"
    "pri-miR-622" "_PROMO" "13q31.3" "a lentiviral vector pLKO"
    "cobblestone-like" "-UTR-luc" "luc" "14q23.2" "bioinformatic algorithms"
    "mesenchyme" "Hypoxia-inducible factor-1α" "Migration/invasion" "∼4.5-fold"
    "TLR2/4" "soluble antigen" "anti-TLR" "gondii" "CD8 +" "Co-administration"
    "LLL12" "Mammosphere" "non-anchored" "phospho-STAT3" "0.5–2"
    "antigen (ESA)" "an aggressive tumor subtype" "/total" "μg/mL" "CSC-like"
    "CD44 +" "non-functional" "neointima" "carotid" "Evans" "enface"
    "the elastic lamina" "lamina" "wtih" "42±15%" "25±6%" "CAECs" "CAMCs"
    "K45R" "K54R" "Subconfluent CASMCs" "AlmarBlue" "non-targeting" "DMEM"
    "CASMCs" "re-endothelialization" "antiplatelet" "re-endothelialize" "G0/G1"
    "H&E" "G 0 /G 1" "R5BD" "fusion/enlargement" "sh848" "sh386" "Ronen"
    "Aviel" "Sarit" "CKLF" "CMTMs" "mammospheres" "SKOV3/DDP" "mono-bound"
    "eIFs" "approximately ∼90%" "∼75%" "co-sedimented" "NSLCC" "μg/ml"
    "E-box (CAGGTG)" "CAGGTG" "mesoderm" "Smuc" "Hu" "apico" "Lgl"
    "melanogaster" "∼90%" "∼25%" "ZEB1/2" "JNK/" "oxalipatin"
    "only group III SLFNs" "multigene" "Schlieffen" "German" "mt" "DFS"
    "well/moderate" "SLFN 11" "Wald" "HRs" "LR" "SPSS" "Biosystems" "GTCCTG"
    "dideoxy" "BIOMIGA" "sen" "Yat" "SLFNs" "SLFN" "Schlafen" "SLFN11"
    "95 % CI" "= 0.005" "= 0.003" "anti-angiogenesis" "co-cultured" "△CT"
    "immunocytochemistry" "weeks/five" "PECs" "PEC" "microvessel" "−9"
    "= 0.001" "Kit-8" "CLOVES" "Duclos" "Lhermitte" "Cowden" "dendrite" "Rett"
    "forebrain" "monogenic syndromic mTORopathies" "mTORopathies"
    "epileptiform" "telencephalon" "commonalities" "co-electroporation"
    "the cortical anlage" "Retzius" "preplate" "anlage" "RFPcassette" "IZ"
    "Non-cell" "neurospheres" "neurosphere" "subplate" "hNPCs" "birthdate"
    "glia" "Developmental neuropathology" "neuropathology"
    "disrupted neuronal circuitry" "EEG" "loCP" "mCP" "VI"
    "neuronal heterotopias" "heterotopias" "FMCDs" "hemispherectomy"
    "a clinically devastating pediatric FMCD" "HME" "Focal MCDs (FMCD)" "MCDs"
    "non-cell" "FMCD" "= 1.5" "non-phosphorylatable" "de-repression"
    "Z/EGanimals" "f/+" "orNestin" "OPCs" "OPC" "inNestin" "CreERT2" "Z/EG"
    "inducibleNestin" "RGLs" "SVZ" "bi" "C57BL/6" "inPten" "Koulich" "WB"
    "Zhang" "subfamilies" "AGC" "RxRxxS" "RxxS" "SGKs" "undergoes"
    "Randy Schekman" "Schekman" "proteome" "at least two replicates" "TMT"
    "cODC" "GFPu" "p-S432" "Burk" "Lineweaver" "S143A/S432A" "co-incubation"
    "Scansite" "orthologs" "BL1" "Ubal" "phosphoinoside"
    "an important intracellular signaling transducer" "disposal-like"
    "workhorses" "eLife" "DOI" "phosphoinosotide" "Anti-FLAG" "Kostourou"
    "mucosa" "μ L" "10.1038/srep15821" "Burnett" "trasuzumab" "CD44 + "
    "a triple negative molecular subtype" "LLT" "1/522" "ELDA" "eosin"
    "stepwise" "Iliopoulos" "hetero" "mammosphere" "shPTEN" "BCSCs" "BCSC"
    "LTT" "Korkaya" "NOD/SCID" "10.1038/srep15993" "Yoon" "anti-breast" "CDI"
    "GLEBS" "GLE" "anti-CSC" "#2" "shBub1-" "shBub" "shLuc" "shBub1"
    "10.1038/srep15798" "stressors"
    "B-cell lymphoma protein 2 (BCL-2) homologous antagonist/killer (BAK)"
    "co-activators" "intermembrane" "caspase 3/7" "tATP" "cNO" "SubG1" "PFT-α"
    "disrupter" "chlorophenylhydrazone" "carbonyl" "MitoTracker" "impedance"
    "hemocytometer" "double-minute" "ArrayScan" "Parkinson’s" "Parkinson"
    "Polymorphisms" "parthanatos" "sequential poly-(ADP-ribosyl)ation" "ation"
    "Alzheimer’s" "Alzheimer" "RHIM" "necrosome" "mROS" "cATP" "DOX"
    "N -acetyl" "cutis" "sibship" "atypical ketotic hypoglycemia"
    "hypoglycemia" "dysphagia" "14/20" "cerebellar tonsillar ectopia"
    "a variably thick
corpus callosum"
    "5/20" "vergae" "pellucidum" "cavum" "ectopia" "17/20" "callosum"
    "ventriculostomy" "7/20" "OFC" "17·1%" "43·3%" "·4" "275/634" "2030/6889"
    "37/216" "36·7%" "·2–73·4%" "·6" "39/106" "10/377" "19/" "ExAC" "Amplicon"
    "IGV" "workflow" "megalencephaly-polymicrogyria-polydactyly-hydrocephalus"
    "29·4%" "·3%" "·1%" "·4%" "·7%" "·5%" "amplicon" "smMIPs"
    "child-parent (trio)-based whole exome" "BPP" "22q11.2" "STA-7346" "Kd"
    "GA" "pY1234/1235" "anti-FLAG" "pcDNA" "IntERactome" "LUMIER" "IL213/5AA"
    "N-domain" "hygroscopicus" "Taipale" "hypoxia inducible factor 1α" "6p"
    "14q" "HSP90α" "stress-inducible HSP90α" "RHT2" "underwritten" "‘pLYN’"
    "RHT1" "pLYN" "both parental HZ" "BIMEL" "HZ" "nucleases" "RHZ" "BCR-ABL1"
    "SNU-2535" "H3122 CR1" "the synergistic anti-tumor" "SNU" "exressiong"
    "EAV" "repamycin" "hydrogels" "thermo"
    "almost ten fold fewer tumorospheres" "tumorospheres" "Co-treatment" "nano"
    "A549/no" "transfectoin" "EAV3" "EAV1"
    "approximately four fold fewer tumorspheres" "tumorspheres" "siGFP" "siALK"
    "tumorosphere" "intractableEML" "synergistic anti-tumor" "a unique subset"
    "mmol/L" "co-administration" "Stem-like" "resistnat" "Davis" "Δ5" "Jeko1-"
    "Jeko" "mTORs" "CD79A/B" "Oerlemans" "ChT" "Mino/BTZ" "Jeko1/BTZ"
    "Parental Jeko1" "Jeko1" "Philadelphia" "cells/dish" "IC50" "Granta519"
    "farnesyl" "β3/β1" "Millipore" "cells/well" "αv" "cytomemetry" "HuH"
    "geranylgeranyl" "anti-proliferation" "simvistatin"
    "diabetic nephropathies" "nephropathies" "β3"
    "a 3-hydroxy-3-methylglutaryl-coenzyme-CoA" "capsid" "VCA" "IgA" "CTAR"
    "EBV+" "EBNA1itself" "Hunan" "the Burkitt's" "the viral re-infection"
    "C2089/neo" "lysis" "Rhex-1" "293–2" "Fm" "EBNA" "lenth"
    "the whole viral genome" "a ubiquitous human gammaherpesvirus"
    "gammaherpesvirus" "sublineages" "293–1" "sublineage" "Maxi"
    "re-introduction" "11q" "ITIM" "HyperCVAD/MA" "β2-MG" "Setoodeh" "Mitelman"
    "BCLU" "R/MA" "CVAD" "Hyper" "CHOP/CHOP-like" "HyperCVAD" "17p" "13q"
    "gain/amplification" "JVM-13" "MAVER1" "Nebraska" "Chan" "MIPI" "14q32"
    "mg/L" "CD33+" "qChIP" "/L" "NuRD/Mi2" "AITL" "Burkitt's" "Burkitt" "WBC"
    "= 0.009" "chr" "IG20" "methylation/silencing" "miRDB" "microT" "TaqMan"
    "AzadC" "miR-34b/c" "karyotypes" "Ct" "232B4" "Taqman" "ΔCt" "UU"
    "WAC3CD5+" "BAALC" "8q22.3" "miR-34b" "methylcytosine" "b" "30/98" "5/7"
    "/ total" "48 as" "+ 10" "high/intermediate" "p-ERK1/2" "p85α" "1/2"
    "T1989" "regrow" "BW" "shATM" "SYTOX" "Loewe" "2–3" "S1981" "greatest" "GI"
    "Zeneca" "Astra" "IC 50" "anti-PaC" "BD" "o" "‘Oncomine’"
    "PTTG knockdown reliably boosts mitochondrial OXPHOS" "ECAR" "OXPHOS"
    "oligomycin" "DG" "PFK" "hexokinasse" "HK" "biomass" "shRNA1" "shRNA2"
    "non-cancerous" "allostery"
    "several different vertical combination stategies" "stategies"
    "doxcycyline" "Talalay" "Chou" "chosen" "complex-2" "Alk" "co-targeting"
    "neoadjuvant" "sensitiveness" "MCF-7/D" "MCF-7/E" "OC" "°C" "Tm"
    "TargetScan" "centromere" "epidermal growth factor receptor-2" "MCF-7/DOC"
    "MCF-7/EPI" "MCE" "mimics /inhibitors" "a unique pathophysiology" "XT"
    "growth/survival" "CNS" "a germinal center B cell immunophenotype" "Aukema"
    "MZ" "Xeno" "Anderson" "mapback" "immunoglobulin" "lambda"
    "immunophenotypes" "Epstein-Barr viral genomes" "Granta" "Barr" "frozen"
    "timepoint" "approximately 5 × 10 6 cells/mL" "cells/mL" "EJ-1" "Hooper"
    "CJ" "another recurrent oncogene breakpoint" "/8q24.4" "/3q27"
    "immunotherapy" "immunophenotype" "usually BCL2 /18q21.3" "/18q21.3"
    "another recurrent breakpoint" "/8q24.2" "log2" "non-Hodgkin"
    "non-promyelocytic" "pathophysiology" "monocytic-like" "NSC-95397"
    "Toulouse" "TKD" "IC-50" "CD34+" "FLT3-ITD+" "granulo" "karyotype"
    "transducer" "IRC-083864" "IRC" "ITD" "glandular epithelia" "CD133ΔE5"
    "cateninaxis" "ΔE5" "CD133 WT" "ΔE9" "GSK3βaxis" "fallen" "poly-d-lysine-"
    "before/after" "MβCD" "CD133ΔC7" "CD133ΔC3" "β6" "α3" "CD133ΔC11"
    "CD133ΔC3-7" "DLD1" "/Mock" "TOPflash" "microdomains" "evaginations"
    "stem-like" "anokis" "OH" "Nu/Nu" "Goosecoid" "MBA" "HMLE" "Puthier"
    "Oshiro" "Heinrich" "Falcone" "Catlett" "SYF-c-Src-TrkB" "TrkB"
    "Klinghoffer" "c-Src-shRNA" "c-Src-shRNAs" "ΔKD-2" "stem cell–like" "TGFb"
    "Knudsen" "CHI3L1" "RTD" "Greater" "DRB5" "ANGPLT2" "Serpine" "Venn"
    "transferase-1" "Levene" "dis" "T-circles" "HB-2" "PHA"
    "phytohemagglutinine" "chromatid" "chromatids" "nonmalignant"
    "hexameric TTAGGG" "TTAGGG" "non-homologous" "written" "Written"
    "NNPredict" "Chiu" "A/G" "A/T" "helix" "ureter" "Grote" "vesico" "aplasia"
    "GATA3/WT" "GATA3/R299Q" "ZnF1" "RBVI" "UCSF" "PDBj" "SFAS" "liker" "CGG "
    "pg/mL" "thalamus" "urea" "mg/dL" "examination showed severe hypocalcemia"
    "hyperphosphatemia" "hypocalcemia" "viz" "10p15" "year-old" "Multi"
    "Co-inhibition" "Wahlberg" "LIGlV" "PKCS" "BioMarin" "re-growth"
    "notable re-growth" "isograft" "NEHJ" "methanesulfonate (MMS)"
    "methanesulfonate" "μmol/L" "PARP5a" "readout" "nmol/L" "Trevigen"
    "9-dihydro-3H-pyridazino" "quinazolin-3-one" "ylmethyl" "isoindolin"
    "AbbVie" "TNKS1/2" "Zn" "Tesaro" "AstraZeneca" "de-stabilization"
    "Polymerase1" "lympendothelium" "MCF-7/LEC" "Xa" "flavonoids" "lactone"
    "parthenium" "Identifier" "~30%" "Bay11–7802" "~ 10%" "~ 30%" "Bay11-7802"
    "monolayers" "epidermoid" "lymphendothelium" "transmigrate" "emboli"
    "enroute" "CCID" "CCIDs" "ΔC" "non-canonical" "Raf-1/MAPK/AP-1"
    "Raf-1/MAPK" "Raf-1/" "MKKK" "231-CM" "231/Lap#6-CM" "hrs" "transwells"
    "231/Lap#6" "#6" "#12" "231/Lap" "MDA-MB-231/Lap" "miR-29bmay"
    "favorable anti-tumor" "‘antagomirs’" "antagomirs" "mediatedcontrolof"
    "hexokinases" "seemd" "agomirs" "and 3AO" "NAD+/NADH" "NAD + /NADH"
    "isozymes" "AKT2/3" "human cancerous ovarian epithelia"
    "normal ovarian epithelia" "correlatedwithmiR" "websites" "absorbance"
    "the human cancerous ovarian epithelia" "the normal ovarian epithelia"
    "evidenceofmiR" "approximately 22nt" "Warburg's" "agomir" "EOC" "Log 2"
    "non-small-cell" "NCI-60" "Godinho" "Imaris" "organoids" "#7" "comedo-like"
    "field–hpf-" "E2F3b" "times/week" "the right mammary gland #4"
    "the left mammary gland #9" "#4" "left mammary gland #9" "#9" "Ishida"
    "the mammary epithelium" "poorly prognostic breast cancer subtypes" "Wu"
    "E2F3a" "6/10" "re-established" "non-tumorigenic" "G 1/ S"
    "phosphorylation/activation" "vi" "iv" "invasive/metastatic" "pSTAT3 S727"
    "supernatants" "GOBO" "epithelial-like" "pYB-1 S102" "EMT-like" "pLPCX"
    "non-invasive" "TNBCs" "coworkers" "TNBC" "Hanahan"
    "transcription/splicing factor" "co-dependence" "pSTAT3 S" "pSTAT3"
    "stem cell-like" "co-clinical trial" "precise dosing/pharmacokinetics"
    "5/19" "-A146T" "2/19" "5/5" "1/1" "2/2" "CR0004" "non-responder"
    "non-responders" "G12C/D/V" "∼30%" "8/27" "A146T" "naïve" "histopathology"
    "monotheray" "/Leucovorin (FOLFOX)" "/leucovorin (LV)(IV)" "Vectibix"
    "FOLFIRI" "CAPIRI" "CAPOX" "FOLFOX" "OX"
    "actually no fewer G13D responders" "4/8"
    "no significantly fewer KRAS-12/13-allele responders" "non-/partial"
    "responders" "12/13" "∼50%" "diarylthiazole" "cPARP" "Fatostain"
    "fatostain" "Calcusyn" "STIMA-1" "desaturade-1" "caspase-3/7" "anti-growth"
    "wtp53" "shCon" "mevalonate" "IARC" "mCRPC" "72-hour" "Yao" "Chuang"
    "Philipsen" "Bouwman" "Zeitlin" "Vij" "Ozcan" "Kudlow" "Waby"
    "the SENP3-catalyzed de-conjugation" "polySUMO2/3" "CENP-1" "Breitenbach"
    "Lallemand" "Co-IP" "co-IP" "smear-like" "polySUMO" "Brattain" "Spengler"
    "ubiquitin/proteasome" "Prasad" "Keshava" "Forbes" "DAVID" "Dasso" "Huang"
    "Chang" "Lou" "Kanai" "Honda" "ubiquitination/degradation" "STUbls"
    "Uzunova" "SIMs" "Poulsen" "Erker" "Hickey" "Mukhopadhyay" "de-conjugation"
    "Reverter" "Salvesen" "Matic" "Tatham" "Bylebyl" "Sampson" "Bernier"
    "Friedlander" "Geiss" "Praefcke" "STUbLs" "Schimmel" "Dohmen"
    "Sriramachandran" "Geoffroy" "STUbL" "Marfany" "Denuc" "Ulrich" "Yeh"
    "Herrmann" "SUMO2/3" "SENP" "SENPs" "mol/L" "10.1038/srep15688"
    "Peptidimer" "Tunisia" "ound" "rowth" "hyper" "triphosphate" "biphosphate"
    "hydroxyl" "RIII" "Sahiwals" "indicus" "annulata" "JAM-L/ITG4A" "RII"
    "peptidimer" "Theileria" "Geng" "Helga"
    "the earliest endometrial precancers" "precancers" "Maarabouni" "Mourtada"
    "JEC" "YU" "DONGQI" "Chung" "Boren" "Nishiu" "Matsushima" "ulnar" "axial"
    "calvarial osteoblasts" "NAD(P)H:quinone oxidoreductase" "Perhaps"
    "mature osteoblasts" "MAR" "hyperoxia" "TGACnnnGC" "S-transferases" "NQO"
    "sMafG" "sMafK" "resorb" "Osteoblasts" "osteoblasts" "perhaps" "MISC"
    "immunosurveillance" "TRAIL/DR" "invasison" "condictions" "carcinogenesisi"
    "TPA" "HCT116-DR5KO" "shDR5" "p -ERK1/2" "pLKO" "re-expressed" "HCT" "KO"
    "APCmin" "coli" "ortholog" "re-expression" "Anti-HA" "anti-HA"
    "Re-expression" "non-apoptotic" "10.1038/ncomms9704" "K63R" "=0.009"
    "=0.0175" "GSE14520" "transcriptome" "non-tumoral" "Holm" "Wallis"
    "non-tumour" "NL" "HA" "f/f" "COON-terminal" "COON" "Mig" "knowdown"
    "oligos" "sillico" "anti-Flag" "+6" "+100A" "_1012" "pSXN" "_948"
    ".945_946" "-CERES-" "SRE2" "_946" "polypirimidine" "WMM" "SSPNN" "_1010"
    "_1011" "UAGGGA" "CERES" "pSPL3"
    "the regulatory elements around nucleotides c" "minigenes" "_946delinsAA"
    "DAZAP" "the pathogenic c" "ss" "microdeletions" "multiexon" "HGMD"
    "plexiform" "SR" "ESEs" "ISS" "ISE" "ESE" "dysthymia" "T-allele"
    "haplotypes" "synonymous (Leu→Leu) SIRT1 rs2273773 polymorphism"
    "empirical p-value = 0.001" "Bonferroni" "rs3758391" "haplotype" "Genotype"
    "81.7/134.9" "BMI" "sirtuins" "sirtuin" "rs2273773" "EGIR" "Finnish"
    "= 0.88" "UPPs" "PF/d" "gavage" "bodyweight" "antiubiquitin" "CQ" "CHX"
    "HIAP" "U251" "NAFLD" "the nonclassical CD16+ subtype" "DILI" "woodchucks"
    "ploidy" "MycER"
    "subsequent cyclin D1/cyclin-dependent kinase 4 (CDK4) goes" "goes"
    "anorexia" "dormancy" "circuitry" "viverrini (OV)" "viverrini" "Toll-like"
    "epithelia" "pathobiology" "eosinophils" "SykPTK" "metalloproteinase-1"
    "CLDs" "miRwalk" "Lu" "Shaw" "Bergethon" "Micocci" "Shea" "Zheng"
    "QuickChange" "MCF-7/ctrl" "mirwalk" "miRanda" "Targetscan"
    "MDA-MB-231/ctrl" "MDA-MB-231/miR-33a" "antagomir" "Blenkiron" "Thomas"
    "Ibrahim" "Zhou" "Li" "Rayner" "Shoushtari" "Najafi" "Marquart" "Volinia"
    "Ruan" "Kang" "-untranslated-region" "Ouyang" "Weinberg" "Chaffer" "Dong"
    "Hong" "MiR-33a" "miR-33a" "× 10" "= 3" "5 × 10" "10.1038/srep15793"
    "AGGAU" "G-rich" "URRs" "re-entry" "CREBA" "hexamer" "miR-490-3p" "miR-20a"
    "miR-15a" "oncomiR" "tussues" "Co-expression" "co-transfection" "biotin"
    "UGAA" "duplexes" "TargetScanHuman" "AGAGC" "nts" "miR-138-mediated"
    "miR-138-" "j" "pcDNA3/EGFP" "pri-miR-138" "futher" "pri-miR-346"
    "protein C2" "CCGCAU" "Co-transfection" "Seligson" "rostate" "ouse"
    "Helfer" "Finlay" "the Spearman’s" "Spearman" "significant/borderline"
    "immunoreactions" "ILP2" "procaspase-3" "cIAP1/2" "vera"
    "essential thrombocythemia" "thrombocythemia" "IVS2+1G" "Hodgkin"
    "1100delC" ".444+1G" "Cybulski" "Slovak" "hematological malignances"
    "LUBAC" "penetrant" "FLIPI" "chemoimmunotherapy" "homozygotes" "dupA"
    "DupA" "75/340" "139/445" "intronic polymorphism c" "deeper"
    "neutral polymorphisms" "premature stop codons" "penetrance" "OMIM" "Czech"
    "Non-Hodgkin" ".319+43dupA" "the most frequent intronic variant c" "DHPLC"
    "= 4" "= 9.7" "= 3" "= 0.003" "prostaspheres" "prostasphere" "explants"
    "CWR22Rv1" "SCS" "toremifene" "adenylyl" "epithelium" "xeno" "disruptors"
    "utero" "Japanese" "American" "African" "replicate" "ERS" "aberrancies"
    "non-transcriptional" "HT1080" "8/18" "Neuroendocrine" "fibro"
    "neuroendocrine" "cells/SCs" "brachytherapy" "prostatectomy" "non-genomic"
    "non-malignant" "stem/progenitor" "Helgason" "a public dataset" "Renmin"
    "noncarriers" "= 0.0000435" "E1978X" "relativeness" "II-1" "III-2"
    "Y1203fs" "_000051.3:c" "the proband's" "re-examination" "II-2" "eldest"
    "The proband's" "muscularis" "proband" "Zhejiang" "Sichuan" "Germline"
    "transcript-1" "andnPTB" "thePTB" "+exon" "Warburg" "ofnPTB"
    "repressingnPTB" "+10" "minigene"
    "the CU-element resulted in its skipping [ xref , xref , xref ]"
    "the CU-element" "CU-element" "CU" "exons" "+11" "andPTB" "werenPTB"
    "thenPTB" "miR92a-2-3p" "miR-92a-2-5p" "miR-92a-2-3p" "miR-92a-2"
    "RNAhybrid" "heteroduplexes" "myocytes" "changess" "IIIc"
    "the neuronal polypyrimidine" "polypyrimidine" "~50%" "malignances" "Xu"
    "PI3Kα/δ" "Gleason" "LY3023414" "strong synergism" "synergism"
    "a representative drug PF-04691502" "MTS" "non-CRPC" "HER2/3" "PF-04691502"
    "MDV" "CRPC" "/G1" "induce/restore" "chemoresistance" "NCI"
    "dithiocarbamate (PDTC)" "dithiocarbamate" "~90%" "C/D"
    "hepatocellular carcinoma (HCC) ZFAS1" "biological replicates" "replicates"
    "miRWalk" "interestingly four algorithms" "algorithms" "alignScore"
    "miR-590-3p" "AUKB" "GeneOntology" "SNORD12" "hr" "COADREAD" "SW-620"
    "Colo" "HCT116−/−" "HCT116+/+" "two-times" "ceRNAs" "kilobases" "clinico"
    "ZFAS1" "non-coding" "non-protein" "introns" "colocalizes" "anti-migration"
    "Asian" "25/106" "GAS7C/hnRNP U" "GAS7C/N-WASP" "anti-motility" "ubiqutin"
    "immunocytochemisty" "β1" "&E" "five-weeks" "si" "GAS7B" "GAS7A" "hnRNPs"
    "pseudosubstrate" "Aldrich" "Wiskott" "Ingham" "retrovirus" "GAS7C" "pCMV6"
    "subarachnoid" "adeno" "ITGAVB3" "Morfouace" "effLuc" "MED8A" "pSiCHECK2-"
    "pSiCHECK" "pSiCHECK2" "the cortical dysplasia" "dysplasia"
    "the 4 under-expressed DEmiRs" "cerebellum" "non-seeding"
    "non-SHH-medulloblastoma" "anaplastic histology" "subgroupings" "subtypes"
    "DEmiRs" "× 10" "5 × 10" "4ebp2" "leucemia" "1.4-2.4" "1.4-3.2"
    "histological subtype" "Karnofsky" "Multivariate" "nephrectomy" "leucin"
    "Caki2" "inhibitis" "tubule" "tubules" "chemoresistant"
    "non-phosphorylated" "pre-" "anti-tumoral" "= 0.001" "multi" "greater"
    "toxic DSBs" "hypothesise" "adduct" "Murai" "non-EWSC"
    "the parental line ES8" "adducts" "sulfonate" "OLAR5" "ES7"
    "four representative EWSCs" "EWSC" "a representative cell line ES8" "ES8"
    "Lynparza" "1.2–10μM" "BMN-673" "BMN" "AZD" "anti-tumour" "endpoints"
    "DSBs" "BRCA1/2" "chemotypes" "PARPi" "EWSCs" "breakpoint" "PARP1/2"
    "10.1038/srep15666" "Inoue" "IMRT" "oncologists" "conc" "polyploid" "Liu"
    "TGDT" "mAG1" "IVIS" "mKO2" "pHH3" "&T210D" "Gy" "X-irradiation" "g"
    "Azami" "Kusabira" "FUCCI" "DSB" "radioresistance" "radioresistant" "chemo"
    "PLK1-R136G&T210D" "BALB/c" "8-week-old" "5 × 10" "× 10" "mg/kg" "×10"
    "Hoechst" "-trihydroxy-3-" "rosaceae" "-propiophenone" "propiophenone"
    "hydroxyphenyl" "Ph" "coregulators" "transmodulate" "MICoA" "Foxa"
    "multiprotein" "Oestrogen" "-deoxyuridine" "deoxyuridine" "MOI" "MOIs"
    "pEZX" "nonperfect" "ERE" "EREs" "ovariectomy" "curative hepatectomy"
    "hepatectomy" "Transwell" "μL" "pEGFR" "gatekeeper" "10.1038/ncomms9690"
    "Litchfield" "EGA" "phenome" "European" "further risk SNPs"
    "the previously known risk SNPs" "Sertoli" "multitype" "CONDEL" "missense"
    "undertaken" "ZPFM2" "ZPFM1" "oocytes" "GAB" "exome" "SOX"
    "the significantly associated eQTL SNP" "enhancers" "rs2511156" "CEU"
    "enhancer" "Epigenome" "Roadmap" "HaploReg" "Genomes" "homozygote"
    "rs2018199" "rs2075158" "USP35" "SNP/exome" "eQTL"
    "previously reported SNP rs12699477" "rs12699477" "nonsignificant" "=1.09"
    "rs55637647" "BCAR4" "=1.6" "intron" "=9.7" "rs7107174"
    "confidence interval (CI)=1.09–1.28" "=1.5" "rs11705932" "Illumina"
    "OmniExpressExome" "iii" "ii" "genomes" "iCOGs" "rs4561483" "3q23"
    "11q14.1" "16p13.13" "16q24.2" "multistage" "SNPs" "GWAS" "=3"
    "10.1038/ncomms9528" "doi" "/mGFP" "transwell" "co-culture" "Paracrine"
    "Collagen1a1" "SAβGal" "DIV" "mdx-βgeo" "mdx" "fibroblast-like" "Sirius"
    "Kossa" "heterogenous myofiber" "myofiber" "myonuclei" "Tibialis" "mGFP"
    "Δ/" "F/F" "paralog" "progeny" "non-myogenic" "secretome" "paracrine"
    "myofibers" "Roux" "Le" "Ex" "μg " "appropriateness" "non-responding"
    "histology" "glycinamide" "folic" "monotherapy" "platins" "semi" "Weichert"
    "anti-apoptotic" "0.001and" "Forty-one" "p  " "anti-tumor" "Non-specific"
    "=0.0043" "=0.42" "immunohistochemistry (IHC)" "AJCC" "IHC" "Kiel"
    "soft agar" "co-occur" "p" "CNV" "Affymetrix" "CytoScan" "non-synonymous"
    "LOF" "frameshift" "Genome" "exomes" "mg/mL" "ELISA" "Api" "ΔΨm"
    "monolayer" "anti-telomerase" "coumestans" "oestrogen" "/G 1"
    "anti-inflammatory" "et" "lymphoma-2" "acidic vesicular organelles"
    "organelles" "autophagic vacuoles" "vacuoles" "subtype" "Corp" "Xinchang"
    "Puquitinib" "mol/l" "methyladenine" "anti-proliferative" "naso" "XC-302"
    "XC" "mesylate" "puquitinib" "hotspots" "dural" "rKlotho" "CMV6" "pCMV"
    "lifespan" "gotten" "USA" "μg" "ASCO" "clinicians" "Droplet" "anti-cancer"
    "unmet" "genotypes" "BTC 27P" "BTC 27" "copies /ml" "BTC 29S" "ctDNA"
    "copies/reaction" "Poisson" "wt" "LoD" "Kirsten" "homolog" "CC" "GBC"
    "gallbladder" "intra-" "intra" "BTCs" "gDNA" "copies/ml" "PrimePCR" "Bio"
    "droplet" "*mPGES1" "*PGF2a" "PG/FP" "Pearson's"
    "Skrzypczak Colorectal 2 dataset" "dataset" "bp" "FP" "mPGES1-" "mPGES"
    "HT29-lucD6-COX2" "HT29-lucD6-EV" "-EV" "Boyden" "SW480ADH" "supernatant"
    "EV" "immunohistochemistry" "human colorectal tumor biopsies" "silico"
    "co-occurrence" "TCGA" "Gaedcke" "Skrzypczak" "co-expressed/co-induced"
    "Pearson" "algorithm" "Oncomine" "datasets" "LifeTechnologies" "Compendia"
    "OncoMine" "expression/activity" "lipopolysaccharide" "EGR"
    "their respective synthases" "prostaglandins" "synthases" "undergone"
    "colorectal human tumor biopsies" "5-year" "stressful" "G1/S" "CUGCG"
    "Andreotti" "codon" "ITAFs" "distal 180 nt" "both the proximal 90 nt" "nt"
    "IRESs" "co-transfected" "nearest" "Hydroxyl" "FUSIP" "drawn" "Antigen"
    "TOP-like" "MCF7shp53" "pRuF" "AUG" "Redux" "Fluc" "Renilla" "ITAF"
    "lymphoblastoid" "IRES" "biopsy" "poorer" "cftDNA" "antigens" "peritoneum"
    "usually only fine-needle aspiration (FNA) biopsies" "FNA"
    "yet metastasized or released CTC" "cofounders" "7/35" "wildtype" "Weibull"
    "8/31" "S2b" "S2a" "non-specific" "ddPCR" "μl" "RNaseP" "younger"
    "non-cancer" "ImageStream" "isoflux" "CTCS" "ISET" "CTCs"
    "acute pancreatitis" "pancreatitis" "antigen" "aneuploidy" "Europe"
    "exocrine" "CellSearch" "CTC" "cfDNA" "poorest" "non-tumor" "=  0.001"
    "Haller" "Angelini" "polymorphisms" "genome" "codons" "Brien" "germline"
    "Iurlo" "Dufresne" "desmoid" "Gonçalves" "Merkel" "non-metastatic"
    "Fischer" "Miettinen" "polymorphism (SNP)" "SNP" "ESMO" "gastro" "French"
    "polymorphism" "genotype" "miR-30a" "MK-2206 induced re-distribution"
    "RPRR" "co-localizes" "overview"
    "the canonical PI3K/AKT/mTOR signaling pathway forms another mutational hotspot"
    "hotspot" "broader" "3q26" "co-treated" "co-treatment" "pre" "co-enriched"
    "RPRRX" "co-localization" "co-fractionation" "nucleo" "inspite"
    "a sequential re-appearance" "Akti1/2" "stemness" "co-regulated" "vivo"
    "HAT + " "pack-years" "particularly cytotoxic/pro-inflammatory subsets"
    "bronchial biopsies" "biopsies" "parenchyma" "ie" "mg/ml" "FEV1" "subset"
    "CD28 null" "CD28nullCD8 + " "CD28 + " "sd" "CD8−" "CD" "corticosteroid"
    "cylclosporin" "GCR" "CD28+" "bronchoalveolar lavage (BAL)" "lavage"
    "CD8 + " "subset/s" "ex" "proven" "CD28nullCD8+" "NKT-like" "CD8+"
    "CD28null" "subsets" "corticosteroids" "endpoint" "mir" "-UTRs" "UTRs"
    "mirPath" "DIANA" "BrdUrd" "FACS" "agar" "multivariate" "Univariate" "-UTR"
    "UTR" "overridden" "Rb" "mimics/inhibitors" "199a" "Wilmott" "Sanger"
    "≤25%" "≤20%" "≤18%" "≤15%" "univariate" "≤18" "offs" "Meier" "Kaplan"
    ".1799_1800TG" ".1798_1799GT" "_1799GT" "FFPE" "nonresponders" "PFS"
    "_1800TG" "-c" "c"))

(DEFPARAMETER SPARSER::*BIO-CHEMICAL-HEADS-PHASE3-16201-16500*
  '(("acetyl-CoA or succinyl-CoA" . SPARSER::COLLECTION)
    ("lipids and amino acids" . SPARSER::COLLECTION)
    ("mitochondria, and fatty acid" . SPARSER::COLLECTION)
    ("CPT1 and LCAD" . SPARSER::COLLECTION)
    ("NDUFAF3 , NDUFAF4 , and MPC1" . SPARSER::COLLECTION)
    ("these respiratory complexes" . SPARSER::BIO-COMPLEX)
    ("mitoribosomal proteins" . SPARSER::PROTEIN)
    ("near-cognate tRNAs" . SPARSER::PROTEIN)
    ("AMP/ATP" . SPARSER::PROTEIN-PAIR) ("mt-mRNAs" . SPARSER::COLLECTION)
    ("MnmE and MSS1" . SPARSER::COLLECTION) ("GLS-1" . SPARSER::COLLECTION)
    ("GLS" . SPARSER::PROTEIN)
    ("glutaminase and glutamine" . SPARSER::COLLECTION)
    ("ASCT2 and SN2" . SPARSER::COLLECTION)
    ("long-chain acyl-CoA dehydrogenase (LCAD) and medium-chain acyl-CoA dehydrogenase (MCAD)"
     . SPARSER::COLLECTION)
    ("dehydrogenase (MCAD)" . SPARSER::PROTEIN)
    ("dehydrogenase (LCAD)" . SPARSER::PROTEIN) ("MCAD" . SPARSER::PROTEIN)
    ("LCAD" . SPARSER::PROTEIN)
    ("skeletal muscle, and phosphofructokinase" . SPARSER::COLLECTION)
    ("pyruvate and lactate" . SPARSER::COLLECTION)
    ("NADH and NAD +" . SPARSER::COLLECTION) ("LDHB" . SPARSER::PROTEIN)
    ("MPC and Complex I" . SPARSER::COLLECTION)
    ("the two paralogous subunits" . SPARSER::PROTEIN)
    ("lipids and glutamine" . SPARSER::COLLECTION)
    ("glutamine and fatty acids [ xref , xref ]" . SPARSER::COLLECTION)
    ("NC and shGTPBP3" . SPARSER::COLLECTION)
    ("ND1 and Complex I" . SPARSER::COLLECTION)
    ("subunit and Complex I" . SPARSER::COLLECTION)
    ("the respective mRNA" . SPARSER::PROTEIN)
    ("subunit, and Complex-V" . SPARSER::COLLECTION)
    ("NDUFS3 and NDUFB8" . SPARSER::COLLECTION)
    ("chloramphenicol" . SPARSER::DRUG) ("ND1 and ND3" . SPARSER::COLLECTION)
    ("-cysteine" . SPARSER::COLLECTION) ("-methionine" . SPARSER::COLLECTION)
    ("emetine" . SPARSER::DRUG) ("defective mitochondria" . SPARSER::PROTEIN)
    ("thioredoxin-2, peroxiredoxin-3 and peroxiredoxin-5"
     . SPARSER::COLLECTION)
    ("peroxiredoxin" . SPARSER::PROTEIN)
    ("thioredoxin and thioredoxin reductase" . SPARSER::COLLECTION)
    ("cytometry and polarography" . SPARSER::COLLECTION)
    ("mnmE" . SPARSER::PROTEIN)
    ("tRNAs and S . cerevisiae" . SPARSER::COLLECTION)
    ("mt-tRNA Lys and mt-tRNA Leu(UUR)" . SPARSER::COLLECTION)
    ("the GTPBP3-substrates mt-tRNA Lys and mt-tRNA Leu(UUR)"
     . SPARSER::COLLECTION)
    ("UUR" . SPARSER::AMINO-ACID) ("taurine" . SPARSER::MOLECULE)
    ("fatty acid and glucose" . SPARSER::COLLECTION)
    ("TRMU-" . SPARSER::PROTEIN)
    ("the bacterial MnmA protein" . SPARSER::PROTEIN)
    ("GTPBP3 and MTO1" . SPARSER::COLLECTION)
    ("MnmE and MnmG" . SPARSER::COLLECTION)
    ("Leu, Lys, Glu, Gln and Trp" . SPARSER::COLLECTION)
    ("MnmA" . SPARSER::PROTEIN) ("MnmE" . SPARSER::PROTEIN)
    ("Leu(UUR)" . SPARSER::AMINO-ACID)
    ("MTO1 and GTPBP3" . SPARSER::COLLECTION) ("TRMU" . SPARSER::PROTEIN)
    ("nuclear DNA and a relevant group" . SPARSER::COLLECTION)
    ("mitochondrial tRNAs (mt-tRNAs) and rRNAs [ xref – xref ]"
     . SPARSER::COLLECTION)
    ("mitochondrial tRNAs" . SPARSER::PROTEIN) ("rRNAs" . SPARSER::RNA)
    ("CIII" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Respiratory complexes" . SPARSER::BIO-COMPLEX)
    ("c and ETFs" . SPARSER::COLLECTION)
    ("diverse electron" . SPARSER::MOLECULE)
    ("glycerol-3-phosphate dehydrogenase and ETF-ubiquinone"
     . SPARSER::COLLECTION)
    ("oxidoreductase" . SPARSER::PROTEIN) ("Complexes" . SPARSER::BIO-COMPLEX)
    ("Coenzyme Q (CoQ) and cytochrome c" . SPARSER::COLLECTION)
    ("five multiheteromeric complexes" . SPARSER::BIO-COMPLEX)
    ("NDUFAF3 and NDUFAF4" . SPARSER::COLLECTION) ("MPC" . SPARSER::PROTEIN)
    ("mt-tRNAs" . SPARSER::COLLECTION) ("angiogenin" . SPARSER::PROTEIN)
    ("tRNAs" . SPARSER::PROTEIN)
    ("an evolutionary conserved protein" . SPARSER::PROTEIN)
    ("mt-tRNA" . SPARSER::COLLECTION) ("I-V" . SPARSER::PROTEIN)
    ("protein -1" . SPARSER::PROTEIN) ("min -1" . SPARSER::PROTEIN)
    ("Citrate synthase" . SPARSER::PROTEIN)
    ("citrate synthase" . SPARSER::PROTEIN) ("GSH-Px" . SPARSER::PROTEIN)
    ("Glutathione peroxidase" . SPARSER::PROTEIN)
    ("acetyl-CoA" . SPARSER::MOLECULE) ("U3" . SPARSER::PROTEIN)
    ("MSS1" . SPARSER::PROTEIN) ("α-ketoglutarate" . SPARSER::MOLECULE)
    ("SN2" . SPARSER::PROTEIN) ("ASCT2" . SPARSER::PROTEIN)
    ("PFK1" . SPARSER::PROTEIN) ("lactate dehydrogenase B" . SPARSER::PROTEIN)
    ("MPC1" . SPARSER::PROTEIN) ("compound C" . SPARSER::MOLECULE)
    ("COX IV" . SPARSER::PROTEIN) ("NDUFB8" . SPARSER::PROTEIN)
    ("NDUFS3" . SPARSER::PROTEIN) ("Complex-I" . SPARSER::PROTEIN)
    ("cytochrome b" . SPARSER::PROTEIN) ("subunit A" . SPARSER::PROTEIN)
    ("ND3" . SPARSER::PROTEIN) ("Opa1" . SPARSER::PROTEIN)
    ("Uncoupling protein 2" . SPARSER::PROTEIN)
    ("peroxiredoxin-3" . SPARSER::PROTEIN) ("thioredoxin-2" . SPARSER::PROTEIN)
    ("superoxide anion" . SPARSER::MOLECULE) ("s2" . SPARSER::MOLECULE)
    ("S . cerevisiae" . SPARSER::PROTEIN)
    ("uncoupling protein 2" . SPARSER::PROTEIN) ("s 2" . SPARSER::MOLECULE)
    ("U34" . SPARSER::PROTEIN) ("MTO1" . SPARSER::PROTEIN)
    ("glycerol-3-phosphate dehydrogenase" . SPARSER::PROTEIN)
    ("Coenzyme Q" . SPARSER::PROTEIN) ("NDUFAF4" . SPARSER::PROTEIN)
    ("NDUFAF3" . SPARSER::PROTEIN) ("UCP2" . SPARSER::PROTEIN)
    ("Complex I" . SPARSER::PROTEIN) ("GTPBP3" . SPARSER::PROTEIN)
    ("hnRNPL, hnRNPLL, hnRNPA1 and SFPQ" . SPARSER::COLLECTION)
    ("SFPQ" . SPARSER::PROTEIN) ("hnRNPL" . SPARSER::PROTEIN)
    ("miRNAs and long non-coding RNAs" . SPARSER::COLLECTION)
    ("IL21, IL5 and IL10" . SPARSER::COLLECTION)
    ("IL21, IL22 and TNFa" . SPARSER::COLLECTION)
    ("SYNCRIP and/or ILF2" . SPARSER::COLLECTION)
    ("IL17, IL21, and FOXP3" . SPARSER::COLLECTION)
    ("PIMs, ILF2 and SYNCRIP" . SPARSER::COLLECTION)
    ("associated genes" . SPARSER::GENE)
    ("3 pro-inflammatory cytokines" . SPARSER::PROTEIN)
    ("SYNCRIP or ILF2" . SPARSER::COLLECTION)
    ("7 highly immunologically relevant cytokines" . SPARSER::PROTEIN)
    ("PIM SYNCRIP" . SPARSER::PROTEIN)
    ("receptor, MAPK, and IL21" . SPARSER::COLLECTION)
    ("rIL" . SPARSER::PROTEIN) ("U2AF2’s" . SPARSER::BIO-COMPLEX)
    ("U2AF2 bound genes" . SPARSER::GENE) ("GITR" . SPARSER::PROTEIN)
    ("27 unique genes" . SPARSER::GENE) ("SYNCRIP" . SPARSER::PROTEIN)
    ("1814 unique genes" . SPARSER::GENE)
    ("one CIM (U2AF1) and one PIM (SYNCRIP)" . SPARSER::COLLECTION)
    ("PIM (SYNCRIP)" . SPARSER::PROTEIN)
    ("U2AF1 or SYNCRIP" . SPARSER::COLLECTION)
    ("CASP2 and ABI1" . SPARSER::COLLECTION)
    ("relatively few genes and pathways" . SPARSER::COLLECTION)
    ("IL3, IL9, mTOR, and CCNB1" . SPARSER::COLLECTION)
    ("IL17 and SKAP1" . SPARSER::COLLECTION)
    ("far fewer genes" . SPARSER::GENE)
    ("PIMs, ILF2 or SYNCRIP" . SPARSER::COLLECTION)
    ("a post-transcriptional inhibitor" . SPARSER::INHIBITOR)
    ("SRRM2, ILF2, and SYNCRIP" . SPARSER::COLLECTION)
    ("U2AF1 and SYNCRIP" . SPARSER::COLLECTION)
    ("immune cytokines" . SPARSER::PROTEIN)
    ("U2AF1 and SRRM2" . SPARSER::COLLECTION)
    ("transcript-specific siRNAs and negative control siRNAs"
     . SPARSER::COLLECTION)
    ("transcript-specific siRNAs" . SPARSER::PROTEIN)
    ("IL6, IL13, and IFNg" . SPARSER::COLLECTION)
    ("IL4, IL5, IL10, IL13, IL17, IFNg, RANTES, and TNFa"
     . SPARSER::COLLECTION)
    ("ILF2 and SYNCRIP" . SPARSER::COLLECTION)
    ("IL21, IL22, and TNFa and IL5, IL10 and IL21" . SPARSER::COLLECTION)
    ("TNFa and IL5, IL10 and IL21" . SPARSER::COLLECTION)
    ("IL5, IL10 and IL21" . SPARSER::COLLECTION) ("IFNg" . SPARSER::PROTEIN)
    ("important immune cytokines" . SPARSER::PROTEIN)
    ("CD25 and CD62L" . SPARSER::COLLECTION)
    ("U2AF1 (CIM), SRRM2 (CIM), SYNCRIP (PIM) and ILF2 (PIM)"
     . SPARSER::COLLECTION)
    ("U2AF1 and three proteins" . SPARSER::COLLECTION)
    ("Acetyl" . SPARSER::MOLECULE) ("TOF" . SPARSER::PROTEIN)
    ("U2AF2 and U2AF1" . SPARSER::COLLECTION) ("RNase" . SPARSER::PROTEIN)
    ("CIM" . SPARSER::PROTEIN) ("trypsin" . SPARSER::PROTEIN)
    ("particular mRNAs" . SPARSER::PROTEIN)
    ("IL21, MAPK and NLR" . SPARSER::COLLECTION)
    ("a larger 65KDa protein, U2AF2 or U2AF65" . SPARSER::COLLECTION)
    ("The U2 Auxillary Factor (U2AF) heterodimer" . SPARSER::HETERODIMER)
    ("protein, U2AF1 or U2AF35" . SPARSER::COLLECTION)
    ("protein, U2AF2 or U2AF65" . SPARSER::COLLECTION)
    ("U2AF65" . SPARSER::PROTEIN) ("U2AF35" . SPARSER::PROTEIN)
    ("CD4 and CD8" . SPARSER::COLLECTION)
    ("the 38% unassignable isoform" . SPARSER::ISOFORM)
    ("the exon’s" . SPARSER::PROTEIN) ("CD40L, and CD71" . SPARSER::COLLECTION)
    ("CD25, CD40L, CD62L, CD69, and CD71" . SPARSER::COLLECTION)
    ("the U2AF heterodimer or blocking access" . SPARSER::COLLECTION)
    ("35 kDa U2AF1 and 65 kDa U2AF2 subunits [ xref ]" . SPARSER::COLLECTION)
    ("the essential splicing factor" . SPARSER::PROTEIN)
    ("60 immune-related genes" . SPARSER::GENE)
    ("receptor (TCR)" . SPARSER::RECEPTOR) ("U2AF1" . SPARSER::PROTEIN)
    ("PIM" . SPARSER::PROTEIN) ("PIMs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("RNAse" . SPARSER::PROTEIN) ("U2AF2" . SPARSER::PROTEIN)
    ("AF2" . SPARSER::PROTEIN) ("member U" . SPARSER::PROTEIN)
    ("CTLA4" . SPARSER::PROTEIN) ("ABI1" . SPARSER::PROTEIN)
    ("CASP2" . SPARSER::PROTEIN) ("IL18R1" . SPARSER::PROTEIN)
    ("SKAP1" . SPARSER::PROTEIN) ("IL9" . SPARSER::PROTEIN)
    ("IL3" . SPARSER::PROTEIN) ("IL22" . SPARSER::PROTEIN)
    ("IL13" . SPARSER::PROTEIN) ("IL5" . SPARSER::PROTEIN)
    ("IL4" . SPARSER::PROTEIN) ("TRA2A" . SPARSER::PROTEIN)
    ("SFRS3" . SPARSER::PROTEIN) ("SFRS1" . SPARSER::PROTEIN)
    ("SFRS7" . SPARSER::PROTEIN) ("RNA Binding" . SPARSER::PROTEIN)
    ("IL21" . SPARSER::PROTEIN) ("LY96" . SPARSER::PROTEIN)
    ("IL12RB2" . SPARSER::PROTEIN) ("SFRS10" . SPARSER::PROTEIN)
    ("KHDRBS1" . SPARSER::PROTEIN) ("SAM68" . SPARSER::PROTEIN)
    ("ILF2" . SPARSER::PROTEIN) ("FUSIP1" . SPARSER::PROTEIN)
    ("end 1" . SPARSER::PROTEIN) ("RNA Binding Protein" . SPARSER::PROTEIN)
    ("CD71" . SPARSER::PROTEIN) ("CD62L" . SPARSER::PROTEIN)
    ("CD69" . SPARSER::PROTEIN) ("UCHL1" . SPARSER::PROTEIN)
    ("CD45RO" . SPARSER::PROTEIN) ("SK3" . SPARSER::PROTEIN)
    ("CELF2" . SPARSER::PROTEIN) ("U2AF" . SPARSER::BIO-COMPLEX)
    ("p21 or ERK1/ 2" . SPARSER::COLLECTION)
    ("b, d, f, h, and Fig." . SPARSER::COLLECTION)
    ("shRNA or Notch3" . SPARSER::COLLECTION)
    ("Four Notch receptors (Notch1-4) and 5 ligands (Jag1 and 2 and Dll1, 3, and 4)"
     . SPARSER::COLLECTION)
    ("Notch3 and Notch2" . SPARSER::COLLECTION)
    ("GFP or GFP" . SPARSER::COLLECTION)
    ("Notch2 and Notch3" . SPARSER::COLLECTION) ("Fas-L" . SPARSER::PROTEIN)
    ("ERK1/ 2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Notch 2" . SPARSER::PROTEIN)
    ("3-NT" . SPARSER::PROTEIN) ("Dll1" . SPARSER::PROTEIN)
    ("Notch3" . SPARSER::PROTEIN)
    ("a biostable synthetic ESRRA siRNA" . SPARSER::PROTEIN)
    ("a synthetic biostable siRNA" . SPARSER::PROTEIN)
    ("LNCaP and PC-3" . SPARSER::COLLECTION)
    ("CCND1 , FGF3 , FGF4, TAOS1 and EMS1" . SPARSER::COLLECTION)
    ("a biostable Stealth RNAi TM  ESRRA siRNA" . SPARSER::PROTEIN)
    ("ESRRA and STIL" . SPARSER::COLLECTION)
    ("irrelevant genes" . SPARSER::GENE) ("WT1 and STIL" . SPARSER::COLLECTION)
    ("the vector control pcDNA3.1" . SPARSER::PROTEIN)
    ("RNA and tissue" . SPARSER::COLLECTION)
    ("both estrogen response element (5′TCAAGGTCA3′) and its cognate response element (5′GGTCANNNTGACC3′) xref"
     . SPARSER::COLLECTION)
    ("OPN (osteopontin) and WNT11 (wingless-type MMTV integration site family, member 11) genes"
     . SPARSER::COLLECTION)
    ("osteopontin" . SPARSER::PROTEIN)
    ("a 423-amino acid-long protein" . SPARSER::PROTEIN)
    ("a synthetic biostable ESRRA siRNA" . SPARSER::PROTEIN)
    ("WNT11 and OPN" . SPARSER::COLLECTION) ("OPN" . SPARSER::PROTEIN)
    ("ESRRA" . SPARSER::PROTEIN)
    ("estrogen-related receptor alpha" . SPARSER::PROTEIN)
    ("miR-125a " . SPARSER::PROTEIN) ("as 2 " . SPARSER::PROTEIN)
    ("XCT790" . SPARSER::DRUG) ("EMS1" . SPARSER::PROTEIN)
    ("FGF4" . SPARSER::PROTEIN) ("FGF3" . SPARSER::PROTEIN)
    ("D11" . SPARSER::PROTEIN) ("ESRRA protein" . SPARSER::PROTEIN)
    ("member 11" . SPARSER::PROTEIN)
    ("wingless-type MMTV integration site family" . SPARSER::PROTEIN)
    ("miR-125a" . SPARSER::PROTEIN) ("WNT11" . SPARSER::PROTEIN)
    ("non-small-cell" . SPARSER::PROTEIN) ("rolipram" . SPARSER::DRUG)
    ("PDE4D and its inhibitors" . SPARSER::COLLECTION)
    ("DGKα or PDE4" . SPARSER::COLLECTION)
    ("-PDE4-cAMP-mTOR" . SPARSER::COLLECTION)
    ("TKIs and mTOR" . SPARSER::COLLECTION) ("venetoclax" . SPARSER::DRUG)
    ("navitoclax" . SPARSER::DRUG) ("RAF and MEK" . SPARSER::COLLECTION)
    ("BIM and low/intermediate" . SPARSER::COLLECTION)
    ("PDE4D and mTOR" . SPARSER::COLLECTION)
    ("the predominant cAMP-degrading enzyme" . SPARSER::ENZYME)
    ("mTOR and p70S6K" . SPARSER::COLLECTION)
    ("arm and 6.3" . SPARSER::COLLECTION)
    ("mRNA and P-S6" . SPARSER::COLLECTION)
    ("BIM and P-S6" . SPARSER::COLLECTION)
    ("erlotinib, gefitinib or afatinib" . SPARSER::COLLECTION)
    ("MTOR and BIM" . SPARSER::COLLECTION)
    ("whose BIM mRNA" . SPARSER::PROTEIN)
    ("whose MTOR mRNA" . SPARSER::PROTEIN)
    ("cisplatin or carboplatin" . SPARSER::COLLECTION)
    ("docetaxel or gemcitabine" . SPARSER::COLLECTION)
    ("ribosomal S6 kinase 70 kDa (p70S6K) and eIF4E-binding protein 1 (4EBP1)"
     . SPARSER::COLLECTION)
    ("ribosomal S6 kinase 70 kDa" . SPARSER::PROTEIN)
    ("eIF4E-binding protein 1" . SPARSER::PROTEIN)
    ("PDE4A and PDE4D" . SPARSER::COLLECTION)
    ("diacylglycerol" . SPARSER::PROTEIN)
    ("a rapamycin and nutrient-sensitive complex" . SPARSER::COLLECTION)
    ("a multifunctional 293-kDa serine/threonine protein kinase"
     . SPARSER::PROTEIN)
    ("mTOR or PI3K" . SPARSER::COLLECTION)
    ("vemurafenib (BRAF inhibitor) or selumetinib (MEK inhibitor)"
     . SPARSER::COLLECTION)
    ("selumetinib" . SPARSER::DRUG) ("RAF or MEK" . SPARSER::COLLECTION)
    ("-kinase-AKT" . SPARSER::COLLECTION)
    ("the ultimate effectors" . SPARSER::EFFECTOR)
    ("Bcl-2, Bcl-xL and Mcl-1" . SPARSER::COLLECTION)
    ("effectors and BH3-only" . SPARSER::COLLECTION)
    ("proteins and mitochondria" . SPARSER::COLLECTION)
    ("mTOR or PDE4" . SPARSER::COLLECTION)
    ("BIM and mTOR" . SPARSER::COLLECTION)
    ("mTOR and phosphodiesterase 4D" . SPARSER::COLLECTION)
    ("mTOR and its substrate P-S6" . SPARSER::COLLECTION)
    ("BIM and MTOR" . SPARSER::COLLECTION) ("P70S6" . SPARSER::PROTEIN)
    ("1–8" . SPARSER::PROTEIN) ("4E-binding protein 1" . SPARSER::PROTEIN)
    ("PDE4A" . SPARSER::PROTEIN) ("DGKα" . SPARSER::PROTEIN)
    ("diacylglycerol kinase" . SPARSER::PROTEIN)
    ("regulatory associated protein of mTOR" . SPARSER::PROTEIN)
    ("P-ERK" . SPARSER::PROTEIN) ("PDE4" . SPARSER::PROTEIN)
    ("PDE4D" . SPARSER::PROTEIN) ("phosphodiesterase 4D" . SPARSER::PROTEIN)
    ("a neuronal state" . SPARSER::BIO-STATE)
    ("the conversion (p53 knockdown, serum withdrawal or expression of reprogramming factors) significantly induced Tet1"
     . SPARSER::PROTEIN)
    ("shRNA or MDM2" . SPARSER::COLLECTION)
    ("Na + and K +" . SPARSER::COLLECTION)
    ("dopamine transporter, nomifensine (10 μM) or GBR12909 (10 μM; xref )"
     . SPARSER::COLLECTION)
    ("quinpirole" . SPARSER::DRUG) ("KCl" . SPARSER::MOLECULE)
    ("Dopamine" . SPARSER::DRUG) ("TUBB3 and MAP2" . SPARSER::COLLECTION)
    ("many other neuronal and dopaminergic genes" . SPARSER::GENE)
    ("P4HA1 ( xref ) and vimentin ( xref )" . SPARSER::COLLECTION)
    ("P4HA1 (prolyl 4-hydroxylase, a key enzyme in collagen synthesis; xref ) or vimentin ( xref )"
     . SPARSER::COLLECTION)
    ("midbrain markers FoxA2 ( xref ) and En1 ( xref )" . SPARSER::COLLECTION)
    ("synaptic markers PSD95 ( xref ) and Syntaxin" . SPARSER::COLLECTION)
    ("mature neuronal markers MAP2 ( xref ) and NeuN ( xref )"
     . SPARSER::COLLECTION)
    ("mature neuronal markers MAP2" . SPARSER::PROTEIN)
    ("synaptic markers PSD95" . SPARSER::PROTEIN) ("FoxA2" . SPARSER::PROTEIN)
    ("Pitx3" . SPARSER::PROTEIN) ("DAT" . SPARSER::PROTEIN)
    ("exogenous human Tet1, Tet2 and Tet3" . SPARSER::COLLECTION)
    ("Tet1, Tet2 and Tet3" . SPARSER::COLLECTION)
    ("Tet1 and Tet2" . SPARSER::COLLECTION)
    ("Tet2 or Tet3" . SPARSER::COLLECTION)
    ("Tet1, Tet2 or Tet3" . SPARSER::COLLECTION)
    ("Tet2 ( xref ) or Tet3 ( xref )" . SPARSER::COLLECTION)
    ("Tet1 ( xref ), Tet2 ( xref ) or Tet3 ( xref )" . SPARSER::COLLECTION)
    ("Tet3" . SPARSER::PROTEIN) ("GM" . SPARSER::PROTEIN)
    ("basal media and full media" . SPARSER::COLLECTION)
    ("basal media" . SPARSER::PROTEIN) ("Pur" . SPARSER::PROTEIN)
    ("dorsomorphin" . SPARSER::MOLECULE) ("VC" . SPARSER::MOLECULE)
    ("β3" . SPARSER::PROTEIN) ("bFGF and NGF" . SPARSER::COLLECTION)
    ("bFGF instead of NGF ( xref )" . SPARSER::COLLECTION)
    ("the new media" . SPARSER::PROTEIN)
    ("neural induction media" . SPARSER::PROTEIN)
    ("the CDK2 inhibitor SU9516 or the mTOR inhibitor Torin1—all"
     . SPARSER::COLLECTION)
    ("/F12" . SPARSER::COLLECTION) ("exogenous p21" . SPARSER::PROTEIN)
    ("shRNA or miR124" . SPARSER::COLLECTION)
    ("β3-tubulin" . SPARSER::COLLECTION)
    ("Ascl1, Nurr1 and Lmx1a" . SPARSER::COLLECTION)
    ("virtually any type" . TYPE) ("MyoD" . SPARSER::PROTEIN)
    ("Ascl1, Nurr1, Lmx1a and miR124" . SPARSER::COLLECTION)
    ("Nurr1" . SPARSER::PROTEIN) ("p24" . SPARSER::PROTEIN)
    ("CHIR 99021" . SPARSER::MOLECULE)
    ("dopamine transporter" . SPARSER::PROTEIN)
    ("prolyl 4-hydroxylase" . SPARSER::PROTEIN) ("P4HA1" . SPARSER::PROTEIN)
    ("En1" . SPARSER::PROTEIN) ("VMAT2" . SPARSER::PROTEIN)
    ("ALDH1A1" . SPARSER::PROTEIN) ("Tet2" . SPARSER::PROTEIN)
    ("GFP +" . SPARSER::PROTEIN) ("vitamin C" . SPARSER::MOLECULE)
    ("SU9516" . SPARSER::DRUG) ("Kip1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Tet 1" . SPARSER::PROTEIN) ("miR124" . SPARSER::RNA)
    ("Lmx1a" . SPARSER::PROTEIN)
    ("the proinflammatory cytokines" . SPARSER::PROTEIN)
    ("collagen and proteoglycans" . SPARSER::COLLECTION)
    ("Sirt1, Sirt2 and Sirt6" . SPARSER::COLLECTION)
    ("Lenti-sirt6" . SPARSER::COLLECTION) ("Lenti-NC" . SPARSER::COLLECTION)
    ("Chondrocytes" . SPARSER::PROTEIN)
    ("MMP-13 and Collagen-II" . SPARSER::COLLECTION)
    ("RANTES" . SPARSER::PROTEIN)
    ("wild type sirt6 (sirt6-WT) and mutant type sirt6 (sirt6-H133Y)"
     . SPARSER::COLLECTION)
    ("NF-kB-p65" . SPARSER::COLLECTION) ("NF-kB-P65" . SPARSER::COLLECTION)
    ("MMP-13 and type II" . SPARSER::COLLECTION)
    ("MMP-13 and collagen-II" . SPARSER::COLLECTION)
    ("sirt6 and p16" . SPARSER::COLLECTION)
    ("getting new therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("Lenti-Sirt6" . SPARSER::COLLECTION) ("Lenti" . SPARSER::PROTEIN)
    ("gal" . SPARSER::PROTEIN) ("Sirtuin 6" . SPARSER::PROTEIN)
    ("safranin O" . SPARSER::DRUG) ("SIRT6" . SPARSER::PROTEIN)
    ("sirt6" . SPARSER::PROTEIN) ("NAD + " . SPARSER::MOLECULE)
    ("simultaneously targets p110α" . SPARSER::PROTEIN)
    ("PI3K, and Vps34" . SPARSER::COLLECTION)
    ("chloroquine or inhibitors" . SPARSER::COLLECTION)
    ("HER2/PI3K/mTOR" . SPARSER::COLLECTION)
    ("PI3K/p110α" . SPARSER::COLLECTION)
    ("this ancestral PI3K isoform" . SPARSER::ISOFORM)
    ("PI3K/Vps34" . SPARSER::COLLECTION)
    ("a locked nucleic acid anti-sense oligonucleotide" . SPARSER::MOLECULE)
    ("type I PI3K- and HER2-targeted therapeutics" . SPARSER::COLLECTION)
    ("PI3K-" . SPARSER::PROTEIN-FAMILY)
    ("lapatinib or BYL719" . SPARSER::COLLECTION)
    ("HER2, p110α and Vps34" . SPARSER::COLLECTION)
    ("phosphatidyl" . SPARSER::MOLECULE)
    ("BYL719 or their combination" . SPARSER::COLLECTION)
    ("lapatinib " . SPARSER::DRUG)
    ("lapatinib and BYL719" . SPARSER::COLLECTION)
    ("p110α and/or HER2" . SPARSER::COLLECTION)
    ("Vps34 and/or p110α" . SPARSER::COLLECTION)
    ("HER2, Vps34 and/or p110α" . SPARSER::COLLECTION)
    ("caspase and PARP" . SPARSER::COLLECTION)
    ("caspase 3 and PARP" . SPARSER::COLLECTION)
    ("caspase 3 and/or PARP" . SPARSER::COLLECTION)
    ("p110α or Vps34" . SPARSER::COLLECTION)
    ("Vps34 and p110α" . SPARSER::COLLECTION)
    ("BYL719 or BKM120" . SPARSER::COLLECTION) ("GFP+" . SPARSER::PROTEIN)
    ("BKM120 or BYL719" . SPARSER::COLLECTION)
    ("LC3-GFP+" . SPARSER::COLLECTION) ("LC3-GFP" . SPARSER::COLLECTION)
    ("BKM120 or lapatinib" . SPARSER::COLLECTION)
    ("lapatinib and BKM120" . SPARSER::COLLECTION)
    ("PTEN-null cells preferentially use p110β" . SPARSER::PROTEIN)
    ("a distal effector" . SPARSER::EFFECTOR)
    ("HER2 or PI3K" . SPARSER::COLLECTION)
    ("type I (p110α) and type III (Vps34) PI3Ks" . SPARSER::COLLECTION)
    ("PI3Ks, and mTOR" . SPARSER::COLLECTION)
    ("Vps34/class III PI3K" . SPARSER::PROTEIN-FAMILY)
    ("PI3K and HER2" . SPARSER::COLLECTION) ("HER2/PI3K" . SPARSER::COLLECTION)
    ("HER2 and p110α" . SPARSER::COLLECTION)
    ("Conditional gene" . SPARSER::GENE)
    ("ErbB3 or p110α" . SPARSER::COLLECTION) ("ErbB3" . SPARSER::PROTEIN)
    ("tyrosine kinase (RTK)" . SPARSER::PROTEIN)
    ("ER and HER2" . SPARSER::COLLECTION)
    ("type I and type III" . SPARSER::COLLECTION)
    ("p110α and Vps34" . SPARSER::COLLECTION)
    ("HER2 or type I" . SPARSER::COLLECTION)
    ("HER2 inhibitors or type I PI3K kinase inhibitors" . SPARSER::COLLECTION)
    ("locked nucleic acid antisense oligonucleotides" . SPARSER::MOLECULE)
    ("HER2 and type I" . SPARSER::COLLECTION) ("PIK3C3" . SPARSER::PROTEIN)
    ("yet another example" . SPARSER::EXAMPLE)
    ("a few diagnostic amino acids" . SPARSER::AMINO-ACID)
    ("approximately 500 amino acids" . SPARSER::AMINO-ACID)
    ("approximately 50 missense amino acids" . SPARSER::AMINO-ACID)
    ("the GATA3 protein, which code for the second zinc finger"
     . SPARSER::PROTEIN)
    ("GATA3 and ER-α" . SPARSER::COLLECTION)
    ("both mutated and wild-type alleles" . SPARSER::ALLELE)
    ("GATA3, ER-α, and FOXA1" . SPARSER::COLLECTION)
    ("FOXA1, and XBP1" . SPARSER::COLLECTION)
    ("essential transcription factor" . SPARSER::PROTEIN)
    ("prolyl hydroxylase" . SPARSER::PROTEIN) ("A – G" . SPARSER::PROTEIN)
    ("N – C" . SPARSER::PROTEIN) ("ZF2" . SPARSER::PROTEIN)
    ("ZF1" . SPARSER::PROTEIN) ("ER-α" . SPARSER::PROTEIN)
    ("IF/FISH" . SPARSER::COLLECTION) ("hereditary PRCC" . SPARSER::PROTEIN)
    ("our detailed FISH" . SPARSER::PROTEIN) ("VEGF/MET" . SPARSER::COLLECTION)
    ("Foretinib" . SPARSER::DRUG) ("Hereditary Type 1 PRCC" . SPARSER::PROTEIN)
    ("Further studies using IF" . SPARSER::PROTEIN)
    ("MET and CEP7" . SPARSER::COLLECTION)
    ("Type 1 and Type 2" . SPARSER::COLLECTION)
    ("MET or CEP7" . SPARSER::COLLECTION)
    ("gene and chromosome" . SPARSER::COLLECTION)
    ("Biomarker" . SPARSER::MOLECULE)
    ("mutant MET genes and one wildtype MET gene [ xref ]"
     . SPARSER::COLLECTION)
    ("hereditary Type 1 PRCC" . SPARSER::PROTEIN)
    ("a transmembrane tyrosine kinase receptor" . SPARSER::PROTEIN)
    ("Mesenchymal-epithelial transition factor (MET) protein"
     . SPARSER::PROTEIN)
    ("metastatic PRCC" . SPARSER::PROTEIN) ("sporadic PRCC" . SPARSER::PROTEIN)
    ("IF and FISH" . SPARSER::COLLECTION) ("PRCC" . SPARSER::PROTEIN)
    ("inhibitors and inhibitors" . SPARSER::COLLECTION)
    ("calpain-" . SPARSER::PROTEIN) ("Molecule" . SPARSER::MOLECULE)
    ("hydrolases and activators" . SPARSER::COLLECTION)
    ("hydrolases" . SPARSER::PROTEIN) ("4EBP" . SPARSER::PROTEIN)
    ("mTORC1-" . SPARSER::PROTEIN) ("mTORC1-4EBP1/eIF4E" . SPARSER::COLLECTION)
    ("pp242 and Torin1" . SPARSER::COLLECTION)
    ("S6K1 and S6 protein" . SPARSER::COLLECTION)
    ("mTORC1-pS6" . SPARSER::COLLECTION)
    ("only mTORC1 complex" . SPARSER::BIO-COMPLEX)
    ("mTORC1 inhibitor rapamycin and mTORC1/mTORC2 inhibitor pp242"
     . SPARSER::COLLECTION)
    ("transcription factor EB (TFEB)" . SPARSER::PROTEIN)
    ("TFEB" . SPARSER::PROTEIN)
    ("pro-autophagic kinase ULK1" . SPARSER::PROTEIN)
    ("pro-apoptotic derivatives" . SPARSER::DERIVATIVE)
    ("pro-autophagic proteins" . SPARSER::PROTEIN)
    ("essential autophagy proteins" . SPARSER::PROTEIN)
    ("cas" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("VPS34-Beclin 1" . SPARSER::COLLECTION)
    ("cytometry and DAPI" . SPARSER::COLLECTION)
    ("A weak DAPI" . SPARSER::DRUG)
    ("the ULK1 and another activator" . SPARSER::COLLECTION)
    ("ULK1-ATG13-FIP200" . SPARSER::COLLECTION)
    ("cytostatic rapamycin" . SPARSER::DRUG) ("cyt" . SPARSER::MOLECULE)
    ("autophagosome membrane-associated form LC3-II" . SPARSER::PROTEIN)
    ("PkB" . SPARSER::PROTEIN) ("mTORC2/PKB/Akt" . SPARSER::COLLECTION)
    ("Rapa and pp242" . SPARSER::COLLECTION)
    ("rapamycin and pp242" . SPARSER::COLLECTION) ("Rapa" . SPARSER::DRUG)
    ("pp242 and rapamycin" . SPARSER::COLLECTION)
    ("blot and electron" . SPARSER::COLLECTION)
    ("LC3, p62/SQSTM and Beclin1" . SPARSER::COLLECTION)
    ("cHa-Ras" . SPARSER::COLLECTION)
    ("ribosomes and the endoplasmic reticulum" . SPARSER::COLLECTION)
    ("mediat­ing" . SPARSER::COLLECTION) ("ing" . SPARSER::PROTEIN-FAMILY)
    ("an allosteric mTORC1 inhibitor rapamycin and rapalogs"
     . SPARSER::COLLECTION)
    ("mTORC1-4EBP1" . SPARSER::COLLECTION)
    ("mTORC1/mTORC2" . SPARSER::COLLECTION)
    ("mTORC1-specific inhibitor rapamycin and ATP-competitive mTOR kinase inhibitor pp242"
     . SPARSER::COLLECTION)
    ("Ribosomal Protein" . SPARSER::PROTEIN) ("Ha-ras" . SPARSER::PROTEIN)
    ("BECN1" . SPARSER::PROTEIN) ("AMBRA1" . SPARSER::PROTEIN)
    ("k2" . SPARSER::PROTEIN) ("s6k1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("transcription factor EB" . SPARSER::PROTEIN)
    ("FIP200" . SPARSER::PROTEIN) ("ATG13" . SPARSER::PROTEIN)
    ("cytochrome C" . SPARSER::PROTEIN)
    ("Atg8" . SPARSER::HUMAN-PROTEIN-FAMILY) ("pp242" . SPARSER::DRUG)
    ("Calpain or let-7" . SPARSER::COLLECTION)
    ("only indirectly Myc gene" . SPARSER::GENE)
    ("Myc–Max" . SPARSER::COLLECTION)
    ("Sox2, Octamer-4 and KLF4" . SPARSER::COLLECTION)
    ("Octamer" . SPARSER::PROTEIN)
    ("the Yap target genes Survivin (or Birc5) and Axl receptor tyrosine kinase (AXL)"
     . SPARSER::COLLECTION)
    ("receptor tyrosine kinase (AXL)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Birc5" . SPARSER::PROTEIN) ("Axl" . SPARSER::PROTEIN)
    ("Nucleophosmin" . SPARSER::PROTEIN) ("PTMA" . SPARSER::PROTEIN)
    ("serpins" . SPARSER::HUMAN-PROTEIN-FAMILY) ("ov" . SPARSER::MOLECULE)
    ("ovalbumin" . SPARSER::PROTEIN)
    ("the Yes-associated protein" . SPARSER::PROTEIN)
    ("predominant role Myc" . SPARSER::PROTEIN)
    ("a pleiotropic transcription factor" . SPARSER::PROTEIN)
    ("its overexpression plays some part in Myc-driven pathogenesis and tumor biology xref  xref"
     . SPARSER::COLLECTION)
    ("its overexpression plays some part in Myc-driven pathogenesis"
     . SPARSER::COMPONENT)
    ("HCC and gene" . SPARSER::COLLECTION) ("Myc-nick" . SPARSER::COLLECTION)
    ("Calpain" . SPARSER::PROTEIN)
    ("calpain and Hippo-dependent" . SPARSER::COLLECTION)
    ("Yes-associated protein" . SPARSER::PROTEIN)
    ("serpin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("reducing agent" . SPARSER::MOLECULE) ("calpain 1" . SPARSER::PROTEIN)
    ("HIF-2α" . SPARSER::PROTEIN) ("NPM1" . SPARSER::PROTEIN)
    ("Prothymosin-alpha" . SPARSER::PROTEIN) ("class B" . SPARSER::PROTEIN)
    ("Myc protein" . SPARSER::PROTEIN) ("SerpinB3" . SPARSER::PROTEIN)
    ("Rac1, Cdc42 and RhoA" . SPARSER::COLLECTION)
    ("molecules and ion channels" . SPARSER::COLLECTION)
    ("RhoA and Rac1" . SPARSER::COLLECTION)
    ("constitutive-active or dominant-negative" . SPARSER::COLLECTION)
    ("the globular actin" . SPARSER::PROTEIN)
    ("a temporal derivative" . SPARSER::DERIVATIVE) ("t  " . SPARSER::PROTEIN)
    ("Cdc42 or Rac1" . SPARSER::COLLECTION)
    ("activators and inhibitors" . SPARSER::COLLECTION)
    ("GTPases " . SPARSER::GTPASE)
    ("formin (mDia2) and Ena/VASP" . SPARSER::COLLECTION)
    ("actin-associated proteins" . SPARSER::PROTEIN)
    ("VASP" . SPARSER::PROTEIN) ("formin" . SPARSER::PROTEIN)
    ("fascin" . SPARSER::PROTEIN) ("Arpin" . SPARSER::PROTEIN)
    ("WAVE" . SPARSER::PROTEIN) ("tan −1" . SPARSER::PROTEIN)
    ("K4" . SPARSER::PROTEIN) ("target cell" . SPARSER::PROTEIN)
    ("HT-1080" . SPARSER::PROTEIN) ("mDia2" . SPARSER::PROTEIN)
    ("Arp2/3" . SPARSER::PROTEIN) ("overt PTC and PTMC" . SPARSER::COLLECTION)
    ("PTC and PTMC" . SPARSER::COLLECTION)
    ("GLUT1, GLUT3, and hexokinase" . SPARSER::COLLECTION)
    ("Overt PTC" . SPARSER::PROTEIN)
    ("histological variant" . SPARSER::VARIANT)
    ("Preoperative thyroglobulin" . SPARSER::PROTEIN)
    ("The most common histologic variants" . SPARSER::VARIANT)
    ("both primary and metastatic PTCs" . SPARSER::PROTEIN)
    ("colon cancer, and thyroid" . SPARSER::COLLECTION)
    ("thyroglobulin" . SPARSER::PROTEIN)
    ("the most common histological type" . TYPE)
    ("overt PTC" . SPARSER::PROTEIN) ("GLUT3" . SPARSER::PROTEIN)
    ("1–2 " . SPARSER::PROTEIN) ("F-18" . SPARSER::PROTEIN)
    ("BRAFV 600E" . SPARSER::PROTEIN) ("SRA" . SPARSER::PROTEIN)
    ("Pten and p53" . SPARSER::COLLECTION)
    ("suppressors and oncogenes" . SPARSER::COLLECTION)
    ("TdT" . SPARSER::PROTEIN) ("PTEN and PAX7" . SPARSER::COLLECTION)
    ("GSCs-PAX7" . SPARSER::COLLECTION) ("CREB and PAX7" . SPARSER::COLLECTION)
    ("the parental GSCs" . SPARSER::PROTEIN)
    ("isogenic GSCs" . SPARSER::PROTEIN) ("GSCs-PTEN" . SPARSER::COLLECTION)
    ("PTEN-PAX7" . SPARSER::COLLECTION)
    ("protein phosphatase-dead mutant (Y138L) and lipid phosphatase-dead PTEN mutant (G129E)"
     . SPARSER::COLLECTION)
    ("CBP as well as H3K4" . SPARSER::COLLECTION)
    ("CREB and CBP" . SPARSER::COLLECTION)
    ("WT NSCs PTEN and CREB/CBP co-occupied" . SPARSER::COLLECTION)
    ("CREB/CBP" . SPARSER::COLLECTION) ("p-CREB" . SPARSER::COLLECTION)
    ("PAX7 as well as other genes" . SPARSER::COLLECTION)
    ("PTEN and CREB" . SPARSER::COLLECTION)
    ("A ChIP-based promoter mapping" . SPARSER::PROTEIN)
    ("PAX7 dominant-negative mutants" . SPARSER::MUTANT)
    ("ADP or AMP and ATP" . SPARSER::COLLECTION)
    ("AMP and ATP" . SPARSER::COLLECTION)
    ("glucose-6-phosphate and fructose-6-phosphate" . SPARSER::COLLECTION)
    ("AKT and its downstream targets" . SPARSER::COLLECTION)
    ("mammalian target of rapamycin (mTOR) and glycogen synthase kinase 3 beta (GSK3β)"
     . SPARSER::COLLECTION)
    ("CD34, CD43 and CD45" . SPARSER::COLLECTION)
    ("the most well-known tumour suppressor p53"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("exogenous PTEN" . SPARSER::PROTEIN) ("SRY" . SPARSER::PROTEIN)
    ("Haematoxylin and eosin (H&E) staining" . SPARSER::COLLECTION)
    ("Haematoxylin" . SPARSER::MOLECULE)
    ("neural progenitor markers PAX6, SOX2 and Nestin" . SPARSER::COLLECTION)
    ("PAX6, SOX2 and Nestin" . SPARSER::COLLECTION)
    ("PAX6 and Nestin" . SPARSER::COLLECTION)
    ("nuclease (TALEN)" . SPARSER::PROTEIN) ("-RB" . SPARSER::COLLECTION)
    ("/CREB binding protein (CBP)" . SPARSER::COLLECTION)
    ("/CREB binding protein" . SPARSER::COLLECTION) ("Tet1" . SPARSER::PROTEIN)
    ("5–2 " . SPARSER::PROTEIN) ("NIM-1" . SPARSER::PROTEIN)
    ("Y-27632" . SPARSER::MOLECULE) ("pCR2" . SPARSER::PROTEIN)
    ("SB431542" . SPARSER::DRUG) ("CHIR99021" . SPARSER::MOLECULE)
    ("leukemia inhibitory factor" . SPARSER::PROTEIN)
    ("E −4" . SPARSER::PROTEIN)
    ("glycogen synthase kinase 3 beta" . SPARSER::PROTEIN)
    ("CD73" . SPARSER::PROTEIN) ("TRA-1" . SPARSER::PROTEIN)
    ("Phosphatase and tensin homolog" . SPARSER::PROTEIN)
    ("CREB binding protein" . SPARSER::PROTEIN)
    ("cAMP responsive element binding protein 1" . SPARSER::PROTEIN)
    ("PAX7" . SPARSER::PROTEIN) ("proteins and KRAS" . SPARSER::COLLECTION)
    ("P-gp-" . SPARSER::PROTEIN) ("proteins and EGFR" . SPARSER::COLLECTION)
    ("Both P-glycoprotein (P-gp) and lung resistance-related protein (LRP)"
     . SPARSER::COLLECTION)
    ("P-gp/LRP" . SPARSER::COLLECTION) ("P-gp or LRP" . SPARSER::COLLECTION)
    ("P-gp and LRP" . SPARSER::COLLECTION)
    ("P-glycoprotein (P-gp) and lung resistance-related protein (LRP)"
     . SPARSER::COLLECTION)
    ("EGFR (exons 19 and 21) and Kirsten rat sarcoma viral oncogene homolog (KRAS) (exon 2)"
     . SPARSER::COLLECTION)
    ("HRMA" . SPARSER::PROTEIN) ("major vault protein" . SPARSER::PROTEIN)
    ("Tyrosine kinase" . SPARSER::PROTEIN)
    ("lung resistance-related protein" . SPARSER::PROTEIN)
    ("P-gp" . SPARSER::PROTEIN) ("GPCR, TLR, and miRNAs" . SPARSER::COLLECTION)
    ("ODN" . SPARSER::PROTEIN) ("Oligonucleotide" . SPARSER::MOLECULE)
    ("Oligonucleotides" . SPARSER::MOLECULE)
    ("IL-6/JAK1/STAT3" . SPARSER::COLLECTION)
    ("Homoharringtonine" . SPARSER::DRUG) ("Silibinin" . SPARSER::DRUG)
    ("OPB" . SPARSER::MOLECULE)
    ("cell-permeable small molecule inhibitor" . SPARSER::INHIBITOR)
    ("site-directed computational fragment-based drug" . SPARSER::DRUG)
    ("peptides and peptidomimetics" . SPARSER::COLLECTION)
    ("Indirect inhibitors" . SPARSER::INHIBITOR)
    ("cytokine and kinases" . SPARSER::COLLECTION)
    ("EGFR/STAT3/Sox-2" . SPARSER::COLLECTION)
    ("Nanog, oct3/4, and sox2" . SPARSER::COLLECTION)
    ("RhoC" . SPARSER::PROTEIN) ("STAT3/NF-κB" . SPARSER::COLLECTION)
    ("a multifunctional cytokine" . SPARSER::PROTEIN)
    ("IL-6/gp130/STAT3" . SPARSER::COLLECTION)
    ("OSM, CNTF, CTF-1, and CLC" . SPARSER::COLLECTION)
    ("CLC" . SPARSER::PROTEIN) ("CNTF" . SPARSER::PROTEIN)
    ("LIFR and gp130" . SPARSER::COLLECTION) ("LIFR" . SPARSER::PROTEIN)
    ("leading mediators" . SPARSER::PROTEIN)
    ("junctional adhesion molecules" . SPARSER::MOLECULE)
    ("VEGF and bFGF" . SPARSER::COLLECTION) ("bFGF" . SPARSER::PROTEIN)
    ("STAT3 and NF-κB" . SPARSER::COLLECTION)
    ("exosomal Hsp70" . SPARSER::PROTEIN)
    ("VEGF and IL-10" . SPARSER::COLLECTION)
    ("growth factors and mesenchymal–epithelial cell" . SPARSER::COLLECTION)
    ("IL-8, CCL5, CCL2, CCL3, IL1-β, GM-CSF, VEGF, and MCP-1"
     . SPARSER::COLLECTION)
    ("DLEC1, STAT1 , and PTPN6" . SPARSER::COLLECTION)
    ("DLEC" . SPARSER::PROTEIN) ("ARHI" . SPARSER::PROTEIN)
    ("p300/CREB-binding protein (CBP)" . SPARSER::COLLECTION)
    ("IL-6, LIF, and OSM" . SPARSER::COLLECTION)
    ("p300/CREB-binding protein" . SPARSER::COLLECTION)
    ("OSM" . SPARSER::PROTEIN) ("LIF" . SPARSER::PROTEIN)
    ("relative genes and the development" . SPARSER::COLLECTION)
    ("more accessible chromatin conformation" . SPARSER::BIO-CONFORMATION)
    ("potentially biologically relevant transcription factor"
     . SPARSER::PROTEIN)
    ("NLK" . SPARSER::PROTEIN) ("IL-17/STAT3" . SPARSER::COLLECTION)
    ("SOCS1 and SOCS3" . SPARSER::COLLECTION)
    ("JAK1 and gp130" . SPARSER::COLLECTION)
    ("proteins, SOCS1 and SOCS3" . SPARSER::COLLECTION)
    ("JAK kinase or target JAKs" . SPARSER::COLLECTION)
    ("CIS, SOCS1, SOCS2, SOCS3, SOCS4, SOCS5, SOCS6, and SOCS7"
     . SPARSER::COLLECTION)
    ("CIS" . SPARSER::PROTEIN) ("PIAS3, and PIASy" . SPARSER::COLLECTION)
    ("morin" . SPARSER::DRUG)
    ("SHP2, SHP1, CD45, PTP1B, PTP2B and PTPRT" . SPARSER::COLLECTION)
    ("PTPRT" . SPARSER::PROTEIN) ("PTKs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("STAT3 or re-expression" . SPARSER::COLLECTION)
    ("IL-6–STAT3" . SPARSER::COLLECTION)
    ("CpG–TLR9–FZD4" . SPARSER::COLLECTION)
    ("NF-κB and MAP kinase" . SPARSER::COLLECTION)
    ("a classical activator" . SPARSER::ACTIVATOR)
    ("Rac1/Cdc42" . SPARSER::COLLECTION)
    ("Rac1/MgcRacGAP" . SPARSER::COLLECTION) ("tyr" . SPARSER::AMINO-ACID)
    ("IL-6R/gp130" . SPARSER::COLLECTION)
    ("MgcRacGAP–STAT3" . SPARSER::COLLECTION) ("MgcRacGAP" . SPARSER::PROTEIN)
    ("different heterotrimeric G proteins" . SPARSER::PROTEIN)
    ("JAKs and STATs" . SPARSER::COLLECTION)
    ("GPCRs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("/cadherin" . SPARSER::COLLECTION) ("ABl" . SPARSER::PROTEIN)
    ("EGFR, VEGFR, PDGFR, and colony stimulating factor-1"
     . SPARSER::COLLECTION)
    ("the most well-known traditional activators" . SPARSER::ACTIVATOR)
    ("receptors, receptor tyrosine kinases, and non-receptor"
     . SPARSER::COLLECTION)
    ("the canonical cytokines and growth factors" . SPARSER::COLLECTION)
    ("both a transcription activator and an oncogene that is tightly regulated under normal physiological conditions"
     . SPARSER::COLLECTION)
    ("WP1066" . SPARSER::DRUG) ("Sox-2" . SPARSER::PROTEIN)
    ("sox2" . SPARSER::PROTEIN) ("oct3" . SPARSER::PROTEIN)
    ("HMGB1" . SPARSER::PROTEIN) ("CTF-1" . SPARSER::PROTEIN)
    ("Bcl3" . SPARSER::PROTEIN) ("IL1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NDRG2" . SPARSER::PROTEIN)
    ("N-myc downstream-regulated gene 2" . SPARSER::PROTEIN)
    ("CDKN2" . SPARSER::PROTEIN) ("H-7" . SPARSER::PROTEIN)
    ("PF4" . SPARSER::PROTEIN) ("Platelet factor 4" . SPARSER::PROTEIN)
    ("SOCS7" . SPARSER::PROTEIN) ("SOCS6" . SPARSER::PROTEIN)
    ("SOCS5" . SPARSER::PROTEIN) ("SOCS4" . SPARSER::PROTEIN)
    ("SOCS2" . SPARSER::PROTEIN)
    ("Suppressor of cytokine signaling" . SPARSER::PROTEIN)
    ("suppressor of cytokine signaling 3" . SPARSER::PROTEIN)
    ("FZD4" . SPARSER::PROTEIN) ("Frizzled 4" . SPARSER::PROTEIN)
    ("TLR9" . SPARSER::PROTEIN) ("S1PR1" . SPARSER::PROTEIN)
    ("Ang II" . SPARSER::PROTEIN) ("angiotensin II" . SPARSER::PROTEIN)
    ("colony stimulating factor-1" . SPARSER::PROTEIN)
    ("PY, and WCD" . SPARSER::COLLECTION) ("LF" . SPARSER::PROTEIN)
    ("WCD" . SPARSER::PROTEIN) ("Denosumab" . SPARSER::DRUG)
    ("RANK/RANKL" . SPARSER::COLLECTION)
    ("local and systemic (serum) OPG" . SPARSER::PROTEIN)
    ("RANKL:OPG" . SPARSER::BIO-COMPLEX)
    ("significantly higher OPG" . SPARSER::PROTEIN)
    ("RANKL and Ki67" . SPARSER::COLLECTION)
    ("OPG and Ki67" . SPARSER::COLLECTION)
    ("free OPG and RANKL/OPG complex" . SPARSER::COLLECTION)
    ("Stata" . SPARSER::PROTEIN) ("each mutational status type" . TYPE)
    ("sRANKL and OPG" . SPARSER::COLLECTION)
    ("biotinylated monoclonal antibodies" . SPARSER::ANTIBODY)
    ("streptavidin" . SPARSER::PROTEIN) ("TN" . SPARSER::PROTEIN)
    ("MN" . SPARSER::PROTEIN) ("free soluble OPG" . SPARSER::PROTEIN)
    ("Free soluble RANKL" . SPARSER::PROTEIN)
    ("sRANKL/OPG" . SPARSER::COLLECTION) ("sRANKL" . SPARSER::PROTEIN)
    ("Serum E2 and P" . SPARSER::COLLECTION)
    ("RANKL and its physiological antagonist osteoprotegerin (OPG)"
     . SPARSER::COLLECTION)
    ("osteoprotegerin (OPG)" . SPARSER::PROTEIN)
    ("OPG and RANKL" . SPARSER::COLLECTION)
    ("tumour necrosis factor (TNF)" . SPARSER::PROTEIN)
    ("tamoxifen or aromatase" . SPARSER::COLLECTION)
    ("well-defined parts" . SPARSER::COMPONENT)
    ("E2 and P" . SPARSER::COLLECTION) ("basal E2" . SPARSER::MOLECULE)
    ("using chemo-preventive drugs" . SPARSER::DRUG)
    ("denosumab" . SPARSER::DRUG) ("rho  " . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("RANKL and OPG" . SPARSER::COLLECTION) ("RANKL/OPG" . SPARSER::COLLECTION)
    ("oestradiol" . SPARSER::MOLECULE)
    ("RANKL/osteoprotegerin" . SPARSER::COLLECTION) ("OPG" . SPARSER::PROTEIN)
    ("osteoprotegerin" . SPARSER::PROTEIN) ("(beta " . SPARSER::PROTEIN)
    ("H10" . SPARSER::PROTEIN) ("Steroid Hormone" . SPARSER::MOLECULE)
    ("TNFRSF11B" . SPARSER::PROTEIN) ("TNFSF11" . SPARSER::PROTEIN)
    ("MKI67" . SPARSER::PROTEIN)
    ("Receptor activator of nuclear factor kappa-B ligand" . SPARSER::PROTEIN)
    ("oestrogen-receptor" . SPARSER::PROTEIN)
    ("steroid-hormone" . SPARSER::MOLECULE)
    ("hormone-sensitive" . SPARSER::PROTEIN)
    ("damaged chromatin 53BP1’s" . SPARSER::PROTEIN)
    ("Crb2 and Rad9p" . SPARSER::COLLECTION)
    ("PTIP, and MDC1—have" . SPARSER::COLLECTION)
    ("proteins—MCPH1" . SPARSER::COLLECTION)
    ("KAP1/TRIM28" . SPARSER::COLLECTION)
    ("Heterochromatin" . SPARSER::PROTEIN)
    ("NBS1 or pATM" . SPARSER::COLLECTION)
    ("formed distinct foci" . SPARSER::PROTEIN)
    ("NBS1 and pATM" . SPARSER::COLLECTION)
    ("MRE11-RAD50-NBS1" . SPARSER::COLLECTION)
    ("DNA-damage-responsive PIKK kinases" . SPARSER::PROTEIN)
    ("the canonical DNA-damage-responsive mark γH2AX" . SPARSER::PROTEIN)
    ("bis" . SPARSER::PROTEIN) ("fluorescein-" . SPARSER::MOLECULE)
    ("GYG" . SPARSER::PROTEIN)
    ("MDC1 ( xref , xref ) and Crb2 ( xref )" . SPARSER::COLLECTION)
    ("JMJD2A and L3MBTL1" . SPARSER::COLLECTION)
    ("RNF8 and RNF168" . SPARSER::COLLECTION) ("IRIF" . SPARSER::PROTEIN)
    ("the DNA-damage-responsive protein kinase ATM" . SPARSER::PROTEIN)
    ("AK" . SPARSER::PROTEIN) ("KAP-1" . SPARSER::PROTEIN)
    ("UCN-01" . SPARSER::DRUG) ("MCPH1" . SPARSER::PROTEIN)
    ("NU7441" . SPARSER::MOLECULE) ("L3MBTL1" . SPARSER::PROTEIN)
    ("JMJD2A" . SPARSER::PROTEIN) ("RNF168" . SPARSER::PROTEIN)
    ("Crb2" . SPARSER::PROTEIN) ("Rad9" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Efb and Efb" . SPARSER::COLLECTION)
    ("pro-thrombotic states" . SPARSER::BIO-STATE)
    ("P-selectin and its physiological ligand PSGL-1" . SPARSER::COLLECTION)
    ("at least part" . SPARSER::COMPONENT)
    ("fibrinogen and P-selectin" . SPARSER::COLLECTION)
    ("Efb and platelets" . SPARSER::COLLECTION)
    ("added fibrinogen or plasma proteins ( xref )" . SPARSER::COLLECTION)
    ("weak agonists" . SPARSER::AGONIST)
    ("serotonin or ADP" . SPARSER::COLLECTION) ("PRP" . SPARSER::PROTEIN)
    ("thrombin or fibrinogen" . SPARSER::COLLECTION)
    ("CD42b and CD38" . SPARSER::COLLECTION)
    ("monocytes and platelets" . SPARSER::COLLECTION)
    ("/CD42b" . SPARSER::COLLECTION) ("/CD38" . SPARSER::COLLECTION)
    ("Efb or Efb-N" . SPARSER::COLLECTION)
    ("are complexes" . SPARSER::BIO-COMPLEX) ("1b" . SPARSER::PROTEIN)
    ("P-selectin and PSGL-1" . SPARSER::COLLECTION)
    ("P-selectin and its endogenous ligand PSGL-1" . SPARSER::COLLECTION)
    ("Efb and Efb-N" . SPARSER::COLLECTION) ("PSGL-1-Fc" . SPARSER::COLLECTION)
    ("Efb and P-selectin" . SPARSER::COLLECTION) ("Fc" . SPARSER::PROTEIN)
    ("platelet P-selectin ( i.e. soluble P-selectin-Fc fusion protein) and integrin α IIb β 3 ( i.e. inhibitory anti-CD41 antibody)"
     . SPARSER::COLLECTION)
    ("P-selectin-Fc" . SPARSER::COLLECTION) ("Efb" . SPARSER::PROTEIN)
    ("Efb-P-selectin" . SPARSER::COLLECTION)
    ("P-selectin, multimerin-1, fibronectin, and thrombospondin-1"
     . SPARSER::COLLECTION)
    ("added extracellular fibrinogen" . SPARSER::PROTEIN)
    ("P-selectin (a platelet plasma membrane protein) and multimerin-1, emilin-1, fibronectin, and thrombospondin-1 (soluble extracellular proteins able to interact with cell adhesion receptors on platelets)"
     . SPARSER::COLLECTION)
    ("functionally relevant proteins" . SPARSER::PROTEIN)
    ("multimerin-1, emilin-1, fibronectin, and thrombospondin-1"
     . SPARSER::COLLECTION)
    ("at least one unidentified platelet surface receptor" . SPARSER::RECEPTOR)
    ("fibrinogen/integrin" . SPARSER::COLLECTION)
    ("exogenous fibrinogen" . SPARSER::PROTEIN)
    ("thrombin-" . SPARSER::PROTEIN)
    ("thrombin (0.25 unit/ml) or extracellular fibrinogen (3 mg/ml)"
     . SPARSER::COLLECTION)
    ("extracellular fibrinogen" . SPARSER::PROTEIN)
    ("Fibrinogen" . SPARSER::PROTEIN)
    ("Other bacterial proteins" . SPARSER::PROTEIN)
    ("PSGL-1 and P-selectin" . SPARSER::COLLECTION)
    ("enterotoxin" . SPARSER::PROTEIN) ("SSL" . SPARSER::PROTEIN)
    ("superantigen" . SPARSER::MOLECULE)
    ("fibrinogen ( xref ) and platelets ( xref )" . SPARSER::COLLECTION)
    ("protein (CHIPS)" . SPARSER::PROTEIN)
    ("inhibitor (SCIN)" . SPARSER::INHIBITOR)
    ("staphylococcal" . SPARSER::PROTEIN) ("Emp" . SPARSER::PROTEIN)
    ("Coa" . SPARSER::MOLECULE) ("bacterial adhesins" . SPARSER::PROTEIN)
    ("fibrinogen and fibronectin" . SPARSER::COLLECTION)
    ("adhesins" . SPARSER::PROTEIN) ("P-selectin-PSGL-1" . SPARSER::COLLECTION)
    ("P-selectin and multimerin-1" . SPARSER::COLLECTION)
    ("CD41" . SPARSER::PROTEIN) ("emilin-1" . SPARSER::PROTEIN)
    ("CD42b" . SPARSER::PROTEIN) ("N -hydroxysuccinimide" . SPARSER::DRUG)
    ("α IIb β 3" . SPARSER::PROTEIN) ("PGE1" . SPARSER::DRUG)
    ("PSGL-1" . SPARSER::PROTEIN) ("multimerin-1" . SPARSER::PROTEIN)
    ("membrane-associated Ras" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("oxysterols" . SPARSER::MOLECULE) ("p85 and p110β" . SPARSER::COLLECTION)
    ("CHOD" . SPARSER::PROTEIN) ("noncaveolar lipid" . SPARSER::LIPID)
    ("siRNA and Cav-1" . SPARSER::COLLECTION)
    ("any buoyant fraction p-Akt" . SPARSER::COLLECTION)
    ("buoyant membrane fractions" . SPARSER::COMPONENT)
    ("buoyant lipid" . SPARSER::LIPID) ("Col1a2" . SPARSER::PROTEIN)
    ("Alizarin" . SPARSER::DRUG)
    ("active adhesion receptors (β1 integrins) and co-localized bone morphogenetic protein (BMP) receptors"
     . SPARSER::COLLECTION)
    ("soft two-dimensional substrates" . SPARSER::SUBSTRATE)
    ("BMP" . SPARSER::PROTEIN)
    ("musculoskeletal regenerative medicine" . SPARSER::DRUG)
    ("adipocytes, chondrocytes, and osteoblasts" . SPARSER::COLLECTION)
    ("siRNA and cholesterol oxidase" . SPARSER::COLLECTION)
    ("LY294002 and Akt" . SPARSER::COLLECTION)
    ("dexamethasone, and 1,25-dihydroxyvitamin D" . SPARSER::COLLECTION)
    ("BMP-2" . SPARSER::PROTEIN)
    ("4-nitrophenyl phosphate" . SPARSER::MOLECULE)
    ("FGF-2" . SPARSER::PROTEIN)
    ("fibroblast growth factor 2" . SPARSER::PROTEIN)
    ("phosphatidylinositol 4,5-bisphosphate" . SPARSER::PIP2)
    ("Caveolin-3" . SPARSER::PROTEIN) ("Caveolin-2" . SPARSER::PROTEIN)
    ("cholesterol oxidase" . SPARSER::PROTEIN)
    ("1,25-dihydroxyvitamin D" . SPARSER::MOLECULE)
    ("PARP-1 and mutants" . SPARSER::COLLECTION)
    ("toxic DSBs" . SPARSER::PROTEIN)
    ("the monomeric enzyme" . SPARSER::ENZYME)
    ("SSBs and related DNA" . SPARSER::COLLECTION)
    ("active calf thymus DNA" . SPARSER::DNA)
    ("inactive and active" . SPARSER::COLLECTION)
    ("the ternary F3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("F1F2F3" . SPARSER::PROTEIN) ("PARP-1 and F1F2" . SPARSER::COLLECTION)
    ("F1F2F3-SSB" . SPARSER::PROTEIN-PAIR) ("CSPs" . SPARSER::PROTEIN)
    ("DNA Damage Recognition Drives PARP-1’s" . SPARSER::PROTEIN)
    ("Mre11-Rad50-Nbs1" . SPARSER::COLLECTION)
    ("a hypothetical reversed complex" . SPARSER::BIO-COMPLEX)
    ("reversed complex" . SPARSER::BIO-COMPLEX)
    ("chemically diverse SSB" . SPARSER::PROTEIN) ("DNA " . SPARSER::DNA)
    ("CSP" . SPARSER::PROTEIN) ("undamaged double-helical DNA" . SPARSER::DNA)
    ("flexible multi-domain proteins and their complexes ( xref , xref )"
     . SPARSER::COLLECTION)
    ("flexible multi-domain proteins" . SPARSER::PROTEIN)
    ("protein and DNA" . SPARSER::COLLECTION)
    ("approximately 10-fold weaker" . SPARSER::PROTEIN)
    ("DNA-damage specific" . SPARSER::DNA)
    ("flexible linkers" . SPARSER::LINKER) ("linkers" . SPARSER::LINKER)
    ("understanding PARP-1’s" . SPARSER::PROTEIN)
    ("a highly abundant chromatin-associated protein" . SPARSER::PROTEIN)
    ("monomeric PARP-1" . SPARSER::PROTEIN)
    ("SSBs and drive co-operative" . SPARSER::COLLECTION)
    ("SSBs and PARP-1" . SPARSER::COLLECTION) ("Nbs1" . SPARSER::PROTEIN)
    ("E–1" . SPARSER::PROTEIN) ("Sentinel" . SPARSER::DRUG)
    ("type, and histology" . SPARSER::COLLECTION)
    ("TAp73 and PLK2" . SPARSER::COLLECTION)
    ("aphidicolin and paclitaxel" . SPARSER::COLLECTION)
    ("cisplatin and PLK2" . SPARSER::COLLECTION)
    ("siRNA (Fig.  xref C) and vice versa (Fig.  xref D)"
     . SPARSER::COLLECTION)
    ("siRNA or a PLK2 inhibitor" . SPARSER::COLLECTION)
    ("TAp73" . SPARSER::PROTEIN) ("PLK2 and TAp73" . SPARSER::COLLECTION)
    ("the acidophilic kinase casein kinase 2" . SPARSER::PROTEIN)
    ("GPS" . SPARSER::PROTEIN) ("a unique PLK protein" . SPARSER::PROTEIN)
    ("PLK and p53 families" . SPARSER::COLLECTION)
    ("PLK1, PLK2, PLK3, PLK4, and PLK5" . SPARSER::COLLECTION)
    ("p21 and puma" . SPARSER::COLLECTION)
    ("puma" . SPARSER::HUMAN-PROTEIN-FAMILY) ("E–H" . SPARSER::PROTEIN)
    ("A–F" . SPARSER::PROTEIN) ("TA1" . SPARSER::PROTEIN)
    ("casein kinase 2" . SPARSER::PROTEIN) ("PLK2 " . SPARSER::PROTEIN)
    ("p53 families" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PLK5" . SPARSER::PROTEIN) ("p53 family" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PLK2" . SPARSER::PROTEIN)
    ("ABT-263 and MEKI combination" . SPARSER::COLLECTION)
    ("ABT-737 and PD0325901" . SPARSER::COLLECTION)
    ("CD38–" . SPARSER::PROTEIN) ("MEKI or types" . SPARSER::COLLECTION)
    ("MEKI or ABT-263" . SPARSER::COLLECTION) ("FLT-ITD" . SPARSER::COLLECTION)
    ("FLT" . SPARSER::PROTEIN) ("the BH3 mimetic ABT-263" . SPARSER::DRUG)
    ("ABT-263 or both" . SPARSER::COLLECTION)
    ("CD38- and p" . SPARSER::COLLECTION) ("CD38-" . SPARSER::PROTEIN)
    ("1 μM MEKI or both" . SPARSER::COLLECTION)
    ("anti-CD34, anti-CD38 and anti-CD123" . SPARSER::COLLECTION)
    ("MEKI-" . SPARSER::INHIBITOR)
    ("p27kip1 and p21cip1" . SPARSER::COLLECTION)
    ("ABT-263 and MEKI co-treatment (Figure xref )" . SPARSER::COLLECTION)
    ("MCL-1 nor BCL-xL" . SPARSER::COLLECTION)
    ("expressed PUMA, MCL-1 nor BCL-xL" . SPARSER::COLLECTION)
    ("BCL-xL and PUMA" . SPARSER::COLLECTION)
    ("BCL-2 and BAX" . SPARSER::COLLECTION)
    ("MEKI and ABT-263" . SPARSER::COLLECTION)
    ("FLT-3-ITD" . SPARSER::COLLECTION)
    ("Orally bioavailable MEKI and BH3 mimetics" . SPARSER::COLLECTION)
    ("AS703026 (pimasertib) and ABT-263" . SPARSER::COLLECTION)
    ("Orally bioavailable MEKI" . SPARSER::INHIBITOR)
    ("inhibitors (MEKI)" . SPARSER::INHIBITOR)
    ("BCL-2 and BCL-xL" . SPARSER::COLLECTION)
    ("BCL-2, MCL-1 or BCL-xL" . SPARSER::COLLECTION)
    ("BCL-2, BCL-xL or MCL-1" . SPARSER::COLLECTION)
    ("BAX and BAK" . SPARSER::COLLECTION) ("BIM or BAD" . SPARSER::COLLECTION)
    ("MEKI" . SPARSER::INHIBITOR)
    ("a BH3 mimetic such ABT-263 and the MEK1/2 inhibitor pimasertib (MEKI)"
     . SPARSER::COLLECTION)
    ("pimasertib (MEKI)" . SPARSER::DRUG)
    ("a BH3 mimetic such ABT-263" . SPARSER::DRUG)
    ("pimasertib" . SPARSER::DRUG) ("BCL-2 or BCL-xL" . SPARSER::COLLECTION)
    ("PC5" . SPARSER::PROTEIN) ("DiOC6" . SPARSER::DRUG)
    ("CD123" . SPARSER::PROTEIN) ("p27kip1" . SPARSER::PROTEIN)
    ("FLT-3" . SPARSER::PROTEIN) ("AS703026" . SPARSER::DRUG)
    ("Extracellular signal-regulated kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("BH4" . SPARSER::PROTEIN-FAMILY) ("BH2" . SPARSER::MOLECULE)
    ("BH1" . SPARSER::PROTEIN) ("MAP Kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("tumor vasculature and benefit traditional chemo- and radio-therapy"
     . SPARSER::COLLECTION)
    ("PI3K or NFκB" . SPARSER::COLLECTION)
    ("YC-1 and AG825" . SPARSER::COLLECTION)
    ("other tumor cell-derived angiogenic cytokines" . SPARSER::PROTEIN)
    ("HER2 and HRG" . SPARSER::COLLECTION)
    ("HER3 or HER 4" . SPARSER::COLLECTION)
    ("angiogenic cytokines" . SPARSER::PROTEIN)
    ("AG825 and HRG-β1" . SPARSER::COLLECTION)
    ("receptor-" . SPARSER::RECEPTOR)
    ("the antidiabetic metformin" . SPARSER::DRUG)
    ("metformin-" . SPARSER::DRUG) ("CD31 and HIF-1α" . SPARSER::COLLECTION)
    ("AG825 or YC-1" . SPARSER::COLLECTION)
    ("HER2-HRG-β1" . SPARSER::COLLECTION)
    ("metformin and AG825" . SPARSER::COLLECTION)
    ("AG825, HRG-β1, or metformin" . SPARSER::COLLECTION)
    ("YC-1 and RNAi-HIF-1α" . SPARSER::COLLECTION)
    ("HER2-VEGF" . SPARSER::COLLECTION) ("BEV" . SPARSER::DRUG)
    ("HRG-β1" . SPARSER::PROTEIN) ("HRG-β1-HER2" . SPARSER::COLLECTION)
    ("HRGs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("receptor (PR)" . SPARSER::RECEPTOR)
    ("HIF-1α and VEGFA" . SPARSER::COLLECTION)
    ("phosphos-HER2" . SPARSER::COLLECTION)
    ("HER2, HIF-1α, and VEGF" . SPARSER::COLLECTION)
    ("HER2, and AG825" . SPARSER::COLLECTION) ("ADA" . SPARSER::PROTEIN)
    ("oxygen and nutrients" . SPARSER::COLLECTION)
    ("HIF-1α-VEGF" . SPARSER::COLLECTION) ("Fitc" . SPARSER::MOLECULE)
    ("heregulin" . SPARSER::PROTEIN) ("HIF1" . SPARSER::PROTEIN)
    ("HER 4" . SPARSER::PROTEIN) ("p70S6K1" . SPARSER::PROTEIN)
    ("vascular permeability factor" . SPARSER::PROTEIN)
    ("recombinant heregulin" . SPARSER::DRUG) ("YC-1" . SPARSER::DRUG)
    ("AG825" . SPARSER::DRUG) ("anti-diabetic" . SPARSER::DRUG)
    ("dasatinib and CYT387" . SPARSER::COLLECTION)
    ("YAP1-TAZ" . SPARSER::COLLECTION) ("Yes1" . SPARSER::PROTEIN)
    ("Src and FAK" . SPARSER::COLLECTION)
    ("the dasatinib and CYT 387 co-treatment" . SPARSER::COLLECTION)
    ("dasatinib and CYT387 combination treatment (Normalized Enrichment Score = +1.84, where positive values indicate correlation; P = 0.023; False Discovery Rate = 0.069)"
     . SPARSER::COLLECTION)
    ("YAP1 and TAZ" . SPARSER::COLLECTION)
    ("CDK1, AURKA, AURKB, CCNB1 and CCNB1" . SPARSER::COLLECTION)
    ("AURKB" . SPARSER::PROTEIN) ("CDKN1A and CDKN1B" . SPARSER::COLLECTION)
    ("the transcriptional co-activators YAP1 and transcriptional co-activator"
     . SPARSER::COLLECTION)
    ("the adaptor Sav1" . SPARSER::PROTEIN) ("Sav" . SPARSER::PROTEIN)
    ("robust p-Src" . SPARSER::PROTEIN)
    ("Dasatinib and CYT" . SPARSER::COLLECTION)
    ("Stat3 and Src" . SPARSER::COLLECTION) ("p-Stat3" . SPARSER::COLLECTION)
    ("UO" . SPARSER::PROTEIN)
    ("Dasatinib and CYT387 combinations" . SPARSER::COLLECTION)
    ("TK" . SPARSER::PROTEIN)
    ("Src and its substrate FAK" . SPARSER::COLLECTION)
    ("Src and Stat3" . SPARSER::COLLECTION)
    ("a promising oncologic therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("dasatinib, bosutinib and saracatinib" . SPARSER::COLLECTION)
    ("Src-Stat3" . SPARSER::COLLECTION) ("CYT" . SPARSER::MOLECULE)
    ("The intracytoplasmic tyrosine kinase Src" . SPARSER::PROTEIN)
    ("p-Y" . SPARSER::PROTEIN) ("p-YAP" . SPARSER::PROTEIN)
    ("Jak2" . SPARSER::PROTEIN) ("Yes-associated protein 1" . SPARSER::PROTEIN)
    ("p-Src" . SPARSER::PROTEIN) ("oligopeptides" . SPARSER::MOLECULE)
    ("Sirt1 or Sirt3" . SPARSER::COLLECTION)
    ("human Sirt2 and human Sirt3" . SPARSER::COLLECTION)
    ("conformation and share" . SPARSER::COLLECTION)
    ("either the cofactor NAD + or the product analogue ADPR"
     . SPARSER::COLLECTION)
    ("carboxamide" . SPARSER::MOLECULE)
    ("Sirt1 and Sirt3" . SPARSER::COLLECTION)
    ("human Sirt3 and the archaeal sirtuin Sir2Tm (Gertz et al. , 2013 xref ; Zhao et al. , 2013 xref )"
     . SPARSER::COLLECTION)
    ("human Sirt1, human Sirt3 and the archaeal sirtuin Sir2Tm (Gertz et al. , 2013 xref ; Zhao et al. , 2013 xref )"
     . SPARSER::COLLECTION)
    ("the archaeal sirtuin Sir2Tm" . SPARSER::PROTEIN)
    ("Sirt2–ADPR" . SPARSER::PROTEIN-PAIR) ("NaCl" . SPARSER::PROTEIN)
    ("PEG" . SPARSER::PROTEIN) ("PDB" . SPARSER::MOLECULE)
    ("unexpectedly contained two inhibitor molecules" . SPARSER::MOLECULE)
    ("zinc-binding" . SPARSER::PROTEIN)
    ("Sirt4 and Sirt7" . SPARSER::COLLECTION)
    ("around 275 amino acids" . SPARSER::AMINO-ACID)
    ("antiparasitic drugs" . SPARSER::DRUG)
    ("Sirt1, Sirt2 and Sirt3" . SPARSER::COLLECTION)
    ("Sirt1, Sirt2, Sirt3 and Sirt6" . SPARSER::COLLECTION)
    ("Sirt1" . SPARSER::PROTEIN)
    ("a unique NAD + -dependent enzyme family" . SPARSER::PROTEIN-FAMILY)
    ("indoles" . SPARSER::DRUG) ("sirtuins attractive drug" . SPARSER::DRUG)
    ("Sirtuins" . SPARSER::PROTEIN-FAMILY) ("indole" . SPARSER::DRUG)
    ("Sirt2 and Sirt3" . SPARSER::COLLECTION) ("Sir2Tm" . SPARSER::PROTEIN)
    ("F10" . SPARSER::PROTEIN) ("Sirt3  " . SPARSER::PROTEIN)
    ("CCP 4" . SPARSER::PROTEIN) ("CC 1" . SPARSER::PROTEIN)
    ("bis-tris" . SPARSER::MOLECULE) ("PEG 10 " . SPARSER::PROTEIN)
    ("Q9NTG7" . SPARSER::PROTEIN) ("Q8IXJ6" . SPARSER::PROTEIN)
    ("Sirt7" . SPARSER::PROTEIN) ("Sirt4" . SPARSER::PROTEIN)
    ("fatty-acid" . SPARSER::MOLECULE) ("Sirt6" . SPARSER::PROTEIN)
    ("Sirt5" . SPARSER::PROTEIN) ("EX527" . SPARSER::DRUG)
    ("Sirt3" . SPARSER::PROTEIN) ("MMD and ITPR3" . SPARSER::COLLECTION)
    ("AACS , PVRL3 , RASA1 , ALDH3B1 , and LAD1" . SPARSER::COLLECTION)
    ("PDLIM4 [ xref ] and IQGAP2 [ xref ]" . SPARSER::COLLECTION)
    ("SLC34A2 and ITPR3" . SPARSER::COLLECTION)
    ("DCSTAMP and MMD" . SPARSER::COLLECTION)
    ("MET and ERBB3" . SPARSER::COLLECTION)
    ("MET , ERBB3 , and PLAUR" . SPARSER::COLLECTION)
    ("NIS , TG , and TPO" . SPARSER::COLLECTION) ("TPO" . SPARSER::PROTEIN)
    ("NIS" . SPARSER::PROTEIN)
    ("DCSTAMP , MET , FN1 , DIO1 , EPHA2 , and ERBB3" . SPARSER::COLLECTION)
    ("DIO" . SPARSER::MOLECULE) ("DCSTAMP" . SPARSER::PROTEIN)
    ("PLAUR and EPHA2" . SPARSER::COLLECTION)
    ("PTCs and RAS" . SPARSER::COLLECTION) ("leptin" . SPARSER::PROTEIN)
    ("adipocytokine" . SPARSER::PROTEIN-FAMILY)
    ("BRAF , RET , and RAS" . SPARSER::COLLECTION)
    ("PTCs and PTC" . SPARSER::COLLECTION)
    ("BRAF or RET" . SPARSER::COLLECTION)
    ("follicular variant PTC" . SPARSER::PROTEIN)
    ("almost 400 PTCs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Thyroid" . SPARSER::PROTEIN) ("PDTC and PTC" . SPARSER::COLLECTION)
    ("serrated" . SPARSER::PROTEIN)
    ("the cribriform–morular PTC variant" . SPARSER::VARIANT)
    ("the typical human BRAF (+) PTC classical variant" . SPARSER::VARIANT)
    ("TSH" . SPARSER::PROTEIN) ("PLAUR" . SPARSER::PROTEIN)
    ("PVRL3 , MMD , LAD1 , ITPR3 , ALDH3B1 , RASA1 , and AACS"
     . SPARSER::COLLECTION)
    ("healthy thyroid" . SPARSER::PROTEIN)
    ("BRAF (+) PTCs and RET (+) PTCs" . SPARSER::PROTEIN)
    ("the available human PTCs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PTCs and RET" . SPARSER::COLLECTION)
    ("RAS (+) and PTCs(−)" . SPARSER::COLLECTION)
    ("BRAF (+) or RET (+) PTC" . SPARSER::COLLECTION)
    ("apparently healthy thyroid" . SPARSER::PROTEIN)
    ("BRAF (+) or RET (+) PTCs" . SPARSER::COLLECTION)
    ("the BRAF (+) and BRAF (−)" . SPARSER::COLLECTION)
    ("histological type" . TYPE)
    ("BRAF (+) and BRAF (−)" . SPARSER::COLLECTION)
    ("BRAF (+) and 4 BRAF (−)" . SPARSER::COLLECTION)
    ("being BRAF (+) and 5 BRAF (−)" . SPARSER::COLLECTION)
    ("adjacent fat" . SPARSER::PROTEIN)
    ("fully developed PTC" . SPARSER::PROTEIN)
    ("classical PTC variant" . SPARSER::VARIANT)
    ("BRAFV600E" . SPARSER::PROTEIN) ("tg3" . SPARSER::PROTEIN)
    ("TG-BRAFV600E" . SPARSER::PROTEIN-PAIR) ("AKT/mTOR" . SPARSER::COLLECTION)
    ("serine–threonine" . SPARSER::COLLECTION) ("TRK" . SPARSER::PROTEIN)
    ("MMD , ITPR3 , AACS , LAD1 , PVRL3 , ALDH3B1 , and RASA1"
     . SPARSER::COLLECTION)
    ("AACS" . SPARSER::PROTEIN) ("MMD" . SPARSER::PROTEIN)
    ("BRAF and RET" . SPARSER::COLLECTION) ("HG" . SPARSER::MOLECULE)
    ("IQGAP2" . SPARSER::PROTEIN) ("PDLIM4" . SPARSER::PROTEIN)
    ("SLC34A2" . SPARSER::PROTEIN) ("ERBB3" . SPARSER::PROTEIN)
    ("EPHA2" . SPARSER::PROTEIN) ("RAS -like" . SPARSER::PROTEIN)
    ("RASA1" . SPARSER::PROTEIN) ("ALDH3B1" . SPARSER::PROTEIN)
    ("PVRL3" . SPARSER::PROTEIN) ("LAD1" . SPARSER::PROTEIN)
    ("ITPR3" . SPARSER::PROTEIN) ("Rsk3" . SPARSER::PROTEIN)
    ("Rsk" . SPARSER::PROTEIN)
    ("no clinically available RSK inhibitors" . SPARSER::INHIBITOR)
    ("FMS" . SPARSER::PROTEIN) ("latent TGF-β1" . SPARSER::PROTEIN)
    ("receptor/RAC/SMAD" . SPARSER::COLLECTION) ("RAC" . SPARSER::PROTEIN)
    ("TGF-β1 and FN" . SPARSER::COLLECTION)
    ("α5β1-integrin" . SPARSER::COLLECTION) ("fn1" . SPARSER::PROTEIN)
    ("FN and its major receptor α5β1 integrin" . SPARSER::COLLECTION)
    ("ZEB and SNAIL" . SPARSER::COLLECTION)
    ("fibronectin/TGF-β1" . SPARSER::COLLECTION)
    ("exogenous FN" . SPARSER::PROTEIN)
    ("cortical F-actin" . SPARSER::BIO-COMPLEX)
    ("Endogenous cellular FN" . SPARSER::PROTEIN)
    ("FN and α5β1" . SPARSER::COLLECTION)
    ("ovarian cancer cells RSK1 and RSK2" . SPARSER::COLLECTION)
    ("integrin and TGF-β1" . SPARSER::COLLECTION)
    ("collagen, laminin, and glycosaminoglycans" . SPARSER::COLLECTION)
    ("glycosaminoglycans" . SPARSER::MOLECULE)
    ("Hepatocyte Growth Factor (HGF)" . SPARSER::PROTEIN)
    ("separately re-expressed RSK1 and RSK2" . SPARSER::COLLECTION)
    ("RSK3 and RSK4" . SPARSER::COLLECTION)
    ("HER2, MET, EGFR and LPARs" . SPARSER::COLLECTION)
    ("RAS/MAPK" . SPARSER::COLLECTION)
    ("the 90 kDa ribosomal S6 kinases" . SPARSER::PROTEIN-FAMILY)
    ("fibronectin (FN)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("FN" . SPARSER::PROTEIN) ("RSK1/RSK2" . SPARSER::COLLECTION)
    ("RAS-ERK/MAPK" . SPARSER::COLLECTION) ("p90RSK" . SPARSER::PROTEIN-FAMILY)
    ("alpha5" . SPARSER::PROTEIN) ("RPS6KA6" . SPARSER::PROTEIN)
    ("RPS6KA2" . SPARSER::PROTEIN) ("RPS6KA1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SF1" . SPARSER::PROTEIN) ("Rsk2" . SPARSER::PROTEIN)
    ("Rsk1" . SPARSER::PROTEIN) ("TGFB1" . SPARSER::PROTEIN)
    ("Scatter Factor" . SPARSER::PROTEIN)
    ("Hepatocyte Growth Factor" . SPARSER::PROTEIN) ("RSK4" . SPARSER::PROTEIN)
    ("RSK3" . SPARSER::PROTEIN) ("FN1" . SPARSER::PROTEIN)
    ("extracellular signal regulated kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("S6 kinases" . SPARSER::PROTEIN-FAMILY)
    ("an important biomarker and therapeutic target worthy"
     . SPARSER::COLLECTION)
    ("dasatinib, saracatinib, and bosutinib" . SPARSER::COLLECTION)
    ("saracatinib" . SPARSER::DRUG) ("alisertib" . SPARSER::DRUG)
    ("more common gastrointestinal forms" . SPARSER::FORM)
    ("NETs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("MET/FYN" . SPARSER::COLLECTION)
    ("Fyn-SIL" . SPARSER::PROTEIN-PAIR) ("SYP and AURKA" . SPARSER::COLLECTION)
    ("FYN/MET" . SPARSER::COLLECTION) ("subline" . SPARSER::PROTEIN)
    ("FYN and MET" . SPARSER::COLLECTION) ("TRAMPC2" . SPARSER::PROTEIN)
    ("SYP and CHGA" . SPARSER::COLLECTION)
    ("TRAMPC2-RANKL" . SPARSER::COLLECTION) ("FYN-" . SPARSER::PROTEIN)
    ("NSE, CHGA, CHGB, AURKA, SCG3, and MYCN" . SPARSER::COLLECTION)
    ("FYN and NEPC" . SPARSER::COLLECTION)
    ("AURKA and MYCN" . SPARSER::COLLECTION) ("AURKA" . SPARSER::PROTEIN)
    ("CD44, and CD56" . SPARSER::COLLECTION)
    ("nearly every PCa" . SPARSER::PROTEIN) ("NEPC" . SPARSER::PROTEIN)
    ("ARCaP" . SPARSER::PROTEIN) ("SYP" . SPARSER::PROTEIN)
    ("Messenger RNA" . SPARSER::RNA) ("Secretogranin 3" . SPARSER::PROTEIN)
    ("Aurora Kinase A" . SPARSER::PROTEIN) ("QD585" . SPARSER::MOLECULE)
    ("QD605" . SPARSER::MOLECULE) ("QD655" . SPARSER::MOLECULE)
    ("SCG3" . SPARSER::PROTEIN) ("p70S6K and Tec" . SPARSER::COLLECTION)
    ("chronic ethanol" . SPARSER::PROTEIN)
    ("SKp2 and CRL4" . SPARSER::COLLECTION)
    ("p21, p27 and p57" . SPARSER::COLLECTION)
    ("FAT10 and LMP2" . SPARSER::COLLECTION)
    ("ROS and BRCA1" . SPARSER::COLLECTION)
    ("mRNAs and protein" . SPARSER::COLLECTION)
    ("p21 and Tec" . SPARSER::COLLECTION)
    ("TNFRSF1B (2.77 fold; p =0.023) and FASTKD5 (5.86 fold; p =0.014)"
     . SPARSER::COLLECTION)
    ("TRAF1 (8.12 fold; p =0.006), TNFRSF1B (2.77 fold; p =0.023) and FASTKD5 (5.86 fold; p =0.014)"
     . SPARSER::COLLECTION)
    ("RAN-Seq" . SPARSER::COLLECTION) ("Seq" . SPARSER::PROTEIN)
    ("RAN" . SPARSER::PROTEIN) ("AH and DDC" . SPARSER::COLLECTION)
    ("Bax, ATM and Ki67" . SPARSER::COLLECTION)
    ("BRCA1 and KRT80" . SPARSER::COLLECTION) ("Tec" . SPARSER::PROTEIN)
    ("at least three genes" . SPARSER::GENE) ("UBD" . SPARSER::PROTEIN)
    ("AH and non-alcoholic steatohepatitis (NASH)" . SPARSER::COLLECTION)
    ("AH and non-alcoholic steatohepatitis" . SPARSER::COLLECTION)
    ("cytokeratin (CK) and heat shock proteins (HSPs)" . SPARSER::COLLECTION)
    ("NFκB-CXCR4" . SPARSER::PROTEIN-PAIR)
    ("cytokeratins (CKs) and the undigested proteins" . SPARSER::COLLECTION)
    ("CKs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p16 and p15 inhibitors" . SPARSER::COLLECTION)
    ("Cdkn2a and Cdkn2b" . SPARSER::COLLECTION)
    ("p21 and Wig1" . SPARSER::COLLECTION) ("Cdkn2b" . SPARSER::PROTEIN)
    ("Cdkn2a" . SPARSER::PROTEIN) ("P21 and p27" . SPARSER::COLLECTION)
    ("the cell cycle Cip/Kip family members p21 (Cdkn1a) and p27 (Cdkn1b)"
     . SPARSER::COLLECTION)
    ("Cdkn1b" . SPARSER::PROTEIN) ("oxygen and nitrogen" . SPARSER::COLLECTION)
    ("hepatocytes and MDB" . SPARSER::COLLECTION) ("MDB" . SPARSER::PROTEIN)
    ("DDC" . SPARSER::PROTEIN) ("AH" . SPARSER::MOLECULE)
    ("P70S6K" . SPARSER::PROTEIN) ("Cdt2" . SPARSER::PROTEIN)
    ("SKp2" . SPARSER::PROTEIN) ("LMP2" . SPARSER::PROTEIN)
    ("interferon gamma" . SPARSER::PROTEIN) ("TNFRSF1B" . SPARSER::PROTEIN)
    ("TRAF1" . SPARSER::PROTEIN) ("p15 protein" . SPARSER::PROTEIN)
    ("Ink4" . SPARSER::PROTEIN) ("GNG2" . SPARSER::PROTEIN)
    ("gamma2" . SPARSER::PROTEIN)
    ("guanine nucleotide binding protein (G protein)" . SPARSER::PROTEIN)
    ("HSPA12A" . SPARSER::PROTEIN) ("Keratin80" . SPARSER::PROTEIN)
    ("KRT80" . SPARSER::PROTEIN) ("HSPA2" . SPARSER::PROTEIN)
    ("FAT10" . SPARSER::PROTEIN)
    ("ubiquitin-binding protein p62" . SPARSER::PROTEIN)
    ("Wig1" . SPARSER::PROTEIN)
    ("EGFR inhibitors and MEK inhibitors" . SPARSER::COLLECTION)
    ("MEK as well as upstream receptor tyrosine kinases" . SPARSER::COLLECTION)
    ("any commercially available antibodies" . SPARSER::ANTIBODY)
    ("CRAF and the RAS-association domain family 1 isoform"
     . SPARSER::COLLECTION)
    ("ERK/MEK" . SPARSER::COLLECTION)
    ("heterochromatic foci" . SPARSER::PROTEIN)
    ("H2AX (γH2AX) and Chk1" . SPARSER::COLLECTION)
    ("MRE11-RAD50-NBs1" . SPARSER::COLLECTION)
    ("TAZ and Chk1" . SPARSER::COLLECTION)
    ("TAZ, CHK1, or γH2AX" . SPARSER::COLLECTION)
    ("TAZ and γH2AX" . SPARSER::COLLECTION)
    ("BIBW2992 and PD0325901" . SPARSER::COLLECTION)
    ("SRC or ABL" . SPARSER::COLLECTION)
    ("family and MEK1/2" . SPARSER::COLLECTION)
    ("all 79 unique drugs" . SPARSER::DRUG)
    ("SRC, ABL, or RAF" . SPARSER::COLLECTION)
    ("phosphospecific antibodies" . SPARSER::ANTIBODY)
    ("ERK and MEK" . SPARSER::COLLECTION) ("TAZ or Chk1" . SPARSER::COLLECTION)
    ("Chk1 or TAZ" . SPARSER::COLLECTION)
    ("CCN1 and CCN2" . SPARSER::COLLECTION)
    ("ATM and DNA-PK" . SPARSER::COLLECTION)
    ("ATM, ATR, and DNA-PK" . SPARSER::COLLECTION)
    ("Chk1 and TAZ" . SPARSER::COLLECTION)
    ("only 7 proteins" . SPARSER::PROTEIN)
    ("catalytic subunit (DNA-PKcs) and ERCC3 (Rad25; Figure xref )"
     . SPARSER::COLLECTION)
    ("Rad25" . SPARSER::PROTEIN)
    ("ATM and G2M/DNA damage checkpoint" . SPARSER::COLLECTION)
    ("at least 35 proteins" . SPARSER::PROTEIN) ("MOB" . SPARSER::PROTEIN)
    ("proteins and phosphoproteins" . SPARSER::COLLECTION)
    ("Src/Abl" . SPARSER::COLLECTION) ("bosutinib" . SPARSER::DRUG)
    ("BRAF-CRAF" . SPARSER::COLLECTION)
    ("nearly 40 distinct kinase" . SPARSER::KINASE)
    ("Src and Abl" . SPARSER::COLLECTION) ("CRAF-BRAF" . SPARSER::COLLECTION)
    ("CRAF" . SPARSER::PROTEIN)
    ("homodimers and heterodimers" . SPARSER::COLLECTION)
    ("RAS/RAF/MEK/ERK" . SPARSER::COLLECTION)
    ("EGFR and MEK" . SPARSER::COLLECTION)
    ("Chk1 and p21" . SPARSER::COLLECTION)
    ("Tert-butyl hydroperoxide" . SPARSER::MOLECULE)
    ("Rpl32" . SPARSER::PROTEIN) ("L32" . SPARSER::PROTEIN)
    ("S1981" . SPARSER::PROTEIN) ("CDC6" . SPARSER::PROTEIN)
    ("EBP1" . SPARSER::PROTEIN) ("LC3A" . SPARSER::PROTEIN)
    ("family 1" . SPARSER::PROTEIN) ("c-ABL" . SPARSER::PROTEIN)
    ("NBs1" . SPARSER::PROTEIN) ("BIBW2992" . SPARSER::DRUG)
    ("CCN1" . SPARSER::PROTEIN) ("ERCC3" . SPARSER::PROTEIN)
    ("PIK3CA or loss/mutations" . SPARSER::COLLECTION)
    ("metformin or sirolimus" . SPARSER::COLLECTION)
    ("ErbB" . SPARSER::PROTEIN) ("raptor or TSC2" . SPARSER::COLLECTION)
    ("raptor" . SPARSER::PROTEIN)
    ("hyperosmotic stress, or tissue ischemia" . SPARSER::PROTEIN)
    ("ErbB-receptors" . SPARSER::PROTEIN-PAIR)
    ("HER, AXL and ER" . SPARSER::COLLECTION)
    ("up-regulated ER-associated signaling genes" . SPARSER::GENE)
    ("FOXO3a and caveolin-1, or Akt" . SPARSER::COLLECTION)
    ("caveolin-1, or Akt" . SPARSER::COLLECTION) ("HSPCA" . SPARSER::PROTEIN)
    ("p-AMPK alpha1" . SPARSER::COLLECTION) ("Radical" . SPARSER::MOLECULE)
    ("progesterone receptor (PR)" . SPARSER::PROTEIN)
    ("199 at least one biomarker" . SPARSER::MOLECULE)
    ("PTEN, and cyclin E" . SPARSER::COLLECTION)
    ("HER2 and insulin-like growth factor-1 receptor" . SPARSER::COLLECTION)
    ("Ras/Raf/MAPK" . SPARSER::COLLECTION) ("AMPK/mTOR" . SPARSER::COLLECTION)
    ("At least one biomarker" . SPARSER::MOLECULE)
    ("p-MAPK" . SPARSER::COLLECTION) ("p-AMPK" . SPARSER::COLLECTION)
    ("lapatinib and capecitabine" . SPARSER::COLLECTION)
    ("HIF2alpha" . SPARSER::PROTEIN) ("p-70" . SPARSER::PROTEIN)
    ("AMPK alpha 1" . SPARSER::PROTEIN) ("IRAK1" . SPARSER::PROTEIN)
    ("OS 3" . SPARSER::PROTEIN) ("HIF-2" . SPARSER::PROTEIN)
    ("HIF-2 alpha" . SPARSER::PROTEIN) ("AMPK alpha1" . SPARSER::PROTEIN)
    ("HIF2 alpha" . SPARSER::PROTEIN)
    ("hypoxia-inducible factor 2 alpha" . SPARSER::PROTEIN)
    ("p110-alpha" . SPARSER::PROTEIN)
    ("insulin-like growth factor-1 receptor" . SPARSER::PROTEIN)
    ("HR 3" . SPARSER::PROTEIN) ("P53 or P53" . SPARSER::COLLECTION)
    ("the only target gene" . SPARSER::GENE)
    ("MDR-associated miRNAs" . SPARSER::PROTEIN) ("CCNG" . SPARSER::PROTEIN)
    ("ADR and VCR" . SPARSER::COLLECTION)
    ("miR-27b and miR-508-p" . SPARSER::COLLECTION)
    ("miR-27b or miR-508-5p" . SPARSER::COLLECTION)
    ("miR-27b and miR-508-5p" . SPARSER::COLLECTION)
    ("P53 and P53" . SPARSER::COLLECTION)
    ("exogenous CCNG1" . SPARSER::PROTEIN)
    ("Exogenous CCNG1" . SPARSER::PROTEIN) ("CCNG1-wt" . SPARSER::COLLECTION)
    ("CCNG1-" . SPARSER::PROTEIN)
    ("CCNG1 and the inhibitor" . SPARSER::COLLECTION)
    ("miR-27b and CCNG1" . SPARSER::COLLECTION) ("miR-27b" . SPARSER::PROTEIN)
    ("lenti-miR-27b" . SPARSER::PROTEIN-PAIR)
    ("CCNG1, GOLM1, NAA15, NCOA7, RPS6KA5 and TGOLN2" . SPARSER::COLLECTION)
    ("caspase-3 and −9" . SPARSER::COLLECTION)
    ("ADR, VCR, 5FU and CDDP" . SPARSER::COLLECTION)
    ("adriamycin (ADR)" . SPARSER::DRUG) ("VCR" . SPARSER::DRUG)
    ("at least one chemotherapeutic drug" . SPARSER::DRUG)
    ("MDR-associated molecules" . SPARSER::MOLECULE)
    ("apoptosis-associated molecules" . SPARSER::MOLECULE)
    ("Bax, Bcl-2 and caspases" . SPARSER::COLLECTION)
    ("CCNG1 and P53" . SPARSER::COLLECTION)
    ("ABCB1 and ZNRD1" . SPARSER::COLLECTION) ("Multidrug" . SPARSER::PROTEIN)
    ("TGOLN2" . SPARSER::PROTEIN) ("RPS6KA5" . SPARSER::PROTEIN)
    ("NCOA7" . SPARSER::PROTEIN) ("NAA15" . SPARSER::PROTEIN)
    ("GOLM1" . SPARSER::PROTEIN) ("cis-platinum" . SPARSER::DRUG)
    ("CCNG1" . SPARSER::PROTEIN) ("ZNRD1" . SPARSER::PROTEIN)
    ("ABCB1" . SPARSER::PROTEIN)
    ("additional associated variants" . SPARSER::VARIANT)
    ("genotypes and TERT and CLPTM1L" . SPARSER::COLLECTION)
    ("Ko" . SPARSER::PROTEIN) ("genotypes" . SPARSER::PROTEIN)
    ("biological candidate susceptibility genes" . SPARSER::GENE)
    ("cisplatin-resistance-related genes" . SPARSER::GENE)
    ("telomerase activity and TERT" . SPARSER::COLLECTION)
    ("the telomerase reverse transcriptase ( TERT ) and the cleft lip and palate transmembrane 1-like ( CLPTM1L ) genes"
     . SPARSER::COLLECTION)
    ("telomerase reverse transcriptase ( TERT )" . SPARSER::PROTEIN)
    ("TERT and CLPTM1L" . SPARSER::COLLECTION)
    ("TERT-CLPTM1L" . SPARSER::COLLECTION) ("Rex-1" . SPARSER::PROTEIN)
    ("Oct-4" . SPARSER::PROTEIN) ("chr5" . SPARSER::PROTEIN)
    ("CLPTM1L" . SPARSER::PROTEIN)
    ("the mutated Arg allele variant" . SPARSER::VARIANT)
    ("the Arg allele and the occurrence" . SPARSER::COLLECTION)
    ("Gly/Arg" . SPARSER::COLLECTION) ("allele and T2DM" . SPARSER::COLLECTION)
    ("Gly/Gly" . SPARSER::COLLECTION)
    ("the homozygous mutant genotype" . SPARSER::PROTEIN)
    ("genotype" . SPARSER::PROTEIN) ("Arg/Arg" . SPARSER::COLLECTION)
    ("variant and T2DM" . SPARSER::COLLECTION) ("AGG" . SPARSER::MOLECULE)
    ("GGG" . SPARSER::MOLECULE) ("insulin receptor (IR)" . SPARSER::PROTEIN)
    ("95% confidence interval 0.28 - 3.95" . SPARSER::PROTEIN)
    ("Insulin receptor substrate-1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("IRS-1" . SPARSER::PROTEIN)
    ("insulin receptor substrate-1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NLRC5 and DUB" . SPARSER::COLLECTION)
    ("NLRC5, IKK-α/-β, and NEMO" . SPARSER::COLLECTION)
    ("a previously unrecognized CFL" . SPARSER::PROTEIN)
    ("available IKK complex" . SPARSER::BIO-COMPLEX)
    ("dynamic Ub" . SPARSER::PROTEIN) ("the reversible Ub" . SPARSER::PROTEIN)
    ("ligases and DUBs" . SPARSER::COLLECTION)
    ("NLRC5 and IKK-α/-β" . SPARSER::COLLECTION)
    ("other regulatory NLRs" . SPARSER::PROTEIN)
    ("regulatory NLRs" . SPARSER::PROTEIN)
    ("several regulatory NLRs" . SPARSER::PROTEIN)
    ("NLRC3, NLRC5, NLRX1, and NLRP4" . SPARSER::COLLECTION)
    ("other inflammasome-associated NLRs" . SPARSER::PROTEIN)
    ("Higher intrinsic USP14" . SPARSER::PROTEIN)
    ("pMs, and BMMs" . SPARSER::COLLECTION)
    ("NLRC5 and other signaling proteins" . SPARSER::COLLECTION)
    ("NLRC5, IKK-β, TRAF2, and USP14" . SPARSER::COLLECTION)
    ("USP14, USP22, and CYLD" . SPARSER::COLLECTION)
    ("NLRC5 or DUBs" . SPARSER::COLLECTION)
    ("USP14 and NLRC5" . SPARSER::COLLECTION)
    ("NF-κB–luc" . SPARSER::COLLECTION) ("pMs and BMMs" . SPARSER::COLLECTION)
    ("K63-" . SPARSER::PROTEIN) ("NLRC5 and USP14" . SPARSER::COLLECTION)
    ("USP18 and USP22" . SPARSER::COLLECTION) ("USPs" . SPARSER::PROTEIN)
    ("IKK-β or NF-κB" . SPARSER::COLLECTION)
    ("siRNA or NLRC5" . SPARSER::COLLECTION)
    ("WT NLRC5 or K1178R NLRC5 mutant ( xref )" . SPARSER::COLLECTION)
    ("NLRC5 or CFL" . SPARSER::COLLECTION)
    ("WT NLRC5 or other NLRC5 mutants ( xref ; and S2, G and H)"
     . SPARSER::COLLECTION)
    ("S2, G and H" . SPARSER::COLLECTION)
    ("Ub and the K1178R NLRC5 mutant" . SPARSER::COLLECTION)
    ("considerable polyubiquitination" . SPARSER::PROTEIN)
    ("NLRC5 and TRAF2 or TRAF6" . SPARSER::COLLECTION)
    ("TRAF2 or TRAF6" . SPARSER::COLLECTION)
    ("TRAF6 and TRAF2" . SPARSER::COLLECTION) ("TRAFs" . SPARSER::PROTEIN)
    ("NLRC5-associated Ub" . SPARSER::PROTEIN)
    ("isopeptidase" . SPARSER::PROTEIN) ("IsoT" . SPARSER::PROTEIN)
    ("TRAF2 and TRAF6" . SPARSER::COLLECTION)
    ("the dynamic Ub" . SPARSER::PROTEIN) ("IKK-β–NEMO" . SPARSER::COLLECTION)
    ("pIKK-β" . SPARSER::PROTEIN) ("Ub and NLRC5" . SPARSER::COLLECTION)
    ("NLRC5 underwent polyubiquitination" . SPARSER::PROTEIN)
    ("IKK-β–NLRC5" . SPARSER::COLLECTION) ("NEMO–pIKK-β" . SPARSER::COLLECTION)
    ("NLRC5 and NEMO" . SPARSER::COLLECTION)
    ("IKK-β and pIKK-β" . SPARSER::COLLECTION)
    ("IKK-α and ΙΚΚ-β" . SPARSER::COLLECTION)
    ("NLRC5 and DUBs" . SPARSER::COLLECTION) ("CFL" . SPARSER::PROTEIN)
    ("NLRC5 and IKK-β" . SPARSER::COLLECTION)
    ("USP14, USP18, and USP22" . SPARSER::COLLECTION)
    ("TRAF" . SPARSER::PROTEIN-FAMILY) ("NLRC5–IKK-β" . SPARSER::COLLECTION)
    ("pMs" . SPARSER::PROTEIN) ("Nlrc5" . SPARSER::PROTEIN)
    ("NLRX1, NLRC5, NLRP4, and NLRC3" . SPARSER::COLLECTION)
    ("TLR and RIG-I–like receptor" . SPARSER::COLLECTION)
    ("IKK-α and IKK-β" . SPARSER::COLLECTION)
    ("IKK-α, IKK-β, and NEMO" . SPARSER::COLLECTION)
    ("NF-κB and type I" . SPARSER::COLLECTION) ("NLRs" . SPARSER::PROTEIN)
    ("deubiquitinases and NLRC5" . SPARSER::COLLECTION)
    ("deubiquitinases" . SPARSER::DEUBIQUITINASE)
    ("NLRC5–IκB" . SPARSER::COLLECTION) ("k4" . SPARSER::PROTEIN)
    ("k5" . SPARSER::PROTEIN) ("k1" . SPARSER::PROTEIN)
    ("MD-2" . SPARSER::PROTEIN) ("TRAF5" . SPARSER::PROTEIN)
    ("TRAF3" . SPARSER::PROTEIN) ("CARMA1" . SPARSER::PROTEIN)
    ("NLRC4" . SPARSER::PROTEIN) ("BRCC3" . SPARSER::PROTEIN)
    ("NOD2" . SPARSER::PROTEIN) ("NOD1" . SPARSER::PROTEIN)
    ("B–E" . SPARSER::PROTEIN) ("red 2" . SPARSER::PROTEIN)
    ("k10" . SPARSER::PROTEIN) ("USP22" . SPARSER::PROTEIN)
    ("USP18" . SPARSER::PROTEIN)
    ("major histocompatibility complex" . SPARSER::PROTEIN)
    ("RIG-I–like receptor" . SPARSER::PROTEIN) ("NLRC3" . SPARSER::PROTEIN)
    ("NLRP4" . SPARSER::PROTEIN) ("NLRX1" . SPARSER::PROTEIN)
    ("NLR family" . SPARSER::PROTEIN) ("IKK-β" . SPARSER::PROTEIN)
    ("IKK-α" . SPARSER::PROTEIN) ("RIG-I" . SPARSER::PROTEIN)
    ("NLRC5" . SPARSER::PROTEIN) ("p300 and SIRT2" . SPARSER::COLLECTION)
    ("anti-p300 adenoviral short hairpin RNAs" . SPARSER::RNA)
    ("PEPCK" . SPARSER::PROTEIN) ("K5R" . SPARSER::PROTEIN)
    ("GKRP-KO" . SPARSER::COLLECTION)
    ("ubiquitin and protein" . SPARSER::COLLECTION)
    ("Gln (Q) and Arg (R)" . SPARSER::COLLECTION)
    ("the farnesoid X receptor (FXR) and p53" . SPARSER::COLLECTION)
    ("farnesoid X receptor (FXR)" . SPARSER::PROTEIN)
    ("FXR" . SPARSER::PROTEIN) ("GK- or GKRP-K5R" . SPARSER::COLLECTION)
    ("GKRP-K5R" . SPARSER::PROTEIN-PAIR) ("GK-" . SPARSER::PROTEIN)
    ("GK and GKRP" . SPARSER::COLLECTION) ("GKRP-GK" . SPARSER::COLLECTION)
    ("acetyl-" . SPARSER::MOLECULE)
    ("the aforementioned HDACIs" . SPARSER::MOLECULE)
    ("NAM and TSA" . SPARSER::COLLECTION)
    ("wild-type (WT) GKRP and two GKRP K5 mutants" . SPARSER::COLLECTION)
    ("arginine (Arg, R, and GKRP deacetyl-mimic) or glutamine (Gln, Q, and GKRP acetyl-mimic)"
     . SPARSER::COLLECTION)
    ("Lysines" . SPARSER::AMINO-ACID) ("Flag-p300" . SPARSER::COLLECTION)
    ("p300 and GKRP" . SPARSER::COLLECTION) ("hMOF" . SPARSER::PROTEIN)
    ("PCAF" . SPARSER::PROTEIN)
    ("the histone deacetylase inhibitors (HDACIs) nicotinamide (NAM) and Trichostatin"
     . SPARSER::COLLECTION)
    ("nicotinamide (NAM)" . SPARSER::MOLECULE)
    ("Myc-GKRP" . SPARSER::COLLECTION)
    ("considerable GKRP mRNA" . SPARSER::PROTEIN)
    ("fructose" . SPARSER::PROTEIN) ("glucagon" . SPARSER::PROTEIN)
    ("β-cell-" . SPARSER::PROTEIN) ("GCK" . SPARSER::PROTEIN)
    ("hexose" . SPARSER::MOLECULE) ("GK-GKRP" . SPARSER::COLLECTION)
    ("further inhibiting GK" . SPARSER::PROTEIN) ("GKRP" . SPARSER::PROTEIN)
    ("protein (GKRP)" . SPARSER::PROTEIN) ("glucokinase" . SPARSER::PROTEIN)
    ("GK" . SPARSER::PROTEIN) ("Glucokinase" . SPARSER::PROTEIN)
    ("a 2 " . SPARSER::HUMAN-PROTEIN-FAMILY) ("CCL-2" . SPARSER::PROTEIN)
    ("hSIRT1" . SPARSER::PROTEIN) ("hGCN5" . SPARSER::PROTEIN)
    ("pSG5" . SPARSER::PROTEIN) ("SIRT5" . SPARSER::PROTEIN)
    ("farnesoid X receptor" . SPARSER::PROTEIN)
    ("sirtuin 2" . SPARSER::PROTEIN) ("C646" . SPARSER::MOLECULE)
    ("KAT8" . SPARSER::PROTEIN)
    ("MYST histone acetyltransferase 1" . SPARSER::PROTEIN)
    ("HIV-1 Tat interactive protein" . SPARSER::PROTEIN)
    ("KAT2B" . SPARSER::PROTEIN)
    ("p300/CBP-associated factor" . SPARSER::PROTEIN)
    ("KAT2" . SPARSER::PROTEIN) ("GCN5" . SPARSER::PROTEIN)
    ("leptin receptor" . SPARSER::PROTEIN)
    ("hypoxia inducible factor-1 alpha" . SPARSER::PROTEIN)
    ("SREBP-1c" . SPARSER::PROTEIN) ("β-cell" . SPARSER::PROTEIN)
    ("hexokinase-4" . SPARSER::PROTEIN) ("SIRT2" . SPARSER::PROTEIN)
    ("enzyme and substrate" . SPARSER::COLLECTION)
    ("car" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Talin" . SPARSER::PROTEIN)
    ("talin and vinculin" . SPARSER::COLLECTION)
    ("integrins and actin" . SPARSER::COLLECTION) ("talin" . SPARSER::PROTEIN)
    ("kinase and substrate" . SPARSER::COLLECTION)
    ("substrate and enzyme" . SPARSER::COLLECTION)
    ("actin-" . SPARSER::PROTEIN) ("RhoE" . SPARSER::PROTEIN)
    ("the evolutionarily older ROCK" . SPARSER::PROTEIN-FAMILY)
    ("phosphomimetic activation loop mutants" . SPARSER::MUTANT)
    ("Rho and MRCK" . SPARSER::COLLECTION) ("MRCK" . SPARSER::PROTEIN)
    ("eukaryotic protein kinases" . SPARSER::PROTEIN)
    ("RhoA:ROCK1" . SPARSER::BIO-COMPLEX)
    ("ROCK and RhoA" . SPARSER::COLLECTION)
    ("the two mutated amino acids" . SPARSER::AMINO-ACID)
    ("substrate and kinase" . SPARSER::COLLECTION)
    ("ROCK2 T240A or ROCK2 T240E ( xref )" . SPARSER::COLLECTION)
    ("Many eukaryotic kinases" . SPARSER::KINASE)
    ("the kinase and/or substrate" . SPARSER::COLLECTION)
    ("ROCK1 or ROCK2 and RhoA" . SPARSER::COLLECTION)
    ("ROCK2 and RhoA" . SPARSER::COLLECTION)
    ("LexA and Gal4" . SPARSER::COLLECTION) ("Gal4" . SPARSER::PROTEIN)
    ("GAD-ROCK1" . SPARSER::COLLECTION) ("LexA-RhoA" . SPARSER::COLLECTION)
    ("LexA" . SPARSER::PROTEIN) ("EDTA and Mg 2+" . SPARSER::COLLECTION)
    ("RhoA" . SPARSER::PROTEIN) ("EGFP-RhoA" . SPARSER::COLLECTION)
    ("GMPPNP" . SPARSER::MOLECULE)
    ("ROCK2 and Drosophila" . SPARSER::COLLECTION)
    ("full-length and 60-nm-truncated" . SPARSER::COLLECTION)
    ("wild-type ROCK2 or kinase-dead ROCK2" . SPARSER::COLLECTION)
    ("phalloidin" . SPARSER::MOLECULE) ("static light" . SPARSER::PROTEIN)
    ("ROCK1 and ROCK2" . SPARSER::COLLECTION) ("Fragments" . SPARSER::FRAGMENT)
    ("ROCK1 or ROCK2" . SPARSER::COLLECTION) ("RMLC" . SPARSER::PROTEIN)
    ("regulatory myosin light chain (RMLC)" . SPARSER::PROTEIN)
    ("anchors" . SPARSER::ANCHOR) ("actin and myosin" . SPARSER::COLLECTION)
    ("per 1 " . SPARSER::PROTEIN) ("GAG-POL" . SPARSER::PROTEIN)
    ("CH 3" . SPARSER::MOLECULE) ("MYL12B" . SPARSER::PROTEIN)
    ("exchange factor" . SPARSER::EXCHANGE-FACTOR)
    ("myosin phosphatase" . SPARSER::PROTEIN) ("Cdk2" . SPARSER::PROTEIN)
    ("G-protein-coupled receptor" . SPARSER::PROTEIN)
    ("Rho kinase" . SPARSER::PROTEIN) ("ROCK1" . SPARSER::PROTEIN)
    ("myosin light chain" . SPARSER::PROTEIN) ("ROCK2" . SPARSER::PROTEIN)
    ("NF-κB [ xref ] or p38 MAPK [ xref ]" . SPARSER::COLLECTION)
    ("inhibitor (CKI)" . SPARSER::INHIBITOR)
    ("the multimeric protein complex" . SPARSER::BIO-COMPLEX)
    ("other growth factors or inflammatory cytokines" . SPARSER::COLLECTION)
    ("SB216763 and GSK3β" . SPARSER::COLLECTION)
    ("PKC/PI3K/Akt" . SPARSER::COLLECTION)
    ("β-catenin-LEF/TCF" . SPARSER::COLLECTION)
    ("both the pharmacological inhibitor LiCl and the specific inhibitor SB216763"
     . SPARSER::COLLECTION)
    ("PI3K/-Akt" . SPARSER::COLLECTION)
    ("LiCl and SB216763" . SPARSER::COLLECTION)
    ("LiCl or 10μM" . SPARSER::COLLECTION)
    ("hypertrophic chondrocytes" . SPARSER::PROTEIN)
    ("LiCl and 10μM" . SPARSER::COLLECTION)
    ("γH2AX and growth arrest and DNA damage–inducible protein 45β ( GADD45β )"
     . SPARSER::COLLECTION)
    ("MetS" . SPARSER::PROTEIN) ("global GSK3-α" . SPARSER::PROTEIN)
    ("this maturational arrested state" . SPARSER::BIO-STATE)
    ("IKKα and MMP-10" . SPARSER::COLLECTION)
    ("γH2AX, GADD45β and p21" . SPARSER::COLLECTION)
    ("LiCl or SB216763" . SPARSER::COLLECTION)
    ("diacetate" . SPARSER::MOLECULE) ("deoxyguanosine" . SPARSER::MOLECULE)
    ("β gal" . SPARSER::PROTEIN) ("β Gal" . SPARSER::PROTEIN)
    ("transcript 2" . SPARSER::PROTEIN) ("MMP10" . SPARSER::PROTEIN)
    ("IgG2" . SPARSER::BIO-COMPLEX) ("GSK3-α" . SPARSER::PROTEIN)
    ("MMP-10" . SPARSER::PROTEIN) ("IKKα" . SPARSER::PROTEIN)
    ("β galactosidase" . SPARSER::PROTEIN) ("SB216763" . SPARSER::DRUG)
    ("FLT3 and PI3-K" . SPARSER::COLLECTION)
    ("STAT5 and JAK" . SPARSER::COLLECTION)
    ("TKR and cytokine" . SPARSER::COLLECTION)
    ("STAT5 and AKT" . SPARSER::COLLECTION)
    ("hypoxia and normoxia" . SPARSER::COLLECTION)
    ("EGF-R and KIT" . SPARSER::COLLECTION)
    ("the respective receptors" . SPARSER::PROTEIN)
    ("EGF-R and Epo-R" . SPARSER::COLLECTION)
    ("other tyrosine kinase receptors (TKR) and cytokine receptors"
     . SPARSER::COLLECTION)
    ("receptors (TKR)" . SPARSER::RECEPTOR)
    ("EGF-R, c-KIT and Epo-R" . SPARSER::COLLECTION) ("TKR" . SPARSER::PROTEIN)
    ("CBL" . SPARSER::PROTEIN) ("OCI-AML5" . SPARSER::PROTEIN-PAIR)
    ("CMK" . SPARSER::PROTEIN) ("the mutational state" . SPARSER::BIO-STATE)
    ("its mutational state" . SPARSER::BIO-STATE)
    ("HIF-1 alpha" . SPARSER::PROTEIN)
    ("Heat shock Protein 90" . SPARSER::PROTEIN)
    ("phosphatidylinositide 3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("–3 " . SPARSER::PROTEIN) ("a 20 " . SPARSER::PROTEIN)
    ("Epo-R" . SPARSER::PROTEIN) ("EGF-R" . SPARSER::PROTEIN)
    ("C-kit" . SPARSER::PROTEIN) ("FLT3-L" . SPARSER::PROTEIN)
    ("PI-3K" . SPARSER::HUMAN-PROTEIN-FAMILY) ("EGFRviii" . SPARSER::PROTEIN)
    ("overactive aberrant Ras" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Overactive Ras" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("EGFR, FGFR and PDGFR" . SPARSER::COLLECTION)
    ("EGFR, NF-1 and Ras" . SPARSER::COLLECTION) ("NF-1" . SPARSER::PROTEIN)
    ("Sprouty" . SPARSER::PROTEIN-FAMILY)
    ("RasGAP and GTP" . SPARSER::COLLECTION)
    ("RasGAPs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Grb2/SOS" . SPARSER::COLLECTION)
    ("Son of Sevenless (SOS)" . SPARSER::PROTEIN) ("SOS" . SPARSER::PROTEIN)
    ("Alpha7 neuronal nicotinic acetylcholine receptors" . SPARSER::RECEPTOR)
    ("Ras-pY32" . SPARSER::COLLECTION) ("SHP2 and Ki67" . SPARSER::COLLECTION)
    ("phosphorylated SHP2 and downstream phosphorylated ERK and AKT ( xref )"
     . SPARSER::COLLECTION)
    ("Flag-N-Ras(WT)" . SPARSER::COLLECTION)
    ("a dominant-negative Flag-SHP2(C459S) mutant" . SPARSER::MUTANT)
    ("Flag-N-Ras(Y32F) phosphorylation-defective mutant" . SPARSER::MUTANT)
    ("glial fibrillary acidic protein (GFAP)" . SPARSER::PROTEIN)
    ("H-Ras(12V) and effector Raf:RBD" . SPARSER::COLLECTION)
    ("U87 and RasB8p3" . SPARSER::COLLECTION)
    ("Src/Yes/Fyn (SYF)-triple knockout MEFs" . SPARSER::PROTEIN)
    ("Ras and SHP2" . SPARSER::COLLECTION)
    ("Flag-SHP2(WT)" . SPARSER::COLLECTION)
    ("Flag-N-Ras" . SPARSER::COLLECTION) ("Flag-SHP2" . SPARSER::COLLECTION)
    ("Ras/pERK" . SPARSER::COLLECTION) ("SHP2 and ERK" . SPARSER::COLLECTION)
    ("post-EGF and II-B08" . SPARSER::COLLECTION) ("viii" . SPARSER::PROTEIN)
    ("U87-viii" . SPARSER::COLLECTION) ("PHPs1" . SPARSER::PROTEIN)
    ("HA-H-Ras" . SPARSER::COLLECTION) ("RasB" . SPARSER::PROTEIN)
    ("SHP2 and Ras" . SPARSER::COLLECTION)
    ("GST-H-Ras(WT)" . SPARSER::COLLECTION) ("GST-H-Ras" . SPARSER::COLLECTION)
    ("GST-SHP2" . SPARSER::COLLECTION)
    ("dominant-negative SHP2" . SPARSER::PROTEIN)
    ("a catalytically dead SHP2(C459S) dominant-negative mutant allele"
     . SPARSER::ALLELE)
    ("PHPs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a specific cell-permeable SHP2 inhibitor" . SPARSER::INHIBITOR)
    ("N-Ras(WT)" . SPARSER::PROTEIN) ("HA-N-Ras" . SPARSER::COLLECTION)
    ("Raf and Ras" . SPARSER::COLLECTION)
    ("The ubiquitous tyrosine phosphatase SHP2" . SPARSER::PROTEIN)
    ("epidermal growth factor receptor (EGFR) and platelet-derived growth factor receptor (PDGFR)"
     . SPARSER::COLLECTION)
    ("receptor (PDGFR)" . SPARSER::RECEPTOR)
    ("hyperactive receptor tyrosine kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("phosphatidylinositol 3-kinase/Akt" . SPARSER::COLLECTION)
    ("the otherwise ‘normal' Ras" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("‘ON'" . SPARSER::PROTEIN)
    ("highly related 188–189 amino-acid proteins" . SPARSER::PROTEIN)
    ("receptor and non-receptor" . SPARSER::COLLECTION)
    ("HRas , NRas and KRas" . SPARSER::COLLECTION) ("NRas" . SPARSER::PROTEIN)
    ("Mek/Erk" . SPARSER::COLLECTION)
    ("Ras and a potential therapeutic target" . SPARSER::COLLECTION)
    ("a previously ‘undruggable' oncogenic or hyperactive Ras"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("hyperactive Ras" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("normal astrocytes" . SPARSER::PROTEIN) ("-prone" . SPARSER::COLLECTION)
    ("Ras/ERK/MAPK" . SPARSER::COLLECTION)
    ("β-Mercaptoethanol" . SPARSER::MOLECULE)
    ("Protein tyrosine phosphatase" . SPARSER::PROTEIN)
    ("CA5" . SPARSER::PROTEIN) ("vitamin A" . SPARSER::MOLECULE)
    ("Alpha7" . SPARSER::PROTEIN)
    ("glial fibrillary acidic protein" . SPARSER::PROTEIN)
    ("Ras-binding" . SPARSER::PROTEIN)
    ("nucleotide exchange factors" . SPARSER::NUCLEOTIDE-EXCHANGE-FACTOR)
    ("PCM1-" . SPARSER::PROTEIN) ("centrin" . SPARSER::PROTEIN)
    ("CS-associated OFD1" . SPARSER::PROTEIN)
    ("cellular macromolecules" . SPARSER::MOLECULE)
    ("both negative and positive regulators" . SPARSER::REGULATOR)
    ("MK2-" . SPARSER::PROTEIN)
    ("the centrosomal fraction" . SPARSER::COMPONENT)
    ("centrosomal CEP131" . SPARSER::PROTEIN)
    ("CEP131 and SSX2IP" . SPARSER::COLLECTION)
    ("PCM1, CEP290 and SSX2IP" . SPARSER::COLLECTION)
    ("both CEP131 as well as other CS components" . SPARSER::COLLECTION)
    ("14-3-3/CEP131" . SPARSER::COLLECTION) ("intact CS" . SPARSER::PROTEIN)
    ("MK2 or 14-3-3" . SPARSER::COLLECTION)
    ("CEP131 and other CS components" . SPARSER::COLLECTION)
    ("14-3-3–CEP131" . SPARSER::COLLECTION)
    ("p38, MK2 and HSP27" . SPARSER::COLLECTION)
    ("14-3-3-binding-deficient S47A/S78A allele" . SPARSER::ALLELE)
    ("PCM1 and 14-3-3" . SPARSER::COLLECTION)
    ("14-3-3-CEP131" . SPARSER::COLLECTION)
    ("CEP131 and PCM1" . SPARSER::COLLECTION) ("Difopein" . SPARSER::PROTEIN)
    ("14-3-3/protein" . SPARSER::COLLECTION)
    ("FLAG-Difopein" . SPARSER::COLLECTION) ("Peptide" . SPARSER::PEPTIDE)
    ("promoting ultraviolet-induced CS" . SPARSER::PROTEIN)
    ("GFP-CEP131" . SPARSER::COLLECTION)
    ("14-3-3 and other CS components" . SPARSER::COLLECTION)
    ("GFP-14-3-3" . SPARSER::COLLECTION)
    ("14-3-3 and CEP131" . SPARSER::COLLECTION)
    ("CEP131 and 14-3-3" . SPARSER::COLLECTION)
    ("CEP131/14-3-3" . SPARSER::COLLECTION)
    ("GST-14-3-3" . SPARSER::COLLECTION)
    ("heterodimeric complexes" . SPARSER::BIO-COMPLEX)
    ("CEP131-F3" . SPARSER::COLLECTION)
    ("a generic phospho-specific antibody" . SPARSER::ANTIBODY)
    ("anisomycin" . SPARSER::DRUG) ("p38-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p38 and MK2" . SPARSER::COLLECTION)
    ("stress-induced CS" . SPARSER::PROTEIN)
    ("CEP131, PCM1 and SSX2IP" . SPARSER::COLLECTION)
    ("p38 or MK2" . SPARSER::COLLECTION) ("p38-MK2" . SPARSER::COLLECTION)
    ("a major CS-associated substrate" . SPARSER::SUBSTRATE)
    ("ultraviolet-induced CS" . SPARSER::PROTEIN)
    ("p38 and its downstream kinase MK2 (MAPKAPK2)" . SPARSER::COLLECTION)
    ("MAPK-activated protein kinase" . SPARSER::COLLECTION)
    ("ultraviolet light" . SPARSER::PROTEIN)
    ("PCM1 and CEP290" . SPARSER::COLLECTION) ("AZI" . SPARSER::PROTEIN)
    ("dynamic CS" . SPARSER::PROTEIN) ("MK2 and 14-3-3" . SPARSER::COLLECTION)
    ("new CS" . SPARSER::PROTEIN)
    ("a substrate of the p38 effector kinase MK2 and pinpoint S47 and S78"
     . SPARSER::COLLECTION)
    ("specifically targets CEP131" . SPARSER::PROTEIN)
    ("p38-MK2-14-3-3" . SPARSER::COLLECTION) ("CS" . SPARSER::PROTEIN)
    ("γ-tubulin" . SPARSER::PROTEIN) ("T-rex" . SPARSER::PROTEIN-FAMILY)
    ("E7S" . SPARSER::PROTEIN-FAMILY) ("BBS4" . SPARSER::PROTEIN)
    ("GADD45" . SPARSER::PROTEIN) ("HSP27" . SPARSER::PROTEIN)
    ("SSX2" . SPARSER::PROTEIN) ("MAPKAPK2" . SPARSER::PROTEIN)
    ("OFD1" . SPARSER::PROTEIN) ("CEP290" . SPARSER::PROTEIN)
    ("PCM1" . SPARSER::PROTEIN)
    ("Mitogen-Activated Protein Kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CEP131" . SPARSER::PROTEIN) ("MK2" . SPARSER::PROTEIN)
    ("Son" . SPARSER::PROTEIN) ("LKB1/AMPK" . SPARSER::COLLECTION)
    ("PCa and Xu" . SPARSER::COLLECTION)
    ("an innovative biomarker" . SPARSER::MOLECULE)
    ("estradiol-17β" . SPARSER::MOLECULE) ("LKB1- AMPK" . SPARSER::PROTEIN)
    ("Liver kinase B1" . SPARSER::PROTEIN)
    ("AMPKα/AMPKβ" . SPARSER::COLLECTION)
    ("AICAR and A769662" . SPARSER::COLLECTION)
    ("the latter substrates" . SPARSER::SUBSTRATE)
    ("ACC/Raptor" . SPARSER::COLLECTION) ("NEMO/IKKγ" . SPARSER::COLLECTION)
    ("AMPKα2" . SPARSER::PROTEIN) ("Snf1 and AMPKα" . SPARSER::COLLECTION)
    ("A769662 and rapamycin" . SPARSER::COLLECTION)
    ("rapamycin or both" . SPARSER::COLLECTION)
    ("PIAS4 using lentiviral transduction of two independent short hairpin RNAs ( xref , shPIAS4-5 or shPIAS4-8) and thereafter activated AMPK using A769662"
     . SPARSER::COLLECTION)
    ("AMPKα and AMPKβ" . SPARSER::COLLECTION) ("FK" . SPARSER::MOLECULE)
    ("bacterially produced AMPK complex (α1, β1 and γ1) and GST–PIAS4"
     . SPARSER::COLLECTION)
    ("β1 and γ1" . SPARSER::COLLECTION)
    ("UBC9 (siUBC9) or PIAS4 (siPIAS4)" . SPARSER::COLLECTION)
    ("GST–AMPKα2" . SPARSER::PROTEIN-PAIR) ("GST–AMPKα1" . SPARSER::COLLECTION)
    ("PIAS4−" . SPARSER::PROTEIN)
    ("AMPKα1 ( xref , left panels) or AMPKα2 ( xref , left panels)"
     . SPARSER::COLLECTION)
    ("N-ethylmaleimide (NEM)" . SPARSER::MOLECULE) ("SAMS" . SPARSER::PROTEIN)
    ("immunoprecipitated AMPKα1 from control (siNT) or PIAS4-depleted (siPias4) MEFs"
     . SPARSER::COLLECTION)
    ("GST–TSC2" . SPARSER::COLLECTION)
    ("Flag- and Flag–PIAS4-transfected" . SPARSER::COLLECTION)
    ("Flag-" . SPARSER::PROTEIN-FAMILY)
    ("50 nM rapamycin or both" . SPARSER::COLLECTION)
    ("Flag–PIAS4" . SPARSER::COLLECTION)
    ("PIAS4 and TSC2" . SPARSER::COLLECTION)
    ("TSC2 or Raptor" . SPARSER::COLLECTION)
    ("p-ACC, and Pias4" . SPARSER::COLLECTION) ("–AICAR" . SPARSER::COLLECTION)
    ("AMPKα1 and TSC2" . SPARSER::COLLECTION)
    ("AMPK/SNF1" . SPARSER::COLLECTION)
    ("AMPKα, ACC and S6K" . SPARSER::COLLECTION) ("Mth1" . SPARSER::PROTEIN)
    ("Mms21" . SPARSER::PROTEIN)
    ("AMPKα1- and AMPKα2-specific antibodies ( xref )" . SPARSER::COLLECTION)
    ("AMPKα1-" . SPARSER::PROTEIN)
    ("antidiabetic biguanides" . SPARSER::MOLECULE)
    ("unspecific AMPK activator metformin or phenformin" . SPARSER::COLLECTION)
    ("metformin or phenformin" . SPARSER::COLLECTION)
    ("AMPK and TSC2" . SPARSER::COLLECTION) ("biguanides" . SPARSER::MOLECULE)
    ("phenformin" . SPARSER::DRUG) ("ACC and Raptor" . SPARSER::COLLECTION)
    ("p-Raptor" . SPARSER::COLLECTION) ("p-AMPKα" . SPARSER::COLLECTION)
    ("p-S6K/S6K" . SPARSER::COLLECTION)
    ("eIF4E binding protein 1 (4EBP1) and ribosomal protein S6 (S6)"
     . SPARSER::COLLECTION)
    ("mTORC1 substrates p70 S6 kinase (S6K), eIF4E binding protein 1 (4EBP1) and ribosomal protein S6 (S6)"
     . SPARSER::COLLECTION)
    ("Pias2 and Pias3" . SPARSER::COLLECTION) ("Pias4" . SPARSER::PROTEIN)
    ("Pias3" . SPARSER::PROTEIN) ("Pias2" . SPARSER::PROTEIN)
    ("Pias" . SPARSER::PROTEIN-FAMILY) ("GST–PIAS4" . SPARSER::COLLECTION)
    ("GST–PIAS3" . SPARSER::COLLECTION)
    ("AMPKα1 or AMPKα2" . SPARSER::COLLECTION)
    ("PIAS3 and PIAS4" . SPARSER::COLLECTION)
    ("PIAS1 or PIASx" . SPARSER::COLLECTION)
    ("PIAS4/PIASy" . SPARSER::COLLECTION) ("PIASx/PIAS2" . SPARSER::COLLECTION)
    ("PIASx" . SPARSER::PROTEIN) ("PIAS" . SPARSER::PROTEIN-FAMILY)
    ("AMPKα1–mTORC1" . SPARSER::COLLECTION)
    ("Sip" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Sestrin1 and Sestrin2" . SPARSER::COLLECTION)
    ("Cidea" . SPARSER::PROTEIN) ("AMPKα1 and AMPKα2" . SPARSER::COLLECTION)
    ("a heterotrimeric complex" . SPARSER::BIO-COMPLEX)
    ("AMPKβ and AMPKγ" . SPARSER::COLLECTION)
    ("fatty acid and protein synthesis xref" . SPARSER::COLLECTION)
    ("protein and fatty acid" . SPARSER::COLLECTION)
    ("PIAS4 and its SUMO E3 ligase activity" . SPARSER::COLLECTION)
    ("fatty acid and protein synthesis" . SPARSER::COLLECTION)
    ("P81" . SPARSER::PROTEIN) ("L -arabinose" . SPARSER::MOLECULE)
    ("SF-1" . SPARSER::PROTEIN) ("IKKγ" . SPARSER::PROTEIN)
    ("UBC9" . SPARSER::PROTEIN) ("N-ethylmaleimide" . SPARSER::MOLECULE)
    ("Ubc9" . SPARSER::PROTEIN) ("p-ACC" . SPARSER::PROTEIN)
    ("p-S6K" . SPARSER::PROTEIN) ("PIAS2" . SPARSER::PROTEIN)
    ("PIAS1" . SPARSER::PROTEIN) ("PIAS3" . SPARSER::PROTEIN)
    ("TRIP6" . SPARSER::PROTEIN) ("GAL4" . SPARSER::PROTEIN)
    ("MAGE-A3" . SPARSER::PROTEIN) ("Snf1" . SPARSER::PROTEIN-FAMILY)
    ("SNF1" . SPARSER::PROTEIN-FAMILY) ("Sestrin2" . SPARSER::PROTEIN)
    ("Sestrin1" . SPARSER::PROTEIN) ("KSR2" . SPARSER::PROTEIN)
    ("AMPKβ" . SPARSER::PROTEIN) ("tuberous sclerosis 2" . SPARSER::PROTEIN)
    ("A769662" . SPARSER::DRUG) ("AMPKα" . SPARSER::PROTEIN-FAMILY)
    ("PIAS4" . SPARSER::PROTEIN)
    ("the TLR4 protein ( xref ) and the protein" . SPARSER::COLLECTION)
    ("Erk and SAPK/JNK proteins" . SPARSER::COLLECTION)
    ("TLR5/caveolin-1" . SPARSER::COLLECTION)
    ("TLR4/caveolin-1" . SPARSER::COLLECTION)
    ("TLR5/MyD88" . SPARSER::COLLECTION)
    ("TLR1, TLR2, TLR4, TLR5, and TLR7" . SPARSER::COLLECTION)
    ("mature mRNA" . SPARSER::PROTEIN)
    ("TLR4 and other TLRs, mRNA and proteins" . SPARSER::COLLECTION)
    ("TLRs, mRNA and proteins" . SPARSER::COLLECTION)
    ("caveolin-1 and TLR5" . SPARSER::COLLECTION)
    ("SAPK/JNK" . SPARSER::COLLECTION) ("p-SAPK/JNK" . SPARSER::COLLECTION)
    ("p-Erk" . SPARSER::COLLECTION)
    ("TLR5, TLR4, and caveolin-1" . SPARSER::COLLECTION)
    ("caveolin-1 and TLR4" . SPARSER::COLLECTION)
    ("caveolin-1, TLR4, and TLR5" . SPARSER::COLLECTION)
    ("TLR5 and caveolin-1" . SPARSER::COLLECTION)
    ("membrane receptors and their ligands ( xref )" . SPARSER::COLLECTION)
    ("caveolin-1/TLR5" . SPARSER::COLLECTION)
    ("the most well-known receptors" . SPARSER::PROTEIN)
    ("microbial flagellin" . SPARSER::PROTEIN) ("flagellin" . SPARSER::PROTEIN)
    ("TLR1" . SPARSER::PROTEIN) ("Erk1" . SPARSER::PROTEIN)
    ("TLR5" . SPARSER::PROTEIN) ("BRCA1 and 53BP1" . SPARSER::COLLECTION)
    ("refs" . SPARSER::PROTEIN) ("calbindin" . SPARSER::PROTEIN)
    ("extrasynaptic NMDA receptors" . SPARSER::RECEPTOR)
    ("LTP" . SPARSER::PROTEIN) ("patch-clamp" . SPARSER::PROTEIN-FAMILY)
    ("biocytin" . SPARSER::DRUG) ("BRCA1 and pERK1/2" . SPARSER::COLLECTION)
    ("extrasynaptic NMDARs" . SPARSER::PROTEIN) ("NMDARs" . SPARSER::PROTEIN)
    ("exploration-induced neuronal DSBs" . SPARSER::PROTEIN)
    ("NMDA" . SPARSER::MOLECULE) ("Neuronal BRCA1" . SPARSER::PROTEIN)
    ("doublecortin" . SPARSER::PROTEIN)
    ("hippocampal BRCA1" . SPARSER::PROTEIN)
    ("neuronal activity transiently increase neuronal DSBs" . SPARSER::PROTEIN)
    ("53BP1 and γH2A" . SPARSER::COLLECTION)
    ("reduced neuronal BRCA1" . SPARSER::PROTEIN)
    ("BRCA1 knockdown increases neuronal DSBs" . SPARSER::PROTEIN)
    ("amyloid" . SPARSER::PROTEIN) ("CA1 and CA3" . SPARSER::COLLECTION)
    ("CA1" . SPARSER::PROTEIN) ("a Huntington's" . SPARSER::PROTEIN)
    ("Striatal BRCA1" . SPARSER::PROTEIN)
    ("nuclease activity around DSBs" . SPARSER::PROTEIN)
    ("MRE11, NBS1 and RAD51" . SPARSER::COLLECTION) ("DG" . SPARSER::PROTEIN)
    ("gyrus (DG)" . SPARSER::PROTEIN) ("hAPP-J20" . SPARSER::COLLECTION)
    ("neuronal DSBs" . SPARSER::PROTEIN)
    ("predominantly extrasynaptic N -methyl- D -aspartate receptors"
     . SPARSER::RECEPTOR)
    ("neuronal BRCA1" . SPARSER::PROTEIN) ("hAPP" . SPARSER::PROTEIN)
    ("glutamate receptor" . SPARSER::PROTEIN) ("MgSO 4" . SPARSER::DRUG)
    ("N -acetyl- L -cysteine" . SPARSER::MOLECULE)
    ("N -methyl- D -glucamine" . SPARSER::MOLECULE)
    ("P42/44" . SPARSER::PROTEIN) ("phospholipase A2" . SPARSER::PROTEIN)
    ("Lys9" . SPARSER::PROTEIN) ("N-methyl-D-aspartate" . SPARSER::MOLECULE)
    ("microtubule-associated protein 2" . SPARSER::PROTEIN)
    ("CA3" . SPARSER::PROTEIN) ("nuclease activity" . SPARSER::PROTEIN)
    ("β 1" . SPARSER::PROTEIN) ("J20" . SPARSER::PROTEIN)
    ("N -methyl- D -aspartate" . SPARSER::MOLECULE)
    ("Amyloid-β" . SPARSER::MOLECULE)
    ("amyloid precursor protein" . SPARSER::PROTEIN)
    ("the Ddb1 (Chromosome 19) or Trp53 (Chromosome 11) genes"
     . SPARSER::COLLECTION)
    ("Ddb1 and Cdkn1" . SPARSER::COLLECTION) ("Cdkn1" . SPARSER::PROTEIN)
    ("exogenous DDB1" . SPARSER::PROTEIN)
    ("p53 -/- or p21 -/-" . SPARSER::COLLECTION)
    ("Cul-DDB1" . SPARSER::PROTEIN-PAIR) ("Cul4-DDB1" . SPARSER::COLLECTION)
    ("both p21 and phospo-p53" . SPARSER::COLLECTION)
    ("phospo-p53" . SPARSER::COLLECTION)
    ("total p53 western blot" . SPARSER::PROTEIN) ("b" . SPARSER::PROTEIN)
    ("ddb1" . SPARSER::PROTEIN)
    ("the targeted alleles and histocompatibility alleles"
     . SPARSER::COLLECTION)
    ("vprbp" . SPARSER::PROTEIN) ("dda" . SPARSER::DRUG)
    ("ddb" . SPARSER::DRUG) ("vav-Cre" . SPARSER::COLLECTION)
    ("vav" . SPARSER::PROTEIN) ("CUL4B-DDB1" . SPARSER::COLLECTION)
    ("CUL4A-DDB1" . SPARSER::COLLECTION)
    ("p53 and phosphor-p53 and p21" . SPARSER::COLLECTION)
    ("phosphor-p53 and p21" . SPARSER::COLLECTION)
    ("b-actin" . SPARSER::COLLECTION)
    ("VprBP and DCAF11" . SPARSER::COLLECTION)
    ("Cul4 or Cul4A/4B" . SPARSER::COLLECTION)
    ("CUL4A and CUL4B" . SPARSER::COLLECTION)
    ("\"CUL4-DDB1" . SPARSER::COLLECTION)
    ("CUL4-DDB1-DCAF" . SPARSER::COLLECTION)
    ("Vprbp and DCAF11" . SPARSER::COLLECTION) ("Vprbp" . SPARSER::PROTEIN)
    ("the previous identified substrates" . SPARSER::SUBSTRATE)
    ("IKZF1 and IKZF3" . SPARSER::COLLECTION) ("CRBN" . SPARSER::PROTEIN)
    ("p27 kip1 and the CUL4-DDB1 complex" . SPARSER::COLLECTION)
    ("a CDK and cell cycle inhibitor" . SPARSER::COLLECTION)
    ("PR-set7" . SPARSER::COLLECTION)
    ("c-JUN and Cdkn1a" . SPARSER::COLLECTION)
    ("CDT1 and p27 Kip1" . SPARSER::COLLECTION)
    ("the quiescent HSCs" . SPARSER::PROTEIN)
    ("the multipotent progenitor (MPP) fraction" . SPARSER::COMPONENT)
    ("Cre-" . SPARSER::PROTEIN) ("adult and fetal HSPCs" . SPARSER::PROTEIN)
    ("both LSK and Lineage neg c-Kit + HSPC ( xref )" . SPARSER::COLLECTION)
    ("Nanog-GFP" . SPARSER::COLLECTION)
    ("VprBP and DDB1" . SPARSER::COLLECTION) ("DDA" . SPARSER::DRUG)
    ("VprBP" . SPARSER::PROTEIN) ("CUL4A and proteins" . SPARSER::COLLECTION)
    ("HA/Flag" . SPARSER::COLLECTION) ("StrepII/Flag" . SPARSER::COLLECTION)
    ("Cul4 and DDB1" . SPARSER::COLLECTION)
    ("a potent CDK and cell cycle inhibitor" . SPARSER::COLLECTION)
    ("the Cdkn1a cip1 protein, a potent CDK and cell cycle inhibitor"
     . SPARSER::COLLECTION)
    ("cip1" . SPARSER::PROTEIN) ("cip" . SPARSER::PROTEIN)
    ("BrdU and DAPI" . SPARSER::COLLECTION) ("CFSE" . SPARSER::DRUG)
    ("anti-CD3/CD28" . SPARSER::COLLECTION) ("CD4/CD8" . SPARSER::COLLECTION)
    ("::Ddb1" . SPARSER::BIO-COMPLEX) ("ST-HSCs" . SPARSER::COLLECTION)
    ("LT-" . SPARSER::PROTEIN) ("LT" . SPARSER::PROTEIN)
    ("AnnexinV " . SPARSER::PROTEIN) ("competitive BMT" . SPARSER::PROTEIN)
    ("AnnexinV" . SPARSER::PROTEIN) ("BMT" . SPARSER::PROTEIN)
    ("methylcellulose" . SPARSER::DRUG)
    ("HSPCs and their downstream progeny" . SPARSER::COLLECTION)
    ("ST-" . SPARSER::PROTEIN) ("MPPs" . SPARSER::PROTEIN)
    ("CD150 and CD48" . SPARSER::COLLECTION) ("SLAM" . SPARSER::PROTEIN)
    ("MP and LSK" . SPARSER::COLLECTION) ("Angpt1" . SPARSER::PROTEIN)
    ("LSK and cKit" . SPARSER::COLLECTION)
    ("Mature lymphoid" . SPARSER::PROTEIN) ("::Vav1Cre" . SPARSER::BIO-COMPLEX)
    ("Itch ( xref ) and c-Cbl ( xref )" . SPARSER::COLLECTION)
    ("LSK" . SPARSER::PROTEIN) ("cKit" . SPARSER::PROTEIN)
    ("HSPC" . SPARSER::PROTEIN) ("Cul4b" . SPARSER::PROTEIN)
    ("Cul4a" . SPARSER::PROTEIN) ("IKZF1 and IKF3" . SPARSER::COLLECTION)
    ("the cell cycle inhibitor p27 Kip1 ( xref ) and Cdkn1a Cip1 ( xref ; xref )"
     . SPARSER::COLLECTION)
    ("Cip1" . SPARSER::PROTEIN) ("CUL4-DDB1 " . SPARSER::COLLECTION)
    ("DCAF" . SPARSER::PROTEIN) ("CUL4A or CUL4B" . SPARSER::COLLECTION)
    ("OCT4 and NANOG" . SPARSER::COLLECTION) ("Huwe1" . SPARSER::PROTEIN)
    ("HECT" . SPARSER::PROTEIN) ("Itch and c-Cbl" . SPARSER::COLLECTION)
    ("Itch" . SPARSER::PROTEIN)
    ("an E2 ubiquitin conjugating enzyme and an E3 ubiquitin ligase ( xref )"
     . SPARSER::COLLECTION)
    ("enzyme, an E2 ubiquitin conjugating enzyme and an E3 ubiquitin ligase ( xref )"
     . SPARSER::COLLECTION)
    ("three sequential enzymes" . SPARSER::ENZYME)
    ("cell cycle regulators ( xref ) and metabolic pathways ( xref )"
     . SPARSER::COLLECTION)
    ("a novel post-translational regulator" . SPARSER::REGULATOR)
    ("DDB1 and distinct DCAFs" . SPARSER::COLLECTION)
    ("CUL4-DDB1" . SPARSER::COLLECTION) ("Ddb1" . SPARSER::PROTEIN)
    ("Ddb" . SPARSER::DRUG) ("Chromosome 17" . SPARSER::PROTEIN)
    ("pI- pC" . SPARSER::PROTEIN) ("G-I" . SPARSER::PROTEIN)
    ("p21cip1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("CRL4" . SPARSER::PROTEIN)
    ("Cul4A" . SPARSER::PROTEIN) ("DCAF1" . SPARSER::PROTEIN)
    ("A20" . SPARSER::PROTEIN) ("C11" . SPARSER::PROTEIN)
    ("NK1.1" . SPARSER::PROTEIN) ("B8)" . SPARSER::PROTEIN)
    ("c-kit" . SPARSER::PROTEIN) ("IKZF3" . SPARSER::PROTEIN)
    ("set7" . SPARSER::HUMAN-PROTEIN-FAMILY) ("CDT1" . SPARSER::PROTEIN)
    ("DCAF7" . SPARSER::PROTEIN) ("Sox17" . SPARSER::PROTEIN)
    ("Meox1" . SPARSER::PROTEIN) ("IFNα" . SPARSER::PROTEIN)
    ("Thy1" . SPARSER::PROTEIN) ("Vav1" . SPARSER::PROTEIN)
    ("CD48" . SPARSER::PROTEIN) ("CD150" . SPARSER::PROTEIN)
    ("DDB  1" . SPARSER::PROTEIN) ("Cul4" . SPARSER::PROTEIN)
    ("Epe1" . SPARSER::PROTEIN) ("PR-Set7" . SPARSER::PROTEIN)
    ("Cdt1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("DDB1 " . SPARSER::PROTEIN)
    ("RING finger protein" . SPARSER::PROTEIN) ("CUL4B" . SPARSER::PROTEIN)
    ("CUL4A" . SPARSER::PROTEIN) ("DDB2" . SPARSER::PROTEIN)
    ("Cullin4" . SPARSER::PROTEIN)
    ("DNA damage binding protein 1" . SPARSER::PROTEIN)
    ("ubiquitin conjugating enzyme" . SPARSER::PROTEIN-FAMILY)
    ("DDB1" . SPARSER::PROTEIN) ("CUL4" . SPARSER::PROTEIN)
    ("AKT and ARRP19" . SPARSER::COLLECTION) ("MEK-MAPK" . SPARSER::COLLECTION)
    ("this western blot" . SPARSER::PROTEIN)
    ("GSK3 and AKT" . SPARSER::COLLECTION)
    ("AKT and ARPP19" . SPARSER::COLLECTION)
    ("the mitosis-regulatory kinase Greatwall (GWL)" . SPARSER::PROTEIN)
    ("Greatwall (GWL)" . SPARSER::PROTEIN)
    ("the first oncogenic mitotic protein" . SPARSER::PROTEIN)
    ("AKT " . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ARPP19/ENSA" . SPARSER::COLLECTION) ("PP2AB55" . SPARSER::PROTEIN)
    ("hTERT and large-T antigen" . SPARSER::COLLECTION)
    ("ENSA-PP2AB55" . SPARSER::PROTEIN-PAIR)
    ("at least a 20" . SPARSER::PROTEIN) ("SCF-βTrCP" . SPARSER::COLLECTION)
    ("GWL, ARPP19 or ENSA" . SPARSER::COLLECTION)
    ("SW480 and MDA-MB-231 cells" . SPARSER::COLLECTION)
    ("Antibody" . SPARSER::PROTEIN) ("-shRNA" . SPARSER::COLLECTION)
    ("control shRNA (SH LUC) or GWL shRNA (SH GWL)" . SPARSER::COLLECTION)
    ("GWL or D3H2LN" . SPARSER::COLLECTION) ("LUC" . SPARSER::PROTEIN)
    ("particularly K72M GWL" . SPARSER::PROTEIN)
    ("telomerase reverse transcriptase (hTERT) and SV40 large T antigen ( xref )"
     . SPARSER::COLLECTION)
    ("FACs" . SPARSER::PROTEIN)
    ("hyperactive kinase (K72M) or kinase dead (G44S) GWL"
     . SPARSER::COLLECTION)
    ("RAS-RAF-MAPK" . SPARSER::COLLECTION)
    ("AKT and mitotic-activated protein kinase (MAPK)" . SPARSER::COLLECTION)
    ("AKT and mitotic-activated protein kinase" . SPARSER::COLLECTION)
    ("cyclinB-CDK1" . SPARSER::COLLECTION)
    ("originally named Microtubule-Associated Serine Threonine Kinase"
     . SPARSER::KINASE)
    ("MASTL" . SPARSER::PROTEIN) ("Threonine" . SPARSER::AMINO-ACID)
    ("ARPP19 and ENSA" . SPARSER::COLLECTION) ("ENSA" . SPARSER::PROTEIN)
    ("cyclinB-cyclin-dependent kinase 1" . SPARSER::COLLECTION)
    ("cyclinB" . SPARSER::PROTEIN) ("Vera" . SPARSER::PROTEIN)
    ("the Greatwall (GWL) kinase and its substrates endosulfines"
     . SPARSER::COLLECTION)
    ("endosulfines" . SPARSER::PROTEIN-FAMILY) ("GWL" . SPARSER::PROTEIN)
    ("Greatwall" . SPARSER::PROTEIN) ("pErk 1/2" . SPARSER::PROTEIN)
    ("pERk1/2" . SPARSER::PROTEIN) ("pErk1/2" . SPARSER::PROTEIN)
    ("Phospho-Kinase" . SPARSER::PROTEIN) ("v-Ras" . SPARSER::PROTEIN)
    ("βTrCP" . SPARSER::PROTEIN) ("S21" . SPARSER::PROTEIN)
    ("T antigen" . SPARSER::MOLECULE) ("RAF1" . SPARSER::PROTEIN)
    ("PPP2R2B" . SPARSER::PROTEIN) ("PPP2R2A" . SPARSER::PROTEIN)
    ("B subunit" . SPARSER::PROTEIN) ("PLX1" . SPARSER::PROTEIN)
    ("ARPP19" . SPARSER::PROTEIN) ("B55" . SPARSER::PROTEIN)
    ("proteins and Bak" . SPARSER::COLLECTION)
    ("Bcl-2-proteins" . SPARSER::COLLECTION)
    ("Bim and Bid" . SPARSER::COLLECTION) ("Mcl-1-" . SPARSER::PROTEIN)
    ("Bim, Puma and Bid" . SPARSER::COLLECTION)
    ("Bim and Puma" . SPARSER::COLLECTION)
    ("Mcl-1-deficient MEFs and successfully silenced Bim, Bid and Puma ( xref )"
     . SPARSER::COLLECTION)
    ("Bim, Bid, Bad or Puma" . SPARSER::COLLECTION)
    ("Bad or Bik" . SPARSER::COLLECTION) ("/Mcl-1-siRNA" . SPARSER::COLLECTION)
    ("Bim-mRNA" . SPARSER::COLLECTION)
    ("Bim, Bid and Puma" . SPARSER::COLLECTION) ("Bax-" . SPARSER::PROTEIN)
    ("Mcl-1 and Bcl- X" . SPARSER::COLLECTION) ("/Mcl-1" . SPARSER::COLLECTION)
    ("Noxa specifically targets Mcl-1" . SPARSER::PROTEIN)
    ("caspase-9 and caspase-3" . SPARSER::COLLECTION)
    ("/Bcl-w" . SPARSER::COLLECTION)
    ("the anti-apoptotic Bcl-2 proteins, Bcl-2," . SPARSER::PROTEIN)
    ("Bid, Bim and Puma" . SPARSER::COLLECTION) ("tBid" . SPARSER::PROTEIN)
    ("Bax/Bak" . SPARSER::COLLECTION)
    ("proteins and effectors" . SPARSER::COLLECTION)
    ("proteins and auto-activate" . SPARSER::COLLECTION)
    ("Bad, Bik, Hrk, Noxa or Puma" . SPARSER::COLLECTION)
    ("Peptides" . SPARSER::PEPTIDE)
    ("mitochondria or liposomes" . SPARSER::COLLECTION)
    ("Bim or Bid" . SPARSER::COLLECTION)
    ("Bik (Bcl-2-interacting killer) and Hrk (activator of apoptosis hara-kiri)"
     . SPARSER::COLLECTION)
    ("the pro-apoptotic effectors Bcl-2-associated X protein (Bax) and Bcl-2 homologous antagonist/killer (Bak)"
     . SPARSER::COLLECTION)
    ("the pro-apoptotic effectors Bcl-2-associated X protein"
     . SPARSER::PROTEIN)
    ("hara" . SPARSER::PROTEIN) ("Hrk" . SPARSER::PROTEIN)
    ("Bik" . SPARSER::PROTEIN) ("Bax or Bak" . SPARSER::COLLECTION)
    ("the effectors Bcl-2-associated X protein (Bax) and Bcl-2 homologous antagonist/killer (Bak)"
     . SPARSER::COLLECTION)
    ("the effectors Bcl-2-associated X protein" . SPARSER::PROTEIN)
    ("α -tubulin" . SPARSER::PROTEIN) ("Anti- β" . SPARSER::PROTEIN)
    ("Bcl- X" . SPARSER::PROTEIN) ("Bcl-2-like" . SPARSER::PROTEIN)
    ("Bcl-2-modifying factor" . SPARSER::PROTEIN)
    ("Bcl-2-interacting killer" . SPARSER::PROTEIN)
    ("Bcl-2-associated death promoter" . SPARSER::PROTEIN)
    ("Phorbol-12-myristate-13-acetate-induced protein 1" . SPARSER::PROTEIN)
    ("Bcl-2-related protein A1" . SPARSER::PROTEIN)
    ("Bcl-2-like protein 2" . SPARSER::PROTEIN)
    ("BH3-interacting domain death agonist" . SPARSER::PROTEIN)
    ("Bcl-2 homologous antagonist/killer" . SPARSER::PROTEIN)
    ("PV-" . SPARSER::PROTEIN) ("Lamp1-BFP" . SPARSER::COLLECTION)
    ("EGFR and PTP1B" . SPARSER::COLLECTION) ("TAMRA-" . SPARSER::MOLECULE)
    ("a clickable unnatural amino acid" . SPARSER::AMINO-ACID)
    ("paGFP" . SPARSER::PROTEIN) ("EGFR-mCherry" . SPARSER::COLLECTION)
    ("PM-associated PTPs" . SPARSER::PROTEIN) ("c-Cbl-" . SPARSER::PROTEIN)
    ("perinuclear PTP1B" . SPARSER::PROTEIN)
    ("the autocatalytic tyrosine" . SPARSER::AMINO-ACID)
    ("wt and mutant" . SPARSER::COLLECTION)
    ("Shp" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ER-associated PTPs" . SPARSER::PROTEIN)
    ("a unique solution" . SPARSER::MOLECULE)
    ("the ER and/or other perturbed organelles" . SPARSER::COLLECTION)
    ("newly-synthesized EGFR" . SPARSER::PROTEIN)
    ("EGFR or Rab11" . SPARSER::COLLECTION)
    ("ER-associated PTP-1B" . SPARSER::PROTEIN)
    ("transmembrane PTPs" . SPARSER::PROTEIN)
    ("EGFR and ligand-occupied EGFR" . SPARSER::COLLECTION)
    ("activated Y1045 monomeric EGFR" . SPARSER::PROTEIN)
    ("cbl" . SPARSER::PROTEIN) ("BFP-Rab11A" . SPARSER::COLLECTION)
    ("perinuclear protein tyrosine phosphatase" . SPARSER::PROTEIN)
    ("EphA" . SPARSER::PROTEIN-FAMILY)
    ("monomeric receptors" . SPARSER::PROTEIN)
    ("the c-Cbl-binding-impaired mutants" . SPARSER::MUTANT)
    ("Liganded" . SPARSER::MOLECULE)
    ("these diffusible PTPs" . SPARSER::PROTEIN)
    ("PTP1B or TC-PTP" . SPARSER::COLLECTION) ("RPTPs" . SPARSER::PROTEIN)
    ("the ER-associated PTP1B" . SPARSER::PROTEIN)
    ("a concurrent asymmetric phosphatase" . SPARSER::PHOSPHATASE)
    ("ptp" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("vesicular EGFR" . SPARSER::PROTEIN)
    ("unidirectional receptor" . SPARSER::RECEPTOR)
    ("c-Cbl-mCherry" . SPARSER::COLLECTION) ("BFP-PTP1B" . SPARSER::COLLECTION)
    ("catalytically efficient PTP1B" . SPARSER::PROTEIN)
    ("monomeric EGFR" . SPARSER::PROTEIN) ("EGFR-paGFP" . SPARSER::COLLECTION)
    ("liganded" . SPARSER::MOLECULE) ("Rab5-mCherry" . SPARSER::COLLECTION)
    ("LAMP1-BFP" . SPARSER::COLLECTION) ("-GFP" . SPARSER::COLLECTION)
    ("TCOK" . SPARSER::AMINO-ACID)
    ("This unnatural amino acid" . SPARSER::AMINO-ACID)
    ("lysine (TCOK)" . SPARSER::AMINO-ACID) ("EGFR-GFP" . SPARSER::COLLECTION)
    ("TAMRA" . SPARSER::MOLECULE) ("tetrazine" . SPARSER::MOLECULE)
    ("FLAP and FRAP" . SPARSER::COLLECTION)
    ("photoactivatable GFP" . SPARSER::PROTEIN)
    ("Rab11a-BFP" . SPARSER::COLLECTION) ("FLAP" . SPARSER::PROTEIN)
    ("BFP-Rab11a" . SPARSER::COLLECTION) ("BFP" . SPARSER::PROTEIN)
    ("Monomeric EGFR" . SPARSER::PROTEIN)
    ("self-associated EGFR" . SPARSER::PROTEIN)
    ("PTB-mCherry" . SPARSER::COLLECTION)
    ("EGFR-QG-mCitrine" . SPARSER::COLLECTION)
    ("pervanadate" . SPARSER::PROTEIN) ("Cbl" . SPARSER::PROTEIN)
    ("mCitrine" . SPARSER::PROTEIN) ("EGFR-mCitrine" . SPARSER::COLLECTION)
    ("pY/EGFR" . SPARSER::COLLECTION)
    ("ligand-bound dimeric receptors" . SPARSER::PROTEIN)
    ("unliganded monomeric receptors" . SPARSER::PROTEIN)
    ("Y845—a regulatory autocatalytic tyrosine" . SPARSER::AMINO-ACID)
    ("PTP1B and TCPTP" . SPARSER::COLLECTION) ("TCPTP" . SPARSER::PROTEIN)
    ("c-Cbl (Y1045) or Grb2 (Y1068 and Y1086)" . SPARSER::COLLECTION)
    ("Ligand " . SPARSER::LIGAND) ("Enzymes" . SPARSER::ENZYME)
    ("EGFRs" . SPARSER::PROTEIN)
    ("tyrosine and ubiquitination of the receptor" . SPARSER::COLLECTION)
    ("Cos-7" . SPARSER::PROTEIN) ("c- Cbl" . SPARSER::PROTEIN)
    ("PTP-1B" . SPARSER::PROTEIN) ("PTB-1" . SPARSER::PROTEIN)
    ("Rab11A" . SPARSER::PROTEIN) ("ephrin receptor" . SPARSER::PROTEIN)
    ("TC-PTP" . SPARSER::PROTEIN) ("LAMP1" . SPARSER::PROTEIN)
    ("–3  " . SPARSER::PROTEIN)
    ("receptor protein" . SPARSER::RECEPTOR-PROTEIN)
    ("c-Cbl" . SPARSER::PROTEIN) ("PTP1B" . SPARSER::PROTEIN)
    ("received 1st line TKIs" . SPARSER::PROTEIN)
    ("EGFR and MET" . SPARSER::COLLECTION) ("-TKIs" . SPARSER::COLLECTION)
    ("poor PS" . SPARSER::PROTEIN)
    ("the 1st chemotherapy/2nd TKIs" . SPARSER::PROTEIN)
    ("epidermal growth factor receptor (EGFR)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("EGFR -TKI" . SPARSER::PROTEIN) ("autoantibodies" . SPARSER::PROTEIN)
    ("ESR2 and anti-mitochondrial" . SPARSER::COLLECTION)
    ("ESRs" . SPARSER::PROTEIN) ("IGF-1 and estrogens" . SPARSER::COLLECTION)
    ("GH/IGF-1" . SPARSER::COLLECTION)
    ("growth hormone/insulin-like growth factor" . SPARSER::COLLECTION)
    ("GH" . SPARSER::PROTEIN)
    ("IL-10, IL-4, and transforming growth factor-beta" . SPARSER::COLLECTION)
    ("normal GGT" . SPARSER::PROTEIN) ("normal ALP" . SPARSER::PROTEIN)
    ("TBIL" . SPARSER::MOLECULE) ("alleles or genotypes" . SPARSER::COLLECTION)
    ("ESR1 (rs2234693, rs2228480, and rs3798577) and ESR2 (rs1256030 and rs1048315) SNPs"
     . SPARSER::COLLECTION)
    ("San" . SPARSER::PROTEIN) ("CRH" . SPARSER::PROTEIN)
    ("bilirubin (TBIL)" . SPARSER::MOLECULE)
    ("ALP and GGT" . SPARSER::COLLECTION)
    ("bilirubin, ALP, and GGT" . SPARSER::COLLECTION)
    ("alkaline phosphatase (ALP)" . SPARSER::PROTEIN-FAMILY)
    ("bilirubin, and gamma-glutamyl" . SPARSER::COLLECTION)
    ("GGT" . SPARSER::PROTEIN) ("ALP" . SPARSER::PROTEIN)
    ("EDTA" . SPARSER::MOLECULE) ("antibody, and AMA" . SPARSER::COLLECTION)
    ("estrogen receptor (ESR)" . SPARSER::PROTEIN)
    ("antigen-4 and vitamin D" . SPARSER::COLLECTION)
    ("AIH" . SPARSER::PROTEIN) ("DPB" . SPARSER::PROTEIN)
    ("HLA" . SPARSER::PROTEIN) ("TGC" . SPARSER::PROTEIN)
    ("ESR" . SPARSER::PROTEIN)
    ("Primary biliary cirrhosis (PBC)" . SPARSER::PROTEIN)
    ("AF-1" . SPARSER::PROTEIN) ("growth hormone" . SPARSER::PROTEIN)
    ("transforming growth factor-beta" . SPARSER::PROTEIN)
    ("UTR - 3" . SPARSER::PROTEIN)
    ("tumor necrosis factor-alpha" . SPARSER::PROTEIN)
    ("antigen-4" . SPARSER::PROTEIN) ("DQB1" . SPARSER::PROTEIN)
    ("C4A" . SPARSER::PROTEIN) ("DR8" . SPARSER::PROTEIN)
    ("gamma-glutamyl" . SPARSER::MOLECULE) ("Inka1-LacZ" . SPARSER::COLLECTION)
    ("Inka1 and Inka2" . SPARSER::COLLECTION) ("Pak4" . SPARSER::PROTEIN)
    ("Raf1 and GRK2" . SPARSER::COLLECTION) ("RKIP" . SPARSER::PROTEIN)
    ("JIP" . SPARSER::PROTEIN) ("p21 Cip1/Waf1/Sdi1" . SPARSER::COLLECTION)
    ("p16INK4a, p15INK4b, p18INK4c and p19INK4d" . SPARSER::COLLECTION)
    ("Two closely related Ca 2+ calmodulin-dependent protein kinase II inhibitors"
     . SPARSER::INHIBITOR)
    ("CaM" . SPARSER::PROTEIN) ("only six classes" . CLASS)
    ("macromolecular filaments" . SPARSER::PROTEIN-FAMILY)
    ("cofilin-actin" . SPARSER::COLLECTION)
    ("GFP–Inka1:HA–PAK4cat" . SPARSER::BIO-COMPLEX)
    ("Flag-iBox-PAK4" . SPARSER::COLLECTION)
    ("Flag–PAK4cat" . SPARSER::COLLECTION) ("GFP–Inka1" . SPARSER::COLLECTION)
    ("PAK4 and Inka1" . SPARSER::COLLECTION)
    ("PAK4cat and PAK4cat" . SPARSER::COLLECTION)
    ("apo peptide inhibitors and small-molecule inhibitor"
     . SPARSER::COLLECTION)
    ("apo" . SPARSER::PROTEIN)
    ("the large 80-Å-diameter central solvent" . SPARSER::MOLECULE)
    ("FIG" . SPARSER::PROTEIN) ("only two types" . TYPE)
    ("Inka1:PAK4" . SPARSER::BIO-COMPLEX)
    ("the iBox Leu(+1) and Leu (+3)" . SPARSER::COLLECTION)
    ("PAK4:Inka1" . SPARSER::BIO-COMPLEX)
    ("iBox and iBox-C" . SPARSER::COLLECTION)
    ("arginines" . SPARSER::AMINO-ACID)
    ("AID Arg(−3) or Inka1 Arg(−2)" . SPARSER::COLLECTION)
    ("similarly feature Arg-mediated salt" . SPARSER::MOLECULE)
    ("AID and Inka1" . SPARSER::COLLECTION) ("−2 and −3" . SPARSER::COLLECTION)
    ("RRNA" . SPARSER::PROTEIN) ("PKIs" . SPARSER::PROTEIN-FAMILY)
    ("the favourable PAK4-binding conformation" . SPARSER::BIO-CONFORMATION)
    ("iBox and AID" . SPARSER::COLLECTION)
    ("R-2 and R-4" . SPARSER::COLLECTION)
    ("purified PAK4cat and a synthetic iBox 24mer peptide ( xref )"
     . SPARSER::COLLECTION)
    ("the ATP-bound crystallization-competent conformation"
     . SPARSER::BIO-CONFORMATION)
    ("lobe" . SPARSER::PROTEIN)
    ("the catalytic competent state" . SPARSER::BIO-STATE)
    ("a typical ‘closed' active kinase conformation"
     . SPARSER::BIO-CONFORMATION)
    ("PAK4cat" . SPARSER::PROTEIN) ("iBox–PAK4cat" . SPARSER::COLLECTION)
    ("trypsinized" . SPARSER::PROTEIN)
    ("The C-terminal 31 amino acid of Inka1 (255–285)" . SPARSER::PROTEIN)
    ("the central iBox or iBox-C" . SPARSER::COLLECTION)
    ("Inka1 and PAK4" . SPARSER::COLLECTION)
    ("Inka1 or Inka2" . SPARSER::COLLECTION)
    ("lip" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("iBox or iBox-C" . SPARSER::COLLECTION)
    ("the iBox or the iBox-C" . SPARSER::COLLECTION) ("mer" . SPARSER::PROTEIN)
    ("the C-terminal 22 amino acids of Inka1 ( xref )" . SPARSER::PROTEIN)
    ("PAK4-AID" . SPARSER::COLLECTION) ("iBox" . SPARSER::PROTEIN)
    ("GST–Inka1" . SPARSER::COLLECTION) ("PKI" . SPARSER::PROTEIN-FAMILY)
    ("PAK5 and PAK6" . SPARSER::COLLECTION)
    ("GST-iBox" . SPARSER::PROTEIN-PAIR)
    ("protein termed Inka1" . SPARSER::PROTEIN)
    ("Src–PAK4" . SPARSER::COLLECTION) ("carboxy" . SPARSER::MOLECULE)
    ("Inca" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("A coral fluorescent protein" . SPARSER::PROTEIN)
    ("Cdc42/Rac" . SPARSER::COLLECTION) ("PAKs1–3" . SPARSER::COLLECTION)
    ("Inka1" . SPARSER::PROTEIN) ("Inka1–GFP" . SPARSER::PROTEIN-PAIR)
    ("PAK4–PAK4" . SPARSER::COLLECTION)
    ("cellular ATP and the Inka1 inhibitor" . SPARSER::COLLECTION)
    ("metazoan" . SPARSER::PROTEIN-FAMILY) ("1–4" . SPARSER::PROTEIN)
    ("18 h" . SPARSER::PROTEIN)
    ("glutathione S -transferase" . SPARSER::PROTEIN)
    ("β–globin" . SPARSER::PROTEIN) ("6–16 " . SPARSER::PROTEIN)
    ("GRK2" . SPARSER::PROTEIN) ("p57Kip2" . SPARSER::PROTEIN)
    ("Sdi1" . SPARSER::PROTEIN) ("Waf1" . SPARSER::PROTEIN)
    ("p19INK4d" . SPARSER::PROTEIN) ("INK4c" . SPARSER::PROTEIN)
    ("p15INK4b" . SPARSER::PROTEIN)
    ("calmodulin-dependent protein kinase" . SPARSER::PROTEIN)
    ("CTP synthase" . SPARSER::PROTEIN) ("PF3758309" . SPARSER::DRUG)
    ("PAK4 inhibitor PF-03758309" . SPARSER::DRUG) ("PKIα" . SPARSER::PROTEIN)
    ("R-2" . SPARSER::PROTEIN) ("Pak1" . SPARSER::PROTEIN)
    ("PAKs1" . SPARSER::PROTEIN) ("types and locations" . SPARSER::COLLECTION)
    ("these causative variants" . SPARSER::VARIANT) ("VIII" . SPARSER::PROTEIN)
    ("VIB" . SPARSER::DRUG) ("types and sites" . SPARSER::COLLECTION)
    ("STRAD" . SPARSER::PROTEIN) ("bp" . SPARSER::PROTEIN)
    ("a premature stop" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a 2-bp" . SPARSER::COLLECTION) ("insC" . SPARSER::PROTEIN)
    ("family, and Jeghers" . SPARSER::COLLECTION)
    ("het" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a rare autosomal dominant" . SPARSER::PROTEIN)
    ("MO25" . SPARSER::PROTEIN) ("STe20" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("l19" . SPARSER::PROTEIN) ("elF" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ever‐changing and ATM substrates" . SPARSER::SUBSTRATE)
    ("ATM and metformin" . SPARSER::COLLECTION) ("glu" . SPARSER::AMINO-ACID)
    ("ins" . SPARSER::PROTEIN) ("incremental AUC glucose" . SPARSER::MOLECULE)
    ("JNK, PI3K, IRS2 and AKT" . SPARSER::COLLECTION)
    ("a role ofATMin glucose and insulin metabolic pathways"
     . SPARSER::COLLECTION)
    ("Serial glucose" . SPARSER::PROTEIN) ("GLUT4" . SPARSER::PROTEIN)
    ("Ataxia Telangiectasia Mutated" . SPARSER::PROTEIN)
    ("Type 2" . SPARSER::PROTEIN) ("Viral T-antigens" . SPARSER::PROTEIN)
    ("NF κ B and Bcl-2" . SPARSER::COLLECTION)
    ("viral T-antigen" . SPARSER::PROTEIN) ("miR-S1-5p" . SPARSER::COLLECTION)
    ("CTL" . SPARSER::PROTEIN) ("cellular miRNAs" . SPARSER::PROTEIN)
    ("some viral microRNAs" . SPARSER::RNA)
    ("viral molecules" . SPARSER::MOLECULE)
    ("the transformed state" . SPARSER::BIO-STATE)
    ("T-antigens" . SPARSER::PROTEIN) ("NF κ B" . SPARSER::PROTEIN)
    ("T-antigen" . SPARSER::PROTEIN) ("S1-5" . SPARSER::PROTEIN)
    ("CH2" . SPARSER::MOLECULE) ("large T-antigen" . SPARSER::PROTEIN)
    ("the distinct SHARPIN" . SPARSER::PROTEIN)
    ("SHARPIN and its interacting proteins" . SPARSER::COLLECTION)
    ("PTEN and SHARPIN" . SPARSER::COLLECTION)
    ("SHARPIN and filamin" . SPARSER::COLLECTION)
    ("filamin and SHARPIN" . SPARSER::COLLECTION)
    ("EYA1 and EYA2" . SPARSER::COLLECTION) ("EYA" . SPARSER::PROTEIN)
    ("SPN" . SPARSER::PROTEIN)
    ("these seemingly distinct SHARPIN" . SPARSER::PROTEIN)
    ("integrin and NF-κB" . SPARSER::COLLECTION)
    ("RNF31-SHARPIN" . SPARSER::COLLECTION)
    ("RNF31 and vice versa" . SPARSER::COLLECTION)
    ("Integrin and RNF31" . SPARSER::COLLECTION)
    ("Integrin" . SPARSER::PROTEIN) ("SHARPIN-RNF31" . SPARSER::COLLECTION)
    ("using fluorescently-labelled fibronectin" . SPARSER::PROTEIN)
    ("RFP-TALIN" . SPARSER::COLLECTION) ("CHO" . SPARSER::PROTEIN)
    ("ITGA5-mCherry" . SPARSER::COLLECTION)
    ("SHARPIN I272A and SHARPIN L276A" . SPARSER::COLLECTION)
    ("longer isoform" . SPARSER::ISOFORM)
    ("SHARPIN and RNF31" . SPARSER::COLLECTION) ("Type" . TYPE)
    ("integrins and RNF31" . SPARSER::COLLECTION)
    ("GST-SHARPIN" . SPARSER::COLLECTION) ("GFP-SHARPIN" . SPARSER::COLLECTION)
    ("GFP and GST" . SPARSER::COLLECTION) ("NZF" . SPARSER::PROTEIN)
    ("heterodimers and cell types" . SPARSER::COLLECTION)
    ("SHARPIN and integrin" . SPARSER::COLLECTION)
    ("RNF31 and integrin" . SPARSER::COLLECTION)
    ("HOIL-1-Interacting Protein (HOIP)" . SPARSER::PROTEIN)
    ("HOIP" . SPARSER::PROTEIN) ("Complex (LUBAC)" . SPARSER::BIO-COMPLEX)
    ("Complex" . SPARSER::BIO-COMPLEX)
    ("pro-inflammatory transcription factor" . SPARSER::PROTEIN)
    ("ITGAL-ITGB2" . SPARSER::COLLECTION) ("ITGAL" . SPARSER::PROTEIN)
    ("TALIN and FERMTs" . SPARSER::COLLECTION) ("TALIN" . SPARSER::PROTEIN)
    ("a large macromolecular complex" . SPARSER::BIO-COMPLEX)
    ("kindlins" . SPARSER::PROTEIN-FAMILY)
    ("integrin or RNF31" . SPARSER::COLLECTION)
    ("integrin or NF-κB" . SPARSER::COLLECTION)
    ("SHARPIN-integrin" . SPARSER::COLLECTION)
    ("integrin and RNF31" . SPARSER::COLLECTION) ("UBL" . SPARSER::PROTEIN)
    ("integrin and LUBAC" . SPARSER::COLLECTION)
    ("LUBAC" . SPARSER::BIO-COMPLEX) ("complex (LUBAC)" . SPARSER::BIO-COMPLEX)
    ("kappaB" . SPARSER::PROTEIN) ("SHARPIN" . SPARSER::PROTEIN)
    ("tail peptide" . SPARSER::PROTEIN) ("α5β1" . SPARSER::PROTEIN)
    ("eyes absent homolog 1" . SPARSER::PROTEIN) ("EYA2" . SPARSER::PROTEIN)
    ("EYA1" . SPARSER::PROTEIN) ("ITGA1" . SPARSER::PROTEIN)
    ("Tumor Necrosis Factor" . SPARSER::PROTEIN)
    ("in Chinese Hamster" . SPARSER::PROTEIN) ("RBCK1" . SPARSER::PROTEIN)
    ("Zinc Finger" . SPARSER::PROTEIN) ("HOIL1" . SPARSER::PROTEIN)
    ("NPL4" . SPARSER::PROTEIN) ("pleckstrin homology" . SPARSER::PROTEIN)
    ("HOIL-1-Interacting Protein" . SPARSER::PROTEIN)
    ("LFA-1" . SPARSER::PROTEIN) ("beta 2" . SPARSER::PROTEIN)
    ("beta 1" . SPARSER::PROTEIN) ("ring finger protein 31" . SPARSER::PROTEIN)
    ("the previously analyzed Pdgfb  −/−" . SPARSER::PROTEIN)
    ("PDGF-B and PDGFRβ" . SPARSER::COLLECTION)
    ("the inorganic phosphate transporter Pit-2" . SPARSER::PROTEIN)
    ("HEK and PAE" . SPARSER::COLLECTION)
    ("a benign variant" . SPARSER::VARIANT)
    ("doubly heterozygous Pdgfb  +/-" . SPARSER::PROTEIN)
    ("a biologically active PDGF-BB dimer" . SPARSER::DIMER)
    ("familial monogenic forms" . SPARSER::FORM) ("tracer" . SPARSER::MOLECULE)
    ("Pdgfrb  +/- and Pdgfrb  redeye/redeye mice" . SPARSER::COLLECTION)
    ("a putative dominant-negative PDGF-Rβ mutant" . SPARSER::MUTANT)
    ("Pdgfb and Pdgfrb" . SPARSER::COLLECTION)
    ("PDGF-B and PDGF-Rβ" . SPARSER::COLLECTION)
    ("only PDGF-Rβ dimers" . SPARSER::DIMER)
    ("dominant-negative proteins" . SPARSER::PROTEIN)
    ("Pdgfb and/or Pdgfrb" . SPARSER::COLLECTION)
    ("ERK1/2 and Akt" . SPARSER::COLLECTION)
    ("slightly weaker Y1009 and Y1021 phosphotyrosine" . SPARSER::PROTEIN)
    ("MG-132 and chloroquine" . SPARSER::COLLECTION)
    ("The KD and R987W PDGF-Rβ mutants" . SPARSER::COLLECTION)
    ("PAE" . SPARSER::PROTEIN-FAMILY)
    ("HEKs, or PDGF-BB" . SPARSER::COLLECTION) ("HEKs" . SPARSER::PROTEIN)
    ("kDa-protein" . SPARSER::COLLECTION) ("HEK" . SPARSER::PROTEIN)
    ("PDGF-Rβ, and actin" . SPARSER::COLLECTION)
    ("hypomorphic Pdgfb alleles" . SPARSER::ALLELE)
    ("receptor or ligand" . SPARSER::COLLECTION)
    ("the two prototypical PDGFRs, PDGF-Rα and PDGF-Rβ" . SPARSER::COLLECTION)
    ("PDGFRs, PDGF-Rα and PDGF-Rβ" . SPARSER::COLLECTION)
    ("the platelet-derived growth factors (PDGFs) and their tyrosine kinase receptors (PDGFRs)"
     . SPARSER::COLLECTION)
    ("PDGFRs" . SPARSER::PROTEIN) ("BBB" . SPARSER::PROTEIN)
    ("PDGFB or PDGFRB" . SPARSER::COLLECTION)
    ("PDGF-B/PDGF-Rβ" . SPARSER::COLLECTION)
    ("calcification-prone and non-calcification-prone" . SPARSER::COLLECTION)
    ("Pdgfb or Pdgfrb" . SPARSER::COLLECTION) ("Pdgfrb" . SPARSER::PROTEIN)
    ("Pdgfb" . SPARSER::PROTEIN)
    ("the two sporadic PDGFRB mutations R987W and E1071V" . SPARSER::PROTEIN)
    ("PDGFB and PDGFRB" . SPARSER::COLLECTION) ("PDGFRB" . SPARSER::PROTEIN)
    ("PDGFB" . SPARSER::PROTEIN) ("SP8" . SPARSER::PROTEIN)
    ("PLCγ1" . SPARSER::PROTEIN) ("GAG-3" . SPARSER::PROTEIN)
    ("CCA-3" . SPARSER::PROTEIN) ("SLC20A2" . SPARSER::PROTEIN)
    ("Pit-2" . SPARSER::PROTEIN) ("PDGF-A" . SPARSER::PROTEIN)
    ("PDGF-BB" . SPARSER::PROTEIN) ("PDGF-R" . SPARSER::PROTEIN)
    ("derived growth factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PLCγ" . SPARSER::PROTEIN-FAMILY) ("PDGF-Rβ" . SPARSER::PROTEIN)
    ("PDGF-B" . SPARSER::PROTEIN) ("glycogenin" . SPARSER::PROTEIN)
    ("TRIM3, TRIM16, TRIM29 and TRIM36" . SPARSER::COLLECTION)
    ("cyclin B1, CDC25C and CDK1" . SPARSER::COLLECTION)
    ("CDC2, CCNA1, CCNB1, CCNB2 and CDC25C" . SPARSER::COLLECTION)
    ("TRIM59 siRNA or control siRNA" . SPARSER::COLLECTION)
    ("HDAC1/E2F" . SPARSER::COLLECTION)
    ("cyclin D1 and p27" . SPARSER::COLLECTION)
    ("NCL1, HT2A and LIN41" . SPARSER::COLLECTION) ("RBCC" . SPARSER::PROTEIN)
    ("The tripartite motif (TRIM) protein family" . SPARSER::PROTEIN-FAMILY)
    ("CDC25C and CDK1" . SPARSER::COLLECTION)
    ("Ras and RB" . SPARSER::COLLECTION)
    ("TRIM3, TRIM7, TRIM14, TRIM16, TRIM21, TRIM22, TRIM29, TRIM59, TRIM66 and TRIM70"
     . SPARSER::COLLECTION)
    ("TRIM4, TRIM9, TRIM36, TRIM46, TRIM54, TRIM67 and TRIM76"
     . SPARSER::COLLECTION)
    ("HBE" . SPARSER::PROTEIN) ("TRIM" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TRIM 59" . SPARSER::PROTEIN) ("CCNA1" . SPARSER::PROTEIN)
    ("LIN41" . SPARSER::PROTEIN) ("HT2A" . SPARSER::PROTEIN)
    ("NCL1" . SPARSER::PROTEIN) ("B-box" . SPARSER::PROTEIN)
    ("TRIM46" . SPARSER::PROTEIN) ("TRIM36" . SPARSER::PROTEIN)
    ("TRIM9" . SPARSER::PROTEIN) ("TRIM4" . SPARSER::PROTEIN)
    ("TRIM59" . SPARSER::PROTEIN) ("TRIM29" . SPARSER::PROTEIN)
    ("TRIM22" . SPARSER::PROTEIN) ("TRIM21" . SPARSER::PROTEIN)
    ("TRIM16" . SPARSER::PROTEIN) ("TRIM14" . SPARSER::PROTEIN)
    ("TRIM3" . SPARSER::PROTEIN)
    ("BRCA1, Rad51, or ERCC1" . SPARSER::COLLECTION)
    ("MRE11, Rad50, BRCA1, BRCA2, Rad51, and ERCC1" . SPARSER::COLLECTION)
    ("Rad51 [ xref , xref ] and ERCC1 [ xref ]" . SPARSER::COLLECTION)
    ("lack functional p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the Rad51 gene and abrogation Rad51 polymerization"
     . SPARSER::COLLECTION)
    ("Rad51 and ERCC1" . SPARSER::COLLECTION)
    ("BRCA1 and Rad51" . SPARSER::COLLECTION)
    ("Rad50 and BRCA1" . SPARSER::COLLECTION)
    ("MRE11, BRCA2, Rad51, and ERCC1" . SPARSER::COLLECTION)
    ("BRCA1, BRCA2, Rad51, Rad52, and ERCC1" . SPARSER::COLLECTION)
    ("MRE11-Rad50-p95/NBS1" . SPARSER::COLLECTION)
    ("IR and IR" . SPARSER::COLLECTION)
    ("metformin and IR" . SPARSER::COLLECTION)
    ("-p53/p21 cip1" . SPARSER::COLLECTION)
    ("-adenosine monophosphate" . SPARSER::MOLECULE)
    ("biguanide" . SPARSER::MOLECULE) ("radiosensitizers" . SPARSER::DRUG)
    ("the Rad51 gene and abrogation of Rad51 polymerization"
     . SPARSER::COLLECTION)
    ("radiosensitizer" . SPARSER::DRUG) ("Metformin" . SPARSER::DRUG)
    ("DNA repair protein" . SPARSER::PROTEIN) ("member X" . SPARSER::PROTEIN)
    ("H2A histone family" . SPARSER::PROTEIN) ("cdc2" . SPARSER::PROTEIN)
    ("p95" . SPARSER::PROTEIN) ("cancer 2" . SPARSER::PROTEIN)
    ("Rad52" . SPARSER::PROTEIN) ("Rad51" . SPARSER::PROTEIN)
    ("Akt and Mcl-1" . SPARSER::COLLECTION)
    ("AKT and STAT3" . SPARSER::COLLECTION)
    ("NOTCH1, NOTCH3, HES1, MAML1, DLL-3, and JAG2" . SPARSER::COLLECTION)
    ("abdominal macrophages" . SPARSER::PROTEIN)
    ("the macrophage-depleting liposomal clodronate" . SPARSER::DRUG)
    ("clodronate" . SPARSER::DRUG) ("TAFs" . SPARSER::PROTEIN)
    ("The SER of GSI" . SPARSER::PROTEIN) ("SER" . SPARSER::AMINO-ACID)
    ("pAkt and anti-apoptotic" . SPARSER::COLLECTION)
    ("Notch1/Hes1" . SPARSER::COLLECTION)
    ("Akt and Bcl-2" . SPARSER::COLLECTION) ("GSI" . SPARSER::PROTEIN)
    ("Notch1 and NICD" . SPARSER::COLLECTION) ("NICD" . SPARSER::PROTEIN)
    ("SU3, SU3-5R and ihBTC2" . SPARSER::COLLECTION)
    ("SU3, SU3-5R, C6 and ihBTC2" . SPARSER::COLLECTION)
    ("CNP" . SPARSER::PROTEIN) ("protein (EGFP)" . SPARSER::PROTEIN)
    ("protein (RFP)" . SPARSER::PROTEIN)
    ("the glioma stem/progenitor cell SU3 and its radiation sub-strain SU3-5R"
     . SPARSER::COLLECTION)
    ("SU3" . SPARSER::PROTEIN) ("gene (EGFP)" . SPARSER::GENE)
    ("SU3-RFP" . SPARSER::PROTEIN-PAIR) ("GSIs" . SPARSER::PROTEIN)
    ("Notch 1, pAkt and Bcl-2" . SPARSER::COLLECTION)
    ("Notch 1 and Hes1" . SPARSER::COLLECTION)
    ("Gamma secretase" . SPARSER::PROTEIN) ("JAG2" . SPARSER::PROTEIN)
    ("DLL-3" . SPARSER::PROTEIN) ("MAML1" . SPARSER::PROTEIN)
    ("HES1" . SPARSER::PROTEIN) ("NOTCH3" . SPARSER::PROTEIN)
    ("β1-integrin" . SPARSER::PROTEIN) ("Hes2" . SPARSER::PROTEIN)
    ("gamma-secretase" . SPARSER::PROTEIN) ("Delta-" . SPARSER::PROTEIN)
    ("Jag1" . SPARSER::PROTEIN) ("Notch-1" . SPARSER::PROTEIN)
    ("γ-secretase" . SPARSER::PROTEIN) ("Hes1" . SPARSER::PROTEIN)
    ("Notch 1" . SPARSER::PROTEIN)
    ("competitive ATP inhibitors" . SPARSER::INHIBITOR)
    ("an attractive candidate drug target" . SPARSER::TARGET-PROTEIN)
    ("PAK4, RhoU, and PKA" . SPARSER::COLLECTION)
    ("myosin" . SPARSER::PROTEIN-FAMILY)
    ("PKC, PKA, PKG, and myosin light chain kinase" . SPARSER::COLLECTION)
    ("PKG" . SPARSER::PROTEIN) ("Staurosporine" . SPARSER::DRUG)
    ("residual PAK4" . SPARSER::PROTEIN)
    ("RhoJ and the GIT–PIX complex ( xref )" . SPARSER::COLLECTION)
    ("GIT–PIX" . SPARSER::COLLECTION) ("PIX" . SPARSER::PROTEIN)
    ("GIT" . SPARSER::PROTEIN) ("vesicular RhoU" . SPARSER::PROTEIN)
    ("Rab40A (Oncomine Research Edition; Neve and Bild datasets accessed May 2015) and Cullin 5 ( xref ) genes"
     . SPARSER::COLLECTION)
    ("PAK4 and PAK1" . SPARSER::COLLECTION)
    ("Elongin and Cullin" . SPARSER::COLLECTION)
    ("RhoU and Rab40A" . SPARSER::COLLECTION)
    ("an unconventional Rho GTPase" . SPARSER::PROTEIN)
    ("the classical Rho GTPase Cdc42" . SPARSER::PROTEIN)
    ("PAK4–RhoU" . SPARSER::COLLECTION) ("GFP-RhoU" . SPARSER::COLLECTION)
    ("GFP-PAK4" . SPARSER::COLLECTION)
    ("Rab40A and PAK4" . SPARSER::COLLECTION)
    ("Rab40A and Cullin 5" . SPARSER::COLLECTION)
    ("ElonginB" . SPARSER::PROTEIN) ("Elongin" . SPARSER::PROTEIN)
    ("nearly 20,000 human full-length proteins" . SPARSER::PROTEIN)
    ("enzymes, E1, E2, and E3" . SPARSER::COLLECTION)
    ("lysines" . SPARSER::AMINO-ACID) ("diglycine" . SPARSER::MOLECULE)
    ("RhoU–Ub" . SPARSER::COLLECTION) ("HA-RhoU" . SPARSER::COLLECTION)
    ("RhoU–ubiquitin" . SPARSER::COLLECTION)
    ("an atypical GTPase" . SPARSER::GTPASE)
    ("PAK4 and histone" . SPARSER::COLLECTION)
    ("RhoU and PAK4" . SPARSER::COLLECTION)
    ("RhoU and PAK" . SPARSER::COLLECTION)
    ("neither PAK1 nor PAK4" . SPARSER::COLLECTION)
    ("PAK1 or PAK4" . SPARSER::COLLECTION) ("HA-PAK4" . SPARSER::COLLECTION)
    ("GFP-PAK1" . SPARSER::COLLECTION) ("Cdc42 and RhoU" . SPARSER::COLLECTION)
    ("PAK4 and both the ΔN- and ΔC-terminal mutants" . SPARSER::COLLECTION)
    ("effector and GTPase" . SPARSER::COLLECTION)
    ("RhoU ( xref ) and RhoV (Fig. S2 B)" . SPARSER::COLLECTION)
    ("Rac1, RhoG, RhoA, RhoJ, or RhoQ" . SPARSER::COLLECTION)
    ("RhoQ" . SPARSER::PROTEIN) ("RhoJ" . SPARSER::PROTEIN)
    ("Cdc42 and PAK4" . SPARSER::COLLECTION)
    ("paxillin and vinculin" . SPARSER::COLLECTION)
    ("PAK1/PAK2" . SPARSER::COLLECTION)
    ("Both weak and strong cytoplasmic PAK4" . SPARSER::PROTEIN)
    ("Most known PAK4" . SPARSER::PROTEIN)
    ("Cdc42 and related Rho family small GTPases ( xref ; xref ; xref )"
     . SPARSER::COLLECTION)
    ("group I PAKs (PAK1–3) and group II PAKs (PAK4–6; xref )"
     . SPARSER::COLLECTION)
    ("PAK1–3" . SPARSER::COLLECTION) ("PAKs" . SPARSER::PROTEIN-FAMILY)
    ("PAK" . SPARSER::PROTEIN-FAMILY) ("PAK4 and RhoU" . SPARSER::COLLECTION)
    ("Rab40A–Cullin 5" . SPARSER::COLLECTION)
    ("Rab40A/Cullin 5" . SPARSER::COLLECTION) ("RhoU" . SPARSER::PROTEIN)
    ("Wrch1" . SPARSER::PROTEIN) ("PAK5" . SPARSER::PROTEIN)
    ("myosin light chain kinase" . SPARSER::PROTEIN)
    ("Rabex-5" . SPARSER::PROTEIN) ("Wnt6" . SPARSER::PROTEIN)
    ("Rap2" . SPARSER::PROTEIN)
    ("suppressor of cytokine signaling" . SPARSER::PROTEIN)
    ("GTP-binding protein" . SPARSER::PROTEIN) ("Cul5" . SPARSER::PROTEIN)
    ("K63R" . SPARSER::PROTEIN) ("PAK2" . SPARSER::PROTEIN)
    ("PAK6" . SPARSER::PROTEIN) ("LIMK1" . SPARSER::PROTEIN)
    ("group I" . SPARSER::PROTEIN)
    ("P21-activated kinase 4" . SPARSER::PROTEIN)
    ("Cullin 5" . SPARSER::PROTEIN) ("PAK4" . SPARSER::PROTEIN)
    ("ARF/HDM2" . SPARSER::COLLECTION) ("nutlins" . SPARSER::DRUG)
    ("cyclin D/CDK" . SPARSER::COLLECTION)
    ("an essential effector" . SPARSER::EFFECTOR)
    ("intact p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Arf and Mdm2" . SPARSER::COLLECTION) ("Arf/Mdm2" . SPARSER::COLLECTION)
    ("Bisulfite" . SPARSER::MOLECULE)
    ("both p53 and its downstream effector" . SPARSER::COLLECTION)
    ("pERK and p19 Arf" . SPARSER::COLLECTION)
    ("p53-mdm2" . SPARSER::COLLECTION)
    ("P10 (proliferating presenescent cells) and P49 (senescent cells)"
     . SPARSER::COLLECTION)
    ("Arf" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p16 Ink4a , and p15 Ink4b" . SPARSER::COLLECTION)
    ("/−MEFs" . SPARSER::COLLECTION)
    ("Dec1, and p15 Ink4b" . SPARSER::COLLECTION) ("SABG" . SPARSER::PROTEIN)
    ("Dec1 and p15Ink4b" . SPARSER::COLLECTION)
    ("senescence-associated heterochromatin foci (SAHF)" . SPARSER::PROTEIN)
    ("foci (SAHF)" . SPARSER::PROTEIN) ("SAHF" . SPARSER::BIO-COMPLEX)
    ("TAM" . SPARSER::PROTEIN) ("Irbp-Cyclin D1" . SPARSER::COLLECTION)
    ("p53 and RB" . SPARSER::COLLECTION) ("p53-Mdm2" . SPARSER::COLLECTION)
    ("Thrombospondin-1" . SPARSER::PROTEIN) ("mdm2" . SPARSER::PROTEIN)
    ("HDM2" . SPARSER::PROTEIN) ("P90" . SPARSER::PROTEIN)
    ("p15Ink4b" . SPARSER::PROTEIN) ("P70" . SPARSER::PROTEIN)
    ("P60" . SPARSER::PROTEIN) ("p16 Ink4a" . SPARSER::PROTEIN)
    ("Dec1" . SPARSER::PROTEIN) ("p19Arf" . SPARSER::PROTEIN)
    ("p14 Arf" . SPARSER::PROTEIN) ("p21 Cip1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p15 Ink4b" . SPARSER::PROTEIN) ("DEC1" . SPARSER::PROTEIN)
    ("RasV12" . SPARSER::DRUG) ("p19 Arf" . SPARSER::PROTEIN)
    ("RRM2 and Bcl-2" . SPARSER::COLLECTION)
    ("cohort (KOR)" . SPARSER::MOLECULE) ("KOR" . SPARSER::PROTEIN)
    ("Genes and Genomes" . SPARSER::COLLECTION) ("Heme" . SPARSER::PROTEIN)
    ("a promising prognostic biomarker" . SPARSER::MOLECULE)
    ("50 tumor-associated genes" . SPARSER::GENE)
    ("NAMS" . SPARSER::PROTEIN-FAMILY)
    ("a promising therapeutic target and useful biomarker"
     . SPARSER::COLLECTION)
    ("critical antioxidant and stress-responsive genes" . SPARSER::COLLECTION)
    ("stress-responsive genes" . SPARSER::GENE)
    ("a key cytoprotective gene" . SPARSER::GENE)
    ("Jak-STAT" . SPARSER::PROTEIN)
    ("NF-E2-Related Factor 2" . SPARSER::PROTEIN)
    ("Nuclear factor, erythroid 2" . SPARSER::PROTEIN)
    ("genes and phenotypes" . SPARSER::COLLECTION)
    ("five representative traits" . SPARSER::PROTEIN)
    ("a recent quantitative trait locus (QTL) mapping" . SPARSER::PROTEIN)
    ("St14" . SPARSER::PROTEIN) ("filaggrin" . SPARSER::PROTEIN)
    ("MC5R , FA2H , DGAT1 , DGAT2 , SCD1, and ELOVL4" . SPARSER::COLLECTION)
    ("DCT , OCA2 , and TYRP1" . SPARSER::COLLECTION)
    ("KLF4, FLG, POF1B, and SPINK5" . SPARSER::COLLECTION)
    ("EDA1 , EDAR , EDARADD , and PKP1" . SPARSER::COLLECTION)
    ("EDARADD" . SPARSER::PROTEIN) ("EDAR" . SPARSER::PROTEIN)
    ("DCT" . SPARSER::PROTEIN) ("detergents" . SPARSER::MOLECULE)
    ("purines, and pyrimidines" . SPARSER::COLLECTION)
    ("pyrimidines" . SPARSER::DRUG) ("purines" . SPARSER::DRUG)
    ("PCoA" . SPARSER::PROTEIN)
    ("acid-susceptible bacteria—such as Staphylococcal" . SPARSER::PROTEIN)
    ("Staphylococcal" . SPARSER::PROTEIN)
    ("sebaceous wax ester" . SPARSER::MOLECULE) ("wax" . SPARSER::MOLECULE)
    ("the functional traits and Nearest" . SPARSER::COLLECTION)
    ("traits and Nearest" . SPARSER::COLLECTION)
    ("amino acid, vitamin, and nucleotide" . SPARSER::COLLECTION)
    ("the right upper arm" . SPARSER::PROTEIN) ("rRNA" . SPARSER::PROTEIN)
    ("quantitative traits" . SPARSER::PROTEIN)
    ("detergent" . SPARSER::MOLECULE) ("FLG" . SPARSER::PROTEIN)
    ("a 2  " . SPARSER::HUMAN-PROTEIN-FAMILY) ("e 2" . SPARSER::MOLECULE)
    ("PKP1" . SPARSER::PROTEIN) ("EDA1" . SPARSER::PROTEIN)
    ("SPINK5" . SPARSER::PROTEIN) ("AQP3" . SPARSER::PROTEIN)
    ("TYRP1" . SPARSER::PROTEIN) ("OCA2" . SPARSER::PROTEIN)
    ("ELOVL4" . SPARSER::PROTEIN) ("SCD1" . SPARSER::PROTEIN)
    ("DGAT2" . SPARSER::PROTEIN) ("DGAT1" . SPARSER::PROTEIN)
    ("MC5R" . SPARSER::PROTEIN) ("Lactic acid" . SPARSER::MOLECULE)
    ("histological types" . TYPE) ("pilar" . SPARSER::PROTEIN)
    ("keratinocytes and sebocytes" . SPARSER::COLLECTION)
    ("representative examples" . SPARSER::EXAMPLE)
    ("G-A-T-A" . SPARSER::COLLECTION) ("CC1" . SPARSER::PROTEIN)
    ("T-A" . SPARSER::PROTEIN) ("G-A" . SPARSER::PROTEIN)
    ("PI3K/AKT/β-catenin" . SPARSER::COLLECTION) ("repertaxin" . SPARSER::DRUG)
    ("tyrosine kinase and cytokine" . SPARSER::COLLECTION)
    ("AKT/FOXO3A" . SPARSER::COLLECTION)
    ("PI3K/AKT/FOXO" . SPARSER::COLLECTION)
    ("organic substances" . SPARSER::SUBSTANCE)
    ("DKK1 and FRAT1" . SPARSER::COLLECTION)
    ("catenin, HIFα and p53" . SPARSER::COLLECTION)
    ("catenin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ID2 and GATA3" . SPARSER::COLLECTION)
    ("keratins, IGFBP7 and TIMP3" . SPARSER::COLLECTION)
    ("growth arrest and DNA damage-inducible gene GADD45A" . SPARSER::PROTEIN)
    ("alanines" . SPARSER::AMINO-ACID) ("prolactin" . SPARSER::PROTEIN)
    ("HC11" . SPARSER::PROTEIN) ("FOXO3A and HSPA1B" . SPARSER::COLLECTION)
    ("FOXO3A, HSPA1B, and MPP2" . SPARSER::COLLECTION)
    ("HMGB2, FOXO3A, HSPA1B, CD47 and HMG1L10" . SPARSER::COLLECTION)
    ("cytokeratins" . SPARSER::PROTEIN) ("FKBPL" . SPARSER::PROTEIN)
    ("which relays PI3K" . SPARSER::PROTEIN-FAMILY)
    ("cytokine and growth factor" . SPARSER::COLLECTION)
    ("CD44, CD24, ESA and CD133" . SPARSER::COLLECTION)
    ("FKHRL1" . SPARSER::PROTEIN) ("Serum Albumin" . SPARSER::PROTEIN)
    ("Fluorescein isothiocyanate" . SPARSER::MOLECULE)
    ("β-casein" . SPARSER::PROTEIN) ("FOX1" . SPARSER::PROTEIN)
    ("CXCR1" . SPARSER::PROTEIN) ("IL-8 receptor" . SPARSER::PROTEIN)
    ("Foxo3A" . SPARSER::PROTEIN) ("receptor gamma" . SPARSER::PROTEIN)
    ("IL2" . SPARSER::PROTEIN) ("BMP7" . SPARSER::PROTEIN)
    ("FRAT1" . SPARSER::PROTEIN) ("TIMP3" . SPARSER::PROTEIN)
    ("IGFBP7" . SPARSER::PROTEIN) ("ID2" . SPARSER::PROTEIN)
    ("A3" . SPARSER::HUMAN-PROTEIN-FAMILY) ("MPP2" . SPARSER::PROTEIN)
    ("HMG1" . SPARSER::PROTEIN) ("HSPA1B" . SPARSER::PROTEIN)
    ("HMGB2" . SPARSER::PROTEIN)
    ("Survivin , CDC25C, and PLK1" . SPARSER::COLLECTION)
    ("KIF23 , PLK4 , Survivin, CDC25C , and PLK1" . SPARSER::COLLECTION)
    ("Cyclin B1/CCNB1" . SPARSER::COLLECTION)
    ("p73 and p63" . SPARSER::COLLECTION)
    ("ubiquitin and SUMO-1" . SPARSER::COLLECTION)
    ("PLK1 and p53-related proteins" . SPARSER::COLLECTION)
    ("Survivin , Cdc25C , and Plk1" . SPARSER::COLLECTION)
    ("p107 and p130" . SPARSER::COLLECTION)
    ("CDKN1A , MDM2 , and BBC3" . SPARSER::COLLECTION)
    ("E2F4/DP1" . SPARSER::COLLECTION) ("MDM2, and PUMA" . SPARSER::COLLECTION)
    ("DREAM and MMB" . SPARSER::COLLECTION)
    ("CCNB2, KIF23, and PLK4" . SPARSER::COLLECTION)
    ("Lin9" . SPARSER::PROTEIN) ("DREAM and MuvB" . SPARSER::COLLECTION)
    ("DREAM-" . SPARSER::PROTEIN)
    ("CDC25C , PLK1, and Survivin" . SPARSER::COLLECTION)
    ("B-MYB and FOXM1" . SPARSER::COLLECTION)
    ("E2F4, LIN9, and p130" . SPARSER::COLLECTION)
    ("the repressive DREAM complex" . SPARSER::BIO-COMPLEX)
    ("two representative components" . SPARSER::COMPONENT)
    ("p130 and E2F4" . SPARSER::COLLECTION)
    ("CDC25C , PLK1, or Survivin" . SPARSER::COLLECTION)
    ("Survivin or PLK1" . SPARSER::COLLECTION)
    ("CDKN1A and MDM2" . SPARSER::COLLECTION) ("GAPDHS" . SPARSER::PROTEIN)
    ("p53 as well as DNMT1 and HDAC1" . SPARSER::COLLECTION)
    ("an adenovirus E1b minimal promoter" . SPARSER::PROMOTER)
    ("CCNB2 and KIF23" . SPARSER::COLLECTION) ("CDE/CHR" . SPARSER::PROTEIN)
    ("CCNB2 , KIF23 , and PLK4" . SPARSER::COLLECTION)
    ("DREAM-CDE/CHR" . SPARSER::COLLECTION)
    ("CDC25C and PLK1" . SPARSER::COLLECTION)
    ("NF-Y/p53" . SPARSER::COLLECTION)
    ("Nutlin-3a or 5-FU" . SPARSER::COLLECTION)
    ("Survivin, CDC25C , and PLK1" . SPARSER::COLLECTION)
    ("doxorubicin and Nutlin-3a" . SPARSER::COLLECTION)
    ("the positive controls CDKN1A ( p21 ) and MDM2 mRNA"
     . SPARSER::COLLECTION)
    ("the DNA damaging agent doxorubicin, the MDM2 inhibitor Nutlin-3a, or the pyrimidine analogue 5-fluorouracil (5-FU)"
     . SPARSER::COLLECTION)
    ("p53-dependent repression employs p21 and the DREAM complex"
     . SPARSER::COLLECTION)
    ("KIF23 , and PLK4" . SPARSER::COLLECTION)
    ("Survivin and PLK1" . SPARSER::COLLECTION)
    ("PLK1 and CDC25C" . SPARSER::COLLECTION)
    ("Survivin and CDC25C" . SPARSER::COLLECTION)
    ("DP, RB-like, E2F4, and MuvB" . SPARSER::COLLECTION)
    ("p53-p21-DREAM" . SPARSER::COLLECTION)
    ("p53-p21-E2F4" . SPARSER::COLLECTION)
    ("p53-p21-RB/E2F2" . SPARSER::COLLECTION)
    ("p53-E2F1" . SPARSER::COLLECTION) ("p53-Sp1" . SPARSER::COLLECTION)
    ("p53-NF-Y-CCAAT" . SPARSER::COLLECTION)
    ("Survivin, CDC25C, and PLK1" . SPARSER::COLLECTION)
    ("p73/TP73" . SPARSER::COLLECTION) ("protein/Topors" . SPARSER::COLLECTION)
    ("RACGAP1/CYK4" . SPARSER::COLLECTION)
    ("CENPU/PBIP1" . SPARSER::COLLECTION) ("FBXO5/EMI1" . SPARSER::COLLECTION)
    ("BUB1B/BUBR1/MAD3L" . SPARSER::COLLECTION)
    ("SGOL1/SGO" . SPARSER::COLLECTION)
    ("Protein regulator of cytokinesis 1/PRC1" . SPARSER::COLLECTION)
    ("KIF20A/MKLP2" . SPARSER::COLLECTION) ("Topors" . SPARSER::PROTEIN)
    ("CENPU" . SPARSER::PROTEIN) ("BORA" . SPARSER::PROTEIN)
    ("MISP" . SPARSER::PROTEIN) ("SGO" . SPARSER::PROTEIN)
    ("PPP1R12A/MYPT1" . SPARSER::COLLECTION)
    ("Anaphase-Promoting Complex/Cyclosome" . SPARSER::COLLECTION)
    ("Cyclosome" . SPARSER::PROTEIN) ("particular PLK1" . SPARSER::PROTEIN)
    ("serines and threonines of proteins which have already been"
     . SPARSER::PROTEIN)
    ("serines and threonines" . SPARSER::COLLECTION)
    ("phospho-serine/threonine" . SPARSER::COLLECTION)
    ("threonines" . SPARSER::AMINO-ACID) ("serines" . SPARSER::AMINO-ACID)
    ("CDK1/CDC2" . SPARSER::COLLECTION)
    ("Cyclin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("complex (CPC)" . SPARSER::BIO-COMPLEX) ("INCENP" . SPARSER::PROTEIN)
    ("Borealin" . SPARSER::PROTEIN) ("CPC" . SPARSER::PROTEIN)
    ("phosphatase, and Polo-like kinase" . SPARSER::COLLECTION)
    ("p130-" . SPARSER::PROTEIN) ("E2F4-" . SPARSER::PROTEIN)
    ("p21-" . SPARSER::PROTEIN)
    ("Survivin , CDC25C , and PLK1" . SPARSER::COLLECTION)
    ("E2F4 and p130" . SPARSER::COLLECTION) ("DREAM" . SPARSER::PROTEIN)
    ("Myb" . SPARSER::PROTEIN) ("MMB" . SPARSER::PROTEIN)
    ("CDC25C , and PLK1" . SPARSER::COLLECTION) ("SUMO-1" . SPARSER::PROTEIN)
    ("p107" . SPARSER::PROTEIN) ("DP1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("BBC3" . SPARSER::PROTEIN) ("LIN9" . SPARSER::PROTEIN)
    ("PLK4" . SPARSER::PROTEIN) ("KIF23" . SPARSER::PROTEIN)
    ("TP73" . SPARSER::PROTEIN) ("CYK4" . SPARSER::PROTEIN)
    ("RACGAP1" . SPARSER::PROTEIN) ("NEDD1" . SPARSER::PROTEIN)
    ("EMI1" . SPARSER::PROTEIN) ("FBXO5" . SPARSER::PROTEIN)
    ("CEP55" . SPARSER::PROTEIN) ("MAD3L" . SPARSER::PROTEIN)
    ("BUBR1" . SPARSER::PROTEIN) ("BUB1B" . SPARSER::PROTEIN)
    ("SGOL1" . SPARSER::PROTEIN) ("PRC1" . SPARSER::PROTEIN)
    ("Protein regulator of cytokinesis 1" . SPARSER::PROTEIN)
    ("ECT2" . SPARSER::PROTEIN) ("KIF2A" . SPARSER::PROTEIN)
    ("MKLP2" . SPARSER::PROTEIN) ("KIF20A" . SPARSER::PROTEIN)
    ("LRRK1" . SPARSER::PROTEIN) ("Cyclin B2" . SPARSER::PROTEIN)
    ("MYPT1" . SPARSER::PROTEIN) ("PPP1R12A" . SPARSER::PROTEIN)
    ("Anaphase-Promoting Complex" . SPARSER::PROTEIN)
    ("phospho-serine" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("B/CDK1" . SPARSER::PROTEIN) ("CDC2" . SPARSER::PROTEIN)
    ("CDCA8" . SPARSER::PROTEIN) ("p130" . SPARSER::PROTEIN)
    ("E2F4" . SPARSER::PROTEIN) ("B-MYB" . SPARSER::PROTEIN)
    ("agouti" . SPARSER::PROTEIN-FAMILY) ("FABP4-Wnt10b" . SPARSER::COLLECTION)
    ("MSCs instead of preadipocytes" . SPARSER::COLLECTION)
    ("lipid and cholesterol" . SPARSER::COLLECTION)
    ("new adipocytes" . SPARSER::PROTEIN) ("LXR or Wnt" . SPARSER::COLLECTION)
    ("MSC/GFP" . SPARSER::COLLECTION)
    ("beta-catenin and GAPDH" . SPARSER::COLLECTION)
    ("Wnt1, Wnt3a, Wnt5a, and Wnt10b" . SPARSER::COLLECTION)
    ("PPAR-gamma and fatty acid synthase" . SPARSER::COLLECTION)
    ("PPAR-gamma and Fatty acid synthase" . SPARSER::COLLECTION)
    ("streptomycin" . SPARSER::DRUG) ("indomethacin" . SPARSER::DRUG)
    ("IBMX" . SPARSER::MOLECULE) ("xanthine" . SPARSER::MOLECULE)
    ("LXRα/LXRβ" . SPARSER::COLLECTION) ("preadipocytes" . SPARSER::PROTEIN)
    ("LXRs" . SPARSER::PROTEIN) ("oxysterol" . SPARSER::PROTEIN)
    ("cellular beta-catenin" . SPARSER::PROTEIN)
    ("Wnt/beta-catenin" . SPARSER::COLLECTION) ("LXRα" . SPARSER::PROTEIN)
    ("GFP-LXRα (mMSC/LXRα/GFP) or GFP" . SPARSER::COLLECTION)
    ("mMSC/GFP" . SPARSER::COLLECTION) ("GFP-LXRα" . SPARSER::COLLECTION)
    ("LXR" . SPARSER::PROTEIN) ("FABP4" . SPARSER::PROTEIN)
    ("VP16" . SPARSER::DRUG) ("Wnt 3a" . SPARSER::PROTEIN)
    ("Fatty acid synthase" . SPARSER::PROTEIN) ("OH-" . SPARSER::MOLECULE)
    ("CD29" . SPARSER::PROTEIN) ("Wnt10b" . SPARSER::PROTEIN)
    ("peroxisome proliferator-activated receptor-gamma" . SPARSER::PROTEIN)
    ("Wnt 10b" . SPARSER::PROTEIN) ("LXRβ" . SPARSER::PROTEIN)
    ("Liver X receptor-alpha" . SPARSER::PROTEIN)
    ("lipid droplet" . SPARSER::PROTEIN)
    ("liver X receptor-alpha" . SPARSER::PROTEIN) ("MRC" . SPARSER::PROTEIN)
    ("SMS" . SPARSER::PROTEIN) ("GSK, Eisai and UCB" . SPARSER::COLLECTION)
    ("GSK" . SPARSER::PROTEIN) ("Our heterogeneous cohort" . SPARSER::MOLECULE)
    ("The previously-unreported variants and those SNPs" . SPARSER::COLLECTION)
    ("KCNJ11 or BAD" . SPARSER::COLLECTION)
    ("KCNJ11 (present in one partial responder) and NM_004322.3:c"
     . SPARSER::COLLECTION)
    ("a highly-conserved amino acid" . SPARSER::AMINO-ACID)
    ("p  " . SPARSER::PROTEIN) ("CMH" . SPARSER::MOLECULE)
    ("KCNJ11 , rs5215 and rs5219" . SPARSER::COLLECTION)
    ("Cohort" . SPARSER::MOLECULE) ("phenotypic traits" . SPARSER::PROTEIN)
    ("kainic acid-induced seizures" . SPARSER::PROTEIN)
    ("the minimal death domain BH3-only protein" . SPARSER::PROTEIN)
    ("KCNJ11 and BAD" . SPARSER::COLLECTION)
    ("dominant and recessive" . SPARSER::PROTEIN) ("Kir6.2" . SPARSER::PROTEIN)
    ("KCNJ11" . SPARSER::PROTEIN) ("BRCA 2" . SPARSER::PROTEIN)
    ("BRCA 1" . SPARSER::PROTEIN)
    ("the mesenchymal markers N-cadherin and Vimentin" . SPARSER::COLLECTION)
    ("Snail, and ZEB1/2" . SPARSER::COLLECTION)
    ("N-cadherin and Vimentin" . SPARSER::COLLECTION)
    ("EMT-associated genes" . SPARSER::GENE)
    ("Vimentin and E-cadherin" . SPARSER::COLLECTION)
    ("Vimentin and N-cadherin" . SPARSER::COLLECTION)
    ("mesenchymal genes" . SPARSER::GENE)
    ("N-cadherin, Snail, and Vimentin" . SPARSER::COLLECTION)
    ("Drosha/p68" . SPARSER::COLLECTION) ("p68/Drosha" . SPARSER::COLLECTION)
    ("Drosha-p68" . SPARSER::COLLECTION)
    ("Drosha and multiple RNA-associated proteins" . SPARSER::COLLECTION)
    ("multiple RNA-associated proteins" . SPARSER::PROTEIN)
    ("p68-drosha" . SPARSER::COLLECTION) ("drosha" . SPARSER::PROTEIN)
    ("EZH2 and p53" . SPARSER::COLLECTION)
    ("only one expressed EZH2" . SPARSER::PROTEIN)
    ("EZH2 and mutp53" . SPARSER::COLLECTION)
    ("subtypes, type I and type II" . SPARSER::COLLECTION)
    ("Drosha and p68" . SPARSER::COLLECTION)
    ("EZH2, N-cadherin, Vimentin, and Snail" . SPARSER::COLLECTION)
    ("p68-Drosha" . SPARSER::COLLECTION) ("Drosha" . SPARSER::PROTEIN)
    ("The tumor suppressor p53 and the transcriptional repressor Enhancer of Zeste Homolog 2 (EZH2)"
     . SPARSER::COLLECTION)
    ("Rab coupling protein" . SPARSER::PROTEIN)
    ("RNase III" . SPARSER::PROTEIN) ("pre-miRNAs" . SPARSER::RNA)
    ("pri-miRNAs" . SPARSER::RNA) ("PRC2" . SPARSER::PROTEIN)
    ("Polycomb Repressive Complex 2" . SPARSER::PROTEIN)
    ("p68" . SPARSER::PROTEIN)
    ("Enhancer of Zeste Homolog 2" . SPARSER::PROTEIN)
    ("a new biomarker" . SPARSER::MOLECULE)
    ("ERβ/DAB2IP" . SPARSER::COLLECTION)
    ("ERβ, IFN-γ, CCL3, CCL5 and IGF" . SPARSER::COLLECTION)
    ("IGF-1R (IGF-1 receptor) and insulin receptors" . SPARSER::COLLECTION)
    ("EREs" . SPARSER::PROTEIN) ("CCL3 and CCL5" . SPARSER::COLLECTION)
    ("receptors, CCR5 and CXCR3" . SPARSER::COLLECTION)
    ("CXCL10 or CCL5" . SPARSER::COLLECTION)
    ("ERs/EZH2/DAB2IP" . SPARSER::COLLECTION)
    ("ERβ and DAB2IP" . SPARSER::COLLECTION)
    ("immunoregulatory cytokines" . SPARSER::PROTEIN)
    ("TGF-β, IL-10, and IL-4" . SPARSER::COLLECTION)
    ("CD25-" . SPARSER::PROTEIN)
    ("growth factors, cytokines, chemokines, and components"
     . SPARSER::COLLECTION)
    ("IFN-γ and IGF-1" . SPARSER::COLLECTION)
    ("IGF-1 and FGF7" . SPARSER::COLLECTION)
    ("ERβ-shRNA" . SPARSER::COLLECTION)
    ("conditional conditioned media (CM)" . SPARSER::PROTEIN)
    ("conditioned media (CM)" . SPARSER::PROTEIN)
    ("media (CM)" . SPARSER::PROTEIN) ("VEGFa and HIF2α" . SPARSER::COLLECTION)
    ("VEGFa" . SPARSER::PROTEIN) ("ERβ, VEGFA and HIF2α" . SPARSER::COLLECTION)
    ("IGF-1 and FGF-7" . SPARSER::COLLECTION)
    ("IFN-γ, CCL3 and CCL5" . SPARSER::COLLECTION)
    ("miR-125b" . SPARSER::MOLECULE) ("Tc1" . SPARSER::PROTEIN)
    ("CXCR3" . SPARSER::PROTEIN) ("CCR5" . SPARSER::PROTEIN)
    ("FOXP3" . SPARSER::PROTEIN) ("FGF7" . SPARSER::PROTEIN)
    ("DAP2" . SPARSER::PROTEIN) ("ICI182,780" . SPARSER::DRUG)
    ("disabled homolog 2" . SPARSER::PROTEIN) ("HIF2α" . SPARSER::PROTEIN)
    ("von Hippel–Lindau" . SPARSER::PROTEIN) ("FGF-7" . SPARSER::PROTEIN)
    ("CCL3" . SPARSER::PROTEIN) ("JAKs" . SPARSER::PROTEIN)
    ("the IL-6 receptor ( IL6ST ) and all three Janus kinases ( JAK1-3 )"
     . SPARSER::COLLECTION)
    ("TLR2 and TLR7" . SPARSER::COLLECTION)
    ("pro-angiogenic GHSR and NLRP3" . SPARSER::COLLECTION)
    ("GHSR and NLRP3" . SPARSER::COLLECTION) ("GHSR" . SPARSER::PROTEIN)
    ("ADIPOQ" . SPARSER::PROTEIN)
    ("pro-inflammatory and pro-angiogenic cytokines" . SPARSER::PROTEIN)
    ("The TGF-β type I (TβRI) and type II receptors (TβRII)"
     . SPARSER::COLLECTION)
    ("sunitinib and sorafenib" . SPARSER::COLLECTION)
    ("SDF-1, collagens and integrins" . SPARSER::COLLECTION)
    ("ITGAV and ITGB1" . SPARSER::COLLECTION)
    ("pro-angiogenic genes" . SPARSER::GENE)
    ("many more angiogenic genes" . SPARSER::GENE)
    ("these angiogenic genes" . SPARSER::GENE)
    ("Phospholipase D1 (encoded for by PLD1 genes) and neurexins (encoded for by NXRN genes)"
     . SPARSER::COLLECTION)
    ("VEGF and TIE-2" . SPARSER::COLLECTION)
    ("neurexins" . SPARSER::PROTEIN-FAMILY)
    ("BMPER , GPLD1 , and NXRN1 and NXRN3" . SPARSER::COLLECTION)
    ("BMPER" . SPARSER::PROTEIN)
    ("Islet-1 ( ISL1 ) and secretoneurin" . SPARSER::COLLECTION)
    ("secretoneurin" . SPARSER::PROTEIN)
    ("ANGPTL3 , ISL1 and SCG2" . SPARSER::COLLECTION)
    ("SCG" . SPARSER::PROTEIN) ("metastatic PDAC" . SPARSER::MOLECULE)
    ("VEGF and PDGF receptor" . SPARSER::COLLECTION)
    ("vatalanib" . SPARSER::DRUG) ("endothelial JAK1" . SPARSER::PROTEIN)
    ("Conditioned media" . SPARSER::PROTEIN)
    ("conditioned media" . SPARSER::PROTEIN)
    ("SB505124 and ruxolitinib" . SPARSER::COLLECTION)
    ("ruxolitinib selectively targets JAK1 and JAK2" . SPARSER::COLLECTION)
    ("JAK1 and JAK2" . SPARSER::COLLECTION)
    ("JAK1 , JAK2 and JAK3" . SPARSER::COLLECTION)
    ("JAK and TGF-β" . SPARSER::COLLECTION)
    ("IUSCC-PC-1" . SPARSER::COLLECTION) ("PC-1" . SPARSER::PROTEIN)
    ("IUSCC-PC1" . SPARSER::COLLECTION) ("PC1" . SPARSER::PROTEIN)
    ("TGF-β target genes and an inflammation signature" . SPARSER::COLLECTION)
    ("TβRI and JAK" . SPARSER::COLLECTION)
    ("only 16 (−) inflammation genes" . SPARSER::GENE)
    ("IL1B , IL6 and JAK2" . SPARSER::COLLECTION)
    ("an oncogene and survival factor that can exert" . SPARSER::COLLECTION)
    ("ANGPT1 , TIE1 , TEK , CYP1B1 and HIF1A" . SPARSER::COLLECTION)
    ("KRC" . SPARSER::PROTEIN)
    ("TIE1 and TEK , and HIF1A" . SPARSER::COLLECTION)
    ("TEK , and HIF1A" . SPARSER::COLLECTION)
    ("ANGPT1 , TIE1 , TEK , CYP1B1 , HIF1A and HDAC9" . SPARSER::COLLECTION)
    ("TEK" . SPARSER::PROTEIN)
    ("CD31- and wild-type SMAD4-detecting antibodies [ xref ]"
     . SPARSER::COLLECTION)
    ("SMAD4 and CD31" . SPARSER::COLLECTION) ("CD31-" . SPARSER::PROTEIN)
    ("TGF-β1 and TGF-β2" . SPARSER::COLLECTION)
    ("ITGB1 , NRP1 and FLT4" . SPARSER::COLLECTION)
    ("pro-angiogenic CTGF and ITGA5" . SPARSER::COLLECTION)
    ("CTGF and ITGA5" . SPARSER::COLLECTION)
    ("SMAD4 and CDKN2A" . SPARSER::COLLECTION)
    ("SMAD4 (19%) and CDKN2A (19%)" . SPARSER::COLLECTION)
    ("− 2 ( KDR ) and − 3 ( FLT4 )" . SPARSER::COLLECTION)
    ("FGFR1 , and VEGFR-1" . SPARSER::COLLECTION) ("KDR" . SPARSER::PROTEIN)
    ("PDAC and PNET" . SPARSER::COLLECTION)
    ("PDACs and PNETs" . SPARSER::COLLECTION)
    ("SB505124 and JAK" . SPARSER::COLLECTION)
    ("the angiogenic genes" . SPARSER::GENE) ("new light" . SPARSER::PROTEIN)
    ("BRCA-1 or -2" . SPARSER::COLLECTION)
    ("hyaluronan, and fibronectin" . SPARSER::COLLECTION)
    ("TGF-β and JAK1" . SPARSER::COLLECTION)
    ("SMAD4 and HDAC9" . SPARSER::COLLECTION)
    ("several pro-inflammatory genes" . SPARSER::GENE)
    ("multiple pro-angiogenic genes" . SPARSER::GENE)
    ("PDACs" . SPARSER::MOLECULE) ("IL6ST" . SPARSER::PROTEIN)
    ("TLR7" . SPARSER::PROTEIN) ("thrombospondin-1" . SPARSER::PROTEIN)
    ("TGF-βs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("TIE2" . SPARSER::PROTEIN)
    ("CXCL12" . SPARSER::PROTEIN) ("COL4A3" . SPARSER::PROTEIN)
    ("COL15A1" . SPARSER::PROTEIN) ("TIE-2" . SPARSER::PROTEIN)
    ("PLD1" . SPARSER::PROTEIN) ("Phospholipase D1" . SPARSER::PROTEIN)
    ("FGFR-2" . SPARSER::PROTEIN) ("Islet-1" . SPARSER::PROTEIN)
    ("Angiopoietin-like 3" . SPARSER::PROTEIN) ("ISL1" . SPARSER::PROTEIN)
    ("ANGPTL3" . SPARSER::PROTEIN) ("PDGF receptor" . SPARSER::PROTEIN)
    ("IL10" . SPARSER::PROTEIN) ("TIE1" . SPARSER::PROTEIN)
    ("ANGPT1" . SPARSER::PROTEIN) ("NRP1" . SPARSER::PROTEIN)
    ("ITGA5" . SPARSER::PROTEIN) ("KBTBD6" . SPARSER::PROTEIN)
    ("FLT4" . SPARSER::PROTEIN) ("− 3" . SPARSER::PROTEIN)
    ("− 2" . SPARSER::PROTEIN) ("FLT1" . SPARSER::PROTEIN)
    ("VEGFR-1" . SPARSER::PROTEIN) ("SB505124" . SPARSER::DRUG)
    ("ATR and other PIKKs" . SPARSER::COLLECTION)
    ("ATM, ATR and other PIKKs" . SPARSER::COLLECTION)
    ("ATM or ATR" . SPARSER::COLLECTION) ("repetitive DNA" . SPARSER::DNA)
    ("the subsequent G2/M" . SPARSER::PROTEIN)
    ("RNA and telomerase" . SPARSER::COLLECTION)
    ("ATM or TRF1" . SPARSER::COLLECTION) ("ATM/TRF1" . SPARSER::COLLECTION)
    ("an active complex" . SPARSER::BIO-COMPLEX)
    ("hTERT and hTR" . SPARSER::COLLECTION)
    ("cellular telomerase components and their assembly capabilities"
     . SPARSER::COLLECTION)
    ("dramatic telomere length elongation" . SPARSER::PROTEIN)
    ("Myc-POT1ΔOB" . SPARSER::PROTEIN-PAIR)
    ("ATM and Chk2" . SPARSER::COLLECTION)
    ("aphidicolin and thymidine" . SPARSER::COLLECTION)
    ("phosphodeficient S367A TRF1" . SPARSER::PROTEIN)
    ("other DNA binding-defective TRF1 mutants" . SPARSER::MUTANT)
    ("myc-tagged exogenous TRF1" . SPARSER::PROTEIN)
    ("Exogenous TRF1" . SPARSER::PROTEIN)
    ("TRF1, or TRF1" . SPARSER::COLLECTION)
    ("residual TRF1" . SPARSER::PROTEIN) ("ATM and TRF1" . SPARSER::COLLECTION)
    ("thymidine/aphidicolin" . SPARSER::COLLECTION)
    ("ATM and/or other PIKK kinases" . SPARSER::COLLECTION)
    ("PIKK" . SPARSER::KINASE)
    ("thymidine and aphidicolin" . SPARSER::COLLECTION)
    ("KU-55933 and VE-822" . SPARSER::COLLECTION) ("TEL" . SPARSER::PROTEIN)
    ("oligosaccharide" . SPARSER::MOLECULE)
    ("TPP1 and POT1" . SPARSER::COLLECTION)
    ("the shelterin components TIN2 and the TPP1/POT1 heterodimer ( xref )"
     . SPARSER::COLLECTION)
    ("TPP1/POT1" . SPARSER::COLLECTION) ("POT1 and TPP1" . SPARSER::COLLECTION)
    ("proteins, and Rap1" . SPARSER::COLLECTION)
    ("‘shelterin’" . SPARSER::PROTEIN)
    ("telomerase RNA (hTR) and the protein dyskerin ( xref )"
     . SPARSER::COLLECTION)
    ("repetitive TTAGGG DNA" . SPARSER::DNA) ("OB" . SPARSER::PROTEIN)
    ("Taz1" . SPARSER::PROTEIN)
    ("single-stranded DNA binding protein" . SPARSER::PROTEIN)
    ("KU-55933" . SPARSER::DRUG) ("Rap1" . SPARSER::PROTEIN)
    ("Chk2 and p53" . SPARSER::COLLECTION)
    ("even essential genes" . SPARSER::GENE)
    ("KU55933 or Olaparib" . SPARSER::COLLECTION)
    ("Southern blot" . SPARSER::PROTEIN)
    ("Olaparib and KU55933" . SPARSER::COLLECTION)
    ("ATM-S1981" . SPARSER::PROTEIN-PAIR)
    ("reproducible decreased elongation" . SPARSER::PROTEIN)
    ("either KU55933 or the ATR inhibitor VE821 ( xref )"
     . SPARSER::COLLECTION)
    ("both KU55933 and siATM specifically inhibited ATM signaling"
     . SPARSER::COLLECTION)
    ("Class" . CLASS) ("a 2-nt" . SPARSER::PROTEIN-PAIR)
    ("the in vitro IScerette control sample showed no elongation"
     . SPARSER::PROTEIN)
    ("mTR−" . SPARSER::PROTEIN) ("Flp" . SPARSER::PROTEIN)
    ("HYG" . SPARSER::PROTEIN) ("a Southern blot" . SPARSER::PROTEIN)
    ("a conditional mTR allele and a modified chromosome 4 (chr4)"
     . SPARSER::COLLECTION)
    ("a conditional mTR allele" . SPARSER::ALLELE) ("mTR" . SPARSER::PROTEIN)
    ("SL" . SPARSER::PROTEIN) ("CAST" . SPARSER::PROTEIN)
    ("both Tel1 ATM and Mec1 ATR" . SPARSER::COLLECTION)
    ("ATM and tankyrase" . SPARSER::COLLECTION) ("32P" . SPARSER::|32P|)
    ("1L" . SPARSER::PROTEIN) ("Est1" . SPARSER::PROTEIN)
    ("S. cerevisiae" . SPARSER::PROTEIN) ("Class 2" . SPARSER::PROTEIN)
    ("AGGG)" . SPARSER::PROTEIN) ("Class 1" . SPARSER::PROTEIN-FAMILY)
    ("neither ATM nor H2AX" . SPARSER::COLLECTION)
    ("distal DNA" . SPARSER::DNA) ("distant DSBs" . SPARSER::PROTEIN)
    ("linearly or spatially proximal chromatin" . SPARSER::PROTEIN)
    ("broken chromatin" . SPARSER::PROTEIN)
    ("spatially proximal 53BP1 foci" . SPARSER::PROTEIN)
    ("larger foci" . SPARSER::PROTEIN)
    ("megabase-wide γH2AX" . SPARSER::PROTEIN)
    ("nucleosomal H2AX" . SPARSER::PROTEIN)
    ("a restricted domain around most DSBs" . SPARSER::PROTEIN)
    ("ATR, JNK, or mTOR" . SPARSER::COLLECTION)
    ("residual γH2AX" . SPARSER::PROTEIN)
    ("euchromatin" . SPARSER::BIO-COMPLEX)
    ("active or inactive genes" . SPARSER::GENE)
    ("HR or non-HR-prone" . SPARSER::COLLECTION)
    ("active or inactive" . SPARSER::COLLECTION)
    ("both non-HR-prone DSBs as well as HR-prone DSBs" . SPARSER::COLLECTION)
    ("clean and easily repairable DSBs" . SPARSER::PROTEIN)
    ("Cohesive DSBs" . SPARSER::PROTEIN)
    ("ionizing radiation-induced nuclear foci (IRIF)" . SPARSER::PROTEIN)
    ("foci (IRIF)" . SPARSER::PROTEIN) ("bigger foci" . SPARSER::PROTEIN)
    ("53BP1-GFP" . SPARSER::COLLECTION) ("Foci" . SPARSER::PROTEIN)
    ("the γH2AX signal around DSBs" . SPARSER::PROTEIN)
    ("H2AX phosphorylation around distinct DSBs" . SPARSER::PROTEIN)
    ("DSB" . SPARSER::PROTEIN)
    ("a ∼5-kb window around DSBs" . SPARSER::PROTEIN)
    ("DSBs" . SPARSER::PROTEIN) ("P-ATM and P-DNA-PKcs" . SPARSER::COLLECTION)
    ("AsiSI-DSBs" . SPARSER::COLLECTION) ("DIvA" . SPARSER::PROTEIN)
    ("HR and non-HR-prone" . SPARSER::COLLECTION)
    ("HR-prone" . SPARSER::COLLECTION)
    ("HR- and non-HR-prone" . SPARSER::COLLECTION)
    ("inactive genes" . SPARSER::GENE) ("“HR-prone" . SPARSER::COLLECTION)
    ("AsiSI" . SPARSER::PROTEIN) ("AsiSI-ER" . SPARSER::COLLECTION)
    ("auxin" . SPARSER::MOLECULE) ("AID-DIvA" . SPARSER::PROTEIN-PAIR)
    ("genotoxic drugs" . SPARSER::DRUG) ("PpoI" . SPARSER::PROTEIN)
    ("γ-H2AX/MDC1" . SPARSER::COLLECTION) ("anchor" . SPARSER::ANCHOR)
    ("XRCC4/DNA Ligase 4" . SPARSER::COLLECTION)
    ("ATRIP (ATR)" . SPARSER::PROTEIN) ("complex (ATM)" . SPARSER::BIO-COMPLEX)
    ("ATRIP" . SPARSER::PROTEIN) ("DNA-PKcs and ATM" . SPARSER::COLLECTION)
    ("DNA-PKcs, ATM, and ATR" . SPARSER::COLLECTION)
    ("minimal homology" . SPARSER::PROTEIN)
    ("kinases, ATM and DNA-PKcs" . SPARSER::COLLECTION)
    ("ATM and DNA-PKcs" . SPARSER::COLLECTION)
    ("ataxia telangiectasia mutated (ATM) and DNA-dependent protein kinase (DNA-PKcs)"
     . SPARSER::COLLECTION)
    ("Tel1" . SPARSER::PROTEIN) ("macroH2A1" . SPARSER::PROTEIN)
    ("TDP2" . SPARSER::PROTEIN) ("A–3" . SPARSER::PROTEIN)
    ("A–S2" . SPARSER::PROTEIN) ("Nu7441" . SPARSER::MOLECULE)
    ("4OHT" . SPARSER::DRUG) ("I-SceI" . SPARSER::PROTEIN)
    ("MDC1" . SPARSER::PROTEIN) ("DNA Ligase 4" . SPARSER::PROTEIN)
    ("XRCC4" . SPARSER::PROTEIN) ("DNA-PKcs" . SPARSER::PROTEIN)
    ("MyD88 and/or NF-κB" . SPARSER::COLLECTION)
    ("TLR4, MyD88 and/or NF-κB" . SPARSER::COLLECTION)
    ("Paris" . SPARSER::PROTEIN) ("norepinephrine" . SPARSER::DRUG)
    ("leukocytes/monocytes" . SPARSER::COLLECTION)
    ("chemokines and adhesion molecules" . SPARSER::COLLECTION)
    ("MyD88, TIRAP, TRIF and TRAM" . SPARSER::COLLECTION)
    ("TRAM" . SPARSER::PROTEIN) ("TRIF" . SPARSER::PROTEIN)
    ("TIRAP" . SPARSER::PROTEIN) ("PV and IVC" . SPARSER::COLLECTION)
    ("that BUN and SCr serum" . SPARSER::COLLECTION)
    ("cava (SVC)" . SPARSER::PROTEIN) ("IVC and PV" . SPARSER::COLLECTION)
    ("IVC" . SPARSER::PROTEIN) ("cava (IVC)" . SPARSER::PROTEIN)
    ("cava" . SPARSER::PROTEIN) ("PV" . SPARSER::PROTEIN)
    ("TLR4 and NF-κB" . SPARSER::COLLECTION)
    ("LDH and cytokines" . SPARSER::COLLECTION)
    ("p65 and cytokines" . SPARSER::COLLECTION)
    ("H/R and/or Dex" . SPARSER::COLLECTION) ("-AR" . SPARSER::COLLECTION)
    ("-adrenoceptor" . SPARSER::COLLECTION) ("-antagonist" . SPARSER::MOLECULE)
    ("TLR4/NF-κB/p65" . SPARSER::COLLECTION)
    ("TLR4/NF-κB" . SPARSER::COLLECTION)
    ("Proinflammatory cytokine" . SPARSER::PROTEIN)
    ("TNF-α and IL-1β" . SPARSER::COLLECTION)
    ("nitrogen (BUN)" . SPARSER::MOLECULE) ("adrenoceptor" . SPARSER::PROTEIN)
    ("IL-1, IL-6 and TNF-α" . SPARSER::COLLECTION)
    ("renal ischemia" . SPARSER::PROTEIN)
    ("TLR4/MyD88/NF-κB" . SPARSER::COLLECTION)
    ("-adrenergic" . SPARSER::COLLECTION) ("ARC" . SPARSER::PROTEIN)
    ("BUN" . SPARSER::MOLECULE)
    ("TLR4, NF-κB, tumor necrosis factor-α, and interleukin-1β"
     . SPARSER::COLLECTION)
    ("nitrogen(BUN)" . SPARSER::MOLECULE) ("dexmedetomidine" . SPARSER::DRUG)
    ("Dexmedetomidine" . SPARSER::DRUG) ("H3A" . SPARSER::PROTEIN)
    ("Adrenoceptor alpha 2A" . SPARSER::PROTEIN)
    ("Green fluorescent protein" . SPARSER::PROTEIN)
    ("adrenoceptor alpha 2A" . SPARSER::PROTEIN) ("myD88" . SPARSER::PROTEIN)
    ("NF–κB" . SPARSER::PROTEIN) ("a2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("interleukin-1β" . SPARSER::PROTEIN)
    ("reactive platinum" . SPARSER::MOLECULE)
    ("an effective chemotherapeutic drug" . SPARSER::DRUG)
    ("the favorable 399Arg allele" . SPARSER::ALLELE)
    ("allele, GlnGln, and GlnArg" . SPARSER::COLLECTION)
    ("HR " . SPARSER::PROTEIN)
    ("the unfavorable 194Arg allele" . SPARSER::ALLELE)
    ("allele, TrpTrp, and TrpArg" . SPARSER::COLLECTION)
    ("tryptophan" . SPARSER::MOLECULE)
    ("cisplatin (DDP) and carboplatin (CBP)" . SPARSER::COLLECTION)
    ("cross-complementing" . SPARSER::PROTEIN)
    ("complementing" . SPARSER::PROTEIN)
    ("optimal therapeutic and prognostic biomarkers" . SPARSER::MOLECULE)
    ("IIIB" . SPARSER::DRUG) ("ArgArg" . SPARSER::MOLECULE)
    ("X-ray repair" . SPARSER::PROTEIN)
    ("either heterozygous or homozygous R172H alleles" . SPARSER::ALLELE)
    ("one p53 GOF and DNA binding mutant" . SPARSER::COLLECTION)
    ("homozygous 53 alleles" . SPARSER::ALLELE)
    ("this apoptotic-related gene" . SPARSER::GENE)
    ("the exogenous p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("heterozygous p53 alleles" . SPARSER::ALLELE)
    ("mutant heterozygous alleles" . SPARSER::ALLELE)
    ("a stress-induced cell death or 2" . SPARSER::MOLECULE)
    ("Smarca4" . SPARSER::PROTEIN) ("Puma and Dnajc3" . SPARSER::COLLECTION)
    ("Dnajc3" . SPARSER::PROTEIN) ("Casp3" . SPARSER::PROTEIN)
    ("Casp" . SPARSER::PROTEIN)
    ("heterozygous mutant p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("genes, and genes" . SPARSER::COLLECTION)
    ("homozygous R248Q, R273H, or R172H alleles" . SPARSER::ALLELE)
    ("TP53 protein and its target gene p21" . SPARSER::COLLECTION)
    ("homozygous mutants" . SPARSER::MUTANT)
    ("Mdm2 or Brca1" . SPARSER::COLLECTION)
    ("a chromatin-associated high mobility–group protein" . SPARSER::PROTEIN)
    ("either WT p53 or specific p53 mutants ( xref )" . SPARSER::COLLECTION)
    ("Hmgb2" . SPARSER::PROTEIN) ("Hmgb" . SPARSER::PROTEIN-FAMILY)
    ("Cdkn1a and Mdm2" . SPARSER::COLLECTION) ("Cdkn1a" . SPARSER::PROTEIN)
    ("the homozygous mutants" . SPARSER::MUTANT)
    ("the exogenous WT p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p21 mRNA ( xref ) or protein ( xref )" . SPARSER::COLLECTION)
    ("homozygous GOF mutants" . SPARSER::MUTANT)
    ("exogenous WT p53 and nutlin-3a" . SPARSER::COLLECTION)
    ("p53 and nutlin-3a" . SPARSER::COLLECTION)
    ("ovarian cancer differentially" . SPARSER::PROTEIN)
    ("a heterozygous allele" . SPARSER::ALLELE)
    ("exogenous WT p53 and the C277F mutant" . SPARSER::COLLECTION)
    ("GFP-WT TP53 and most GFP-mutant TP53 proteins" . SPARSER::COLLECTION)
    ("GFP and p53" . SPARSER::COLLECTION)
    ("WT TP53 and specific TP53 mutants" . SPARSER::COLLECTION)
    ("GFP-tagged WT p53 and 10 mutants" . SPARSER::COLLECTION)
    ("even reduced p21 protein" . SPARSER::PROTEIN)
    ("exogenous WT TP53" . SPARSER::PROTEIN)
    ("those expressing homozygous mutant p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("no p53 (IC 50 = 60 μM) or mutant p53 (IC 50 = 20 μM)"
     . SPARSER::COLLECTION)
    ("TP53 or containing only mutant TP53" . SPARSER::COLLECTION)
    ("exogenous WT p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the WT allele and the mutant allele" . SPARSER::COLLECTION)
    ("this heterozygous tumor type" . TYPE)
    ("HOXA5 and HOXA9" . SPARSER::COLLECTION)
    ("TBX2, FOXA2, HOXA5, HOXA9, PPARG, and SMARCA4" . SPARSER::COLLECTION)
    ("PPARG" . SPARSER::PROTEIN) ("heterozygous alleles" . SPARSER::ALLELE)
    ("TGF, and HOX related genes and tumor subtypes xref"
     . SPARSER::COLLECTION)
    ("TGF, and HOX" . SPARSER::COLLECTION)
    ("GATA4 and TBX5" . SPARSER::COLLECTION)
    ("SOX2 , TBX2 , and TGFB2" . SPARSER::COLLECTION)
    ("chemokines, cytokines, and MMP" . SPARSER::COLLECTION)
    ("immune-related genes and HOX genes" . SPARSER::COLLECTION)
    ("immune-related genes" . SPARSER::GENE) ("HOX" . SPARSER::PROTEIN)
    ("miRNAs, and RNA binding" . SPARSER::COLLECTION)
    ("all ovarian tumor p53 mutants" . SPARSER::MUTANT)
    ("Mutants" . SPARSER::MUTANT)
    ("specific target genes and the responses of cells to nutlin-3a"
     . SPARSER::COLLECTION)
    ("mutant alleles and clearly support previous studies xref"
     . SPARSER::COLLECTION)
    ("one WT allele and one mutant allele" . SPARSER::COLLECTION)
    ("homozygous mutant alleles" . SPARSER::ALLELE)
    ("homozygous R172H mutant alleles" . SPARSER::ALLELE)
    ("Ren" . SPARSER::PROTEIN) ("nuclease" . SPARSER::PROTEIN)
    ("R175H/R175H homozygous alleles" . SPARSER::ALLELE)
    ("there many p53 mutants" . SPARSER::MUTANT)
    ("mutant p53 as well as WT p53" . SPARSER::COLLECTION)
    ("immune-related cytokines" . SPARSER::PROTEIN)
    ("homozygous alleles" . SPARSER::ALLELE) ("p21protein" . SPARSER::PROTEIN)
    ("Brca1" . SPARSER::PROTEIN) ("Mdm2" . SPARSER::PROTEIN)
    ("DNAJC3" . SPARSER::PROTEIN) ("CASP3" . SPARSER::PROTEIN)
    ("p53 " . SPARSER::HUMAN-PROTEIN-FAMILY) ("HOXA5" . SPARSER::PROTEIN)
    ("SMARCA4" . SPARSER::PROTEIN) ("TGFB2" . SPARSER::PROTEIN)
    ("KMT2A" . SPARSER::PROTEIN)
    ("cystathionine-beta-synthase" . SPARSER::PROTEIN)
    ("TRP53" . SPARSER::PROTEIN) ("Nutlin-3a" . SPARSER::DRUG)
    ("PRIMA-1" . SPARSER::PROTEIN) ("double minute 2" . SPARSER::PROTEIN)
    ("nutlin-3a" . SPARSER::DRUG)
    ("paediatric and adult PTCs" . SPARSER::PROTEIN)
    ("post-Chernobyl radiation-induced PTCs" . SPARSER::PROTEIN)
    ("both radiation-associated paediatric PTCs and sporadic paediatric PTCs"
     . SPARSER::COLLECTION)
    ("both radiation-associated paediatric PTCs" . SPARSER::PROTEIN)
    ("radiation-induced PTCs" . SPARSER::PROTEIN)
    ("sporadic PTCs" . SPARSER::PROTEIN)
    ("sporadic paediatric PTCs" . SPARSER::PROTEIN)
    ("the post-Chernobyl paediatric PTCs" . SPARSER::PROTEIN)
    ("cribriform-morular PTCs" . SPARSER::PROTEIN)
    ("the BRAF  V600E -negative PTCs" . SPARSER::PROTEIN)
    ("cribriform-morular variant PTCs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("/NTRK3" . SPARSER::COLLECTION) ("AKAP9/BRAF" . SPARSER::COLLECTION)
    ("HRAS , KRAS and NRAS" . SPARSER::COLLECTION)
    ("61 classical PTCs" . SPARSER::PROTEIN)
    ("adult sporadic PTCs" . SPARSER::PROTEIN)
    ("BRAF and RAS family" . SPARSER::COLLECTION)
    ("RET/PTC" . SPARSER::COLLECTION) ("PTC" . SPARSER::PROTEIN)
    ("grasp" . SPARSER::PROTEIN) ("iodine" . SPARSER::MOLECULE)
    ("paediatric PTCs" . SPARSER::PROTEIN)
    ("classic and follicular variant PTCs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ETV6/NTRK3" . SPARSER::COLLECTION) ("RET/PTC3" . SPARSER::COLLECTION)
    ("RET/PTC1" . SPARSER::COLLECTION)
    ("four cribriform-morular variant PTCs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("two follicular variant PTCs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PTCs" . SPARSER::PROTEIN) ("AKAP9" . SPARSER::PROTEIN)
    ("ETV6" . SPARSER::PROTEIN) ("PTC3" . SPARSER::PROTEIN)
    ("PTC1" . SPARSER::PROTEIN) ("ribonuclease" . SPARSER::PROTEIN)
    ("presumably RNA-DNA ICLs" . SPARSER::PROTEIN)
    ("BRCA2 and BRCA1" . SPARSER::COLLECTION) ("SETX" . SPARSER::PROTEIN)
    ("BRCA2- and BRCA1-" . SPARSER::COLLECTION) ("BRCA1-" . SPARSER::PROTEIN)
    ("BRCA2-" . SPARSER::PROTEIN) ("cordycepin" . SPARSER::DRUG)
    ("RNA and DNA" . SPARSER::COLLECTION) ("ICL" . SPARSER::PROTEIN)
    ("APOE and RPL13A" . SPARSER::COLLECTION) ("SNRPN" . SPARSER::PROTEIN)
    ("APOE , RPL13A and EGR1" . SPARSER::COLLECTION)
    ("APOE , RPL13A , EGR1 and BTBD19" . SPARSER::COLLECTION)
    ("APOE" . SPARSER::PROTEIN) ("DRIP" . SPARSER::PROTEIN)
    ("FANCA or FANCD2" . SPARSER::COLLECTION) ("FA-" . SPARSER::PROTEIN)
    ("BRCA2/FANCD1" . SPARSER::COLLECTION)
    ("premature chromatin condensation" . SPARSER::PROTEIN-FAMILY)
    ("condensation and heterochromatin" . SPARSER::COLLECTION)
    ("the THO complex or the SRSF splicing factor" . SPARSER::COLLECTION)
    ("Senataxin" . SPARSER::PROTEIN)
    ("reactive aldehydes (RA)" . SPARSER::MOLECULE)
    ("aldehydes" . SPARSER::MOLECULE) ("ICLs" . SPARSER::PROTEIN)
    ("MMC" . SPARSER::PROTEIN) ("FANCD2 or FANCA" . SPARSER::COLLECTION)
    ("FANCA" . SPARSER::PROTEIN) ("of pregnancy" . SPARSER::PROTEIN)
    ("FA-A" . SPARSER::PROTEIN) ("RNaseH1" . SPARSER::PROTEIN)
    ("pcDNA3" . SPARSER::PROTEIN) ("replication/repair" . SPARSER::PROTEIN)
    ("mitomycin C" . SPARSER::DRUG) ("3-1" . SPARSER::PROTEIN)
    ("RPL13A" . SPARSER::PROTEIN) ("Fanconi Anemia" . SPARSER::PROTEIN)
    ("FANCD1" . SPARSER::PROTEIN) ("β1 and nucleolin" . SPARSER::COLLECTION)
    ("APPL1-TβRI" . SPARSER::COLLECTION)
    ("the cancer-associated matrix metalloprotease" . SPARSER::PROTEIN)
    ("metalloprotease" . SPARSER::PROTEIN)
    ("significantly less TβRI" . SPARSER::PROTEIN)
    ("transiently co-transfected GFP-tagged APPL1 and C-terminally HA-tagged TβRI"
     . SPARSER::PROTEIN)
    ("APPL1 and C-terminally" . SPARSER::COLLECTION)
    ("APPL1 and PKCζ" . SPARSER::COLLECTION)
    ("TRAF6 and PKCζ" . SPARSER::COLLECTION)
    ("polyubiquitin and APPL1" . SPARSER::COLLECTION)
    ("antisera" . SPARSER::PROTEIN) ("TβRI–APPL" . SPARSER::COLLECTION)
    ("TβRI and APPL1" . SPARSER::COLLECTION) ("GFP-APPL" . SPARSER::COLLECTION)
    ("HA-TβRI" . SPARSER::COLLECTION)
    ("endogenous APPL1 and the full length TβRI (Figure xref , xref )"
     . SPARSER::COLLECTION)
    ("a physical complex" . SPARSER::BIO-COMPLEX)
    ("adiponectin" . SPARSER::PROTEIN)
    ("APPL1 and APPL2-" . SPARSER::COLLECTION) ("APPL2-" . SPARSER::PROTEIN)
    ("APPL1-" . SPARSER::PROTEIN) ("p-SMAD2" . SPARSER::COLLECTION)
    ("GFP-APPL1" . SPARSER::COLLECTION)
    ("APPL1 and TβRI" . SPARSER::COLLECTION)
    ("APPL1 and the C-terminal part" . SPARSER::COLLECTION)
    ("APPL1 and TβRI-ICD" . SPARSER::COLLECTION)
    ("a TβRI- and PKCζ-associated protein" . SPARSER::COLLECTION)
    ("PKCζ-associated protein" . SPARSER::PROTEIN) ("TβRI-" . SPARSER::PROTEIN)
    ("APPL1 and Rab5a" . SPARSER::COLLECTION)
    ("Akt [ xref ] and PI3K [ xref , xref ]" . SPARSER::COLLECTION)
    ("bin1" . SPARSER::PROTEIN) ("amphiphysin" . SPARSER::PROTEIN)
    ("bin" . SPARSER::PROTEIN) ("EEA1 and PI3K" . SPARSER::COLLECTION)
    ("SMAD7 and the ubiquitin ligase Smurf2" . SPARSER::COLLECTION)
    ("SMAD anchor for receptor activation (SARA)" . SPARSER::PROTEIN)
    ("SARA" . SPARSER::PROTEIN)
    ("receptor and G protein-coupled" . SPARSER::COLLECTION)
    ("caveolin" . SPARSER::PROTEIN) ("p38/JNK" . SPARSER::COLLECTION)
    ("phosphatidylinositol 3-kinase (PI3K) and the tyrosine kinase Src [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("Erk, JNK and p38" . SPARSER::COLLECTION)
    ("SMAD" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("heterotetrameric complexes" . SPARSER::BIO-COMPLEX)
    ("TβRII and TβRI" . SPARSER::COLLECTION)
    ("glycine-serine" . SPARSER::COLLECTION)
    ("type I and type II" . SPARSER::COLLECTION)
    ("TβRI and TβRII" . SPARSER::COLLECTION)
    ("APPL–TβRI" . SPARSER::COLLECTION) ("APPL" . SPARSER::PROTEIN)
    ("the endocytic adaptor molecules APPL1 and APPL2" . SPARSER::COLLECTION)
    ("APPL1 and APPL2" . SPARSER::COLLECTION)
    ("pro-invasive genes" . SPARSER::GENE)
    ("Smad and non-Smad" . SPARSER::COLLECTION)
    ("Protein-G" . SPARSER::PROTEIN) ("SB-3CT" . SPARSER::DRUG)
    ("SB 505124" . SPARSER::DRUG) ("PKCζ" . SPARSER::PROTEIN)
    ("Rab5a" . SPARSER::PROTEIN) ("PI-3" . SPARSER::PROTEIN)
    ("Rvs 167" . SPARSER::PROTEIN) ("Smurf2" . SPARSER::PROTEIN)
    ("SMAD7" . SPARSER::PROTEIN)
    ("SMAD anchor for receptor activation" . SPARSER::PROTEIN)
    ("early endosome antigen-1" . SPARSER::PROTEIN)
    ("G protein-coupled" . SPARSER::PROTEIN) ("TAK1" . SPARSER::PROTEIN)
    ("SMAD2" . SPARSER::PROTEIN)
    ("receptor-activated SMADs" . SPARSER::PROTEIN-FAMILY)
    ("TβRII" . SPARSER::PROTEIN) ("APPL2" . SPARSER::PROTEIN)
    ("TβRI" . SPARSER::PROTEIN) ("HBx, and p62" . SPARSER::COLLECTION)
    ("HBx and Keap1" . SPARSER::COLLECTION)
    ("nucleotide and lipid" . SPARSER::COLLECTION)
    ("a major pathogenic protein" . SPARSER::PROTEIN)
    ("Nrf2 or G6PD" . SPARSER::COLLECTION)
    ("Nrf2 and G6PD" . SPARSER::COLLECTION)
    ("Nqo1 and Cyp2a5" . SPARSER::COLLECTION)
    ("Phox and Bem1p" . SPARSER::COLLECTION) ("Phox" . SPARSER::PROTEIN)
    ("HBx and p62" . SPARSER::COLLECTION) ("fix" . SPARSER::PROTEIN)
    ("HBx-Cherry puncta" . SPARSER::PROTEIN) ("FLIP" . SPARSER::PROTEIN)
    ("GFP-Keap1" . SPARSER::COLLECTION) ("GFP-HBx" . SPARSER::COLLECTION)
    ("Flag-p62T352A" . SPARSER::PROTEIN-PAIR)
    ("HBx–Keap1" . SPARSER::COLLECTION) ("Keap1 and p62" . SPARSER::COLLECTION)
    ("Keap1–HBx" . SPARSER::COLLECTION) ("Keap1 and HBx" . SPARSER::COLLECTION)
    ("p62–Keap1" . SPARSER::COLLECTION)
    ("Nqo1 , Gstm1 , and Cyp2a5" . SPARSER::COLLECTION)
    ("a classic Nrf2 activator" . SPARSER::ACTIVATOR)
    ("HBx-GFP" . SPARSER::COLLECTION) ("DNA and HBVX" . SPARSER::COLLECTION)
    ("Cyp2a5" . SPARSER::PROTEIN) ("Gstm1" . SPARSER::PROTEIN)
    ("HBx-Myc" . SPARSER::COLLECTION)
    ("the typical cytoprotective genes" . SPARSER::GENE)
    ("HBsAg" . SPARSER::DRUG) ("p62 and Keap1" . SPARSER::COLLECTION)
    ("K-Ras and Myc" . SPARSER::COLLECTION)
    ("Bcl-2 and Bcl" . SPARSER::COLLECTION)
    ("TAp" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ample oxygen" . SPARSER::MOLECULE)
    ("p62 and the Nrf2 repressor Keap1" . SPARSER::COLLECTION)
    ("UBA and PB1" . SPARSER::COLLECTION)
    ("HBx–p62–Keap1" . SPARSER::COLLECTION) ("UBA" . SPARSER::PROTEIN)
    ("anti- β" . SPARSER::PROTEIN)
    ("hypoxia-inducible factor" . SPARSER::PROTEIN) ("Bem1" . SPARSER::PROTEIN)
    ("glutathione S-transferase M1" . SPARSER::PROTEIN)
    ("hepatitis B surface antigen" . SPARSER::DRUG)
    ("p53-related protein" . SPARSER::PROTEIN)
    ("Glucose-6-phosphate dehydrogenase" . SPARSER::PROTEIN)
    ("p53 and Fra-1" . SPARSER::COLLECTION)
    ("p53 as well as Fra-1" . SPARSER::COLLECTION)
    ("c-Fos, c-Jun and MMP-9" . SPARSER::COLLECTION)
    ("c-Jun, c-Fos and MMP-9" . SPARSER::COLLECTION)
    ("Raf-MEK-ERK" . SPARSER::COLLECTION)
    ("MMP-9 and ECM" . SPARSER::COLLECTION)
    ("MMP-9, cyclin D1 and Bcl-2" . SPARSER::COLLECTION)
    ("MMP-9, Cyclin D1 and Bcl-2" . SPARSER::COLLECTION)
    ("p53 ( xref ) and Fra-1" . SPARSER::COLLECTION) ("Das" . SPARSER::DRUG)
    ("JunB/c-Fos" . SPARSER::COLLECTION)
    ("JunB instead of c-Jun" . SPARSER::COLLECTION)
    ("JunD/JunD" . SPARSER::COLLECTION) ("c-Fos/JunD" . SPARSER::COLLECTION)
    ("c-Fos-Fra-2" . SPARSER::COLLECTION)
    ("c-Jun and Fra-2" . SPARSER::COLLECTION) ("CRE" . SPARSER::PROTEIN)
    ("an altered functional AP-1 complex formed by heterodimerization between c-Fos and Fra-2 instead of canonical partners"
     . SPARSER::COLLECTION)
    ("these viral oncoproteins" . SPARSER::PROTEIN)
    ("nicotine" . SPARSER::DRUG) ("the most predominant type" . TYPE)
    ("Bcl-2, MMP-9 and Cyclin D1" . SPARSER::COLLECTION)
    ("Fra-2-siRNA" . SPARSER::COLLECTION)
    ("cyclin D1 and Bcl-2" . SPARSER::COLLECTION)
    ("Bcl-2, MMP-9 and cyclin D1" . SPARSER::COLLECTION)
    ("c-Fos and c-Jun" . SPARSER::COLLECTION)
    ("Bcl-2 and Cyclin D1" . SPARSER::COLLECTION)
    ("MMP-9, Bcl-2 and Cyclin D1" . SPARSER::COLLECTION)
    ("MMP-9, CyclinD1 and Bcl-2" . SPARSER::COLLECTION)
    ("c-Jun, JunB, JunD, c-Fos and Fra-2" . SPARSER::COLLECTION)
    ("c-Jun, c-Fos and Fra-2" . SPARSER::COLLECTION)
    ("JunB (p = 0.003) and JunD (p = 0.0001) proteins" . SPARSER::COLLECTION)
    ("c-Fos (80%; 40/50, p = 0.0001) and Fra-2 (76%; 38/50, p = 0.0001)"
     . SPARSER::COLLECTION)
    ("c-Jun, JunD, JunB, c-Fos, FosB, Fra-1 and Fra-2" . SPARSER::COLLECTION)
    ("JunB and JunD" . SPARSER::COLLECTION)
    ("functional AP-1" . SPARSER::PROTEIN) ("JunD/JunB" . SPARSER::COLLECTION)
    ("JunD" . SPARSER::PROTEIN) ("homologous AP-1" . SPARSER::PROTEIN)
    ("blot (RLB)" . SPARSER::PROTEIN) ("Fra-2/c-Fos" . SPARSER::COLLECTION)
    ("AP-1 and its family proteins" . SPARSER::COLLECTION)
    ("c-Fos, c-Jun and JunB" . SPARSER::COLLECTION) ("Dl" . SPARSER::MOLECULE)
    ("FosB" . SPARSER::PROTEIN)
    ("HPV particularly high-risk HPV (HR-HPV) type" . TYPE)
    ("nut" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("c-Fos/Fra-2" . SPARSER::COLLECTION)
    ("c-Fos, c-Jun, MMP-9 and HPVE6/E7" . SPARSER::COLLECTION)
    ("Fra-1 and p53" . SPARSER::COLLECTION)
    ("c-Fos and Fra-2" . SPARSER::COLLECTION) ("ATP 5" . SPARSER::PROTEIN)
    ("Transcription factor" . SPARSER::PROTEIN) ("CyclinD1" . SPARSER::PROTEIN)
    ("Fos-related antigen 2" . SPARSER::PROTEIN)
    ("Fos-related antigen 1" . SPARSER::PROTEIN) ("Jun-D" . SPARSER::PROTEIN)
    ("Jun-B" . SPARSER::PROTEIN) ("activator protein-1" . SPARSER::PROTEIN)
    ("Fra-2" . SPARSER::PROTEIN) ("TP53 and Rb" . SPARSER::COLLECTION)
    ("CREBBP and EP300" . SPARSER::COLLECTION)
    ("PIK3CA (5 % mutations and 10 % amplifications) and MET (4.4 % mutation)"
     . SPARSER::COLLECTION)
    ("TTF-1, cytokeratin, CAM, CD56, NSE, chromogranin, synoptophysin and EMA"
     . SPARSER::COLLECTION)
    ("NSE" . SPARSER::PROTEIN)
    ("EGFR , NRAS , KRAS and BRAF" . SPARSER::COLLECTION)
    ("CD56 and synaptophsin" . SPARSER::COLLECTION)
    ("Carboplatin" . SPARSER::DRUG)
    ("KRAS (35 cases) and NRAS (37 cases) genes (Table  xref )"
     . SPARSER::COLLECTION)
    ("the EGFR (31 cases), KRAS (35 cases) and NRAS (37 cases) genes (Table  xref )"
     . SPARSER::COLLECTION)
    ("EGFR , KRAS , BRAF and NRAS" . SPARSER::COLLECTION)
    ("Group (ECOG)" . SPARSER::MOLECULE)
    ("EGFR , BRAF , KRAS and NRAS" . SPARSER::COLLECTION)
    ("phosphatase and tensin homolog ( PTEN ; 5 %) and KRAS (5 %)"
     . SPARSER::COLLECTION)
    ("rapamycin-insensitive companion of mTOR ( RICTOR ; 10 %), stem cell factor receptor tyrosine kinase ( KIT ; 7 %), PI3KCA (6 %) epidermal growth factor receptor ( EGFR ; 5 %), phosphatase and tensin homolog ( PTEN ; 5 %) and KRAS (5 %)"
     . SPARSER::COLLECTION)
    ("PCI" . SPARSER::PROTEIN) ("EGFR , KRAS and NRAS" . SPARSER::COLLECTION)
    ("BRAF and NRAS" . SPARSER::COLLECTION)
    ("ALK and MET" . SPARSER::COLLECTION)
    ("epidermal growth factor receptors ( EGFR )"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("KRAS, NRAS and BRAF" . SPARSER::COLLECTION)
    ("year-old" . SPARSER::PROTEIN) ("HER-2" . SPARSER::PROTEIN)
    ("C- MET" . SPARSER::PROTEIN)
    ("stem cell factor receptor" . SPARSER::PROTEIN)
    ("epidermal growth factor receptors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("normal myoepithelial cells form" . SPARSER::FORM)
    ("A type I" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("dense collagen" . SPARSER::PROTEIN) ("fibrotic foci" . SPARSER::PROTEIN)
    ("Wnt1/iFGFR1" . SPARSER::PROTEIN) ("EGFR and FGFR" . SPARSER::COLLECTION)
    ("Areg" . SPARSER::PROTEIN) ("p-EGFR" . SPARSER::COLLECTION)
    ("disrupted vasculature and markedly decreased tumor-infiltrating MDSCs"
     . SPARSER::COLLECTION)
    ("anti-CD11b and anti-GR1 antibodies (Additional file xref : Figure S6B) as well as anti-Ly6G (data not shown)"
     . SPARSER::COLLECTION)
    ("anti-CD11b and anti-GR1" . SPARSER::COLLECTION)
    ("MMTV-Wnt1/iFGFR1" . SPARSER::PROTEIN-PAIR)
    ("Hematoxylin and eosin staining staining" . SPARSER::COLLECTION)
    ("Hematoxylin" . SPARSER::MOLECULE)
    ("a nonpalpable state" . SPARSER::BIO-STATE)
    ("Wnt/iR1" . SPARSER::COLLECTION) ("p-c-Fos" . SPARSER::COLLECTION)
    ("p-4E-BP1" . SPARSER::COLLECTION) ("p-4EBP1" . SPARSER::COLLECTION)
    ("K5 and HA" . SPARSER::COLLECTION) ("K5 and the HA" . SPARSER::COLLECTION)
    ("the luminal marker Keratin 8 (K8) and the basal marker Keratin 5 (K5)"
     . SPARSER::COLLECTION)
    ("Wnt and FGFR1" . SPARSER::COLLECTION) ("MMTV-Wnt1" . SPARSER::COLLECTION)
    ("MMTV-Wnt1/iR1" . SPARSER::COLLECTION)
    ("FGFR1 and EGFR" . SPARSER::COLLECTION)
    ("EGFR and FGFR1" . SPARSER::COLLECTION) ("Wnt1/iR1" . SPARSER::COLLECTION)
    ("FGFR and Wnt" . SPARSER::COLLECTION)
    ("c-MYC and CCND1" . SPARSER::COLLECTION) ("erbB2" . SPARSER::PROTEIN)
    ("Tenascin-C" . SPARSER::PROTEIN) ("Ly6G" . SPARSER::PROTEIN)
    ("p-MEK1" . SPARSER::PROTEIN) ("K5" . SPARSER::PROTEIN)
    ("Keratin 5" . SPARSER::PROTEIN) ("Keratin 8" . SPARSER::PROTEIN)
    ("S100A8" . SPARSER::PROTEIN) ("iR1" . SPARSER::PROTEIN)
    ("tenascin-C" . SPARSER::PROTEIN)
    ("a Belgian clinical patient cohort" . SPARSER::MOLECULE)
    ("p62 and OPTN" . SPARSER::COLLECTION)
    ("OPTN and TBK1" . SPARSER::COLLECTION)
    ("TBK1 and OPTN" . SPARSER::COLLECTION) ("VCP" . SPARSER::PROTEIN)
    ("OPTN" . SPARSER::PROTEIN) ("optineurin" . SPARSER::PROTEIN)
    ("Substrates" . SPARSER::SUBSTRATE)
    ("carried both the TBK1 p" . SPARSER::PROTEIN) ("sibs" . SPARSER::DRUG)
    ("DFG" . SPARSER::PROTEIN) ("GAA" . SPARSER::PROTEIN)
    ("sporadic ALS" . SPARSER::PROTEIN)
    ("TDP-43 and p62" . SPARSER::COLLECTION) ("TDP" . SPARSER::TDP)
    ("ALS or FTD-ALS" . SPARSER::COLLECTION)
    ("spinal onset ALS" . SPARSER::PROTEIN) ("sib" . SPARSER::DRUG)
    ("e-2" . SPARSER::PROTEIN) ("e-1" . SPARSER::PROTEIN)
    ("the Belgian FTD cohort" . SPARSER::MOLECULE)
    ("ALS, and ALS" . SPARSER::COLLECTION)
    ("a strong genetic component" . SPARSER::COMPONENT)
    ("the Belgian clinically based patient cohort" . SPARSER::MOLECULE)
    ("C9orf72 and GRN" . SPARSER::COLLECTION) ("GRN" . SPARSER::PROTEIN)
    ("ALS and an extended Belgian FTD-ALS family DR158" . SPARSER::COLLECTION)
    ("Belgian FTD and ALS patient cohorts" . SPARSER::MOLECULE)
    ("NF-KB" . SPARSER::PROTEIN) ("VPS37C" . SPARSER::PROTEIN)
    ("type B" . SPARSER::PROTEIN) ("PSEN1" . SPARSER::PROTEIN)
    ("CHMP2B" . SPARSER::PROTEIN) ("C9orf72" . SPARSER::PROTEIN)
    ("TBK1" . SPARSER::PROTEIN) ("keratins" . SPARSER::PROTEIN)
    ("ERK-MNK2" . SPARSER::COLLECTION) ("β4 and plectin" . SPARSER::COLLECTION)
    ("ERK1/2 and RSK" . SPARSER::COLLECTION)
    ("PA-JEB/β4" . SPARSER::COLLECTION) ("β4" . SPARSER::PROTEIN)
    ("β4-keratinocytes" . SPARSER::PROTEIN-PAIR)
    ("neither CsA nor FK506" . SPARSER::COLLECTION)
    ("CsA and FK506" . SPARSER::COLLECTION) ("Calcineurin" . SPARSER::PROTEIN)
    ("MEK1/2 or RSK" . SPARSER::COLLECTION)
    ("PKCs, PKCɛ, PKCη and PKCδ" . SPARSER::COLLECTION)
    ("PKD3 and β4" . SPARSER::COLLECTION)
    ("ERK1/2 and RSK1/2" . SPARSER::COLLECTION)
    ("α6β4 and plectin" . SPARSER::COLLECTION)
    ("plectin and integrin" . SPARSER::COLLECTION)
    ("GDC-0941 or AZD 8055" . SPARSER::COLLECTION)
    ("the PI3K inhibitor (GDC-0941) and the mTOR kinase inhibitor (AZD 8055)"
     . SPARSER::COLLECTION)
    ("RSK1 and RSK2" . SPARSER::COLLECTION)
    ("RSK1 and RSK2, and kinase-inactive" . SPARSER::COLLECTION)
    ("RSK2, and kinase-inactive" . SPARSER::COLLECTION)
    ("RSK1 or RSK2" . SPARSER::COLLECTION) ("PMA or EGF" . SPARSER::COLLECTION)
    ("EGF or PMA" . SPARSER::COLLECTION)
    ("PKD (S744/748 and S916) and β4-T1736" . SPARSER::COLLECTION)
    ("PKD and β4" . SPARSER::COLLECTION) ("S744/748" . SPARSER::PROTEIN)
    ("PKD-S744/748 and β4-T1736" . SPARSER::COLLECTION)
    ("PKD-S744/748" . SPARSER::COLLECTION)
    ("PKCε and PKCη" . SPARSER::COLLECTION)
    ("PKCε or PKCη" . SPARSER::COLLECTION)
    ("PKCδ and PKCη" . SPARSER::COLLECTION)
    ("PKCε, PKCδ and PKCη" . SPARSER::COLLECTION)
    ("PKCs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PKD2 or both proteins" . SPARSER::COLLECTION)
    ("PKD1, PKD2 or both proteins" . SPARSER::COLLECTION)
    ("PKD1 and PKD2" . SPARSER::COLLECTION)
    ("PKD2 or PKD3" . SPARSER::COLLECTION)
    ("PKD2 and PKD3" . SPARSER::COLLECTION)
    ("PKC and EGFR" . SPARSER::COLLECTION)
    ("PKC (Gő6983) and MEK1/2 (UO126)" . SPARSER::COLLECTION)
    ("PKD and MAPK" . SPARSER::COLLECTION) ("PKD" . SPARSER::PROTEIN)
    ("FK506 and CsA" . SPARSER::COLLECTION) ("JEB" . SPARSER::PROTEIN)
    ("PA-JEB" . SPARSER::PROTEIN-PAIR) ("ionophore" . SPARSER::MOLECULE)
    ("BAPTA" . SPARSER::MOLECULE) ("chelator" . SPARSER::MOLECULE)
    ("ERK-1/2 and their downstream effector kinases RSK-1/2"
     . SPARSER::COLLECTION)
    ("Epidermal Growth factor (EGF)" . SPARSER::PROTEIN)
    ("α6β4 or plectin" . SPARSER::COLLECTION)
    ("cytoskeletal linker proteins" . SPARSER::PROTEIN)
    ("plectin and BP230" . SPARSER::COLLECTION)
    ("a transmembrane collagen" . SPARSER::PROTEIN) ("α6β4" . SPARSER::PROTEIN)
    ("junctional protein" . SPARSER::PROTEIN)
    ("PKD2 or RSK1" . SPARSER::COLLECTION) ("PMA-" . SPARSER::PROTEIN)
    ("calcineurin" . SPARSER::PROTEIN) ("PMA and EGF" . SPARSER::COLLECTION)
    ("plakin" . SPARSER::PROTEIN) ("α6β4-plectin" . SPARSER::PROTEIN-PAIR)
    ("the cytoskeletal linker protein plectin" . SPARSER::PROTEIN)
    ("HDs" . SPARSER::PROTEIN) ("MNK2" . SPARSER::PROTEIN)
    ("calcium/calmodulin" . SPARSER::CALCIUM-CALMODULIN-COMPLEX)
    ("MNK1" . SPARSER::PROTEIN) ("calcineurin inhibitor" . SPARSER::PROTEIN)
    ("cyclophilin A" . SPARSER::PROTEIN) ("calyculin A" . SPARSER::MOLECULE)
    ("AZD 8055" . SPARSER::DRUG) ("FK506" . SPARSER::DRUG)
    ("Epidermolysis Bullosa" . SPARSER::PROTEIN) ("B-5" . SPARSER::PROTEIN)
    ("PKCε" . SPARSER::PROTEIN) ("p90" . SPARSER::PROTEIN)
    ("RSK2" . SPARSER::PROTEIN) ("PKD3" . SPARSER::PROTEIN)
    ("RSK-1" . SPARSER::PROTEIN) ("ERK-1/2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Epidermal Growth factor" . SPARSER::PROTEIN) ("BP230" . SPARSER::PROTEIN)
    ("BP180" . SPARSER::PROTEIN) ("RSK1" . SPARSER::PROTEIN)
    ("BI-D1870" . SPARSER::MOLECULE) ("PKD2" . SPARSER::PROTEIN)
    ("PKD1" . SPARSER::PROTEIN)
    ("the underlying biological traits" . SPARSER::PROTEIN)
    ("ER−/PgR+" . SPARSER::COLLECTION) ("PR-B and ER" . SPARSER::COLLECTION)
    ("PR-A or PR-B" . SPARSER::COLLECTION) ("RgR" . SPARSER::PROTEIN)
    ("PR-A and PR-B" . SPARSER::COLLECTION) ("PgR+" . SPARSER::PROTEIN)
    ("ER− and ER+" . SPARSER::COLLECTION) ("ER−PgR+" . SPARSER::PROTEIN-PAIR)
    ("PgR−" . SPARSER::PROTEIN) ("Adjuvant" . SPARSER::DRUG)
    ("a functional ER" . SPARSER::PROTEIN) ("HER2−" . SPARSER::PROTEIN)
    ("PR-B" . SPARSER::PROTEIN) ("PR-A" . SPARSER::PROTEIN)
    ("HR2" . SPARSER::PROTEIN) ("HR 1" . SPARSER::PROTEIN-FAMILY)
    ("type and ethnicity" . SPARSER::COLLECTION)
    ("cyclins and cyclin-dependent kinase" . SPARSER::COLLECTION)
    ("Cyclin-dependent kinases (CDKs) and CDK inhibitors (CKIs)"
     . SPARSER::COLLECTION)
    ("CKI" . SPARSER::PROTEIN) ("CKIs" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase inhibitor 1B" . SPARSER::PROTEIN)
    ("Cyclin-dependent kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("FOXK2 and the closely related FOXK1" . SPARSER::COLLECTION)
    ("GR and ER" . SPARSER::COLLECTION)
    ("FOXO3 and vice versa" . SPARSER::COLLECTION)
    ("only one protein can" . SPARSER::PROTEIN)
    ("FOXK2 and this transcription factor" . SPARSER::COLLECTION)
    ("tA" . SPARSER::PROTEIN) ("CAAC" . SPARSER::PROTEIN)
    ("aTA" . SPARSER::MOLECULE) ("ANKRD1 and TRIB1" . SPARSER::COLLECTION)
    ("Sso7d" . SPARSER::PROTEIN) ("FOXK2-Sso7d" . SPARSER::COLLECTION)
    ("FOS , ANKRD1 and TRIB1" . SPARSER::COLLECTION)
    ("highest around genes" . SPARSER::GENE)
    ("at least one FOX transcription factor" . SPARSER::PROTEIN)
    ("FOXK2-FOXO3" . SPARSER::COLLECTION)
    ("FOXK2 or FOXJ3" . SPARSER::COLLECTION)
    ("a triple Flag-tagged fusion protein" . SPARSER::PROTEIN)
    ("FOXK2/FOXO3" . SPARSER::COLLECTION)
    ("FOXK2 or FOXO3" . SPARSER::COLLECTION)
    ("FOXO3 and FOXK2" . SPARSER::COLLECTION)
    ("HOMER" . SPARSER::PROTEIN-FAMILY)
    ("a triple FLAG" . SPARSER::PROTEIN-FAMILY)
    ("triple flag" . SPARSER::PROTEIN-FAMILY)
    ("purine and Y" . SPARSER::COLLECTION)
    ("FOXK2 and FOXO3" . SPARSER::COLLECTION)
    ("FOXK2 and FOXJ3" . SPARSER::COLLECTION)
    ("FOXK2, FOXO3 and FOXJ3" . SPARSER::COLLECTION)
    ("FOXK1" . SPARSER::PROTEIN) ("A-T" . SPARSER::PROTEIN)
    ("S12" . SPARSER::PROTEIN) ("TRIB1" . SPARSER::PROTEIN)
    ("ANKRD1" . SPARSER::PROTEIN) ("e −5" . SPARSER::PROTEIN)
    ("MACS 1" . SPARSER::PROTEIN) ("K18" . SPARSER::PROTEIN)
    ("CYP27" . SPARSER::PROTEIN) ("LMNB1" . SPARSER::PROTEIN)
    ("ILF1" . SPARSER::PROTEIN) ("ETS1" . SPARSER::PROTEIN)
    ("FOXK2" . SPARSER::PROTEIN) ("DNA and re‐biopsy" . SPARSER::COLLECTION)
    ("AZD9291 and CO" . SPARSER::COLLECTION) ("MBP" . SPARSER::PROTEIN)
    ("AZD9291" . SPARSER::DRUG) ("opt" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("RAD51C, RAD51 and BRCA2" . SPARSER::COLLECTION)
    ("class 1– 3" . SPARSER::COLLECTION) ("Pal" . SPARSER::PROTEIN)
    ("our premenopausal cohort" . SPARSER::MOLECULE)
    ("insA" . SPARSER::PROTEIN) ("delG" . SPARSER::PROTEIN)
    ("the premenopausal breast cancer group" . SPARSER::MOLECULE)
    ("progesterone receptors and HER2/NEU receptors" . SPARSER::COLLECTION)
    ("HER2/NEU" . SPARSER::COLLECTION) ("NEU" . SPARSER::PROTEIN)
    ("BRCA1 , BRCA2 and PALB2" . SPARSER::COLLECTION)
    ("a strong heritable component" . SPARSER::COMPONENT)
    ("RAD51C" . SPARSER::PROTEIN) ("class 1" . SPARSER::PROTEIN-FAMILY)
    ("growth factor/cytokine" . SPARSER::COLLECTION)
    ("a mechanical inducer" . SPARSER::PROTEIN)
    ("Noxa and Bim" . SPARSER::COLLECTION)
    ("MAPKs or PI3K" . SPARSER::COLLECTION)
    ("firsthand cigarette smoke" . SPARSER::MOLECULE)
    ("MCP-1 and p53" . SPARSER::COLLECTION) ("AMO" . SPARSER::PROTEIN)
    ("FPCM" . SPARSER::PROTEIN-FAMILY)
    ("SP600125 (20 nmol/L, JNK inhibitor) or SB203580 (20 nmol/L, p38 inhibitor)"
     . SPARSER::COLLECTION)
    ("the commercially available small molecule U0126" . SPARSER::DRUG)
    ("MAPK and Akt" . SPARSER::COLLECTION)
    ("MAPKs or Akt" . SPARSER::COLLECTION)
    ("MAPKs and PI3K/Akt" . SPARSER::COLLECTION)
    ("MAPKs and Akt" . SPARSER::COLLECTION) ("Vla1" . SPARSER::PROTEIN)
    ("HGF/scatter factor" . SPARSER::COLLECTION) ("Vla" . SPARSER::MOLECULE)
    ("chemokines and cytokines" . SPARSER::COLLECTION)
    ("AMOs" . SPARSER::PROTEIN) ("p53/PUMA" . SPARSER::COLLECTION)
    ("p53 and PUMA protein" . SPARSER::COLLECTION)
    ("p53 and PUMA" . SPARSER::COLLECTION) ("SiO" . SPARSER::MOLECULE)
    ("1–4 " . SPARSER::PROTEIN) ("P3-4" . SPARSER::PROTEIN)
    ("Rho GTPase" . SPARSER::PROTEIN) ("LY-294002" . SPARSER::PROTEIN)
    ("PAl-1" . SPARSER::PROTEIN)
    ("macrophage-stimulating protein" . SPARSER::PROTEIN)
    ("scatter factor" . SPARSER::PROTEIN) ("PUMA protein" . SPARSER::PROTEIN)
    ("monocyte chemotactic protein 1" . SPARSER::PROTEIN)
    ("significantly higher PLK1 and KI67" . SPARSER::COLLECTION)
    ("PLK1 and KI67" . SPARSER::COLLECTION)
    ("rapidly proliferating tissues given PLK1’s" . SPARSER::PROTEIN)
    ("rapidly proliferating tissues given PLK1" . SPARSER::PROTEIN)
    ("protein and RNA" . SPARSER::COLLECTION)
    ("protein, and PLK1 and FOXM1" . SPARSER::COLLECTION)
    ("both PLK1 (paired T test p = 0.007) and FOXM1 (paired T test p = 0.001)"
     . SPARSER::COLLECTION)
    ("18S ribosomal RNA" . SPARSER::RNA)
    ("a commercially available antibody" . SPARSER::PROTEIN)
    ("FOXM1 or PLK1" . SPARSER::COLLECTION)
    ("FOXM1and PLK1" . SPARSER::COLLECTION)
    ("FOXM1 and cellcycle" . SPARSER::COLLECTION)
    ("CCNB1 and PLK1" . SPARSER::COLLECTION)
    ("FOXM1 and its target gene PLK1" . SPARSER::COLLECTION)
    ("FOXM1 and PLK1" . SPARSER::COLLECTION)
    ("PLK1 and FOXM1" . SPARSER::COLLECTION)
    ("PLK1 or FOXM1" . SPARSER::COLLECTION)
    ("PLK1 and the forkhead transcription factor FOXM1" . SPARSER::COLLECTION)
    ("KI67" . SPARSER::PROTEIN) ("GSK461364" . SPARSER::DRUG)
    ("β - actin" . SPARSER::PROTEIN) ("K19" . SPARSER::PROTEIN)
    ("FoxM1" . SPARSER::PROTEIN) ("β -catenin" . SPARSER::PROTEIN)
    ("CCNB1" . SPARSER::PROTEIN) ("Polo-like Kinase" . SPARSER::PROTEIN)
    ("Atg5 and Atg7" . SPARSER::COLLECTION)
    ("mTOR and AMPK" . SPARSER::COLLECTION) ("Atg1" . SPARSER::PROTEIN)
    ("phosphatidylethanolamine (PE)" . SPARSER::MOLECULE)
    ("Atg 7 and Atg" . SPARSER::COLLECTION)
    ("phosphatidylethanolamine" . SPARSER::MOLECULE)
    ("Atg 7" . SPARSER::PROTEIN) ("Atg16L" . SPARSER::PROTEIN)
    ("Atg12-Atg5" . SPARSER::COLLECTION)
    ("the E1-like enzyme Atg7 and the E2-like enzyme Atg10"
     . SPARSER::COLLECTION)
    ("Atg10" . SPARSER::PROTEIN) ("atg5 or atg7" . SPARSER::COLLECTION)
    ("atg7" . SPARSER::PROTEIN) ("Atg5-" . SPARSER::PROTEIN)
    ("Atg5" . SPARSER::PROTEIN)
    ("BSA and other proteins" . SPARSER::COLLECTION)
    ("extracellular albumin or dextran" . SPARSER::COLLECTION)
    ("albumin or dextran" . SPARSER::COLLECTION)
    ("extracellular lipids [ xref ] or internalizing extracellular ATP [ xref ]"
     . SPARSER::COLLECTION)
    ("glutamine and essential amino acids" . SPARSER::COLLECTION)
    ("essential amino acids" . SPARSER::AMINO-ACID)
    ("an anabolic signaling molecule" . SPARSER::MOLECULE)
    ("rapamycin or amiloride" . SPARSER::COLLECTION)
    ("amiloride or rapamycin" . SPARSER::COLLECTION)
    ("CQ and rapamycin or amiloride and rapamycin" . SPARSER::COLLECTION)
    ("rapamycin or amiloride and rapamycin" . SPARSER::COLLECTION)
    ("amiloride and rapamycin" . SPARSER::COLLECTION)
    ("amiloride, and rapamycin" . SPARSER::COLLECTION)
    ("phospho-S6K and -S6" . SPARSER::COLLECTION)
    ("p70 S6 kinase (S6K) and S6 ribosomal protein (S6)" . SPARSER::COLLECTION)
    ("atg5" . SPARSER::PROTEIN) ("Atg7" . SPARSER::PROTEIN)
    ("TMR-BSA" . SPARSER::COLLECTION) ("Atg" . SPARSER::DRUG)
    ("atg" . SPARSER::DRUG) ("Dextran" . SPARSER::DEXTRAN)
    ("extracellular BSA" . SPARSER::PROTEIN)
    ("either KRas G12V (Figure xref ) or HRas G12V (Figure xref )"
     . SPARSER::COLLECTION)
    ("visualized using fluorescent molecule-labeled BSA" . SPARSER::PROTEIN)
    ("bovine serum albumin (BSA)" . SPARSER::PROTEIN)
    ("KRas" . SPARSER::PROTEIN) ("EIPA" . SPARSER::DRUG)
    ("amiloride" . SPARSER::DRUG) ("normal MEF" . SPARSER::PROTEIN)
    ("HRas" . SPARSER::PROTEIN) ("TMR" . SPARSER::PROTEIN)
    ("tetramethylrhodamine" . SPARSER::MOLECULE)
    ("glucose and glutamine" . SPARSER::COLLECTION) ("HBP" . SPARSER::PROTEIN)
    ("hexosamine" . SPARSER::MOLECULE)
    ("extracellular macromolecules" . SPARSER::MOLECULE)
    ("albumin" . SPARSER::PROTEIN) ("clathrin" . SPARSER::PROTEIN)
    ("sulforhodamine B" . SPARSER::MOLECULE) ("Ulk1" . SPARSER::PROTEIN)
    ("Torin2" . SPARSER::DRUG) ("P62" . SPARSER::PROTEIN)
    ("ULK2" . SPARSER::PROTEIN) ("Atg12" . SPARSER::PROTEIN)
    ("E1" . SPARSER::MOLECULE) ("ATG12" . SPARSER::PROTEIN)
    ("ULK1" . SPARSER::PROTEIN)
    ("CTNNB1, TP53, ARID1A, ARID2, NFE2L2, AXIN1, PIK3CA, KEAP1, RPS6KA3, and CDKN2A"
     . SPARSER::COLLECTION)
    ("HCA" . SPARSER::PROTEIN) ("CLS" . SPARSER::PROTEIN)
    ("the multimeric GA-binding protein (GABP) transcription factor"
     . SPARSER::PROTEIN)
    ("both the variant and mutation combination" . SPARSER::COLLECTION)
    ("the TERT promoter and further decreased TERT promoter methylation in HepG2 cells (Figure xref )"
     . SPARSER::COLLECTION)
    ("E2F1 and ETS2" . SPARSER::COLLECTION)
    ("ETS2 and the TERT promoter" . SPARSER::COLLECTION)
    ("a methylated TERT promoter" . SPARSER::PROMOTER)
    ("DNMT1 or HDAC1" . SPARSER::COLLECTION)
    ("WT E2F1 (increased E2F1) or DN-E2F1 (decreased E2F1)"
     . SPARSER::COLLECTION)
    ("E2F1 and the rs2853669 variant" . SPARSER::COLLECTION)
    ("Pol" . SPARSER::PROTEIN) ("a dominant-negative E2F1" . SPARSER::PROTEIN)
    ("DNMT1, HDAC1, and E2F1" . SPARSER::COLLECTION)
    ("DNMT1 and HDAC1" . SPARSER::COLLECTION)
    ("DNMT1 and E2F1" . SPARSER::COLLECTION) ("ATG" . SPARSER::DRUG)
    ("a dominant-negative E2F1 mutant" . SPARSER::MUTANT)
    ("Eco" . SPARSER::PROTEIN) ("mRNA and TERT" . SPARSER::COLLECTION)
    ("the rs2853669 variant and the mutation combination"
     . SPARSER::COLLECTION)
    ("rs2853669 variant and the TERT promoter mutation combination"
     . SPARSER::COLLECTION)
    ("SMH" . SPARSER::PROTEIN) ("an essential enzyme" . SPARSER::ENZYME)
    ("a methylated promoter" . SPARSER::PROMOTER)
    ("DNA methyltransferase 1 and histone deacetylase 1" . SPARSER::COLLECTION)
    ("RPS6KA3" . SPARSER::PROTEIN) ("AXIN1" . SPARSER::PROTEIN)
    ("DNMT1" . SPARSER::PROTEIN) ("ETS2" . SPARSER::PROTEIN)
    ("Telomerase reverse transcriptase" . SPARSER::PROTEIN)
    ("histone deacetylase 1" . SPARSER::PROTEIN)
    ("DNA methyltransferase 1" . SPARSER::PROTEIN)
    ("formononetin or sunitinib" . SPARSER::COLLECTION)
    ("PI3K, Akt, MMP-2, MMP-9, and STAT3" . SPARSER::COLLECTION)
    ("CD31 and p-FGFR2 Tyr463 antibodies" . SPARSER::COLLECTION)
    ("MBN" . SPARSER::PROTEIN)
    ("a well-known inducer of MMPs and angiogenic factors"
     . SPARSER::COLLECTION)
    ("TGF-β, CD31, COX-2 and Ang2" . SPARSER::COLLECTION)
    ("Protein-protein" . SPARSER::COLLECTION)
    ("VEGF and VEGFR2" . SPARSER::COLLECTION)
    ("25 μM formononetin, 10 μM sunitinib, or their combination"
     . SPARSER::COLLECTION)
    ("Formononetin and sunitinib" . SPARSER::COLLECTION)
    ("formononetin and VEGFR2" . SPARSER::COLLECTION)
    ("FGF2/FGFR2" . SPARSER::COLLECTION)
    ("PI3K, Akt, STAT3, and MMP-2/9" . SPARSER::COLLECTION)
    ("p-FGFR2" . SPARSER::COLLECTION)
    ("group and formononetin" . SPARSER::COLLECTION)
    ("FGFR1 and its downstream regulatory proteins" . SPARSER::COLLECTION)
    ("PI3k" . SPARSER::PROTEIN-FAMILY) ("FGFR2-PI3K-Akt" . SPARSER::COLLECTION)
    ("CD31, COX-2, and Ang2" . SPARSER::COLLECTION)
    ("transforming growth factor-β1" . SPARSER::COLLECTION)
    ("c-Jun and NF-κB" . SPARSER::COLLECTION)
    ("further suppressing FGFR2" . SPARSER::PROTEIN)
    ("FGF2-FGFR2" . SPARSER::COLLECTION)
    ("PI3K, and Akt" . SPARSER::COLLECTION)
    ("PI3K and Akt" . SPARSER::COLLECTION)
    ("the Immunoprecipitation-western blot" . SPARSER::PROTEIN)
    ("FGFR1 and formononetin" . SPARSER::COLLECTION)
    ("FGF2 and its downstream protein kinase" . SPARSER::COLLECTION)
    ("extracellular FGF2" . SPARSER::PROTEIN)
    ("FGFR2 and FGFR1" . SPARSER::COLLECTION)
    ("FGFR1, VEGFR2, PDGFRα, and PDGFRβ" . SPARSER::COLLECTION)
    ("formononetin and sunitinib" . SPARSER::COLLECTION)
    ("PI3k-Akt" . SPARSER::COLLECTION) ("VEGFRs" . SPARSER::PROTEIN)
    ("Akt/Cyclin D1/CDK4" . SPARSER::COLLECTION)
    ("isoflavonoid" . SPARSER::MOLECULE)
    ("cytotoxic antineoplastic drugs" . SPARSER::DRUG)
    ("Phytochemicals" . SPARSER::DRUG) ("VEGF-VEGFR2" . SPARSER::COLLECTION)
    ("cyclooxygenase-2 (COX-2) and angiopoietin-2 (Ang-2)"
     . SPARSER::COLLECTION)
    ("a latent transcription factor" . SPARSER::PROTEIN)
    ("c-Jun and nuclear factor kappa-light-chain-enhancer"
     . SPARSER::COLLECTION)
    ("signal transducer and activator of transcription 3 (STAT3), c-Jun and nuclear factor kappa-light-chain-enhancer"
     . SPARSER::COLLECTION)
    ("a pivotal downstream target" . SPARSER::TARGET-PROTEIN)
    ("-protein kinase B" . SPARSER::COLLECTION)
    ("placenta growth factor (PIGF)" . SPARSER::PROTEIN)
    ("c-Met, and platelet-derived growth factor receptor-alpha"
     . SPARSER::COLLECTION)
    ("sunitinib, sorafenib, and vandetanib" . SPARSER::COLLECTION)
    ("vandetanib" . SPARSER::DRUG)
    ("receptor tyrosine kinase (RTK)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("FGFR2 and protein kinase B" . SPARSER::COLLECTION)
    ("Formononetin" . SPARSER::DRUG) ("formononetin" . SPARSER::DRUG)
    ("RPLP0" . SPARSER::PROTEIN) ("MnCl2" . SPARSER::DRUG)
    ("Ang2" . SPARSER::PROTEIN) ("c-Kit" . SPARSER::PROTEIN)
    ("PDGFRβ" . SPARSER::PROTEIN) ("Ang-2" . SPARSER::PROTEIN)
    ("angiopoietin-2" . SPARSER::PROTEIN)
    ("phosphatidylinositol-4, 5-bisphosphate 3-kinase"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("derived growth factor receptor-alpha" . SPARSER::PROTEIN)
    ("Fms-like tyrosine kinase 3" . SPARSER::PROTEIN)
    ("FGF1" . SPARSER::PROTEIN) ("placenta growth factor" . SPARSER::PROTEIN)
    ("Vascular endothelial growth factor receptor 2" . SPARSER::PROTEIN)
    ("Snail and Vimentin" . SPARSER::COLLECTION)
    ("TGFβ and hypoxia" . SPARSER::COLLECTION)
    ("premalignant prostatic" . SPARSER::PROTEIN)
    ("parathyroid hormone-related protein (PTHrP) and RANKL"
     . SPARSER::COLLECTION)
    ("PTHrP" . SPARSER::PROTEIN) ("Wnts" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("BMPs" . SPARSER::PROTEIN) ("FGFs" . SPARSER::PROTEIN)
    ("osteocalcin" . SPARSER::PROTEIN) ("alizarin" . SPARSER::DRUG)
    ("AR or ERβ" . SPARSER::COLLECTION) ("Luc-GFP" . SPARSER::PROTEIN-PAIR)
    ("Collagen, and Osteocalcin" . SPARSER::COLLECTION)
    ("Osteocalcin" . SPARSER::PROTEIN)
    ("estrogen and two different ER antagonists, tamoxifen and ICI 182,780 (ICI)"
     . SPARSER::COLLECTION)
    ("antagonists, tamoxifen and ICI 182,780 (ICI)" . SPARSER::COLLECTION)
    ("antagonists, tamoxifen and ICI 182,780" . SPARSER::COLLECTION)
    ("ERE" . SPARSER::PROTEIN) ("MPP" . SPARSER::PROTEIN)
    ("PPT" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ERE-luciferase" . SPARSER::PROTEIN-PAIR)
    ("PC-3 and BPH-1" . SPARSER::COLLECTION)
    ("ERα, ERβ and AR" . SPARSER::COLLECTION)
    ("estrogen and ERα" . SPARSER::COLLECTION)
    ("subtypes, ERα and ERβ" . SPARSER::COLLECTION)
    ("receptors (ER)" . SPARSER::RECEPTOR)
    ("androgen and estrogen" . SPARSER::COLLECTION)
    ("ERα and estrogen" . SPARSER::COLLECTION) ("ESR2" . SPARSER::PROTEIN)
    ("acid-2" . SPARSER::PROTEIN)
    ("Alkaline phosphatase" . SPARSER::PROTEIN-FAMILY)
    ("ICI 182, 780" . SPARSER::DRUG)
    ("fibroblast growth factors" . SPARSER::PROTEIN-FAMILY)
    ("endothelin-1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Runx-2" . SPARSER::PROTEIN) ("C4–2" . SPARSER::PROTEIN)
    ("ERβ2" . SPARSER::PROTEIN) ("KLF5" . SPARSER::PROTEIN)
    ("Anti-estrogens" . SPARSER::DRUG)
    ("selective estrogen receptor modulator" . SPARSER::DRUG)
    ("ICI 182,780" . SPARSER::DRUG)
    ("estrogen receptor beta" . SPARSER::PROTEIN)
    ("the full-length and the truncated SET 76–277 proteins"
     . SPARSER::COLLECTION)
    ("SET and PP2Ac" . SPARSER::COLLECTION) ("RalA" . SPARSER::PROTEIN)
    ("cisplatin and docetaxel" . SPARSER::COLLECTION)
    ("the drug target or apoptosis regulatory genes [ xref – xref ]"
     . SPARSER::COLLECTION)
    ("SET/PP2A/p-Akt" . SPARSER::COLLECTION)
    ("SET and SET" . SPARSER::COLLECTION) ("DDK" . SPARSER::BIO-COMPLEX)
    ("PP2Ac and SET" . SPARSER::COLLECTION) ("SPR" . SPARSER::PROTEIN)
    ("PP2Ac and these truncated SET proteins (Figure xref )"
     . SPARSER::COLLECTION)
    ("blot and PP2A" . SPARSER::COLLECTION)
    ("antagonist and paclitaxel" . SPARSER::COLLECTION)
    ("SET-KD" . SPARSER::COLLECTION)
    ("siRNA or a novel SET inhibitor" . SPARSER::COLLECTION)
    ("urethane" . SPARSER::MOLECULE) ("SET-PP2Ac" . SPARSER::COLLECTION)
    ("BCR/ABL" . SPARSER::COLLECTION) ("T200" . SPARSER::PROTEIN)
    ("PP2A-C" . SPARSER::PROTEIN) ("apolipoprotein-E" . SPARSER::PROTEIN)
    ("SET 1" . SPARSER::PROTEIN) ("FTY720" . SPARSER::DRUG)
    ("Further studies using βAR-specific antagonists" . SPARSER::MOLECULE)
    ("−6.3" . SPARSER::COLLECTION)
    ("propranolol or vehicle 40 mg/kg" . SPARSER::COLLECTION)
    ("MSC" . SPARSER::PROTEIN) ("Analog" . SPARSER::ANALOG)
    ("Annexin V and caspase-3" . SPARSER::COLLECTION)
    ("propranolol, and ERK1/2" . SPARSER::COLLECTION)
    ("Isoprenaline" . SPARSER::DRUG) ("forskolin" . SPARSER::PROTEIN)
    ("a nonselective βAR antagonist" . SPARSER::MOLECULE)
    ("β1- and β2-Adrenergic Receptors" . SPARSER::COLLECTION)
    ("β2-Adrenergic" . SPARSER::COLLECTION) ("β1-" . SPARSER::PROTEIN)
    ("Receptors" . SPARSER::RECEPTOR) ("Adrenergic" . SPARSER::PROTEIN)
    ("cAMP and ERK1/2" . SPARSER::COLLECTION)
    ("cAMP and MAPK" . SPARSER::COLLECTION) ("isoprenaline" . SPARSER::DRUG)
    ("mediating propranolol’s" . SPARSER::DRUG)
    ("proliferating IHs" . SPARSER::MOLECULE)
    ("a nonselective β-adrenergic receptor (βAR) antagonist"
     . SPARSER::MOLECULE)
    ("problematic IHs" . SPARSER::MOLECULE) ("IH" . SPARSER::MOLECULE)
    ("β2-adrenergic" . SPARSER::COLLECTION) ("propranolol" . SPARSER::DRUG)
    ("adrenergic" . SPARSER::PROTEIN) ("Propranolol" . SPARSER::DRUG)
    ("IHs" . SPARSER::MOLECULE) ("β-arrestin" . SPARSER::PROTEIN)
    ("—2" . SPARSER::PROTEIN) ("pH 3" . SPARSER::MOLECULE)
    ("pERK1/2" . SPARSER::PROTEIN) ("β2ARs" . SPARSER::PROTEIN)
    ("β-arrestins" . SPARSER::PROTEIN) ("β2AR" . SPARSER::PROTEIN)
    ("dobutamine" . SPARSER::DRUG)
    ("The reported YAP antagonists verteporfin and Vgll4-mimicking peptide"
     . SPARSER::COLLECTION)
    ("verteporfin" . SPARSER::DRUG) ("DSS" . SPARSER::PROTEIN)
    ("primary biliary cirrhosis" . SPARSER::PROTEIN) ("BDL" . SPARSER::PROTEIN)
    ("the severe I/R group" . SPARSER::MOLECULE)
    ("The reported YAP downstream target CTGF and the two YAP partners TEAD2 and TEAD3"
     . SPARSER::COLLECTION)
    ("TEAD2 and TEAD3" . SPARSER::COLLECTION)
    ("vimentin, PCNA and αSMA" . SPARSER::COLLECTION)
    ("the cardiac glycoside digitoxin" . SPARSER::DRUG)
    ("glycoside" . SPARSER::MOLECULE)
    ("pro-fibrotic-related genes" . SPARSER::GENE)
    ("G 2 /M-" . SPARSER::PROTEIN)
    ("kidney-specific cadherin, AQP1 and γ-glutamyltransferase"
     . SPARSER::COLLECTION)
    ("fibrotic proteins" . SPARSER::PROTEIN)
    ("megalin, AQP1 and E-cadherin" . SPARSER::COLLECTION)
    ("megalin" . SPARSER::PROTEIN)
    ("vimentin, pSmad2/3 and PCNA" . SPARSER::COLLECTION)
    ("vimentin, αSMA and PCNA" . SPARSER::COLLECTION)
    ("CTGF, TEAD2 and TEAD3" . SPARSER::COLLECTION)
    ("vestigial" . SPARSER::PROTEIN-FAMILY)
    ("TEAD2 (TEA domain family member 2) and TEAD3" . SPARSER::COLLECTION)
    ("TEAD/TEF" . SPARSER::COLLECTION) ("TEF" . SPARSER::PROTEIN)
    ("the I/R 30 min group and the sham operation control group"
     . SPARSER::COLLECTION)
    ("digitoxin" . SPARSER::DRUG) ("sodium sulfate" . SPARSER::MOLECULE)
    ("kidney-specific cadherin" . SPARSER::PROTEIN)
    ("type I" . SPARSER::HUMAN-PROTEIN-FAMILY) ("TEAD3" . SPARSER::PROTEIN)
    ("TEA domain family member 2" . SPARSER::PROTEIN)
    ("TEAD2" . SPARSER::PROTEIN) ("K +" . SPARSER::MOLECULE)
    ("Na +" . SPARSER::MOLECULE)
    ("connective tissue growth factor" . SPARSER::PROTEIN)
    ("epithelial cadherin" . SPARSER::PROTEIN)
    ("aquaporin 1" . SPARSER::PROTEIN) ("AQP1" . SPARSER::PROTEIN)
    ("Lats1" . SPARSER::PROTEIN) ("I/R" . SPARSER::PROTEIN)
    ("erlotinib or docetaxel" . SPARSER::COLLECTION)
    ("ECOG" . SPARSER::PROTEIN) ("ECOG-PS" . SPARSER::COLLECTION)
    ("infrequent allele" . SPARSER::ALLELE) ("LCS6" . SPARSER::PROTEIN)
    ("KRAS-LCS6" . SPARSER::COLLECTION)
    ("docetaxel instead of erlotinib" . SPARSER::COLLECTION)
    ("K 2" . SPARSER::PROTEIN) ("G protein" . SPARSER::PROTEIN)
    ("ras family" . SPARSER::PROTEIN) ("MYBL1 and LIMD1" . SPARSER::COLLECTION)
    ("“LIMD1-MYBL1" . SPARSER::COLLECTION)
    ("antiapoptotic BCL2" . SPARSER::PROTEIN)
    ("BCL2 or MYC" . SPARSER::COLLECTION)
    ("pro- and anti-apoptotic" . SPARSER::COLLECTION)
    ("almost all MYC/BCL6" . SPARSER::COLLECTION)
    ("Concurrent MYC" . SPARSER::PROTEIN)
    ("BCL6 and MYC" . SPARSER::COLLECTION)
    ("SORL1 , RFTN1 , GNA13 , SWAP70 , and ANKRD13A" . SPARSER::COLLECTION)
    ("MARCKSL1 , VNN2 , OSBPL3 , ACTR2 and etc." . SPARSER::COLLECTION)
    ("ACTR" . SPARSER::PROTEIN)
    ("BMP3 , SWAP70 , and CELSR1" . SPARSER::COLLECTION)
    ("PLA2G7 and DOCK10" . SPARSER::COLLECTION)
    ("TMEM49 , CFLAR , CARD16 and CASP1" . SPARSER::COLLECTION)
    ("SRGN" . SPARSER::PROTEIN) ("CFLAR" . SPARSER::PROTEIN)
    ("CELSR" . SPARSER::PROTEIN)
    ("DLBCL included 24 upregulated genes and 14 downregulated genes"
     . SPARSER::COLLECTION)
    ("DLBCL included 24 upregulated genes" . SPARSER::GENE)
    ("concurrent MYC/BCL2" . SPARSER::COLLECTION)
    ("concurrent MYC/BCL6" . SPARSER::COLLECTION)
    ("MYC, BCL2, and BCL6" . SPARSER::COLLECTION)
    ("BCL2 and BCL6" . SPARSER::COLLECTION) ("BCL2/BCL6" . SPARSER::COLLECTION)
    ("MYC , BCL2 , and BCL6" . SPARSER::COLLECTION)
    ("concurrent MYC" . SPARSER::PROTEIN)
    ("CCND2 and MYC" . SPARSER::COLLECTION)
    ("rarely other known oncogenes" . SPARSER::ONCOGENE)
    ("the biologic and diagnostic hallmarks" . SPARSER::COLLECTION)
    ("heterogeneous biologic" . SPARSER::DRUG) ("/BCL6" . SPARSER::COLLECTION)
    ("/BCL2" . SPARSER::COLLECTION)
    ("MYC , BCL2 and BCL6" . SPARSER::COLLECTION)
    ("MYC and BCL6" . SPARSER::COLLECTION) ("LIMD1" . SPARSER::PROTEIN)
    ("ALDH4A1" . SPARSER::PROTEIN) ("CASP10" . SPARSER::PROTEIN)
    ("OSBPL3" . SPARSER::PROTEIN) ("MARCKSL1" . SPARSER::PROTEIN)
    ("ANKRD13" . SPARSER::PROTEIN) ("GNA13" . SPARSER::PROTEIN)
    ("SORL1" . SPARSER::PROTEIN) ("STAP1" . SPARSER::PROTEIN)
    ("catalytic subunit gamma" . SPARSER::PROTEIN)
    ("PIK3CG" . SPARSER::PROTEIN) ("HMGN1" . SPARSER::PROTEIN)
    ("bromodomain and WD repeat domain containing 1" . SPARSER::PROTEIN)
    ("BRWD1" . SPARSER::PROTEIN) ("NEK6" . SPARSER::PROTEIN)
    ("MYBL1" . SPARSER::PROTEIN) ("TPM4" . SPARSER::PROTEIN)
    ("SLAMF7" . SPARSER::PROTEIN) ("MYO3" . SPARSER::PROTEIN)
    ("TMEM49" . SPARSER::PROTEIN) ("DOCK10" . SPARSER::PROTEIN)
    ("PLA2G7" . SPARSER::PROTEIN) ("SWAP70" . SPARSER::PROTEIN)
    ("BMP3" . SPARSER::PROTEIN) ("p27 and p21" . SPARSER::COLLECTION)
    ("SGK1 and SGK3" . SPARSER::COLLECTION) ("VPS" . SPARSER::PROTEIN)
    ("exogenous INPP4B or myr-SGK3" . SPARSER::COLLECTION)
    ("INPP4B or myr-SGK3" . SPARSER::COLLECTION)
    ("c-Myc and eIF4E" . SPARSER::COLLECTION)
    ("co-introduced exogenous INPP4B" . SPARSER::PROTEIN)
    ("the anti-miRNA" . SPARSER::ANTIBODY) ("myr" . SPARSER::MOLECULE)
    ("exogenous INPP4B" . SPARSER::PROTEIN)
    ("INPP4B and Mel-RM" . SPARSER::COLLECTION) ("RM" . SPARSER::MOLECULE)
    ("BRAF or NRAS" . SPARSER::COLLECTION)
    ("BRAF (BRAF V600E ) and NRAS (NRAS Q61R )" . SPARSER::COLLECTION)
    ("PIK3CA , PTEN, and PIB5PA" . SPARSER::COLLECTION)
    ("HEMn-DP" . SPARSER::COLLECTION) ("HEMn-MP" . SPARSER::COLLECTION)
    ("PI3K/SGK3" . SPARSER::COLLECTION)
    ("PTEN and some 5-phosphatases" . SPARSER::COLLECTION)
    ("SHIP2 and PIB5PA" . SPARSER::COLLECTION)
    ("inositol polyphosphate 4-phosphatase type I (INPP4A) and type II (INPP4B)"
     . SPARSER::COLLECTION)
    ("inositol 5- phosphatase (SHIP) and phosphatidylinositol 4,5-Bisphosphate 5-Phosphatase (PIB5PA)"
     . SPARSER::COLLECTION)
    ("phosphatase (PIPP)" . SPARSER::PHOSPHATASE)
    ("phosphatase (SHIP)" . SPARSER::PHOSPHATASE) ("PIPP" . SPARSER::PROTEIN)
    ("Phosphatase" . SPARSER::PHOSPHATASE) ("SHIP" . SPARSER::PROTEIN)
    ("polyphosphate" . SPARSER::MOLECULE)
    ("Akt, SGK1 and SGK3" . SPARSER::COLLECTION)
    ("PDK1 and mTORC2" . SPARSER::COLLECTION)
    ("SGK1, SGK2, and SGK3" . SPARSER::COLLECTION)
    ("glucocorticoid-regulated kinase" . SPARSER::COLLECTION)
    ("glucocorticoid-regulated kinase 3" . SPARSER::COLLECTION)
    ("glucocorticoid" . SPARSER::PROTEIN) ("shRNA1" . SPARSER::PROTEIN)
    ("z-VAD-fmk" . SPARSER::DRUG) ("SHIP2" . SPARSER::PROTEIN)
    ("INPP4A" . SPARSER::PROTEIN) ("PIB5PA" . SPARSER::PROTEIN)
    ("phosphatidylinositol 4,5-Bisphosphate" . SPARSER::PIP2)
    ("regulated kinase" . SPARSER::PROTEIN)
    ("P 3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("mitogen activated protein kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("regulated kinase 3" . SPARSER::PROTEIN) ("INPP4B" . SPARSER::PROTEIN)
    ("Inositol polyphosphate 4-phosphatase type II" . SPARSER::PROTEIN)
    ("microphthalmia" . SPARSER::PROTEIN)
    ("PAX2 and cytokeratin" . SPARSER::COLLECTION)
    ("CHD7, SIX4, and SALL4" . SPARSER::COLLECTION)
    ("a heterozygous PAX2 mutation c" . SPARSER::PROTEIN)
    ("son" . SPARSER::PROTEIN) ("dl" . SPARSER::MOLECULE)
    ("KIF26B , CHD7 , and SIX4" . SPARSER::COLLECTION)
    ("Proteinuria" . SPARSER::PROTEIN) ("GFR" . SPARSER::PROTEIN)
    ("serine and threonine" . SPARSER::COLLECTION)
    ("glycine and arginine" . SPARSER::COLLECTION)
    ("CHD7 , SALL4 , KIF26B , and SIX4" . SPARSER::COLLECTION)
    ("The novel heterozygous mutation ex2 c" . SPARSER::PROTEIN)
    ("PAX2 and 25 other genes" . SPARSER::COLLECTION)
    ("GDF11 , GDNF , FOXC1 , SIX1 , SALL1 , PAX8 , and WT1"
     . SPARSER::COLLECTION)
    ("GDNF" . SPARSER::PROTEIN)
    ("PTIP and the mixed-lineage leukemia (MLL) complex [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("Hox11 and Eya1" . SPARSER::COLLECTION) ("Hox11" . SPARSER::PROTEIN)
    ("RET/glial" . SPARSER::COLLECTION) ("PTIP" . SPARSER::PROTEIN)
    ("Hox" . SPARSER::PROTEIN) ("RET" . SPARSER::PROTEIN)
    ("thin hypoplastic peripheral retinas" . SPARSER::DRUG)
    ("disc" . SPARSER::BIO-COMPLEX) ("proteinuria" . SPARSER::PROTEIN)
    ("CHD7, SALL4, KIF26B, and SIX4" . SPARSER::COLLECTION)
    ("PAX2 and 25 candidate genes" . SPARSER::COLLECTION)
    ("kinesin family" . SPARSER::PROTEIN) ("PAX1" . SPARSER::PROTEIN)
    ("ex1" . SPARSER::PROTEIN) ("WT1" . SPARSER::PROTEIN)
    ("PAX8" . SPARSER::PROTEIN) ("SALL1" . SPARSER::PROTEIN)
    ("SIX1" . SPARSER::PROTEIN) ("FOXC1" . SPARSER::PROTEIN)
    ("GDF11" . SPARSER::PROTEIN) ("Eya1" . SPARSER::PROTEIN)
    ("neurotrophic factor" . SPARSER::PROTEIN) ("SIX4" . SPARSER::PROTEIN)
    ("KIF26B" . SPARSER::PROTEIN) ("SALL4" . SPARSER::PROTEIN)
    ("these peptides or their protection" . SPARSER::COLLECTION)
    ("F9 A353V" . SPARSER::PROTEIN) ("TERC (TR)" . SPARSER::PROTEIN)
    ("GSE4" . SPARSER::PROTEIN) ("GSE4-NLS1" . SPARSER::COLLECTION)
    ("p-Chk2" . SPARSER::COLLECTION)
    ("anti γ H2AX and p-Chk2Thr68 antibodies ( xref )" . SPARSER::COLLECTION)
    ("phosphorylated γ H2AX and Chk2Thr68 proteins" . SPARSER::COLLECTION)
    ("pcDNA3-myc" . SPARSER::PROTEIN-PAIR)
    ("NLS1 and NLS2" . SPARSER::COLLECTION) ("Superoxide" . SPARSER::MOLECULE)
    ("the Ki67 nucleolar protein" . SPARSER::PROTEIN)
    ("F9A353V" . SPARSER::PROTEIN)
    ("several smaller peptides" . SPARSER::PEPTIDE)
    ("just eleven amino acids" . SPARSER::AMINO-ACID)
    ("a smaller peptide" . SPARSER::PEPTIDE) ("EMA" . SPARSER::PROTEIN)
    ("TERT and c-myc" . SPARSER::COLLECTION)
    ("a 55 amino acids-long fragment" . SPARSER::FRAGMENT)
    ("PUA" . SPARSER::PROTEIN-FAMILY) ("Dyskerin" . SPARSER::PROTEIN)
    ("nucleolar RNAs and some mRNAs [ xref , xref ]" . SPARSER::COLLECTION)
    ("nucleolar RNAs" . SPARSER::RNA)
    ("the predominant X-linked form" . SPARSER::FORM)
    ("DNA-repair" . SPARSER::DNA) ("NOP10, GAR and NHP2" . SPARSER::COLLECTION)
    ("A third essential component" . SPARSER::COMPONENT)
    ("dkc1" . SPARSER::PROTEIN) ("pseudouridine" . SPARSER::MOLECULE)
    ("c-myc and TERT promoters and increase of c-myc, TERT and TERC expression"
     . SPARSER::COLLECTION)
    ("c-myc and TERT" . SPARSER::COLLECTION)
    ("c-myc, TERT and TERC" . SPARSER::COLLECTION) ("TERC" . SPARSER::PROTEIN)
    ("dyskerin" . SPARSER::PROTEIN) ("perinuclear region" . SPARSER::PROTEIN)
    ("Aspartic acid" . SPARSER::AMINO-ACID) ("γ H2AX" . SPARSER::PROTEIN)
    ("SOD2" . SPARSER::PROTEIN) ("SOD1" . SPARSER::PROTEIN)
    ("Green Fluorescent" . SPARSER::PROTEIN) ("NLS1" . SPARSER::PROTEIN)
    ("K2" . SPARSER::PROTEIN) ("DKC1" . SPARSER::PROTEIN)
    ("TINF2" . SPARSER::PROTEIN) ("NHP2" . SPARSER::PROTEIN)
    ("NOP10" . SPARSER::PROTEIN) ("Aspartic Acid" . SPARSER::AMINO-ACID)
    ("IL-6, IL-8, IL-12,TNF-α, and MIP-1β" . SPARSER::COLLECTION)
    ("IFN-α and TNF-α" . SPARSER::COLLECTION) ("Hara" . SPARSER::PROTEIN)
    ("Myeloid" . SPARSER::PROTEIN)
    ("AP-1 components Fos (approximately 3-fold higher in both SVR and NR versus SC, p < 0.001 for both) and Jun"
     . SPARSER::COLLECTION)
    ("regulators and effectors" . SPARSER::COLLECTION)
    ("best-fit" . SPARSER::PROTEIN-FAMILY) ("assessed genes" . SPARSER::GENE)
    ("statin and NSAID" . SPARSER::COLLECTION)
    ("statin or NSAID" . SPARSER::COLLECTION) ("statin" . SPARSER::MOLECULE)
    ("Newer technologies employ multiplex oligonucleotide" . SPARSER::MOLECULE)
    ("viral RNA" . SPARSER::RNA)
    ("a persistent undetectable serum HCV RNA" . SPARSER::RNA)
    ("directly acting antivirals" . SPARSER::DRUG)
    ("antivirals" . SPARSER::DRUG) ("RBV" . SPARSER::DRUG)
    ("ribavirin" . SPARSER::DRUG)
    ("these 24 acute and chronic inflammatory cascade genes" . SPARSER::GENE)
    ("Fos , CEBPB , and MyD88" . SPARSER::COLLECTION)
    ("CEBPB" . SPARSER::PROTEIN) ("GX" . SPARSER::PROTEIN)
    ("interferon-" . SPARSER::PROTEIN) ("NS3" . SPARSER::PROTEIN)
    ("IFN- α" . SPARSER::PROTEIN) ("Histone Deacetylase 4" . SPARSER::PROTEIN)
    ("CCAAT/enhancer-binding protein beta" . SPARSER::PROTEIN)
    ("IL-1A" . SPARSER::PROTEIN) ("PGK1" . SPARSER::PROTEIN)
    ("FIB-4" . SPARSER::PROTEIN) ("NF-κB and c-myb" . SPARSER::COLLECTION)
    ("a complex and multi-step process" . SPARSER::COLLECTION)
    ("those relevant genes" . SPARSER::GENE)
    ("relevant cohort" . SPARSER::MOLECULE) ("c-myb" . SPARSER::PROTEIN)
    ("Cox-2" . SPARSER::PROTEIN) ("PDAC and PanIN" . SPARSER::COLLECTION)
    ("MST1/STK4" . SPARSER::COLLECTION) ("plasminogen" . SPARSER::PROTEIN)
    ("these transcriptional co-factors" . SPARSER::MOLECULE)
    ("1A1" . SPARSER::PROTEIN) ("CTGF/CCN2" . SPARSER::COLLECTION)
    ("CTGF" . SPARSER::PROTEIN)
    ("growth factor or cytokines" . SPARSER::COLLECTION)
    ("taxol" . SPARSER::DRUG)
    ("Sdf1, c-Met, nestin, and SOX9" . SPARSER::COLLECTION)
    ("Sdf1" . SPARSER::PROTEIN) ("CAII and Anxa2" . SPARSER::COLLECTION)
    ("CAII" . SPARSER::PROTEIN) ("ADM" . SPARSER::PROTEIN)
    ("a mild and reversible form" . SPARSER::FORM) ("cerulein" . SPARSER::DRUG)
    ("Pdx1-Cre" . SPARSER::COLLECTION)
    ("Pdx1-Cre/LSL-KrasG12D" . SPARSER::COLLECTION)
    ("KrasG" . SPARSER::PROTEIN) ("LSL" . SPARSER::PROTEIN)
    ("PDAC and chronic pancreatitis" . SPARSER::COLLECTION)
    ("anhydrase" . SPARSER::PROTEIN) ("TAZ/WWTR1" . SPARSER::COLLECTION)
    ("AMOT" . SPARSER::PROTEIN) ("angiomotin" . SPARSER::PROTEIN)
    ("molecules and proteins" . SPARSER::COLLECTION)
    ("transcriptional cofactors" . SPARSER::PROTEIN)
    ("WW Domain Containing Transcription Regulator 1, or WWTR1"
     . SPARSER::COLLECTION)
    ("digestive enzymes" . SPARSER::ENZYME)
    ("Yes-associated protein (YAP) and its homolog transcriptional co-activator"
     . SPARSER::COLLECTION)
    ("Yes-associated protein (YAP)" . SPARSER::PROTEIN)
    ("MST1R" . SPARSER::PROTEIN) ("STK4" . SPARSER::PROTEIN)
    ("CCN2" . SPARSER::PROTEIN) ("TGF β" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SOX-9" . SPARSER::PROTEIN) ("Anxa2" . SPARSER::PROTEIN)
    ("alpha-SMA" . SPARSER::PROTEIN) ("Pdx1" . SPARSER::PROTEIN)
    ("α-SMA" . SPARSER::PROTEIN) ("ANXA2" . SPARSER::PROTEIN)
    ("annexin A2" . SPARSER::PROTEIN) ("PTPN14" . SPARSER::PROTEIN)
    ("WW Domain Containing Transcription Regulator 1" . SPARSER::PROTEIN)
    ("CAV1-protein" . SPARSER::COLLECTION)
    ("cytokine/chemokine" . SPARSER::COLLECTION)
    ("the available genes" . SPARSER::GENE)
    ("an immunomodulatory cytokine" . SPARSER::PROTEIN)
    ("TRAC" . SPARSER::PROTEIN)
    ("proximal signaling molecules" . SPARSER::MOLECULE)
    ("Forkhead" . SPARSER::PROTEIN)
    ("GILZ , STAT5A , and RICTOR" . SPARSER::COLLECTION)
    ("FOXP1 and HVEM" . SPARSER::COLLECTION)
    ("IFN-γ/IL-2" . SPARSER::COLLECTION)
    ("Rel- or I-κB-related proteins [ xref ]" . SPARSER::COLLECTION)
    ("Rel-" . SPARSER::PROTEIN) ("CD5 , and UBASH3A" . SPARSER::COLLECTION)
    ("STS" . SPARSER::PROTEIN) ("HVEM" . SPARSER::PROTEIN)
    ("NF-kB/NFAT" . SPARSER::COLLECTION) ("NFAT" . SPARSER::PROTEIN)
    ("TNFRSF21 (also known as DR6 ) and CCNB2" . SPARSER::COLLECTION)
    ("APC:T-cell" . SPARSER::BIO-COMPLEX)
    ("CAV1 and ENAH" . SPARSER::COLLECTION) ("Pred" . SPARSER::DRUG)
    ("only 4 proteins" . SPARSER::PROTEIN) ("x" . SPARSER::PROTEIN)
    ("CAV1 and CAV1-interacting proteins" . SPARSER::COLLECTION)
    ("RPI" . SPARSER::PROTEIN) ("intergenic non-coding RNA" . SPARSER::RNA)
    ("LINC" . SPARSER::PROTEIN) ("GILZ" . SPARSER::PROTEIN)
    ("chemokine and cytokine" . SPARSER::COLLECTION)
    ("Chemokine/cytokine" . SPARSER::COLLECTION)
    ("Chemokine" . SPARSER::PROTEIN)
    ("chemokine/cytokine" . SPARSER::COLLECTION)
    ("CAV1 and BCL10" . SPARSER::COLLECTION)
    ("CAV1-BCL10" . SPARSER::COLLECTION)
    ("CAV1 ( xref ) and BCL10 ( xref )" . SPARSER::COLLECTION)
    ("the 21 pan-regulated genes" . SPARSER::GENE) ("TSP" . SPARSER::PROTEIN)
    ("CD3G" . SPARSER::PROTEIN) ("RICTOR" . SPARSER::PROTEIN)
    ("PRKCQ" . SPARSER::PROTEIN) ("LAT" . SPARSER::PROTEIN)
    ("ITK" . SPARSER::PROTEIN) ("ENAH" . SPARSER::PROTEIN)
    ("mature nodal" . SPARSER::PROTEIN) ("mega" . SPARSER::MOLECULE)
    ("mature T-cell lymphomas aims" . SPARSER::PROTEIN)
    ("T-Cell" . SPARSER::PROTEIN) ("MAS5" . SPARSER::PROTEIN)
    ("CD26" . SPARSER::PROTEIN) ("IL12RB1" . SPARSER::PROTEIN)
    ("IL23" . SPARSER::PROTEIN) ("TRAT1" . SPARSER::PROTEIN)
    ("TRBC1" . SPARSER::PROTEIN) ("scaffolding molecule" . SPARSER::PROTEIN)
    ("CD3 complex" . SPARSER::PROTEIN) ("I-κB" . SPARSER::PROTEIN)
    ("glucocorticoid-induced leucine zipper" . SPARSER::PROTEIN)
    ("Thy-1" . SPARSER::PROTEIN) ("UBASH3A" . SPARSER::PROTEIN)
    ("TSC22D3" . SPARSER::PROTEIN) ("TNFRSF14" . SPARSER::PROTEIN)
    ("PDE4B" . SPARSER::PROTEIN) ("PAG1" . SPARSER::PROTEIN)
    ("IL23A" . SPARSER::PROTEIN) ("FOXP1" . SPARSER::PROTEIN)
    ("BCL10" . SPARSER::PROTEIN) ("TNFRSF21" . SPARSER::PROTEIN)
    ("THY1" . SPARSER::PROTEIN) ("PSEN2" . SPARSER::PROTEIN)
    ("CCNB2" . SPARSER::PROTEIN) ("T-cell receptor" . SPARSER::PROTEIN)
    ("CAV1" . SPARSER::PROTEIN) ("survivin and Mcl-1" . SPARSER::COLLECTION)
    ("Ruxolitinib and other JAK kinase inhibitors" . SPARSER::COLLECTION)
    ("Mcl-1, Bcl-2, survivin and c-Myc" . SPARSER::COLLECTION)
    ("Mcl-1, Bcl-2 and survivin" . SPARSER::COLLECTION)
    ("JAK3/STAT3" . SPARSER::COLLECTION)
    ("IFN-α, IL-2, IL-6 and IL-10" . SPARSER::COLLECTION)
    ("tyrosine of STAT3" . SPARSER::PROTEIN)
    ("Mcl-1 and survivin" . SPARSER::COLLECTION)
    ("Bcl-2 and c-Myc" . SPARSER::COLLECTION)
    ("Bcl-2 , survivin, Mcl-1 and c-Myc" . SPARSER::COLLECTION)
    ("Ruxolitinib and SAR302503" . SPARSER::COLLECTION)
    ("PTPN6 or mutants" . SPARSER::COLLECTION)
    ("SAR302503 (a JAK2 specific inhibitor) or WHI-P154 (JAK3 specific inhibitor)"
     . SPARSER::COLLECTION)
    ("JAK1, JAK2 or JAK3" . SPARSER::COLLECTION)
    ("JAK1/JAK2" . SPARSER::COLLECTION) ("Ruxolitinib" . SPARSER::DRUG)
    ("a promising target in DLBCL and several other types"
     . SPARSER::COLLECTION)
    ("JAK1 or JAK2" . SPARSER::COLLECTION)
    ("PTPN6 and the JAK proteins" . SPARSER::COLLECTION)
    ("STAT3 and PTPN6" . SPARSER::COLLECTION)
    ("JAK1, JAK2 and JAK3" . SPARSER::COLLECTION)
    ("either PTPN6 mutants or WT constructs (Figure xref )"
     . SPARSER::COLLECTION)
    ("PTPN6 and STAT3" . SPARSER::COLLECTION)
    ("STAT3 and its upstream activators JAK1-3 kinases" . SPARSER::COLLECTION)
    ("IFN-α, IL-2, IL-6 or IL-10" . SPARSER::COLLECTION)
    ("STAT5 (Figure xref ) or STAT6 (Figure xref )" . SPARSER::COLLECTION)
    ("STAT1, STAT3, STAT5 and STAT6" . SPARSER::COLLECTION)
    ("PTPs" . SPARSER::PROTEIN)
    ("pLEX-PTPN6 N225K and pLEX-PTPN6 A550V" . SPARSER::COLLECTION)
    ("Lentiviral vectors pLEX-PTPN6" . SPARSER::PROTEIN-PAIR)
    ("pLEX-PTPN6" . SPARSER::PROTEIN-PAIR) ("asparagine" . SPARSER::AMINO-ACID)
    ("Valine" . SPARSER::AMINO-ACID) ("Alanine" . SPARSER::AMINO-ACID)
    ("Asparagine" . SPARSER::AMINO-ACID)
    ("SOCS1 [ xref – xref ] and protein tyrosine phosphatases"
     . SPARSER::COLLECTION)
    ("PTP" . SPARSER::PROTEIN) ("JAK3 and PTPN6" . SPARSER::COLLECTION)
    ("STAT3 and WT or mutated PTPN6" . SPARSER::COLLECTION)
    ("STAT1, STAT5 or STAT6" . SPARSER::COLLECTION)
    ("PTPN6 N225K and PTPN6 A550V" . SPARSER::COLLECTION)
    ("TG101348" . SPARSER::DRUG) ("SAR302503" . SPARSER::DRUG)
    ("Src-homology" . SPARSER::PROTEIN) ("1B" . SPARSER::PROTEIN)
    ("PTPN6" . SPARSER::PROTEIN) ("self-activating Sos" . SPARSER::PROTEIN)
    ("a fully functional heterotrimeric complex" . SPARSER::BIO-COMPLEX)
    ("GTP or its analog" . SPARSER::COLLECTION)
    ("GTP and mantGTP" . SPARSER::COLLECTION)
    ("functional GDP" . SPARSER::NUCLEOTIDE)
    ("GDP and GTP" . SPARSER::COLLECTION)
    ("the modest homonucleotide GDP" . SPARSER::NUCLEOTIDE)
    ("Sos Cat W729E and H-RasY64A·GTPγS" . SPARSER::COLLECTION)
    ("State" . SPARSER::BIO-STATE) ("the largest chemical" . SPARSER::MOLECULE)
    ("DH-PH and histone" . SPARSER::COLLECTION)
    ("H-Ras and Sos" . SPARSER::COLLECTION) ("HMQC" . SPARSER::DRUG)
    ("GDP, GTPγS, and GTPγS" . SPARSER::COLLECTION)
    ("Ras:Sos" . SPARSER::BIO-COMPLEX)
    ("uniformly 15 N-labeled H-Ras" . SPARSER::PROTEIN)
    ("GDP-" . SPARSER::NUCLEOTIDE) ("Amide" . SPARSER::MOLECULE)
    ("Nucleotides" . SPARSER::NUCLEOTIDE)
    ("K-Ras and H-Ras" . SPARSER::COLLECTION)
    ("GTPγS, GppNp, and GppCp" . SPARSER::COLLECTION)
    ("a common cancer-associated mutant" . SPARSER::MUTANT)
    ("H-Ras and K-Ras" . SPARSER::COLLECTION) ("Ras/Sos" . SPARSER::COLLECTION)
    ("methionines" . SPARSER::AMINO-ACID) ("Ras and Sos" . SPARSER::COLLECTION)
    ("more conformational states" . SPARSER::BIO-STATE)
    ("static snap" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("x-ray" . SPARSER::PROTEIN-PAIR) ("snap" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("GDP or GTP" . SPARSER::COLLECTION)
    ("neighboring histone, Dbl homology (DH), and pleckstrin homology (PH) domains of Sos ( xref , xref )"
     . SPARSER::COLLECTION)
    ("histone, Dbl homology (DH), and pleckstrin homology (PH) domains of Sos ( xref , xref )"
     . SPARSER::COLLECTION)
    ("homology (DH)" . SPARSER::PROTEIN)
    ("neighboring histone" . SPARSER::PROTEIN) ("Dbl" . SPARSER::PROTEIN)
    ("guanine nucleotide exchange factors ( xref ) and effector proteins ( xref )"
     . SPARSER::COLLECTION)
    ("G10–S17" . SPARSER::COLLECTION)
    ("H-Ras, K-Ras, and N-Ras" . SPARSER::COLLECTION)
    ("unidirectional GDP" . SPARSER::NUCLEOTIDE) ("Sos" . SPARSER::PROTEIN)
    ("uniformly 15 N-labeled Ras" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Ras-Sos" . SPARSER::COLLECTION) ("Met" . SPARSER::AMINO-ACID)
    ("GTP-" . SPARSER::NUCLEOTIDE) ("B–D" . SPARSER::PROTEIN)
    ("GTPγS" . SPARSER::PROTEIN) ("d -glucose" . SPARSER::MOLECULE)
    ("d -1" . SPARSER::PROTEIN) ("DH-PH" . SPARSER::PROTEIN)
    ("two domains" . SPARSER::PROTEIN) ("S17" . SPARSER::PROTEIN)
    ("hydrolase activity" . SPARSER::PROTEIN) ("N-Ras" . SPARSER::PROTEIN)
    ("guanine nucleotide exchange factors" . SPARSER::GEF)
    ("Son of Sevenless" . SPARSER::PROTEIN)
    ("some CSC-associated molecules" . SPARSER::MOLECULE)
    ("TWIST1, SNAIL and Zeb1/2" . SPARSER::COLLECTION)
    ("SNAIL" . SPARSER::PROTEIN) ("IL-8, MMPs and VEGF" . SPARSER::COLLECTION)
    ("a sequence-specific transcription factor" . SPARSER::PROTEIN)
    ("Wnt//β-catenin" . SPARSER::COLLECTION)
    ("DAB2IP-PP2A-GSK3-β" . SPARSER::COLLECTION)
    ("APC, TP53 and SMAD4" . SPARSER::COLLECTION)
    ("KRAS, PIK3CA and BRAF" . SPARSER::COLLECTION)
    ("snail, slug and CD44" . SPARSER::COLLECTION) ("slug" . SPARSER::PROTEIN)
    ("Snail and Slug" . SPARSER::COLLECTION)
    ("E-cadherin and IκB-α" . SPARSER::COLLECTION)
    ("E-cadherin, IκB-α and p65" . SPARSER::COLLECTION)
    ("SW480, and DAB2IP" . SPARSER::COLLECTION)
    ("siRNA and NF-κB" . SPARSER::COLLECTION) ("si-p65" . SPARSER::COLLECTION)
    ("si-IκB-α" . SPARSER::COLLECTION)
    ("EMT and stemness" . SPARSER::COLLECTION) ("Cytometry" . SPARSER::PROTEIN)
    ("HT29-KD4 and HCT116-KD2" . SPARSER::COLLECTION)
    ("oxaliplatin and 5-fluorouracil" . SPARSER::COLLECTION)
    ("CD24, CD44, CD133, LGR5, ASCL2, DCLK1 and OLFM4" . SPARSER::COLLECTION)
    ("NANOG, Oct4, SOX2, Bmi1, Notch1, Notch2, Wnt1 and Gli-1"
     . SPARSER::COLLECTION)
    ("HT29-KD4, HT29-KD6 and HCT116-KD3" . SPARSER::COLLECTION)
    ("Twist1, Snail, Slug, FOXC-2 and ZEB1" . SPARSER::COLLECTION)
    ("Snail, FOXC-2 and ZEB1" . SPARSER::COLLECTION)
    ("DAB2IP and E-cadherin" . SPARSER::COLLECTION)
    ("DAB2IP, E-cadherin and Vimentin" . SPARSER::COLLECTION)
    ("GTPase activating protein (GAP)" . SPARSER::PROTEIN)
    ("ASK1-JNK" . SPARSER::COLLECTION) ("Ras-Raf" . SPARSER::COLLECTION)
    ("a DOC-2/DAB2 interactive protein" . SPARSER::PROTEIN)
    ("DOC-2/DAB2" . SPARSER::COLLECTION)
    ("twist1, snail and ZEB1/2" . SPARSER::COLLECTION)
    ("CD133, CD44, CD166 and ALDH1" . SPARSER::COLLECTION)
    ("EMT and stem cell–like" . SPARSER::COLLECTION)
    ("GSK3-β" . SPARSER::PROTEIN) ("IκB-α" . SPARSER::PROTEIN)
    ("Gli-1" . SPARSER::PROTEIN) ("Notch2" . SPARSER::PROTEIN)
    ("OLFM4" . SPARSER::PROTEIN) ("DCLK1" . SPARSER::PROTEIN)
    ("ASCL2" . SPARSER::PROTEIN) ("KD4" . SPARSER::PROTEIN)
    ("GTPase activating protein" . SPARSER::PROTEIN)
    ("AIP1" . SPARSER::PROTEIN) ("ASK1" . SPARSER::PROTEIN)
    ("DAB2" . SPARSER::PROTEIN) ("DOC-2" . SPARSER::PROTEIN)
    ("twist1" . SPARSER::PROTEIN) ("CD166" . SPARSER::PROTEIN)
    ("DAB2IP" . SPARSER::PROTEIN)
    ("Myc, Omomyc, and H4R3" . SPARSER::COLLECTION)
    ("a sizeable fraction" . SPARSER::COMPONENT)
    ("PRMT1/PRMT5/MEP50/CHTOP" . SPARSER::COLLECTION)
    ("PRMT1/PRMT5/MEP50" . SPARSER::COLLECTION) ("CHTOP" . SPARSER::PROTEIN)
    ("Myc/PRMT5" . SPARSER::COLLECTION)
    ("Myc or Omomyc and PRMT5" . SPARSER::COLLECTION)
    ("PRMT5 and Myc" . SPARSER::COLLECTION)
    ("Myc or Omomyc" . SPARSER::COLLECTION)
    ("adipogenic genes" . SPARSER::GENE)
    ("Myc and PRMT5" . SPARSER::COLLECTION)
    ("histones and Omomyc" . SPARSER::COLLECTION)
    ("U87MG or GSCs" . SPARSER::COLLECTION)
    ("N-Myc/PRMT5" . SPARSER::COLLECTION)
    ("Ref" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("complex and H4R3" . SPARSER::COLLECTION) ("methylase" . SPARSER::PROTEIN)
    ("Myc and shCOPR5" . SPARSER::COLLECTION)
    ("cycD1 and nucleolin" . SPARSER::COLLECTION) ("Ncl" . SPARSER::PROTEIN)
    ("carbamoyl" . SPARSER::MOLECULE)
    ("at least two co-factors" . SPARSER::MOLECULE)
    ("U87MG and BT168" . SPARSER::COLLECTION)
    ("Omomyc, Myc, PRMT5 and H4R3" . SPARSER::COLLECTION)
    ("Myc, PRMT5 and H4R3" . SPARSER::COLLECTION)
    ("Omomyc and PRMT5" . SPARSER::COLLECTION)
    ("Myc, Omomyc, and PRMT5" . SPARSER::COLLECTION)
    ("Flag-Myc" . SPARSER::COLLECTION) ("Omomyc" . SPARSER::PROTEIN)
    ("Flag-Omomyc" . SPARSER::COLLECTION) ("the largest class" . CLASS)
    ("AdoMet" . SPARSER::MOLECULE)
    ("both DNA and histone methylation profiles" . SPARSER::COLLECTION)
    ("GSCs" . SPARSER::PROTEIN) ("TICs" . SPARSER::PROTEIN)
    ("Polycomb" . SPARSER::PROTEIN)
    ("proteins and multicomponent complexes" . SPARSER::COLLECTION)
    ("multicomponent complexes" . SPARSER::BIO-COMPLEX)
    ("c-" . SPARSER::PROTEIN) ("bHLH-Zip" . SPARSER::COLLECTION)
    ("Zip" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PRMT5-MEP50" . SPARSER::COLLECTION)
    ("c-Myc, PRMT5 and H4R" . SPARSER::COLLECTION)
    ("Myc and Omomyc" . SPARSER::COLLECTION)
    ("Protein Arginine Methyltransferase 5" . SPARSER::PROTEIN)
    ("H3K27me3" . SPARSER::PROTEIN) ("P40" . SPARSER::PROTEIN)
    ("PLP1" . SPARSER::PROTEIN)
    ("Chromatin Target of PRMT1" . SPARSER::PROTEIN)
    ("Dnmt3a" . SPARSER::PROTEIN) ("N-Myc" . SPARSER::PROTEIN)
    ("cycD1" . SPARSER::PROTEIN) ("COPR5" . SPARSER::PROTEIN)
    ("cooperator of PRMT5" . SPARSER::PROTEIN)
    ("methylosome protein 50" . SPARSER::PROTEIN)
    ("co-factors" . SPARSER::MOLECULE) ("S-adenosylmethionine" . SPARSER::DRUG)
    ("MEP50" . SPARSER::PROTEIN) ("Methylosome Protein 50" . SPARSER::PROTEIN)
    ("co-factor" . SPARSER::MOLECULE)
    ("protein Arginine Methyltransferase 5" . SPARSER::PROTEIN)
    ("MYC and AR" . SPARSER::COLLECTION)
    ("PI3K-Akt and AR" . SPARSER::COLLECTION)
    ("PP2A and its known regulators" . SPARSER::COLLECTION)
    ("PP2A (CIP2A) and SET (I2PP2A)" . SPARSER::COLLECTION)
    ("exogenous SET" . SPARSER::PROTEIN)
    ("P-Erk and PI3K-Akt" . SPARSER::COLLECTION)
    ("SET and CIP2A" . SPARSER::COLLECTION)
    ("compensatory survival cues" . SPARSER::PROTEIN-FAMILY)
    ("treated mouse mutants" . SPARSER::MUTANT)
    ("Akt, P-S6 and P-4" . SPARSER::COLLECTION)
    ("PB-Cre" . SPARSER::COLLECTION) ("LNCaP " . SPARSER::PROTEIN)
    ("RV" . SPARSER::MOLECULE) ("SHO" . SPARSER::PROTEIN)
    ("introduced SET or control shRNAs" . SPARSER::COLLECTION)
    ("SET-PEB-1" . SPARSER::PROTEIN-PAIR) ("PIN" . SPARSER::PROTEIN)
    ("Matrigel/Media" . SPARSER::COLLECTION) ("Media" . SPARSER::PROTEIN)
    ("FUCRW" . SPARSER::PROTEIN) ("SET-FUCRW" . SPARSER::COLLECTION)
    ("exogenous SET-HA" . SPARSER::COLLECTION) ("SET-HA" . SPARSER::COLLECTION)
    ("c-Myc and Akt" . SPARSER::COLLECTION)
    ("a ubiquitously expressed serine/threonine phosphatase and key regulator"
     . SPARSER::COLLECTION)
    ("SET-PP2A" . SPARSER::COLLECTION) ("drug (PAD)" . SPARSER::DRUG)
    ("OP" . SPARSER::MOLECULE) ("3 d" . SPARSER::PROTEIN-FAMILY)
    ("ARR2" . SPARSER::PROTEIN) ("protein phosphatase 2" . SPARSER::PROTEIN)
    ("I-R" . SPARSER::PROTEIN) ("K-R" . SPARSER::PROTEIN)
    ("N-20" . SPARSER::PROTEIN) ("P-Erk" . SPARSER::PROTEIN)
    ("eBP1" . SPARSER::PROTEIN) ("P-4" . SPARSER::PROTEIN)
    ("P-S6" . SPARSER::PROTEIN) ("Protein Phosphatase 2" . SPARSER::PROTEIN)
    ("I2PP2A" . SPARSER::PROTEIN) ("PP2A" . SPARSER::PROTEIN)
    ("NF-κB/AP-1" . SPARSER::COLLECTION)
    ("IL-36R and IL-1RAcP" . SPARSER::COLLECTION)
    ("p38 and ERK1/2" . SPARSER::COLLECTION)
    ("PD98059 and U0126" . SPARSER::COLLECTION)
    ("ERK1/2, and U0126" . SPARSER::COLLECTION)
    ("MEK1 and MEK2" . SPARSER::COLLECTION)
    ("p44 and p42" . SPARSER::COLLECTION)
    ("two major proinflammatory cytokines, IL-1β and TNF-α"
     . SPARSER::COLLECTION)
    ("cytokines, IL-1β and TNF-α" . SPARSER::COLLECTION)
    ("NF-κB- and AP-1-DNA binding" . SPARSER::COLLECTION)
    ("ERK1/2 and p38 MAPKs" . SPARSER::COLLECTION)
    ("ERK1/2, p38 MAPK, and JNK1/2" . SPARSER::COLLECTION)
    ("the IL-36 receptor (IL-36R) subunit and the IL-1 receptor accessory protein (IL-1RAcP)"
     . SPARSER::COLLECTION)
    ("a heterodimeric receptor" . SPARSER::RECEPTOR)
    ("NF-κB and MAPK" . SPARSER::COLLECTION)
    ("IL-1β and TNF-α" . SPARSER::COLLECTION)
    ("NF-κB and AP-1" . SPARSER::COLLECTION)
    ("p65 and AP-1" . SPARSER::COLLECTION)
    ("ERK1/2 (PD98059 and U0216) and a p38 MAPK (SB203580)"
     . SPARSER::COLLECTION)
    ("MEK2" . SPARSER::PROTEIN) ("c-jun" . SPARSER::PROTEIN)
    ("IL-1RAcP" . SPARSER::PROTEIN)
    ("IL-1 receptor accessory protein" . SPARSER::PROTEIN)
    ("IL-36R" . SPARSER::PROTEIN) ("IL-1 family" . SPARSER::PROTEIN)
    ("IL-1F9" . SPARSER::PROTEIN) ("IL-1F8" . SPARSER::PROTEIN)
    ("IL-1F6" . SPARSER::PROTEIN) ("Vemurafenib" . SPARSER::DRUG)
    ("LNA" . SPARSER::PROTEIN) ("intentional mismatch" . SPARSER::PROTEIN)
    ("are run" . SPARSER::PROTEIN-FAMILY) ("DNA–under" . SPARSER::DNA)
    ("BRAF V600E and PTEN T167A" . SPARSER::COLLECTION)
    ("specifically BRAF V600E" . SPARSER::PROTEIN)
    ("target and non-target" . SPARSER::COLLECTION)
    ("two distinct polymerases" . SPARSER::PROTEIN)
    ("cfDNA and ctDNA" . SPARSER::COLLECTION)
    ("was run" . SPARSER::PROTEIN-FAMILY)
    ("the SNVs BRAF V600E, PTEN T167A and NRAS Q61L" . SPARSER::COLLECTION)
    ("BRAF V600E, PTEN T167A and NRAS Q61L" . SPARSER::COLLECTION)
    ("spiking" . SPARSER::PROTEIN) ("1 mutated DNA" . SPARSER::DNA)
    ("ARMS" . SPARSER::PROTEIN) ("mutated DNA" . SPARSER::DNA)
    ("prognostic and predictive biomarker" . SPARSER::MOLECULE)
    ("PTEN T167A and NRAS Q61L" . SPARSER::COLLECTION)
    ("point mutations BRAF V600E, PTEN T167A and NRAS Q61L"
     . SPARSER::COLLECTION)
    ("per 2" . SPARSER::PROTEIN) ("GS4" . SPARSER::PROTEIN)
    ("exonuclease activity" . SPARSER::PROTEIN)
    ("p65 homodimers and p50/p65 heterodimers" . SPARSER::COLLECTION)
    ("proteins, and IκBα" . SPARSER::COLLECTION)
    ("p50/p65" . SPARSER::COLLECTION) ("homodimers" . SPARSER::HOMODIMER)
    ("Importin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("siRNA or pifithrin-α" . SPARSER::COLLECTION)
    ("DR downstream apoptotic proteins" . SPARSER::PROTEIN)
    ("caspase-9 and Bax" . SPARSER::COLLECTION)
    ("p-hydroxyphenyl" . SPARSER::PROTEIN-PAIR) ("Bis" . SPARSER::PROTEIN)
    ("Zerumbone" . SPARSER::DRUG) ("benzophenone" . SPARSER::DRUG)
    ("Cyclin D1, Bax, caspase-3, caspase-9, Bcl-2, IAP and survivin"
     . SPARSER::COLLECTION)
    ("NF-κB and caspase" . SPARSER::COLLECTION)
    ("Bax, caspase-3, caspase-8 and caspase-9" . SPARSER::COLLECTION)
    ("DR3, DR4 and DR6" . SPARSER::COLLECTION)
    ("The possible molecular targets" . SPARSER::TARGET-PROTEIN)
    ("caspase-8 and Bax" . SPARSER::COLLECTION)
    ("DR4, DR5 and active" . SPARSER::COLLECTION)
    ("melittin and NF-κB" . SPARSER::COLLECTION)
    ("melittin and molecular binding btween NF-κB p50 and melittin"
     . SPARSER::COLLECTION)
    ("p50 and melittin" . SPARSER::COLLECTION)
    ("siRNA or p53" . SPARSER::COLLECTION)
    ("inhibitor (PAO)" . SPARSER::INHIBITOR)
    ("oxide (PAO)" . SPARSER::MOLECULE) ("PAO" . SPARSER::PROTEIN)
    ("DR4 or DR5 or TRAIL" . SPARSER::COLLECTION)
    ("DR5 or TRAIL" . SPARSER::COLLECTION)
    ("DR5 and their ligand TRAIL" . SPARSER::COLLECTION)
    ("siRNA and TRAIL" . SPARSER::COLLECTION)
    ("DR3, DR4, DR5 and Fas" . SPARSER::COLLECTION) ("FHC" . SPARSER::PROTEIN)
    ("p50 and p65" . SPARSER::COLLECTION) ("Melittin" . SPARSER::PROTEIN)
    ("melittin" . SPARSER::PROTEIN) ("toxin" . SPARSER::MOLECULE)
    ("quercetin" . SPARSER::MOLECULE) ("zerumbone" . SPARSER::DRUG)
    ("TRAIL-R1 (DR4) and TRAIL-R2 (DR5)" . SPARSER::COLLECTION)
    ("Bcl-2 and IAP" . SPARSER::COLLECTION)
    ("cyclooxygenase-2 and cyclins" . SPARSER::COLLECTION)
    ("stromal macrophages" . SPARSER::PROTEIN)
    ("micronutrient" . SPARSER::MOLECULE)
    ("siRNA or NF-κB" . SPARSER::COLLECTION)
    ("3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide"
     . SPARSER::MOLECULE)
    ("Histone-H1" . SPARSER::PROTEIN) ("P50" . SPARSER::PROTEIN)
    ("DR6" . SPARSER::PROTEIN) ("DR3" . SPARSER::PROTEIN)
    ("Fas-associated death domain protein" . SPARSER::PROTEIN)
    ("TRAIL-R1" . SPARSER::PROTEIN) ("Factor-κB" . SPARSER::PROTEIN)
    ("Colon cancer" . SPARSER::PROTEIN) ("C62" . SPARSER::PROTEIN)
    ("Nile" . SPARSER::PROTEIN) ("RSAD2 and FDX1L" . SPARSER::COLLECTION)
    ("aconitase" . SPARSER::PROTEIN) ("systemic iron" . SPARSER::MOLECULE)
    ("ferroportin, and iron" . SPARSER::COLLECTION)
    ("ferroportin" . SPARSER::PROTEIN) ("FTH1 and TFRC" . SPARSER::COLLECTION)
    ("nickel" . SPARSER::MOLECULE) ("Tfrc" . SPARSER::PROTEIN)
    ("Fth1" . SPARSER::PROTEIN) ("transferrin" . SPARSER::PROTEIN)
    ("FTH1 protein and decrease TFRC protein" . SPARSER::COLLECTION)
    ("IRP1 and the IRE" . SPARSER::COLLECTION)
    ("IRE-protein" . SPARSER::COLLECTION) ("IRP1-IRE" . SPARSER::COLLECTION)
    ("ISCU2 and siISCU" . SPARSER::COLLECTION)
    ("IRP1 and iron" . SPARSER::COLLECTION) ("IRE" . SPARSER::PROTEIN)
    ("Iron regulatory protein 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("both human ISCU and mouse Iscu" . SPARSER::COLLECTION)
    ("Iscu" . SPARSER::PROTEIN) ("Ad-p53 or Ad-LacZ" . SPARSER::COLLECTION)
    ("BS" . SPARSER::PROTEIN) ("mRNA and ISCU2" . SPARSER::COLLECTION)
    ("mature ISCU2 protein" . SPARSER::PROTEIN)
    ("a mature form" . SPARSER::FORM) ("ISCU1 and ISCU2" . SPARSER::COLLECTION)
    ("an essential cofactor" . SPARSER::MOLECULE) ("a 20-" . SPARSER::PROTEIN)
    ("dietary iron" . SPARSER::MOLECULE) ("Iron" . SPARSER::MOLECULE)
    ("p53RDL1, XEDAR, and PADI4" . SPARSER::COLLECTION)
    ("XEDAR" . SPARSER::PROTEIN) ("p53-ISCU" . SPARSER::COLLECTION)
    ("excess dietary iron" . SPARSER::MOLECULE)
    ("iron regulatory protein 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ISCU" . SPARSER::PROTEIN) ("ferritin heavy chain" . SPARSER::PROTEIN)
    ("CA-1" . SPARSER::PROTEIN) ("iron-sulfur cluster" . SPARSER::MOLECULE)
    ("FDX1L" . SPARSER::PROTEIN) ("RSAD2" . SPARSER::PROTEIN)
    ("IRP2" . SPARSER::PROTEIN) ("precursor protein" . SPARSER::PROTEIN)
    ("ISCU2" . SPARSER::PROTEIN) ("ISCU1" . SPARSER::PROTEIN)
    ("iron-sulfur" . SPARSER::MOLECULE) ("Ad-p53" . SPARSER::DRUG)
    ("hydroxyl radicals" . SPARSER::MOLECULE) ("PADI4" . SPARSER::PROTEIN)
    ("p53RDL1" . SPARSER::PROTEIN) ("transferrin receptor" . SPARSER::PROTEIN)
    ("FTH1" . SPARSER::PROTEIN) ("heavy polypeptide 1" . SPARSER::PROTEIN)
    ("IRP1" . SPARSER::PROTEIN) ("Fe-S" . SPARSER::PROTEIN)
    ("iron-sulfur cluster assembly enzyme" . SPARSER::PROTEIN)
    ("estrogen and AR" . SPARSER::COLLECTION) ("Ezh2" . SPARSER::PROTEIN)
    ("anti-androgen and TOP2A" . SPARSER::COLLECTION)
    ("TOP2A or AR" . SPARSER::COLLECTION)
    ("TOP2A and AR" . SPARSER::COLLECTION) ("Antibodies" . SPARSER::ANTIBODY)
    ("prostate-specific antigen (PSA)" . SPARSER::PROTEIN)
    ("the proximal and distal ARE" . SPARSER::ANTI-OXIDANT-RESPONSE-ELEMENT)
    ("the proximal genes" . SPARSER::GENE)
    ("palindromic androgen response element (ARE)"
     . SPARSER::DNA-RESPONSE-ELEMENT)
    ("AR and TOP2A" . SPARSER::COLLECTION)
    ("drugs and anti-androgens" . SPARSER::COLLECTION)
    ("casodex" . SPARSER::DRUG)
    ("TOP2A poisons and combination" . SPARSER::COLLECTION)
    ("anti-androgen and doxorubicin" . SPARSER::COLLECTION)
    ("castration-resistant metastatic PCa" . SPARSER::PROTEIN)
    ("mitoxantrone and doxorubicin" . SPARSER::COLLECTION)
    ("TOP2A and B proteins" . SPARSER::COLLECTION)
    ("androgen receptor (AR) and TOP2B" . SPARSER::COLLECTION)
    ("TOP2A and Gleason" . SPARSER::COLLECTION) ("GS" . SPARSER::PROTEIN)
    ("myelogenous leukemia" . SPARSER::PROTEIN)
    ("etoposide and doxorubicin" . SPARSER::COLLECTION)
    ("Etoposide and doxorubicin" . SPARSER::COLLECTION)
    ("Etoposide" . SPARSER::PROTEIN)
    ("an essential nuclear enzyme" . SPARSER::ENZYME)
    ("TOP2A and androgen receptor" . SPARSER::COLLECTION)
    ("PARD3B" . SPARSER::PROTEIN) ("Emi1" . SPARSER::PROTEIN)
    ("tumor antigen" . SPARSER::DRUG) ("KLK3" . SPARSER::PROTEIN)
    ("p46" . SPARSER::PROTEIN) ("CKS2" . SPARSER::PROTEIN)
    ("highly expressed in cancer" . SPARSER::PROTEIN)
    ("DLX4" . SPARSER::PROTEIN) ("TOP2" . SPARSER::PROTEIN)
    ("DNA topoisomerase 2" . SPARSER::PROTEIN)
    ("Anti-androgen" . SPARSER::DRUG) ("LiCl or GSK3β" . SPARSER::COLLECTION)
    ("steady-state GSK3β protein and Ser9 phosphorylated GSK3β protein"
     . SPARSER::COLLECTION)
    ("cellular β-catenin" . SPARSER::PROTEIN)
    ("DVL2 and β-catenin" . SPARSER::COLLECTION)
    ("AR-A014418 or siRNA" . SPARSER::COLLECTION)
    ("FasL and IκBα" . SPARSER::COLLECTION)
    ("The mRNA ( xref ) and protein ( xref )" . SPARSER::COLLECTION)
    ("Exogenous HPV16 E6 or E7" . SPARSER::COLLECTION)
    ("exogenous HPV16 E6" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("E6 or E7" . SPARSER::COLLECTION)
    ("HPV16 E6 and/or E7" . SPARSER::COLLECTION)
    ("a multifunctional Ser/Thr kinase" . SPARSER::KINASE)
    ("APC, Axin, or β-catenin" . SPARSER::COLLECTION)
    ("Axin" . SPARSER::PROTEIN) ("E6 and E7" . SPARSER::COLLECTION)
    ("E6/E7" . SPARSER::COLLECTION) ("Lithium chloride" . SPARSER::DRUG)
    ("Siah-1" . SPARSER::PROTEIN) ("DVL2" . SPARSER::PROTEIN)
    ("AR-A014418" . SPARSER::DRUG)
    ("low density lipoprotein receptor-related protein" . SPARSER::PROTEIN)
    ("casein kinase 1" . SPARSER::PROTEIN)
    ("plasminogen activator inhibitor-1 and PAI-1" . SPARSER::COLLECTION)
    ("serine proteinase" . SPARSER::PROTEIN) ("PAI-1" . SPARSER::PROTEIN)
    ("plasminogen activator inhibitor-1" . SPARSER::PROTEIN)
    ("SERPINE1" . SPARSER::PROTEIN) ("member 1" . SPARSER::PROTEIN)
    ("serine protease inhibitor" . SPARSER::PROTEIN)
    ("mRNA and Argonaute" . SPARSER::COLLECTION)
    ("Argonaute" . SPARSER::PROTEIN-FAMILY) ("Ambs" . SPARSER::DRUG)
    ("PIK3CA and over‐expression" . SPARSER::COLLECTION)
    ("AKT and p70S6K" . SPARSER::COLLECTION)
    ("PI3K/Akt/mTORC1" . SPARSER::COLLECTION)
    ("suppressor and play" . SPARSER::COLLECTION) ("LacZ" . SPARSER::PROTEIN)
    ("flag" . SPARSER::PROTEIN-FAMILY)
    ("a previously reported protein" . SPARSER::PROTEIN)
    ("Caki" . SPARSER::PROTEIN) ("PM" . SPARSER::PROTEIN)
    ("anti" . SPARSER::PROTEIN) ("type and stage" . SPARSER::COLLECTION)
    ("target mRNAs which in turn mediate miRNA's" . SPARSER::PROTEIN)
    ("VHL , PBRM1 , BAP1 and SETD2" . SPARSER::COLLECTION)
    ("VHL" . SPARSER::PROTEIN) ("peroxidase" . SPARSER::PROTEIN)
    ("‐kinase/Akt" . SPARSER::COLLECTION) ("SA1" . SPARSER::PROTEIN)
    ("Akt/PKB" . SPARSER::PROTEIN)
    ("catalytic subunit of PI3K" . SPARSER::PROTEIN)
    ("HK­2" . SPARSER::PROTEIN) ("SETD2" . SPARSER::PROTEIN)
    ("BAP1" . SPARSER::PROTEIN) ("PBRM1" . SPARSER::PROTEIN)
    ("neurotrophins" . SPARSER::PROTEIN) ("Rac1/LIMK" . SPARSER::COLLECTION)
    ("NGF or netrin-1" . SPARSER::COLLECTION)
    ("X enopus laevis spinal neurons xref , and nerve growth factor (NGF) and netrin-1"
     . SPARSER::COLLECTION)
    ("X enopus laevis spinal neurons xref , and nerve growth factor (NGF)"
     . SPARSER::GROWTH-FACTOR)
    ("growth factor (NGF)" . SPARSER::GROWTH-FACTOR)
    ("bone morphogenic proteins" . SPARSER::PROTEIN)
    ("retinal neurons cofilin 1" . SPARSER::PROTEIN)
    ("BDNF" . SPARSER::PROTEIN)
    ("complexes and proteins" . SPARSER::COLLECTION)
    ("axonal elongation" . SPARSER::PROTEIN)
    ("the exogenous protein" . SPARSER::PROTEIN)
    ("RFP-cofilin" . SPARSER::COLLECTION)
    ("dominant negative and positive cofilin 1" . SPARSER::PROTEIN)
    ("p-cofilin 1" . SPARSER::COLLECTION) ("LatA" . SPARSER::DRUG)
    ("Jasplakinolide" . SPARSER::DRUG)
    ("cytoskeletal polymerization state" . SPARSER::BIO-STATE)
    ("particular actin" . SPARSER::PROTEIN)
    ("fluorescent cofilin 1" . SPARSER::PROTEIN)
    ("actin and cofilin 1" . SPARSER::COLLECTION) ("tip" . SPARSER::PROTEIN)
    ("cue" . SPARSER::PROTEIN-FAMILY) ("attractant" . SPARSER::PROTEIN)
    ("polymerized state" . SPARSER::BIO-STATE)
    ("actin-YFP" . SPARSER::COLLECTION) ("YFP" . SPARSER::PROTEIN)
    ("The purified proteins contained no aggregated or cleaved forms"
     . SPARSER::FORM)
    ("wt and A30P" . SPARSER::COLLECTION)
    ("Actin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("extracellularly-delivered wt or A30P mutant Syn" . SPARSER::PROTEIN)
    ("wt or A30P" . SPARSER::COLLECTION) ("LRRK" . SPARSER::PROTEIN)
    ("serine/threonine-protein kinase (LRRK)" . SPARSER::PROTEIN)
    ("LIMK" . SPARSER::PROTEIN) ("rod" . SPARSER::PROTEIN)
    ("Slingshot" . SPARSER::PROTEIN)
    ("Extracellular monomeric Syn" . SPARSER::PROTEIN)
    ("Syn and actin" . SPARSER::COLLECTION) ("elegans" . SPARSER::PROTEIN)
    ("extracellular Syn" . SPARSER::PROTEIN)
    ("monomeric cellular Syn" . SPARSER::PROTEIN)
    ("secreted extracellular Syn" . SPARSER::PROTEIN)
    ("Syn" . SPARSER::PROTEIN) ("cofilin" . SPARSER::PROTEIN)
    ("extracellular alpha-synuclein" . SPARSER::PROTEIN)
    ("DIV 1" . SPARSER::PROTEIN) ("or 2 " . SPARSER::MOLECULE)
    ("netrin-1" . SPARSER::PROTEIN)
    ("brain-derived neurotrophic factor" . SPARSER::PROTEIN)
    ("serine3" . SPARSER::PROTEIN) ("assembly/disassembly" . SPARSER::PROTEIN)
    ("Cofilin 1" . SPARSER::PROTEIN) ("Latrunculin A" . SPARSER::DRUG)
    ("leucine-rich repeat" . SPARSER::PROTEIN)
    ("Amyloid-beta peptide" . SPARSER::PROTEIN)
    ("cofilin 1" . SPARSER::PROTEIN) ("alpha-synuclein" . SPARSER::PROTEIN)
    ("Alpha-synuclein" . SPARSER::PROTEIN)
    ("EHT1864 or Cdc42" . SPARSER::COLLECTION)
    ("GEFs, GAPs and GDIs" . SPARSER::COLLECTION) ("GDIs" . SPARSER::PROTEIN)
    ("isoprenoid" . SPARSER::MOLECULE) ("GGTI" . SPARSER::PROTEIN)
    ("FTI" . SPARSER::DRUG)
    ("the currently known inhibitors" . SPARSER::INHIBITOR)
    ("Cdc42 and ketorolac" . SPARSER::COLLECTION)
    ("nucleotide, and drug" . SPARSER::COLLECTION) ("COOH" . SPARSER::MOLECULE)
    ("beta-catenin/TCF" . SPARSER::COLLECTION) ("etodolac" . SPARSER::DRUG)
    ("COXs" . SPARSER::PROTEIN)
    ("a recent dramatic example" . SPARSER::EXAMPLE)
    ("Enantiomeric drug" . SPARSER::DRUG)
    ("Rac1 and/or Cdc42 inhibitors" . SPARSER::COLLECTION)
    ("protein—protein" . SPARSER::COLLECTION)
    ("the DOCK9 (Val1951) and DOCK2 (Val1540* or Val1539**, note position differs in Kulkarni et al.*, as compared to crystal structure** and human DOCK2 amino acid sequence NP_004937.1**) GEFs [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("Cdc42 and Rac1" . SPARSER::COLLECTION) ("valine" . SPARSER::AMINO-ACID)
    ("Rac and Cdc42" . SPARSER::COLLECTION)
    ("an irrelevant effector, and non-specific" . SPARSER::COLLECTION)
    ("effector, and non-specific" . SPARSER::COLLECTION)
    ("Detergent" . SPARSER::MOLECULE) ("aryl" . SPARSER::PROTEIN)
    ("the inert 6-MNA derivative" . SPARSER::DERIVATIVE)
    ("Rac1 or Tiam1" . SPARSER::COLLECTION)
    ("Rac1 and Tiam1" . SPARSER::COLLECTION)
    ("guanine nucleotide exchange factor (GEF)" . SPARSER::GEF)
    ("Rac1 or Cdc42" . SPARSER::COLLECTION)
    ("celecoxib and valdecoxib" . SPARSER::COLLECTION)
    ("valdecoxib" . SPARSER::DRUG) ("HTS" . SPARSER::PROTEIN)
    ("sulindac" . SPARSER::DRUG) ("Only four NSAIDs" . SPARSER::DRUG)
    ("GST-GFP" . SPARSER::COLLECTION) ("BODIPY" . SPARSER::DRUG)
    ("Ras, Rho and Rab" . SPARSER::COLLECTION) ("patent drugs" . SPARSER::DRUG)
    ("nonsteroidal anti-inflammatory drugs (NSAID) naproxen" . SPARSER::DRUG)
    ("drugs and drug-like small molecules" . SPARSER::COLLECTION)
    ("inhibitors and activators" . SPARSER::COLLECTION)
    ("mutant and hyperactivity" . SPARSER::COLLECTION)
    ("established Rac1 (NSC23766) and Cdc42 (CID2950007/ML141) specific inhibitors"
     . SPARSER::COLLECTION)
    ("NSAID" . SPARSER::PROTEIN) ("naphthalene" . SPARSER::MOLECULE)
    ("Rac1 and Cdc42" . SPARSER::COLLECTION) ("naproxen" . SPARSER::DRUG)
    ("Rac, Rho and Cdc42" . SPARSER::COLLECTION)
    ("Rho" . SPARSER::HUMAN-PROTEIN-FAMILY) ("EHT1864" . SPARSER::DRUG)
    ("guanine nucleotide exchange factor" . SPARSER::GEF)
    ("Small G-protein" . SPARSER::PROTEIN) ("alpha10" . SPARSER::PROTEIN)
    ("ID 2" . SPARSER::PROTEIN) ("DOCK2" . SPARSER::PROTEIN)
    ("DOCK9" . SPARSER::PROTEIN) ("di-methyl" . SPARSER::DRUG)
    ("Alpha-" . SPARSER::PROTEIN) ("G-protein" . SPARSER::PROTEIN)
    ("cyclooxygenase 1" . SPARSER::PROTEIN) ("NSC 23766" . SPARSER::DRUG)
    ("IgG2a" . SPARSER::PROTEIN) ("beta-glycerophosphate" . SPARSER::DRUG)
    ("Tiam1" . SPARSER::PROTEIN) ("TIAM1" . SPARSER::PROTEIN)
    ("NS398" . SPARSER::DRUG) ("PAK-1" . SPARSER::PROTEIN)
    ("PAK1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("RasG12V" . SPARSER::PROTEIN)
    ("Rab2" . SPARSER::PROTEIN) ("NSC23766" . SPARSER::DRUG)
    ("Rho family" . SPARSER::PROTEIN)
    ("the exact downstream target" . SPARSER::TARGET-PROTEIN)
    ("Quercetin" . SPARSER::MOLECULE) ("aziridine" . SPARSER::DRUG)
    ("amine" . SPARSER::MOLECULE) ("diol" . SPARSER::MOLECULE)
    ("The PCNA basic isoforms" . SPARSER::ISOFORM)
    ("PCNA and p21" . SPARSER::COLLECTION)
    ("Gadd45, MyD118, CR6, and p21" . SPARSER::COLLECTION)
    ("Gadd45a and two BER-mediated repair proteins, PCNA and apurinic/apyrimidinic endonuclease (APE1/Ref-1)"
     . SPARSER::COLLECTION)
    ("proteins, PCNA and apurinic/apyrimidinic" . SPARSER::COLLECTION)
    ("APE1/Ref-1" . SPARSER::COLLECTION) ("endonuclease" . SPARSER::PROTEIN)
    ("SeMet" . SPARSER::DRUG) ("p53 and PCNA" . SPARSER::COLLECTION)
    ("p53 and Bax" . SPARSER::COLLECTION)
    ("condensations" . SPARSER::PROTEIN-FAMILY)
    ("p53 and proapoptotic gene" . SPARSER::COLLECTION)
    ("tumor suppressor protein and proliferating cell nuclear antigen (PCNA)"
     . SPARSER::PROTEIN)
    ("tumor suppressor protein and proliferating cell nuclear antigen"
     . SPARSER::COLLECTION)
    ("an evolutionally well-conserved protein" . SPARSER::PROTEIN)
    ("Proliferating cell nuclear antigen (PCNA)" . SPARSER::PROTEIN)
    ("an essential regulator" . SPARSER::REGULATOR)
    ("trigonelline" . SPARSER::DRUG) ("alkaloids" . SPARSER::MOLECULE)
    ("diosgenin" . SPARSER::DRUG) ("steroidal sapogenins" . SPARSER::MOLECULE)
    ("antipyretic" . SPARSER::DRUG) ("sapogenins" . SPARSER::MOLECULE)
    ("a traditional medicine" . SPARSER::DRUG)
    ("Food and Drug Administration [ xref ]" . SPARSER::COLLECTION)
    ("food or medicine" . SPARSER::COLLECTION)
    ("a plant derived-bioactive substance" . SPARSER::SUBSTANCE)
    ("substance" . SPARSER::SUBSTANCE)
    ("p53, Bax, and PCNA" . SPARSER::COLLECTION)
    ("Terpenoids" . SPARSER::MOLECULE)
    ("p53, Bax, PCNA, and caspase-3" . SPARSER::COLLECTION)
    ("protein, Bax, and proliferating cell nuclear antigen (PCNA)"
     . SPARSER::COLLECTION)
    ("protein, Bax, and proliferating cell nuclear antigen"
     . SPARSER::COLLECTION)
    ("a crude methanol" . SPARSER::MOLECULE) ("methanol" . SPARSER::MOLECULE)
    ("CR6" . SPARSER::PROTEIN) ("MyD118" . SPARSER::PROTEIN)
    ("Gadd45" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Ref-1" . SPARSER::PROTEIN)
    ("Gadd45a" . SPARSER::PROTEIN) ("β -actin" . SPARSER::PROTEIN)
    ("Asp-Glu" . SPARSER::MOLECULE) ("RNase-A" . SPARSER::PROTEIN)
    ("Proliferating cell nuclear antigen" . SPARSER::PROTEIN)
    ("a chemotherapeutic cancer target" . SPARSER::TARGET-PROTEIN)
    ("the most promising mitotic kinase" . SPARSER::KINASE)
    ("other vital protein kinases" . SPARSER::PROTEIN)
    ("PB1 and PB2" . SPARSER::COLLECTION)
    ("phosphoserine/phosphothreonine" . SPARSER::COLLECTION)
    ("a cell cycle-regulating mitotic kinase" . SPARSER::KINASE)
    ("SBR" . SPARSER::PROTEIN)
    ("previously published inhibitors" . SPARSER::INHIBITOR)
    ("integrase and prolyl endopeptidase" . SPARSER::COLLECTION)
    ("integrase" . SPARSER::PROTEIN) ("PPG" . SPARSER::PROTEIN)
    ("poloxin and its parental molecule thymoquinone" . SPARSER::COLLECTION)
    ("its parental molecule thymoquinone" . SPARSER::DRUG)
    ("poloxin" . SPARSER::DRUG)
    ("a well-known PBD antineoplastic inhibitor" . SPARSER::INHIBITOR)
    ("thymoquinone" . SPARSER::DRUG) ("Poloxin" . SPARSER::DRUG)
    ("cis/trans isomerase" . SPARSER::COLLECTION)
    ("peptidyl-prolyl" . SPARSER::COLLECTION) ("prolyl" . SPARSER::PROTEIN)
    ("phosphothreonine" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("phosphoserine" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("a pan-specific inhibitor" . SPARSER::INHIBITOR)
    ("molecules and phosphopeptides" . SPARSER::COLLECTION)
    ("paralogs" . SPARSER::PROTEIN) ("NET" . SPARSER::PROTEIN)
    ("LNP" . SPARSER::PROTEIN) ("nanoparticle" . SPARSER::MOLECULE)
    ("TP53 and KRAS" . SPARSER::COLLECTION)
    ("orally bioavailable and selective ATP-competitive inhibitor"
     . SPARSER::INHIBITOR)
    ("Bcl-2, BTK, and CASP1" . SPARSER::COLLECTION) ("RO" . SPARSER::PROTEIN)
    ("relapsed B-cell precursor acute lymphoblastic leukemia"
     . SPARSER::PROTEIN)
    ("the antileukemic drug vincristine" . SPARSER::DRUG)
    ("GST-CDC25" . SPARSER::COLLECTION)
    ("a leflunomide metabolite analog and a selective inhibitor of PLK-1 [ xref ]"
     . SPARSER::COLLECTION)
    ("leflunomide" . SPARSER::DRUG) ("imidazopyridine" . SPARSER::MOLECULE)
    ("vanillin" . SPARSER::DRUG) ("PLK1/2/3" . SPARSER::COLLECTION)
    ("TAL" . SPARSER::MOLECULE) ("DAP" . SPARSER::PROTEIN)
    ("non-ATP-competitive type inhibitor" . SPARSER::INHIBITOR)
    ("DLT" . SPARSER::PROTEIN) ("BI" . SPARSER::PROTEIN)
    ("Nutlin" . SPARSER::DRUG)
    ("nutlin (nutlin-3) and BI 2536" . SPARSER::COLLECTION)
    ("nutlin" . SPARSER::DRUG) ("PLK-2 and PLK-3" . SPARSER::COLLECTION)
    ("a well-tolerated inhibitor" . SPARSER::INHIBITOR)
    ("only 10 additional kinases" . SPARSER::PROTEIN)
    ("Cytarabine" . SPARSER::MOLECULE)
    ("acute myelogenous leukemia (AML)" . SPARSER::PROTEIN)
    ("TCTP" . SPARSER::PROTEIN) ("quinazoline" . SPARSER::MOLECULE)
    ("hyperglycemia" . SPARSER::PROTEIN) ("MTD" . SPARSER::PROTEIN)
    ("prodrug" . SPARSER::DRUG) ("PLK-1/2/3" . SPARSER::COLLECTION)
    ("PLKs" . SPARSER::PROTEIN) ("fungi" . SPARSER::PROTEIN)
    ("MDS" . SPARSER::PROTEIN) ("Bid, Bcl-xl and Mcl-1" . SPARSER::COLLECTION)
    ("NOXA and BIM" . SPARSER::COLLECTION)
    ("a hydrophilic benzyl styryl sulphone analog" . SPARSER::ANALOG)
    ("sulphone" . SPARSER::MOLECULE)
    ("a nonselective inhibitor" . SPARSER::INHIBITOR)
    ("myelin" . SPARSER::PROTEIN) ("Scytonemin" . SPARSER::MOLECULE)
    ("WEE/MYT1" . SPARSER::COLLECTION) ("WEE" . SPARSER::PROTEIN)
    ("scytonemin" . SPARSER::MOLECULE) ("ATP-mimetic" . SPARSER::ATP)
    ("PLK-1 and non-PLK-1" . SPARSER::COLLECTION)
    ("AMPPNP" . SPARSER::MOLECULE) ("Ser/Thr/Tyr" . SPARSER::COLLECTION)
    ("attractive therapeutic drug target" . SPARSER::TARGET-PROTEIN)
    ("small interfering (si) RNA and small molecules targeting"
     . SPARSER::COLLECTION)
    ("PB" . SPARSER::PROTEIN) ("a mitotic proto-oncogene" . SPARSER::PROTEIN)
    ("ATR-ATM" . SPARSER::COLLECTION) ("TOPORS-" . SPARSER::PROTEIN)
    ("protein-" . SPARSER::PROTEIN) ("TOPORS" . SPARSER::PROTEIN)
    ("Topo" . SPARSER::PROTEIN)
    ("an attractive anticancer therapeutic drug target"
     . SPARSER::TARGET-PROTEIN)
    ("a crucial mitotic protein kinase" . SPARSER::KINASE)
    ("Polo-like kinase-1" . SPARSER::COLLECTION) ("PBIP1" . SPARSER::PROTEIN)
    ("PB2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Bcl -XL" . SPARSER::PROTEIN)
    ("prolyl endopeptidase" . SPARSER::PROTEIN) ("PIN1" . SPARSER::PROTEIN)
    ("trans isomerase" . SPARSER::PROTEIN) ("CHK-2" . SPARSER::PROTEIN)
    ("p-Thr" . SPARSER::PROTEIN) ("CASP1" . SPARSER::PROTEIN)
    ("homolog of" . SPARSER::PROTEIN) ("Plx1" . SPARSER::PROTEIN)
    ("LFM-A13" . SPARSER::DRUG) ("DAP81" . SPARSER::DRUG)
    ("polo-like" . SPARSER::PROTEIN) ("nutlin-3" . SPARSER::DRUG)
    ("PLK-3" . SPARSER::PROTEIN) ("PLK-2" . SPARSER::PROTEIN)
    ("GSK461364A" . SPARSER::DRUG) ("NF-Y" . SPARSER::PROTEIN)
    ("Nuclear Transcription Factor Y subunit alpha" . SPARSER::PROTEIN)
    ("Chk-1" . SPARSER::PROTEIN) ("checkpoint kinase-1" . SPARSER::PROTEIN)
    ("MYT1" . SPARSER::PROTEIN) ("BI 2536" . SPARSER::DRUG)
    ("ankyrin repeat" . SPARSER::PROTEIN) ("CDK-1" . SPARSER::PROTEIN)
    ("GTSE1" . SPARSER::PROTEIN) ("PLK-4" . SPARSER::PROTEIN)
    ("PLK-1" . SPARSER::PROTEIN)
    ("a ubiquitous transcription factor" . SPARSER::PROTEIN)
    ("AG490 and AZD1480" . SPARSER::COLLECTION) ("g" . SPARSER::PROTEIN)
    ("putative self-renewal marker Bmi1" . SPARSER::PROTEIN)
    ("angiogenic genes" . SPARSER::GENE) ("mTOR/STAT3" . SPARSER::COLLECTION)
    ("Notch1 , P53 , NF-κB and EGFR" . SPARSER::COLLECTION)
    ("chemotherapeutic reagent treatment 10 mg/kg CDDP" . SPARSER::DRUG)
    ("CDDP and 5-FU" . SPARSER::COLLECTION)
    ("OCT4, SOX2 and ALDH1" . SPARSER::COLLECTION)
    ("Tgfbr1/Pten" . SPARSER::COLLECTION) ("cKO" . SPARSER::PROTEIN)
    ("Tgfbr1 and Pten" . SPARSER::COLLECTION)
    ("ALDH1 and regulator" . SPARSER::COLLECTION)
    ("Cyclin D1 and Bcl2" . SPARSER::COLLECTION)
    ("S3I-201 and control group" . SPARSER::COLLECTION)
    ("self-renewal marker Nanog, OCT4, ALDH1 and CD44" . SPARSER::COLLECTION)
    ("Nanog, OCT4, ALDH1 and CD44" . SPARSER::COLLECTION)
    ("Cyclin D1 and Bcl-2" . SPARSER::COLLECTION)
    ("SOX2, CD44, ALDH1 and OCT4" . SPARSER::COLLECTION)
    ("SCC4" . SPARSER::PROTEIN)
    ("CSCs self-renewal related markers ALDH1, CD44, OCT4 and SOX2"
     . SPARSER::COLLECTION)
    ("ALDH1, CD44, OCT4 and SOX2" . SPARSER::COLLECTION)
    ("gefitinib [ xref ] and erlotinib [ xref ]" . SPARSER::COLLECTION)
    ("paclitaxel [ xref ], imatinib [ xref ], gefitinib [ xref ] and erlotinib [ xref ]"
     . SPARSER::COLLECTION)
    ("monomers" . SPARSER::MONOMER)
    ("possible molecular biomarkers" . SPARSER::MOLECULE)
    ("conventional chemotherapeutic drugs" . SPARSER::DRUG)
    ("NSC74859" . SPARSER::DRUG) ("K14" . SPARSER::PROTEIN)
    ("stat3" . SPARSER::PROTEIN) ("AZD1480" . SPARSER::DRUG)
    ("Jagged-1" . SPARSER::PROTEIN) ("Notch1" . SPARSER::PROTEIN)
    ("5–FU" . SPARSER::PROTEIN) ("Tgfbr1" . SPARSER::PROTEIN)
    ("E-4" . SPARSER::PROTEIN)
    ("miRNAs and cyto- or chemokines" . SPARSER::COLLECTION)
    ("miRNAs and pro- or anti-inflammatory" . SPARSER::COLLECTION)
    ("pro- or anti-inflammatory" . SPARSER::COLLECTION)
    ("miRNAs and cytokines" . SPARSER::COLLECTION)
    ("indirectly modulating adenine and uridine-rich elements binding proteins [ xref ]"
     . SPARSER::COLLECTION)
    ("cytokines and miRNAs" . SPARSER::COLLECTION)
    ("IL-4 and TNF-alpha" . SPARSER::COLLECTION)
    ("many immune-related genes" . SPARSER::GENE)
    ("a pro-inflammatory cytokine" . SPARSER::PROTEIN)
    ("anti- and pro-tumorigenic" . SPARSER::COLLECTION)
    ("IFNG" . SPARSER::PROTEIN)
    ("cytokines, IL-6, TNF-α, IL-1β, Il-4, IL-10, VEGF, and chemokines"
     . SPARSER::COLLECTION)
    ("IL-6, IFN-γ, TNF-α, IL-1β, Il-4, IL-10 and IL-8" . SPARSER::COLLECTION)
    ("growth factors and adhesion molecules" . SPARSER::COLLECTION)
    ("γ-catenin and BCL-2" . SPARSER::COLLECTION)
    ("tristetraprolin and let-7" . SPARSER::COLLECTION)
    ("miRPath" . SPARSER::PROTEIN) ("Wt" . SPARSER::PROTEIN)
    ("dys" . SPARSER::PROTEIN)
    ("p53, miRNAs and cytokines" . SPARSER::COLLECTION)
    ("oncogenes and tumor suppressor genes" . SPARSER::COLLECTION)
    ("VEGF and has-miR-1" . SPARSER::COLLECTION)
    ("interleukin 1βand miRanda" . SPARSER::COLLECTION)
    ("MIP-1-" . SPARSER::PROTEIN) ("PITA and RNA22" . SPARSER::COLLECTION)
    ("VEGF and let-7f-5p" . SPARSER::COLLECTION)
    ("MIP-1αand IL-8" . SPARSER::COLLECTION) ("microT" . SPARSER::PROTEIN)
    ("DIANA-microT" . SPARSER::COLLECTION)
    ("miRNAs and cyto- and chemokine" . SPARSER::COLLECTION)
    ("MIP-1α and VEGF" . SPARSER::COLLECTION)
    ("TNF-α and IFN-γ" . SPARSER::COLLECTION)
    ("the 20 cytokines [GM-CSF, IL-15, IL-1α, IL-16, IL-5, IL-17, IL-7, TNF-β, IL-12p40, VEGF, IFN-γ, IL-8 (high-ab), IL-1β, IL-10, IL-2, IL-12p70, IL-4, IL-13, IL-6, TNF-α] and 10 chemokines [MIP-1α, MIP-1β, TARC, Eotaxin, Eotaxin-3, MCP-1, MCP-4, MDC, IP-10, IL-8 (chem)]"
     . SPARSER::COLLECTION)
    ("IL-8 and MIP-1α" . SPARSER::COLLECTION) ("Eotaxin" . SPARSER::PROTEIN)
    ("TARC" . SPARSER::PROTEIN) ("the mostly target gene" . SPARSER::GENE)
    ("DIANA-miRPath" . SPARSER::COLLECTION) ("DIANA" . SPARSER::PROTEIN)
    ("miR-1, miR-127-5p, miR-142-5p and miR-202-5p" . SPARSER::COLLECTION)
    ("the radiation only 3 miRNAs" . SPARSER::PROTEIN)
    ("miRNAs, cyto-, chemokines and p53" . SPARSER::COLLECTION)
    ("what causes colon cancer" . SPARSER::PROTEIN)
    ("a water-soluble derivative" . SPARSER::DERIVATIVE)
    ("both resectable and advanced CRCs" . SPARSER::PROTEIN)
    ("p53, pro- or anti-inflammatory" . SPARSER::COLLECTION)
    ("Cytokines, IL-6, TNF-α, IL-1β, Il-4, IL-10, VEGF, and chemokines"
     . SPARSER::COLLECTION)
    ("VEGF and MIP-1α" . SPARSER::COLLECTION) ("Il-4" . SPARSER::PROTEIN)
    ("a functionally null p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("miRNAs, cyto- and chemokines" . SPARSER::COLLECTION)
    ("miRNAs, cytokines and chemokines" . SPARSER::COLLECTION)
    ("D-1" . SPARSER::PROTEIN) ("s 5A" . SPARSER::PROTEIN)
    ("interleukin-4" . SPARSER::PROTEIN) ("γ-catenin" . SPARSER::PROTEIN)
    ("down-regulated in gastric cancer" . SPARSER::PROTEIN)
    ("NGX6" . SPARSER::PROTEIN) ("IL8" . SPARSER::PROTEIN)
    ("Let-7" . SPARSER::RNA) ("MIP-1 α" . SPARSER::PROTEIN)
    ("IL-1beta" . SPARSER::PROTEIN) ("interleukin 1β" . SPARSER::PROTEIN)
    ("MIP-1" . SPARSER::PROTEIN) ("interleukin 4" . SPARSER::PROTEIN)
    ("IP-10" . SPARSER::PROTEIN) ("MCP-4" . SPARSER::PROTEIN)
    ("Eotaxin-3" . SPARSER::PROTEIN) ("MIP-1β" . SPARSER::PROTEIN)
    ("IL-12p70" . SPARSER::PROTEIN) ("IL-12p40" . SPARSER::PROTEIN)
    ("IL-5" . SPARSER::PROTEIN) ("IL-16" . SPARSER::PROTEIN)
    ("K-ras" . SPARSER::PROTEIN) ("miR-450b-5p" . SPARSER::MOLECULE)
    ("miR-302b" . SPARSER::MOLECULE) ("miR-199a-3p" . SPARSER::MOLECULE)
    ("miR-133a" . SPARSER::PROTEIN) ("CPT-11" . SPARSER::DRUG)
    ("MIP-1α" . SPARSER::PROTEIN) ("SN38" . SPARSER::DRUG)
    ("p100, BID and FAF2" . SPARSER::COLLECTION)
    ("pro-apoptotic proteins BID and fas-associated factor 2 (FAF2)"
     . SPARSER::COLLECTION)
    ("fas-associated factor 2" . SPARSER::PROTEIN)
    ("pro-apoptotic proteins BID" . SPARSER::PROTEIN)
    ("BRCA1 and CCND1" . SPARSER::COLLECTION)
    ("MYC and NCL" . SPARSER::COLLECTION)
    ("p105 and p100" . SPARSER::COLLECTION) ("Inactive" . SPARSER::INACTIVE)
    ("the transcriptionally active p52/RelB dimer" . SPARSER::DIMER)
    ("p52/RelB" . SPARSER::COLLECTION)
    ("PCNA, MCM2, Nup155, Hsp70, GRP78, PDIA6, and HLA-DR"
     . SPARSER::COLLECTION)
    ("NFkB2" . SPARSER::PROTEIN) ("TOP2A and TOP2B" . SPARSER::COLLECTION)
    ("enzymes, TOP2A and TOP2B" . SPARSER::COLLECTION)
    ("the replicative helicase" . SPARSER::PROTEIN) ("MCM" . SPARSER::PROTEIN)
    ("RFC4 and RFC5" . SPARSER::COLLECTION) ("RFC" . SPARSER::PROTEIN)
    ("PRKDC and XRCC5" . SPARSER::COLLECTION) ("broken DNA" . SPARSER::DNA)
    ("PRKDC" . SPARSER::PROTEIN)
    ("protein, SNRNP200 and ribosome biogenesis factor" . SPARSER::COLLECTION)
    ("YARS" . SPARSER::PROTEIN) ("AARS" . SPARSER::PROTEIN)
    ("PSMC6, PSMD7 and USP39" . SPARSER::COLLECTION)
    ("BRCA1/BARD1" . SPARSER::COLLECTION) ("MYC and p53" . SPARSER::COLLECTION)
    ("C1QBP, GAPDH and MFAP1" . SPARSER::COLLECTION)
    ("SLC16A1" . SPARSER::PROTEIN) ("2-FaraA-induced DNA" . SPARSER::DNA)
    ("the DNA damage and repair proteins (TOP2A, POLD1, SSBP1, SET and RUVBL2) and cell cycle proteins (SKP1, ANAPC5, PARP10 and SEPTIN11)"
     . SPARSER::COLLECTION)
    ("TOP2A, POLD1, SSBP1, SET and RUVBL2" . SPARSER::COLLECTION)
    ("SKP1, ANAPC5, PARP10 and SEPTIN11" . SPARSER::COLLECTION)
    ("receptor and caspase 8" . SPARSER::COLLECTION) ("FAS" . SPARSER::PROTEIN)
    ("Molecules" . SPARSER::MOLECULE) ("YWHAZ" . SPARSER::PROTEIN)
    ("nucleobase, nucleoside, nucleotide and nucleic acid metabolism"
     . SPARSER::COLLECTION)
    ("DNA damage proteins TOP2A (6.5-ratio) and TOP2B (6.0-ratio)"
     . SPARSER::COLLECTION)
    ("nucleoside, nucleotide and nucleic acid metabolism (48 molecules)"
     . SPARSER::COLLECTION)
    ("FUS" . SPARSER::PROTEIN) ("NONO" . SPARSER::PROTEIN)
    ("BRCA1 and BARD1" . SPARSER::COLLECTION)
    ("the DNA damage protein TOP2A (12.5-ratio) and proteins"
     . SPARSER::COLLECTION)
    ("nucleobase" . SPARSER::NUCLEOBASE)
    ("peptide and protein" . SPARSER::COLLECTION)
    ("proteins and peptides" . SPARSER::COLLECTION) ("AAG" . SPARSER::PROTEIN)
    ("200 ‘client’ proteins" . SPARSER::PROTEIN)
    ("oncoproteins" . SPARSER::PROTEIN)
    ("functional p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("fas" . SPARSER::PROTEIN) ("BRCA1 and cyclin D1" . SPARSER::COLLECTION)
    ("MYC and nucleolin" . SPARSER::COLLECTION)
    ("nucleolin" . SPARSER::PROTEIN) ("shotgun" . SPARSER::PROTEIN)
    ("Leukemia" . SPARSER::PROTEIN) ("OG" . SPARSER::PROTEIN)
    ("FaraA" . SPARSER::DRUG) ("nucleoside" . SPARSER::MOLECULE)
    ("SNX" . SPARSER::PROTEIN) ("H2AFX" . SPARSER::PROTEIN)
    ("HSP-90" . SPARSER::PROTEIN) ("NVP-AUY922" . SPARSER::MOLECULE)
    ("HLA-DR" . SPARSER::PROTEIN) ("PDIA6" . SPARSER::PROTEIN)
    ("Hsp70" . SPARSER::PROTEIN) ("Nup155" . SPARSER::PROTEIN)
    ("Promyelocytic leukemia protein" . SPARSER::PROTEIN)
    ("X-ray repair cross-complementing protein 5" . SPARSER::PROTEIN)
    ("NOL11" . SPARSER::PROTEIN)
    ("ribosome biogenesis factor" . SPARSER::PROTEIN)
    ("SNRNP200" . SPARSER::PROTEIN) ("NUP155" . SPARSER::PROTEIN)
    ("NUP93" . SPARSER::PROTEIN) ("NUP50" . SPARSER::PROTEIN)
    ("nuclear pore" . SPARSER::BIO-COMPLEX) ("DNAJB1" . SPARSER::PROTEIN)
    ("HSPB1" . SPARSER::PROTEIN) ("HSPH1" . SPARSER::PROTEIN)
    ("YARS2" . SPARSER::PROTEIN) ("tyrosyl-tRNA synthetase" . SPARSER::PROTEIN)
    ("USP39" . SPARSER::PROTEIN) ("PSMD7" . SPARSER::PROTEIN)
    ("PSMC6" . SPARSER::PROTEIN) ("USP47" . SPARSER::PROTEIN)
    ("USP15" . SPARSER::PROTEIN) ("UBE2V1" . SPARSER::PROTEIN)
    ("TCEB1" . SPARSER::PROTEIN) ("PSMD12" . SPARSER::PROTEIN)
    ("PSMB1" . SPARSER::PROTEIN) ("PSMA4" . SPARSER::PROTEIN)
    ("DNAJB11" . SPARSER::PROTEIN) ("MFAP1" . SPARSER::PROTEIN)
    ("C1QBP" . SPARSER::PROTEIN) ("SLC7A5" . SPARSER::PROTEIN)
    ("SLC38A1" . SPARSER::PROTEIN) ("PAX2" . SPARSER::PROTEIN)
    ("MAT2A" . SPARSER::PROTEIN) ("GLUD1" . SPARSER::PROTEIN)
    ("AK2" . SPARSER::PROTEIN) ("POLD1" . SPARSER::PROTEIN)
    ("NFκB2" . SPARSER::PROTEIN) ("SEPT11" . SPARSER::PROTEIN)
    ("TP53BP1" . SPARSER::PROTEIN) ("RFC4" . SPARSER::PROTEIN)
    ("RFC5" . SPARSER::PROTEIN) ("TOP2B" . SPARSER::PROTEIN)
    ("RRM2" . SPARSER::PROTEIN) ("SSRP1" . SPARSER::PROTEIN)
    ("MCM5" . SPARSER::PROTEIN) ("MCM7" . SPARSER::PROTEIN)
    ("MCM6" . SPARSER::PROTEIN) ("BARD1" . SPARSER::PROTEIN)
    ("SEPTIN11" . SPARSER::PROTEIN) ("PARP10" . SPARSER::PROTEIN)
    ("ANAPC5" . SPARSER::PROTEIN) ("SKP1" . SPARSER::PROTEIN)
    ("RUVBL2" . SPARSER::PROTEIN) ("SSBP1" . SPARSER::PROTEIN)
    ("TOP2A" . SPARSER::PROTEIN) ("other histological types" . TYPE)
    ("ATRX" . SPARSER::PROTEIN)
    ("Methylated MGMT promoter" . SPARSER::PROMOTER) ("TGT" . SPARSER::PROTEIN)
    ("CGT" . SPARSER::PROTEIN) ("DA" . SPARSER::MOLECULE)
    ("Ets/TCF" . SPARSER::COLLECTION) ("Ets" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("an RNA subunit and a telomerase reverse transcriptase (TERT) catalytic subunit"
     . SPARSER::COLLECTION)
    ("MGMT" . SPARSER::PROTEIN) ("tel-1" . SPARSER::PROTEIN)
    ("IDH1" . SPARSER::PROTEIN) ("COX-2 as well as PGE2" . SPARSER::COLLECTION)
    ("the western blot" . SPARSER::PROTEIN)
    ("miR-101 directly targets COX-2" . SPARSER::PROTEIN)
    ("COX-2 and PGE2" . SPARSER::COLLECTION)
    ("a complex and heterogeneous disease with multiple underlying pathogenic mechanisms"
     . SPARSER::COLLECTION)
    ("pMIR-COX-2" . SPARSER::COLLECTION) ("hsa" . SPARSER::PROTEIN)
    ("the vector group or the miR-101 group" . SPARSER::COLLECTION)
    ("Microrna" . SPARSER::RNA) ("Ebi" . SPARSER::PROTEIN)
    ("approximately 22 nucleotides" . SPARSER::NUCLEOTIDE)
    ("Cyclooxygenases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("COX-2 and PEG2" . SPARSER::COLLECTION)
    ("prostaglandin E2" . SPARSER::MOLECULE) ("PEG2" . SPARSER::PROTEIN)
    ("our studies newly link two key NSCLC oncogenes" . SPARSER::ONCOGENE)
    ("EGFR, or ROR1 or LMO3" . SPARSER::COLLECTION)
    ("ROR1 or LMO3" . SPARSER::COLLECTION)
    ("Egfr-driven murine tumors perhaps more closely modeling NKX2-1"
     . SPARSER::PROTEIN)
    ("Egfr" . SPARSER::PROTEIN) ("MAPK and PI3K" . SPARSER::COLLECTION)
    ("erlotinib and gefitinib" . SPARSER::COLLECTION)
    ("ROR1 and LMO3" . SPARSER::COLLECTION) ("genes (EGFR)" . SPARSER::GENE)
    ("substantially up/downregulated genes" . SPARSER::GENE)
    ("presumptive direct targets" . SPARSER::TARGET-PROTEIN)
    ("possibly reflecting NKX2-1’s" . SPARSER::PROTEIN)
    ("PVT1 and ZC3H7A" . SPARSER::COLLECTION)
    ("MYOD1, NFE2 and TCF3" . SPARSER::COLLECTION)
    ("844 NKX2-1 binding site-associated genes" . SPARSER::GENE)
    ("-seq" . SPARSER::COLLECTION)
    ("indirect NKX2-1 transcriptional targets" . SPARSER::TARGET-PROTEIN)
    ("only 9 genes" . SPARSER::GENE) ("only 4 genes" . SPARSER::GENE)
    ("NBL1 , UNC84B , RRBP1 , and FA2H" . SPARSER::COLLECTION)
    ("approximately 10,000 genes" . SPARSER::GENE)
    ("well-measured genes" . SPARSER::GENE) ("SFTPB" . SPARSER::PROTEIN)
    ("NTC" . SPARSER::PROTEIN) ("NKX2-1 regulated genes" . SPARSER::GENE)
    ("Nkx2-1" . SPARSER::PROTEIN)
    ("ROR1 [ xref ] and LMO3 [ xref ]" . SPARSER::COLLECTION)
    ("surfactant" . SPARSER::PROTEIN)
    ("thyroid and forebrain" . SPARSER::COLLECTION)
    ("TITF1 and TTF-1" . SPARSER::COLLECTION)
    ("valuable therapeutic targets" . SPARSER::TARGET-PROTEIN)
    ("EGFR , KRAS , BRAF and ERBB2" . SPARSER::COLLECTION)
    ("ALK and ROS1" . SPARSER::COLLECTION)
    ("NKX2-1 and EGFR" . SPARSER::COLLECTION)
    ("MAP-kinase and PI3-kinase" . SPARSER::COLLECTION)
    ("relevant downstream transcriptional targets" . SPARSER::TARGET-PROTEIN)
    ("HMGA2" . SPARSER::PROTEIN) ("ZC3" . SPARSER::PROTEIN)
    ("PVT1" . SPARSER::PROTEIN) ("TCF3" . SPARSER::PROTEIN)
    ("NFE2" . SPARSER::PROTEIN) ("MYOD1" . SPARSER::PROTEIN)
    ("ZBTB4" . SPARSER::PROTEIN) ("TP53INP1" . SPARSER::PROTEIN)
    ("PIK3CB" . SPARSER::PROTEIN) ("ID3" . SPARSER::PROTEIN)
    ("HIST1H2BE" . SPARSER::PROTEIN) ("HIST1H2BD" . SPARSER::PROTEIN)
    ("HIST1H2BC" . SPARSER::PROTEIN) ("CHD7" . SPARSER::PROTEIN)
    ("FA2H" . SPARSER::PROTEIN) ("RRBP1" . SPARSER::PROTEIN)
    ("UNC84B" . SPARSER::PROTEIN) ("NBL1" . SPARSER::PROTEIN)
    ("surfactant protein B" . SPARSER::PROTEIN) ("WNT5A" . SPARSER::PROTEIN)
    ("isoform 1" . SPARSER::PROTEIN) ("L-glutamate" . SPARSER::MOLECULE)
    ("LMO3" . SPARSER::PROTEIN) ("ROR1" . SPARSER::PROTEIN)
    ("TTF-1" . SPARSER::PROTEIN) ("TITF1" . SPARSER::PROTEIN)
    ("NKX2-1" . SPARSER::PROTEIN)
    ("a widely-expressed cytoplasmic enzyme" . SPARSER::ENZYME)
    ("paxillin and FAK" . SPARSER::COLLECTION) ("SHP" . SPARSER::PROTEIN)
    ("Integrins and Src" . SPARSER::COLLECTION)
    ("Integrins" . SPARSER::PROTEIN)
    ("paxillin and SHP-2" . SPARSER::COLLECTION)
    ("kinases and phosphatases" . SPARSER::COLLECTION)
    ("CagA" . SPARSER::PROTEIN)
    ("a few micronemal proteins" . SPARSER::PROTEIN)
    ("Micronemal proteins" . SPARSER::PROTEIN) ("Saracatinib" . SPARSER::DRUG)
    ("Possible downstream targets" . SPARSER::TARGET-PROTEIN)
    ("very few proteins" . SPARSER::PROTEIN)
    ("an adaptor protein and a substrate" . SPARSER::COLLECTION)
    ("PTPase" . SPARSER::PROTEIN)
    ("SHP-2 and sporozoite co-localization" . SPARSER::COLLECTION)
    ("orthovanadate" . SPARSER::MOLECULE)
    ("a progressive part" . SPARSER::COMPONENT) ("Paxillin" . SPARSER::PROTEIN)
    ("paxillin, IRS1, IRS2, and GAB1" . SPARSER::COLLECTION)
    ("pTyr" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("GDP/GTP" . SPARSER::PROTEIN-PAIR) ("frabin" . SPARSER::PROTEIN)
    ("Neural Wiskott-Aldrich syndrome protein (N-WASP) and p34-Arc"
     . SPARSER::COLLECTION)
    ("CDC42, Neural Wiskott-Aldrich syndrome protein (N-WASP) and p34-Arc"
     . SPARSER::COLLECTION)
    ("Gal" . SPARSER::PROTEIN) ("lectin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("galactose" . SPARSER::MOLECULE)
    ("SHP-2 and its down-stream target paxillin" . SPARSER::COLLECTION)
    ("paxillin and Src" . SPARSER::COLLECTION) ("SHPS-1" . SPARSER::PROTEIN)
    ("SHP2" . SPARSER::PROTEIN) ("Gab1" . SPARSER::PROTEIN)
    ("scaffolding protein" . SPARSER::PROTEIN)
    ("virulence factor" . SPARSER::PROTEIN-FAMILY)
    ("virulence factors" . SPARSER::PROTEIN-FAMILY) ("AZD0530" . SPARSER::DRUG)
    ("NSC-87877" . SPARSER::DRUG) ("SHP 2" . SPARSER::PROTEIN)
    ("CF-1" . SPARSER::PROTEIN) ("sodium bicarbonate" . SPARSER::DRUG)
    ("GAB1" . SPARSER::PROTEIN) ("IRS2" . SPARSER::PROTEIN)
    ("erythropoietin receptor" . SPARSER::PROTEIN)
    ("protein phosphatase" . SPARSER::PROTEIN) ("C-SH2" . SPARSER::PROTEIN)
    ("PTPN11" . SPARSER::PROTEIN) ("p34-Arc" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Neural Wiskott-Aldrich syndrome protein" . SPARSER::PROTEIN)
    ("CDC42" . SPARSER::PROTEIN) ("p30" . SPARSER::PROTEIN)
    ("SHP-2" . SPARSER::PROTEIN) ("phosphatase 2" . SPARSER::PROTEIN)
    ("protein tyrosine phosphatase" . SPARSER::PROTEIN)
    ("our findings strongly support diacerein" . SPARSER::DRUG)
    ("methotrexate and docetaxel" . SPARSER::COLLECTION)
    ("p38-MAPKs" . SPARSER::COLLECTION)
    ("the MAPK kinase MKK6 (SKK3) and MKK3" . SPARSER::COLLECTION)
    ("p38α, p38β, p38γ, and p38δ" . SPARSER::COLLECTION)
    ("cyclin B1 and CDK1" . SPARSER::COLLECTION)
    ("CDK1-cyclin B1" . SPARSER::COLLECTION)
    ("CDK1, CDK2, and cyclin B1" . SPARSER::COLLECTION)
    ("Rhein" . SPARSER::DRUG) ("Annexin" . SPARSER::PROTEIN)
    ("Staurosporin" . SPARSER::MOLECULE)
    ("Akt1, Akt2, and Akt3" . SPARSER::COLLECTION)
    ("Akt (pAkt) and p38 (pp38)" . SPARSER::COLLECTION)
    ("MKK3 and MKK6" . SPARSER::COLLECTION)
    ("p38α (17.07 % change) and p38β (34.01 %) MAPKs" . SPARSER::COLLECTION)
    ("cyclin B1 and its corresponding cyclin-dependent kinases CDK1 and CDK2"
     . SPARSER::COLLECTION)
    ("cyclin B1 and CDK2" . SPARSER::COLLECTION)
    ("cyclin B1, CDK1, and CDK2" . SPARSER::COLLECTION)
    ("caspase as well as MEK1/2 and p38MAPK inhibitors" . SPARSER::COLLECTION)
    ("MEK1/2 and p38MAPK" . SPARSER::COLLECTION)
    ("proteoglycans" . SPARSER::PROTEIN)
    ("p38α and p38β" . SPARSER::COLLECTION)
    ("MAPKs, and Akt1, Akt2, and Akt 3" . SPARSER::COLLECTION)
    ("Akt1, Akt2, and Akt 3" . SPARSER::COLLECTION)
    ("the cyclin B1-CDK1 complex and a reduction in CDK2 expression"
     . SPARSER::COLLECTION)
    ("cyclin B1-CDK1" . SPARSER::COLLECTION) ("diacerein" . SPARSER::DRUG)
    ("a symptomatic slow acting drug" . SPARSER::DRUG)
    ("Diacerein" . SPARSER::DRUG) ("SKK3" . SPARSER::PROTEIN)
    ("MAPK kinase" . SPARSER::PROTEIN) ("p38δ" . SPARSER::PROTEIN)
    ("p38γ" . SPARSER::PROTEIN) ("pp38" . SPARSER::PROTEIN)
    ("Akt3" . SPARSER::PROTEIN) ("MKK6" . SPARSER::PROTEIN)
    ("MKK3" . SPARSER::PROTEIN) ("p17" . SPARSER::PROTEIN)
    ("Histone H2A.X" . SPARSER::PROTEIN) ("HPRT-1" . SPARSER::PROTEIN)
    ("DNase-I" . SPARSER::PROTEIN) ("interleukin-1" . SPARSER::PROTEIN)
    ("Akt 3" . SPARSER::PROTEIN) ("p38α" . SPARSER::PROTEIN)
    ("neurotoxin" . SPARSER::PROTEIN) ("Naringenin" . SPARSER::DRUG)
    ("dysfunctional mitochondria" . SPARSER::PROTEIN)
    ("NRF2 and KEAP1" . SPARSER::COLLECTION) ("Mei" . SPARSER::MOLECULE)
    ("MafF, MafG, and MafK" . SPARSER::COLLECTION)
    ("NRF2 and PINK1" . SPARSER::COLLECTION)
    ("PINK1 (PINK1-WT) or kinase-dead type" . SPARSER::COLLECTION)
    ("PINK1-KD" . SPARSER::COLLECTION)
    ("oxidative stress inducers, 6-OHDA and CdCl 2" . SPARSER::COLLECTION)
    ("inducers, 6-OHDA and CdCl 2" . SPARSER::COLLECTION)
    ("H 2 O 2 and PINK1" . SPARSER::COLLECTION)
    ("N -acetylcysteine (NAC)" . SPARSER::DRUG)
    ("aberrant KEAP1" . SPARSER::PROTEIN)
    ("caffeine [ xref ] and curcumin [ xref ]" . SPARSER::COLLECTION)
    ("caffeine" . SPARSER::MOLECULE)
    ("single CCCP-treatment ( xref )" . SPARSER::MOLECULE)
    ("single CCCP-treatment" . SPARSER::MOLECULE)
    ("Single CCCP-treatment" . SPARSER::MOLECULE)
    ("CCCP-treatment" . SPARSER::MOLECULE)
    ("tBHQ and CCCP" . SPARSER::COLLECTION)
    ("a mitochondrial proteinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PARL" . SPARSER::PROTEIN) ("a strong inducer" . SPARSER::PROTEIN)
    ("tBHQ" . SPARSER::DRUG) ("NRF2-Mut" . SPARSER::COLLECTION)
    ("TGA" . SPARSER::PROTEIN)
    ("a possible target transcription factor" . SPARSER::PROTEIN)
    ("mitochondrial respiratory complex I" . SPARSER::PROTEIN)
    ("a neurotoxic reagent" . SPARSER::MOLECULE)
    ("paraquat" . SPARSER::MOLECULE) ("rotenone" . SPARSER::PROTEIN)
    ("SH-SY5Y" . SPARSER::PROTEIN)
    ("KEAP1 and release NRF2" . SPARSER::COLLECTION)
    ("Kelch-like ECH-associated protein 1 (KEAP1) and Cullin 3"
     . SPARSER::COLLECTION)
    ("ligase ( GCL )" . SPARSER::LIGASE)
    ("a basic leucine zipper (bZIP) transcription factor" . SPARSER::PROTEIN)
    ("ubiquitin ligase, and Parkin" . SPARSER::COLLECTION)
    ("Parkin" . SPARSER::PROTEIN) ("TIR" . SPARSER::PROTEIN-FAMILY)
    ("Sterile" . SPARSER::PROTEIN-FAMILY)
    ("a 581-amino-acid protein" . SPARSER::PROTEIN)
    ("NRF2-PINK1" . SPARSER::COLLECTION)
    ("peroxisome proliferator-activated receptor gamma coactivator 1-alpha"
     . SPARSER::PROTEIN)
    ("ARE2" . SPARSER::PROTEIN) ("ARE1" . SPARSER::PROTEIN)
    ("N -acetylcysteine" . SPARSER::DRUG)
    ("tert -Butylhydroquinone" . SPARSER::DRUG) ("CdCl 2" . SPARSER::MOLECULE)
    ("6-OHDA" . SPARSER::MOLECULE) ("Cullin 3" . SPARSER::PROTEIN)
    ("heme oxygenase 1" . SPARSER::PROTEIN)
    ("Forkhead box O3" . SPARSER::PROTEIN) ("SARM1" . SPARSER::PROTEIN)
    ("nuclear factor (erythroid-derived 2)" . SPARSER::PROTEIN)
    ("autosomal recessive" . SPARSER::PROTEIN)
    ("HER2 [ xref ] or p53 [ xref ]" . SPARSER::COLLECTION)
    ("virtually all previously established clinically useful biomarkers"
     . SPARSER::MOLECULE)
    ("TMPRSS2-ERG" . SPARSER::COLLECTION) ("ERG" . SPARSER::PROTEIN)
    ("AZD4547 and BGJ398" . SPARSER::COLLECTION) ("FGFR" . SPARSER::PROTEIN)
    ("FGFR1 and related tyrosine kinases" . SPARSER::COLLECTION)
    ("dovitinib, Ki23057, and ponatinib" . SPARSER::COLLECTION)
    ("ponatinib" . SPARSER::DRUG) ("dovitinib" . SPARSER::DRUG)
    ("GATA4 and GATA6" . SPARSER::COLLECTION)
    ("these two histological subtypes" . SPARSER::PROTEIN)
    ("histological subtypes" . SPARSER::PROTEIN) ("MAPK-" . SPARSER::PROTEIN)
    ("Particularly growth factor receptors" . SPARSER::RECEPTOR)
    ("HER2 , EGFR , VEGFR or c-KIT" . SPARSER::COLLECTION)
    ("AZD4547" . SPARSER::DRUG) ("Ki23057" . SPARSER::DRUG)
    ("non-selective" . SPARSER::PROTEIN) ("GATA6" . SPARSER::PROTEIN)
    ("GATA4" . SPARSER::PROTEIN) ("chi 2" . SPARSER::PROTEIN)
    ("RP11" . SPARSER::PROTEIN) ("c-KIT" . SPARSER::PROTEIN)
    ("FGFR1" . SPARSER::PROTEIN)
    ("fibroblast growth factor receptor 1" . SPARSER::PROTEIN)
    ("onco-proteins" . SPARSER::COLLECTION)
    ("NF1 and MAX" . SPARSER::COLLECTION)
    ("MVD , MAFA , RNF123 , SPIN4 , and SELP" . SPARSER::COLLECTION)
    ("CCD" . SPARSER::PROTEIN) ("PDGFRA-" . SPARSER::PROTEIN)
    ("hetero-dimeric partners MYC , MYCL1 , and MYCN" . SPARSER::COLLECTION)
    ("MYC , MYCL1 , and MYCN" . SPARSER::COLLECTION)
    ("the paternal allele" . SPARSER::ALLELE)
    ("a targeted cancer-associated gene" . SPARSER::GENE)
    ("exonic variants" . SPARSER::VARIANT)
    ("available anti-NF1 antibodies" . SPARSER::ANTIBODY)
    ("KIT , PDGFR , and BRAF" . SPARSER::COLLECTION)
    ("PDGFR" . SPARSER::PROTEIN) ("decarboxylase ( MVD )" . SPARSER::PROTEIN)
    ("SELP" . SPARSER::PROTEIN) ("SPIN" . SPARSER::PROTEIN)
    ("MAFA" . SPARSER::PROTEIN) ("g-p" . SPARSER::PROTEIN-PAIR)
    ("exhibited strong or intermediate nuclear MAX" . SPARSER::PROTEIN)
    ("TMAs" . SPARSER::MOLECULE) ("LZ" . SPARSER::PROTEIN)
    ("the MYC-associated factor ( MAX ) gene" . SPARSER::GENE)
    ("KIT and SDHB" . SPARSER::COLLECTION) ("PDGFA" . SPARSER::PROTEIN)
    ("KIT , PDGFRA , or BRAF" . SPARSER::COLLECTION)
    ("the MYC-associated factor X ( MAX ) gene" . SPARSER::GENE)
    ("protein and negative regulator" . SPARSER::COLLECTION)
    ("Approximately 1–2" . SPARSER::PROTEIN)
    ("serine-threonine" . SPARSER::COLLECTION) ("SDHA" . SPARSER::PROTEIN)
    ("SDHB , SDHC , and SDHD" . SPARSER::COLLECTION)
    ("SDHD" . SPARSER::PROTEIN) ("SDHC" . SPARSER::PROTEIN)
    ("SDHB" . SPARSER::PROTEIN) ("succinate" . SPARSER::PROTEIN)
    ("Cajal (ICC)" . SPARSER::PROTEIN) ("MAX" . SPARSER::PROTEIN)
    ("succinate-dehydrogenase" . SPARSER::COLLECTION)
    ("SDH" . SPARSER::PROTEIN)
    ("KIT and platelet-derived growth factor receptor alpha"
     . SPARSER::COLLECTION)
    ("CCDC6" . SPARSER::PROTEIN) ("BRG1" . SPARSER::PROTEIN)
    ("MYCL1" . SPARSER::PROTEIN) ("selectin P" . SPARSER::PROTEIN)
    ("KIP1" . SPARSER::PROTEIN) ("RNF123" . SPARSER::PROTEIN)
    ("musculoaponeurotic fibrosarcoma oncogene" . SPARSER::PROTEIN)
    ("RTN4" . SPARSER::PROTEIN) ("reticulon 4" . SPARSER::PROTEIN)
    ("H-L" . SPARSER::PROTEIN) ("glucuronidase beta" . SPARSER::PROTEIN)
    ("MYC associated factor X" . SPARSER::PROTEIN)
    ("platelet-derived growth factor receptor alpha" . SPARSER::PROTEIN)
    ("a chemopreventive drug" . SPARSER::DRUG)
    ("Akt and ERK" . SPARSER::COLLECTION)
    ("PDCD4 and PTEN mRNA (Fig. xref E) and protein (Fig. xref F)"
     . SPARSER::COLLECTION)
    ("significantly less PGE2" . SPARSER::DRUG)
    ("PDCD4 or PTEN" . SPARSER::COLLECTION)
    ("CD133 or EpCAM" . SPARSER::COLLECTION) ("Letters" . SPARSER::MOLECULE)
    ("verapamil" . SPARSER::DRUG)
    ("effectively treating HCC" . SPARSER::PROTEIN)
    ("PDCD4 and PTEN" . SPARSER::COLLECTION) ("TIMP2" . SPARSER::PROTEIN)
    ("MAP4K1" . SPARSER::PROTEIN) ("Prostaglandin E2" . SPARSER::MOLECULE)
    ("Phenylmethanesulfonyl fluoride" . SPARSER::MOLECULE)
    ("prostaglandin-endoperoxide synthase 2" . SPARSER::PROTEIN)
    ("PDCD4" . SPARSER::PROTEIN)
    ("cell cycle-associated genes and pathways" . SPARSER::COLLECTION)
    ("genes and pathways" . SPARSER::COLLECTION)
    ("our prospectively-collected validation cohort" . SPARSER::MOLECULE)
    ("AR and HER2" . SPARSER::COLLECTION)
    ("immunoreactive protein" . SPARSER::PROTEIN)
    ("our prospective cohort" . SPARSER::MOLECULE)
    ("potential predictive biomarkers" . SPARSER::MOLECULE)
    ("Bicalutamide" . SPARSER::DRUG)
    ("DHT, bicalutamide or enzalutamide" . SPARSER::COLLECTION)
    ("AR and AR-V7" . SPARSER::COLLECTION)
    ("DHT and enzalutamide" . SPARSER::COLLECTION)
    ("a contemporary AR antagonist" . SPARSER::MOLECULE)
    ("using MTT (Figure xref ) and Trypan Blue (Figure xref ) growth assays"
     . SPARSER::COLLECTION)
    ("the METABRIC cohort" . SPARSER::MOLECULE)
    ("AR-V7 and ERα" . SPARSER::COLLECTION)
    ("cell cycle-associated genes" . SPARSER::GENE)
    ("targets and 70/85" . SPARSER::COLLECTION)
    ("the prototypical AR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the AR-LBD antagonists" . SPARSER::MOLECULE)
    ("antagonists, bicalutamide and enzalutamide" . SPARSER::COLLECTION)
    ("probasin" . SPARSER::PROTEIN) ("DHT" . SPARSER::PROTEIN)
    ("EPR" . SPARSER::PROTEIN) ("AR-V7 and AR-FL" . SPARSER::COLLECTION)
    ("AR-V1, AR-V2 or AR-V4" . SPARSER::COLLECTION)
    ("the larger METABRIC breast cancer cohort" . SPARSER::MOLECULE)
    ("PAM" . SPARSER::PROTEIN) ("abiraterone" . SPARSER::DRUG)
    ("GnRH" . SPARSER::PROTEIN) ("gonadotropin" . SPARSER::PROTEIN)
    ("antagonists and androgen" . SPARSER::COLLECTION)
    ("Wnt and c-MYC" . SPARSER::COLLECTION)
    ("HER2 and a clinically relevant biomarker" . SPARSER::COLLECTION)
    ("breast tumors lack ERα, HER2 and a clinically relevant biomarker"
     . SPARSER::COLLECTION)
    ("a clinically relevant biomarker" . SPARSER::MOLECULE)
    ("PGR" . SPARSER::PROTEIN) ("Gene 2" . SPARSER::PROTEIN)
    ("ARR3" . SPARSER::PROTEIN) ("CE4" . SPARSER::PROTEIN)
    ("AR-V1" . SPARSER::PROTEIN) ("AR-V7" . SPARSER::PROTEIN)
    ("EMT or IGF1R" . SPARSER::COLLECTION)
    ("IGF-1/IGF1R" . SPARSER::COLLECTION) ("reversed EMT" . SPARSER::PROTEIN)
    ("EGFR/IGFIR" . SPARSER::COLLECTION) ("ERK and pERK" . SPARSER::COLLECTION)
    ("β-catenin and Snail" . SPARSER::COLLECTION)
    ("IGF1R and pIGF1R" . SPARSER::COLLECTION)
    ("exogenous IGF-1" . SPARSER::PROTEIN)
    ("Snail and nuclear β-catenin" . SPARSER::COLLECTION)
    ("Vimentin, Snail and nuclear β-catenin" . SPARSER::COLLECTION)
    ("PC-9/GR-CDH1" . SPARSER::COLLECTION)
    ("H460/ER-CDH1" . SPARSER::COLLECTION) ("GR-CDH1" . SPARSER::PROTEIN-PAIR)
    ("exogenous TGF-β1" . SPARSER::PROTEIN)
    ("parental PC-9" . SPARSER::PROTEIN)
    ("transcription factor Snail and nuclear β-catenin" . SPARSER::COLLECTION)
    ("the mesenchymal marker Vimentin" . SPARSER::PROTEIN)
    ("IGFIR" . SPARSER::PROTEIN) ("H460/ER" . SPARSER::PROTEIN)
    ("H460/ER-siIGF1R" . SPARSER::PROTEIN-PAIR)
    ("PC-9/GR-siIGF1R" . SPARSER::COLLECTION) ("siIGF1R" . SPARSER::PROTEIN)
    ("EGFR and pEGFR" . SPARSER::COLLECTION)
    ("GR-siIGF1R" . SPARSER::PROTEIN-PAIR) ("pIGF" . SPARSER::PROTEIN)
    ("HRM" . SPARSER::PROTEIN-FAMILY) ("delE" . SPARSER::PROTEIN)
    ("the parental PC-9" . SPARSER::PROTEIN) ("ERK/MAPK" . SPARSER::COLLECTION)
    ("extracellular signal-regulated kinases/mitogen-activated protein kinase"
     . SPARSER::COLLECTION)
    ("their receptors and binding proteins" . SPARSER::COLLECTION)
    ("IGF1R and EMT" . SPARSER::COLLECTION)
    ("Exogenous IGF-1" . SPARSER::PROTEIN)
    ("EGFR-TKIs-resistant PC-9/GR" . SPARSER::COLLECTION)
    ("PC-9/GR" . SPARSER::COLLECTION) ("EMT and IGF1R" . SPARSER::COLLECTION)
    ("PC-9" . SPARSER::PROTEIN)
    ("epidermal growth factor receptor-tyrosine kinase" . SPARSER::COLLECTION)
    ("C-3" . SPARSER::PROTEIN) ("p-ERK 1" . SPARSER::PROTEIN)
    ("ERK 1" . SPARSER::PROTEIN) ("Snail 1" . SPARSER::PROTEIN)
    ("C-Met" . SPARSER::PROTEIN) ("c-MET" . SPARSER::PROTEIN)
    ("extracellular signal-regulated kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("AMIGO2 and AMIGO1" . SPARSER::COLLECTION)
    ("AMIGO2 and AMIGO3" . SPARSER::COLLECTION)
    ("effectors and substrates" . SPARSER::COLLECTION)
    ("PHT" . SPARSER::MOLECULE) ("PI3K–Akt and MAPK" . SPARSER::COLLECTION)
    ("VEGF and several other growth factors ( xref ; xref )"
     . SPARSER::COLLECTION)
    ("PDK1 and PTD-A2" . SPARSER::COLLECTION)
    ("soluble PTD-A2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Given Grb14 and Freud/Aki1" . SPARSER::COLLECTION)
    ("Grb14 and Freud/Aki1" . SPARSER::COLLECTION)
    ("Akt, S6K, and SGK" . SPARSER::COLLECTION)
    ("PDK1 and Akt" . SPARSER::COLLECTION)
    ("shRNA and Amigo2-" . SPARSER::COLLECTION) ("Amigo2-" . SPARSER::PROTEIN)
    ("PBS- or Con-injected" . SPARSER::COLLECTION) ("NGR" . SPARSER::PROTEIN)
    ("TAT" . SPARSER::PROTEIN) ("PBS- and Con-injected" . SPARSER::COLLECTION)
    ("TAT-A2 and NGR-A2" . SPARSER::COLLECTION)
    ("NGR-A2" . SPARSER::COLLECTION) ("TAT-A2" . SPARSER::COLLECTION)
    ("PBS-" . SPARSER::PROTEIN) ("normal oxygen" . SPARSER::MOLECULE)
    ("antiangiogenic molecules" . SPARSER::MOLECULE)
    ("containing VEGF or control peptide" . SPARSER::COLLECTION)
    ("PTD-A2–injected retinas" . SPARSER::DRUG)
    ("Akt and PDK1" . SPARSER::COLLECTION) ("PTD" . SPARSER::PROTEIN)
    ("PTD-A2" . SPARSER::PROTEIN-PAIR) ("–A2" . SPARSER::COLLECTION)
    ("the C-terminal amino acids of AMIGO2" . SPARSER::PROTEIN)
    ("PH and AMIGO2" . SPARSER::COLLECTION)
    ("PI3K–PDK1–Akt" . SPARSER::COLLECTION)
    ("GST-AMIGO2" . SPARSER::COLLECTION) ("LRR" . SPARSER::PROTEIN)
    ("AMIGO2 or PDK1" . SPARSER::COLLECTION)
    ("Flag-PDK1" . SPARSER::COLLECTION) ("GFP-AMIGO2" . SPARSER::COLLECTION)
    ("AMIGO2 and PDK1" . SPARSER::COLLECTION)
    ("S6K and SGK" . SPARSER::COLLECTION)
    ("S6K (at threonine 229) and SGK (at threonine 256)" . SPARSER::COLLECTION)
    ("Akt, S6K, and serum/glucocorticoid-regulated kinase"
     . SPARSER::COLLECTION)
    ("SGK" . SPARSER::PROTEIN)
    ("p70 ribosomal S6 kinase" . SPARSER::PROTEIN-FAMILY)
    ("PI3K and PDK1" . SPARSER::COLLECTION)
    ("retinal vasculature" . SPARSER::PROTEIN) ("siRNA–" . SPARSER::PROTEIN)
    ("siRNA and shRNA" . SPARSER::COLLECTION) ("Amigo2" . SPARSER::PROTEIN)
    ("EC–ECM" . SPARSER::COLLECTION)
    ("caspase-3 and FAK" . SPARSER::COLLECTION)
    ("fibronectin, and collagen" . SPARSER::COLLECTION)
    ("hemopoietic monocytes" . SPARSER::PROTEIN) ("LRRs" . SPARSER::PROTEIN)
    ("amphoterin" . SPARSER::PROTEIN)
    ("membrane-associated Akt" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("phosphatidylinositol-" . SPARSER::PROTEIN)
    ("angiogenic ligands" . SPARSER::LIGAND)
    ("PI3K, PTEN, and PDK1" . SPARSER::COLLECTION)
    ("–protein kinase B" . SPARSER::COLLECTION)
    ("PDK1–Akt" . SPARSER::COLLECTION) ("AMIGO2–PDK1" . SPARSER::COLLECTION)
    ("3-phosphoinositide–dependent kinase" . SPARSER::KINASE)
    ("phosphoinositide 3-kinase–Akt" . SPARSER::COLLECTION)
    ("PDK1–AMIGO2" . SPARSER::COLLECTION) ("anti-S" . SPARSER::ANTIBODY)
    ("FGF-B" . SPARSER::PROTEIN) ("VEGF-A" . SPARSER::PROTEIN)
    ("signal peptide" . SPARSER::PROTEIN) ("AMIGO3" . SPARSER::PROTEIN)
    ("Freud1" . SPARSER::PROTEIN) ("Grb14" . SPARSER::PROTEIN)
    ("growth factor receptor–bound protein 14" . SPARSER::PROTEIN)
    ("CD-" . SPARSER::PROTEIN) ("A2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PIT-1" . SPARSER::PROTEIN) ("3 D" . SPARSER::PROTEIN-FAMILY)
    ("serum/glucocorticoid-regulated kinase" . SPARSER::PROTEIN)
    ("p70" . SPARSER::PROTEIN) ("F–K" . SPARSER::PROTEIN)
    ("PI3K–Akt" . SPARSER::PROTEIN) ("AMIGO2" . SPARSER::PROTEIN)
    ("NHE3 ( xref ) and CFTR ( xref )" . SPARSER::COLLECTION)
    ("NHE3, CFTR, and GLUT5" . SPARSER::COLLECTION)
    ("possibly other still unknown genes" . SPARSER::GENE)
    ("Myo5B and STX3" . SPARSER::COLLECTION) ("DPPIV/SI" . SPARSER::COLLECTION)
    ("Myo5B, Rab11a, Rab8a, Slp4a, Vamp7, Munc18-2, and Stx3"
     . SPARSER::COLLECTION)
    ("Stx3 and the Rab GAPs TBC1D30 and Evi5" . SPARSER::COLLECTION)
    ("GTPases and Myo5B" . SPARSER::COLLECTION)
    ("the v-SNARE–like Slp4a and the apical t-SNARE Stx3"
     . SPARSER::COLLECTION)
    ("the apical t-SNARE Stx3" . SPARSER::PROTEIN)
    ("Slp4a and Stx3" . SPARSER::COLLECTION)
    ("Rab11/Rab8" . SPARSER::COLLECTION)
    ("both the motor protein Myo5B and the t-SNARE Stx3" . SPARSER::COLLECTION)
    ("complex and undergoes" . SPARSER::COLLECTION)
    ("Sec15–Slp4a" . SPARSER::COLLECTION)
    ("Stx3, TBC1D30, Evi5, and Snap23a" . SPARSER::COLLECTION)
    ("Snap" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Stx3, Myo5B, and Slp4a" . SPARSER::COLLECTION)
    ("their respective Rab GTPases" . SPARSER::GTPASE)
    ("GAP, and Evi5" . SPARSER::COLLECTION) ("Rab/Myo5" . SPARSER::COLLECTION)
    ("Saccharomyces" . SPARSER::PROTEIN)
    ("Myo5B, Slp4a, Munc18-2, Vamp7, and Stx3" . SPARSER::COLLECTION)
    ("NHE3, CFTR, or GLUT5" . SPARSER::COLLECTION)
    ("DPPIV, SI, and aminopeptidase N" . SPARSER::COLLECTION)
    ("Myo5B, Slp4a, Vamp3, and Stx3" . SPARSER::COLLECTION)
    ("Slp4a" . SPARSER::PROTEIN)
    ("DPPIV ( xref and xref ) and SI ( xref )" . SPARSER::COLLECTION)
    ("a dominant-negative Stx3 mutant" . SPARSER::MUTANT)
    ("the apical brush border enzymes DPPIV" . SPARSER::PROTEIN)
    ("Myo5B, NHE3, CFTR, and GLUT5" . SPARSER::COLLECTION)
    ("pivotal transporters" . SPARSER::PROTEIN)
    ("three functionally distinct transmembrane transporters"
     . SPARSER::PROTEIN)
    ("Myo5b" . SPARSER::PROTEIN) ("apical cargo proteins" . SPARSER::PROTEIN)
    ("Myo5B-" . SPARSER::PROTEIN) ("Spl" . SPARSER::PROTEIN)
    ("Rab8a or Myo5B" . SPARSER::COLLECTION)
    ("Vamp8–Stx3" . SPARSER::COLLECTION)
    ("two other apical v-SNAREs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Vamp7 and Vamp8" . SPARSER::COLLECTION) ("Vamp8" . SPARSER::PROTEIN)
    ("Stx3–Munc18-2" . SPARSER::COLLECTION)
    ("Slp4a–Stx3" . SPARSER::PROTEIN-PAIR)
    ("Sec15, Rab11a, Rab8a, and Rab3b" . SPARSER::COLLECTION)
    ("Rab3b" . SPARSER::PROTEIN)
    ("Stx3, Rab11a, and Rab8a" . SPARSER::COLLECTION)
    ("Vamp3 and v-SNARE–like" . SPARSER::COLLECTION)
    ("Vamp3" . SPARSER::PROTEIN) ("v-SNARE–t-SNARE" . SPARSER::COLLECTION)
    ("the apical Stx3" . SPARSER::PROTEIN)
    ("Rab8 or Rab11" . SPARSER::COLLECTION)
    ("Stx3, Rab8, and Rab11" . SPARSER::COLLECTION)
    ("the respective protein" . SPARSER::PROTEIN)
    ("Stx3 and Rab8a" . SPARSER::COLLECTION)
    ("Rab8a, Rab11a, or Myo5B" . SPARSER::COLLECTION)
    ("Rab11a/Myo5B" . SPARSER::COLLECTION)
    ("a possible effector" . SPARSER::EFFECTOR)
    ("Rab11a/Rab8a" . SPARSER::COLLECTION)
    ("Stx3, Rab8a, and Rab11a" . SPARSER::COLLECTION)
    ("Rab8a, Rab11a, and Myo5B" . SPARSER::COLLECTION)
    ("Rab11a and Rab8a" . SPARSER::COLLECTION) ("Rab3B" . SPARSER::PROTEIN)
    ("Sepharose" . SPARSER::MOLECULE)
    ("GTP-locked state ( xref ; xref ) as well as the CaCo2-specific WT isoform of Myo5B ( xref )"
     . SPARSER::COLLECTION)
    ("HA–Strep-Tactin II (HS)–tagged human Rab8a and Rab11a"
     . SPARSER::COLLECTION)
    ("Rab8a and Rab11a" . SPARSER::COLLECTION)
    ("protein, and Stx3" . SPARSER::COLLECTION) ("Rab8a" . SPARSER::PROTEIN)
    ("exocyst" . SPARSER::BIO-COMPLEX)
    ("Neither HRP nor BSA-Au" . SPARSER::COLLECTION)
    ("the fluid phase tracers HRP and colloidal gold" . SPARSER::COLLECTION)
    ("colloidal gold" . SPARSER::MOLECULE) ("BSA" . SPARSER::PROTEIN)
    ("HRP" . SPARSER::PROTEIN) ("tracers" . SPARSER::MOLECULE)
    ("Electron" . SPARSER::MOLECULE) ("Myo5A and Myo5C" . SPARSER::COLLECTION)
    ("Myo5C" . SPARSER::PROTEIN) ("Myo5A" . SPARSER::PROTEIN)
    ("protein ( xref ) and cytoplasmic RNA" . SPARSER::COLLECTION)
    ("Myo5B or Stx3" . SPARSER::COLLECTION) ("SI" . SPARSER::PROTEIN)
    ("Myo5B selectively transports apical cargo proteins" . SPARSER::PROTEIN)
    ("Myo5B and Rab" . SPARSER::COLLECTION)
    ("Myo5B and Syntaxin" . SPARSER::COLLECTION)
    ("an apical t-SNARE protein" . SPARSER::PROTEIN)
    ("Rab8-" . SPARSER::PROTEIN)
    ("an unconventional actin motor protein" . SPARSER::PROTEIN)
    ("Rab8 and Rab11" . SPARSER::COLLECTION)
    ("proteins, and t-SNAREs" . SPARSER::COLLECTION)
    ("Rab" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("transporters, ion channels, and enzymes" . SPARSER::COLLECTION)
    ("junctional complexes" . SPARSER::BIO-COMPLEX)
    ("metazoans" . SPARSER::PROTEIN-FAMILY)
    ("Myo5B, Stx3, Slp4a, Vamp7, Munc18-2, and Rab8/11" . SPARSER::COLLECTION)
    ("DPPIV and sucrase-isomaltase" . SPARSER::COLLECTION)
    ("DPPIV" . SPARSER::PROTEIN)
    ("Rab11, Myo5B, Slp4a, Munc18-2, and Vamp7" . SPARSER::COLLECTION)
    ("CFTR" . SPARSER::PROTEIN) ("Myo5B and Stx3" . SPARSER::COLLECTION)
    ("the soluble NSF attachment protein receptor Syntaxin" . SPARSER::PROTEIN)
    ("Syntaxin" . SPARSER::PROTEIN) ("NSF" . SPARSER::PROTEIN)
    ("Vamp7" . SPARSER::PROTEIN) ("Stx3" . SPARSER::PROTEIN)
    ("t-SNARE" . SPARSER::PROTEIN-PAIR) ("Myo5B" . SPARSER::PROTEIN)
    ("Slp" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Stx" . SPARSER::PROTEIN)
    ("SNARE" . SPARSER::PROTEIN) ("CS6" . SPARSER::PROTEIN)
    ("Polyvinylidene fluoride" . SPARSER::DRUG) ("EF1α" . SPARSER::PROTEIN)
    ("Rab11b" . SPARSER::PROTEIN) ("Evi5" . SPARSER::PROTEIN)
    ("TBC1" . SPARSER::PROTEIN)
    ("aminopeptidase N" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("v-SNAREs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("C–E" . SPARSER::PROTEIN)
    ("Rab3" . SPARSER::PROTEIN) ("Rab11a" . SPARSER::PROTEIN)
    ("Sec15" . SPARSER::PROTEIN-FAMILY) ("1 D" . SPARSER::PROTEIN)
    ("1 B" . SPARSER::PROTEIN)
    ("synaptotagmin-like protein 4" . SPARSER::PROTEIN)
    ("STX3" . SPARSER::PROTEIN) ("t-SNAREs" . SPARSER::PROTEIN)
    ("ion channels" . SPARSER::PROTEIN-FAMILY) ("Rab8" . SPARSER::PROTEIN)
    ("sucrase-isomaltase" . SPARSER::PROTEIN) ("GLUT5" . SPARSER::PROTEIN)
    ("cystic fibrosis transmembrane conductance regulator" . SPARSER::PROTEIN)
    ("NHE3" . SPARSER::PROTEIN) ("Rab11" . SPARSER::PROTEIN)
    ("Munc18-2" . SPARSER::PROTEIN) ("Munc18" . SPARSER::PROTEIN)
    ("Sec1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("v-SNARE" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Myo5" . SPARSER::PROTEIN)
    ("an essential gene" . SPARSER::GENE) ("Chek2" . SPARSER::PROTEIN)
    ("BRCAX and CHEK2 *1100delC" . SPARSER::COLLECTION)
    ("only 2 genes" . SPARSER::GENE)
    ("Few characteristic CNAs" . SPARSER::PROTEIN)
    ("differential CNAs" . SPARSER::PROTEIN)
    ("ERBB2 and nearby genes ( GRB7, STARD3 )" . SPARSER::COLLECTION)
    ("very few CNAs" . SPARSER::PROTEIN)
    ("Neu and luminal" . SPARSER::COLLECTION)
    ("14 BRCAX and three CHEK2 *1100delC" . SPARSER::COLLECTION)
    ("BRCA1 , BRCA2 and CHEK2" . SPARSER::COLLECTION)
    ("ER/PR" . SPARSER::COLLECTION)
    ("progesterone receptor/progesterone receptor" . SPARSER::COLLECTION)
    ("TP53, CDC25A, CDC25C, PLK and BRCA1" . SPARSER::COLLECTION)
    ("PLK" . SPARSER::PROTEIN) ("CHEK2 , ATM and BRIP1" . SPARSER::COLLECTION)
    ("BRCA1, BRCA2, and PALB2" . SPARSER::COLLECTION)
    ("CNAs" . SPARSER::PROTEIN) ("CNA" . SPARSER::PROTEIN)
    ("BRCAX" . SPARSER::PROTEIN) ("a larger cohort" . SPARSER::MOLECULE)
    ("BRCA1 , BRCA2 , and CHEK2" . SPARSER::COLLECTION)
    ("STARD3" . SPARSER::PROTEIN) ("GRB7" . SPARSER::PROTEIN)
    ("Checkpoint kinase 2" . SPARSER::PROTEIN) ("BRIP1" . SPARSER::PROTEIN)
    ("active telomerase ribonucleoprotein complexes" . SPARSER::BIO-COMPLEX)
    ("one CC-insertion allele and one eGFP cassette-insertion allele"
     . SPARSER::COLLECTION)
    ("CC" . SPARSER::PROTEIN) ("underwent HR" . SPARSER::PROTEIN)
    ("originally carried one WT allele and one C-124T mutant allele"
     . SPARSER::COLLECTION)
    ("cellular telomerase activity" . SPARSER::PROTEIN)
    ("GABP" . SPARSER::PROTEIN)
    ("sequential telomere elongation" . SPARSER::PROTEIN)
    ("non-telomere associated foci" . SPARSER::PROTEIN)
    ("FLAG-" . SPARSER::PROTEIN-FAMILY) ("melt" . SPARSER::DRUG)
    ("The cellular telomerase activity" . SPARSER::PROTEIN)
    ("protein and telomerase activity" . SPARSER::COLLECTION)
    ("cytidines" . SPARSER::MOLECULE)
    ("only one TERT allele" . SPARSER::ALLELE)
    ("neo-Cajal" . SPARSER::COLLECTION)
    ("approximately 40 TRF2 foci" . SPARSER::PROTEIN)
    ("TRF2 and coilin" . SPARSER::COLLECTION) ("coilin" . SPARSER::PROTEIN)
    ("a cell-permeable substrate" . SPARSER::SUBSTRATE)
    ("glass" . SPARSER::MOLECULE) ("TERT and TR" . SPARSER::COLLECTION)
    ("RNA (TR)" . SPARSER::RNA) ("dGTP" . SPARSER::DGTP)
    ("TERT and FLAG-SNAP-TERT purified using the anti-TERT IP (Fig.  xref ; samples from edited clones did not include IP ctrl)"
     . SPARSER::COLLECTION)
    ("FLAG and TERT" . SPARSER::COLLECTION)
    ("ProA-FLAG-TERT" . SPARSER::COLLECTION) ("ProA" . SPARSER::PROTEIN)
    ("FLAG-SNAP-TERT" . SPARSER::COLLECTION)
    ("HR alleles and NHEJ alleles" . SPARSER::COLLECTION)
    ("the FLAG-SNAP-tagged alleles" . SPARSER::ALLELE)
    ("eGFP-Cre" . SPARSER::COLLECTION) ("the circular DT" . SPARSER::PROTEIN)
    ("DT" . SPARSER::PROTEIN)
    ("expressing FLAG-SNAP-tagged TERT protein" . SPARSER::PROTEIN)
    ("commercially available TERT antibodies" . SPARSER::ANTIBODY)
    ("only several hundred molecules" . SPARSER::MOLECULE)
    ("SNAP" . SPARSER::PROTEIN) ("adequate antibodies" . SPARSER::ANTIBODY)
    ("HD2" . SPARSER::PROTEIN)
    ("phenylmethanesulfonyl fluoride" . SPARSER::MOLECULE)
    ("EF1alpha" . SPARSER::PROTEIN) ("and −1" . SPARSER::PROTEIN)
    ("enhanced green fluorescent protein" . SPARSER::PROTEIN)
    ("ribonucleoprotein complex" . SPARSER::BIO-COMPLEX)
    ("ER and PgR" . SPARSER::COLLECTION) ("PgR" . SPARSER::PROTEIN)
    ("A commercially available AR antibody" . SPARSER::ANTIBODY)
    ("pT1" . SPARSER::PROTEIN) ("anti-androgen" . SPARSER::DRUG)
    ("release several soluble mediators (such as PGE 2 , TXA 2 , PDGF, TGF-β and Wnt3a) and MPs/exosomes [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("release several soluble mediators" . SPARSER::PROTEIN)
    ("TGF-β and Wnt3a" . SPARSER::COLLECTION) ("rottlerin" . SPARSER::DRUG)
    ("TXA 2 and PGE 2" . SPARSER::COLLECTION) ("rofecoxib" . SPARSER::DRUG)
    ("WAF1/CIP1" . SPARSER::COLLECTION)
    ("galectin-3, Gal-3C and anti-galectin-3" . SPARSER::COLLECTION)
    ("/protein" . SPARSER::COLLECTION) ("–PI3K" . SPARSER::COLLECTION)
    ("NHE" . SPARSER::PROTEIN) ("Wnt3a–β-catenin" . SPARSER::COLLECTION)
    ("β-catenin and target" . SPARSER::COLLECTION)
    ("a multifunctional protein" . SPARSER::PROTEIN)
    ("platelet collagen receptors (in particular, GPVI) and tumour components"
     . SPARSER::COLLECTION)
    ("tristetraprolin (TTP)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("tristetraprolin" . SPARSER::PROTEIN) ("prostacyclin" . SPARSER::MOLECULE)
    ("COX-1 and COX-2" . SPARSER::COLLECTION)
    ("decapentaplegic protein" . SPARSER::PROTEIN)
    ("approximately 22 nt RNAs" . SPARSER::RNA)
    ("mRNA and miRNA" . SPARSER::COLLECTION)
    ("P-selectin (CD62P) and GP IIb-IIIa" . SPARSER::COLLECTION)
    ("a dimeric Fc fusion protein" . SPARSER::PROTEIN)
    ("GPVI" . SPARSER::PROTEIN)
    ("G-protein coupled receptor (GPCR)" . SPARSER::PROTEIN)
    ("GPCR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("receptor (PAR)" . SPARSER::RECEPTOR)
    ("proteinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("thienopyridines" . SPARSER::DRUG) ("IIb" . SPARSER::DRUG)
    ("ADP and growth factors, chemokines and proteases" . SPARSER::COLLECTION)
    ("growth factors, chemokines and proteases" . SPARSER::COLLECTION)
    ("epithelial mesenchymal transition genes" . SPARSER::GENE)
    ("mRNAs and miRNAs" . SPARSER::COLLECTION) ("MPs" . SPARSER::PROTEIN)
    ("A 2 and prostaglandin" . SPARSER::COLLECTION)
    ("ADP and growth factors, chemokines, proteases and Wnt"
     . SPARSER::COLLECTION)
    ("growth factors, chemokines, proteases and Wnt" . SPARSER::COLLECTION)
    ("TX" . SPARSER::PROTEIN) ("thromboxane" . SPARSER::MOLECULE)
    ("PKCδ" . SPARSER::PROTEIN) ("CIP1" . SPARSER::PROTEIN)
    ("WAF1" . SPARSER::PROTEIN) ("Gal-3" . SPARSER::PROTEIN)
    ("phosphoinositide 3-kinase" . SPARSER::PROTEIN)
    ("thrombin receptor" . SPARSER::PROTEIN) ("Wnt3a" . SPARSER::PROTEIN)
    ("galectin-3" . SPARSER::PROTEIN) ("TXA 2" . SPARSER::MOLECULE)
    ("CD62P" . SPARSER::PROTEIN) ("P-selectin" . SPARSER::PROTEIN)
    ("glycoprotein VI" . SPARSER::PROTEIN) ("PAR-1" . SPARSER::PROTEIN)
    ("G-protein coupled receptor" . SPARSER::PROTEIN)
    ("P2Y12" . SPARSER::PROTEIN) ("COX-1" . SPARSER::PROTEIN)
    ("αIIbβ3" . SPARSER::PROTEIN) ("E 2" . SPARSER::MOLECULE)
    ("A 2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Nrf2-mediated pathological states" . SPARSER::BIO-STATE)
    ("KEAP1, NRF2 and CUL3" . SPARSER::COLLECTION)
    ("the correct E3 ubiquitin ligase" . SPARSER::PROTEIN)
    ("an IRE1 inhibitor and a Hrd1 inhibitor" . SPARSER::COLLECTION)
    ("Nrf2 and hemeoxygenase-1" . SPARSER::COLLECTION) ("NDGA" . SPARSER::DRUG)
    ("DMF" . SPARSER::DRUG) ("dimethylfumarate" . SPARSER::DRUG)
    ("natural electrophiles" . SPARSER::MOLECULE)
    ("B-Raf V619E and Myc ERT2" . SPARSER::COLLECTION)
    ("brusatol" . SPARSER::DRUG) ("TPA" . SPARSER::DRUG)
    ("B-Raf V619E and Myc ERT2 [ xref ]" . SPARSER::COLLECTION)
    ("K-Ras G12D , B-Raf V619E and Myc ERT2 [ xref ]" . SPARSER::COLLECTION)
    ("water" . SPARSER::MOLECULE) ("DPP" . SPARSER::MOLECULE)
    ("Nrf2–Keap1" . SPARSER::COLLECTION) ("IRE1–XBP1" . SPARSER::COLLECTION)
    ("IRE1 and 78 kDa glucose-regulated protein (GRP78)" . SPARSER::COLLECTION)
    ("a mature mRNA" . SPARSER::PROTEIN) ("BiP" . SPARSER::PROTEIN)
    ("protein kinase RNA-like ER kinase (PERK) and activating transcription factor 6 (ATF6)"
     . SPARSER::COLLECTION)
    ("other secretory proteins" . SPARSER::PROTEIN)
    ("kinase (PERK)" . SPARSER::KINASE)
    ("a pathogenic state" . SPARSER::BIO-STATE)
    ("GSK-3β/β-TrCP" . SPARSER::COLLECTION)
    ("β-TrCP, DSAPGS and DSGIS" . SPARSER::COLLECTION)
    ("β-TrCP–Skp1–Cul1–Rbx1" . SPARSER::COLLECTION)
    ("GSK-3β/β-TrCP–Skp1–Cul1–Rbx1" . SPARSER::COLLECTION)
    ("electrophiles or ROS" . SPARSER::COLLECTION)
    ("Dimeric Keap1" . SPARSER::PROTEIN) ("–ring-box 1" . SPARSER::COLLECTION)
    ("stress response proteins and metabolic enzymes [ xref – xref ]"
     . SPARSER::COLLECTION)
    ("enzymes, transporters, stress response proteins and metabolic enzymes [ xref – xref ]"
     . SPARSER::COLLECTION)
    ("Typical ARE-harbouring genes" . SPARSER::GENE)
    ("Nrf2–Maf" . SPARSER::COLLECTION) ("adjuvants" . SPARSER::DRUG)
    ("both beta-transducin repeat-containing E3 ubiquitin protein ligase (β-TrCP) and E3 ubiquitin-protein ligase synoviolin (Hrd1)"
     . SPARSER::COLLECTION)
    ("synoviolin" . SPARSER::PROTEIN) ("–ring-box1" . SPARSER::COLLECTION)
    ("–cullin3" . SPARSER::COLLECTION) ("U8" . SPARSER::PROTEIN)
    ("nordihydroguaiaretic acid" . SPARSER::DRUG)
    ("12- O -Tetradecanoylphorbol-13-acetate" . SPARSER::DRUG)
    ("B-Raf" . SPARSER::PROTEIN) ("PALB2" . SPARSER::PROTEIN)
    ("partner and localizer of BRCA2" . SPARSER::PROTEIN)
    ("XBP1s" . SPARSER::PROTEIN) ("XBP1" . SPARSER::PROTEIN)
    ("X-box-binding protein 1" . SPARSER::PROTEIN) ("HSP70" . SPARSER::PROTEIN)
    ("heat-shock protein 70" . SPARSER::PROTEIN) ("GRP78" . SPARSER::PROTEIN)
    ("glucose-regulated protein" . SPARSER::PROTEIN)
    ("ATF6" . SPARSER::PROTEIN)
    ("activating transcription factor 6" . SPARSER::PROTEIN)
    ("IRE1" . SPARSER::PROTEIN) ("GSK-3" . SPARSER::PROTEIN)
    ("ring-box 1" . SPARSER::PROTEIN)
    ("ubiquitin-protein ligase" . SPARSER::PROTEIN)
    ("ring-box1" . SPARSER::PROTEIN) ("severe forms" . SPARSER::FORM)
    ("an immunoregulatory transcription factor" . SPARSER::PROTEIN)
    ("Ferritin" . SPARSER::PROTEIN) ("HO-1-" . SPARSER::PROTEIN)
    ("Nrf2-" . SPARSER::PROTEIN)
    ("the prosthetic haeme group" . SPARSER::MOLECULE)
    ("haemoglobin" . SPARSER::MOLECULE)
    ("Keap1–Cul3–Rbx1" . SPARSER::COLLECTION) ("clock" . SPARSER::PROTEIN)
    ("PERK" . SPARSER::PROTEIN)
    ("The HMG (high mobility group)-coA reductase degradation 1 (Hrd1) E3 ubiquitin–protein ligase"
     . SPARSER::PROTEIN)
    ("Hrd1" . SPARSER::PROTEIN) ("-coA" . SPARSER::MOLECULE)
    ("the Skp1 (S-phase kinase-associated protein 1)–Cul1–F-box (SCF)–β-transducin repeats-containing proteins (β-TrCP) complex"
     . SPARSER::BIO-COMPLEX)
    ("transducin" . SPARSER::PROTEIN)
    ("MafF, MafG and MafK" . SPARSER::COLLECTION) ("MafG" . SPARSER::PROTEIN)
    ("MafF" . SPARSER::PROTEIN)
    ("the reactive cysteines of Keap1" . SPARSER::PROTEIN)
    ("which targets Nrf2" . SPARSER::PROTEIN)
    ("the cullin (Cul)3–RING (really interesting new gene)-box protein (Rbx)1 ubiquitin ligase complex"
     . SPARSER::BIO-COMPLEX)
    ("Rbx" . SPARSER::PROTEIN)
    ("the phagocytic NADPH oxidase" . SPARSER::PROTEIN)
    ("NOX2/gp91 phox" . SPARSER::COLLECTION)
    ("TLR4–MyD88–NF-κB" . SPARSER::COLLECTION)
    ("monocytes/macrophages" . SPARSER::COLLECTION) ("PAMP" . SPARSER::PROTEIN)
    ("PRRs" . SPARSER::PROTEIN) ("p45, Nrf1 and Nrf3" . SPARSER::COLLECTION)
    ("collar basic leucine zipper family transcription factor"
     . SPARSER::PROTEIN)
    ("ancestral forms" . SPARSER::FORM) ("ferroportin-1" . SPARSER::PROTEIN)
    ("ATF3" . SPARSER::PROTEIN)
    ("activating transcription factor 3" . SPARSER::PROTEIN)
    ("caspase 1" . SPARSER::PROTEIN)
    ("NACHT, LRR and PYD domains-containing protein 3" . SPARSER::PROTEIN)
    ("NLRP3" . SPARSER::PROTEIN) ("Ferroportin-1" . SPARSER::PROTEIN)
    ("VP24" . SPARSER::PROTEIN) ("ubiquitin–protein ligase" . SPARSER::PROTEIN)
    ("Cul1" . SPARSER::PROTEIN) ("gp91 phox" . SPARSER::PROTEIN)
    ("Myd88" . SPARSER::PROTEIN) ("toll-like receptor 4" . SPARSER::PROTEIN)
    ("NF–E2" . SPARSER::PROTEIN)
    ("nuclear factor-erythroid 2-related factor 2" . SPARSER::PROTEIN)
    ("a given xenobiotic" . SPARSER::MOLECULE)
    ("dimethyl fumarate [ xref ] and bardoxolone methyl [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("MIP-DILI" . SPARSER::PROTEIN-PAIR) ("MIP" . SPARSER::PROTEIN)
    ("an accessible biomarker" . SPARSER::MOLECULE)
    ("Nrf2 and/or its target genes" . SPARSER::COLLECTION)
    ("fumaric acid esters" . SPARSER::MOLECULE)
    ("art" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the cytoprotective genes" . SPARSER::GENE)
    ("activating transcription factor 4/X-box binding protein 1"
     . SPARSER::COLLECTION)
    ("sub-lethal chemical" . SPARSER::MOLECULE)
    ("cellular adenosine triphosphate" . SPARSER::MOLECULE)
    ("transgene" . SPARSER::PROTEIN)
    ("cyclosporin A [ xref , xref ] and the neurotoxins 1-methyl-4-phenyl-1,2"
     . SPARSER::COLLECTION)
    ("neurotoxins" . SPARSER::PROTEIN) ("diclofenac" . SPARSER::DRUG)
    ("NAPQI" . SPARSER::DRUG)
    ("an oxidative stress component" . SPARSER::COMPONENT)
    ("thioredoxin reductase 1 (TXNRD1) and sulfiredoxin 1 (SRXN1)"
     . SPARSER::COLLECTION)
    ("the aldo-keto reductase (AKR) and GST families" . SPARSER::COLLECTION)
    ("aldo-keto reductase (AKR)" . SPARSER::PROTEIN)
    ("local redox" . SPARSER::PROTEIN)
    ("a basic leucine zipper transcription factor" . SPARSER::PROTEIN)
    ("the ubiquitously-expressed transcription factor nuclear factor erythroid 2-related factor 2"
     . SPARSER::PROTEIN)
    ("electrophiles and ROS" . SPARSER::COLLECTION)
    ("cellular oxidase enzymes or the redox" . SPARSER::COLLECTION)
    ("macromolecule" . SPARSER::MOLECULE)
    ("chemicals and drugs that are likely to provoke toxicity in humans"
     . SPARSER::COLLECTION)
    ("HMOX1" . SPARSER::PROTEIN) ("bardoxolone methyl" . SPARSER::DRUG)
    ("X-box binding protein 1" . SPARSER::PROTEIN)
    ("activating transcription factor 4" . SPARSER::PROTEIN)
    ("6-hydroxydopamine" . SPARSER::DRUG) ("cyclosporin A" . SPARSER::MOLECULE)
    ("aldo-keto reductase" . SPARSER::PROTEIN) ("SRXN1" . SPARSER::PROTEIN)
    ("sulfiredoxin 1" . SPARSER::PROTEIN) ("TXNRD1" . SPARSER::PROTEIN)
    ("thioredoxin reductase 1" . SPARSER::PROTEIN)
    ("GSK-3β" . SPARSER::PROTEIN)
    ("nuclear factor erythroid 2-related factor 2" . SPARSER::PROTEIN)
    ("coA" . SPARSER::MOLECULE) ("malonyl" . SPARSER::PROTEIN)
    ("flox" . SPARSER::PROTEIN) ("G6pd and Tkt" . SPARSER::COLLECTION)
    ("phosphoribosyl pyrophosphate amidotransferase ( Ppat ) and methylenetetrahydrofolate dehydrogenase"
     . SPARSER::COLLECTION)
    ("Other anabolic genes" . SPARSER::GENE) ("Mthfd2" . SPARSER::PROTEIN)
    ("Ppat" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("malic enzyme 1 ( Me1 ) and isocitrate dehydrogenase 1 ( Idh1 )"
     . SPARSER::COLLECTION)
    ("Idh1" . SPARSER::PROTEIN)
    ("transketolase ( Tkt ) and transaldolase 1 ( Taldo1 )"
     . SPARSER::COLLECTION)
    ("Taldo1" . SPARSER::PROTEIN) ("Tkt" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("transketolase" . SPARSER::PROTEIN)
    ("protein 1 (Srebp-1) and Pparγ" . SPARSER::COLLECTION)
    ("Srebp-1" . SPARSER::PROTEIN) ("Srebp" . SPARSER::PROTEIN-FAMILY)
    ("Hif-1" . SPARSER::PROTEIN) ("Hif" . SPARSER::PROTEIN-FAMILY)
    ("Glut1 and hexokinase 2" . SPARSER::COLLECTION)
    ("NADPH and ribose" . SPARSER::COLLECTION) ("Ldha" . SPARSER::PROTEIN)
    ("transporter and monocarboxylate" . SPARSER::COLLECTION)
    ("glutaminase" . SPARSER::PROTEIN) ("DNA and lipid" . SPARSER::COLLECTION)
    ("endocrine and paracrine" . SPARSER::COLLECTION)
    ("Pepck (phosphoenolpyruvate carboxylase) and G6Pase (glucose-6 phosphatase)"
     . SPARSER::COLLECTION)
    ("Acc1" . SPARSER::PROTEIN) ("Acc" . SPARSER::PROTEIN)
    ("Fasn" . SPARSER::PROTEIN) ("Pepck" . SPARSER::PROTEIN)
    ("lipid and glucose metabolism genes" . SPARSER::COLLECTION)
    ("Rxr" . SPARSER::PROTEIN)
    ("its cytoprotective and antioxidative gene" . SPARSER::GENE)
    ("antioxidant and cytoprotective genes" . SPARSER::COLLECTION)
    ("oxide" . SPARSER::MOLECULE)
    ("isothiocyanates and other inducers" . SPARSER::COLLECTION)
    ("triterpenoids, isothiocyanates and other inducers" . SPARSER::COLLECTION)
    ("pyrene" . SPARSER::PROTEIN)
    ("antioxidant and xenobiotic" . SPARSER::COLLECTION)
    ("Nrf2 or Keap1" . SPARSER::COLLECTION) ("BG" . SPARSER::PROTEIN)
    ("isothiocyanates" . SPARSER::MOLECULE)
    ("Gst" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("-TGAG/CNNNGC-3" . SPARSER::COLLECTION)
    ("oxidants and electrophiles" . SPARSER::COLLECTION)
    ("cysteines" . SPARSER::AMINO-ACID)
    ("lipid and nucleic acid synthesis" . SPARSER::COLLECTION)
    ("methylenetetrahydrofolate dehydrogenase" . SPARSER::PROTEIN)
    ("phosphoribosyl pyrophosphate amidotransferase" . SPARSER::PROTEIN)
    ("transaldolase 1" . SPARSER::PROTEIN) ("G6pd" . SPARSER::PROTEIN)
    ("Oct-1" . SPARSER::PROTEIN)
    ("Octamer-binding protein 1" . SPARSER::PROTEIN)
    ("glucose-6-phosphate" . SPARSER::MOLECULE)
    ("hexokinase 2" . SPARSER::PROTEIN) ("Glut1" . SPARSER::PROTEIN)
    ("monoglyceride lipase" . SPARSER::PROTEIN)
    ("acetyl-coA" . SPARSER::MOLECULE) ("G6Pase" . SPARSER::PROTEIN)
    ("phosphoenolpyruvate carboxylase" . SPARSER::PROTEIN)
    ("Pparγ" . SPARSER::PROTEIN) ("CDDO-Me" . SPARSER::DRUG)
    ("Nqo1" . SPARSER::PROTEIN) ("TrxR1 or Prxs" . SPARSER::COLLECTION)
    ("structural thiols" . SPARSER::MOLECULE)
    ("oxidants or nucleophiles" . SPARSER::COLLECTION)
    ("nucleophiles" . SPARSER::MOLECULE)
    ("thiols or selenols" . SPARSER::COLLECTION) ("selenols" . SPARSER::DRUG)
    ("paracetamol" . SPARSER::MOLECULE) ("acetaminophen" . SPARSER::DRUG)
    ("lipogenic genes" . SPARSER::GENE) ("glycogen" . SPARSER::PROTEIN)
    ("hydroperoxides" . SPARSER::MOLECULE)
    ("a conditional-null allele" . SPARSER::ALLELE)
    ("use extracellular cystine" . SPARSER::MOLECULE)
    ("homocysteine" . SPARSER::MOLECULE) ("Txnrd1" . SPARSER::PROTEIN)
    ("TrxR1 and GSH" . SPARSER::COLLECTION) ("Trx1-" . SPARSER::PROTEIN)
    ("GSH and Trx" . SPARSER::COLLECTION)
    ("a transferrable electron" . SPARSER::MOLECULE)
    ("γ -glutamyl-" . SPARSER::MOLECULE) ("tripeptide" . SPARSER::MOLECULE)
    ("selenium" . SPARSER::MOLECULE) ("reductive enzymes" . SPARSER::ENZYME)
    ("Gpx" . SPARSER::PROTEIN) ("Prx" . SPARSER::PROTEIN)
    ("the homodimeric TrxR1 enzyme" . SPARSER::ENZYME)
    ("disulfide (GSSG)" . SPARSER::MOLECULE)
    ("flavoproteins" . SPARSER::MOLECULE) ("selenol" . SPARSER::DRUG)
    ("Trx1 and GSH" . SPARSER::COLLECTION)
    ("molecules or residues" . SPARSER::COLLECTION)
    ("dithiol" . SPARSER::MOLECULE) ("NADPH and GSH" . SPARSER::COLLECTION)
    ("GSH or saccharides" . SPARSER::COLLECTION)
    ("saccharides" . SPARSER::MOLECULE)
    ("glutathione reductase (GR) and drug metabolism enzymes"
     . SPARSER::COLLECTION)
    ("disulfides" . SPARSER::MOLECULE)
    ("Kelch-like ECH-associated protein-1" . SPARSER::PROTEIN)
    ("BZIP" . SPARSER::PROTEIN-FAMILY)
    ("hazardous molecules" . SPARSER::MOLECULE)
    ("electrophilic xenobiotics" . SPARSER::MOLECULE)
    ("proteins or GSH" . SPARSER::COLLECTION) ("thiol" . SPARSER::MOLECULE)
    ("disulfide" . SPARSER::MOLECULE) ("RNR" . SPARSER::PROTEIN)
    ("ribonucleotides" . SPARSER::MOLECULE)
    ("deoxyribonucleotides" . SPARSER::MOLECULE)
    ("‘oxidant’ and ‘electrophile’" . SPARSER::COLLECTION)
    ("hydrogen peroxide or superoxide" . SPARSER::COLLECTION)
    ("‘electrophile’" . SPARSER::MOLECULE) ("‘oxidant’" . SPARSER::PROTEIN)
    ("TrxR" . SPARSER::PROTEIN)
    ("TrxR1 and peroxiredoxins" . SPARSER::COLLECTION)
    ("oxidants or electrophiles" . SPARSER::COLLECTION)
    ("Trx1" . SPARSER::PROTEIN) ("Prxs" . SPARSER::PROTEIN)
    ("peroxiredoxins" . SPARSER::PROTEIN)
    ("The proximal regulator" . SPARSER::REGULATOR) ("Trx" . SPARSER::PROTEIN)
    ("TrxR1 or GR" . SPARSER::COLLECTION)
    ("dietary methionine" . SPARSER::AMINO-ACID)
    ("TrxR1 and GR" . SPARSER::COLLECTION) ("GR" . SPARSER::PROTEIN)
    ("Buthionine sulfoximine" . SPARSER::DRUG)
    ("γ -glutamyl" . SPARSER::MOLECULE)
    ("glutathione peroxidases" . SPARSER::PROTEIN-FAMILY)
    ("homolog)" . SPARSER::PROTEIN)
    ("musculoaponeurotic fibrosarcoma" . SPARSER::PROTEIN)
    ("cullin-3" . SPARSER::PROTEIN) ("thioredoxin-1" . SPARSER::PROTEIN)
    ("TrxR1" . SPARSER::PROTEIN) ("Tecfidera" . SPARSER::DRUG)
    ("neuronal receptors" . SPARSER::PROTEIN)
    ("triterpenoids and phytochemical" . SPARSER::COLLECTION)
    ("SFP" . SPARSER::PROTEIN) ("phytochemical" . SPARSER::DRUG)
    ("triterpenoids" . SPARSER::MOLECULE) ("ALS" . SPARSER::PROTEIN)
    ("p65 and CBP" . SPARSER::COLLECTION) ("NGF" . SPARSER::PROTEIN)
    ("antioxidant and inflammatory activities" . SPARSER::COLLECTION)
    ("Skp1–Cullin1–β-TrCP" . SPARSER::COLLECTION)
    ("Keap1–IKKβ" . SPARSER::COLLECTION) ("IKB" . SPARSER::PROTEIN)
    ("its proximal promoter" . SPARSER::PROMOTER) ("MafK" . SPARSER::PROTEIN)
    ("Nrf2–CBP" . SPARSER::COLLECTION) ("Nrf2 and p65" . SPARSER::COLLECTION)
    ("CBP–p300" . SPARSER::COLLECTION) ("–p300" . SPARSER::COLLECTION)
    ("HO-1 and NQO1" . SPARSER::COLLECTION)
    ("importin" . SPARSER::HUMAN-PROTEIN-FAMILY) ("type " . TYPE)
    ("E-Selectin and vascular cell adhesion molecule 1 (VCAM-1)"
     . SPARSER::COLLECTION)
    ("vascular cell adhesion molecule 1" . SPARSER::PROTEIN)
    ("ions" . SPARSER::MOLECULE) ("iron" . SPARSER::MOLECULE)
    ("carbon monoxide and biliverdin" . SPARSER::COLLECTION)
    ("bilirubin" . SPARSER::MOLECULE)
    ("iNOS (inducible nitric oxide synthase) and IL-1β" . SPARSER::COLLECTION)
    ("COX-2 (cyclooxygenase 2), TNFα, iNOS (inducible nitric oxide synthase) and IL-1β"
     . SPARSER::COLLECTION)
    ("CDDO" . SPARSER::DRUG) ("imidazolide" . SPARSER::MOLECULE)
    ("dien" . SPARSER::MOLECULE) ("phytochemicals" . SPARSER::DRUG)
    ("NF-κB and Nrf2" . SPARSER::COLLECTION)
    ("β-TrCP–Skp1–Cullin1" . SPARSER::COLLECTION)
    ("Pro-inflammatory cytokines" . SPARSER::PROTEIN)
    ("Pro" . SPARSER::AMINO-ACID)
    ("RelB, c-rel, p50 and p52" . SPARSER::COLLECTION)
    ("β-TrCP–GSK3β axis" . SPARSER::PROTEIN-PAIR)
    ("–Cullin3–Rbx1" . SPARSER::COLLECTION) ("pentose" . SPARSER::MOLECULE)
    ("protein and organelle" . SPARSER::COLLECTION)
    ("the catalytic subunit (GCLC) and ferritin" . SPARSER::COLLECTION)
    ("catalytic subunit (GCLC)" . SPARSER::PROTEIN)
    ("γ-glutamyl cysteine ligase modulatory subunit (GCLM)"
     . SPARSER::FRAGMENT)
    ("ferritin" . SPARSER::PROTEIN) ("GCLM" . SPARSER::PROTEIN)
    ("toxic metabolites" . SPARSER::PROTEIN)
    ("Nrf2 and NF-κB" . SPARSER::COLLECTION)
    ("dimethyl fumarate" . SPARSER::DRUG)
    ("Ras-related C3 botulinum toxin substrate 1" . SPARSER::PROTEIN)
    ("RAC1" . SPARSER::PROTEIN) ("CREB-binding protein" . SPARSER::PROTEIN)
    ("KPNA6" . SPARSER::PROTEIN) ("alpha 7" . SPARSER::PROTEIN)
    ("karyopherin alpha" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cell adhesion molecule 1" . SPARSER::PROTEIN)
    ("E-Selectin" . SPARSER::PROTEIN) ("carbon monoxide" . SPARSER::MOLECULE)
    ("IKKβ" . SPARSER::PROTEIN) ("c-rel" . SPARSER::PROTEIN)
    ("Cullin3" . SPARSER::PROTEIN) ("HO-1" . SPARSER::PROTEIN)
    ("Nuclear factor (erythroid-derived 2)" . SPARSER::PROTEIN)
    ("glucoraphanin" . SPARSER::DRUG)
    ("antioxidant and anti-inflammatory" . SPARSER::COLLECTION)
    ("MPTP" . SPARSER::PROTEIN) ("tetrahydropyridine" . SPARSER::MOLECULE)
    ("a synthetic triterpenoid [ xref ] or sulforaphane (50 nM)"
     . SPARSER::COLLECTION)
    ("PINK1-KO" . SPARSER::COLLECTION) ("triterpenoid" . SPARSER::MOLECULE)
    ("RTA" . SPARSER::PROTEIN) ("PINK1 and Nrf2" . SPARSER::COLLECTION)
    ("a long-chain fatty acyl-CoA" . SPARSER::MOLECULE)
    ("palmitoyltransferase (CPT)" . SPARSER::PROTEIN)
    ("CPT1 and CPT2" . SPARSER::COLLECTION) ("CPT" . SPARSER::PROTEIN)
    ("palmitoyltransferase" . SPARSER::PROTEIN) ("ubiquinone" . SPARSER::DRUG)
    ("malate, pyruvate and succinate" . SPARSER::COLLECTION)
    ("-glucose" . SPARSER::COLLECTION)
    ("malate and methyl succinate" . SPARSER::COLLECTION)
    ("pyruvate and malate" . SPARSER::COLLECTION)
    ("malate" . SPARSER::MOLECULE) ("swollen mitochondria" . SPARSER::PROTEIN)
    ("KO or KD" . SPARSER::COLLECTION) ("Keap1-KO" . SPARSER::COLLECTION)
    ("Nrf2 and phosphoglycerate" . SPARSER::COLLECTION)
    ("phosphoglycerate" . SPARSER::MOLECULE)
    ("nuclear respiratory factor 1 and peroxisome" . SPARSER::COLLECTION)
    ("NOX" . SPARSER::PROTEIN) ("Nrf2-KO" . SPARSER::COLLECTION)
    ("Keap1-KD" . SPARSER::COLLECTION)
    ("glucose-6-phosphate dehydrogenase (G6PD) and 6-phosphogluconate dehydrogenase (PGD) [ xref – xref ]"
     . SPARSER::COLLECTION)
    ("the cellular NADPH" . SPARSER::PROTEIN)
    ("GSR and TXNR and Nrf2" . SPARSER::COLLECTION)
    ("TXNR and Nrf2" . SPARSER::COLLECTION) ("ME-1" . SPARSER::COLLECTION)
    ("PGD" . SPARSER::PROTEIN) ("isocitrate" . SPARSER::PROTEIN)
    ("ME" . SPARSER::PROTEIN) ("glutathione and TXN" . SPARSER::COLLECTION)
    ("thioredoxin (TXN)" . SPARSER::PROTEIN)
    ("sulfiredoxin (SRX)" . SPARSER::PROTEIN)
    ("sulfiredoxin" . SPARSER::PROTEIN) ("TXNR" . SPARSER::PROTEIN)
    ("TXN" . SPARSER::PROTEIN) ("thioredoxin" . SPARSER::PROTEIN)
    ("thiols" . SPARSER::MOLECULE)
    ("Glutathione peroxidase 2 (GPX2) and glutathione reductase"
     . SPARSER::COLLECTION)
    ("GSSG" . SPARSER::DRUG) ("GSR" . SPARSER::PROTEIN)
    ("ligase (GCL)" . SPARSER::LIGASE)
    ("cytoprotective target genes" . SPARSER::GENE)
    ("alkyne (STCA)" . SPARSER::MOLECULE)
    ("the electrophilic isothiocyanate sulforaphane" . SPARSER::DRUG)
    ("STCA" . SPARSER::PROTEIN) ("alkyne" . SPARSER::MOLECULE)
    ("‘DLG’ and ‘ETGE’" . SPARSER::COLLECTION)
    ("dimeric Keap1" . SPARSER::PROTEIN) ("‘DLG’" . SPARSER::PROTEIN)
    ("single live cells expressing Keap1–mCherry and EGFP–Nrf2 fusion proteins"
     . SPARSER::PROTEIN)
    ("EGFP–Nrf2" . SPARSER::COLLECTION) ("Keap1–mCherry" . SPARSER::COLLECTION)
    ("FLIM" . SPARSER::PROTEIN-FAMILY)
    ("continuously targets Nrf2" . SPARSER::PROTEIN)
    ("electrophiles and oxidants" . SPARSER::COLLECTION)
    ("cullin3–RING-box protein 1" . SPARSER::COLLECTION)
    ("state, and highlight" . SPARSER::COLLECTION)
    ("Keap1–Nrf2" . SPARSER::COLLECTION)
    ("Electrophiles and oxidants" . SPARSER::COLLECTION)
    ("Electrophiles" . SPARSER::MOLECULE)
    ("transcription factor Nrf2 and its main negative cytoplasmic regulator Keap1"
     . SPARSER::COLLECTION)
    ("–NF-E2" . SPARSER::COLLECTION)
    ("serine/threonine-protein kinase" . SPARSER::PROTEIN)
    ("PINK1" . SPARSER::PROTEIN) ("CPT2" . SPARSER::PROTEIN)
    ("CPT1" . SPARSER::PROTEIN) ("palmitic acid" . SPARSER::MOLECULE)
    ("complex I" . SPARSER::PROTEIN) ("PGAM5" . SPARSER::PROTEIN)
    ("nuclear respiratory factor 1" . SPARSER::PROTEIN)
    ("NOX2" . SPARSER::PROTEIN)
    ("phosphogluconate dehydrogenase" . SPARSER::PROTEIN)
    ("G6PD" . SPARSER::PROTEIN)
    ("glucose-6-phosphate dehydrogenase" . SPARSER::PROTEIN)
    ("IDH-1" . SPARSER::PROTEIN) ("glutathione reductase" . SPARSER::PROTEIN)
    ("GPX2" . SPARSER::PROTEIN) ("Glutathione peroxidase 2" . SPARSER::PROTEIN)
    ("γ-glutamyl" . SPARSER::MOLECULE)
    ("RING-box protein 1" . SPARSER::PROTEIN) ("cullin3" . SPARSER::PROTEIN)
    ("factor 2" . SPARSER::PROTEIN) ("p45" . SPARSER::PROTEIN)
    ("Kelch-like ECH associated protein 1" . SPARSER::PROTEIN)
    ("HPX [ xref ]and TMEM184B [ xref ]" . SPARSER::COLLECTION)
    ("SLC25A21 [ xref ], PFN1 [ xref ], HPX [ xref ]and TMEM184B [ xref ]"
     . SPARSER::COLLECTION)
    ("ZNF536, ZNF592 and ZFAND5" . SPARSER::COLLECTION)
    ("ZNF536, ZNF592, NARS, SLC25A21, HERPUD2, NRIP2, PPP1R12C, DPAGT1, PFN1, ZFAND5, HPX and TMEM184B"
     . SPARSER::COLLECTION)
    ("HPX" . SPARSER::PROTEIN) ("Only 10 featured genes" . SPARSER::GENE)
    ("CpGs and genes" . SPARSER::COLLECTION)
    ("adjacent CpGs" . SPARSER::PROTEIN)
    ("NARS and SLC25A21" . SPARSER::COLLECTION) ("NARS" . SPARSER::PROTEIN)
    ("MRS and receptor" . SPARSER::COLLECTION)
    ("high-MRS and Her2-" . SPARSER::COLLECTION)
    ("ER-, PR+ and PR-" . SPARSER::COLLECTION)
    ("differential MRS" . SPARSER::PROTEIN)
    ("The methylation prognostic biomarkers" . SPARSER::MOLECULE)
    ("some genes and a positive regulatory effect" . SPARSER::COLLECTION)
    ("CpGs and gene" . SPARSER::COLLECTION)
    ("promoter and gene" . SPARSER::COLLECTION)
    ("a good prognostic biomarker" . SPARSER::MOLECULE)
    ("HR-" . SPARSER::PROTEIN)
    ("estrogen receptor (ER) and progesterone receptor (PR)"
     . SPARSER::COLLECTION)
    ("receptors (HR)" . SPARSER::RECEPTOR)
    ("ER-, PR- or Her2-" . SPARSER::COLLECTION)
    ("PR-" . SPARSER::HUMAN-PROTEIN-FAMILY) ("ER-" . SPARSER::PROTEIN)
    ("MRS" . SPARSER::PROTEIN) ("TMEM184B" . SPARSER::PROTEIN)
    ("PFN1" . SPARSER::PROTEIN) ("DPAGT1" . SPARSER::PROTEIN)
    ("PPP1R12C" . SPARSER::PROTEIN) ("NRIP2" . SPARSER::PROTEIN)
    ("ZNF536" . SPARSER::PROTEIN) ("SLC25A21" . SPARSER::PROTEIN)
    ("C-5" . SPARSER::PROTEIN)
    ("mRNA and mHsp72 and lHSP72" . SPARSER::COLLECTION)
    ("the weak LPS" . SPARSER::PROTEIN) ("nanoparticles" . SPARSER::MOLECULE)
    ("LDHs-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Hydroxides-" . SPARSER::MOLECULE)
    ("LDHs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Hydroxides" . SPARSER::MOLECULE)
    ("TNF- α and macrophages" . SPARSER::COLLECTION)
    ("TLR-2 or TLR-4" . SPARSER::COLLECTION) ("TLR-2" . SPARSER::PROTEIN)
    ("Simply measuring extracellular HSP72" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("A conditionally essential nutrient" . SPARSER::MOLECULE)
    ("Hsf1" . SPARSER::PROTEIN) ("HSP72 and TNF- α" . SPARSER::COLLECTION)
    ("glutathione and malondialdehyde" . SPARSER::COLLECTION)
    ("malondialdehyde" . SPARSER::MOLECULE)
    ("proteins or HSP72" . SPARSER::COLLECTION)
    ("mRNA and HSP72" . SPARSER::COLLECTION)
    ("IL-6, IL-10, TNF, IL-8, and MCP-1" . SPARSER::COLLECTION)
    ("both HSP72 mRNA and intracellular HSP72" . SPARSER::COLLECTION)
    ("IL-8 and MCP-1" . SPARSER::COLLECTION)
    ("IFN- γ or IL-17" . SPARSER::COLLECTION)
    ("secreted cytokines and intracellular HSP72" . SPARSER::COLLECTION)
    ("healthy individuals increases baseline HSP72"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Only neutrophil HSP72" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Neither baseline mRNA nor intracellular HSP72 proteins"
     . SPARSER::COLLECTION)
    ("serum IL-17 ( r  s = 0.84, p < 0.0001) and IL-10 ( r  s = 0.82, p < 0.0001)"
     . SPARSER::COLLECTION)
    ("cytokines and cortisol" . SPARSER::COLLECTION)
    ("INF-" . SPARSER::PROTEIN) ("INF" . SPARSER::PROTEIN)
    ("proteins and mRNA" . SPARSER::COLLECTION)
    ("IL-6 and IL-10" . SPARSER::COLLECTION)
    ("mRNA or intracellular HSP72 proteins" . SPARSER::COLLECTION)
    ("LPS and Gln" . SPARSER::COLLECTION)
    ("mRNA, mHSP72, and lHSP72" . SPARSER::COLLECTION)
    ("extracellular HSP72" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("healthy male" . SPARSER::MOLECULE)
    ("parenteral Gln" . SPARSER::AMINO-ACID)
    ("Glutamine" . SPARSER::AMINO-ACID) ("/interleukin" . SPARSER::COLLECTION)
    ("proteins and HSP72" . SPARSER::COLLECTION)
    ("mRNA and l/mHSP72" . SPARSER::COLLECTION)
    ("IL-6, IL-8, IL-10, and MCP-1" . SPARSER::COLLECTION)
    ("cortisol" . SPARSER::PROTEIN) ("interleukins" . SPARSER::PROTEIN)
    ("1  μ g/mL LPS or 43°HS" . SPARSER::COLLECTION)
    ("glutamine" . SPARSER::AMINO-ACID) ("TLR-4" . SPARSER::PROTEIN)
    ("IFN- γ" . SPARSER::PROTEIN)
    ("heat shock 70 kDa protein 1A" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HI30" . SPARSER::PROTEIN) ("tissue factor" . SPARSER::PROTEIN)
    ("factor- κ B" . SPARSER::PROTEIN) ("HSF-1" . SPARSER::PROTEIN)
    ("chemoattractant protein-1" . SPARSER::PROTEIN)
    ("HSP72" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("EGFR and β4" . SPARSER::COLLECTION)
    ("varied microenvironmental cues" . SPARSER::PROTEIN-FAMILY)
    ("microenvironmental cues" . SPARSER::PROTEIN-FAMILY)
    ("Microenvironmental cues" . SPARSER::PROTEIN-FAMILY)
    ("integrins and FAK" . SPARSER::COLLECTION)
    ("an AKT inhibitor (AKT-in) and a p38MAPK inhibitor (SB203580)"
     . SPARSER::COLLECTION)
    ("AKT-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("paxillin/FAK" . SPARSER::COLLECTION)
    ("AKT and p38MAPK" . SPARSER::COLLECTION)
    ("the FAK Y397F or kinase dead (FAK K454M ) mutant" . SPARSER::COLLECTION)
    ("-transfectants" . SPARSER::COLLECTION) ("EGF/EGFR" . SPARSER::COLLECTION)
    ("Tyrosine" . SPARSER::AMINO-ACID)
    ("PP2, an Src kinase inhibitor, compared to PP3- or DMSO-treated cells ( xref )"
     . SPARSER::COLLECTION)
    ("PP3-" . SPARSER::PROTEIN) ("integrin, and FAK" . SPARSER::COLLECTION)
    ("EGF/Src" . SPARSER::COLLECTION)
    ("the essential amino acids of the 11 amino acids" . SPARSER::AMINO-ACID)
    ("the essential amino acids" . SPARSER::AMINO-ACID)
    ("Val" . SPARSER::AMINO-ACID) ("Asn" . SPARSER::AMINO-ACID)
    ("serial FAK" . SPARSER::PROTEIN)
    ("the first 400 amino acids of FAK" . SPARSER::PROTEIN)
    ("FRNK" . SPARSER::PROTEIN) ("integrin or FAK" . SPARSER::COLLECTION)
    ("Fak" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("apoptosis-inducing and anti-HER2" . SPARSER::COLLECTION)
    ("Ras and MAPKs" . SPARSER::COLLECTION)
    ("Shc, and Shp2" . SPARSER::COLLECTION) ("Shc" . SPARSER::PROTEIN)
    ("currently few effective therapeutics" . SPARSER::THERAPEUTICS)
    ("a pro-metastatic EGFR/Src-dependent β4 integrin/FAK complex"
     . SPARSER::BIO-COMPLEX)
    ("integrin/FAK" . SPARSER::COLLECTION)
    ("integrin and FAK" . SPARSER::COLLECTION)
    ("β4 integrin and focal adhesion kinase (FAK)" . SPARSER::COLLECTION)
    ("ITGB4" . SPARSER::PROTEIN) ("C20" . SPARSER::PROTEIN)
    ("phospho-tyrosine" . SPARSER::MOLECULE) ("PP3" . SPARSER::PROTEIN)
    ("Lys-Gln" . SPARSER::MOLECULE) ("Shp2" . SPARSER::PROTEIN)
    ("Qin" . SPARSER::PROTEIN) ("Bcl-2/Beclin 1" . SPARSER::COLLECTION)
    ("an autophagic inhibitor" . SPARSER::INHIBITOR)
    ("STAT3Y705F" . SPARSER::PROTEIN)
    ("LC3-II, p62, Beclin 1, and VPS34" . SPARSER::COLLECTION)
    ("IFN-γ, IL-4, and IL-13" . SPARSER::COLLECTION)
    ("Cytokines" . SPARSER::PROTEIN) ("IL-6 and Atg14" . SPARSER::COLLECTION)
    ("p150, PI3 kinase, Beclin 1, and Atg 14 or UVRAG" . SPARSER::COLLECTION)
    ("Atg 14 or UVRAG" . SPARSER::COLLECTION)
    ("Beclin 1 and Atg14" . SPARSER::COLLECTION)
    ("wild-type STAT3 (STAT3WT) and dominant-negative STAT3 (STAT3Y705F)"
     . SPARSER::COLLECTION)
    ("dominant-negative STAT3" . SPARSER::PROTEIN)
    ("p-STAT3/STAT3" . SPARSER::COLLECTION)
    ("VPS34 and Beclin 1" . SPARSER::COLLECTION)
    ("Beclin 1, VPS34 and p62" . SPARSER::COLLECTION)
    ("Beclin 1 and VPS34" . SPARSER::COLLECTION)
    ("p-ERK1, and p-ERK2" . SPARSER::COLLECTION)
    ("ATK, ERK1/2 and STAT3" . SPARSER::COLLECTION)
    ("fluorescent puncta" . SPARSER::PROTEIN)
    ("baf" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("receptor-cytokine" . SPARSER::COLLECTION)
    ("Ras/Erk" . SPARSER::COLLECTION)
    ("the IL-6/IL-6Rα/gp130 ternary complex" . SPARSER::BIO-COMPLEX)
    ("an 80-kD alpha subunit (IL-6Rα) and glycoprotein 130 (gp130)"
     . SPARSER::COLLECTION)
    ("arsenite" . SPARSER::DRUG)
    ("monocytes and mononuclear macrophages" . SPARSER::COLLECTION)
    ("mononuclear macrophages" . SPARSER::PROTEIN)
    ("long-lived proteins and destructive organelles" . SPARSER::COLLECTION)
    ("long-lived proteins" . SPARSER::PROTEIN)
    ("Bcl-2 and Beclin1" . SPARSER::COLLECTION)
    ("Beclin 1 or Atg14" . SPARSER::COLLECTION)
    ("type II (LC3-II) and Beclin 1" . SPARSER::COLLECTION)
    ("Anti-ERK" . SPARSER::PROTEIN) ("LC3B" . SPARSER::PROTEIN)
    ("IL-13" . SPARSER::PROTEIN) ("Atg 14" . SPARSER::PROTEIN)
    ("PI3 kinase" . SPARSER::PROTEIN) ("p150" . SPARSER::PROTEIN)
    ("p-ERK2" . SPARSER::PROTEIN) ("Amino acid" . SPARSER::AMINO-ACID)
    ("glycoprotein 130" . SPARSER::PROTEIN) ("VPS34" . SPARSER::PROTEIN)
    ("Beclin1" . SPARSER::PROTEIN) ("Atg14" . SPARSER::PROTEIN)
    ("microtubule-associated protein" . SPARSER::PROTEIN)
    ("IL-6-STAT3-IL17" . SPARSER::COLLECTION)
    ("Smad7 and p53" . SPARSER::COLLECTION)
    ("polyubiquitination and proteasomal" . SPARSER::COLLECTION)
    ("deacetylases and EX-527" . SPARSER::COLLECTION)
    ("nicotinamide (NAM) and EX-527" . SPARSER::COLLECTION)
    ("NAM" . SPARSER::PROTEIN-FAMILY) ("nicotinamide" . SPARSER::MOLECULE)
    ("Trichostatin" . SPARSER::MOLECULE)
    ("acetyltransferases and deacetylases" . SPARSER::COLLECTION)
    ("HDAC7 and HDAC9" . SPARSER::COLLECTION) ("Stub1" . SPARSER::PROTEIN)
    ("eomesodermin" . SPARSER::PROTEIN)
    ("GATA3 and Foxp3" . SPARSER::COLLECTION)
    ("IL-17A as well as RORγt ( xref )" . SPARSER::COLLECTION)
    ("IL-17A, IL-17F and IL-23R" . SPARSER::COLLECTION)
    ("Myc-HDAC1" . SPARSER::COLLECTION) ("DMSO or HDAC" . SPARSER::COLLECTION)
    ("DMSO-only" . SPARSER::MOLECULE)
    ("Flag-tagged RORγt and HA-tagged p300" . SPARSER::COLLECTION)
    ("p300 and Myc-tagged" . SPARSER::COLLECTION)
    ("Foxp3 and p53" . SPARSER::COLLECTION)
    ("p300 and RORγt" . SPARSER::COLLECTION) ("HA-p300" . SPARSER::COLLECTION)
    ("HATs and RORγt" . SPARSER::COLLECTION)
    ("Flag-RORγt" . SPARSER::COLLECTION)
    ("p300 and HDAC1" . SPARSER::COLLECTION)
    ("p300 and the deacetylase Sirt2" . SPARSER::COLLECTION)
    ("HDAC1, HDAC2, HDAC3 and HDAC8" . SPARSER::COLLECTION)
    ("transcriptional activators, and histone" . SPARSER::COLLECTION)
    ("histone and non-histone" . SPARSER::COLLECTION)
    ("acetyltransferases and histone" . SPARSER::COLLECTION)
    ("p53, NF-κB and Foxp3" . SPARSER::COLLECTION)
    ("intrinsic acetyltransferase activity" . SPARSER::PROTEIN)
    ("a transcriptional cofactor" . SPARSER::MOLECULE)
    ("an adenovirus E1A-associated 300- kDa protein" . SPARSER::PROTEIN)
    ("Ep300 or KAT3B" . SPARSER::COLLECTION)
    ("HIF1α and RORγt" . SPARSER::COLLECTION)
    ("IL-17A, IL-17F, IL-21 and IL-23R" . SPARSER::COLLECTION)
    ("transcription factor (BATF)" . SPARSER::PROTEIN)
    ("RORγt and RORα" . SPARSER::COLLECTION)
    ("Sox5 and c-MAF" . SPARSER::COLLECTION) ("BATF" . SPARSER::PROTEIN)
    ("IL-23 and proinflammatory cytokines (e.g., IL-1β and IL-6)"
     . SPARSER::COLLECTION)
    ("proinflammatory cytokines and chemokines" . SPARSER::COLLECTION)
    ("IL-17A and IL-17F" . SPARSER::COLLECTION)
    ("IL6 and CXCL8" . SPARSER::COLLECTION)
    ("the histone acetyltransferase p300 and the histone deacetylase HDAC1"
     . SPARSER::COLLECTION)
    ("IL-17 A" . SPARSER::PROTEIN) ("CD45RA" . SPARSER::PROTEIN)
    ("CD25" . SPARSER::PROTEIN) ("a 37 " . SPARSER::PROTEIN)
    ("IL17" . SPARSER::PROTEIN) ("ITF2357" . SPARSER::DRUG)
    ("Smad7" . SPARSER::PROTEIN) ("Foxp3  " . SPARSER::PROTEIN)
    ("EX-527" . SPARSER::DRUG) ("HDAC9" . SPARSER::PROTEIN)
    ("HDAC7" . SPARSER::PROTEIN) ("Tip60" . SPARSER::PROTEIN)
    ("TIP60" . SPARSER::PROTEIN) ("T-bet" . SPARSER::PROTEIN)
    ("Myc-tagged" . SPARSER::PROTEIN)
    ("activated protein kinase" . SPARSER::PROTEIN)
    ("adenosine monophosphate" . SPARSER::MOLECULE)
    ("Sirt2" . SPARSER::PROTEIN)
    ("transcriptional coactivator" . SPARSER::PROTEIN)
    ("HDAC8" . SPARSER::PROTEIN) ("Foxp3" . SPARSER::PROTEIN)
    ("acetyltransferase activity" . SPARSER::PROTEIN)
    ("KAT3B" . SPARSER::PROTEIN) ("Ep300" . SPARSER::PROTEIN)
    ("JmjC domain-containing protein 3" . SPARSER::PROTEIN)
    ("USP17" . SPARSER::PROTEIN) ("c-MAF" . SPARSER::PROTEIN)
    ("Sox5" . SPARSER::PROTEIN) ("Runx1" . SPARSER::PROTEIN)
    ("Runt-related transcription factor 1" . SPARSER::PROTEIN)
    ("IRF4" . SPARSER::PROTEIN)
    ("interferon regulatory factor 4" . SPARSER::PROTEIN)
    ("RORα" . SPARSER::PROTEIN) ("IL-21" . SPARSER::PROTEIN)
    ("IL-23R" . SPARSER::PROTEIN) ("IL-23 receptor" . SPARSER::PROTEIN)
    ("CXCL8" . SPARSER::PROTEIN) ("IL-17F" . SPARSER::PROTEIN)
    ("IL-17A" . SPARSER::PROTEIN) ("RORγt" . SPARSER::PROTEIN)
    ("orphan receptor" . SPARSER::PROTEIN)
    ("Src and E-cadherin" . SPARSER::COLLECTION) ("Rapl" . SPARSER::PROTEIN)
    ("RASSF" . SPARSER::PROTEIN-FAMILY) ("YAP1 and TBX3" . SPARSER::COLLECTION)
    ("the pS127" . SPARSER::PROTEIN) ("TEAD-" . SPARSER::PROTEIN)
    ("SRC and YAP1" . SPARSER::COLLECTION) ("CAFs" . SPARSER::PROTEIN)
    ("partial-EMT" . SPARSER::COLLECTION)
    ("growth factor or cytokine" . SPARSER::COLLECTION)
    ("striatum" . SPARSER::PROTEIN) ("BIRC5 and MYC" . SPARSER::COLLECTION)
    ("significantly more genes" . SPARSER::GENE) ("p " . SPARSER::PROTEIN)
    ("TEAD/TBX3" . SPARSER::COLLECTION)
    ("BCL2L1, BIRC5, and MYC" . SPARSER::COLLECTION)
    ("TBX3 and TEAD1" . SPARSER::COLLECTION)
    ("YAP1/TEAD1" . SPARSER::COLLECTION)
    ("β-catenin/TBX3" . SPARSER::COLLECTION) ("invasive genes" . SPARSER::GENE)
    ("TEAD1/TBX3" . SPARSER::COLLECTION)
    ("YAP1/β-catenin" . SPARSER::COLLECTION)
    ("β-catenin [ xref ] and YAP/TEAD1 [ xref ]" . SPARSER::COLLECTION)
    ("cMYC" . SPARSER::PROTEIN)
    ("similarly induced BCL2L1 and BIRC5" . SPARSER::COLLECTION)
    ("YAP1/β-catenin/TBX" . SPARSER::COLLECTION)
    ("TBX2 and TBX3" . SPARSER::COLLECTION)
    ("BCL2L1 and BIRC5" . SPARSER::COLLECTION)
    ("β-catenin/YAP1" . SPARSER::COLLECTION)
    ("Strong E-cadherin" . SPARSER::PROTEIN)
    ("the mobile fraction of E-cadherin and its turnover"
     . SPARSER::COLLECTION)
    ("α-catenin [ xref , xref ] or E-cadherin [ xref ]" . SPARSER::COLLECTION)
    ("junctional components" . SPARSER::COMPONENT)
    ("eGFP-E-cadherin" . SPARSER::COLLECTION)
    ("GFP-E-cadherin" . SPARSER::COLLECTION)
    ("E-cadherin and β-catenin" . SPARSER::COLLECTION)
    ("p120-catenin or FAK" . SPARSER::COLLECTION)
    ("Phosphotyrosine" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("SRC, and pY416-SRC" . SPARSER::COLLECTION)
    ("GFP-SRC" . SPARSER::COLLECTION) ("Targets" . SPARSER::TARGET-PROTEIN)
    ("RASSF1A and RASSF1C" . SPARSER::COLLECTION)
    ("RASSF1A, SRC, and CSK" . SPARSER::COLLECTION)
    ("c-SRC" . SPARSER::COLLECTION)
    ("RASSF1A or RASSF1C" . SPARSER::COLLECTION)
    ("RASSF1 or RASSF1A" . SPARSER::COLLECTION)
    ("tumor-suppressive YAP1/p73" . SPARSER::COLLECTION)
    ("YAP1/p73" . SPARSER::COLLECTION) ("Isoforms" . SPARSER::ISOFORM)
    ("β-catenin and YAP1" . SPARSER::COLLECTION) ("cMyc" . SPARSER::PROTEIN)
    ("additionally scaffolds CSK" . SPARSER::PROTEIN)
    ("an internal promoter" . SPARSER::PROMOTER) ("gene " . SPARSER::GENE)
    ("YAP1-β-catenin" . SPARSER::COLLECTION)
    ("E-cadherin, p120-catenin, and β-catenin" . SPARSER::COLLECTION)
    ("WNT and RAS" . SPARSER::COLLECTION) ("kinase (SFK)" . SPARSER::KINASE)
    ("pS" . SPARSER::PROTEIN) ("SAV1 and RASSFs" . SPARSER::COLLECTION)
    ("RASSFs" . SPARSER::PROTEIN-FAMILY) ("MST" . SPARSER::PROTEIN)
    ("NF2/merlin" . SPARSER::COLLECTION) ("GNAQ" . SPARSER::PROTEIN)
    ("pseudo-EMT" . SPARSER::PROTEIN) ("TBX" . SPARSER::PROTEIN-FAMILY)
    ("E-cadherin, β-catenin, and YAP1" . SPARSER::COLLECTION)
    ("the RAS effector and hippo kinase scaffold RASSF1A"
     . SPARSER::COLLECTION)
    ("WWTR1" . SPARSER::PROTEIN) ("Arp3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("RUNX2" . SPARSER::PROTEIN) ("TEAD1" . SPARSER::PROTEIN)
    ("TBX3" . SPARSER::PROTEIN) ("TBX2" . SPARSER::PROTEIN)
    ("TBX5" . SPARSER::PROTEIN)
    ("T-box transcription factor TBX5" . SPARSER::PROTEIN)
    ("YES1" . SPARSER::PROTEIN) ("S6B" . SPARSER::PROTEIN)
    ("S5B" . SPARSER::PROTEIN) ("S3B" . SPARSER::PROTEIN)
    ("MST1" . SPARSER::PROTEIN) ("p73" . SPARSER::PROTEIN)
    ("BIRC5" . SPARSER::PROTEIN) ("E-cadherin " . SPARSER::PROTEIN)
    ("p120-catenin" . SPARSER::PROTEIN) ("SAV1" . SPARSER::PROTEIN)
    ("LATS1" . SPARSER::PROTEIN) ("RASSF1" . SPARSER::PROTEIN)
    ("RASSF1A" . SPARSER::PROTEIN) ("YAP1" . SPARSER::PROTEIN)
    ("Oncogene" . SPARSER::ONCOGENE)
    ("WRNIP1, ATMIN and RAD18" . SPARSER::COLLECTION)
    ("ubiquitinated PCNA and ATMIN/ATM" . SPARSER::COLLECTION)
    ("WRNIP1 and ATM" . SPARSER::COLLECTION)
    ("GFP-ATMIN" . SPARSER::COLLECTION)
    ("No currently available antibodies" . SPARSER::ANTIBODY)
    ("RPA and RAD18" . SPARSER::COLLECTION)
    ("RAD18 and WRNIP1" . SPARSER::COLLECTION)
    ("ATMIN or ATM" . SPARSER::COLLECTION)
    ("pATM or 53BP1" . SPARSER::COLLECTION) ("mask" . SPARSER::PROTEIN)
    ("ATMIN and pATM" . SPARSER::COLLECTION)
    ("WRNIP1 or RAD18 and RPA" . SPARSER::COLLECTION)
    ("RAD18 and RPA" . SPARSER::COLLECTION)
    ("the replicative polymerase" . SPARSER::PROTEIN)
    ("Kap-1 and P53" . SPARSER::COLLECTION) ("Kap-1" . SPARSER::PROTEIN)
    ("Kap" . SPARSER::PROTEIN) ("WRNIP1 or RAD18" . SPARSER::COLLECTION)
    ("Kap1, p53 or Chk2" . SPARSER::COLLECTION)
    ("ATMIN, WRNIP1 or RAD18" . SPARSER::COLLECTION)
    ("P-ATM and 53BP1" . SPARSER::COLLECTION) ("-PCNA" . SPARSER::COLLECTION)
    ("aspartate" . SPARSER::PROTEIN) ("WRNIP1 and RAD18" . SPARSER::COLLECTION)
    ("UBZ" . SPARSER::PROTEIN) ("monoubiquitin" . SPARSER::PROTEIN)
    ("aphidicolin, WRNIP1, pATM and 53BP1" . SPARSER::COLLECTION)
    ("This protein-bound repetitive DNA" . SPARSER::DNA)
    ("WRNIP1, pATM and 53BP1" . SPARSER::COLLECTION)
    ("hydroxyurea" . SPARSER::DRUG) ("Hydroxyurea" . SPARSER::DRUG)
    ("pATM and 53BP1" . SPARSER::COLLECTION)
    ("ATMIN/WRNIP1" . SPARSER::COLLECTION)
    ("Aph" . SPARSER::HUMAN-PROTEIN-FAMILY) ("pATM" . SPARSER::PROTEIN)
    ("ATMIN-WRNIP1" . SPARSER::COLLECTION)
    ("ATMIN and WRNIP1" . SPARSER::COLLECTION)
    ("RAD18, WRNIP1 and ATMIN" . SPARSER::COLLECTION)
    ("a cellular trigger" . SPARSER::PROTEIN)
    ("the BLM helicase and the SNF2-family Plk1-interacting checkpoint helicase (PICH)"
     . SPARSER::COLLECTION)
    ("helicase (PICH)" . SPARSER::PROTEIN) ("PICH" . SPARSER::PROTEIN)
    ("under-replicated DNA" . SPARSER::DNA) ("kinase (ATR)" . SPARSER::KINASE)
    ("replisome" . SPARSER::BIO-COMPLEX) ("Aphidicolin" . SPARSER::PROTEIN)
    ("distinct cofactors" . SPARSER::PROTEIN)
    ("ATMIN/ATM" . SPARSER::COLLECTION)
    ("ATMIN, WRNIP1 and RAD18" . SPARSER::COLLECTION)
    ("Proliferating Cell Nuclear Antigen (PCNA)" . SPARSER::PROTEIN)
    ("WRN" . SPARSER::PROTEIN) ("ATMIN" . SPARSER::PROTEIN)
    ("alpha-tubulin" . SPARSER::PROTEIN) ("pS15" . SPARSER::PROTEIN)
    ("KU55933" . SPARSER::DRUG) ("min −1" . SPARSER::PROTEIN)
    ("FBH1" . SPARSER::PROTEIN) ("poly-ubiquitin" . SPARSER::PROTEIN)
    ("Kap1" . SPARSER::PROTEIN) ("P-ATM" . SPARSER::PROTEIN)
    ("Zinc finger" . SPARSER::PROTEIN) ("yeast homolog" . SPARSER::PROTEIN)
    ("Rad18" . SPARSER::PROTEIN) ("ATM interactor" . SPARSER::PROTEIN)
    ("ATM Interactor" . SPARSER::PROTEIN) ("Rad50" . SPARSER::PROTEIN)
    ("Mre11" . SPARSER::PROTEIN) ("WRNIP1" . SPARSER::PROTEIN)
    ("Proliferating Cell Nuclear Antigen" . SPARSER::PROTEIN)
    ("electrons" . SPARSER::MOLECULE) ("oxidase (COX)" . SPARSER::PROTEIN)
    ("COX1 , COX2 and COX3" . SPARSER::COLLECTION)
    ("oxidase" . SPARSER::PROTEIN) ("COX2 and COX3" . SPARSER::COLLECTION)
    ("Slc25a3" . SPARSER::PROTEIN) ("pGL3-PTEN" . SPARSER::COLLECTION)
    ("DIANA-miR" . SPARSER::PROTEIN-PAIR)
    ("the pro-inflammatory cytokines" . SPARSER::PROTEIN)
    ("IL-6 and TNF-α" . SPARSER::COLLECTION)
    ("high-glucose" . SPARSER::PROTEIN) ("IL-6 or TNF-α" . SPARSER::COLLECTION)
    ("interleukin 6, IL-6 and tumor necrosis factor" . SPARSER::COLLECTION)
    ("regulating pro-inflammatory cytokines" . SPARSER::PROTEIN)
    ("triglyceride (TG)" . SPARSER::MOLECULE)
    ("triglyceride" . SPARSER::MOLECULE) ("Seahorse" . SPARSER::PROTEIN)
    ("ROS and MDA" . SPARSER::COLLECTION) ("malonaldehyde" . SPARSER::MOLECULE)
    ("HOMA-IR" . SPARSER::COLLECTION) ("ITT" . SPARSER::MOLECULE)
    ("glycolipid" . SPARSER::MOLECULE) ("TC" . SPARSER::PROTEIN)
    ("ROS and electron" . SPARSER::COLLECTION) ("ETC" . SPARSER::PROTEIN)
    ("Excessive ROS" . SPARSER::PROTEIN) ("FFA" . SPARSER::PROTEIN)
    ("13 essential proteins" . SPARSER::PROTEIN) ("mL −1" . SPARSER::PROTEIN)
    ("Hexokinase 2" . SPARSER::PROTEIN)
    ("glutathione peroxidase" . SPARSER::PROTEIN)
    ("a3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("solute carrier family 25 member 3" . SPARSER::PROTEIN)
    ("SIAH1" . SPARSER::PROTEIN) ("CCNE2" . SPARSER::PROTEIN)
    ("ZMAT3" . SPARSER::PROTEIN) ("COX3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("miR-126" . SPARSER::PROTEIN) ("LDL-C" . SPARSER::PROTEIN)
    ("low density lipoprotein" . SPARSER::PROTEIN) ("HDL-C" . SPARSER::PROTEIN)
    ("high density lipoprotein" . SPARSER::PROTEIN)
    ("ACAN and MMP-13" . SPARSER::COLLECTION)
    ("cytokines and growth factors" . SPARSER::COLLECTION)
    ("IL-1β or hydrogen peroxide" . SPARSER::COLLECTION)
    ("caveolin 1 and p21" . SPARSER::COLLECTION) ("Dai" . SPARSER::PROTEIN)
    ("-STAT" . SPARSER::COLLECTION) ("ACAN or MMP13" . SPARSER::COLLECTION)
    ("the normal chondrocytes" . SPARSER::PROTEIN)
    ("p21 and cartilage matrix–related genes" . SPARSER::COLLECTION)
    ("p-STAT" . SPARSER::COLLECTION) ("STAT3 and MMP-13" . SPARSER::COLLECTION)
    ("hyaline" . SPARSER::PROTEIN) ("DMM" . SPARSER::DRUG)
    ("p21 , ACAN , or MMP13" . SPARSER::COLLECTION)
    ("ACAN and MMP13" . SPARSER::COLLECTION)
    ("COL2A1 , ACAN , MMPs , and ADAMTS" . SPARSER::COLLECTION)
    ("ACAN and catabolic genes" . SPARSER::COLLECTION)
    ("catabolic genes" . SPARSER::GENE) ("p21 and STAT3" . SPARSER::COLLECTION)
    ("proteoglycan" . SPARSER::PROTEIN)
    ("senescence-associated β-galactosidase" . SPARSER::PROTEIN)
    ("p21 and chondrocytes" . SPARSER::COLLECTION)
    ("proteins, E2F, and signal transducer and activator of transcription 3"
     . SPARSER::COLLECTION)
    ("p53, and p21" . SPARSER::COLLECTION)
    ("ADAMTS4 and ADAMTS5" . SPARSER::COLLECTION)
    ("matrix metalloproteinases (MMPs) and a disintegrin and metalloproteinase"
     . SPARSER::COLLECTION)
    ("collagen and ACAN" . SPARSER::COLLECTION)
    ("disintegrin and metalloproteinase" . SPARSER::COLLECTION)
    ("thrombospondin" . SPARSER::PROTEIN) ("disintegrin" . SPARSER::PROTEIN)
    ("collagen and aggrecan (ACAN)" . SPARSER::COLLECTION)
    ("collagen and aggrecan" . SPARSER::COLLECTION) ("ACAN" . SPARSER::PROTEIN)
    ("aggrecan and MMP-13" . SPARSER::COLLECTION)
    ("aggrecan" . SPARSER::PROTEIN) ("chondrocytes" . SPARSER::PROTEIN)
    ("Col2a1" . SPARSER::PROTEIN) ("Safranin O" . SPARSER::DRUG)
    ("p21 protein" . SPARSER::PROTEIN) ("MMP3" . SPARSER::PROTEIN)
    ("COL2A1" . SPARSER::PROTEIN) ("MgC1" . SPARSER::PROTEIN)
    ("type X" . SPARSER::PROTEIN) ("SDF-1" . SPARSER::PROTEIN)
    ("stromal cell–derived factor 1" . SPARSER::PROTEIN)
    ("ADAMTS5" . SPARSER::PROTEIN) ("ADAMTS4" . SPARSER::PROTEIN)
    ("Type II" . SPARSER::HUMAN-PROTEIN-FAMILY) ("MMP-13" . SPARSER::PROTEIN)
    ("DNA fragmentation factor subunit alpha (DFFA)" . SPARSER::PROTEIN)
    ("ICAD" . SPARSER::PROTEIN) ("Inhibitor" . SPARSER::INHIBITOR)
    ("DFFA" . SPARSER::PROTEIN)
    ("-1 and IL-6, and oxygen" . SPARSER::COLLECTION)
    ("IL-6, and oxygen" . SPARSER::COLLECTION)
    ("interleukin" . SPARSER::PROTEIN) ("ligand (TNFSF)" . SPARSER::MOLECULE)
    ("TNFRSF" . SPARSER::PROTEIN)
    ("caspase-activated DNase" . SPARSER::PROTEIN)
    ("DNA fragmentation factor subunit alpha" . SPARSER::PROTEIN)
    ("LRP/LR" . SPARSER::PROTEIN) ("LRP/LR-hTERT" . SPARSER::PROTEIN-PAIR)
    ("TFRC and DICER1" . SPARSER::COLLECTION)
    ("TFRC/DICER1" . SPARSER::COLLECTION)
    ("hTERT and LRP/LR" . SPARSER::COLLECTION)
    ("the fluorescent immuno-labelled proteins" . SPARSER::PROTEIN)
    ("an associated peptide" . SPARSER::PEPTIDE)
    ("siRNA-TFRC/DICER1" . SPARSER::COLLECTION) ("TFRC" . SPARSER::PROTEIN)
    ("siRNA-LAMR1" . SPARSER::COLLECTION)
    ("hTERT and LRP::FLAG" . SPARSER::COLLECTION)
    ("h-TERT (panel A, bound protein) and LRP::FLAG (panel B, bound protein)"
     . SPARSER::COLLECTION)
    ("-M2" . SPARSER::MOLECULE) ("pCIneo-moLRP::FLAG" . SPARSER::BIO-COMPLEX)
    ("M2-" . SPARSER::MOLECULE) ("LRP::FLAG" . SPARSER::BIO-COMPLEX)
    ("hTERT and the integral RNA component, hTR or hTERC [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("the enzymatic reverse transcriptase catalytic subunit, hTERT and the integral RNA component, hTR or hTERC [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("two essential components" . SPARSER::COMPONENT)
    ("component, hTR or hTERC" . SPARSER::COLLECTION) ("hTERC" . SPARSER::RNA)
    ("hTR" . SPARSER::RNA)
    ("a holoenzyme and a cellular ribonucleoprotein" . SPARSER::COLLECTION)
    ("a cellular ribonucleoprotein" . SPARSER::PROTEIN)
    ("holoenzyme" . SPARSER::PROTEIN) ("prion" . SPARSER::PROTEIN-FAMILY)
    ("receptor (LR)" . SPARSER::RECEPTOR) ("37kDa" . SPARSER::PROTEIN)
    ("67kDa" . SPARSER::PROTEIN)
    ("An essential component" . SPARSER::COMPONENT) ("LRP" . SPARSER::PROTEIN)
    ("class1" . SPARSER::PROTEIN-FAMILY) ("DICER1" . SPARSER::PROTEIN)
    ("h-TERT" . SPARSER::PROTEIN) ("LAMR1" . SPARSER::PROTEIN)
    ("laminin-1" . SPARSER::PROTEIN)
    ("ICAM-1 and VCAM-1" . SPARSER::COLLECTION)
    ("ICAM-1, VCAM-1 and E-selectin" . SPARSER::COLLECTION)
    ("LPS and TNF-α" . SPARSER::COLLECTION)
    ("chemokines or cytokines" . SPARSER::COLLECTION)
    ("endothelial nitric oxide synthase" . SPARSER::PROTEIN)
    ("Lysine" . SPARSER::AMINO-ACID)
    ("proinflammatory cytokines and adhesion molecules" . SPARSER::COLLECTION)
    ("GMP" . SPARSER::GMP) ("AICAR and metformin" . SPARSER::COLLECTION)
    ("NF-κB-IκBα" . SPARSER::COLLECTION)
    ("phosphorylated AMPK and its downstream target ACC" . SPARSER::COLLECTION)
    ("retroviral short hairpin RNA" . SPARSER::RNA)
    ("COX-2, ICAM-1 and VCAM-1" . SPARSER::COLLECTION)
    ("IL-6, COX-2, ICAM-1, and VCAM-1" . SPARSER::COLLECTION)
    ("IL-6, COX-2, ICAM-1 and VCAM-1" . SPARSER::COLLECTION)
    ("both AMPK and its downstream target" . SPARSER::COLLECTION)
    ("AMPK and APRT" . SPARSER::COLLECTION)
    ("AMPK and acetyl Co-A carboxylase" . SPARSER::COLLECTION)
    ("pyrophosphate (PRPP)" . SPARSER::MOLECULE) ("PRPP" . SPARSER::MOLECULE)
    ("ribonucleoside (AICAR)" . SPARSER::MOLECULE)
    ("metformin, resveratrol and berberine" . SPARSER::COLLECTION)
    ("berberine" . SPARSER::MOLECULE) ("AICAR" . SPARSER::PROTEIN)
    ("ribonucleoside" . SPARSER::MOLECULE) ("NF-κB-" . SPARSER::PROTEIN)
    ("AMP" . SPARSER::AMP) ("AMPK and ACC" . SPARSER::COLLECTION)
    ("APRT" . SPARSER::PROTEIN) ("Adenine" . SPARSER::NUCLEOBASE)
    ("acetyl Co-A carboxylase (ACC)" . SPARSER::PROTEIN)
    ("ACC" . SPARSER::PROTEIN) ("E-selectin" . SPARSER::PROTEIN)
    ("α1-subunit" . SPARSER::PROTEIN) ("AMPKα1" . SPARSER::PROTEIN)
    ("Adenine phosphoribosyltransferase" . SPARSER::PROTEIN)
    ("5-aminoimidazole-4-carboxamide" . SPARSER::MOLECULE)
    ("glucagon-like peptide" . SPARSER::PROTEIN) ("AMPK α1" . SPARSER::PROTEIN)
    ("acetyl Co-A carboxylase" . SPARSER::PROTEIN)
    ("MDM2/HIF1alpha" . SPARSER::COLLECTION)
    ("TP53 and CDKNA2A" . SPARSER::COLLECTION)
    ("the two main histologic subtypes" . SPARSER::PROTEIN)
    ("merlin" . SPARSER::PROTEIN) ("MDM2-p53" . SPARSER::COLLECTION)
    ("p53 and pRb" . SPARSER::COLLECTION)
    ("the different histologic subtypes" . SPARSER::PROTEIN)
    ("the two MPM histologic subtypes" . SPARSER::PROTEIN)
    ("different histologic types" . TYPE)
    ("MDM2-HIF1alpha" . SPARSER::COLLECTION)
    ("HIF1alpha [ xref ] and VEGF [ xref , xref ]" . SPARSER::COLLECTION)
    ("p16/INK4A" . SPARSER::COLLECTION) ("p14/ARF" . SPARSER::COLLECTION)
    ("INK4A/ARF" . SPARSER::COLLECTION)
    ("/mammalian target of Rapamycin" . SPARSER::COLLECTION)
    ("NFkB" . SPARSER::PROTEIN) ("asbestos" . SPARSER::MOLECULE)
    ("different histologic subtypes" . SPARSER::PROTEIN)
    ("MDM2 and HIF1alpha" . SPARSER::COLLECTION)
    ("date prognostic and tailored therapeutic biomarkers" . SPARSER::MOLECULE)
    ("IF2" . SPARSER::PROTEIN) ("MIB-1" . SPARSER::PROTEIN)
    ("nutlin3a" . SPARSER::DRUG) ("PS 1" . SPARSER::PROTEIN)
    ("Double Minute 2" . SPARSER::PROTEIN) ("INK4A" . SPARSER::PROTEIN)
    ("BAP-1" . SPARSER::PROTEIN)
    ("BRCA1-associated protein" . SPARSER::PROTEIN)
    ("mammalian target of Rapamycin" . SPARSER::PROTEIN)
    ("phosphatidylinositol3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HIF1alpha" . SPARSER::PROTEIN)
    ("the ‘classic’ KIT receptor" . SPARSER::RECEPTOR)
    ("KIT and CDKN1A" . SPARSER::COLLECTION)
    ("the SMARCB1 and SWI/SNF complex" . SPARSER::COLLECTION)
    ("WNT/β-Catenin" . SPARSER::COLLECTION)
    ("cyclin D1/CDK4" . SPARSER::COLLECTION)
    ("the entire arm" . SPARSER::PROTEIN)
    ("proteins and glycoproteins" . SPARSER::COLLECTION)
    ("everolimus and temsirolimus" . SPARSER::COLLECTION)
    ("the upper arm" . SPARSER::PROTEIN)
    ("flavopiridol (Alvocidib or HMR-1275) and palbociclib (PD0332991)"
     . SPARSER::COLLECTION)
    ("HMR" . SPARSER::PROTEIN) ("Alvocidib" . SPARSER::DRUG)
    ("flavopiridol" . SPARSER::DRUG)
    ("p16INK4 and p14ARF" . SPARSER::COLLECTION)
    ("CDK4 and p53" . SPARSER::COLLECTION) ("p16INK4" . SPARSER::PROTEIN)
    ("a well-conserved cyclin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CDK4 or CDK6" . SPARSER::COLLECTION)
    ("the metastatic cohort" . SPARSER::MOLECULE)
    ("CCND2, KRAS, BRAF, ETV1, EGFR, MYCN, SMO and TERT" . SPARSER::COLLECTION)
    ("SMO" . SPARSER::PROTEIN) ("GLI" . SPARSER::PROTEIN)
    ("SMARCB1 ( p = 0,0009) and SMAD4 (not significant)" . SPARSER::COLLECTION)
    ("PTEN ( p = 0,0062), SMARCB1 ( p = 0,0009) and SMAD4 (not significant)"
     . SPARSER::COLLECTION)
    ("chr1 (a protein that negatively regulates ETV1, ETV4 and ETV5) and DMD"
     . SPARSER::COLLECTION)
    ("ETV1, ETV4 and ETV5" . SPARSER::COLLECTION)
    ("STOP" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ARID1A and SMARCB1" . SPARSER::COLLECTION)
    ("CCND2 (CN = 6) and KRAS (CN = 4)" . SPARSER::COLLECTION)
    ("MYCN (CN = 5) and TERT (CN = 6) genes" . SPARSER::COLLECTION)
    ("ETV1 and EGFR" . SPARSER::COLLECTION) ("TERT" . SPARSER::PROTEIN)
    ("MYCN" . SPARSER::PROTEIN) ("the mutated allele" . SPARSER::ALLELE)
    ("the metastatic KIT-mutated GIST group" . SPARSER::MOLECULE)
    ("MEAF6-SEPSECS" . SPARSER::COLLECTION)
    ("DOK6-MYO5B" . SPARSER::COLLECTION) ("SEPSECS" . SPARSER::PROTEIN)
    ("KEAP1 and LATS2" . SPARSER::COLLECTION)
    ("CDKN2A, CDKN1B and PTEN" . SPARSER::COLLECTION)
    ("WTS" . SPARSER::PROTEIN) ("loco" . SPARSER::PROTEIN)
    ("sunitinib and regorafenib" . SPARSER::COLLECTION)
    ("regorafenib" . SPARSER::DRUG) ("sunitinib" . SPARSER::DRUG)
    ("KIT/PDGFRα" . SPARSER::COLLECTION)
    ("KIT or PDGFRα" . SPARSER::COLLECTION)
    ("new targets and novel therapeutics" . SPARSER::COLLECTION)
    ("CCND2 and EGFR" . SPARSER::COLLECTION)
    ("CDKN2A, CDKN2C, SMARCB1, PTEN and DMD" . SPARSER::COLLECTION)
    ("KIT-exon" . SPARSER::COLLECTION) ("KIT and PDGFRα" . SPARSER::COLLECTION)
    ("sonic hedgehog" . SPARSER::PROTEIN) ("X chromosome" . SPARSER::PROTEIN)
    ("p14ARF" . SPARSER::PROTEIN) ("INK4" . SPARSER::PROTEIN)
    ("PHF1" . SPARSER::PROTEIN) ("PTCH1" . SPARSER::PROTEIN)
    ("GLI3" . SPARSER::PROTEIN) ("GLI2" . SPARSER::PROTEIN)
    ("GANT61" . SPARSER::DRUG) ("p32" . SPARSER::PROTEIN)
    ("ETV5" . SPARSER::PROTEIN) ("ETV4" . SPARSER::PROTEIN)
    ("COP1" . SPARSER::PROTEIN) ("ARID1A" . SPARSER::PROTEIN)
    ("KIF1B" . SPARSER::PROTEIN) ("chr1" . SPARSER::PROTEIN)
    ("ETV1" . SPARSER::PROTEIN) ("NuA4" . SPARSER::PROTEIN-FAMILY)
    ("MEAF6" . SPARSER::PROTEIN) ("MYO5B" . SPARSER::PROTEIN)
    ("DOK6" . SPARSER::PROTEIN) ("CDKN1B" . SPARSER::PROTEIN)
    ("LATS2" . SPARSER::PROTEIN) ("SMARCB1" . SPARSER::PROTEIN)
    ("CDKN2C" . SPARSER::PROTEIN) ("PDGFRα" . SPARSER::PROTEIN)
    ("CBP/p300" . SPARSER::COLLECTION) ("polycomb" . SPARSER::PROTEIN)
    ("CBP" . SPARSER::PROTEIN)
    ("a well-defined tumor suppressor" . SPARSER::SUPPRESSOR)
    ("demethylase" . SPARSER::PROTEIN)
    ("Fas mRNA ( xref ) and Fas promoter" . SPARSER::COLLECTION)
    ("5-aza-2" . SPARSER::PROTEIN) ("two major inducers" . SPARSER::MOLECULE)
    ("TNFα and FasL" . SPARSER::COLLECTION) ("-PARP" . SPARSER::COLLECTION)
    ("Nrf1, Nrf2, SREBF1, CREB1, HSF1, EGR1 and ING4" . SPARSER::COLLECTION)
    ("H-Ras or K-Ras" . SPARSER::COLLECTION)
    ("5-aza-2-deoxycytidine" . SPARSER::COLLECTION) ("DNMT" . SPARSER::PROTEIN)
    ("AID (activation induced deaminase) and TDG" . SPARSER::COLLECTION)
    ("TET1 (ten-eleven translocation 1), AID (activation induced deaminase) and TDG"
     . SPARSER::COLLECTION)
    ("AID" . SPARSER::PROTEIN)
    ("thymine-DNA glycosylase (TDG)" . SPARSER::PROTEIN)
    ("DNMTs" . SPARSER::PROTEIN) ("Cytosine" . SPARSER::NUCLEOBASE)
    ("TDG" . SPARSER::PROTEIN) ("H 3 K 27 Me 3" . SPARSER::MOLECULE)
    ("APO-1" . SPARSER::PROTEIN) ("pGL2" . SPARSER::PROTEIN)
    ("PANC-1" . SPARSER::PROTEIN) ("p300" . SPARSER::PROTEIN)
    ("Histone 3" . SPARSER::PROTEIN) ("Caspase3" . SPARSER::PROTEIN)
    ("CREB1" . SPARSER::PROTEIN) ("SREBF1" . SPARSER::PROTEIN)
    ("TET1" . SPARSER::PROTEIN) ("JMJD3" . SPARSER::PROTEIN)
    ("histone lysine demethylase" . SPARSER::PROTEIN)
    ("ING4" . SPARSER::PROTEIN) ("thymine-DNA glycosylase" . SPARSER::PROTEIN)
    ("Aggrus/podoplanin" . SPARSER::COLLECTION)
    ("podoplanin" . SPARSER::PROTEIN) ("Aggrus" . SPARSER::PROTEIN)
    ("This further supports non-invasive RNA" . SPARSER::RNA)
    ("ceritinib or alectinib" . SPARSER::COLLECTION)
    ("free-circulating RNA molecules or low abundance" . SPARSER::COLLECTION)
    ("a 37-year-old" . SPARSER::PROTEIN-PAIR) ("NR" . SPARSER::PROTEIN)
    ("PKH" . SPARSER::PROTEIN)
    ("the cancer-associated RNA biomarkers EGFRvIII and prostate cancer antigen 3"
     . SPARSER::COLLECTION)
    ("EGFRvIII and prostate cancer antigen 3" . SPARSER::COLLECTION)
    ("EGFRvIII" . SPARSER::PROTEIN)
    ("crizotinib, ceritinib, and alectinib" . SPARSER::COLLECTION)
    ("alectinib" . SPARSER::DRUG) ("ceritinib" . SPARSER::DRUG)
    ("gefitinib, erlotinib and afatinib" . SPARSER::COLLECTION)
    ("e6" . SPARSER::HUMAN-PROTEIN-FAMILY) ("a20" . SPARSER::PROTEIN)
    ("DNAse-I" . SPARSER::PROTEIN)
    ("vascular endothelial growth factor A" . SPARSER::PROTEIN)
    ("CLEC-2" . SPARSER::PROTEIN) ("PCA3" . SPARSER::RNA)
    ("prostate cancer antigen 3" . SPARSER::RNA)
    ("KRAS/NRAS/HRAS" . SPARSER::COLLECTION)
    ("AZD6244 and the AKT inhibitor MK2206" . SPARSER::COLLECTION)
    ("RAS- or BRAF-mutant" . SPARSER::COLLECTION)
    ("RAS-" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Ib" . SPARSER::DRUG)
    ("Trametinib" . SPARSER::DRUG) ("the dual PI3K/mTOR" . SPARSER::COLLECTION)
    ("possible drugs" . SPARSER::DRUG) ("PI3K or mTOR" . SPARSER::COLLECTION)
    ("HRAS and NRAS" . SPARSER::COLLECTION)
    ("HRAS, NRAS, BRAF, ERBB2, MET, MAP2K1 and RIT1" . SPARSER::COLLECTION)
    ("receptor tyrosine kinase (RTK) and RAS pathway oncogenes"
     . SPARSER::COLLECTION)
    ("EGFR and KRAS" . SPARSER::COLLECTION)
    ("AZD6244 and Everolimus" . SPARSER::COLLECTION)
    ("AZD6244 or Everolimus" . SPARSER::COLLECTION)
    ("MEK162 or Everolimus" . SPARSER::COLLECTION)
    ("mTOR and MEK" . SPARSER::COLLECTION)
    ("Everolimus and AZD6244 or MEK162" . SPARSER::COLLECTION)
    ("AZD6244 or MEK162" . SPARSER::COLLECTION)
    ("Everolimus and MEK" . SPARSER::COLLECTION)
    ("The clinically available mTOR inhibitor Everolimus" . SPARSER::MOLECULE)
    ("basal AKT" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("AZD6244 and MEK162" . SPARSER::COLLECTION)
    ("AZD6244 (Selumetinib) and MEK162 (Binimetinib)" . SPARSER::COLLECTION)
    ("Binimetinib" . SPARSER::DRUG) ("Selumetinib" . SPARSER::DRUG)
    ("KNS" . SPARSER::PROTEIN) ("MEK and PI3K" . SPARSER::COLLECTION)
    ("NSCL" . SPARSER::PROTEIN) ("Histological subtypes" . SPARSER::PROTEIN)
    ("RAS–RAF–MEK–ERK" . SPARSER::COLLECTION)
    ("Harvey-RAS" . SPARSER::COLLECTION) ("GTPases" . SPARSER::GTPASE)
    ("RAS and mTOR" . SPARSER::COLLECTION)
    ("MEK and mTOR" . SPARSER::COLLECTION)
    ("AZD6244, MEK162 and PD0325901" . SPARSER::COLLECTION)
    ("HRAS" . SPARSER::PROTEIN) ("3d" . SPARSER::PROTEIN-FAMILY)
    ("PI3K inhibitor BYL719" . SPARSER::DRUG) ("BKM120" . SPARSER::DRUG)
    ("RIT1" . SPARSER::PROTEIN) ("MAP2K1" . SPARSER::PROTEIN)
    ("interleukin-3" . SPARSER::PROTEIN)
    ("S6 kinase" . SPARSER::PROTEIN-FAMILY) ("BYL719" . SPARSER::DRUG)
    ("PI3K inhibitor BKM120" . SPARSER::DRUG) ("RO5126766" . SPARSER::DRUG)
    ("Mitogen-activated protein kinase kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("RAS family" . SPARSER::PROTEIN) ("MEK162" . SPARSER::DRUG)
    ("these genes [ xref ] or complete exomes or genomes"
     . SPARSER::COLLECTION)
    ("only 2 A5 homopolymer" . SPARSER::MOLECULE)
    ("homopolymer" . SPARSER::MOLECULE) ("Tech" . SPARSER::PROTEIN)
    ("A recently developed enzyme" . SPARSER::ENZYME)
    ("homopolymers" . SPARSER::MOLECULE) ("mononucleotide" . SPARSER::MOLECULE)
    ("all available primate BRCA1 and BRCA2 amino acid" . SPARSER::AMINO-ACID)
    ("BRCA1 and E1308X" . SPARSER::COLLECTION) ("c" . SPARSER::PROTEIN)
    ("premature stop codon alleles" . SPARSER::ALLELE)
    ("Variants" . SPARSER::VARIANT) ("VCs" . SPARSER::MOLECULE)
    ("Variant" . SPARSER::VARIANT) ("BAM" . SPARSER::PROTEIN)
    ("PGM" . SPARSER::PROTEIN) ("Ion" . SPARSER::MOLECULE)
    ("poly-ADP" . SPARSER::PROTEIN)
    ("estrogen, progesterone, and HER2" . SPARSER::COLLECTION)
    ("mTOR and Wnt" . SPARSER::COLLECTION)
    ("family and MET" . SPARSER::COLLECTION)
    ("AKT and p-S6" . SPARSER::COLLECTION)
    ("MET inhibitor and RAF inhibitor" . SPARSER::COLLECTION)
    ("fusion-activated BRAF" . SPARSER::PROTEIN)
    ("PHA665752 and PI-103" . SPARSER::COLLECTION)
    ("p-MET" . SPARSER::COLLECTION) ("MET and PI3K" . SPARSER::COLLECTION)
    ("antibodies or biological antagonists" . SPARSER::COLLECTION)
    ("biological antagonists" . SPARSER::MOLECULE) ("RTK" . SPARSER::PROTEIN)
    ("the receptor and downstream signaling proteins" . SPARSER::COLLECTION)
    ("transmembrane glycoproteins" . SPARSER::PROTEIN)
    ("glycoproteins" . SPARSER::PROTEIN)
    ("study PI3K p110α ’s" . SPARSER::PROTEIN) ("aims" . SPARSER::PROTEIN)
    ("p-ERK" . SPARSER::PROTEIN) ("B-raf" . SPARSER::PROTEIN)
    ("DNA-dependent protein kinase" . SPARSER::PROTEIN)
    ("PI-103" . SPARSER::DRUG) ("p110 α" . SPARSER::PROTEIN)
    ("Receptor tyrosine kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PHA665752" . SPARSER::MOLECULE)
    ("crizotinib and DIDS" . SPARSER::COLLECTION) ("Multi" . SPARSER::PROTEIN)
    ("succinic dehydrogenase and F 0 F 1 -ATP synthase [ xref ]"
     . SPARSER::COLLECTION)
    ("succinic dehydrogenase" . SPARSER::PROTEIN)
    ("-ATP synthase" . SPARSER::COLLECTION)
    ("DIDS and H2DIDS inhibited HGF-mediated phenotypes" . SPARSER::COLLECTION)
    ("5 μM DIDS and H2DIDS" . SPARSER::COLLECTION)
    ("complete media" . SPARSER::PROTEIN)
    ("that DIDS and H2DIDS" . SPARSER::COLLECTION)
    ("a unique collective form" . SPARSER::FORM)
    ("EGF and HGF" . SPARSER::COLLECTION)
    ("DIDS and H2DIDS" . SPARSER::COLLECTION)
    ("EGFR or IGFR" . SPARSER::COLLECTION)
    ("DIDS and H2DIDS known to inhibit c-Met activation" . SPARSER::COLLECTION)
    ("DIDS and H2DIDS consistently demonstrated" . SPARSER::COLLECTION)
    ("isothiocyanate" . SPARSER::MOLECULE) ("anion" . SPARSER::MOLECULE)
    ("anti-HGF and anti-c-Met antibodies, HGF and c-Met competitive antagonists"
     . SPARSER::MOLECULE)
    ("anti-HGF and anti-c-Met" . SPARSER::COLLECTION)
    ("antibodies, HGF and c-Met" . SPARSER::COLLECTION)
    ("c-Met or HGF" . SPARSER::COLLECTION)
    ("ROS proto-oncogene 1, receptor tyrosine kinase (ROS1) and anaplastic lymphoma kinase (ALK)"
     . SPARSER::COLLECTION)
    ("crizotinib (Xalkori; Pfizer) and cabozantinib (Cometriq; Exelixis)"
     . SPARSER::COLLECTION)
    ("cabozantinib" . SPARSER::DRUG) ("Xalkori" . SPARSER::DRUG)
    ("DIDS and H2DIDS reduced hepatocyte growth factor (HGF)-induced"
     . SPARSER::COLLECTION)
    ("-dinitrostilbene-2" . SPARSER::COLLECTION)
    ("acetamido" . SPARSER::MOLECULE) ("DIDS" . SPARSER::MOLECULE)
    ("HGFR or c-Met" . SPARSER::COLLECTION) ("HGFR" . SPARSER::PROTEIN)
    ("Phenol Red" . SPARSER::DRUG) ("- 2" . SPARSER::PROTEIN)
    ("acetamido group" . SPARSER::MOLECULE) ("VEGFR2" . SPARSER::PROTEIN)
    ("vascular endothelial growth factor receptor 2" . SPARSER::PROTEIN)
    ("ROS proto-oncogene 1, receptor tyrosine kinase" . SPARSER::PROTEIN)
    ("SU11274" . SPARSER::DRUG)
    ("receptor tyrosine kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("spikes" . SPARSER::PROTEIN) ("Nrf2 and Keap1" . SPARSER::COLLECTION)
    ("c-neu" . SPARSER::PROTEIN-PAIR) ("Tamoxifen" . SPARSER::MOLECULE)
    ("mt-catalase" . SPARSER::COLLECTION)
    ("Nrf2-luciferase" . SPARSER::COLLECTION)
    ("exogenous H 2 O 2" . SPARSER::DRUG)
    ("Keap1 and Nrf2" . SPARSER::COLLECTION) ("Dimedone" . SPARSER::DRUG)
    ("dimedone" . SPARSER::DRUG)
    ("glutathione peroxidase 1, GPx-1, and thioredoxin reductase"
     . SPARSER::COLLECTION)
    ("Nrf2 and MnSOD" . SPARSER::COLLECTION)
    ("Cav-1/MnSOD" . SPARSER::COLLECTION) ("TMA" . SPARSER::MOLECULE)
    ("Cav-1 and Nrf2" . SPARSER::COLLECTION)
    ("more invasive forms" . SPARSER::FORM)
    ("high Cav-1 and low MnSOD" . SPARSER::COLLECTION)
    ("more aggressive forms" . SPARSER::FORM) ("/MnSOD" . SPARSER::COLLECTION)
    ("an active regulator" . SPARSER::REGULATOR)
    ("Cav-1 and MnSOD" . SPARSER::COLLECTION) ("Er/Src" . SPARSER::COLLECTION)
    ("MnSOD" . SPARSER::PROTEIN)
    ("an indispensable component" . SPARSER::COMPONENT)
    ("Hydrogen Peroxide" . SPARSER::MOLECULE) ("NRF2" . SPARSER::PROTEIN)
    ("Ad5" . SPARSER::PROTEIN) ("Keap-1" . SPARSER::PROTEIN)
    ("Nrf-2" . SPARSER::PROTEIN) ("PFK2" . SPARSER::PROTEIN)
    ("thioredoxin reductase" . SPARSER::PROTEIN) ("GPx-1" . SPARSER::PROTEIN)
    ("glutathione peroxidase 1" . SPARSER::PROTEIN) ("– 3" . SPARSER::PROTEIN)
    ("– 2" . SPARSER::PROTEIN) ("NF-E2-related factor 2" . SPARSER::PROTEIN)
    ("Cav-1" . SPARSER::PROTEIN) ("aura" . SPARSER::PROTEIN)
    ("an anticonvulsant and mood stabilizer approved by FDA"
     . SPARSER::COLLECTION)
    ("valproate (VPA)" . SPARSER::DRUG) ("stabilizer" . SPARSER::MOLECULE)
    ("anticonvulsant" . SPARSER::DRUG) ("VPA" . SPARSER::PROTEIN)
    ("methamphetamine" . SPARSER::DRUG)
    ("drug, or alcohol" . SPARSER::COLLECTION) ("valproate" . SPARSER::DRUG)
    ("intense chronic migraine" . SPARSER::PROTEIN)
    ("analgesics" . SPARSER::DRUG) ("protein expressed in" . SPARSER::PROTEIN)
    ("Ras/Raf/ERK" . SPARSER::COLLECTION)
    ("PKM2 or molecules" . SPARSER::COLLECTION)
    ("PKM2/STAT3" . SPARSER::COLLECTION)
    ("gefitinib, Stattic and gefitinib" . SPARSER::COLLECTION)
    ("p27Kip1 and caspase-3" . SPARSER::COLLECTION)
    ("EGFR and gefitinib" . SPARSER::COLLECTION)
    ("STAT3 and EGFR" . SPARSER::COLLECTION)
    ("KRAS, BRAF, PIK3CA, and phosphatase and tensin homolog"
     . SPARSER::COLLECTION)
    ("Stattic and gefitinib" . SPARSER::COLLECTION) ("nick" . SPARSER::PROTEIN)
    ("dUTP" . SPARSER::MOLECULE)
    ("siRNA or the small molecule inhibitor Stattic" . SPARSER::COLLECTION)
    ("a Flag-tagged STAT3 mutant (Y705A) and HA-NLS-PKM2"
     . SPARSER::COLLECTION)
    ("gefitinib and PKM2" . SPARSER::COLLECTION)
    ("cyclin D1 and p27Kip1" . SPARSER::COLLECTION)
    ("DNA-intercalating" . SPARSER::DNA)
    ("nonspecific shRNA" . SPARSER::PROTEIN)
    ("a possible molecular target" . SPARSER::TARGET-PROTEIN)
    ("EGFR and STAT3" . SPARSER::COLLECTION)
    ("OCT-4, HIF-1α, cyclin D1 and c-Myc" . SPARSER::COLLECTION)
    ("tetramer" . SPARSER::TETRAMER) ("PEP" . SPARSER::DRUG)
    ("phosphoenolpyruvate" . SPARSER::MOLECULE)
    ("kinase (PK)" . SPARSER::KINASE) ("Pyruvate" . SPARSER::PROTEIN)
    ("Gao" . SPARSER::PROTEIN)
    ("the upstream receptor and/or non-receptor kinases" . SPARSER::COLLECTION)
    ("kinases (JAK)" . SPARSER::PROTEIN) ("Janus" . SPARSER::PROTEIN-FAMILY)
    ("many new biomarkers" . SPARSER::MOLECULE) ("Iressa" . SPARSER::DRUG)
    ("L15" . SPARSER::PROTEIN) ("p27Kip1" . SPARSER::PROTEIN)
    ("OCT-4" . SPARSER::PROTEIN)
    ("isoleucine or phenylalanine" . SPARSER::COLLECTION)
    ("phenylalanine" . SPARSER::AMINO-ACID)
    ("isoleucine" . SPARSER::AMINO-ACID)
    ("causative MTOR missense variants" . SPARSER::VARIANT)
    ("ESP" . SPARSER::PROTEIN) ("clamp" . SPARSER::PROTEIN-FAMILY)
    ("salt" . SPARSER::MOLECULE)
    ("structurally adjacent MTOR" . SPARSER::PROTEIN)
    ("Arginine" . SPARSER::AMINO-ACID) ("clamps" . SPARSER::PROTEIN-FAMILY)
    ("external growth and development cues" . SPARSER::PROTEIN-FAMILY)
    ("4E-PB1 and AKT" . SPARSER::COLLECTION) ("PB1" . SPARSER::PROTEIN)
    ("ribosomal P70 S6 Kinase" . SPARSER::KINASE)
    ("heterozygous Phosphatidylinositol 3-Kinase"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Neurotensin (NT)" . SPARSER::PROTEIN) ("Neurotensin" . SPARSER::PROTEIN)
    ("toxins" . SPARSER::MOLECULE) ("allergens" . SPARSER::MOLECULE)
    ("mast cell" . SPARSER::PROTEIN)
    ("approximately 11,000 variants" . SPARSER::VARIANT)
    ("synonymous variants" . SPARSER::VARIANT)
    ("non-splice-related intronic variants" . SPARSER::VARIANT)
    ("trio-DES" . SPARSER::COLLECTION) ("normal PTEN" . SPARSER::PROTEIN)
    ("CGH" . SPARSER::PROTEIN) ("mild ASD" . SPARSER::PROTEIN)
    ("diazoxide" . SPARSER::DRUG) ("pathogenic variants" . SPARSER::VARIANT)
    ("focal cortical malformations (FCM)" . SPARSER::PROTEIN)
    ("FCM" . SPARSER::MOLECULE)
    ("ribosomal P70 S6 (S6) and ribosomal P70 S6 kinase (S6K)"
     . SPARSER::COLLECTION)
    ("ribosomal P70 S6 kinase" . SPARSER::KINASE)
    ("ribosomal P70 S6" . SPARSER::PROTEIN) ("-MTOR" . SPARSER::COLLECTION)
    ("–AKT" . SPARSER::COLLECTION) ("Homologue" . SPARSER::PROTEIN)
    ("This exact variant" . SPARSER::VARIANT) ("iris" . SPARSER::PROTEIN)
    ("ASD" . SPARSER::PROTEIN) ("family-trio" . SPARSER::PROTEIN)
    ("DES" . SPARSER::PROTEIN) ("at least 800 proteins" . SPARSER::PROTEIN)
    ("Glutamic acid" . SPARSER::AMINO-ACID) ("S6K1" . SPARSER::PROTEIN)
    ("4E-Binding Protein 1" . SPARSER::PROTEIN)
    ("AKT/ Protein" . SPARSER::PROTEIN) ("PIK3R1" . SPARSER::PROTEIN)
    ("Regulatory Subunit 1" . SPARSER::PROTEIN)
    ("Phosphatidylinositol 3-Kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("OPHN1" . SPARSER::PROTEIN) ("Oligophrenin-1" . SPARSER::PROTEIN)
    ("Y-linked" . SPARSER::PROTEIN) ("P70 S6" . SPARSER::PROTEIN)
    ("AKT/Protein" . SPARSER::PROTEIN)
    ("Phosphoinositide 3-Kinase" . SPARSER::PROTEIN)
    ("serine/ threonine protein kinase" . SPARSER::PROTEIN)
    ("Mammalian Target of Rapamycin" . SPARSER::PROTEIN)
    ("Chen" . SPARSER::PROTEIN)
    ("HOXA9, AML1, MLL and RAR α" . SPARSER::COLLECTION)
    ("FLT3, ABL, RAS, KIT and CDK6" . SPARSER::COLLECTION)
    ("HuR and let-7" . SPARSER::COLLECTION)
    ("HuR and miR" . SPARSER::COLLECTION)
    ("the post-transcriptional regulatory network much more complex"
     . SPARSER::BIO-COMPLEX)
    ("ELAVL1, AUF1, KHSRP and Nucleolin" . SPARSER::COLLECTION)
    ("NCL" . SPARSER::PROTEIN) ("Nucleolin" . SPARSER::PROTEIN)
    ("KHSRP" . SPARSER::PROTEIN) ("at least three classes" . CLASS)
    ("proto-oncogenes and nuclear transcription factors xref"
     . SPARSER::COLLECTION)
    ("labile" . SPARSER::PROTEIN) ("RBP-ZFP36L1" . SPARSER::COLLECTION)
    ("many RBPs and other proteins" . SPARSER::COLLECTION)
    ("noncoding RNAs and RBPs xref  xref  xref  xref" . SPARSER::COLLECTION)
    ("CD14 and CD11B" . SPARSER::COLLECTION)
    ("a repressive regulator" . SPARSER::REGULATOR)
    ("lenti-CDK6" . SPARSER::COLLECTION)
    ("protein and CDK6" . SPARSER::COLLECTION)
    ("ARE-site" . SPARSER::ANTI-OXIDANT-RESPONSE-ELEMENT)
    ("AREs and its deleted form (CDK6-Del)" . SPARSER::COLLECTION)
    ("its deleted form" . SPARSER::FORM) ("lenti" . SPARSER::PROTEIN)
    ("CD11B, CD14 and CSF1R" . SPARSER::COLLECTION)
    ("lenti-ctrl" . SPARSER::COLLECTION)
    ("ZFP36L1 (lenti-shZFP36L1) or ZFP36L1 (lenti-ZFP36L1)"
     . SPARSER::COLLECTION)
    ("lenti-ZFP36L1" . SPARSER::COLLECTION)
    ("ZFP36 and ZFP36L2" . SPARSER::COLLECTION)
    ("ZFP36L1, ZFP36 and ZFP36L2" . SPARSER::COLLECTION)
    ("the mRNA ( xref ) and protein ( xref )" . SPARSER::COLLECTION)
    ("ATRA" . SPARSER::DRUG) ("ZFP36L1 and CDK6" . SPARSER::COLLECTION)
    ("ZFP36L1 and ZFP36" . SPARSER::COLLECTION)
    ("erythroid" . SPARSER::PROTEIN)
    ("T lymphoblastic leukemia" . SPARSER::PROTEIN)
    ("platelets" . SPARSER::PROTEIN)
    ("ZFP36L1 and ZFP36L2" . SPARSER::COLLECTION)
    ("VEGF and BCL2" . SPARSER::COLLECTION)
    ("adesine-uridine (AU)" . SPARSER::COLLECTION)
    ("adesine-uridine" . SPARSER::COLLECTION)
    ("Cys-Cys-Cys-His" . SPARSER::COLLECTION) ("TZF" . SPARSER::PROTEIN)
    ("ZFP36L2/TIS11D" . SPARSER::COLLECTION)
    ("ZFP36/TIS11" . SPARSER::COLLECTION)
    ("12-O-tetradecanoylphorbol-13-acetate (TPA)" . SPARSER::DRUG)
    ("ester" . SPARSER::MOLECULE) ("RBPs and ncRNAs" . SPARSER::COLLECTION)
    ("RBPs and RNAs" . SPARSER::COLLECTION) ("ncRNAs" . SPARSER::RNA)
    ("Approximately 1000 genes" . SPARSER::GENE)
    ("diverse RBPs" . SPARSER::PROTEIN) ("RNP" . SPARSER::PROTEIN)
    ("adenine-uridine" . SPARSER::PROTEIN) ("uridine" . SPARSER::PROTEIN)
    ("HSPCs" . SPARSER::PROTEIN) ("RNA-Binding Protein" . SPARSER::PROTEIN)
    ("A-1" . SPARSER::PROTEIN) ("CER1" . SPARSER::PROTEIN)
    ("RAR α" . SPARSER::PROTEIN) ("HOXA9" . SPARSER::PROTEIN)
    ("NCL 3" . SPARSER::PROTEIN) ("AUF1" . SPARSER::PROTEIN)
    ("ELAVL1" . SPARSER::PROTEIN)
    ("transcriptional regulators" . SPARSER::PROTEIN-FAMILY)
    ("CD11B" . SPARSER::PROTEIN) ("protein 4.1" . SPARSER::PROTEIN)
    ("stat5b" . SPARSER::PROTEIN) ("CCR4" . SPARSER::PROTEIN)
    ("TIS11D" . SPARSER::PROTEIN) ("ZFP36L2" . SPARSER::PROTEIN)
    ("TIS11" . SPARSER::PROTEIN)
    ("12-O-tetradecanoylphorbol-13-acetate" . SPARSER::DRUG)
    ("TIS11B" . SPARSER::PROTEIN) ("single-stranded RNA" . SPARSER::RNA)
    ("ZFP36" . SPARSER::PROTEIN) ("ZFP36L1" . SPARSER::PROTEIN)
    ("ATR-Chk1/ATM-Chk2" . SPARSER::COLLECTION)
    ("n -ethyl- n -nitrosourea (ENU)" . SPARSER::MOLECULE)
    ("ENU" . SPARSER::MOLECULE) ("PLK3 and GADD45a" . SPARSER::COLLECTION)
    ("Chk2 and CDK4" . SPARSER::COLLECTION)
    ("DNA damage-inducible transcript 3" . SPARSER::PROTEIN)
    ("FOS" . SPARSER::PROTEIN) ("a Chk1’s" . SPARSER::PROTEIN)
    ("SET , histone H2B, and histone" . SPARSER::COLLECTION)
    ("FANCD2, Claspin , and CDK2" . SPARSER::COLLECTION)
    ("ATM/ATR" . SPARSER::COLLECTION) ("c-Jun/c-Fos" . SPARSER::COLLECTION)
    ("Claspin" . SPARSER::PROTEIN) ("SET" . SPARSER::PROTEIN)
    ("NDPK" . SPARSER::PROTEIN) ("TrCP" . SPARSER::PROTEIN)
    ("GEP" . SPARSER::PROTEIN)
    ("forms characteristic nuclear foci" . SPARSER::PROTEIN)
    ("phosphorylated Cdc25c (Ser216) and Cdc2 (Tyr 15)" . SPARSER::COLLECTION)
    ("Cdc25C and cyclin-dependent kinase" . SPARSER::COLLECTION)
    ("ATR/ATM" . SPARSER::COLLECTION)
    ("Chk2, and Cdc25C" . SPARSER::COLLECTION)
    ("Chk1 (Ser345) and Cdc25c (Ser216)" . SPARSER::COLLECTION)
    ("Cdc25c" . SPARSER::PROTEIN) ("SUP-B15" . SPARSER::COLLECTION)
    ("REH" . SPARSER::PROTEIN) ("SUP" . SPARSER::PROTEIN)
    ("gemcitabine and carboplatin" . SPARSER::COLLECTION)
    ("ATP-competitive, small-molecule inhibitor of Chk1, synthesized by Pfizer"
     . SPARSER::ATP)
    ("ATP-competitive, small-molecule inhibitor of Chk1," . SPARSER::ATP)
    ("Cdc25A and Cdc25C" . SPARSER::COLLECTION)
    ("the transducers ataxia telangiectasia mutated (ATM) and ataxia telangiectasia and Rad3-related protein (ATR)"
     . SPARSER::COLLECTION)
    ("ataxia telangiectasia mutated (ATM)" . SPARSER::PROTEIN)
    ("Chk2 and Chk1" . SPARSER::COLLECTION) ("ATM-Chk2" . SPARSER::COLLECTION)
    ("ATR-Chk1" . SPARSER::COLLECTION) ("Chk" . SPARSER::PROTEIN)
    ("Acute lymphoblastic leukemia" . SPARSER::PROTEIN)
    ("acute lymphoblastic leukemia" . SPARSER::PROTEIN)
    ("Chk1-Cdc25-Cdc2" . SPARSER::COLLECTION)
    ("Chk1 and Chk2" . SPARSER::COLLECTION)
    ("l -glutamine" . SPARSER::MOLECULE) ("PLK3" . SPARSER::PROTEIN)
    ("activating protein" . SPARSER::PROTEIN) ("DDIT3" . SPARSER::PROTEIN)
    ("transcript 3" . SPARSER::PROTEIN) ("FANCD2" . SPARSER::PROTEIN)
    ("GADD45a" . SPARSER::PROTEIN) ("PHAP1" . SPARSER::PROTEIN)
    ("granzyme A" . SPARSER::PROTEIN) ("NCOA3" . SPARSER::PROTEIN)
    ("CARM1" . SPARSER::PROTEIN) ("ESR1" . SPARSER::PROTEIN)
    ("estrogen receptor 1" . SPARSER::PROTEIN) ("14-3-3" . SPARSER::PROTEIN)
    ("S3-A" . SPARSER::PROTEIN) ("B15" . SPARSER::PROTEIN)
    ("Cdc25A" . SPARSER::PROTEIN)
    ("ataxia telangiectasia and Rad3-related protein" . SPARSER::PROTEIN)
    ("Cdc25" . SPARSER::PROTEIN)
    ("n -ethyl- n -nitrosourea" . SPARSER::MOLECULE)
    ("checkpoint kinase 1" . SPARSER::PROTEIN) ("PF-00477736" . SPARSER::DRUG)
    ("β-catenin and its downstream target Cyclin D1" . SPARSER::COLLECTION)
    ("symmetrical dimethylarginine" . SPARSER::DRUG)
    ("asymmetrical dimethylarginine" . SPARSER::DRUG)
    ("PRMT1, PRMT3, PRMT4, and PRMT6" . SPARSER::COLLECTION)
    ("sDMA" . SPARSER::MOLECULE) ("aDMA" . SPARSER::MOLECULE)
    ("dimethylarginine" . SPARSER::DRUG)
    ("type I or type II" . SPARSER::COLLECTION)
    ("TCF/LEF" . SPARSER::COLLECTION)
    ("Annexin V-FITC/propidium iodide staining and flow cytometry"
     . SPARSER::COLLECTION)
    ("Bax and Bcl-2" . SPARSER::COLLECTION)
    ("β-catenin and Cyclin D1" . SPARSER::COLLECTION)
    ("PRMT5 and PRMT7" . SPARSER::COLLECTION)
    ("si-PRMT5" . SPARSER::COLLECTION) ("NATs" . SPARSER::PROTEIN)
    ("β-catenin and its downstream effector Cyclin D1" . SPARSER::COLLECTION)
    ("Sorafenib" . SPARSER::DRUG)
    ("β-catenin and the downstream effector Cyclin D1" . SPARSER::COLLECTION)
    ("AMI-1 (a small molecule inhibitor of PRMTs) or small interference RNA (siRNA)"
     . SPARSER::COLLECTION)
    ("PRMT" . SPARSER::PROTEIN) ("PRMT6" . SPARSER::PROTEIN)
    ("PRMT4" . SPARSER::PROTEIN) ("PRMT3" . SPARSER::PROTEIN)
    ("PRMT1" . SPARSER::PROTEIN) ("chemo-attractant" . SPARSER::PROTEIN)
    ("CTNNB1" . SPARSER::PROTEIN) ("PRMT7" . SPARSER::PROTEIN)
    ("inhibitor 1" . SPARSER::PROTEIN) ("H4R" . SPARSER::PROTEIN)
    ("AMI-1" . SPARSER::PROTEIN) ("PRMT5" . SPARSER::PROTEIN)
    ("Protein arginine methyltransferase 5" . SPARSER::PROTEIN)
    ("residual (24 h post-IR) foci" . SPARSER::PROTEIN)
    ("highly specific monoclonal antibodies" . SPARSER::ANTIBODY)
    ("radiation-induced foci" . SPARSER::PROTEIN) ("van" . SPARSER::PROTEIN)
    ("FU" . SPARSER::PROTEIN) ("bad" . SPARSER::PROTEIN)
    ("residual 53BP1 foci" . SPARSER::PROTEIN)
    ("radiation-induced 53BP1 foci" . SPARSER::PROTEIN)
    ("rays" . SPARSER::PROTEIN) ("Ataxia" . SPARSER::PROTEIN)
    ("TRG" . SPARSER::PROTEIN) ("γ-H2AX and 53BP1" . SPARSER::COLLECTION)
    ("S1B" . SPARSER::PROTEIN) ("of 45 " . SPARSER::PROTEIN)
    ("A-D" . SPARSER::PROTEIN) ("or 2 " . SPARSER::MOLECULE)
    ("TRG 1" . SPARSER::PROTEIN) ("TRG 3" . SPARSER::PROTEIN)
    ("many classic oncogenes" . SPARSER::ONCOGENE)
    ("SPHK1 mRNA as well as its production S1P" . SPARSER::COLLECTION)
    ("pGL3-E2F1-mut" . SPARSER::COLLECTION) ("pGL3-E2F1" . SPARSER::COLLECTION)
    ("proteins and SPHK1" . SPARSER::COLLECTION)
    ("si-E2F1-2" . SPARSER::COLLECTION) ("si-E2F1-1" . SPARSER::COLLECTION)
    ("si-SPHK1-2" . SPARSER::COLLECTION) ("si-SPHK1-1" . SPARSER::COLLECTION)
    ("monocyte chemoattractant protein 1 (MCP1) and SPHK1 [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("Sphingosine kinase/S1P/S1P" . SPARSER::COLLECTION)
    ("a conservative enzyme" . SPARSER::ENZYME)
    ("sphingolipid" . SPARSER::MOLECULE)
    ("vascular endothelial growth factor (VEGF) and fibroblast growth factor (FGF) families"
     . SPARSER::COLLECTION)
    ("tilt" . SPARSER::DRUG) ("RXRA" . SPARSER::PROTEIN)
    ("si-SPHK1" . SPARSER::COLLECTION) ("CAM" . SPARSER::PROTEIN)
    ("phosphoglycerate kinase 1" . SPARSER::PROTEIN)
    ("MCP1" . SPARSER::PROTEIN)
    ("monocyte chemoattractant protein 1" . SPARSER::PROTEIN)
    ("TGF-βR" . SPARSER::PROTEIN)
    ("transforming growth factor-beta receptor" . SPARSER::PROTEIN)
    ("SPHK2" . SPARSER::PROTEIN) ("Sphingosine kinase" . SPARSER::PROTEIN)
    ("Sphingosine kinase 1" . SPARSER::PROTEIN)
    ("Sphingosine-1-phosphate" . SPARSER::DRUG) ("p18" . SPARSER::PROTEIN)
    ("S1P" . SPARSER::PROTEIN) ("sphingosine-1-phosphate" . SPARSER::DRUG)
    ("SPHK1" . SPARSER::PROTEIN) ("sphingosine kinase 1" . SPARSER::PROTEIN)
    ("ER−" . SPARSER::PROTEIN) ("polymer" . SPARSER::MOLECULE)
    ("c-Jun, which is the fundamental member and the most potent transcriptional activator of the AP-1 family [ xref ]"
     . SPARSER::COLLECTION)
    ("E-cadherin, N-cadherin, MMP-2 and MMP-9" . SPARSER::COLLECTION)
    ("two EMT-associated proteins" . SPARSER::PROTEIN)
    ("COX-2 and c-Jun" . SPARSER::COLLECTION)
    ("c-Jun and COX-2" . SPARSER::COLLECTION)
    ("ERK and p -ERK" . SPARSER::COLLECTION)
    ("NFκB (p50) and c-Jun" . SPARSER::COLLECTION)
    ("NFκB and c-Jun" . SPARSER::COLLECTION)
    ("LPS (2mg/ml) and palbociclib (7.5 μM)" . SPARSER::COLLECTION)
    ("celecoxib and LPS" . SPARSER::COLLECTION) ("Celecoxib" . SPARSER::DRUG)
    ("Sigma's" . SPARSER::PROTEIN-FAMILY) ("Sigma" . SPARSER::PROTEIN-FAMILY)
    ("celecoxib" . SPARSER::DRUG) ("Vimentin and Snail" . SPARSER::COLLECTION)
    ("Vimentin" . SPARSER::PROTEIN)
    ("the relatively wider gap" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("gap" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("E-cadherin, occludins and claudins" . SPARSER::COLLECTION)
    ("vimentin and N-cadherin" . SPARSER::COLLECTION)
    ("claudins" . SPARSER::PROTEIN)
    ("Palbociclib and anti-estrogen" . SPARSER::COLLECTION)
    ("letrozole" . SPARSER::DRUG) ("TRIO" . SPARSER::PROTEIN)
    ("c-Jun/COX-2" . SPARSER::COLLECTION)
    ("vimentin and Snail" . SPARSER::COLLECTION)
    ("Palbociclib" . SPARSER::DRUG) ("streptavidin-agarose" . SPARSER::DRUG)
    ("p -Rb" . SPARSER::PROTEIN) ("C-Jun" . SPARSER::PROTEIN)
    ("p -ERK" . SPARSER::PROTEIN) ("c -Jun" . SPARSER::PROTEIN)
    ("Cyclooxygenase-2" . SPARSER::PROTEIN) ("FOX2" . SPARSER::PROTEIN)
    ("PD0332991" . SPARSER::DRUG) ("PGE2" . SPARSER::DRUG)
    ("the specific inhibitors idelalisib (PI3Kδ) or sotrastaurin (PKCβ)"
     . SPARSER::COLLECTION)
    ("the BH3-mimetic MIM1" . SPARSER::PROTEIN)
    ("PI3Kδ-PKCβ/NF-κB-STAT3/Mcl-1" . SPARSER::COLLECTION)
    ("the pro-apoptotic members Bim, Bax, Noxa or Puma" . SPARSER::COLLECTION)
    ("Bim, Bax, Noxa or Puma" . SPARSER::COLLECTION)
    ("Idelalisib" . SPARSER::DRUG)
    ("Bruton tyrosine kinase (BTK)" . SPARSER::PROTEIN)
    ("another B-cell receptor-associated kinase" . SPARSER::KINASE)
    ("adhesion molecules and chemokines [ xref , xref ]" . SPARSER::COLLECTION)
    ("IL-4 or phorbol" . SPARSER::COLLECTION) ("esters" . SPARSER::MOLECULE)
    ("phorbol" . SPARSER::DRUG) ("Lyn, ERK, Akt and PKC" . SPARSER::COLLECTION)
    ("β1 and β2" . SPARSER::COLLECTION)
    ("PI3Kδ-PKCβ/STAT3-NF-κB" . SPARSER::COLLECTION)
    ("Bcl-xL or Bcl-2" . SPARSER::COLLECTION)
    ("Mcl-1 or control siRNAs and co-cultured" . SPARSER::COLLECTION)
    ("siRNAs and co-cultured" . SPARSER::COLLECTION)
    ("PI3Kδ/PKCβ-NF-κB/STAT3" . SPARSER::COLLECTION)
    ("mere" . SPARSER::PROTEIN-FAMILY) ("NF-κB or STAT3" . SPARSER::COLLECTION)
    ("NF-κB and/or STAT3" . SPARSER::COLLECTION)
    ("The pro-apoptotic proteins Bim, Noxa, Bax and Puma"
     . SPARSER::COLLECTION)
    ("Bim, Noxa, Bax and Puma" . SPARSER::COLLECTION)
    ("Puma" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Bcl-xL, Bcl-2 or Bfl-1" . SPARSER::COLLECTION)
    ("that idelalisib and sotrastaurin significantly downregulated Mcl-1"
     . SPARSER::COLLECTION)
    ("S473-Akt, STAT3 and IκB" . SPARSER::COLLECTION)
    ("idelalisib and sotrastaurin significantly reduced the stroma-induced phosphorylation of S473-Akt, IκB and STAT3 (Figure xref )"
     . SPARSER::COLLECTION)
    ("S473-Akt, IκB and STAT3" . SPARSER::COLLECTION)
    ("idelalisib and sotrastaurin inhibited the activation of Akt, NF-κB and STAT3 (see Figure xref )"
     . SPARSER::COLLECTION)
    ("Akt, NF-κB and STAT3" . SPARSER::COLLECTION)
    ("PI3Kδ or PKCβ" . SPARSER::COLLECTION)
    ("ATO and these inhibitors" . SPARSER::COLLECTION)
    ("idelalisib and sotrastaurin significantly reduced CLL cell viability in a dose-dependent manner"
     . SPARSER::COLLECTION)
    ("UO126 or Lyn" . SPARSER::COLLECTION)
    ("PI3K, Akt, PKC, NF-κB or STAT3" . SPARSER::COLLECTION)
    ("LY294002 or STAT3" . SPARSER::COLLECTION) ("Stattic" . SPARSER::DRUG)
    ("Mcl-1, Bcl-xL and Bfl-1" . SPARSER::COLLECTION)
    ("Mcl-1 and Bfl-1" . SPARSER::COLLECTION)
    ("Bim and Noxa" . SPARSER::COLLECTION) ("Noxa" . SPARSER::PROTEIN)
    ("IκB and STAT3" . SPARSER::COLLECTION)
    ("the associated inhibitory protein IκB" . SPARSER::PROTEIN)
    ("Akt, PKC, ERK and Lyn" . SPARSER::COLLECTION)
    ("Akt, PKC, and Lyn" . SPARSER::COLLECTION)
    ("ATO and fludarabine" . SPARSER::COLLECTION)
    ("fludarabine and bendamustine" . SPARSER::COLLECTION)
    ("Akt/FoxO3a/Bim" . SPARSER::COLLECTION)
    ("bendamustine, fludarabine, and dexamethasone" . SPARSER::COLLECTION)
    ("dexamethasone" . SPARSER::PROTEIN) ("bendamustine" . SPARSER::DRUG)
    ("acute promyelocytic leukemia" . SPARSER::PROTEIN)
    ("CAL" . SPARSER::PROTEIN) ("obinutuzumab" . SPARSER::DRUG)
    ("IgH" . SPARSER::PROTEIN) ("cytostatic drugs" . SPARSER::DRUG)
    ("that idelalisib or sotrastaurin" . SPARSER::COLLECTION)
    ("siRNAs or inhibitors" . SPARSER::COLLECTION)
    ("idelalisib and sotrastaurin" . SPARSER::COLLECTION)
    ("PI3Kδ and PKCβ" . SPARSER::COLLECTION)
    ("NF-κB/STAT3" . SPARSER::COLLECTION)
    ("PI3K and PKC" . SPARSER::COLLECTION)
    ("Mcl-1, Bcl-xL, and Bfl-1" . SPARSER::COLLECTION)
    ("Lyn, ERK, PI3K and PKC" . SPARSER::COLLECTION) ("ATO" . SPARSER::PROTEIN)
    ("API-2" . SPARSER::PROTEIN) ("Bisindolylmaleimide I" . SPARSER::DRUG)
    ("HP1" . SPARSER::PROTEIN)
    ("intercellular adhesion molecule-1" . SPARSER::PROTEIN)
    ("vascular cell adhesion molecule-1" . SPARSER::PROTEIN)
    ("MIM1" . SPARSER::PROTEIN) ("UO126" . SPARSER::DRUG)
    ("αLβ2" . SPARSER::PROTEIN)
    ("matrix metalloproteinase-9" . SPARSER::PROTEIN)
    ("FoxO3a" . SPARSER::PROTEIN) ("Bruton tyrosine kinase" . SPARSER::PROTEIN)
    ("PKCβ" . SPARSER::PROTEIN) ("Bfl-1" . SPARSER::PROTEIN)
    ("Arsenic trioxide" . SPARSER::MOLECULE)
    ("a possible downstream target" . SPARSER::TARGET-PROTEIN)
    ("NF-κB or AKT" . SPARSER::COLLECTION)
    ("ATM and PIASy" . SPARSER::COLLECTION) ("PIASy" . SPARSER::PROTEIN)
    ("PARP−" . SPARSER::PROTEIN) ("rho" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PARP1 (scores 0–3, 4–5, 6–8) or FOXO3A (scores 0–2, 3–6, 7–8)"
     . SPARSER::COLLECTION)
    ("PARP1 (Mean Allred score ± standard error; 4.8 ± 0.2) and FOXO3A (Mean Allred score ± standard error; 3.8 ± 0.2)"
     . SPARSER::COLLECTION)
    ("PARP1 or FOXO3A" . SPARSER::COLLECTION)
    ("PARP1, and FOXO3A" . SPARSER::COLLECTION)
    ("CEA and CA 19–9" . SPARSER::COLLECTION)
    ("Caspase 3 or Bax" . SPARSER::COLLECTION)
    ("PARP1 mRNAs as well as proteins (Figure xref )" . SPARSER::COLLECTION)
    ("FOXO3A and its targets [ xref ]" . SPARSER::COLLECTION)
    ("paclitaxel, imatinib, and doxorubicin" . SPARSER::COLLECTION)
    ("histones and p53" . SPARSER::COLLECTION) ("PARP1−" . SPARSER::PROTEIN)
    ("FOXO3A−" . SPARSER::PROTEIN) ("PARP1 and FOXO3A" . SPARSER::COLLECTION)
    ("Olaparib or PARP1" . SPARSER::COLLECTION) ("19A" . SPARSER::PROTEIN)
    ("caspase3" . SPARSER::PROTEIN) ("Tween20" . SPARSER::MOLECULE)
    ("FOXO3" . SPARSER::PROTEIN) ("PHLPP1" . SPARSER::PROTEIN)
    ("IKK beta" . SPARSER::PROTEIN) ("NF- κB" . SPARSER::PROTEIN)
    ("IKK gamma" . SPARSER::PROTEIN) ("14–3–3" . SPARSER::PROTEIN)
    ("Trim28" . SPARSER::PROTEIN) ("Trim" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the best characterized Fbw7 substrate and a key component"
     . SPARSER::COLLECTION)
    ("MAGE-C2 or cyclin E" . SPARSER::COLLECTION)
    ("cyclin E and MAGE-C2" . SPARSER::COLLECTION) ("Brdu" . SPARSER::DRUG)
    ("transfectants" . SPARSER::PROTEIN)
    ("cyclinB1, cyclinD1, CDK2 and CDK6" . SPARSER::COLLECTION)
    ("Flag-MAGE-C2" . SPARSER::COLLECTION)
    ("anti-cyclin E or anti-HA" . SPARSER::COLLECTION)
    ("HA-ubiquitin" . SPARSER::COLLECTION)
    ("Cullin1 or Rbx1" . SPARSER::COLLECTION)
    ("MAGE-C2-Cullin1" . SPARSER::COLLECTION)
    ("endogeneous Rbx1" . SPARSER::PROTEIN)
    ("GFP-MAGE-C2" . SPARSER::COLLECTION)
    ("Skp1 and Rbx1" . SPARSER::COLLECTION)
    ("Cullin-Skp1-Fbw7" . SPARSER::COLLECTION)
    ("Cullin" . SPARSER::PROTEIN-FAMILY)
    ("Rbx1, Cullin1, and MAGE-C2" . SPARSER::COLLECTION)
    ("HA-Skp1" . SPARSER::COLLECTION) ("Fbw7-myc" . SPARSER::COLLECTION)
    ("MAGE-C2, Rbx1 and Cullin1" . SPARSER::COLLECTION)
    ("SK" . SPARSER::PROTEIN) ("Cullin1 and Rbx1" . SPARSER::COLLECTION)
    ("Rbx1 (Figure xref , lane 5) and Cullin1 (Figure xref )"
     . SPARSER::COLLECTION)
    ("Cullin1-myc protein" . SPARSER::COLLECTION)
    ("GST-Skp1" . SPARSER::COLLECTION) ("GST-MAGE-C2" . SPARSER::COLLECTION)
    ("GST-Rbx1" . SPARSER::COLLECTION)
    ("Cullin 1 and Fbw7" . SPARSER::COLLECTION)
    ("Skp1 or Skp2" . SPARSER::COLLECTION) ("FLAG-Skp2" . SPARSER::COLLECTION)
    ("FLAG-Skp1" . SPARSER::COLLECTION) ("FLAG-Fbw7" . SPARSER::COLLECTION)
    ("FLAG-Cullin1" . SPARSER::COLLECTION)
    ("Fbw7 or Skp2" . SPARSER::COLLECTION) ("Fbw7" . SPARSER::PROTEIN)
    ("FLAG-Rbx1" . SPARSER::COLLECTION) ("HA-MAGE-C2" . SPARSER::COLLECTION)
    ("Rbx1 and Cullin1" . SPARSER::COLLECTION)
    ("Cullin1/Rbx1" . SPARSER::COLLECTION)
    ("Skp1 and F-box protein family" . SPARSER::COLLECTION)
    ("Rbx1, Cullin1, Skp1 and F-box protein family" . SPARSER::COLLECTION)
    ("the largest E3 ligases SCF complex" . SPARSER::BIO-COMPLEX)
    ("MAGE-B18-LNX1" . SPARSER::COLLECTION) ("etc" . SPARSER::PROTEIN)
    ("MAGE" . SPARSER::PROTEIN-FAMILY) ("T-2" . SPARSER::PROTEIN)
    ("cyclinD1" . SPARSER::PROTEIN) ("cyclinB1" . SPARSER::PROTEIN)
    ("MG-132" . SPARSER::DRUG) ("myc protein" . SPARSER::PROTEIN)
    ("Cullin 1" . SPARSER::PROTEIN) ("MAGE family" . SPARSER::PROTEIN-FAMILY)
    ("ubiquitin conjugating enzymes" . SPARSER::PROTEIN-FAMILY)
    ("RING Box Protein-1" . SPARSER::PROTEIN) ("LNX1" . SPARSER::PROTEIN)
    ("B18" . SPARSER::PROTEIN) ("TRIM28" . SPARSER::PROTEIN)
    ("MAGE-A2" . SPARSER::PROTEIN) ("Type I" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Cullin1" . SPARSER::PROTEIN) ("Skp1" . SPARSER::PROTEIN)
    ("MAGE-C2" . SPARSER::PROTEIN)
    ("the chemotherapeutic agent CDDP" . SPARSER::DRUG)
    ("NQO1 and NQO2" . SPARSER::COLLECTION) ("NQO1–p53" . SPARSER::COLLECTION)
    ("Catalase and glutathione S-transferase" . SPARSER::COLLECTION)
    ("Catalase" . SPARSER::PROTEIN)
    ("a proinflammatory cytokine" . SPARSER::PROTEIN)
    ("Il20" . SPARSER::PROTEIN) ("IL20–ERK" . SPARSER::COLLECTION)
    ("NQO1-p53" . SPARSER::COLLECTION) ("Curcumin" . SPARSER::DRUG)
    ("p53 and NQO1" . SPARSER::COLLECTION)
    ("NQO1 and p53" . SPARSER::COLLECTION)
    ("p53 and MDM2" . SPARSER::COLLECTION)
    ("Ell3 and p53" . SPARSER::COLLECTION)
    ("RNA and protein" . SPARSER::COLLECTION)
    ("NOXA , GADD45A , and cyclin-dependent kinase inhibitor 1A"
     . SPARSER::COLLECTION)
    ("Ell" . SPARSER::PROTEIN) ("sip" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Ell3-KD" . SPARSER::COLLECTION) ("IL20 and ERK" . SPARSER::COLLECTION)
    ("STAT3 and ERK" . SPARSER::COLLECTION)
    ("MAPK, and JNK" . SPARSER::COLLECTION)
    ("particular cis-diamminedichloroplatinum(II)" . SPARSER::DRUG)
    ("dicumarol" . SPARSER::DRUG) ("NADH or NADPH" . SPARSER::COLLECTION)
    ("NADPH" . SPARSER::PROTEIN) ("quinones" . SPARSER::MOLECULE)
    ("flavin" . SPARSER::MOLECULE) ("ELL" . SPARSER::PROTEIN)
    ("Chemical" . SPARSER::MOLECULE)
    ("the chemotherapeutic agent cis-diamminedichloroplatinum(II) (CDDP)"
     . SPARSER::DRUG)
    ("cis-diamminedichloroplatinum(II) (CDDP)" . SPARSER::DRUG)
    ("CDDP" . SPARSER::DRUG) ("NaHCO 3" . SPARSER::DRUG)
    ("lamin B" . SPARSER::PROTEIN-FAMILY) ("Caspase-9" . SPARSER::PROTEIN)
    ("S15" . SPARSER::PROTEIN) ("NQO2" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase inhibitor 1" . SPARSER::PROTEIN)
    ("GADD45A" . SPARSER::PROTEIN) ("z-VAD-FMK" . SPARSER::DRUG)
    ("IL22R" . SPARSER::PROTEIN) ("interleukin 20" . SPARSER::PROTEIN)
    ("ELL3" . SPARSER::PROTEIN) ("IL20" . SPARSER::PROTEIN)
    ("interleukin-20" . SPARSER::PROTEIN)
    ("cis-diamminedichloroplatinum" . SPARSER::DRUG)
    ("Ell3" . SPARSER::PROTEIN) ("elongation factor" . SPARSER::PROTEIN)
    ("ZEB1/hTERT" . SPARSER::COLLECTION) ("ZEB1-Brg1" . SPARSER::COLLECTION)
    ("ubiquitin ligase and Wnt" . SPARSER::COLLECTION)
    ("RNA-dependent RNA polymerase and Wnt" . SPARSER::COLLECTION)
    ("hTERT/ZEB1" . SPARSER::COLLECTION) ("hTERT-ZEB1" . SPARSER::COLLECTION)
    ("hT-HCT116 cells underwent MET" . SPARSER::PROTEIN)
    ("LiCl" . SPARSER::DRUG) ("the snail's" . SPARSER::PROTEIN)
    ("snail" . SPARSER::PROTEIN)
    ("N -cadherin and vimentin" . SPARSER::COLLECTION)
    ("Brg1" . SPARSER::PROTEIN) ("T-cell and lymphoid" . SPARSER::COLLECTION)
    ("hTERT and ZEB1" . SPARSER::COLLECTION)
    ("Dual-luciferase" . SPARSER::PROTEIN)
    ("RNA-dependent RNA polymerase" . SPARSER::PROTEIN)
    ("N -cadherin" . SPARSER::PROTEIN) ("homeobox 1" . SPARSER::PROTEIN)
    ("TCF–LEF" . SPARSER::PROTEIN-FAMILY) ("typical TSC" . SPARSER::PROTEIN)
    ("diagnosable TSC" . SPARSER::PROTEIN) ("fits" . SPARSER::PROTEIN-FAMILY)
    ("P24, and P36" . SPARSER::COLLECTION)
    ("intronic variants" . SPARSER::VARIANT) ("P22" . SPARSER::PROTEIN)
    ("the remaining eight (seven unique) putative intronic variants"
     . SPARSER::VARIANT)
    ("P38, and TSC2" . SPARSER::COLLECTION)
    ("P8, P14, P18, and P37" . SPARSER::COLLECTION)
    ("P35, and P41" . SPARSER::COLLECTION) ("sporadic TSC" . SPARSER::PROTEIN)
    ("P27 and P49" . SPARSER::COLLECTION)
    ("any pathogenic variants" . SPARSER::VARIANT)
    ("P3, P11, P21, P25, P43, and P52" . SPARSER::COLLECTION)
    ("parental DNA" . SPARSER::DNA) ("Intronic variants" . SPARSER::VARIANT)
    ("DEPTOR , PRAS40 , TBC1D7 , DEPDC5 , NPRL2 , and NPRL3"
     . SPARSER::COLLECTION)
    ("DEPTOR" . SPARSER::PROTEIN)
    ("promoter and enhancer" . SPARSER::COLLECTION)
    ("TSC1 and TSC2" . SPARSER::COLLECTION) ("TSC1/TSC2" . SPARSER::COLLECTION)
    ("‘NMI’" . SPARSER::PROTEIN) ("NMI" . SPARSER::PROTEIN)
    ("TSC1 or TSC2" . SPARSER::COLLECTION) ("S11" . SPARSER::PROTEIN)
    ("P29" . SPARSER::PROTEIN) ("NF2" . SPARSER::PROTEIN)
    ("P28" . SPARSER::PROTEIN) ("P26" . SPARSER::PROTEIN)
    ("P36" . SPARSER::PROTEIN) ("P24" . SPARSER::PROTEIN)
    ("P34" . SPARSER::PROTEIN) ("P10" . SPARSER::PROTEIN)
    ("P46" . SPARSER::PROTEIN) ("P37" . SPARSER::PROTEIN)
    ("P8" . SPARSER::HUMAN-PROTEIN-FAMILY) ("P41" . SPARSER::PROTEIN)
    ("P35" . SPARSER::PROTEIN) ("P49" . SPARSER::PROTEIN)
    ("P14" . SPARSER::PROTEIN) ("P42" . SPARSER::PROTEIN)
    ("P51" . SPARSER::PROTEIN) ("P32" . SPARSER::PROTEIN)
    ("P17" . SPARSER::PROTEIN) ("P52" . SPARSER::PROTEIN)
    ("P43" . SPARSER::PROTEIN) ("P25" . SPARSER::PROTEIN)
    ("P11" . SPARSER::PROTEIN) ("NPRL3" . SPARSER::PROTEIN)
    ("NPRL2" . SPARSER::PROTEIN) ("DEPDC5" . SPARSER::PROTEIN)
    ("TBC1D7" . SPARSER::PROTEIN)
    ("HDAC4-associated deacetylase activity" . SPARSER::PROTEIN)
    ("soluble mHTT protein" . SPARSER::PROTEIN)
    ("HTT and the yeast autophagy regulatory proteins" . SPARSER::COLLECTION)
    ("HDAC4 and its associated deacetylase activity" . SPARSER::COLLECTION)
    ("its associated deacetylase activity" . SPARSER::PROTEIN)
    ("HDAC4-huntingtin" . SPARSER::COLLECTION)
    ("aggregate-prone mutant Huntington's" . SPARSER::PROTEIN)
    ("gene (HTT)" . SPARSER::GENE) ("Huntington" . SPARSER::PROTEIN)
    ("transcription factors MEF2 [ xref ] and Runx2 [ xref ]"
     . SPARSER::COLLECTION)
    ("MAP1S-HDAC4" . SPARSER::COLLECTION) ("HBD or HBD" . SPARSER::COLLECTION)
    ("the HA-tagged R653-Q855 fragment (HA-HBD) alone further indicated HBD"
     . SPARSER::PROTEIN)
    ("HA-HBD" . SPARSER::COLLECTION)
    ("either HA- or MAP1S-specific antibody" . SPARSER::COLLECTION)
    ("both HDAC4 and HA-tagged MAP1S (HA-MAP1S)" . SPARSER::COLLECTION)
    ("HA-MAP1S" . SPARSER::COLLECTION) ("HA-" . SPARSER::PROTEIN)
    ("short chain (SC) and light chain (LC) (Figure xref )"
     . SPARSER::COLLECTION)
    ("heavy chain (HC), short chain (SC) and light chain (LC) (Figure xref )"
     . SPARSER::COLLECTION)
    ("light chain (LC)" . SPARSER::PROTEIN) ("MAP1S (FL)" . SPARSER::PROTEIN)
    ("RFP-LC3" . SPARSER::COLLECTION) ("Bafilomycin A1 (BAF)" . SPARSER::DRUG)
    ("the autophagic marker LC3-II" . SPARSER::PROTEIN)
    ("BAF" . SPARSER::PROTEIN) ("GFP-HTT74Q" . SPARSER::COLLECTION)
    ("Agarose" . SPARSER::MOLECULE) ("GFP-HTT72Q" . SPARSER::COLLECTION)
    ("Huntingtin" . SPARSER::PROTEIN)
    ("the short chain (SC) and the heavy chain (HC)" . SPARSER::COLLECTION)
    ("heavy chain (HC)" . SPARSER::PROTEIN)
    ("short chain (SC)" . SPARSER::PROTEIN) ("HC" . SPARSER::PROTEIN)
    ("HDAC4 and MAP1S" . SPARSER::COLLECTION)
    ("Bcl-2 and P27" . SPARSER::COLLECTION)
    ("MAP1A and MAP1B" . SPARSER::COLLECTION) ("homologues" . SPARSER::PROTEIN)
    ("the mutant HTT (mHTT) and colocalizes" . SPARSER::COLLECTION)
    ("HTT" . SPARSER::PROTEIN) ("polyglutamine" . SPARSER::MOLECULE)
    ("HDAC4-MAP1S" . SPARSER::COLLECTION) ("HD" . SPARSER::PROTEIN)
    ("HBD" . SPARSER::PROTEIN) ("huntingtin" . SPARSER::PROTEIN)
    ("triton X-100" . SPARSER::MOLECULE) ("guide RNAs" . SPARSER::RNA)
    ("Guide RNAs" . SPARSER::RNA) ("B-1" . SPARSER::PROTEIN)
    ("MEF2" . SPARSER::PROTEIN) ("HDAC6" . SPARSER::PROTEIN)
    ("histone deacetylase 6" . SPARSER::PROTEIN) ("LAMP2" . SPARSER::PROTEIN)
    ("Bafilomycin A1" . SPARSER::DRUG) ("a polypeptide" . SPARSER::PROTEIN)
    ("MAP1" . SPARSER::PROTEIN) ("short chain" . SPARSER::PROTEIN)
    ("P27" . SPARSER::PROTEIN) ("MAP1B" . SPARSER::PROTEIN)
    ("MAP1A" . SPARSER::PROTEIN) ("C19ORF5" . SPARSER::PROTEIN)
    ("Microtubule-associated protein 1S" . SPARSER::PROTEIN)
    ("HDAC4" . SPARSER::PROTEIN) ("MAP1S" . SPARSER::PROTEIN)
    ("CD133–p53" . SPARSER::COLLECTION)
    ("NANOG, OCT4, SOX2, or c-MYC" . SPARSER::COLLECTION)
    ("G9a, SUV39, and EZH2" . SPARSER::COLLECTION) ("SUV" . SPARSER::PROTEIN)
    ("azacytidine" . SPARSER::DRUG)
    ("NANOG, OCT4, SOX2, and c-MYC" . SPARSER::COLLECTION)
    ("exogenous p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("exogenous CD133" . SPARSER::PROTEIN) ("CDS" . SPARSER::PROTEIN)
    ("DAB" . SPARSER::MOLECULE)
    ("known repressive histone marker H3K" . SPARSER::PROTEIN)
    ("p53 and HDAC1" . SPARSER::COLLECTION) ("thymine" . SPARSER::MOLECULE)
    ("only one promoter" . SPARSER::PROMOTER)
    ("p53 repressive target gene" . SPARSER::GENE)
    ("p21 or PUMA" . SPARSER::COLLECTION)
    ("CD133 and p53" . SPARSER::COLLECTION)
    ("carrying wild-type (WT) p53 or various p53 mutants ( xref )"
     . SPARSER::COLLECTION)
    ("p53 and CD133" . SPARSER::COLLECTION)
    ("Doxorubicin (Dox) and 5-fluorouracil (5-FU)" . SPARSER::COLLECTION)
    ("SAHA" . SPARSER::DRUG) ("apicidin" . SPARSER::DRUG)
    ("CD44, and CD24" . SPARSER::COLLECTION)
    ("SOX2, and c-MYC" . SPARSER::COLLECTION) ("octamer" . SPARSER::PROTEIN)
    ("L-15" . SPARSER::PROTEIN) ("s 5a" . SPARSER::PROTEIN)
    ("pG5" . SPARSER::PROTEIN) ("G9a" . SPARSER::PROTEIN)
    ("As2O3" . SPARSER::DRUG) ("P1-3" . SPARSER::PROTEIN)
    ("Enhancer of zeste homolog 2" . SPARSER::PROTEIN)
    ("FOXA2" . SPARSER::PROTEIN) ("1A" . SPARSER::PROTEIN)
    ("Nutlin-3" . SPARSER::DRUG)
    ("suberoylanilide hydroxamic acid" . SPARSER::DRUG)
    ("Histone deacetylase" . SPARSER::PROTEIN) ("Bay 11-7082" . SPARSER::DRUG)
    ("I κ B α" . SPARSER::PROTEIN) ("surface protein" . SPARSER::PROTEIN)
    ("PROM1" . SPARSER::PROTEIN) ("prominin-1" . SPARSER::PROTEIN)
    ("transcription factor 4" . SPARSER::PROTEIN)
    ("Histone Deacetylase 1" . SPARSER::PROTEIN)
    ("even triple drugs" . SPARSER::DRUG)
    ("Cav1 and BMPR2" . SPARSER::COLLECTION)
    ("a nonspecific biomarker" . SPARSER::MOLECULE)
    ("COPD-PAH" . SPARSER::COLLECTION) ("PAP, and PVR" . SPARSER::COLLECTION)
    ("PVR" . SPARSER::PROTEIN) ("PAP" . SPARSER::MOLECULE)
    ("PA" . SPARSER::PROTEIN) ("a good biomarker" . SPARSER::MOLECULE)
    ("monocrotaline" . SPARSER::MOLECULE)
    ("new biomarkers" . SPARSER::MOLECULE)
    ("atrial natriuretic peptide (ANP)" . SPARSER::PROTEIN)
    ("troponin, and uric acid" . SPARSER::COLLECTION)
    ("troponin" . SPARSER::PROTEIN) ("proBNP" . SPARSER::PROTEIN)
    ("ANP" . SPARSER::PROTEIN) ("COPD-PH" . SPARSER::COLLECTION)
    ("PAH" . SPARSER::PROTEIN) ("C-reactive protein" . SPARSER::PROTEIN)
    ("Cav 1" . SPARSER::PROTEIN) ("BMPR2" . SPARSER::PROTEIN)
    ("uric acid" . SPARSER::MOLECULE)
    ("natriuretic peptide" . SPARSER::PROTEIN) ("Cav1" . SPARSER::PROTEIN)
    ("All sporadic RB" . SPARSER::PROTEIN) ("patient RB45" . SPARSER::PROTEIN)
    ("The most common mutational type" . TYPE)
    ("RB and their families" . SPARSER::COLLECTION) ("pRb" . SPARSER::PROTEIN)
    ("CGA" . SPARSER::PROTEIN) ("Heritable RB" . SPARSER::PROTEIN)
    ("ID" . SPARSER::PROTEIN) ("strabismus" . SPARSER::PROTEIN)
    ("14.5 new RB" . SPARSER::PROTEIN) ("heritable RB" . SPARSER::PROTEIN)
    ("unilateral RB" . SPARSER::PROTEIN) ("bilateral RB" . SPARSER::PROTEIN)
    ("RB protein" . SPARSER::PROTEIN) ("ddH 2" . SPARSER::PROTEIN)
    ("Group B" . SPARSER::PROTEIN) ("Group D" . SPARSER::PROTEIN)
    ("Group E" . SPARSER::PROTEIN) ("Group A" . SPARSER::PROTEIN)
    ("RB1" . SPARSER::PROTEIN) ("JAT/STAT" . SPARSER::COLLECTION)
    ("onco-miRNA" . SPARSER::COLLECTION)
    ("a typical multifunctional miRNA" . SPARSER::PROTEIN)
    ("ranibizumab" . SPARSER::DRUG) ("PI3K-pAkt" . SPARSER::COLLECTION)
    ("pAkt" . SPARSER::PROTEIN-FAMILY)
    ("hypoxia and VEGF" . SPARSER::COLLECTION)
    ("SHIP1 and phospho-Akt" . SPARSER::COLLECTION)
    ("FITC-isolectin" . SPARSER::MOLECULE)
    ("the anti-ctrl" . SPARSER::ANTIBODY) ("FA" . SPARSER::PROTEIN)
    ("the normal retina and anti-control-treated retina ( xref )"
     . SPARSER::COLLECTION)
    ("the normal retina" . SPARSER::DRUG) ("RPEs" . SPARSER::PROTEIN)
    ("WEE1, SHIP1, and SOCS1" . SPARSER::COLLECTION)
    ("divergent cell-specific target genes" . SPARSER::GENE)
    ("AMD" . SPARSER::PROTEIN) ("retinas" . SPARSER::DRUG)
    ("fluorescein" . SPARSER::MOLECULE) ("-dextran" . SPARSER::DEXTRAN)
    ("retina" . SPARSER::DRUG) ("PIP2" . SPARSER::PIP2)
    ("VEGF Trap" . SPARSER::DRUG) ("anti-VEGF" . SPARSER::DRUG)
    ("beta-actin" . SPARSER::PROTEIN) ("P18" . SPARSER::PROTEIN)
    ("WEE1" . SPARSER::PROTEIN) ("Myc and TGFβ" . SPARSER::COLLECTION)
    ("ECM and adhesion protein genes" . SPARSER::COLLECTION)
    ("numerous ECM and adhesion proteins" . SPARSER::COLLECTION)
    ("the metastasis-repressive response arm" . SPARSER::PROTEIN)
    ("competitive and allosteric mTOR inhibitors" . SPARSER::INHIBITOR)
    ("ECM-protein" . SPARSER::COLLECTION)
    ("ECM and adhesion genes ( xref A)" . SPARSER::COLLECTION)
    ("myc" . SPARSER::PROTEIN)
    ("ECM and adhesion proteins" . SPARSER::COLLECTION)
    ("Myc-mTOR" . SPARSER::COLLECTION) ("Ribo" . SPARSER::PROTEIN)
    ("Ribo-seq" . SPARSER::COLLECTION) ("RP" . SPARSER::PROTEIN)
    ("seq" . SPARSER::PROTEIN) ("GRO-seq" . SPARSER::COLLECTION)
    ("GRO" . SPARSER::PROTEIN) ("miRs and RBPs" . SPARSER::COLLECTION)
    ("its associated factor TAF1" . SPARSER::PROTEIN)
    ("RNAPII" . SPARSER::PROTEIN) ("polysome" . SPARSER::BIO-COMPLEX)
    ("laminins" . SPARSER::PROTEIN-FAMILY) ("RNA-and" . SPARSER::RNA)
    ("the combined dataset detected 972 unique genes" . SPARSER::GENE)
    ("RNA-" . SPARSER::RNA)
    ("multiple secondary regulators" . SPARSER::REGULATOR)
    ("Myc and MIZ1" . SPARSER::COLLECTION) ("MIZ1" . SPARSER::PROTEIN)
    ("-CACGTG-3" . SPARSER::COLLECTION) ("N-term" . SPARSER::PROTEIN)
    ("MS 2" . SPARSER::PROTEIN) ("Lys-C" . SPARSER::PROTEIN)
    ("polynucleotide kinase" . SPARSER::PROTEIN) ("MLN0128" . SPARSER::DRUG)
    ("MYC protein" . SPARSER::PROTEIN) ("Torin-1" . SPARSER::DRUG)
    ("CDKN1A" . SPARSER::PROTEIN) ("TAF1" . SPARSER::PROTEIN)
    ("RNA polymerase II" . SPARSER::PROTEIN) ("A–C" . SPARSER::PROTEIN)
    ("basic helix–loop–helix" . SPARSER::PROTEIN)
    ("the pathological role mTOR" . SPARSER::PROTEIN)
    ("Rosiglitazone" . SPARSER::DRUG)
    ("AKT (Ser473) and p70S6K" . SPARSER::COLLECTION)
    ("GSK3αβ, AKT (Ser473) and p70S6K" . SPARSER::COLLECTION)
    ("a peroxisome proliferator-activated receptor γ (PPARγ) antagonist"
     . SPARSER::MOLECULE)
    ("rapamycin and rosiglitazone" . SPARSER::COLLECTION)
    ("lipoxygenase and lipoxygenase" . SPARSER::COLLECTION)
    ("the rapamycin and nutrient-sensitive multiprotein complex"
     . SPARSER::COLLECTION)
    ("PIA" . SPARSER::PROTEIN)
    ("adipocytes and Dictostylium" . SPARSER::COLLECTION)
    ("kinase/PDK2" . SPARSER::COLLECTION)
    ("nutrient and oxygen" . SPARSER::COLLECTION) ("GSK3αβ" . SPARSER::PROTEIN)
    ("Wnt-GSK3" . SPARSER::COLLECTION) ("glucocorticoids" . SPARSER::PROTEIN)
    ("RAS-MAPK" . SPARSER::COLLECTION) ("TSC and mTORC1" . SPARSER::COLLECTION)
    ("the hamartomatous syndrome tuberous sclerosis complex (TSC)"
     . SPARSER::BIO-COMPLEX)
    ("tsc2" . SPARSER::PROTEIN) ("tsc1" . SPARSER::PROTEIN)
    ("the respective drugs" . SPARSER::DRUG)
    ("ACSL4 inhibitor and ER inhibitor" . SPARSER::COLLECTION)
    ("p-GSK3αβ" . SPARSER::PROTEIN-PAIR)
    ("ACSL4 and estrogen" . SPARSER::COLLECTION)
    ("a representative component" . SPARSER::COMPONENT)
    ("10 nM rapamycin or 75 μM rosiglitazone" . SPARSER::COLLECTION)
    ("MTT and BrdU" . SPARSER::COLLECTION) ("diphenyl" . SPARSER::DRUG)
    ("bromo" . SPARSER::MOLECULE) ("immunophilin" . SPARSER::PROTEIN)
    ("macrolide" . SPARSER::MOLECULE) ("ACSL4 and mTOR" . SPARSER::COLLECTION)
    ("p70S6K (Thr389) and its substrates" . SPARSER::COLLECTION)
    ("zileuton" . SPARSER::DRUG) ("metabolites" . SPARSER::MOLECULE)
    ("Lipoxygenase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("WNT6 and WNT10A" . SPARSER::COLLECTION)
    ("eIF4 and p70S6K" . SPARSER::COLLECTION) ("eIF4" . SPARSER::PROTEIN)
    ("IPA" . SPARSER::MOLECULE) ("ACSL4 and ERα" . SPARSER::COLLECTION)
    ("types, and studies" . SPARSER::COLLECTION)
    ("growth factors and their receptors" . SPARSER::COLLECTION)
    ("phosphoproteins" . SPARSER::PROTEIN) ("Proline" . SPARSER::AMINO-ACID)
    ("Substrate" . SPARSER::SUBSTRATE) ("hamartin" . SPARSER::PROTEIN)
    ("tuberin" . SPARSER::PROTEIN) ("AMPK or protein" . SPARSER::COLLECTION)
    ("phosphoprotein" . SPARSER::PROTEIN)
    ("initiation factor 4E-BP1" . SPARSER::COLLECTION)
    ("a rapamycin- and nutrient-sensitive multiprotein complex (mTORC1) and a growth factor-sensitive nutrient-insensitive complex (mTORC2)"
     . SPARSER::COLLECTION)
    ("nutrient-sensitive multiprotein complex (mTORC1) and a growth factor-sensitive nutrient-insensitive complex (mTORC2)"
     . SPARSER::COLLECTION)
    ("rapamycin-" . SPARSER::DRUG) ("ACSL4 and ER" . SPARSER::COLLECTION)
    ("GSK3α and GSK3β" . SPARSER::COLLECTION)
    ("protein kinase B or PKB" . SPARSER::COLLECTION)
    ("p70S6K and component" . SPARSER::COLLECTION)
    ("ribosomal protein S6-" . SPARSER::PROTEIN) ("70kDa" . SPARSER::PROTEIN)
    ("rosiglitazone and tamoxifen" . SPARSER::COLLECTION)
    ("rapamycin and ACSL4" . SPARSER::COLLECTION)
    ("rosiglitazone" . SPARSER::DRUG)
    ("regulators and substrates" . SPARSER::COLLECTION)
    ("tetracycline" . SPARSER::DRUG) ("synthetase" . SPARSER::PROTEIN)
    ("ribosomal protein" . SPARSER::PROTEIN) ("p70 S6" . SPARSER::PROTEIN)
    ("GSK-3α" . SPARSER::PROTEIN) ("GW9662" . SPARSER::DRUG)
    ("PDK2" . SPARSER::PROTEIN)
    ("extracellular-signal-regulated kinase 1" . SPARSER::PROTEIN)
    ("growth-factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("AKT1S1" . SPARSER::PROTEIN) ("TCS2" . SPARSER::PROTEIN)
    ("p-S6" . SPARSER::PROTEIN) ("FK 506" . SPARSER::DRUG)
    ("LOX-5" . SPARSER::PROTEIN) ("lipoxygenase-5" . SPARSER::PROTEIN)
    ("WNT10A" . SPARSER::PROTEIN) ("WNT6" . SPARSER::PROTEIN)
    ("Wingless-Type MMTV Integration Site Family" . SPARSER::PROTEIN)
    ("WIF1" . SPARSER::PROTEIN) ("IRS1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("insulin receptor substrate 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("IGFBP2" . SPARSER::PROTEIN)
    ("insulin-like growth factor binding protein" . SPARSER::PROTEIN)
    ("TCS1" . SPARSER::PROTEIN)
    ("regulatory-associated protein of mTOR" . SPARSER::PROTEIN)
    ("PRKAA1" . SPARSER::PROTEIN)
    ("eukaryotic initiation factor 4E" . SPARSER::PROTEIN-FAMILY)
    ("BP1" . SPARSER::PROTEIN) ("initiation factor 4E" . SPARSER::PROTEIN)
    ("GSK3α" . SPARSER::PROTEIN)
    ("Glycogen synthase kinase-3 alpha" . SPARSER::PROTEIN)
    ("rapamycin-insensitive companion of mTOR" . SPARSER::PROTEIN)
    ("polypeptide 1" . SPARSER::PROTEIN)
    ("progesterone-receptor" . SPARSER::PROTEIN)
    ("estrogen-receptor" . SPARSER::PROTEIN) ("ACSL4" . SPARSER::PROTEIN)
    ("acyl-CoA" . SPARSER::MOLECULE)
    ("a possible solution" . SPARSER::MOLECULE) ("exp" . SPARSER::PROTEIN)
    ("Freq" . SPARSER::PROTEIN)
    ("a steady state around C  max" . SPARSER::PROTEIN)
    ("max" . SPARSER::PROTEIN) ("traditional cytotoxic drugs" . SPARSER::DRUG)
    ("Sprycel" . SPARSER::DRUG) ("Gleevec" . SPARSER::DRUG)
    ("Tarceva" . SPARSER::DRUG)
    ("NAC and vitamin E increase tumor cell proliferation by reducing ROS"
     . SPARSER::COLLECTION)
    ("antioxidant and chemotherapeutic drug" . SPARSER::COLLECTION)
    ("caspase and Nrf2" . SPARSER::COLLECTION)
    ("PARP and other target proteins" . SPARSER::COLLECTION)
    ("GST, p53, PARP, and caspase" . SPARSER::COLLECTION)
    ("conventional anticancer drugs (cisplatin, 5-FU) and a drug"
     . SPARSER::COLLECTION)
    ("GST and NQO1" . SPARSER::COLLECTION)
    ("cisplatin and EGCG" . SPARSER::COLLECTION)
    ("Nrf2 and its downstream target genes" . SPARSER::COLLECTION)
    ("Nrf2-siRNA" . SPARSER::COLLECTION)
    ("EGCG and RRx-001 combinations" . SPARSER::COLLECTION)
    ("xCT-symporter" . SPARSER::COLLECTION) ("GSH" . SPARSER::DRUG)
    ("cystine" . SPARSER::MOLECULE) ("symporter" . SPARSER::PROTEIN)
    ("xCT" . SPARSER::PROTEIN) ("sulfasalazine" . SPARSER::DRUG)
    ("drug-antioxidant" . SPARSER::PROTEIN)
    ("another chemotherapeutic drug" . SPARSER::DRUG)
    ("Cisplatin and 5-FU" . SPARSER::COLLECTION)
    ("Fluorouracil" . SPARSER::DRUG) ("PTS and EGCG" . SPARSER::COLLECTION)
    ("EGCG and PTS" . SPARSER::COLLECTION)
    ("the two clinically relevant anticancer drugs" . SPARSER::DRUG)
    ("cisplatin and 5-FU" . SPARSER::COLLECTION)
    ("EGCG or PTS" . SPARSER::COLLECTION)
    ("GST1 and NQO1" . SPARSER::COLLECTION)
    ("NaAs and PTS" . SPARSER::COLLECTION)
    ("-Luciferase" . SPARSER::COLLECTION) ("Fluc2" . SPARSER::PROTEIN)
    ("PTS and NaAs" . SPARSER::COLLECTION)
    ("NaAs, and DMSO" . SPARSER::COLLECTION) ("solvent" . SPARSER::MOLECULE)
    ("NaAs" . SPARSER::MOLECULE)
    ("the 350 aa and 435 aa" . SPARSER::COLLECTION)
    ("Nrf2-FLuc2 fusion constructs expressing 50, 100, 150, 250, 350, and 435 N-terminal amino acids of Nrf2 protein"
     . SPARSER::PROTEIN)
    ("chemotherapeutic drug" . SPARSER::DRUG)
    ("Nrf2 activators and chemotherapeutic drugs" . SPARSER::COLLECTION)
    ("the developed Nrf2-FLuc2 fusion protein" . SPARSER::PROTEIN)
    ("Nrf2-FLuc2/Keap1" . SPARSER::COLLECTION)
    ("activators or inhibitors" . SPARSER::COLLECTION)
    ("FLuc2" . SPARSER::PROTEIN) ("Nrf2-FLuc2" . SPARSER::COLLECTION)
    ("The N-terminal 435 amino acids of Nrf2" . SPARSER::PROTEIN)
    ("retinoic" . SPARSER::PROTEIN) ("DLG and ETGE" . SPARSER::COLLECTION)
    ("DLG" . SPARSER::PROTEIN) ("CNC–bZIP" . SPARSER::COLLECTION)
    ("bZIP" . SPARSER::PROTEIN-FAMILY)
    ("the pro-inflammatory state" . SPARSER::BIO-STATE)
    ("oxygenase (HO)" . SPARSER::PROTEIN) ("oxygenase" . SPARSER::PROTEIN)
    ("heme" . SPARSER::PROTEIN) ("hydrolase" . SPARSER::PROTEIN)
    ("epoxide" . SPARSER::MOLECULE) ("quinone" . SPARSER::PROTEIN)
    ("Map" . SPARSER::PROTEIN) ("an inactive complex" . SPARSER::BIO-COMPLEX)
    ("ischemia" . SPARSER::PROTEIN)
    ("the currently used anticancer drugs" . SPARSER::DRUG)
    ("toxic chemicals" . SPARSER::MOLECULE) ("PTS" . SPARSER::PROTEIN)
    ("EGCG" . SPARSER::DRUG)
    ("endogenous ARE-signaling" . SPARSER::ANTI-OXIDANT-RESPONSE-ELEMENT)
    ("ARE-signaling" . SPARSER::ANTI-OXIDANT-RESPONSE-ELEMENT)
    ("Nrf2-Keap1" . SPARSER::COLLECTION)
    ("aspartic acid" . SPARSER::AMINO-ACID) ("hNQO1" . SPARSER::PROTEIN)
    ("SP2" . SPARSER::PROTEIN) ("GST1" . SPARSER::PROTEIN)
    ("sodium arsenite" . SPARSER::DRUG)
    ("epigallocatechin gallate" . SPARSER::DRUG)
    ("glycogen synthase kinase-3" . SPARSER::PROTEIN)
    ("Neh2" . SPARSER::PROTEIN) ("Neh1" . SPARSER::PROTEIN)
    ("gamma-glutamylcysteine synthetase" . SPARSER::PROTEIN)
    ("UDP-" . SPARSER::PROTEIN)
    ("glutathione S-transferase" . SPARSER::PROTEIN)
    ("protein-1" . SPARSER::PROTEIN)
    ("NF-E2-related factor-2" . SPARSER::PROTEIN)
    ("cytochrome p450" . SPARSER::PROTEIN-FAMILY)
    ("MUC16 and TTN" . SPARSER::COLLECTION)
    ("NOTCH1 or RHOA" . SPARSER::COLLECTION)
    ("NOTCH2, NOTCH4, RHOV and RHOBTB1" . SPARSER::COLLECTION)
    ("RHOV" . SPARSER::PROTEIN)
    ("the highly recurrent mutated genes" . SPARSER::GENE)
    ("pimozide" . SPARSER::DRUG) ("STATs" . SPARSER::PROTEIN)
    ("tofacitinib" . SPARSER::DRUG) ("ruxolitinib" . SPARSER::DRUG)
    ("JAK3 and STAT5B" . SPARSER::COLLECTION)
    ("IL-2, IL-7, and IL-15" . SPARSER::COLLECTION)
    ("the protein’s" . SPARSER::PROTEIN) ("pSTAT5B" . SPARSER::PROTEIN)
    ("phosphotyrosine" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("histidine" . SPARSER::AMINO-ACID)
    ("which shares extensive sequence homology" . SPARSER::PROTEIN)
    ("IL2RG , JAK3 , and STAT5B" . SPARSER::COLLECTION)
    ("STAT3, STAT5B, JAK1, and JAK3" . SPARSER::COLLECTION)
    ("ATM and p53" . SPARSER::COLLECTION)
    ("TP53 , BRAT1 , CREBBP , MAPK9 , MAPK14 , NFKBIA , and TLK1"
     . SPARSER::COLLECTION)
    ("NFKBIA" . SPARSER::PROTEIN) ("CREBBP" . SPARSER::PROTEIN)
    ("FRAP-ATM-TRRAP" . SPARSER::COLLECTION) ("TRRAP" . SPARSER::PROTEIN)
    ("FRAP" . SPARSER::PROTEIN) ("FAT" . SPARSER::PROTEIN)
    ("TCF12 R300L and TMEM51 E169del" . SPARSER::COLLECTION)
    ("TCF12 R300L (transcriptional regulator) and TMEM51 E169del (transmembrane protein)"
     . SPARSER::COLLECTION)
    ("monocarboxylate" . SPARSER::MOLECULE)
    ("cotransporter" . SPARSER::PROTEIN) ("citrate" . SPARSER::PROTEIN)
    ("dynein" . SPARSER::PROTEIN) ("titin" . SPARSER::PROTEIN)
    ("TTN" . SPARSER::PROTEIN)
    ("functionally relevant amino acid" . SPARSER::AMINO-ACID)
    ("all recurrent genes" . SPARSER::GENE) ("a rare tRNA" . SPARSER::PROTEIN)
    ("tRNA" . SPARSER::PROTEIN)
    ("T-cell large granular lymphocytic leukemia" . SPARSER::PROTEIN)
    ("SS" . SPARSER::PROTEIN)
    ("STAT3 , STAT5B , JAK1 , JAK3 , FYN , RHOA , NOTCH1 , CD58 , B2M , PLCG1 , PTPN2 , EZH2 , FBXW10 , TET2 , DNMT3A , IDH2 , ATM , CHEK2 , and p53"
     . SPARSER::COLLECTION)
    ("TP53 , TP63 , CDKN2A , WWOX , and ANKRD11" . SPARSER::COLLECTION)
    ("WWOX" . SPARSER::PROTEIN) ("RHOA" . SPARSER::PROTEIN)
    ("FYN" . SPARSER::PROTEIN)
    ("denileukin diftitox and brentuximab" . SPARSER::COLLECTION)
    ("brentuximab" . SPARSER::DRUG)
    ("ATM , RUNX1T1 , WDR17 , NTRK3 , TP53 , TRMT12 , CACNA2D1 , INTS8 , and KCNH8"
     . SPARSER::COLLECTION)
    ("RHOBTB1" . SPARSER::PROTEIN) ("NOTCH4" . SPARSER::PROTEIN)
    ("NOTCH2" . SPARSER::PROTEIN)
    ("peroxisome proliferator-activated receptor gamma" . SPARSER::PROTEIN)
    ("IL-15" . SPARSER::PROTEIN) ("IL-7" . SPARSER::PROTEIN)
    ("6.3" . SPARSER::PROTEIN) ("TLK1" . SPARSER::PROTEIN)
    ("MAPK14" . SPARSER::PROTEIN) ("MAPK9" . SPARSER::PROTEIN)
    ("BRAT1" . SPARSER::PROTEIN) ("PI3Kinase" . SPARSER::PROTEIN)
    ("transmembrane protein" . SPARSER::PROTEIN) ("TCF12" . SPARSER::PROTEIN)
    ("sodium channel" . SPARSER::PROTEIN) ("UNC79" . SPARSER::PROTEIN)
    ("tumor necrosis factor receptor superfamily" . SPARSER::PROTEIN)
    ("TNFRSF19" . SPARSER::PROTEIN) ("SRRM2" . SPARSER::PROTEIN)
    ("16A" . SPARSER::PROTEIN) ("SLC13A5" . SPARSER::PROTEIN)
    ("RASAL2" . SPARSER::PROTEIN) ("NOP2" . SPARSER::PROTEIN)
    ("LRP1B" . SPARSER::PROTEIN) ("heavy chain" . SPARSER::PROTEIN)
    ("CCR8" . SPARSER::PROTEIN) ("CASP8" . SPARSER::PROTEIN)
    ("CASP8AP2" . SPARSER::PROTEIN)
    ("potassium voltage-gated channel" . SPARSER::PROTEIN)
    ("calcium channel" . SPARSER::PROTEIN)
    ("voltage-dependent" . SPARSER::PROTEIN) ("CACNA2" . SPARSER::PROTEIN)
    ("cyclin-D" . SPARSER::PROTEIN) ("Set 1" . SPARSER::PROTEIN)
    ("RNAse A" . SPARSER::PROTEIN) ("CD7" . SPARSER::PROTEIN)
    ("CD2" . SPARSER::PROTEIN) ("ANKRD11" . SPARSER::PROTEIN)
    ("TP63" . SPARSER::PROTEIN) ("DNMT3A" . SPARSER::PROTEIN)
    ("TET2" . SPARSER::PROTEIN) ("FBXW10" . SPARSER::PROTEIN)
    ("EZH2" . SPARSER::PROTEIN) ("PTPN2" . SPARSER::PROTEIN)
    ("PLCG1" . SPARSER::PROTEIN) ("CD58" . SPARSER::PROTEIN)
    ("denileukin diftitox" . SPARSER::MOLECULE) ("IL2RG" . SPARSER::PROTEIN)
    ("JAK3" . SPARSER::PROTEIN)
    ("ataxia telangiectasia-mutated" . SPARSER::PROTEIN)
    ("KCNH8" . SPARSER::PROTEIN) ("INTS8" . SPARSER::PROTEIN)
    ("CACNA2D1" . SPARSER::PROTEIN) ("TRMT12" . SPARSER::PROTEIN)
    ("NTRK3" . SPARSER::PROTEIN) ("WDR17" . SPARSER::PROTEIN)
    ("RUNX1" . SPARSER::PROTEIN) ("OCT4/SOX2" . SPARSER::COLLECTION)
    ("iNSc" . SPARSER::PROTEIN)
    ("mRNAs [ xref ] and microRNAs [ xref ]" . SPARSER::COLLECTION)
    ("some immature type" . TYPE) ("GABA—the" . SPARSER::MOLECULE)
    ("SOX2 (2955.8, p = 0.008 fold) and MSI1 (2016.6, p = 0.008 fold)"
     . SPARSER::COLLECTION)
    ("even one transcription factor" . SPARSER::PROTEIN)
    ("p53, p16INK4a, and p21CIP" . SPARSER::COLLECTION)
    ("CIP" . SPARSER::PROTEIN) ("Laminin" . SPARSER::PROTEIN)
    ("NKX2.2 and MSI1" . SPARSER::COLLECTION)
    ("wave" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("methyltransferases" . SPARSER::PROTEIN) ("SOX1-" . SPARSER::PROTEIN)
    ("SOX2 or SOX2" . SPARSER::COLLECTION)
    ("Senescence-Associated (SA)-β-galactosidase" . SPARSER::COLLECTION)
    ("-β-galactosidase" . SPARSER::COLLECTION)
    ("-β-Galactosidase" . SPARSER::COLLECTION) ("the former type" . TYPE)
    ("Tau/Synapsin I" . SPARSER::COLLECTION)
    ("neurotransmitters" . SPARSER::MOLECULE) ("GABA" . SPARSER::MOLECULE)
    ("CO 2 and γ-aminobutyric" . SPARSER::COLLECTION)
    ("Tau and Synapsin I" . SPARSER::COLLECTION) ("Tau" . SPARSER::PROTEIN)
    ("SOX2-" . SPARSER::PROTEIN)
    ("SOX2 and SOX2-MYC-directly" . SPARSER::COLLECTION)
    ("star" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SOX2, SOX1, nestin, MSI1 and vimentin" . SPARSER::COLLECTION)
    ("SOX2/nestin" . SPARSER::COLLECTION)
    ("SOX1 and SOX2" . SPARSER::COLLECTION)
    ("integrin-beta-1" . SPARSER::COLLECTION)
    ("SOX2, SOX1 and nestin" . SPARSER::COLLECTION)
    ("TWIST2 and COL1A1" . SPARSER::COLLECTION)
    ("mesenchymal marker genes" . SPARSER::GENE)
    ("neural stem cells-associated genes" . SPARSER::GENE)
    ("–MSI1" . SPARSER::COLLECTION) ("nestin" . SPARSER::PROTEIN)
    ("endoderm—SOX17" . SPARSER::COLLECTION)
    ("SOX2 and PAX6" . SPARSER::COLLECTION)
    ("OCT4 or NANOG" . SPARSER::COLLECTION)
    ("neural precursor genes" . SPARSER::GENE)
    ("SOX1 , SOX3 , OLIG2 , NCAM and PAX6" . SPARSER::COLLECTION)
    ("NCAM" . SPARSER::PROTEIN)
    ("growth factors and proper surface substrates" . SPARSER::COLLECTION)
    ("only one transcription factor" . SPARSER::PROTEIN)
    ("the pluripotent state" . SPARSER::BIO-STATE)
    ("regenerative medicine" . SPARSER::DRUG)
    ("Bromodeoxyuridine" . SPARSER::DRUG)
    ("either SOX2 (SiNSc-like) or SOX2 and c-MYC (SMiNSc-like)"
     . SPARSER::COLLECTION)
    ("SOX2 and c-MYC" . SPARSER::COLLECTION) ("p16INK4a" . SPARSER::PROTEIN)
    ("CIP2A" . SPARSER::PROTEIN) ("GABA)" . SPARSER::PROTEIN)
    ("GAD65" . SPARSER::PROTEIN) ("VGLUT1" . SPARSER::PROTEIN)
    ("Synapsin I" . SPARSER::PROTEIN) ("beta-1" . SPARSER::PROTEIN)
    ("NKX2 . 2" . SPARSER::PROTEIN) ("TWIST2" . SPARSER::PROTEIN)
    ("COL1A1" . SPARSER::PROTEIN) ("NKX2.2" . SPARSER::PROTEIN)
    ("MSI1" . SPARSER::PROTEIN) ("Musashi-1" . SPARSER::PROTEIN)
    ("SOX17" . SPARSER::PROTEIN) ("αSMA" . SPARSER::PROTEIN)
    ("Tra-1" . SPARSER::PROTEIN) ("X-Gal" . SPARSER::MOLECULE)
    ("β-Gal" . SPARSER::PROTEIN) ("β-Galactosidase" . SPARSER::PROTEIN)
    ("HPRT1" . SPARSER::PROTEIN) ("L-Ornithine" . SPARSER::DRUG)
    ("Mitomycin C" . SPARSER::DRUG) ("Amino Acids" . SPARSER::AMINO-ACID)
    ("F-12" . SPARSER::PROTEIN) ("OLIG2" . SPARSER::PROTEIN)
    ("SOX3" . SPARSER::PROTEIN) ("SOX1" . SPARSER::PROTEIN)
    ("beta-galactosidase" . SPARSER::PROTEIN) ("poison" . SPARSER::MOLECULE)
    ("an inefficient SAC" . SPARSER::PROTEIN)
    ("hMps1 and ATM" . SPARSER::COLLECTION)
    ("ATM-RNF20/RNF40-H2B" . SPARSER::COLLECTION)
    ("histone and DNA" . SPARSER::COLLECTION)
    ("orthologs, RNF20 and RNF40" . SPARSER::COLLECTION)
    ("the oxidative DDR" . SPARSER::PROTEIN)
    ("MDM2 and histone H2B" . SPARSER::COLLECTION)
    ("hMps1 and H2B" . SPARSER::COLLECTION)
    ("MDM2 and Mps1" . SPARSER::COLLECTION)
    ("RPA and XRCC1" . SPARSER::COLLECTION) ("soluble H2B" . SPARSER::PROTEIN)
    ("soluble histones" . SPARSER::PROTEIN)
    ("Ataxia telangiectasia mutated and Rad3" . SPARSER::COLLECTION)
    ("CHK2 or ATM" . SPARSER::COLLECTION) ("DsRed-MDM2" . SPARSER::COLLECTION)
    ("PARP-1 and XRCC1" . SPARSER::COLLECTION)
    ("hMps1 and the proteins" . SPARSER::COLLECTION)
    ("MDM2, hMps1 and the proteins" . SPARSER::COLLECTION)
    ("hMps1-MDM2" . SPARSER::COLLECTION)
    ("MDM2 or hMps1" . SPARSER::COLLECTION) ("Flag-H2B" . SPARSER::COLLECTION)
    ("KR" . SPARSER::PROTEIN-FAMILY)
    ("DNA (Figure xref ) and consequently reduced clonogenic cell survival (Figure xref )"
     . SPARSER::COLLECTION)
    ("SNF2h" . SPARSER::PROTEIN)
    ("the T4/T306/S307D triple mutant" . SPARSER::MUTANT)
    ("WT MDM2 and the Ala mutants" . SPARSER::COLLECTION)
    ("KD hMps1with MDM2 and His-tagged ubiquitin" . SPARSER::COLLECTION)
    ("the truncated MDM2 (amino acids 1–13) and Thr306/Ser307"
     . SPARSER::COLLECTION)
    ("Thr/Ser" . SPARSER::COLLECTION) ("GST-fused" . SPARSER::COLLECTION)
    ("mutant (KD)" . SPARSER::MUTANT)
    ("human Mps1 (hMps1) and MDM2" . SPARSER::COLLECTION)
    ("oxidative DDR" . SPARSER::PROTEIN)
    ("ubiquitin ligase, RNF20 and RNF40" . SPARSER::COLLECTION)
    ("Mdmx ( xref ) and histone H2B ( xref )" . SPARSER::COLLECTION)
    ("APE1 ( xref ), Mdmx ( xref ) and histone H2B ( xref )"
     . SPARSER::COLLECTION)
    ("Mdmx" . SPARSER::PROTEIN) ("SAC" . SPARSER::PROTEIN)
    ("p53-MDM2" . SPARSER::COLLECTION)
    ("Human Mps1 (hMps1) or TTK" . SPARSER::COLLECTION)
    ("TTK" . SPARSER::PROTEIN) ("hMps1-MDM2-H2B" . SPARSER::COLLECTION)
    ("hMps1 and MDM2" . SPARSER::COLLECTION)
    ("MDM2 and hMps1" . SPARSER::COLLECTION)
    ("hMps1 or MDM2" . SPARSER::COLLECTION) ("ATM-CHK2" . SPARSER::COLLECTION)
    ("ATR-CHK1" . SPARSER::COLLECTION) ("MDM2-H2B" . SPARSER::COLLECTION)
    ("PARP-1" . SPARSER::PROTEIN) ("S6E" . SPARSER::PROTEIN-FAMILY)
    ("S6D" . SPARSER::PROTEIN) ("SNF2" . SPARSER::PROTEIN)
    ("S4" . SPARSER::PROTEIN-FAMILY) ("S3A" . SPARSER::PROTEIN)
    ("ligase activity" . SPARSER::PROTEIN) ("1D" . SPARSER::PROTEIN)
    ("T4A" . SPARSER::PROTEIN) ("1C" . SPARSER::PROTEIN)
    ("yoyo-1" . SPARSER::MOLECULE) ("CRM1" . SPARSER::PROTEIN)
    ("pS33" . SPARSER::PROTEIN) ("RPA2" . SPARSER::PROTEIN)
    ("2KR" . SPARSER::PROTEIN) ("T-1" . SPARSER::PROTEIN)
    ("H3 histone" . SPARSER::PROTEIN) ("RNF40" . SPARSER::PROTEIN)
    ("RNF20" . SPARSER::PROTEIN)
    ("Histone H2B" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Ataxia telangiectasia mutated" . SPARSER::PROTEIN)
    ("MDM2 protein" . SPARSER::PROTEIN) ("APE1" . SPARSER::PROTEIN)
    ("c-Abl" . SPARSER::PROTEIN)
    ("histone H2B" . SPARSER::HUMAN-PROTEIN-FAMILY) ("H2B" . SPARSER::PROTEIN)
    ("hMps1" . SPARSER::PROTEIN) ("Mps1" . SPARSER::PROTEIN)
    ("TNF receptor fusion protein etanercept and anti-TNF-1α monoclonal antibody infliximab"
     . SPARSER::COLLECTION)
    ("infliximab" . SPARSER::DRUG) ("etanercept" . SPARSER::DRUG)
    ("adalimumab" . SPARSER::DRUG)
    ("multiple pro-inflammatory molecules" . SPARSER::MOLECULE)
    ("ubiquitin-specific peptidase 18 and MX dynamin-like guanosine triphosphatase"
     . SPARSER::COLLECTION)
    ("a well-defined miRNA" . SPARSER::PROTEIN)
    ("IFN-α/IFN-β" . SPARSER::COLLECTION) ("triphosphatase" . SPARSER::PROTEIN)
    ("dynamin" . SPARSER::PROTEIN) ("MX" . SPARSER::PROTEIN)
    ("miR-16, miR-221 and let-7i" . SPARSER::COLLECTION)
    ("IFN" . SPARSER::DRUG) ("interferon" . SPARSER::PROTEIN)
    ("RA or OA" . SPARSER::COLLECTION)
    ("HAT as well as HDAC ( xref )" . SPARSER::COLLECTION)
    ("HAT/HDAC" . SPARSER::COLLECTION) ("RA" . SPARSER::PROTEIN)
    ("histones as well as non-histone signal transduction proteins"
     . SPARSER::COLLECTION)
    ("HAT and HDAC" . SPARSER::COLLECTION)
    ("acetyltransferase (HAT)" . SPARSER::PROTEIN)
    ("acetyltransferase" . SPARSER::PROTEIN)
    ("interferon-induced" . SPARSER::PROTEIN) ("IFN-β" . SPARSER::PROTEIN)
    ("regulator of calcineurin 1" . SPARSER::PROTEIN)
    ("miRNA-16" . SPARSER::RNA) ("g protein" . SPARSER::PROTEIN)
    ("murine leukemia virus" . SPARSER::PROTEIN) ("let-7" . SPARSER::RNA)
    ("HDAC3" . SPARSER::PROTEIN)
    ("an mTOR inhibitor (e.g., rapamycin) and an autophagy inhibitor (e.g., Spautin-1)"
     . SPARSER::COLLECTION)
    ("temsirolimus" . SPARSER::DRUG) ("CQ and rapamycin" . SPARSER::COLLECTION)
    ("our western blot" . SPARSER::PROTEIN)
    ("cellular proteins and cytoplasmic organelles" . SPARSER::COLLECTION)
    ("S6K and 4E-BP1" . SPARSER::COLLECTION)
    ("Raptor, mLST8 and PRAS40" . SPARSER::COLLECTION)
    ("mSIN1 and Protor-1" . SPARSER::COLLECTION)
    ("the Rap group and the Rap-plus-Spa group" . SPARSER::COLLECTION)
    ("the control group and the Spa group" . SPARSER::COLLECTION)
    ("Annexin V/PI" . SPARSER::COLLECTION)
    ("polyubiquitinated" . SPARSER::PROTEIN)
    ("p62/SQSTM1" . SPARSER::COLLECTION)
    ("20 μM rapamycin and 100 μM Spautin-1" . SPARSER::COLLECTION)
    ("rapamycin and/or Spautin-1" . SPARSER::COLLECTION)
    ("rapamycin and Spautin-1" . SPARSER::COLLECTION)
    ("nutrient" . SPARSER::MOLECULE) ("USP10 and USP13" . SPARSER::COLLECTION)
    ("Vps34" . SPARSER::PROTEIN)
    ("mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2)"
     . SPARSER::COLLECTION)
    ("Akt and its downstream target" . SPARSER::COLLECTION)
    ("an essential serine/threonine kinase" . SPARSER::KINASE)
    ("growth factor receptors or intracellular signaling proteins"
     . SPARSER::COLLECTION)
    ("an mTOR inhibitor and an autophagy inhibitor" . SPARSER::COLLECTION)
    ("Protor-1" . SPARSER::PROTEIN) ("mSIN1" . SPARSER::PROTEIN)
    ("PRAS40" . SPARSER::PROTEIN) ("mLST8" . SPARSER::PROTEIN)
    ("sequestosome 1" . SPARSER::PROTEIN) ("LC-3" . SPARSER::PROTEIN)
    ("SQSTM1" . SPARSER::PROTEIN) ("Beclin-1" . SPARSER::PROTEIN)
    ("USP13" . SPARSER::PROTEIN) ("USP10" . SPARSER::PROTEIN)
    ("PI 3 kinase" . SPARSER::PROTEIN)
    ("Mammalian target of rapamycin" . SPARSER::PROTEIN)
    ("Spautin-1" . SPARSER::DRUG)
    ("both MITF and its melanocytic target genes" . SPARSER::COLLECTION)
    ("global cell state" . SPARSER::BIO-STATE)
    ("its melanocytic target genes" . SPARSER::GENE)
    ("Gli2, Tcf4 and Brn-2" . SPARSER::COLLECTION) ("Gli" . SPARSER::PROTEIN)
    ("MITF- and NF-κB" . SPARSER::COLLECTION) ("MITF-" . SPARSER::PROTEIN)
    ("a stable ‘invasive' melanoma cell state" . SPARSER::BIO-STATE)
    ("TEAD and AP-1" . SPARSER::COLLECTION) ("TEAD" . SPARSER::PROTEIN)
    ("Sox10/MITF" . SPARSER::COLLECTION) ("JunB-ATF2" . SPARSER::COLLECTION)
    ("ERK/JNK" . SPARSER::COLLECTION)
    ("the MITF-driven proliferative cell state" . SPARSER::BIO-STATE)
    ("genes and turns" . SPARSER::COLLECTION)
    ("TNF-α and other cytokines" . SPARSER::COLLECTION)
    ("The NF-κB and c-Jun/AP-1 transcription factor complexes"
     . SPARSER::COLLECTION)
    ("a major pro-inflammatory cytokine" . SPARSER::PROTEIN)
    ("c-Jun/AP-1 transcription factor" . SPARSER::COLLECTION)
    ("Tnf and its downstream target Ccl2" . SPARSER::COLLECTION)
    ("Tnf" . SPARSER::PROTEIN)
    ("syngeneic HCmel3-R-2514 melanomas re-differentiated and re-expressed gp100"
     . SPARSER::DRUG)
    ("the melanocytic antigen gp100" . SPARSER::DRUG)
    ("c-Jun and chemokine" . SPARSER::COLLECTION)
    ("Ccl5, Ccl2 and Cxcl10" . SPARSER::COLLECTION)
    ("Cxcl10" . SPARSER::PROTEIN) ("Ccl2" . SPARSER::PROTEIN)
    ("Ccl5" . SPARSER::PROTEIN) ("Ccl" . SPARSER::DRUG)
    ("chemoattractants" . SPARSER::PROTEIN)
    ("the dedifferentiated ( in vitro ) HCmel3-R cell lines (gp100 − ) re-differentiated and re-expressed gp100"
     . SPARSER::DRUG)
    ("Hgf-Cdk4" . SPARSER::COLLECTION) ("/c-JUN" . SPARSER::COLLECTION)
    ("CD14 and CSF1R" . SPARSER::COLLECTION)
    ("MITF or its target MLANA" . SPARSER::COLLECTION)
    ("c-JUN or AXL" . SPARSER::COLLECTION)
    ("CSF1R or CD14" . SPARSER::COLLECTION)
    ("CD14 , CSF1R and CD3D" . SPARSER::COLLECTION) ("CD3E" . SPARSER::PROTEIN)
    ("CD3D" . SPARSER::PROTEIN) ("/c- JUN" . SPARSER::COLLECTION)
    ("AXL , NGFR and EGFR" . SPARSER::COLLECTION)
    ("IL1B , IL6 and CCL20" . SPARSER::COLLECTION)
    ("transcription factor and inducer" . SPARSER::COLLECTION)
    ("JunB/ATF2" . SPARSER::COLLECTION) ("JunB" . SPARSER::PROTEIN)
    ("Jun–GFP" . SPARSER::COLLECTION)
    ("AXL , NGFR and IL1B" . SPARSER::COLLECTION)
    ("MITF and MLANA" . SPARSER::COLLECTION)
    ("AXL and NGFR" . SPARSER::COLLECTION) ("AXL" . SPARSER::PROTEIN)
    ("MLANA" . SPARSER::PROTEIN) ("bona fide TNF-α" . SPARSER::PROTEIN)
    ("IL-1β and IL-6" . SPARSER::COLLECTION)
    ("particular IL-1β" . SPARSER::PROTEIN)
    ("several other pro-inflammatory cytokines" . SPARSER::PROTEIN)
    ("interferon-γ, IL-1β, IL-6, IL-8 and chemokine" . SPARSER::COLLECTION)
    ("interferon-γ" . SPARSER::PROTEIN)
    ("cytokine or chemokine" . SPARSER::COLLECTION)
    ("IL1B , IL6 , CCL20 and THBS1" . SPARSER::COLLECTION)
    ("c-JUN and MITF" . SPARSER::COLLECTION)
    ("MITF and c-JUN" . SPARSER::COLLECTION)
    ("MITF/c-Jun" . SPARSER::COLLECTION)
    ("Ma-Mel-65 cells (MITF low ) conditionally re-expressing MITF"
     . SPARSER::PROTEIN)
    ("triple haemagglutinin (HA)-tagged MITF" . SPARSER::PROTEIN)
    ("haemagglutinin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("c-Jun/FOSL1" . SPARSER::COLLECTION)
    ("the respective proteins" . SPARSER::PROTEIN)
    ("strongly and consistently anti-correlated genes" . SPARSER::GENE)
    ("c-JUN and FOSL1" . SPARSER::COLLECTION)
    ("SRF, NF-κB and AP-1" . SPARSER::COLLECTION) ("SRF" . SPARSER::PROTEIN)
    ("AP-1 and NF-κB" . SPARSER::COLLECTION)
    ("eGFP-MITF" . SPARSER::COLLECTION) ("eGFP" . SPARSER::PROTEIN)
    ("Mel" . SPARSER::PROTEIN) ("p65/RelA" . SPARSER::COLLECTION)
    ("MITF and its targets" . SPARSER::COLLECTION)
    ("IL1B and IL6" . SPARSER::COLLECTION)
    ("the melanocytic lineage transcription factor MITF" . SPARSER::PROTEIN)
    ("NGFR" . SPARSER::PROTEIN)
    ("the melanocytic target antigen gp100" . SPARSER::DRUG)
    ("Pmel" . SPARSER::PROTEIN) ("pmel" . SPARSER::PROTEIN)
    ("These developmental traits" . SPARSER::PROTEIN)
    ("morphogenetic cues" . SPARSER::PROTEIN-FAMILY)
    ("TNFa" . SPARSER::PROTEIN) ("/c-Jun" . SPARSER::COLLECTION)
    ("cytokine and chemokine" . SPARSER::COLLECTION)
    ("MITF and c-Jun" . SPARSER::COLLECTION) ("MITF" . SPARSER::PROTEIN)
    ("GK1" . SPARSER::PROTEIN) ("Gr1" . SPARSER::PROTEIN)
    ("M1" . SPARSER::MOLECULE) ("HMB45" . SPARSER::DRUG)
    ("NBP1" . SPARSER::PROTEIN) ("H-2b" . SPARSER::PROTEIN)
    ("TNF-alpha" . SPARSER::DRUG) ("CXCL10" . SPARSER::PROTEIN)
    ("fluorescein isothiocyanate" . SPARSER::MOLECULE)
    ("p42/44" . SPARSER::PROTEIN) ("L35A" . SPARSER::PROTEIN)
    ("N5" . SPARSER::PROTEIN) ("P5" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("gag-pol" . SPARSER::PROTEIN) ("L -glutamine" . SPARSER::MOLECULE)
    ("Brn-2" . SPARSER::PROTEIN) ("Sox10" . SPARSER::PROTEIN)
    ("Gr-1" . SPARSER::PROTEIN) ("CSF1R" . SPARSER::PROTEIN)
    ("c- JUN" . SPARSER::PROTEIN) ("SOX10" . SPARSER::PROTEIN)
    ("C-C motif" . SPARSER::PROTEIN) ("THBS1" . SPARSER::PROTEIN)
    ("CCL20" . SPARSER::PROTEIN) ("H3K27ac" . SPARSER::MOLECULE)
    ("FOSL1" . SPARSER::PROTEIN) ("c-JUN" . SPARSER::PROTEIN)
    ("IL-1β" . SPARSER::PROTEIN) ("messenger RNA" . SPARSER::RNA)
    ("IL1B" . SPARSER::PROTEIN)
    ("microphthalmia-associated transcription factor" . SPARSER::PROTEIN)
    ("gp100" . SPARSER::DRUG) ("MLH1 and BRAF" . SPARSER::COLLECTION)
    ("Tobacco" . SPARSER::DRUG)
    ("the adenomatous polyposis coli (APC) tumor suppressor gene"
     . SPARSER::PROTEIN)
    ("incident CRCs" . SPARSER::PROTEIN) ("smoke" . SPARSER::MOLECULE)
    ("Cigarette" . SPARSER::DRUG) ("cigarette" . SPARSER::DRUG)
    ("triglycerides" . SPARSER::MOLECULE)
    ("mutant KRAS and wild-type KRAS" . SPARSER::COLLECTION)
    ("MMR" . SPARSER::PROTEIN) ("Asp" . SPARSER::AMINO-ACID)
    ("metastatic CRC" . SPARSER::PROTEIN)
    ("KRAS and BRAF" . SPARSER::COLLECTION)
    ("BRAF or KRAS" . SPARSER::COLLECTION)
    ("KRAS (36.6%) and BRAF (3.46%)" . SPARSER::COLLECTION)
    ("methyltransferase activity" . SPARSER::PROTEIN)
    ("HDL-cholesterol" . SPARSER::MOLECULE)
    ("larger patient cohorts" . SPARSER::MOLECULE)
    ("APOBEC" . SPARSER::BIO-COMPLEX)
    ("PIK3CA , or perhaps" . SPARSER::COLLECTION)
    ("a favorable predictive biomarker" . SPARSER::MOLECULE)
    ("receptors and ligands" . SPARSER::COLLECTION)
    ("Trp" . SPARSER::AMINO-ACID) ("mycotoxin" . SPARSER::MOLECULE)
    ("PIK3CA and NOTCH1" . SPARSER::COLLECTION)
    ("TP53 and PIK3CA" . SPARSER::COLLECTION) ("DP" . SPARSER::PROTEIN)
    ("RTCA" . SPARSER::PROTEIN) ("FAM135B and EP300" . SPARSER::COLLECTION)
    ("FAM" . SPARSER::PROTEIN) ("NCCN" . SPARSER::MOLECULE)
    ("NOTCH1 or PIK3CA" . SPARSER::COLLECTION)
    ("others previously identified SMGs" . SPARSER::PROTEIN)
    ("AJUBA" . SPARSER::PROTEIN) ("SMGs" . SPARSER::PROTEIN)
    ("only one pathway component" . SPARSER::COMPONENT)
    ("genes or pathways" . SPARSER::COLLECTION) ("tobacco" . SPARSER::DRUG)
    ("Alcohol" . SPARSER::DRUG) ("NOTCH1 and PIK3CA" . SPARSER::COLLECTION)
    ("pMD2" . SPARSER::MOLECULE) ("m2" . SPARSER::MOLECULE)
    ("apolipoprotein B" . SPARSER::PROTEIN)
    ("gamma secretase" . SPARSER::PROTEIN) ("EP300" . SPARSER::PROTEIN)
    ("ZNF750" . SPARSER::PROTEIN) ("FBXW7" . SPARSER::PROTEIN)
    ("FAT1" . SPARSER::PROTEIN) ("NOTCH1" . SPARSER::PROTEIN)
    ("VEGF, interleukin-8, and basic fibroblast growth factor"
     . SPARSER::COLLECTION)
    ("miR-622 directly targets HIF-1α" . SPARSER::PROTEIN)
    ("ERK-FOXO3a" . SPARSER::COLLECTION) ("ERK-HIF-1α" . SPARSER::COLLECTION)
    ("oligonucleotide" . SPARSER::MOLECULE)
    ("endogenous FOXO3a mRNA ( xref ) and protein ( xref )"
     . SPARSER::COLLECTION)
    ("either promoter construct (−845/+1)-Luc or miR-622 (−376/+1)-Luc"
     . SPARSER::COLLECTION)
    ("-Luc" . SPARSER::COLLECTION) ("Luc" . SPARSER::PROTEIN)
    ("FOXOs" . SPARSER::PROTEIN-FAMILY) ("EGF/ERK" . SPARSER::COLLECTION)
    ("EGF/AKT/ERK" . SPARSER::COLLECTION) ("/AKT/ERK" . SPARSER::COLLECTION)
    ("hematoxylin and eosin staining" . SPARSER::COLLECTION)
    ("hematoxylin" . SPARSER::MOLECULE)
    ("HIF-1α (wild-type HIF-1α 3′-UTR-luc) as well as a 3"
     . SPARSER::COLLECTION)
    ("luc" . SPARSER::PROTEIN) ("-luciferase" . SPARSER::COLLECTION)
    ("mitogen-activated protein kinase/extracellular signal–regulated kinase"
     . SPARSER::COLLECTION)
    ("the mesenchymal markers β-catenin and vimentin" . SPARSER::COLLECTION)
    ("β-catenin and vimentin" . SPARSER::COLLECTION)
    ("genesis" . SPARSER::PROTEIN) ("mesenchymal proteins" . SPARSER::PROTEIN)
    ("Snail, β-catenin, and vimentin" . SPARSER::COLLECTION)
    ("interleukin-8" . SPARSER::PROTEIN)
    ("von Hippel-Lindau" . SPARSER::PROTEIN) ("HIF 1α" . SPARSER::PROTEIN)
    ("pGL4" . SPARSER::PROTEIN)
    ("extracellular signal–regulated kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("hypoxia-inducible factor-1" . SPARSER::PROTEIN)
    ("FOXO3a" . SPARSER::PROTEIN)
    ("Hypoxia-inducible factor-1" . SPARSER::PROTEIN)
    ("PI3K and MAPK" . SPARSER::COLLECTION)
    ("ERK1/2, JNK, and p38" . SPARSER::COLLECTION)
    ("macrophages and neutrophils" . SPARSER::COLLECTION)
    ("CC-chemokine" . SPARSER::PROTEIN-PAIR)
    ("glycosylphosphatidylinositol" . SPARSER::MOLECULE)
    ("matrix metalloproteinase-2 and IL-22" . SPARSER::COLLECTION)
    ("cytotoxic and IFN-γ" . SPARSER::COLLECTION) ("MHC" . SPARSER::PROTEIN)
    ("enteric" . SPARSER::PROTEIN)
    ("excretory/secretory proteins or soluble antigen" . SPARSER::COLLECTION)
    ("ERK1/2 and JNK" . SPARSER::COLLECTION)
    ("AKT and MAPK" . SPARSER::COLLECTION)
    ("p38, ERK1/2 or JNK" . SPARSER::COLLECTION)
    ("ERK1/2 (PD98059) or JNK (SP600125) inhibitors" . SPARSER::COLLECTION)
    ("p38 MAPK (SB203580), ERK1/2 (PD98059) or JNK (SP600125) inhibitors"
     . SPARSER::COLLECTION)
    ("MAPK, ERK1/2 or JNK" . SPARSER::COLLECTION)
    ("MAPK, ERK1/2, and JNK" . SPARSER::COLLECTION)
    ("20 μM LY294002 or 200 nM wortmannin" . SPARSER::COLLECTION)
    ("LY294002 or wortmannin" . SPARSER::COLLECTION)
    ("TLR4, and IL-23" . SPARSER::COLLECTION) ("CSK" . SPARSER::PROTEIN)
    ("Pam" . SPARSER::PROTEIN) ("IL-12 or IL-23" . SPARSER::COLLECTION)
    ("mAbs" . SPARSER::DRUG) ("Solution" . SPARSER::MOLECULE)
    ("p40 and p19" . SPARSER::COLLECTION)
    ("p19, p40 and p35" . SPARSER::COLLECTION)
    ("p19 and p35" . SPARSER::COLLECTION)
    ("two heterodimeric cytokines" . SPARSER::PROTEIN)
    ("IL-12 and IL-23" . SPARSER::COLLECTION)
    ("p35 and p40" . SPARSER::COLLECTION)
    ("IL-12 and p19 and p40" . SPARSER::COLLECTION)
    ("IL-23 or IL-12" . SPARSER::COLLECTION)
    ("anti-TLR2 or anti-TLR4" . SPARSER::COLLECTION)
    ("TLR4 or TLR2" . SPARSER::COLLECTION)
    ("monoclonal antibodies (mAb) and/or specific inhibitors or agonists"
     . SPARSER::COLLECTION)
    ("inhibitors or agonists" . SPARSER::COLLECTION)
    ("PI3K, AKT, and MAPK" . SPARSER::COLLECTION)
    ("TLR2/TLR4" . SPARSER::COLLECTION) ("AKT, and MAPK" . SPARSER::COLLECTION)
    ("TLR2 or TLR4" . SPARSER::COLLECTION) ("Macrophages" . SPARSER::PROTEIN)
    ("MAPK and ERK1/2" . SPARSER::COLLECTION)
    ("stress-activated protein kinases (SAPK)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("kinases (JNK)" . SPARSER::PROTEIN)
    ("MAPK, ERK1/2, and c-Jun" . SPARSER::COLLECTION)
    ("SAPK" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Phosphoinositide" . SPARSER::PROTEIN)
    ("TLR2 and TLR4" . SPARSER::COLLECTION) ("DCs" . SPARSER::MOLECULE)
    ("p19 and p40" . SPARSER::COLLECTION)
    ("a heterodimeric cytokine" . SPARSER::PROTEIN)
    ("p40 and p35" . SPARSER::COLLECTION)
    ("IL-12, IL-23 and IL-27" . SPARSER::COLLECTION)
    ("fetuses" . SPARSER::PROTEIN) ("PI3K and ERK1/2" . SPARSER::COLLECTION)
    ("MAPK, ERK1/2 and JNK" . SPARSER::COLLECTION)
    ("LY294002 and wortmannin" . SPARSER::COLLECTION) ("mAb" . SPARSER::DRUG)
    ("TLR2" . SPARSER::PROTEIN) ("IL-23 and IL-12" . SPARSER::COLLECTION)
    ("THP-1" . SPARSER::PROTEIN) ("Interleukin" . SPARSER::PROTEIN)
    ("CCL2" . SPARSER::PROTEIN)
    ("matrix metalloproteinase-2" . SPARSER::PROTEIN)
    ("IFN-γ" . SPARSER::PROTEIN) ("CCR2" . SPARSER::PROTEIN)
    ("MCP-1" . SPARSER::PROTEIN)
    ("serine/threonine protein kinase" . SPARSER::PROTEIN)
    ("18 h" . SPARSER::PROTEIN)
    ("extracellular signal-regulated kinase 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("JNK2" . SPARSER::PROTEIN)
    ("stress-activated protein kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MyD88" . SPARSER::PROTEIN) ("IL-12 receptor" . SPARSER::PROTEIN)
    ("IL-12Rβ1" . SPARSER::PROTEIN) ("p35" . SPARSER::PROTEIN)
    ("p40" . SPARSER::PROTEIN) ("IL-27" . SPARSER::PROTEIN)
    ("interleukin-12" . SPARSER::PROTEIN) ("IL-23" . SPARSER::PROTEIN)
    ("IL-12" . SPARSER::PROTEIN)
    ("S3I-201 (50 μM) or LLL12 (1 μM)" . SPARSER::COLLECTION)
    ("salinomycin and S3I-201" . SPARSER::COLLECTION)
    ("LLL" . SPARSER::MOLECULE) ("Nanog and Sox2" . SPARSER::COLLECTION)
    ("Nanog and Oct4" . SPARSER::COLLECTION) ("Nanog" . SPARSER::PROTEIN)
    ("phospho-JAK2 and total JAK2" . SPARSER::COLLECTION)
    ("cyclin D1, survivin, and Skp2" . SPARSER::COLLECTION)
    ("cyclin D1 and the matrix metalloproteinases MMP-2 and MMP-9 [ xref , xref , xref ]"
     . SPARSER::COLLECTION)
    ("MMP-2 and MMP-9" . SPARSER::COLLECTION)
    ("JAK2 and phospho-JAK2" . SPARSER::COLLECTION)
    ("STAT3 and phospho-STAT3" . SPARSER::COLLECTION)
    ("HEMA" . SPARSER::PROTEIN) ("an anticoccidial drug" . SPARSER::DRUG)
    ("an attractive therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("cyclin D1 and survivin" . SPARSER::COLLECTION)
    ("kinase (FAK)" . SPARSER::KINASE) ("Anoikis" . SPARSER::PROTEIN)
    ("ESA" . SPARSER::PROTEIN) ("estrogen receptor (ER)" . SPARSER::PROTEIN)
    ("MMP-9 and MMP-2" . SPARSER::COLLECTION) ("Salinomycin" . SPARSER::DRUG)
    ("Aldehyde dehydrogenase" . SPARSER::PROTEIN)
    ("Janus kinase 2" . SPARSER::PROTEIN) ("caspases 3" . SPARSER::PROTEIN)
    ("Murine Leukemia Virus" . SPARSER::PROTEIN) ("ALDH1" . SPARSER::PROTEIN)
    ("p27 kip1 and MARCKS" . SPARSER::COLLECTION)
    ("mTOR inhibitors (mammalian target of rapamycin) and paclitaxel"
     . SPARSER::COLLECTION)
    ("sirolimus" . SPARSER::DRUG) ("wire" . SPARSER::PROTEIN)
    ("enzyme or metabolite" . SPARSER::COLLECTION)
    ("multiple kinases, enzymes, and their substrates in the p27 kip1 pathway"
     . SPARSER::COLLECTION)
    ("CDKI" . SPARSER::DRUG)
    ("CD31 (red) and DAPI ( xref )" . SPARSER::COLLECTION)
    ("BrdU ( xref ) and Ki-67" . SPARSER::COLLECTION)
    ("vascular EC" . SPARSER::PROTEIN)
    ("MARCKS siRNA and WT KIS ( xref , p = not significant)"
     . SPARSER::COLLECTION)
    ("KIS and K45R" . SPARSER::COLLECTION)
    ("KIS and pSer10-p27 kip1" . SPARSER::COLLECTION)
    ("pSer10-p27 kip1 and KIS" . SPARSER::COLLECTION)
    ("pSer10-p27 kip1 , pThr187-p27 kip1 , and ubiquitin ligase"
     . SPARSER::COLLECTION)
    ("pThr" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("stathmin (KIS)" . SPARSER::PROTEIN)
    ("proliferating cell nuclear antigen (PCNA)" . SPARSER::PROTEIN)
    ("siRNA or non-targeting" . SPARSER::COLLECTION)
    ("smooth muscle" . SPARSER::PROTEIN)
    ("p21 cip1 and p27 kip1" . SPARSER::COLLECTION) ("CDKIs" . SPARSER::DRUG)
    ("mitogen" . SPARSER::MITOGEN)
    ("a membrane-associated protein and a major substrate"
     . SPARSER::COLLECTION)
    ("a membrane-associated protein" . SPARSER::PROTEIN)
    ("bromodeoxyuridine" . SPARSER::DRUG)
    ("cyclin D1, and Skp2" . SPARSER::COLLECTION) ("KIS" . SPARSER::PROTEIN)
    ("stathmin" . SPARSER::PROTEIN) ("substrate (MARCKS)" . SPARSER::SUBSTRATE)
    ("MARCKS" . SPARSER::PROTEIN) ("K45" . SPARSER::PROTEIN)
    ("K54" . SPARSER::PROTEIN) ("regulator of cell cycle" . SPARSER::PROTEIN)
    ("DNase I" . SPARSER::PROTEIN)
    ("proliferating cell nuclear antigen" . SPARSER::PROTEIN)
    ("cyclin E 1" . SPARSER::PROTEIN) ("cyclin D 1" . SPARSER::PROTEIN)
    ("1 K" . SPARSER::PROTEIN) ("α-actin" . SPARSER::PROTEIN)
    ("p27 kip1" . SPARSER::PROTEIN)
    ("p21 cip1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("kip1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cyclin-dependent kinase inhibitor p27" . SPARSER::PROTEIN)
    ("HGF-hepatocyte growth factor receptor" . SPARSER::COLLECTION)
    ("cMet" . SPARSER::PROTEIN) ("RTKs" . SPARSER::PROTEIN)
    ("GEFs and GAPs" . SPARSER::COLLECTION) ("GEF" . SPARSER::GEF)
    ("Vps" . SPARSER::PROTEIN) ("GEFs" . SPARSER::PROTEIN)
    ("a dominant-negative Rab5 mutant" . SPARSER::MUTANT)
    ("MP1/p14" . SPARSER::COLLECTION) ("LAMTOR" . SPARSER::PROTEIN-FAMILY)
    ("down less active exogenous or endogenous Rab5" . SPARSER::PROTEIN)
    ("R5BD" . SPARSER::PROTEIN)
    ("a dominant-negative Rab5 S43N mutant" . SPARSER::MUTANT)
    ("GST-R5BD" . SPARSER::COLLECTION) ("Rab5 and EEA1" . SPARSER::COLLECTION)
    ("puncta" . SPARSER::PROTEIN) ("Lamp1-mCherry" . SPARSER::COLLECTION)
    ("CMTM7-GFP" . SPARSER::COLLECTION) ("Lamp1" . SPARSER::PROTEIN)
    ("DsRed-Rab5" . SPARSER::COLLECTION) ("DsRed" . SPARSER::PROTEIN)
    ("Rab5 and EEA1-positive microdomains" . SPARSER::COLLECTION)
    ("TR-EGF" . SPARSER::COLLECTION) ("TR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("EGFR and AKT" . SPARSER::COLLECTION)
    ("CCK8 and Transwell" . SPARSER::COLLECTION)
    ("AKT and ERK" . SPARSER::COLLECTION) ("Ras/ERK" . SPARSER::COLLECTION)
    ("lentiviral short hairpin RNA" . SPARSER::RNA)
    ("EEA1 and Rabaptin-5" . SPARSER::COLLECTION)
    ("an inactive GDP-bound state and an active GTP-bound form"
     . SPARSER::COLLECTION)
    ("link classical chemokines and the transmembrane-4" . SPARSER::COLLECTION)
    ("link classical chemokines" . SPARSER::PROTEIN)
    ("family (CMTM)" . SPARSER::PROTEIN-FAMILY) ("CMTM" . SPARSER::PROTEIN)
    ("EGFR-AKT" . SPARSER::COLLECTION) ("protein-G" . SPARSER::PROTEIN)
    ("Nonidet P-40" . SPARSER::DRUG)
    ("hepatocyte growth factor receptor" . SPARSER::PROTEIN)
    ("Caveolin-1" . SPARSER::PROTEIN) ("GTPase-activating" . SPARSER::PROTEIN)
    ("MP1" . SPARSER::PROTEIN) ("APPL1" . SPARSER::PROTEIN)
    ("Rabaptin5" . SPARSER::PROTEIN) ("Rabaptin-5" . SPARSER::PROTEIN)
    ("EEA1" . SPARSER::PROTEIN) ("1-8" . SPARSER::PROTEIN)
    ("Rab5" . SPARSER::PROTEIN) ("CMTM7" . SPARSER::PROTEIN)
    ("Mst1 and PHLPP" . SPARSER::COLLECTION) ("Mst1" . SPARSER::PROTEIN)
    ("a trimetric complex" . SPARSER::BIO-COMPLEX)
    ("Scribble and Snail" . SPARSER::COLLECTION)
    ("Lats2 and TAZ" . SPARSER::COLLECTION) ("TAZ" . SPARSER::PROTEIN)
    ("DDP" . SPARSER::PROTEIN) ("isoproterenol" . SPARSER::PROTEIN)
    ("HuR and eIF4E" . SPARSER::COLLECTION) ("uridylate" . SPARSER::MOLECULE)
    ("the eukaryotic initiation factors (eIFs) family"
     . SPARSER::PROTEIN-FAMILY)
    ("RNPs" . SPARSER::PROTEIN)
    ("Polyribosomes and Increases Translation" . SPARSER::COLLECTION)
    ("Polyribosomes" . SPARSER::BIO-COMPLEX)
    ("Snail, and Slug" . SPARSER::COLLECTION)
    ("E-cadherin and N-cadherin" . SPARSER::COLLECTION)
    ("cadherins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CRL" . SPARSER::HUMAN-PROTEIN-FAMILY) ("HTB" . SPARSER::DRUG)
    ("The platinum chemotherapeutic agent cisplatin" . SPARSER::MOLECULE)
    ("-type" . TYPE) ("Snai" . SPARSER::PROTEIN-FAMILY)
    ("PKC and p38" . SPARSER::COLLECTION) ("PKC" . SPARSER::PROTEIN)
    ("ELAV" . SPARSER::PROTEIN) ("Rac" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("adherens-1" . SPARSER::COLLECTION) ("Zonula" . SPARSER::PROTEIN)
    ("imaginal discs" . SPARSER::BIO-COMPLEX) ("discs" . SPARSER::BIO-COMPLEX)
    ("Dlg" . SPARSER::PROTEIN) ("Discs" . SPARSER::BIO-COMPLEX)
    ("a neoplastic tumor suppressor gene" . SPARSER::PROTEIN)
    ("developmental transcription factor Snail" . SPARSER::PROTEIN)
    ("Drosophila" . SPARSER::PROTEIN) ("Scribble" . SPARSER::PROTEIN)
    ("Lats2" . SPARSER::PROTEIN) ("p-p38" . SPARSER::PROTEIN)
    ("Lamin B" . SPARSER::PROTEIN-FAMILY) ("N-Cadherin" . SPARSER::PROTEIN)
    ("Actinomycin D" . SPARSER::MOLECULE) ("C 2 H 2" . SPARSER::MOLECULE)
    ("Snai2" . SPARSER::PROTEIN) ("Snai1" . SPARSER::PROTEIN)
    ("KLF8" . SPARSER::PROTEIN) ("abnormal vision" . SPARSER::PROTEIN)
    ("tight junction" . SPARSER::PROTEIN) ("PSD95" . SPARSER::PROTEIN)
    ("topotecan and irinotecan" . SPARSER::COLLECTION)
    ("gemcitabine and fludarabine" . SPARSER::COLLECTION)
    ("fludarabine" . SPARSER::DRUG) ("melphalan" . SPARSER::DRUG)
    ("chlorambucil" . SPARSER::DRUG) ("topotecan" . SPARSER::DRUG)
    ("oxaliplatin and 5-FU" . SPARSER::COLLECTION)
    ("ATP/GTP" . SPARSER::PROTEIN-PAIR) ("NRAS and BRAF" . SPARSER::COLLECTION)
    ("-wt" . SPARSER::COLLECTION) ("mt" . SPARSER::PROTEIN)
    ("KRAS-mt" . SPARSER::COLLECTION) ("KRAS-wt" . SPARSER::COLLECTION)
    ("Rank" . SPARSER::PROTEIN) ("available KRAS" . SPARSER::PROTEIN)
    ("HRs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("CEA" . SPARSER::PROTEIN)
    ("carcinoembryonic" . SPARSER::PROTEIN) ("ABI" . SPARSER::PROTEIN-FAMILY)
    ("-ATGTTCTAATATAGTCACATTTTC-3" . SPARSER::COLLECTION)
    ("CACCAGTAATATGC-3" . SPARSER::COLLECTION)
    ("Pathological tissue bank" . SPARSER::PROTEIN) ("bank" . SPARSER::PROTEIN)
    ("Formalin" . SPARSER::MOLECULE) ("CRCs" . SPARSER::PROTEIN)
    ("Oxaliplatin and cisplatin" . SPARSER::COLLECTION)
    ("Oxaliplatin" . SPARSER::DRUG) ("Top2" . SPARSER::PROTEIN)
    ("DDAs" . SPARSER::DRUG) ("helicases" . SPARSER::PROTEIN)
    ("p  " . SPARSER::PROTEIN) ("Top1" . SPARSER::PROTEIN)
    ("group III" . SPARSER::PROTEIN) ("TOP1" . SPARSER::PROTEIN)
    ("gp130/JAK2/STAT3" . SPARSER::COLLECTION)
    ("elevated peritumoral IL-6" . SPARSER::PROTEIN)
    ("IL-6R(−) and gp130 (+)" . SPARSER::COLLECTION)
    ("the same angiogenic gene" . SPARSER::GENE)
    ("HIFs" . SPARSER::PROTEIN-FAMILY) ("TEC and PEC" . SPARSER::COLLECTION)
    ("TEC" . SPARSER::PROTEIN) ("IL-6R and gp130" . SPARSER::COLLECTION)
    ("hypoxia, IL-6, IL-6R, gp130, and CD68" . SPARSER::COLLECTION)
    ("IL-6R(−) and gp130(+)" . SPARSER::COLLECTION)
    ("Peritumoral HIF-1α" . SPARSER::PROTEIN)
    ("peritumoral MVD" . SPARSER::PROTEIN)
    ("IL-6 , IL-6R , and gp130" . SPARSER::COLLECTION)
    ("IL-6, IL-6R, gp130, and CD68" . SPARSER::COLLECTION)
    ("peritumoral IL-6R" . SPARSER::PROTEIN) ("rr " . SPARSER::MOLECULE)
    ("Peritumoral MVD" . SPARSER::PROTEIN)
    ("IL-6, IL-6R and gp130" . SPARSER::COLLECTION)
    ("IL-6, IL-6R, and gp130" . SPARSER::COLLECTION)
    ("IL-6R, gp130, CD68, and MVD" . SPARSER::COLLECTION)
    ("peritumoral hypoxia" . SPARSER::PROTEIN)
    ("soluble IL-6R" . SPARSER::PROTEIN)
    ("IL-6/IL-6R/gp130" . SPARSER::COLLECTION) ("EC" . SPARSER::PROTEIN)
    ("adriamycin, 5-fluorouracil, and sorafenib" . SPARSER::COLLECTION)
    ("adriamycin" . SPARSER::DRUG) ("/JAK2/STAT3" . SPARSER::COLLECTION)
    ("PI3K and AKT" . SPARSER::COLLECTION)
    ("IL-6, IL-6R, gp130, CD68, and HIF-1α" . SPARSER::COLLECTION)
    ("IL-6 and gp130" . SPARSER::COLLECTION)
    ("IL-6, IL-6R, gp130, CD68, HIF-1α, and microvessel" . SPARSER::COLLECTION)
    ("the interleukin-6 (IL-6)/soluble interleukin-6 receptor (sIL-6R) complex"
     . SPARSER::BIO-COMPLEX)
    ("PECs" . SPARSER::PROTEIN) ("sIL" . SPARSER::PROTEIN)
    ("Texas Red" . SPARSER::DRUG) ("CD105" . SPARSER::PROTEIN)
    ("anti-angiogenic" . SPARSER::DRUG) ("CD68" . SPARSER::PROTEIN)
    ("interleukin-6 receptor" . SPARSER::PROTEIN)
    ("microcephaly" . SPARSER::PROTEIN) ("p53 and Rb" . SPARSER::COLLECTION)
    ("cation" . SPARSER::MOLECULE) ("epileptic seizures" . SPARSER::PROTEIN)
    ("a congenital variant" . SPARSER::VARIANT) ("Tsc1" . SPARSER::PROTEIN)
    ("PTEN and TSC1/2" . SPARSER::COLLECTION)
    ("intractable epilepsy" . SPARSER::PROTEIN)
    ("the phosphomimetic glutamic acid" . SPARSER::AMINO-ACID)
    ("alanine" . SPARSER::AMINO-ACID) ("Foxg1-GFP" . SPARSER::COLLECTION)
    ("Retzius" . SPARSER::PROTEIN) ("FOXO1 or FOXO3A" . SPARSER::COLLECTION)
    ("FOXO" . SPARSER::PROTEIN-FAMILY) ("AKT3-FOXG1" . SPARSER::COLLECTION)
    ("AKT3 E17K and Reln siRNA" . SPARSER::COLLECTION)
    ("Cajal-Retzius" . SPARSER::COLLECTION) ("Reln" . SPARSER::PROTEIN)
    ("Cajal" . SPARSER::PROTEIN) ("RELN" . SPARSER::PROTEIN)
    ("GO" . SPARSER::PROTEIN)
    ("CDKN2B (encoding p15 INK4b ) and CCND1 (encoding cyclin D1)"
     . SPARSER::COLLECTION)
    ("CDKN2A (encoding p16 INK4a and p14 ARF ), CDKN2B (encoding p15 INK4b ) and CCND1 (encoding cyclin D1)"
     . SPARSER::COLLECTION)
    ("p16 INK4a and p14 ARF" . SPARSER::COLLECTION)
    ("homogeneous AKT3 E17K" . SPARSER::PROTEIN)
    ("AKT3 or AKT3" . SPARSER::COLLECTION)
    ("aberrant neuronal migration" . SPARSER::PROTEIN)
    ("pregnant dams" . SPARSER::PROTEIN) ("dams" . SPARSER::PROTEIN)
    ("allele or gene" . SPARSER::COLLECTION)
    ("the kinase-null AKT3 K177M" . SPARSER::PROTEIN)
    ("the neuronal differentiation marker MAP2" . SPARSER::PROTEIN)
    ("RFP" . SPARSER::PROTEIN) ("BLBP" . SPARSER::PROTEIN)
    ("layer-specific markers SATB2 and CTIP2" . SPARSER::COLLECTION)
    ("SATB2 and CTIP2" . SPARSER::COLLECTION) ("microglia" . SPARSER::PROTEIN)
    ("perinatal" . SPARSER::PROTEIN) ("glial" . SPARSER::PROTEIN)
    ("NeuN" . SPARSER::PROTEIN)
    ("human wildtype AKT3 (i.e. overexpression; AKT3 OE ) or AKT3 E17K"
     . SPARSER::COLLECTION)
    ("soma" . SPARSER::DRUG) ("focal malformations" . SPARSER::PROTEIN)
    ("PIK3CA, AKT3, and MTOR" . SPARSER::COLLECTION)
    ("complex (TSC)" . SPARSER::BIO-COMPLEX) ("TSC" . SPARSER::PROTEIN)
    ("the most severe form" . SPARSER::FORM)
    ("Most affected individuals display progressive and catastrophic epilepsy"
     . SPARSER::PROTEIN)
    ("characteristic MCD" . SPARSER::PROTEIN)
    ("especially medically-intractable ‘catastrophic’ epilepsy"
     . SPARSER::PROTEIN)
    ("Malformations" . SPARSER::PROTEIN) ("focal epilepsy" . SPARSER::PROTEIN)
    ("AKT-FOXG1-Reelin" . SPARSER::COLLECTION) ("Reelin" . SPARSER::PROTEIN)
    ("reelin" . SPARSER::PROTEIN)
    ("electrographic seizures" . SPARSER::PROTEIN)
    ("drug-resistant pediatric epilepsy" . SPARSER::PROTEIN)
    ("Focal malformations" . SPARSER::PROTEIN) ("CS4" . SPARSER::PROTEIN)
    ("CC-3" . SPARSER::PROTEIN) ("PAX6" . SPARSER::PROTEIN)
    ("N-2" . SPARSER::PROTEIN) ("LIN28" . SPARSER::PROTEIN)
    ("L-MYC" . SPARSER::PROTEIN) ("OCT3" . SPARSER::PROTEIN)
    ("ion channel" . SPARSER::PROTEIN-FAMILY)
    ("non-syndromic" . SPARSER::PROTEIN)
    ("glutamic acid" . SPARSER::AMINO-ACID) ("Foxg1" . SPARSER::PROTEIN)
    ("FOXO3A" . SPARSER::PROTEIN) ("FOXO1" . SPARSER::PROTEIN)
    ("p15 INK4b" . SPARSER::PROTEIN) ("p14 ARF" . SPARSER::PROTEIN)
    ("MAP2" . SPARSER::PROTEIN) ("neuronal migration" . SPARSER::PROTEIN)
    ("CTIP2" . SPARSER::PROTEIN) ("SATB2" . SPARSER::PROTEIN)
    ("GAD1" . SPARSER::PROTEIN) ("FOXG1" . SPARSER::PROTEIN)
    ("adult striatal astrocytes" . SPARSER::PROTEIN)
    ("Ras and cAMP" . SPARSER::COLLECTION) ("Ascl1" . SPARSER::PROTEIN)
    ("positive instructive cues" . SPARSER::PROTEIN-FAMILY)
    ("multi" . SPARSER::PROTEIN) ("astrocytes, and OPCs" . SPARSER::COLLECTION)
    ("dpi" . SPARSER::PROTEIN) ("RGL" . SPARSER::PROTEIN)
    ("GFAP" . SPARSER::PROTEIN) ("mpi" . SPARSER::PROTEIN)
    ("Nestin" . SPARSER::PROTEIN) ("Nf1" . SPARSER::PROTEIN)
    ("NPCs" . SPARSER::MOLECULE)
    ("hippocampal dentate gyrus" . SPARSER::PROTEIN)
    ("gyrus" . SPARSER::PROTEIN) ("dentate" . SPARSER::PROTEIN)
    ("tri" . SPARSER::PROTEIN) ("astrocytes" . SPARSER::PROTEIN)
    ("CA4" . SPARSER::PROTEIN) ("Prox1" . SPARSER::PROTEIN)
    ("Tbr2" . SPARSER::PROTEIN) ("Gli1" . SPARSER::PROTEIN)
    ("Olig2" . SPARSER::PROTEIN) ("MCM2" . SPARSER::PROTEIN)
    ("neurofibromin 1" . SPARSER::PROTEIN)
    ("phospho-mimetic USP14 mutant" . SPARSER::MUTANT)
    ("MK2206 and AZD5363" . SPARSER::COLLECTION)
    ("GDC0941 and Wortmannin" . SPARSER::COLLECTION)
    ("p-GSK3β" . SPARSER::COLLECTION) ("HA-USP14" . SPARSER::COLLECTION)
    ("IPs" . SPARSER::PROTEIN) ("CAMK" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("RSK" . SPARSER::PROTEIN) ("SGK1, SGK2 and SGK3" . SPARSER::COLLECTION)
    ("the only protein kinase" . SPARSER::KINASE) ("RSKs" . SPARSER::PROTEIN)
    ("endogenous USP14 and the endogenous kinase" . SPARSER::COLLECTION)
    ("PDK1 and TORC2" . SPARSER::COLLECTION)
    ("the editorial decision letter and author response" . SPARSER::COLLECTION)
    ("the editorial decision letter" . SPARSER::MOLECULE)
    ("letter" . SPARSER::MOLECULE) ("Dys" . SPARSER::PROTEIN)
    ("their respective receptors" . SPARSER::PROTEIN)
    ("EGF, IGF, and fibroblast growth factor" . SPARSER::COLLECTION)
    ("USP14 and its ortholog" . SPARSER::COLLECTION)
    ("proteasome-associated USP14" . SPARSER::PROTEIN)
    ("H4 KO and H4 KO cells complemented" . SPARSER::COLLECTION)
    ("phosphorylatable" . SPARSER::PROTEIN)
    ("the global protein" . SPARSER::PROTEIN)
    ("USP14-KO" . SPARSER::COLLECTION)
    ("ornithine decarboxylase-GFP" . SPARSER::COLLECTION)
    ("monomeric Ub" . SPARSER::PROTEIN) ("polyacrylamide" . SPARSER::DRUG)
    ("sulfate" . SPARSER::MOLECULE) ("dodecyl" . SPARSER::MOLECULE)
    ("diubiquitin" . SPARSER::PROTEIN)
    ("phospho-mimetic mutant" . SPARSER::MUTANT)
    ("larger protein complexes" . SPARSER::BIO-COMPLEX)
    ("p-S432 USP14 and total USP14" . SPARSER::COLLECTION)
    ("glycerol" . SPARSER::PROTEIN) ("USP14 and Myr-Akt" . SPARSER::COLLECTION)
    ("antibody and phos-tag" . SPARSER::COLLECTION)
    ("IGF-1 or EGF" . SPARSER::COLLECTION)
    ("insulin-like growth factor (IGF-1) or epidermal growth factor (EGF)"
     . SPARSER::COLLECTION)
    ("Wortmannin or GDC0941" . SPARSER::COLLECTION)
    ("MK2206 or AZD5363" . SPARSER::COLLECTION)
    ("a phospho-Ser432-specific antibody" . SPARSER::PROTEIN)
    ("USP14 and an activated Akt (Myr-Akt)" . SPARSER::COLLECTION)
    ("Myr" . SPARSER::MOLECULE) ("USP14 and Akt" . SPARSER::COLLECTION)
    ("orthologs" . SPARSER::PROTEIN)
    ("USP14, BL1 and BL2" . SPARSER::COLLECTION)
    ("the inactive free form and an adduct" . SPARSER::COLLECTION)
    ("aldehyde" . SPARSER::MOLECULE)
    ("a serine/threonine-specific protein kinase and an important intracellular signaling transducer"
     . SPARSER::COLLECTION)
    ("Akt, a serine/threonine-specific protein kinase and an important intracellular signaling transducer"
     . SPARSER::COLLECTION)
    ("SGK3" . SPARSER::PROTEIN) ("SGK2" . SPARSER::PROTEIN)
    ("SGK1" . SPARSER::PROTEIN) ("PI 3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PDK1" . SPARSER::PROTEIN) ("IGF1" . SPARSER::PROTEIN)
    ("MS2" . SPARSER::PROTEIN) ("TiO 2" . SPARSER::MOLECULE)
    ("guide RNA" . SPARSER::RNA) ("DNA Polymerase" . SPARSER::PROTEIN)
    ("fibroblast growth factor" . SPARSER::PROTEIN-FAMILY)
    ("Ubp6" . SPARSER::PROTEIN) ("ornithine decarboxylase" . SPARSER::PROTEIN)
    ("p-S" . SPARSER::PROTEIN)
    ("insulin-like growth factor" . SPARSER::PROTEIN)
    ("phos-tag" . SPARSER::DRUG) ("MK2206" . SPARSER::DRUG)
    ("BL2" . SPARSER::PROTEIN) ("SHIP1" . SPARSER::PROTEIN)
    ("phosphoinositide 3" . SPARSER::PROTEIN)
    ("P3" . SPARSER::HUMAN-PROTEIN-FAMILY) ("USP14" . SPARSER::PROTEIN)
    ("p53 and iNOS" . SPARSER::COLLECTION) ("wt-p53" . SPARSER::COLLECTION)
    ("iNOS, and p53" . SPARSER::COLLECTION)
    ("si-1 and si-2" . SPARSER::COLLECTION)
    ("siRNA-iNOS" . SPARSER::COLLECTION) ("si-NC" . SPARSER::COLLECTION)
    ("si-2" . SPARSER::COLLECTION) ("nodal" . SPARSER::PROTEIN)
    ("mt-p53" . SPARSER::COLLECTION) ("nNOS" . SPARSER::PROTEIN)
    ("eNOS" . SPARSER::PROTEIN) ("neurotransmitter" . SPARSER::MOLECULE)
    ("iNOS and p53" . SPARSER::COLLECTION)
    ("Inducible nitric oxide synthase (iNOS) and p53" . SPARSER::COLLECTION)
    ("iNOS" . SPARSER::PROTEIN) ("L-arginine" . SPARSER::MOLECULE)
    ("Nitric oxide" . SPARSER::MOLECULE)
    ("nitric oxide synthase" . SPARSER::PROTEIN)
    ("PTEN and HER2" . SPARSER::COLLECTION)
    ("IL-6, GP130, level of p-STAT3, and activity of the NF-κB transcription factor"
     . SPARSER::COLLECTION)
    ("CD24-" . SPARSER::PROTEIN)
    ("up regulating mesenchymal markers N-cadherin" . SPARSER::PROTEIN)
    ("PIK3CA and PTEN" . SPARSER::COLLECTION)
    ("classical breast cancer cell markers ER, PR, and HER2"
     . SPARSER::COLLECTION)
    ("PTEN and p53" . SPARSER::COLLECTION)
    ("typical culture conditions p65" . SPARSER::PROTEIN)
    ("transformed trastuzumab resistant PTEN" . SPARSER::PROTEIN)
    ("p " . SPARSER::PROTEIN) ("secondary mouse fat" . SPARSER::PROTEIN)
    ("haematoxylin" . SPARSER::MOLECULE)
    ("Docetaxel and trastuzumab" . SPARSER::COLLECTION)
    ("docetaxel and trastuzumab" . SPARSER::COLLECTION)
    ("HER2/AKT" . SPARSER::COLLECTION) ("SF" . SPARSER::PROTEIN)
    ("NF-κB, STAT3, and siRNA" . SPARSER::COLLECTION) ("DAPI-" . SPARSER::DRUG)
    ("DAPI" . SPARSER::DRUG) ("NF-κB and STAT3" . SPARSER::COLLECTION)
    ("response element (TRE)" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("TRE" . SPARSER::PROTEIN) ("IL-6 and GP130" . SPARSER::COLLECTION)
    ("PTEN and CYLD" . SPARSER::COLLECTION) ("CYLD" . SPARSER::PROTEIN)
    ("IL6R and complex" . SPARSER::COLLECTION)
    ("HER/AKT" . SPARSER::COLLECTION)
    ("continued use trastuzumab" . SPARSER::DRUG)
    ("HER2, PR and ER" . SPARSER::COLLECTION)
    ("strong HER2" . SPARSER::PROTEIN)
    ("ER, PR, and HER2" . SPARSER::COLLECTION)
    ("MUC4 and IGF-1R" . SPARSER::COLLECTION)
    ("classical breast cancer subtype markers ER and PR" . SPARSER::COLLECTION)
    ("orthotopic mouse xenografts trastuzumab resistant BT474 PTEN"
     . SPARSER::PROTEIN)
    ("mesenchymal cell markers N-cadherin and vimentin" . SPARSER::COLLECTION)
    ("N-cadherin and vimentin" . SPARSER::COLLECTION)
    ("E-cadherin and EpCAM" . SPARSER::COLLECTION) ("CD24−" . SPARSER::PROTEIN)
    ("Bright" . SPARSER::PROTEIN) ("Sulforaphane" . SPARSER::PROTEIN)
    ("HER2, estrogen, and progesterone receptor" . SPARSER::COLLECTION)
    ("IL-6/NF-κB" . SPARSER::COLLECTION) ("PI3-K/AKT" . SPARSER::COLLECTION)
    ("masking" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("EMT and subtype" . SPARSER::COLLECTION)
    ("IL-6/STAT3/NF-κB" . SPARSER::COLLECTION)
    ("sulforaphane" . SPARSER::PROTEIN) ("HRG" . SPARSER::PROTEIN)
    ("ERBB" . SPARSER::PROTEIN) ("ER α" . SPARSER::PROTEIN)
    ("CD44 " . SPARSER::PROTEIN) ("IκB" . SPARSER::PROTEIN)
    ("GP130" . SPARSER::PROTEIN) ("IL6R" . SPARSER::PROTEIN)
    ("a 15" . SPARSER::PROTEIN) ("progesterone receptor" . SPARSER::PROTEIN)
    ("MUC4" . SPARSER::PROTEIN) ("TPR" . SPARSER::PROTEIN)
    ("the mitotic checkpoint proteins" . SPARSER::PROTEIN)
    ("mitotic microtubules" . SPARSER::PROTEIN)
    ("luminal and basal cell" . SPARSER::COLLECTION)
    ("Ding" . SPARSER::PROTEIN)
    ("several mitotic kinases and mitotic checkpoint proteins"
     . SPARSER::COLLECTION)
    ("several mitotic kinases" . SPARSER::KINASE)
    ("AurA, Plk1, and BubR1" . SPARSER::COLLECTION)
    ("PARP and caspase-3" . SPARSER::COLLECTION)
    ("RHAMM shRNAs and a GSK3β inhibitor" . SPARSER::COLLECTION)
    ("RHAMM and GSK3β" . SPARSER::COLLECTION)
    ("RHAMM-GSK3β" . SPARSER::COLLECTION)
    ("anti-CD24 and CD44" . SPARSER::COLLECTION)
    ("CD24 and CD44" . SPARSER::COLLECTION) ("puromycin" . SPARSER::DRUG)
    ("other mitotic regulators" . SPARSER::REGULATOR)
    ("AurA, BubR1, and Plk1" . SPARSER::COLLECTION)
    ("mitotic kinases and mitotic checkpoint proteins" . SPARSER::COLLECTION)
    ("mitotic kinases or mitotic checkpoint proteins" . SPARSER::COLLECTION)
    ("mitotic checkpoint proteins" . SPARSER::PROTEIN)
    ("mitotic kinases" . SPARSER::KINASE) ("AurA" . SPARSER::PROTEIN)
    ("a key mitotic regulator" . SPARSER::REGULATOR)
    ("Mitotic kinases" . SPARSER::KINASE)
    ("extracellular HA" . SPARSER::PROTEIN)
    ("RHAMM or CD168" . SPARSER::COLLECTION) ("RHAMM" . SPARSER::PROTEIN)
    ("CD44 and HA" . SPARSER::COLLECTION)
    ("a type I transmembrane glycoprotein" . SPARSER::PROTEIN)
    ("hyaluronan" . SPARSER::PROTEIN) ("CD24/CD44" . SPARSER::COLLECTION)
    ("a mitotic checkpoint serine/threonine kinase" . SPARSER::KINASE)
    ("benzimidazoles" . SPARSER::DRUG)
    ("glycogen synthase" . SPARSER::PROTEIN-FAMILY) ("A 3D" . SPARSER::PROTEIN)
    ("mitotic checkpoint protein" . SPARSER::PROTEIN)
    ("BubR1" . SPARSER::PROTEIN) ("Aurora kinase A" . SPARSER::PROTEIN)
    ("Plk1" . SPARSER::PROTEIN) ("Bub1" . SPARSER::PROTEIN)
    ("Doxorubicin" . SPARSER::PROTEIN)
    ("numerous pro-apoptotic molecules" . SPARSER::MOLECULE)
    ("respiratory chain complexes" . SPARSER::BIO-COMPLEX)
    ("mature AIF" . SPARSER::PROTEIN)
    ("increased mature AIF" . SPARSER::PROTEIN)
    ("cytochrome c, or non-apoptotic" . SPARSER::COLLECTION)
    ("endonuclease G and AIF" . SPARSER::COLLECTION)
    ("BCL-2-associated X protein (BAX)" . SPARSER::PROTEIN)
    ("BAK" . SPARSER::PROTEIN) ("HL-1" . SPARSER::PROTEIN)
    ("NRF1 and peroxisome proliferator-activated receptors" . SPARSER::PROTEIN)
    ("NRF1 and peroxisome" . SPARSER::COLLECTION) ("PPARs" . SPARSER::PROTEIN)
    ("peroxisome" . SPARSER::PROTEIN)
    ("staurosporine, TNF-α, and ETO" . SPARSER::COLLECTION)
    ("staurosporine" . SPARSER::DRUG) ("TFAM and NRF1" . SPARSER::COLLECTION)
    ("Jurkat" . SPARSER::PROTEIN) ("kinase (AMPK)" . SPARSER::KINASE)
    ("AMPK" . SPARSER::PROTEIN) ("TFAM" . SPARSER::PROTEIN)
    ("-ATPase" . SPARSER::COLLECTION) ("Mitochondria" . SPARSER::PROTEIN)
    ("p53 and H2AX" . SPARSER::COLLECTION)
    ("PARP1 and ATM" . SPARSER::COLLECTION)
    ("DOX and NAC" . SPARSER::COLLECTION)
    ("γ-H2AX, and C-PARP1" . SPARSER::COLLECTION)
    ("opted" . SPARSER::HUMAN-PROTEIN-FAMILY) ("-siRNA" . SPARSER::COLLECTION)
    ("NADH dehydrogenase subunit 1 ( ND1 ; 34.3%) and NADH dehydrogenase subunit 4 ( ND4 ; 33.9%)"
     . SPARSER::COLLECTION)
    ("p-ATM (25.0%) and γ-H2AX (41.3%)" . SPARSER::COLLECTION)
    ("pifithrin" . SPARSER::DRUG) ("DOX-" . SPARSER::PROTEIN)
    ("monomer" . SPARSER::MONOMER) ("MTG and MTR" . SPARSER::COLLECTION)
    ("CCCP" . SPARSER::MOLECULE) ("CMXRos (MTR)" . SPARSER::MOLECULE)
    ("FM (MTG)" . SPARSER::PROTEIN) ("MTR" . SPARSER::PROTEIN)
    ("CMXRos" . SPARSER::MOLECULE) ("MTG" . SPARSER::PROTEIN)
    ("FM" . SPARSER::PROTEIN) ("gold" . SPARSER::MOLECULE)
    ("cytochrome c, endonuclease G, and AIF" . SPARSER::COLLECTION)
    ("MOMP" . SPARSER::PROTEIN) ("DOX and mitoxantrone" . SPARSER::COLLECTION)
    ("mitoxantrone" . SPARSER::DRUG) ("etoposide (ETO)" . SPARSER::DRUG)
    ("DOX and ETO" . SPARSER::COLLECTION) ("p-CHK2" . SPARSER::COLLECTION)
    ("PARP1 and C-PARP1" . SPARSER::COLLECTION)
    ("PARP1 and γ-H2AX" . SPARSER::COLLECTION)
    ("the topoisomerase II (TOP II) complex" . SPARSER::BIO-COMPLEX)
    ("nanotube (CNT)" . SPARSER::MOLECULE) ("AFM" . SPARSER::PROTEIN)
    ("nanotube" . SPARSER::MOLECULE) ("mitochondria-" . SPARSER::PROTEIN)
    ("LLC-PK1" . SPARSER::PROTEIN) ("pro-inflammatory genes" . SPARSER::GENE)
    ("nicotinamide adenine dinucleotide (NAD + ) and adenosine triphosphate (ATP)"
     . SPARSER::COLLECTION)
    ("TNF-receptors" . SPARSER::COLLECTION) ("DAMPs" . SPARSER::DAMP)
    ("PAMPs" . SPARSER::PROTEIN) ("RIP1 and RIP3" . SPARSER::COLLECTION)
    ("MLKL" . SPARSER::PROTEIN)
    ("tumor necrosis factor (TNF) or TNF-related apoptosis-inducing ligand (TRAIL)"
     . SPARSER::COLLECTION)
    ("protein (RIP)" . SPARSER::PROTEIN)
    ("mitochondrial ROS" . SPARSER::PROTEIN)
    ("PARP1 and p53" . SPARSER::COLLECTION) ("DOX" . SPARSER::PROTEIN)
    ("DCF-DA" . SPARSER::DRUG) ("Glo 3" . SPARSER::PROTEIN)
    ("N2" . SPARSER::PROTEIN) ("ATP synthase" . SPARSER::PROTEIN)
    ("tumor-suppressor protein" . SPARSER::PROTEIN)
    ("TNF-α" . SPARSER::PROTEIN) ("AMP-activated" . SPARSER::PROTEIN)
    ("NRF1" . SPARSER::PROTEIN) ("PGC-1α" . SPARSER::PROTEIN)
    ("transcription factor A, mitochondrial" . SPARSER::PROTEIN)
    ("NBS1" . SPARSER::PROTEIN) ("ND4" . SPARSER::PROTEIN)
    ("subunit 4" . SPARSER::PROTEIN) ("NADH dehydrogenase" . SPARSER::PROTEIN)
    ("NADH dehydrogenase subunit 1" . SPARSER::PROTEIN)
    ("PJ-34" . SPARSER::DRUG) ("P4" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("endonuclease G" . SPARSER::PROTEIN) ("Bcl2" . SPARSER::PROTEIN)
    ("p-ATM" . SPARSER::PROTEIN) ("cancer 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p53-binding protein 1" . SPARSER::PROTEIN)
    ("H2A histone family member X" . SPARSER::PROTEIN)
    ("TLR3" . SPARSER::PROTEIN) ("TLR4" . SPARSER::PROTEIN)
    ("NOX1" . SPARSER::PROTEIN) ("NADPH oxidase" . SPARSER::PROTEIN)
    ("mixed lineage kinase domain-like" . SPARSER::PROTEIN)
    ("RIP3" . SPARSER::PROTEIN) ("caspase 8" . SPARSER::PROTEIN)
    ("TNF-related apoptosis-inducing ligand" . SPARSER::PROTEIN)
    ("nitric oxide" . SPARSER::MOLECULE) ("-AKT-MTOR" . SPARSER::COLLECTION)
    ("the underlying architerctural substrate" . SPARSER::SUBSTRATE)
    ("autosomal dominant or
X-linked"
     . SPARSER::COLLECTION)
    ("TUBA1A , TUBB2B and OCLN" . SPARSER::COLLECTION)
    ("TUBB" . SPARSER::PROTEIN) ("FH" . SPARSER::PROTEIN)
    ("EOMES" . SPARSER::PROTEIN) ("OCLN" . SPARSER::PROTEIN)
    ("blood-derived DNA" . SPARSER::DNA)
    ("cutaneous capillary malformations" . SPARSER::PROTEIN)
    ("myoclonic seizures" . SPARSER::PROTEIN)
    ("intractable seizures" . SPARSER::PROTEIN) ("seizures" . SPARSER::PROTEIN)
    ("Seizures" . SPARSER::PROTEIN) ("Epilepsy" . SPARSER::PROTEIN)
    ("MEG" . SPARSER::DRUG)
    ("the occipital and frontal lobes" . SPARSER::PROTEIN)
    ("lobes" . SPARSER::PROTEIN)
    ("Representative brain MRI" . SPARSER::PROTEIN) ("MRI" . SPARSER::PROTEIN)
    ("SH" . SPARSER::PROTEIN-FAMILY)
    ("the PIK3R2 nonsynonymous
variant"
     . SPARSER::VARIANT)
    ("MCD" . SPARSER::PROTEIN) ("saliva-derived DNA" . SPARSER::DNA)
    ("Glu" . SPARSER::AMINO-ACID) ("MPPH" . SPARSER::PROTEIN)
    ("PI3K-AKT-MTOR" . SPARSER::COLLECTION) ("MTOR" . SPARSER::PROTEIN)
    ("Gly" . SPARSER::AMINO-ACID) ("trio" . SPARSER::PROTEIN)
    ("epilepsy" . SPARSER::PROTEIN) ("TSC2" . SPARSER::PROTEIN)
    ("TSC1" . SPARSER::PROTEIN)
    ("phosphatidylinositol-3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TUBB3" . SPARSER::PROTEIN) ("TUBB2B" . SPARSER::PROTEIN)
    ("TUBA8" . SPARSER::PROTEIN) ("TUBA1A" . SPARSER::PROTEIN)
    ("KIF5C" . SPARSER::PROTEIN) ("DYNC1H1" . SPARSER::PROTEIN)
    ("RAB18" . SPARSER::PROTEIN) ("RAB3GAP2" . SPARSER::PROTEIN)
    ("RAB3GAP1" . SPARSER::PROTEIN) ("WDR62" . SPARSER::PROTEIN)
    ("NDE1" . SPARSER::PROTEIN) ("X-linked" . SPARSER::PROTEIN)
    ("1–1" . SPARSER::PROTEIN) ("p36" . SPARSER::PROTEIN)
    ("normal chaperone" . SPARSER::PROTEIN)
    ("HSF1 and ERBB2" . SPARSER::COLLECTION)
    ("similar HSP90 conformational states" . SPARSER::BIO-STATE)
    ("the less bulky synthetically derived inhibitor ganetespib"
     . SPARSER::DRUG)
    ("HSP90 conformational states" . SPARSER::BIO-STATE)
    ("the less bulky synthetic inhibitor ganetespib" . SPARSER::DRUG)
    ("ATP-competitive" . SPARSER::ATP)
    ("multiple HSP90 conformational states" . SPARSER::BIO-STATE)
    ("IL218/20AA and HSP90β" . SPARSER::COLLECTION)
    ("D93A and D88A mutants and the IL218/20AA and IL213/5AA mutants"
     . SPARSER::COLLECTION)
    ("IL218/20AA and IL213/5AA" . SPARSER::COLLECTION)
    ("the tightly binding E47A and E42A mutants" . SPARSER::MUTANT)
    ("ERBB2 or MET" . SPARSER::COLLECTION)
    ("SLC2A1 and VEGFA" . SPARSER::COLLECTION) ("VEGFA" . SPARSER::PROTEIN)
    ("HSPA1A and DNAJ1" . SPARSER::COLLECTION)
    ("the HSF1-driven genes HSPA1A , DNAJ1 and STIP1" . SPARSER::COLLECTION)
    ("HSPA1A , DNAJ1 and STIP1" . SPARSER::COLLECTION)
    ("one conformational state" . SPARSER::BIO-STATE)
    ("conformational state" . SPARSER::BIO-STATE)
    ("conformational states" . SPARSER::BIO-STATE)
    ("a transient conformational state" . SPARSER::BIO-STATE)
    ("ray" . SPARSER::PROTEIN) ("HA-HIF1α" . SPARSER::COLLECTION)
    ("HA-HSF1" . SPARSER::COLLECTION) ("FLAG-HSP90" . SPARSER::COLLECTION)
    ("their respective conformational mutants" . SPARSER::MUTANT)
    ("kinase and transcription factor" . SPARSER::COLLECTION)
    ("complemented" . SPARSER::PROTEIN) ("IL218/20AA" . SPARSER::PROTEIN)
    ("IL" . SPARSER::PROTEIN) ("Geldanamycin" . SPARSER::DRUG)
    ("their conformational mutants" . SPARSER::MUTANT)
    ("RHOBTB2/DBC2" . SPARSER::COLLECTION) ("interactors" . SPARSER::PROTEIN)
    ("ARNT" . SPARSER::PROTEIN)
    ("TFs heat shock factor 1 (HSF1) and hypoxia inducible factor 1α (HIF1α)"
     . SPARSER::COLLECTION)
    ("distinct HSP90 conformational states" . SPARSER::BIO-STATE)
    ("HSP90 conformational mutants" . SPARSER::MUTANT)
    ("conformations" . SPARSER::BIO-CONFORMATION)
    ("HSF1 and HIF1α" . SPARSER::COLLECTION)
    ("ERBB2 and MET" . SPARSER::COLLECTION)
    ("KEAP1 and RHOBTB2" . SPARSER::COLLECTION)
    ("geldanamycin and ganetespib" . SPARSER::COLLECTION)
    ("ganetespib" . SPARSER::DRUG) ("geldanamycin" . SPARSER::DRUG)
    ("concerning possible unique isoform or conformational preferences"
     . SPARSER::COLLECTION)
    ("concerning possible unique isoform" . SPARSER::ISOFORM)
    ("the molecular chaperone HSP90, stress-inducible HSP90α and constitutively expressed HSP90β"
     . SPARSER::COLLECTION)
    ("chaperone" . SPARSER::PROTEIN) ("v-Src" . SPARSER::PROTEIN)
    ("SLC2A1" . SPARSER::PROTEIN) ("STIP1" . SPARSER::PROTEIN)
    ("DNAJ1" . SPARSER::PROTEIN) ("HSPA1A" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ATPase activity" . SPARSER::PROTEIN)
    ("Hsp90" . SPARSER::HUMAN-PROTEIN-FAMILY) ("CCND2" . SPARSER::PROTEIN)
    ("NFE2L2" . SPARSER::PROTEIN) ("DBC2" . SPARSER::PROTEIN)
    ("hypoxia inducible factor 1" . SPARSER::PROTEIN)
    ("HSP90AB1" . SPARSER::PROTEIN) ("HSP90AA1" . SPARSER::PROTEIN)
    ("heat shock protein 90" . SPARSER::PROTEIN) ("RHOBTB2" . SPARSER::PROTEIN)
    ("KEAP1" . SPARSER::PROTEIN) ("HSF1" . SPARSER::PROTEIN)
    ("HSP90β" . SPARSER::PROTEIN) ("ABT-737 or imatinib" . SPARSER::COLLECTION)
    ("Imatinib and dasatinib" . SPARSER::COLLECTION)
    ("Imatinib" . SPARSER::DRUG) ("TKI and ABT-737" . SPARSER::COLLECTION)
    ("second-generation TKIs and BH3 mimetic ABT-737" . SPARSER::COLLECTION)
    ("BH3 mimetic ABT-737" . SPARSER::DRUG)
    ("dasatinib, and ABT-737" . SPARSER::COLLECTION)
    ("TKIs or ABT-737" . SPARSER::COLLECTION)
    ("imatinib and ABT-737" . SPARSER::COLLECTION)
    ("TKIs and ABT-737" . SPARSER::COLLECTION)
    ("second-generation TKIs and/or ABT-737" . SPARSER::COLLECTION)
    ("both the BH3-mimetic ABT-737 and imatinib" . SPARSER::COLLECTION)
    ("ABT-737 and imatinib" . SPARSER::COLLECTION)
    ("Dasatinib and nilotinib" . SPARSER::COLLECTION)
    ("dasatinib and nilotinib" . SPARSER::COLLECTION)
    ("nilotinib" . SPARSER::DRUG)
    ("second-generation TKIs and the BH3-mimetic ABT-737"
     . SPARSER::COLLECTION)
    ("the BH3-mimetic ABT-737" . SPARSER::DRUG)
    ("RC1 and RHT1" . SPARSER::COLLECTION) ("SRC" . SPARSER::PROTEIN)
    ("‘pERK’" . SPARSER::PROTEIN) ("pERK" . SPARSER::PROTEIN)
    ("BCR-ABL1" . SPARSER::PROTEIN) ("glycine" . SPARSER::AMINO-ACID)
    ("pBCR-ABL1" . SPARSER::COLLECTION) ("LYN" . SPARSER::PROTEIN)
    ("significantly less cleaved PARP" . SPARSER::PROTEIN)
    ("monomeric and oligomeric nucleosomes" . SPARSER::PROTEIN)
    ("nucleosomes" . SPARSER::PROTEIN)
    ("cytometry and PI" . SPARSER::COLLECTION)
    ("less pro-apoptotic BH3-containing BIM isoforms" . SPARSER::ISOFORM)
    ("BCL2, BCL-XL , and MCL1" . SPARSER::COLLECTION)
    ("BAX and BAK1" . SPARSER::COLLECTION)
    ("the BH3 mimetic ABT-737" . SPARSER::DRUG)
    ("imatinib (IM)" . SPARSER::DRUG) ("inhibitors (TKI)" . SPARSER::INHIBITOR)
    ("CASPASE3" . SPARSER::PROTEIN) ("ABL1" . SPARSER::PROTEIN)
    ("CASPASE 3" . SPARSER::PROTEIN) ("RC1" . SPARSER::PROTEIN)
    ("MAPK1" . SPARSER::PROTEIN) ("BAK1" . SPARSER::PROTEIN)
    ("BCL-XL" . SPARSER::PROTEIN) ("BH3-only protein" . SPARSER::PROTEIN)
    ("KIT, KRAS, or IGF-1R" . SPARSER::COLLECTION)
    ("EGFR-AKT-mTOR" . SPARSER::COLLECTION)
    ("mTOR and its target S6K" . SPARSER::COLLECTION)
    ("ERK, STAT3, and AKT" . SPARSER::COLLECTION)
    ("ALK and mTOR" . SPARSER::COLLECTION) ("EGFR-mTOR" . SPARSER::COLLECTION)
    ("crizotinib [ xref ] as well as cancer stemness [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("amphiregulin and EGF" . SPARSER::COLLECTION)
    ("EML-ALK" . SPARSER::COLLECTION) ("chitosan" . SPARSER::MOLECULE)
    ("crizotinib and rapamycin" . SPARSER::COLLECTION)
    ("rapamycin, salinomycin, and metformin" . SPARSER::COLLECTION)
    ("metformin" . SPARSER::DRUG) ("salinomycin" . SPARSER::DRUG)
    ("NANOG and OCT4" . SPARSER::COLLECTION)
    ("SOX2, KLF4, and c-MYC" . SPARSER::COLLECTION)
    ("NANOG, OCT4, SOX2, KLF4, and c-MYC" . SPARSER::COLLECTION)
    ("Crizotinib" . SPARSER::DRUG)
    ("anaplastic lymphoma kinase ( ALK ) and echinoderm microtubule-associated protein-like 4 ( EML4 ) genes [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("rapamycin and crizotinib" . SPARSER::COLLECTION)
    ("stemness-associated molecules" . SPARSER::MOLECULE)
    ("ALDH, NANOG, and OCT4" . SPARSER::COLLECTION)
    ("EGFR, KIT, or KRAS" . SPARSER::COLLECTION)
    ("EML4-ALK" . SPARSER::COLLECTION)
    ("anaplastic lymphoma kinase ( ALK ) and echinoderm microtubule-associated protein-like 4 ( EML4 )"
     . SPARSER::COLLECTION)
    ("basic fibroblast growth factor" . SPARSER::PROTEIN)
    ("β-ACTIN" . SPARSER::PROTEIN) ("pS6K" . SPARSER::PROTEIN)
    ("1 L" . SPARSER::PROTEIN) ("IGF-1R" . SPARSER::PROTEIN)
    ("S6K" . SPARSER::PROTEIN) ("CR1" . SPARSER::PROTEIN)
    ("aldehyde dehydrogenase" . SPARSER::PROTEIN) ("EML4" . SPARSER::PROTEIN)
    ("echinoderm microtubule-associated protein-like 4" . SPARSER::PROTEIN)
    ("relapsed or BTZ-resistant MCL" . SPARSER::PROTEIN)
    ("particular Lyn" . SPARSER::PROTEIN) ("Ibrutinib" . SPARSER::DRUG)
    ("Lyn and CD19 or PI3K" . SPARSER::COLLECTION)
    ("CD19 or PI3K" . SPARSER::COLLECTION)
    ("Rec1 and Granta519" . SPARSER::COLLECTION) ("Rec1" . SPARSER::PROTEIN)
    ("Lyn and downstream kinases [ xref ]" . SPARSER::COLLECTION)
    ("Syk and Btk" . SPARSER::COLLECTION)
    ("other BCR-associated kinases" . SPARSER::KINASE)
    ("Src, Fyn, Syk, and Btk" . SPARSER::COLLECTION)
    ("IGF/IGFR" . SPARSER::COLLECTION) ("IGFR" . SPARSER::PROTEIN)
    ("IGF" . SPARSER::PROTEIN) ("idelalisib" . SPARSER::DRUG)
    ("a potential therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("Lyn, Syk, and Btk" . SPARSER::COLLECTION)
    ("a valuable therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("-mTOR" . SPARSER::COLLECTION) ("-Akt" . SPARSER::COLLECTION)
    ("-PI3K" . SPARSER::COLLECTION) ("-Lyn" . SPARSER::COLLECTION)
    ("BTZ (1 mg/kg) or dasatinib (20 mg/kg)" . SPARSER::COLLECTION)
    ("BTZ and dasatinib" . SPARSER::COLLECTION)
    ("Lyn and p85" . SPARSER::COLLECTION)
    ("CD19 and PI3K" . SPARSER::COLLECTION) ("CD19-PI3K" . SPARSER::COLLECTION)
    ("CD19 and p85" . SPARSER::COLLECTION)
    ("PI3K and CD19" . SPARSER::COLLECTION) ("Rec" . SPARSER::PROTEIN)
    ("doxorubicin and vincristine" . SPARSER::COLLECTION)
    ("CD79A/CD19" . SPARSER::COLLECTION) ("IgM" . SPARSER::PROTEIN)
    ("CD79A and CD79B" . SPARSER::COLLECTION) ("ITAMs" . SPARSER::PROTEIN)
    ("Btk inhibitor (ibrutinib) and Syk inhibitor (fostamatinib)"
     . SPARSER::COLLECTION)
    ("fostamatinib" . SPARSER::DRUG)
    ("Src, Syk, Fyn, and Btk" . SPARSER::COLLECTION) ("Lck" . SPARSER::PROTEIN)
    ("Src, Lyn, Syk, and Btk" . SPARSER::COLLECTION) ("Btk" . SPARSER::PROTEIN)
    ("Syk" . SPARSER::PROTEIN) ("Bortezomib" . SPARSER::DRUG)
    ("Philadelphia chromosome-positive acute lymphoblastic leukemia (ALL)"
     . SPARSER::PROTEIN)
    ("ABL and Src" . SPARSER::COLLECTION) ("ABL" . SPARSER::PROTEIN)
    ("receptor (BCR)" . SPARSER::RECEPTOR) ("relapsed MCL" . SPARSER::PROTEIN)
    ("Dasatinib" . SPARSER::DRUG) ("Lyn and PI3K" . SPARSER::COLLECTION)
    ("CD79A and Lyn" . SPARSER::COLLECTION) ("Lyn" . SPARSER::PROTEIN)
    ("CD79A and CD19" . SPARSER::COLLECTION) ("BTZ" . SPARSER::PROTEIN)
    ("p -Src" . SPARSER::PROTEIN) ("Reverse transcriptase" . SPARSER::PROTEIN)
    ("Chymotrypsin-Like" . SPARSER::PROTEIN)
    ("Chymotrypsin-like" . SPARSER::PROTEIN)
    ("co-receptors" . SPARSER::PROTEIN) ("Anti-IgM" . SPARSER::PROTEIN)
    ("CD79B" . SPARSER::PROTEIN) ("phospho-kinase" . SPARSER::PROTEIN)
    ("co-receptor" . SPARSER::PROTEIN) ("PSMB5" . SPARSER::PROTEIN)
    ("insulin-like growth factor receptor" . SPARSER::PROTEIN)
    ("chymotrypsin-like" . SPARSER::PROTEIN) ("CD79A" . SPARSER::PROTEIN)
    ("COX2 and ICAM-1" . SPARSER::COLLECTION)
    ("β-catenin, vimentin, ZO-1 and β-actin" . SPARSER::COLLECTION)
    ("filaments" . SPARSER::PROTEIN-FAMILY)
    ("FAK, VE-cadherin, vinculin, and β-actin" . SPARSER::COLLECTION)
    ("vinculin" . SPARSER::PROTEIN) ("FAK-PI3K" . SPARSER::COLLECTION)
    ("FAK-ERK1/2" . SPARSER::COLLECTION)
    ("extracellular signal-regulated kinase (ERK) or PI3K/Akt"
     . SPARSER::COLLECTION)
    ("ICAM-1 and COX2" . SPARSER::COLLECTION)
    ("filament" . SPARSER::PROTEIN-FAMILY)
    ("vimentin, ZO-1, and β-catenin" . SPARSER::COLLECTION)
    ("integrin/β-catenin" . SPARSER::COLLECTION)
    ("both lovastatin and MβCD reduced the expression of integrin β3"
     . SPARSER::COLLECTION)
    ("TGF-β1 , COX-2, and ICAM-1" . SPARSER::COLLECTION)
    ("trypan" . SPARSER::DRUG) ("Skp2" . SPARSER::PROTEIN)
    ("Skp" . SPARSER::PROTEIN) ("E2F-1/TS" . SPARSER::COLLECTION)
    ("TS" . SPARSER::PROTEIN) ("VCAM-1 and β1" . SPARSER::COLLECTION)
    ("prostate cancer cell integrin αvβ3 and endothelial intercellular adhesion molecule (ICAM)-1 [ xref ]"
     . SPARSER::COLLECTION)
    ("endothelial intercellular adhesion molecule (ICAM)-1" . SPARSER::PROTEIN)
    ("simvastatin" . SPARSER::DRUG) ("Simvastatin" . SPARSER::DRUG)
    ("LDL" . SPARSER::PROTEIN) ("isoprenoids" . SPARSER::MOLECULE)
    ("Statins" . SPARSER::MOLECULE) ("-CoA" . SPARSER::MOLECULE)
    ("statins" . SPARSER::DRUG)
    ("β-catenin, vimentin, ZO-1, and β-actin" . SPARSER::COLLECTION)
    ("TGFβ1, COX2, and ICAM-1" . SPARSER::COLLECTION)
    ("β1 and integrin" . SPARSER::COLLECTION) ("lovastatin" . SPARSER::DRUG)
    ("intercellular adhesion molecule (ICAM)-1" . SPARSER::PROTEIN)
    ("-β1" . SPARSER::COLLECTION) ("ICAM" . SPARSER::PROTEIN-FAMILY)
    ("Lovastatin" . SPARSER::DRUG) ("SP5" . SPARSER::PROTEIN)
    ("Anti-β" . SPARSER::PROTEIN) ("β-Catenin" . SPARSER::PROTEIN)
    ("E2F-1" . SPARSER::PROTEIN) ("S-1" . SPARSER::PROTEIN)
    ("VCAM-1" . SPARSER::PROTEIN) ("ZO-1" . SPARSER::PROTEIN)
    ("αvβ3" . SPARSER::PROTEIN) ("LKB1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TGFβ1" . SPARSER::PROTEIN) ("β5" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("c-Jun/AP-1" . SPARSER::COLLECTION) ("LMP1-mut" . SPARSER::COLLECTION)
    ("– 1" . SPARSER::PROTEIN) ("LMP1and N-LMP1" . SPARSER::COLLECTION)
    ("p38 or c-Jun" . SPARSER::COLLECTION)
    ("p38 and c-Jun" . SPARSER::COLLECTION) ("p38/MAPK" . SPARSER::COLLECTION)
    ("mixture" . SPARSER::MOLECULE) ("Lm" . SPARSER::MOLECULE)
    ("LMP1-driven NF-κB" . SPARSER::PROTEIN)
    ("the viral oncoprotein" . SPARSER::PROTEIN)
    ("hygromycin" . SPARSER::MOLECULE)
    ("viral function proteins" . SPARSER::PROTEIN)
    ("LMP1 and LMP2A and Epstein–Barr nuclear antigen 1" . SPARSER::COLLECTION)
    ("LMP2A and Epstein–Barr nuclear antigen 1" . SPARSER::COLLECTION)
    ("LMP1 and NF-κB" . SPARSER::COLLECTION) ("NL" . SPARSER::PROTEIN)
    ("anti-Histone" . SPARSER::PROTEIN) ("CD21" . SPARSER::PROTEIN)
    ("–2" . SPARSER::PROTEIN)
    ("Epstein–Barr nuclear antigen 1" . SPARSER::PROTEIN)
    ("LMP2A" . SPARSER::PROTEIN) ("LMP1" . SPARSER::PROTEIN)
    ("p53 or ATM" . SPARSER::COLLECTION)
    ("ATM and/or p53" . SPARSER::COLLECTION)
    ("BCL2 and CCND1" . SPARSER::COLLECTION)
    ("relapsed or refractory MCL" . SPARSER::PROTEIN)
    ("lenalidomide" . SPARSER::DRUG) ("ibrutinib" . SPARSER::DRUG)
    ("spleen tyrosine kinase (SYK) and the B-cell linker protein (BLNK) [ xref ]"
     . SPARSER::COLLECTION)
    ("linker protein (BLNK)" . SPARSER::PROTEIN) ("SYK" . SPARSER::PROTEIN)
    ("subsequent targeting immunoreceptor tyrosine inhibitory motif (ITIM) proteins"
     . SPARSER::PROTEIN)
    ("FISH or conventional karyotype [ xref ]" . SPARSER::COLLECTION)
    ("MYC and CCND1" . SPARSER::COLLECTION) ("NOS" . SPARSER::PROTEIN)
    ("ST" . SPARSER::PROTEIN)
    ("BCL2, BCL6, BCL3 or CCND1" . SPARSER::COLLECTION)
    ("cytarabine" . SPARSER::MOLECULE) ("MYC or BCL2" . SPARSER::COLLECTION)
    ("MYC and/or BCL2" . SPARSER::COLLECTION)
    ("normal BCL2" . SPARSER::PROTEIN) ("CCND1/IGH" . SPARSER::COLLECTION)
    ("β2 microglobulin (MG)" . SPARSER::PROTEIN)
    ("The indolent MCL" . SPARSER::PROTEIN)
    ("flow cytometry and bone marrow biopsy" . SPARSER::COLLECTION)
    ("DH" . SPARSER::PROTEIN) ("RB-1" . SPARSER::PROTEIN)
    ("S25" . SPARSER::PROTEIN) ("linker protein" . SPARSER::PROTEIN)
    ("β2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("β2 microglobulin" . SPARSER::PROTEIN)
    ("High c-MYC and/or low MYCBP2" . SPARSER::COLLECTION)
    ("an indirect Ikaros activator" . SPARSER::ACTIVATOR)
    ("NuRD/Mi-2" . SPARSER::COLLECTION) ("c-MYC/MYCBP2" . SPARSER::COLLECTION)
    ("c-MYC or MYCBP2" . SPARSER::COLLECTION)
    ("high c-MYC and low MYCBP2" . SPARSER::COLLECTION)
    ("TBB" . SPARSER::PROTEIN) ("c-MYC and MYCBNP2" . SPARSER::COLLECTION)
    ("PLT" . SPARSER::PROTEIN) ("dehydrogenase (LDH)" . SPARSER::PROTEIN)
    ("dehydrogenase" . SPARSER::PROTEIN)
    ("the transformation-associated gene" . SPARSER::GENE)
    ("acute lymphoblastic leukemia (ALL)" . SPARSER::PROTEIN)
    ("c-MYC and MYCBP2" . SPARSER::COLLECTION) ("Ikaros" . SPARSER::PROTEIN)
    ("a probable E3 ubiquitin ligase" . SPARSER::PROTEIN)
    ("Mi-2" . SPARSER::PROTEIN) ("CD13" . SPARSER::PROTEIN)
    ("B-ALL" . SPARSER::PROTEIN) ("Flt3" . SPARSER::PROTEIN)
    ("CK2" . SPARSER::PROTEIN) ("IKZF1" . SPARSER::PROTEIN)
    ("MYCBP2" . SPARSER::PROTEIN) ("MYC binding protein" . SPARSER::PROTEIN)
    ("BCL2 and NF-κB1" . SPARSER::COLLECTION)
    ("X-linked inhibitor of apoptosis protein (XIAP) and BCL-xL"
     . SPARSER::COLLECTION)
    ("MCL1, X-linked inhibitor of apoptosis protein (XIAP) and BCL-xL"
     . SPARSER::COLLECTION)
    ("MADD and p-ERK1/2" . SPARSER::COLLECTION)
    ("MADD/RAS/ERK" . SPARSER::COLLECTION)
    ("p85 (p85α and p85β [alias PIK3R2]) and a p110 catalytic subunit (α, β, γ)"
     . SPARSER::COLLECTION)
    ("RAS/MEK/ERK" . SPARSER::COLLECTION) ("IG" . SPARSER::MOLECULE)
    ("MADD, PIK3R2, P-ERK1/2, P-AKT (Thr308), P-AKT (Ser473) and MCL1"
     . SPARSER::COLLECTION)
    ("ERK or AKT" . SPARSER::COLLECTION)
    ("PIK3R2/PI3K/AKT" . SPARSER::COLLECTION)
    ("MADD/MEK/ERK" . SPARSER::COLLECTION)
    ("MADD/PIK3R2" . SPARSER::COLLECTION) ("PIK3R2- 3" . SPARSER::COLLECTION)
    ("Mut" . SPARSER::PROTEIN)
    ("potential direct targets" . SPARSER::TARGET-PROTEIN)
    ("PIK3R2 and MADD" . SPARSER::COLLECTION) ("Trypan" . SPARSER::DRUG)
    ("miR-" . SPARSER::PROTEIN) ("hemoglobin" . SPARSER::MOLECULE)
    ("Quantitative bisulfite" . SPARSER::MOLECULE) ("MU" . SPARSER::PROTEIN)
    ("AAT" . SPARSER::PROTEIN) ("MSP and bisulfite" . SPARSER::COLLECTION)
    ("MSP" . SPARSER::PROTEIN) ("a representative cohort" . SPARSER::MOLECULE)
    ("acute leukemia cytoplasmic ( BAALC ) gene" . SPARSER::GENE)
    ("tumor suppressive miRNAs" . SPARSER::PROTEIN) ("BIM" . SPARSER::PROTEIN)
    ("18 putative oncogenic miRNAs and seven putative tumor suppressor miRNAs"
     . SPARSER::COLLECTION)
    ("DAPK1 , ID4 and SFRP1" . SPARSER::COLLECTION)
    ("soluble WNT inhibitors" . SPARSER::INHIBITOR)
    ("SHP1 and SOCS1" . SPARSER::COLLECTION)
    ("CDKN2A and CDKN2B" . SPARSER::COLLECTION) ("TSGs" . SPARSER::PROTEIN)
    ("−CH3" . SPARSER::MOLECULE) ("BCR" . SPARSER::PROTEIN)
    ("CD5, CD19 and CD23" . SPARSER::COLLECTION)
    ("a tumor suppressive miRNA" . SPARSER::PROTEIN)
    ("MADD and PIK3R2" . SPARSER::COLLECTION) ("MEK/ERK" . SPARSER::COLLECTION)
    ("MADD" . SPARSER::PROTEIN) ("-deoxycytidine" . SPARSER::COLLECTION)
    ("deoxycytidine" . SPARSER::PROTEIN) ("Aza" . SPARSER::DRUG)
    ("Site 2" . SPARSER::PROTEIN) ("Site 1" . SPARSER::PROTEIN)
    ("CpG 1" . SPARSER::PROTEIN) ("BCL-xL" . SPARSER::PROTEIN)
    ("p85β" . SPARSER::PROTEIN) ("anti-IgM" . SPARSER::PROTEIN)
    ("P-ERK1/2" . SPARSER::PROTEIN) ("ID4" . SPARSER::PROTEIN)
    ("DAPK1" . SPARSER::PROTEIN) ("CDKN2B" . SPARSER::PROTEIN)
    ("SOCS1" . SPARSER::PROTEIN) ("SHP1" . SPARSER::PROTEIN)
    ("CH3" . SPARSER::MOLECULE) ("MCL1" . SPARSER::PROTEIN)
    ("PIK3R2" . SPARSER::PROTEIN) ("regulatory subunit 2" . SPARSER::PROTEIN)
    ("phosphoinositide-3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MAP-kinase" . SPARSER::PROTEIN) ("ATM-wildtype" . SPARSER::COLLECTION)
    ("ATM-p53-p21" . SPARSER::COLLECTION)
    ("VE-821 and VX-970" . SPARSER::COLLECTION) ("arm" . SPARSER::PROTEIN)
    ("cisplatin, and AZD6738" . SPARSER::COLLECTION)
    ("cisplatin or AZD6738" . SPARSER::COLLECTION)
    ("cisplatin (IP)" . SPARSER::MOLECULE) ("AZD6738 (PO)" . SPARSER::DRUG)
    ("ATM-" . SPARSER::PROTEIN) ("food" . SPARSER::MOLECULE)
    ("net" . SPARSER::HUMAN-PROTEIN-FAMILY) ("wildtype" . SPARSER::PROTEIN)
    ("Caspase-3 and PARP" . SPARSER::COLLECTION)
    ("AZD6738 or cisplatin" . SPARSER::COLLECTION)
    ("caspase-3 and PARP" . SPARSER::COLLECTION)
    ("ATM-p53" . SPARSER::COLLECTION)
    ("AZD6738 and gemcitabine" . SPARSER::COLLECTION)
    ("both AZD6738 (0.56, 1.67 and 5.0 μM) and cisplatin (5.0 and 15.0 μM)"
     . SPARSER::COLLECTION)
    ("AZD6738 and cisplatin" . SPARSER::COLLECTION)
    ("matrices" . SPARSER::PROTEIN-FAMILY)
    ("the standard-of-care chemotherapeutic agents cisplatin, gemcitabine, and docetaxel"
     . SPARSER::COLLECTION)
    ("cisplatin, gemcitabine, and docetaxel" . SPARSER::COLLECTION)
    ("p16, p21, and p27" . SPARSER::COLLECTION) ("AAD" . SPARSER::MOLECULE)
    ("exhibited minimal total ATM protein and no phospho-ATM (S1981)"
     . SPARSER::COLLECTION)
    ("exhibited minimal total ATM protein" . SPARSER::PROTEIN)
    ("p53-wildtype" . SPARSER::COLLECTION)
    ("ATR or Chk1" . SPARSER::COLLECTION)
    ("CellTiter-Glo" . SPARSER::COLLECTION) ("Kras" . SPARSER::PROTEIN)
    ("Glo" . SPARSER::PROTEIN) ("ATM, DNA-PK, and PI3Kα" . SPARSER::COLLECTION)
    ("Kinase" . SPARSER::KINASE) ("DYRK" . SPARSER::PROTEIN)
    ("PI3K and protein" . SPARSER::COLLECTION)
    ("ATM, DNA-PK and mTOR" . SPARSER::COLLECTION)
    ("the first bioavailable ATR kinase inhibitor" . SPARSER::INHIBITOR)
    ("IR and gemcitabine" . SPARSER::COLLECTION)
    ("ERCC1, ATM, XRCC1, and DNA" . SPARSER::COLLECTION)
    ("after hypoxia and ATRi's" . SPARSER::COLLECTION)
    ("hypoxia and ATRi" . SPARSER::COLLECTION) ("ATRi" . SPARSER::MOLECULE)
    ("cisplatin and IR" . SPARSER::COLLECTION) ("atm" . SPARSER::PROTEIN)
    ("pharmacologic ATM kinase inhibitors" . SPARSER::INHIBITOR)
    ("apical DNA damage signaling kinases" . SPARSER::PROTEIN)
    ("cisplatin and AZD6738" . SPARSER::COLLECTION)
    ("AZD6738 and ATR" . SPARSER::COLLECTION)
    ("cisplatin and gemcitabine" . SPARSER::COLLECTION)
    ("bioavailable ATR kinase inhibitor" . SPARSER::INHIBITOR)
    ("an essential protein" . SPARSER::PROTEIN) ("ataxia" . SPARSER::PROTEIN)
    ("sodium chloride" . SPARSER::DRUG) ("l-glutamine" . SPARSER::MOLECULE)
    ("VE-821" . SPARSER::DRUG) ("ETP-46464" . SPARSER::DRUG)
    ("Chk2" . SPARSER::PROTEIN) ("TOPBP1" . SPARSER::PROTEIN)
    ("H2A" . SPARSER::PROTEIN) ("Chk1" . SPARSER::PROTEIN)
    ("PI3Kδ" . SPARSER::PROTEIN) ("VE-822" . SPARSER::DRUG)
    ("VX-970" . SPARSER::DRUG) ("XRCC1" . SPARSER::PROTEIN)
    ("ERCC1" . SPARSER::PROTEIN) ("AZD6738" . SPARSER::DRUG)
    ("acute leukemia" . SPARSER::PROTEIN)
    ("nano-liposomes" . SPARSER::COLLECTION) ("liposomes" . SPARSER::PROTEIN)
    ("miRNAs or anti-miRNAs" . SPARSER::COLLECTION) ("MV" . SPARSER::PROTEIN)
    ("potential drug" . SPARSER::DRUG)
    ("miR-24 directly targets Bim" . SPARSER::PROTEIN) ("Dapi" . SPARSER::DRUG)
    ("Edu" . SPARSER::DRUG) ("sharp" . SPARSER::PROTEIN)
    ("bim" . SPARSER::PROTEIN)
    ("a major regulator of the initiation and progression"
     . SPARSER::COLLECTION)
    ("the potential biomarkers" . SPARSER::MOLECULE)
    ("the pro-apoptotic BCL-2 family" . SPARSER::PROTEIN-FAMILY)
    ("BCL2L11/Bim" . SPARSER::COLLECTION)
    ("BCL2L1/BCL − xL" . SPARSER::COLLECTION) ("BID" . SPARSER::PROTEIN)
    ("2-4" . SPARSER::PROTEIN) ("CD31" . SPARSER::PROTEIN)
    ("CCK8" . SPARSER::PROTEIN) ("BCL2L11" . SPARSER::PROTEIN)
    ("BCL − xL" . SPARSER::PROTEIN) ("BCL2L1" . SPARSER::PROTEIN)
    ("PTTG and c-myc" . SPARSER::COLLECTION)
    ("HIF-1α and p53" . SPARSER::COLLECTION)
    ("LDHA, and glucose" . SPARSER::COLLECTION)
    ("copious oxygen" . SPARSER::MOLECULE) ("Oncogenes" . SPARSER::ONCOGENE)
    ("Pei" . SPARSER::MOLECULE)
    ("several enzymes (HK, PFK, PKM2, and LDHA) and GLUT-1"
     . SPARSER::COLLECTION)
    ("HIF-1 and p53" . SPARSER::COLLECTION)
    ("c-myc, HIF-1, and p53" . SPARSER::COLLECTION)
    ("a lucent swelling matrix" . SPARSER::PROTEIN-FAMILY)
    ("phosphofructokinase" . SPARSER::PROTEIN)
    ("a fluorescent glucose analog" . SPARSER::ANALOG) ("NBDG" . SPARSER::DRUG)
    ("deoxyglucose" . SPARSER::MOLECULE) ("oxa" . SPARSER::MOLECULE)
    ("nucleotides, amino acids, and lipids" . SPARSER::COLLECTION)
    ("macromolecules" . SPARSER::MOLECULE)
    ("Epidermal growth factor (EGF)" . SPARSER::PROTEIN)
    ("agarose" . SPARSER::MOLECULE) ("PTTG-shRNA" . SPARSER::COLLECTION)
    ("shRNA2" . SPARSER::PROTEIN) ("PTTG-shRNA1" . SPARSER::PROTEIN-PAIR)
    ("PTTG-shRNA2" . SPARSER::COLLECTION)
    ("LDHA, PKM2, and GLUT-1" . SPARSER::COLLECTION)
    ("a multifunctional proto-oncogene" . SPARSER::PROTEIN)
    ("securin" . SPARSER::PROTEIN)
    ("both oncogenes and tumor suppressor gene mutants" . SPARSER::COLLECTION)
    ("adenosine triphosphate (ATP)" . SPARSER::MOLECULE)
    ("c-myc and several crucial enzymes" . SPARSER::COLLECTION)
    ("PKM2, LDHA, and glucose" . SPARSER::COLLECTION)
    ("gene (PTTG)" . SPARSER::GENE) ("PTTG" . SPARSER::PROTEIN)
    ("factor 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Proto-oncogene" . SPARSER::PROTEIN) ("D-glucose" . SPARSER::MOLECULE)
    ("lactate dehydrogenase A" . SPARSER::PROTEIN)
    ("lactic acid" . SPARSER::MOLECULE)
    ("Epidermal growth factor" . SPARSER::PROTEIN)
    ("adenosine triphosphate" . SPARSER::MOLECULE)
    ("GLUT-1" . SPARSER::PROTEIN) ("here using shRNA" . SPARSER::PROTEIN)
    ("a ternary complex" . SPARSER::BIO-COMPLEX)
    ("rapamycin and the variety" . SPARSER::COLLECTION)
    ("PP242 and Torin1" . SPARSER::COLLECTION) ("Drugs" . SPARSER::DRUG)
    ("multi-protein" . SPARSER::COLLECTION)
    ("drug or drug" . SPARSER::COLLECTION)
    ("available kinase inhibitors" . SPARSER::INHIBITOR)
    ("PI3K, Akt, MAPK, and mTor" . SPARSER::COLLECTION)
    ("dual HER2/TORC2" . SPARSER::COLLECTION)
    ("HER2/TORC2" . SPARSER::COLLECTION)
    ("TORC1 or TORC2" . SPARSER::COLLECTION) ("Raptor" . SPARSER::PROTEIN)
    ("tet" . SPARSER::PROTEIN)
    ("BEZ235, PP242, or Torin1" . SPARSER::COLLECTION)
    ("lapatinib and PP242" . SPARSER::COLLECTION)
    ("Fa" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Fraction" . SPARSER::COMPONENT)
    ("PI3K/Akt/mTor" . SPARSER::COLLECTION)
    ("BEZ235, PP242, and Torin1" . SPARSER::COLLECTION)
    ("drugs and references" . SPARSER::COLLECTION)
    ("PI3K, Akt, and mTOR" . SPARSER::COLLECTION)
    ("HER3/PI3K/Akt" . SPARSER::COLLECTION)
    ("HER3-PI3K-Akt-mTOR" . SPARSER::COLLECTION)
    ("PI3K, Akt, and mTor" . SPARSER::COLLECTION)
    ("EGFR, Alk, or Ros" . SPARSER::COLLECTION) ("Abl" . SPARSER::PROTEIN)
    ("Ros" . SPARSER::PROTEIN) ("driving oncogenes" . SPARSER::ONCOGENE)
    ("selectively target TORC2" . SPARSER::PROTEIN)
    ("TORC1 and TORC2" . SPARSER::COLLECTION) ("mTor" . SPARSER::PROTEIN)
    ("HER2 or HER3" . SPARSER::COLLECTION) ("HER2-HER3" . SPARSER::COLLECTION)
    ("G-3" . SPARSER::PROTEIN) ("NDRG1" . SPARSER::PROTEIN)
    ("pS6" . SPARSER::PROTEIN) ("GDC0941" . SPARSER::DRUG)
    ("Mk2206" . SPARSER::DRUG) ("TORC1 complex" . SPARSER::BIO-COMPLEX)
    ("PI3K-Akt" . SPARSER::COLLECTION) ("TORC2" . SPARSER::PROTEIN)
    ("TORC1" . SPARSER::PROTEIN) ("mRNA and Bcl-2" . SPARSER::COLLECTION)
    ("mRNA and caspase 3" . SPARSER::COLLECTION)
    ("Bax/Bcl-2" . SPARSER::COLLECTION) ("Nan" . SPARSER::PROTEIN)
    ("both prosurvival and proapoptotic proteins" . SPARSER::PROTEIN)
    ("apoptosis-associated proteins" . SPARSER::PROTEIN)
    ("Some toxic drugs" . SPARSER::DRUG) ("neo" . SPARSER::PROTEIN)
    ("PI , and MCF-7/D" . SPARSER::COLLECTION)
    ("Bcl-2 and caspase 3" . SPARSER::COLLECTION)
    ("the miR-451 inhibitors group and the control group ( xref )"
     . SPARSER::COLLECTION)
    ("The unimodal melting" . SPARSER::DRUG)
    ("internal reference U6" . SPARSER::PROTEIN) ("Dicer" . SPARSER::PROTEIN)
    ("docetaxel and epirubicin" . SPARSER::COLLECTION)
    ("indispensable regulators" . SPARSER::REGULATOR)
    ("a potential target gene" . SPARSER::GENE)
    ("Bcl-2 and Caspase 3" . SPARSER::COLLECTION)
    ("Annexin V-APC/PI" . SPARSER::COLLECTION) ("DOC" . SPARSER::DRUG)
    ("Paclitaxel" . SPARSER::DRUG) ("cyt-c" . SPARSER::PROTEIN)
    ("BCL-2" . SPARSER::PROTEIN) ("mdr1" . SPARSER::PROTEIN)
    ("Caspase 3" . SPARSER::PROTEIN) ("the usual t" . SPARSER::PROTEIN)
    ("MYC/BCL6" . SPARSER::COLLECTION) ("just one example" . SPARSER::EXAMPLE)
    ("bcl-2 and MYC" . SPARSER::COLLECTION) ("Akt/mTOR" . SPARSER::COLLECTION)
    ("panobinostat" . SPARSER::DRUG) ("AKT-mTOR" . SPARSER::COLLECTION)
    ("second-generation monoclonal antibodies" . SPARSER::ANTIBODY)
    ("/t" . SPARSER::COLLECTION) ("IGH-BCL2" . SPARSER::COLLECTION)
    ("PI3K-ATK-mTOR" . SPARSER::COLLECTION) ("ATK" . SPARSER::PROTEIN)
    ("phosphor-AKT and phosphor-mTOR" . SPARSER::COLLECTION)
    ("integrin-MEK-ELK1" . SPARSER::COLLECTION) ("RPPA" . SPARSER::PROTEIN)
    ("unique DNA" . SPARSER::DNA) ("STR" . SPARSER::PROTEIN)
    ("IGH/CCND1" . SPARSER::COLLECTION) ("IGH/MYC" . SPARSER::COLLECTION)
    ("IGH/BCL2" . SPARSER::COLLECTION) ("IGH" . SPARSER::PROTEIN)
    ("dim" . SPARSER::PROTEIN-FAMILY)
    ("our standard anti-kappa or anti-lambda monoclonal reagents"
     . SPARSER::MOLECULE)
    ("Ig" . SPARSER::MOLECULE) ("CD10, CD19, and CD79b" . SPARSER::COLLECTION)
    ("CD45, and CD79b" . SPARSER::COLLECTION)
    ("kappa and lambda" . SPARSER::COLLECTION)
    ("kappa" . SPARSER::PROTEIN-FAMILY) ("coarse chromatin" . SPARSER::PROTEIN)
    ("Sc-1" . SPARSER::PROTEIN) ("OCI" . SPARSER::PROTEIN)
    ("BCL6 or rarely other genes" . SPARSER::COLLECTION)
    ("rarely other genes" . SPARSER::GENE)
    ("cyclophosphamide, doxorubicin, vincristine, and prednisone"
     . SPARSER::COLLECTION)
    ("prednisone" . SPARSER::DRUG) ("MYC and BCL2" . SPARSER::COLLECTION)
    ("p12" . SPARSER::PROTEIN)
    ("CD10, CD19, CD20, CD22, CD38, CD43, CD44, and CD79b"
     . SPARSER::COLLECTION)
    ("CD3, CD4, CD5, CD8, CD11c, CD14, CD30, CD56, and CD200"
     . SPARSER::COLLECTION)
    ("NSG-severe combined immunodeficiency" . SPARSER::COLLECTION)
    ("NSG" . SPARSER::PROTEIN-FAMILY)
    ("valid therapeutic targets" . SPARSER::TARGET-PROTEIN)
    ("MYC/BCL2" . SPARSER::COLLECTION) ("Na3VO4" . SPARSER::MOLECULE)
    ("EBNA2" . SPARSER::PROTEIN) ("EBNA1" . SPARSER::PROTEIN)
    ("1–2 " . SPARSER::PROTEIN) ("bcl-2" . SPARSER::PROTEIN)
    ("BCL3" . SPARSER::PROTEIN) ("AZD8055" . SPARSER::DRUG)
    ("ELK1" . SPARSER::PROTEIN) ("light chain" . SPARSER::PROTEIN)
    ("CD23" . SPARSER::PROTEIN) ("1–2 " . SPARSER::PROTEIN)
    ("BCL6" . SPARSER::PROTEIN) ("–3 " . SPARSER::PROTEIN)
    ("CD200" . SPARSER::PROTEIN) ("CD30" . SPARSER::PROTEIN)
    ("CD11c" . SPARSER::PROTEIN) ("CD5" . SPARSER::PROTEIN)
    ("CD4" . SPARSER::PROTEIN) ("CD79b" . SPARSER::PROTEIN)
    ("CD43" . SPARSER::PROTEIN) ("CD38" . SPARSER::PROTEIN)
    ("CD22" . SPARSER::PROTEIN) ("CD20" . SPARSER::PROTEIN)
    ("CD19" . SPARSER::PROTEIN) ("CD10" . SPARSER::PROTEIN)
    ("sorafenib, lestaurtinib and tandutinib" . SPARSER::COLLECTION)
    ("tandutinib" . SPARSER::DRUG) ("lestaurtinib" . SPARSER::DRUG)
    ("retinoic acid or arsenic trioxide" . SPARSER::COLLECTION)
    ("CDC25C [ xref ] and CDC25B [ xref ]" . SPARSER::COLLECTION)
    ("CDK/cyclin" . SPARSER::COLLECTION) ("MLL" . SPARSER::PROTEIN)
    ("CDK4/CDK6" . SPARSER::COLLECTION)
    ("CDK4/CDK6-cyclin D1" . SPARSER::COLLECTION)
    ("the mitotic cyclin dependent kinase CDK1/cyclin B1"
     . SPARSER::COLLECTION)
    ("CBFβ and C/EBPα" . SPARSER::COLLECTION)
    ("AML1-ETO" . SPARSER::COLLECTION) ("PML-RARA" . SPARSER::COLLECTION)
    ("ETO" . SPARSER::PROTEIN) ("RARA" . SPARSER::PROTEIN)
    ("potential downstream targets" . SPARSER::TARGET-PROTEIN)
    ("Pim and Akt" . SPARSER::COLLECTION)
    ("Pim" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the monocytic-specific differentiation marker CD14" . SPARSER::PROTEIN)
    ("CD11b and CD14" . SPARSER::COLLECTION)
    ("CD11b, CD14 and CD15" . SPARSER::COLLECTION) ("EBP" . SPARSER::PROTEIN)
    ("CDK1 and/or ERK" . SPARSER::COLLECTION)
    ("the granulocytic marker CD15" . SPARSER::DRUG)
    ("the monocytic marker CD14" . SPARSER::PROTEIN)
    ("the early granulo-monocytic marker CD11b" . SPARSER::PROTEIN)
    ("phosphatases" . SPARSER::PHOSPHATASE)
    ("the entire cohort" . SPARSER::MOLECULE)
    ("promyelocytic" . SPARSER::PROTEIN)
    ("quizartinib or sorafenib" . SPARSER::COLLECTION)
    ("sorafenib" . SPARSER::DRUG) ("ligand, and IL-3" . SPARSER::COLLECTION)
    ("CDC25A, CDC25B and CDC25C" . SPARSER::COLLECTION)
    ("GM-CSF, IL-3 or G-CSF" . SPARSER::COLLECTION) ("TF-1" . SPARSER::PROTEIN)
    ("Akt, STAT5 and ERK" . SPARSER::COLLECTION)
    ("CDC25B and CDC25C" . SPARSER::COLLECTION)
    ("cyclin D1 or p27 Kip1" . SPARSER::COLLECTION)
    ("quizartinib" . SPARSER::DRUG) ("NPM-ALK" . SPARSER::COLLECTION)
    ("NPM" . SPARSER::PROTEIN)
    ("the ERK kinase and the cyclin-dependent kinase CDK1"
     . SPARSER::COLLECTION)
    ("CDK or ERK" . SPARSER::COLLECTION) ("wt" . SPARSER::PROTEIN)
    ("ITD" . SPARSER::PROTEIN) ("FLT3-wt" . SPARSER::COLLECTION)
    ("FLT3-ITD" . SPARSER::COLLECTION) ("SP4" . SPARSER::PROTEIN)
    ("p27 KIP1" . SPARSER::PROTEIN) ("C-22" . SPARSER::PROTEIN)
    ("p42" . SPARSER::PROTEIN) ("Erk1/2" . SPARSER::PROTEIN)
    ("p44" . SPARSER::PROTEIN) ("Akt1" . SPARSER::PROTEIN)
    ("Pim1" . SPARSER::PROTEIN) ("HD11" . SPARSER::PROTEIN)
    ("STAT5B" . SPARSER::PROTEIN) ("STAT5A" . SPARSER::PROTEIN)
    ("hIL-3" . SPARSER::PROTEIN) ("PD0325901" . SPARSER::DRUG)
    ("p23" . SPARSER::PROTEIN) ("IDH2" . SPARSER::PROTEIN)
    ("arsenic trioxide" . SPARSER::MOLECULE)
    ("promyelocytic leukemia" . SPARSER::PROTEIN)
    ("cyclin dependent kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CBFβ" . SPARSER::PROTEIN) ("AML1" . SPARSER::PROTEIN)
    ("CD15" . SPARSER::DRUG) ("CD14" . SPARSER::PROTEIN)
    ("G-CSF" . SPARSER::PROTEIN) ("IL-3" . SPARSER::PROTEIN)
    ("p27 Kip1" . SPARSER::PROTEIN) ("CDC25C" . SPARSER::PROTEIN)
    ("CDC25B" . SPARSER::PROTEIN) ("AC220" . SPARSER::DRUG)
    ("BCR-ABL" . SPARSER::PROTEIN)
    ("dual specificity phosphatase" . SPARSER::PROTEIN)
    ("Fms-Like Tyrosine kinase 3" . SPARSER::PROTEIN)
    ("C/EBPα" . SPARSER::PROTEIN) ("CDC25" . SPARSER::PROTEIN)
    ("STAT5" . SPARSER::PROTEIN) ("CDC25A" . SPARSER::PROTEIN)
    ("FLT3" . SPARSER::PROTEIN)
    ("GSK3β and its potential upstream regulator" . SPARSER::COLLECTION)
    ("its potential upstream regulator" . SPARSER::REGULATOR)
    ("membrane-associated proteins" . SPARSER::PROTEIN)
    ("lipids" . SPARSER::LIPID) ("sphingolipids" . SPARSER::MOLECULE)
    ("Par3-Par6-aPKC" . SPARSER::COLLECTION)
    ("microtubules" . SPARSER::PROTEIN)
    ("the highest tumorigenic potential expressed CD133(WT)"
     . SPARSER::PROTEIN)
    ("CD133(WT)" . SPARSER::PROTEIN)
    ("CD133, Par3 or β-catenin" . SPARSER::COLLECTION)
    ("/Cont-siRNA" . SPARSER::COLLECTION) ("/CD133" . SPARSER::COLLECTION)
    ("Cont" . SPARSER::PROTEIN)
    ("WT CD133 or various CD133 mutants" . SPARSER::COLLECTION)
    ("CD133, Par3 or β-catenin, or CD133" . SPARSER::COLLECTION)
    ("β-catenin, or CD133" . SPARSER::COLLECTION)
    ("ABCA3, ABCC1 and ABCG2" . SPARSER::COLLECTION)
    ("a 2-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("DKK1 and SFRP1" . SPARSER::COLLECTION)
    ("Oct4, Sox2 and ALDH" . SPARSER::COLLECTION) ("ALDH" . SPARSER::PROTEIN)
    ("GSK3β and its potential upstream regulator Akt" . SPARSER::COLLECTION)
    ("its potential upstream regulator Akt" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("antagonists, DKK1 and SFRP1" . SPARSER::COLLECTION)
    ("PI3K (LY294002) or MAPK (PD98059)" . SPARSER::COLLECTION)
    ("DKK1 or SFRP1" . SPARSER::COLLECTION)
    ("Src or β-catenin" . SPARSER::COLLECTION)
    ("monoclonal antibodies" . SPARSER::ANTIBODY)
    ("Src, Akt and GSK3β" . SPARSER::COLLECTION)
    ("GSK3β-PS9" . SPARSER::COLLECTION) ("PS" . SPARSER::PROTEIN)
    ("PY" . SPARSER::MOLECULE)
    ("a Src inhibitor (PP2) and siRNA targeting" . SPARSER::COLLECTION)
    ("BrdU" . SPARSER::DRUG) ("inhibitors or mutants" . SPARSER::COLLECTION)
    ("neither PI3K (LY294002) nor MAPK (PD98059) inhibitors"
     . SPARSER::COLLECTION)
    ("Par3 and Par6" . SPARSER::COLLECTION)
    ("CD133, Par3, Par6 and integrins" . SPARSER::COLLECTION)
    ("The Triton X-100-soluble cellular components" . SPARSER::COMPONENT)
    ("caveolin-1 and flotillin-2" . SPARSER::COLLECTION)
    ("sucrose" . SPARSER::MOLECULE) ("CD133/integrins" . SPARSER::COLLECTION)
    ("integrin genes and the consequent transcriptional activity (Figure xref )"
     . SPARSER::COLLECTION)
    ("ITGA2, ITGA3, ITGA4, ITGA10 and ITGA11" . SPARSER::COLLECTION)
    ("collagen receptors (α2, α10 and α11 integrins) and laminin receptors (α3 integrin)"
     . SPARSER::COLLECTION)
    ("fibronectin, collagen and laminin" . SPARSER::COLLECTION)
    ("collagen-" . SPARSER::PROTEIN) ("collagen/laminin" . SPARSER::COLLECTION)
    ("/CD133-shRNA" . SPARSER::COLLECTION) ("CD133-HA" . SPARSER::COLLECTION)
    ("/CD133-HA" . SPARSER::COLLECTION) ("U87MG/CD133" . SPARSER::COLLECTION)
    ("expressing various CD133 mutants or control vectors"
     . SPARSER::COLLECTION)
    ("DLD" . SPARSER::PROTEIN) ("integrin and TGFβ" . SPARSER::COLLECTION)
    ("Par3" . SPARSER::PROTEIN) ("aPKC" . SPARSER::PROTEIN)
    ("ACD" . SPARSER::PROTEIN)
    ("Src and phosphatidylinositol 3-kinase" . SPARSER::COLLECTION)
    ("cholesterol-containing lipid" . SPARSER::LIPID)
    ("CD24, CD34, and CD44" . SPARSER::COLLECTION)
    ("a five-transmembrane glycoprotein" . SPARSER::PROTEIN)
    ("Promonin-1" . SPARSER::COLLECTION) ("glycoprotein" . SPARSER::PROTEIN)
    ("CD133/integrin/Src/Akt/GSK3β/β-catenin" . SPARSER::COLLECTION)
    ("Src and the Par complex" . SPARSER::COLLECTION)
    ("directional cues" . SPARSER::PROTEIN-FAMILY)
    ("Src/Akt/GSK3β" . SPARSER::COLLECTION)
    ("CD133/integrin" . SPARSER::COLLECTION)
    ("CD133, and β-catenin" . SPARSER::COLLECTION)
    ("ITGB6 and ITGB8" . SPARSER::COLLECTION) ("ml 7" . SPARSER::MOLECULE)
    ("ATP-binding cassette" . SPARSER::PROTEIN)
    ("β-cyclodextrin" . SPARSER::MOLECULE) ("GF109203X" . SPARSER::DRUG)
    ("β1" . SPARSER::PROTEIN) ("POU5F1" . SPARSER::PROTEIN)
    ("GLI1" . SPARSER::PROTEIN) ("ABCA3" . SPARSER::PROTEIN)
    ("Oct4" . SPARSER::PROTEIN) ("SFRP1" . SPARSER::PROTEIN)
    ("DKK1" . SPARSER::PROTEIN) ("PP2" . SPARSER::DRUG)
    ("Gö6983" . SPARSER::DRUG) ("flotillin-2" . SPARSER::PROTEIN)
    ("caveolin-1" . SPARSER::PROTEIN) ("ITGA11" . SPARSER::PROTEIN)
    ("ITGA4" . SPARSER::PROTEIN) ("ITGA3" . SPARSER::PROTEIN)
    ("U87MG" . SPARSER::PROTEIN) ("atypical protein kinase" . SPARSER::PROTEIN)
    ("Par6" . SPARSER::HUMAN-PROTEIN-FAMILY) ("CD34" . SPARSER::PROTEIN)
    ("ITGB8" . SPARSER::PROTEIN) ("ITGB6" . SPARSER::PROTEIN)
    ("ITGA10" . SPARSER::PROTEIN) ("ITGA2" . SPARSER::PROTEIN)
    ("key regulators of the p53- and Rb-dependent pathways"
     . SPARSER::COLLECTION)
    ("p53-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("JAK2 and c-Src" . SPARSER::COLLECTION)
    ("kinase/protein kinase B" . SPARSER::COLLECTION)
    ("TrkB-c-Src" . SPARSER::COLLECTION) ("claudin" . SPARSER::PROTEIN)
    ("the mouse mammary fat" . SPARSER::PROTEIN)
    ("N-cadherin and fibronectin" . SPARSER::COLLECTION)
    ("E-cadherin and α-catenin" . SPARSER::COLLECTION)
    ("Twist-1, and Twist-2" . SPARSER::COLLECTION)
    ("E-cadherin, and α-catenin" . SPARSER::COLLECTION)
    ("mRNA and proteins" . SPARSER::COLLECTION)
    ("N-cadherin, fibronectin, and vimentin" . SPARSER::COLLECTION)
    ("Stat3 and AKT" . SPARSER::COLLECTION)
    ("the resulting mesenchymal state" . SPARSER::BIO-STATE)
    ("IL6 , PTGIS , and HAS1" . SPARSER::COLLECTION)
    ("IL-6/STAT3/JAK2" . SPARSER::COLLECTION) ("PTGIS" . SPARSER::PROTEIN)
    ("JAK2-SOCS3" . SPARSER::COLLECTION)
    ("SOCS3-associated JAK2" . SPARSER::PROTEIN)
    ("SOCS3-JAK2" . SPARSER::COLLECTION)
    ("STAT3, Twist-1 and Twist-2" . SPARSER::COLLECTION)
    ("JAK2/STAT3/Twist-1" . SPARSER::COLLECTION)
    ("JAK2, STAT3, and Twist-1" . SPARSER::COLLECTION)
    ("cSrc" . SPARSER::PROTEIN) ("Twist-1 or Twist-2" . SPARSER::COLLECTION)
    ("SYF-TrkB and SYF-c-Src-TrkB" . SPARSER::COLLECTION)
    ("TrkB-JAK2" . SPARSER::COLLECTION) ("Fyn" . SPARSER::PROTEIN)
    ("c-Src or SU6656" . SPARSER::COLLECTION)
    ("c-Src/JAK2" . SPARSER::COLLECTION) ("TrkB/c-Src" . SPARSER::COLLECTION)
    ("JAK and STAT3" . SPARSER::COLLECTION) ("Ras-MAPK" . SPARSER::COLLECTION)
    ("Mek1 and AKT" . SPARSER::COLLECTION) ("Mek1" . SPARSER::PROTEIN)
    ("Mek" . SPARSER::HUMAN-PROTEIN-FAMILY) ("ΔKD-1" . SPARSER::COLLECTION)
    ("V5-tagged TrkB and HA-tagged c-Src" . SPARSER::COLLECTION)
    ("V5-tagged TrkB" . SPARSER::PROTEIN) ("HA" . SPARSER::PROTEIN)
    ("MEK1/2 and AKT" . SPARSER::COLLECTION)
    ("TrkB-shRNA" . SPARSER::COLLECTION) ("MAD" . SPARSER::PROTEIN)
    ("TrkC" . SPARSER::PROTEIN) ("TrkB and c-Src" . SPARSER::COLLECTION)
    ("/ERK" . SPARSER::COLLECTION)
    ("MAP/extracellular signal-regulated kinase" . SPARSER::COLLECTION)
    ("MAP" . SPARSER::PROTEIN) ("neurotrophin" . SPARSER::PROTEIN)
    ("Trk" . SPARSER::PROTEIN) ("tropomyosin" . SPARSER::PROTEIN)
    ("STAT3 and AKT" . SPARSER::COLLECTION)
    ("IL-6/JAK2/STAT3" . SPARSER::COLLECTION) ("/CD24" . SPARSER::COLLECTION)
    ("JAK2 and STAT3" . SPARSER::COLLECTION)
    ("Twist-1 and Twist-2" . SPARSER::COLLECTION)
    ("JAK2/STAT3" . SPARSER::COLLECTION) ("JAK/STAT" . SPARSER::COLLECTION)
    ("TrkB" . SPARSER::PROTEIN) ("IL6/JAK2/STAT3" . SPARSER::COLLECTION)
    ("phosphatidylinositol-3" . SPARSER::PROTEIN)
    ("SIP1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("α-catenin" . SPARSER::PROTEIN)
    ("HAS1" . SPARSER::PROTEIN) ("JAK–STAT" . SPARSER::PROTEIN)
    ("Src kinase" . SPARSER::PROTEIN) ("AG490" . SPARSER::DRUG)
    ("c-Src kinase" . SPARSER::PROTEIN) ("SU6656" . SPARSER::PROTEIN)
    ("K252a" . SPARSER::MOLECULE) ("RIE-1" . SPARSER::PROTEIN)
    ("CD24" . SPARSER::PROTEIN) ("SOCS3" . SPARSER::PROTEIN)
    ("c-Src-" . SPARSER::PROTEIN) ("Twist-2" . SPARSER::PROTEIN)
    ("Twist-1" . SPARSER::PROTEIN) ("c-Src" . SPARSER::PROTEIN)
    ("TRF1 and TIN2" . SPARSER::COLLECTION)
    ("proteins, TRF1 and TIN2" . SPARSER::COLLECTION)
    ("ANXA8 (Annexin A8) and MUC16 (Mucin 16, cell surface associated)"
     . SPARSER::COLLECTION)
    ("Kallikrein" . SPARSER::PROTEIN) ("Chitinase" . SPARSER::PROTEIN)
    ("TIN2 and TRF1" . SPARSER::COLLECTION) ("TRF" . SPARSER::PROTEIN)
    ("ABCA12 (downregulated by 63%) and BLNK (downregulated by 47%)"
     . SPARSER::COLLECTION)
    ("BLNK" . SPARSER::PROTEIN) ("DRB" . SPARSER::PROTEIN)
    ("TRF1 and TIN 2" . SPARSER::COLLECTION)
    ("TPP1, POT1, TRF2 and PARP1" . SPARSER::COLLECTION)
    ("Chromatin" . SPARSER::PROTEIN)
    ("only minimal or negligible telomerase activity" . SPARSER::PROTEIN)
    ("FISH" . SPARSER::PROTEIN) ("BRCA1 and BRCA2" . SPARSER::COLLECTION)
    ("TRF1 and TRF2" . SPARSER::COLLECTION) ("Active" . SPARSER::ACTIVE)
    ("elongation" . SPARSER::PROTEIN) ("CpG" . SPARSER::PROTEIN)
    ("subtelomeric chromatin" . SPARSER::PROTEIN)
    ("Shelterin" . SPARSER::PROTEIN)
    ("the shelterin complex and the methylation status" . SPARSER::COLLECTION)
    ("TRF1, TRF2, TIN2, TPP1, POT1, and RAP1" . SPARSER::COLLECTION)
    ("BRCA1 and p53" . SPARSER::COLLECTION) ("shelterin" . SPARSER::PROTEIN)
    ("Gene 1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("sh-RNA" . SPARSER::RNA)
    ("sh-RNAs" . SPARSER::RNA) ("pTH2" . SPARSER::PROTEIN)
    ("SLC7A11" . SPARSER::PROTEIN) ("HERC5" . SPARSER::PROTEIN)
    ("Mucin 16, cell surface associated" . SPARSER::PROTEIN)
    ("MUC16" . SPARSER::PROTEIN) ("Annexin A8" . SPARSER::PROTEIN)
    ("ANXA8" . SPARSER::PROTEIN) ("KLK1" . SPARSER::PROTEIN)
    ("Mucin 1" . SPARSER::PROTEIN) ("MUC1" . SPARSER::PROTEIN)
    ("CHI3" . SPARSER::PROTEIN) ("OCT1" . SPARSER::PROTEIN)
    ("stn-1" . SPARSER::PROTEIN) ("ABCA12" . SPARSER::PROTEIN)
    ("GPRC5B" . SPARSER::PROTEIN) ("TLE4" . SPARSER::PROTEIN)
    ("MLL3" . SPARSER::PROTEIN) ("TIN 2" . SPARSER::PROTEIN)
    ("RAD50" . SPARSER::PROTEIN) ("RAP1" . SPARSER::PROTEIN)
    ("POT1" . SPARSER::PROTEIN) ("TPP1" . SPARSER::PROTEIN)
    ("TIN2" . SPARSER::PROTEIN) ("TRF2" . SPARSER::PROTEIN)
    ("TRF1" . SPARSER::PROTEIN) ("Fanconi anemia" . SPARSER::PROTEIN)
    ("DNMT-1" . SPARSER::PROTEIN) ("Telomerase activity" . SPARSER::PROTEIN)
    ("-promoter" . SPARSER::PROMOTER)
    ("nonpolar, polar, acidic, and basic amino acids" . SPARSER::AMINO-ACID)
    ("Ali" . SPARSER::PROTEIN) ("Ile" . SPARSER::AMINO-ACID)
    ("neutral amino acid" . SPARSER::AMINO-ACID)
    ("the basic amino acid" . SPARSER::AMINO-ACID)
    ("Gln" . SPARSER::AMINO-ACID)
    ("the 3-dimensional conformation" . SPARSER::BIO-CONFORMATION)
    ("runs" . SPARSER::PROTEIN-FAMILY) ("GATA (FOG)" . SPARSER::PROTEIN)
    ("cofactor" . SPARSER::MOLECULE) ("Cys-" . SPARSER::AMINO-ACID)
    ("Cys" . SPARSER::AMINO-ACID)
    ("urogenital malformations" . SPARSER::PROTEIN)
    ("malformations" . SPARSER::PROTEIN) ("ZnF2" . SPARSER::PROTEIN)
    ("ion" . SPARSER::MOLECULE) ("linker" . SPARSER::LINKER)
    ("Bank" . SPARSER::PROTEIN)
    ("This codon 299 amino acid of GATA3" . SPARSER::PROTEIN)
    ("A novel heterozygous p" . SPARSER::PROTEIN)
    ("idiopathic hypoparathyroidism, and calcium lactate" . SPARSER::MOLECULE)
    ("hypoparathyroidism, and calcium" . SPARSER::COLLECTION)
    ("nitrogen" . SPARSER::MOLECULE) ("creatinine" . SPARSER::PROTEIN)
    ("intact PTH" . SPARSER::PROTEIN) ("dL" . SPARSER::MOLECULE)
    ("parathyroid" . SPARSER::PROTEIN-FAMILY)
    ("a dual zinc finger transcription factor" . SPARSER::PROTEIN)
    ("PTH" . SPARSER::PROTEIN) ("conformation" . SPARSER::BIO-CONFORMATION)
    ("bilateral sensorineural deafness" . SPARSER::PROTEIN)
    ("hypoparathyroidism" . SPARSER::PROTEIN) ("deafness" . SPARSER::PROTEIN)
    ("Hypoparathyroidism" . SPARSER::PROTEIN)
    ("Amino acids" . SPARSER::AMINO-ACID) ("FOG2" . SPARSER::PROTEIN)
    ("GATA 1–6" . SPARSER::PROTEIN)
    ("glial cell line-derived neurotrophic factor" . SPARSER::PROTEIN)
    ("Gata3" . SPARSER::PROTEIN) ("per 1 " . SPARSER::PROTEIN)
    ("Full-length" . SPARSER::PROTEIN) ("GATA3" . SPARSER::PROTEIN)
    ("promiscuous multi-kinase inhibitors" . SPARSER::INHIBITOR)
    ("PARP/TNKS" . SPARSER::COLLECTION)
    ("MEK and tankyrase" . SPARSER::COLLECTION) ("LK" . SPARSER::PROTEIN)
    ("axin and tankyrase" . SPARSER::COLLECTION)
    ("rucaparib or talazoparib" . SPARSER::COLLECTION)
    ("olaparib or veliparib" . SPARSER::COLLECTION)
    ("olaparib, niraparib, and veliparib" . SPARSER::COLLECTION)
    ("previously described inhibitors" . SPARSER::INHIBITOR)
    ("traditional PARP inhibitors" . SPARSER::INHIBITOR)
    ("KU70 , PKCS , and LIGlV" . SPARSER::COLLECTION)
    ("the traditional PARP inhibitors" . SPARSER::INHIBITOR)
    ("olaparib, niraparib and talazoparib" . SPARSER::COLLECTION)
    ("talazoparib" . SPARSER::DRUG)
    ("Wnt pathway proteins and Wnt-related genes" . SPARSER::COLLECTION)
    ("a dual PARP1/2 and TNKS1/2 inhibitor" . SPARSER::INHIBITOR)
    ("CAR2, FZD9, LEF1, and VIL1" . SPARSER::COLLECTION)
    ("NOS3, LGR5 and LEF1" . SPARSER::COLLECTION)
    ("NKD1, CYR61 and MMP7" . SPARSER::COLLECTION)
    ("XAV939 or olaparib" . SPARSER::COLLECTION)
    ("axin2 and β-catenin" . SPARSER::COLLECTION)
    ("axin2 and cyclin D1" . SPARSER::COLLECTION)
    ("axin2 as well as tankyrase proteins" . SPARSER::COLLECTION)
    ("platinum" . SPARSER::MOLECULE) ("temozolomide (TMZ)" . SPARSER::DRUG)
    ("TMZ" . SPARSER::DRUG)
    ("temozolomide and carboplatin" . SPARSER::COLLECTION)
    ("carboplatin" . SPARSER::DRUG) ("ATM and RAD17" . SPARSER::COLLECTION)
    ("FEN1, POLD, and POLB" . SPARSER::COLLECTION) ("BLM" . SPARSER::PROTEIN)
    ("helicase" . SPARSER::PROTEIN) ("RecQ" . SPARSER::PROTEIN-FAMILY)
    ("POLB" . SPARSER::PROTEIN) ("POLD" . SPARSER::PROTEIN)
    ("NER" . SPARSER::PROTEIN) ("Minimal PARP" . SPARSER::PROTEIN)
    ("poisons" . SPARSER::MOLECULE) ("tankyrase" . SPARSER::PROTEIN)
    ("PARP3 or PARPs" . SPARSER::COLLECTION)
    ("available full length recombinant human PARP enzymes" . SPARSER::ENZYME)
    ("substrate and auto-PARylation" . SPARSER::COLLECTION)
    ("traditional inhibitors" . SPARSER::INHIBITOR)
    ("Tankyrase" . SPARSER::PROTEIN) ("tankyrases" . SPARSER::PROTEIN)
    ("Tankyrases" . SPARSER::PROTEIN)
    ("substrate proteins and a sterile α-motif (SAM)" . SPARSER::COLLECTION)
    ("SAM" . SPARSER::MOLECULE) ("sterile" . SPARSER::PROTEIN-FAMILY)
    ("ankyrin" . SPARSER::PROTEIN) ("Medicines" . SPARSER::DRUG)
    ("olaparib (AstraZeneca) and niraparib (Tesaro)" . SPARSER::COLLECTION)
    ("BRCA1 or BRCA2" . SPARSER::COLLECTION) ("Polymerases" . SPARSER::PROTEIN)
    ("a novel dual PARP1/2 and TNKS1/2 inhibitor" . SPARSER::INHIBITOR)
    ("axin and TNKS" . SPARSER::COLLECTION) ("axin" . SPARSER::PROTEIN)
    ("TNKS" . SPARSER::PROTEIN) ("Polymerase" . SPARSER::PROTEIN)
    ("tankyrase 1" . SPARSER::PROTEIN) ("axin 2" . SPARSER::PROTEIN)
    ("E6" . SPARSER::HUMAN-PROTEIN-FAMILY) ("N 5" . SPARSER::PROTEIN)
    ("18 H" . SPARSER::PROTEIN) ("RNF146" . SPARSER::PROTEIN)
    ("GSK3β" . SPARSER::PROTEIN) ("KU70" . SPARSER::PROTEIN)
    ("E6201" . SPARSER::DRUG) ("FZD9" . SPARSER::PROTEIN)
    ("int-1" . SPARSER::PROTEIN) ("Wnt1" . SPARSER::PROTEIN)
    ("MMP7" . SPARSER::PROTEIN) ("CYR61" . SPARSER::PROTEIN)
    ("NKD1" . SPARSER::PROTEIN) ("LEF1" . SPARSER::PROTEIN)
    ("LGR5" . SPARSER::PROTEIN) ("NOS3" . SPARSER::PROTEIN)
    ("axin2" . SPARSER::PROTEIN) ("FEN1" . SPARSER::PROTEIN)
    ("RAD18" . SPARSER::PROTEIN) ("RAD17" . SPARSER::PROTEIN)
    ("Rad54" . SPARSER::PROTEIN) ("XAV939" . SPARSER::DRUG)
    ("PARP4" . SPARSER::PROTEIN) ("6–16" . SPARSER::PROTEIN)
    ("PARP3" . SPARSER::PROTEIN) ("P-glycoprotein" . SPARSER::PROTEIN)
    ("TNKS1" . SPARSER::PROTEIN) ("tankyrase1" . SPARSER::PROTEIN)
    ("ZEB" . SPARSER::PROTEIN) ("CCL" . SPARSER::DRUG)
    ("ICAM-1 and MMP9" . SPARSER::COLLECTION)
    ("a major trigger" . SPARSER::PROTEIN)
    ("an arachidonic acid metabolite" . SPARSER::MOLECULE)
    ("lipoxygenase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("metabolite" . SPARSER::MOLECULE) ("MMP2 and MMP9" . SPARSER::COLLECTION)
    ("the ITGAM(CD11b)/ITGB2(CD18) heterodimer" . SPARSER::HETERODIMER)
    ("vascular ICAM-1" . SPARSER::PROTEIN) ("/ITGB2" . SPARSER::COLLECTION)
    ("heterodimer" . SPARSER::HETERODIMER) ("ITGAM" . SPARSER::PROTEIN)
    ("ICAM-1 and its counter receptor" . SPARSER::COLLECTION)
    ("MMPs and NF-κB" . SPARSER::COLLECTION)
    ("stromal MMP1" . SPARSER::PROTEIN) ("MMP1-PAR1" . SPARSER::COLLECTION)
    ("the lymphendothelial vasculature" . SPARSER::PROTEIN)
    ("the haemangiogenic vasculature" . SPARSER::PROTEIN)
    ("activated lymphendothelial MLC2 and FAK" . SPARSER::COLLECTION)
    ("protein C, thrombin and plasmin" . SPARSER::COLLECTION)
    ("plasmin" . SPARSER::PROTEIN) ("migraine" . SPARSER::PROTEIN)
    ("parthenolide" . SPARSER::MOLECULE) ("sesquiterpene" . SPARSER::MOLECULE)
    ("traditional medicine" . SPARSER::DRUG) ("curcumin" . SPARSER::DRUG)
    ("just RELA/NFKB1" . SPARSER::COLLECTION)
    ("MMP1 and PAR1" . SPARSER::COLLECTION)
    ("MMP1 and ICAM-1" . SPARSER::COLLECTION)
    ("si-ICAM-1" . SPARSER::COLLECTION) ("si-NFKB2" . SPARSER::COLLECTION)
    ("si-NFKB1" . SPARSER::COLLECTION)
    ("MLC2, FAK and paxillin" . SPARSER::COLLECTION)
    ("thrombin" . SPARSER::PROTEIN)
    ("Lymphendothelial Protease-Activated Receptor 1" . SPARSER::PROTEIN)
    ("Protease" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("si-MMP1" . SPARSER::COLLECTION)
    ("mRNA- and protein" . SPARSER::COLLECTION) ("mRNA-" . SPARSER::PROTEIN)
    ("respective mRNAs and proteins" . SPARSER::COLLECTION)
    ("mRNAs and proteins" . SPARSER::COLLECTION)
    ("just RELA or NFKB1" . SPARSER::COLLECTION)
    ("RELA or NFKB1" . SPARSER::COLLECTION)
    ("NFKB2, and NEMO" . SPARSER::COLLECTION)
    ("RELA, NFKB1, or NEMO" . SPARSER::COLLECTION)
    ("mRNAs ( xref ) and proteins" . SPARSER::COLLECTION)
    ("RELB nor NFKB1" . SPARSER::COLLECTION)
    ("RELA, CREL, NFKB1 and NEMO" . SPARSER::COLLECTION)
    ("RELB, CREL, NFKB2 and NIK" . SPARSER::COLLECTION)
    ("IKBKG" . SPARSER::PROTEIN)
    ("NEMO (IκBKγ) and NIK (MAP3K14)" . SPARSER::COLLECTION)
    ("RELA, RELB, CREL, NFKB1 (p50; p105), NFKB2 (p52; p100), NEMO (IκBKγ) and NIK (MAP3K14)"
     . SPARSER::COLLECTION)
    ("respective si-RNAs" . SPARSER::RNA) ("BK" . SPARSER::PROTEIN)
    ("monolayers" . SPARSER::PROTEIN)
    ("the angiogenic vasculature" . SPARSER::PROTEIN)
    ("MMP1/PAR1" . SPARSER::COLLECTION) ("chemorepellent" . SPARSER::PROTEIN)
    ("ZEB1 [ xref ] and ICAM-1 [ xref , xref ]" . SPARSER::COLLECTION)
    ("-HETE" . SPARSER::MOLECULE) ("HETE" . SPARSER::MOLECULE)
    ("the lymphatic barrier" . SPARSER::PROTEIN)
    ("MLC2 and FAK" . SPARSER::COLLECTION) ("RELA/NFKB1" . SPARSER::COLLECTION)
    ("RELA and NFKB1" . SPARSER::COLLECTION)
    ("RELB, NFKB2 and NIK" . SPARSER::COLLECTION)
    ("the lymphatic vasculature" . SPARSER::PROTEIN)
    ("RELA, NFKB1 and NEMO" . SPARSER::COLLECTION)
    ("vasculature" . SPARSER::PROTEIN) ("vascular barrier" . SPARSER::PROTEIN)
    ("RELA, RELB, CREL, NFKB1 and NFKB2" . SPARSER::COLLECTION)
    ("NEMO and NIK" . SPARSER::COLLECTION) ("NIK" . SPARSER::PROTEIN)
    ("NEMO" . SPARSER::PROTEIN) ("CREL" . SPARSER::PROTEIN)
    ("RELB" . SPARSER::PROTEIN) ("RELA" . SPARSER::PROTEIN)
    ("3-phosphate dehydrogenase" . SPARSER::PROTEIN)
    ("Bay11–7082" . SPARSER::DRUG) ("CD54" . SPARSER::PROTEIN)
    ("myosin light chain 2" . SPARSER::PROTEIN) ("ALOX15" . SPARSER::PROTEIN)
    ("CD18" . SPARSER::PROTEIN) ("ITGB2" . SPARSER::PROTEIN)
    ("CD11b" . SPARSER::PROTEIN) ("70 kD" . SPARSER::PROTEIN)
    ("Receptor 1" . SPARSER::PROTEIN) ("MMP11" . SPARSER::PROTEIN)
    ("GM6001" . SPARSER::DRUG) ("matrix metalloproteinase" . SPARSER::PROTEIN)
    ("SiRNA-mediated" . SPARSER::PROTEIN) ("si-RNAs" . SPARSER::RNA)
    ("MAP3K14" . SPARSER::PROTEIN) ("p100" . SPARSER::PROTEIN)
    ("IκBα" . SPARSER::PROTEIN) ("VE-cadherin" . SPARSER::PROTEIN)
    ("ICAM-1" . SPARSER::PROTEIN) ("MLC2" . SPARSER::PROTEIN)
    ("SCH79797" . SPARSER::DRUG) ("Ca 2+" . SPARSER::CALCIUM-ION)
    ("PAR1" . SPARSER::PROTEIN) ("NFKB2" . SPARSER::PROTEIN)
    ("NFKB1" . SPARSER::PROTEIN)
    ("EGFR mRNA and other genes" . SPARSER::COLLECTION)
    ("NOX4/p38" . SPARSER::COLLECTION)
    ("Raf-1, MEK and JNK" . SPARSER::COLLECTION)
    ("Raf-1, MEK, JNK and p38" . SPARSER::COLLECTION)
    ("ERK, JNK and p38" . SPARSER::COLLECTION)
    ("COX-2 and EGFR" . SPARSER::COLLECTION)
    ("IL-6 and VEGF" . SPARSER::COLLECTION)
    ("extracellular proteases" . SPARSER::PROTEIN)
    ("glycolitic enzymes" . SPARSER::ENZYME)
    ("angiogenic and autocrine growth factors" . SPARSER::GROWTH-FACTOR)
    ("neither hormone receptors nor HER2" . SPARSER::COLLECTION)
    ("MDA" . SPARSER::DRUG) ("Raf-1/MAPK/c-Jun" . SPARSER::COLLECTION)
    ("Raf-1 and ERK" . SPARSER::COLLECTION)
    ("ERK1/2 and c-Jun" . SPARSER::COLLECTION)
    ("MAPK/ERK" . SPARSER::COLLECTION) ("MicroRNA" . SPARSER::RNA)
    ("PD98059, U0126 and AZD6244" . SPARSER::COLLECTION)
    ("c-Jun and c-Fos" . SPARSER::COLLECTION)
    ("PD98059, AZD6244 and U0126" . SPARSER::COLLECTION)
    ("SB203580 and SB202190" . SPARSER::COLLECTION)
    ("ERK1/2, p38, and JNK" . SPARSER::COLLECTION)
    ("MAPK/AP-1" . SPARSER::COLLECTION) ("hrs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Lap" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Raf-1/MAPK/AP-1" . SPARSER::COLLECTION) ("TSA" . SPARSER::PROTEIN)
    ("EGFR and cyclooxygenase-2" . SPARSER::COLLECTION)
    ("an oral dual tyrosine kinase inhibitor (TKI)" . SPARSER::INHIBITOR)
    ("estrogen and progesterone receptors (ER and PR) and HER2 [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("estrogen and progesterone" . SPARSER::COLLECTION)
    ("ER and PR" . SPARSER::COLLECTION) ("progesterone" . SPARSER::PROTEIN)
    ("hormone and HER2" . SPARSER::COLLECTION) ("miR7" . SPARSER::PROTEIN)
    ("MAPK, and activator protein 1" . SPARSER::COLLECTION)
    ("Raf-1/mitogen-activated protein kinases" . SPARSER::COLLECTION)
    ("JNKs" . SPARSER::PROTEIN)
    ("a dual epidermal growth factor receptor (EGFR) and HER2 tyrosine kinase inhibitor (TKI)"
     . SPARSER::COLLECTION)
    ("inhibitor (TKI)" . SPARSER::INHIBITOR)
    ("a dual epidermal growth factor receptor (EGFR)"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("protein A" . SPARSER::PROTEIN) ("phospho-JNK" . SPARSER::PROTEIN)
    ("mitogen-activated protein kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ago2" . SPARSER::PROTEIN) ("Ago2" . SPARSER::PROTEIN)
    ("MiR-7" . SPARSER::PROTEIN) ("Gw5074" . SPARSER::DRUG)
    ("GW5074" . SPARSER::DRUG) ("c-fos" . SPARSER::PROTEIN)
    ("Transcription factor AP-1" . SPARSER::PROTEIN)
    ("SB203580" . SPARSER::DRUG) ("AZD6244" . SPARSER::DRUG)
    ("Interleukin-6" . SPARSER::PROTEIN) ("COX-2" . SPARSER::PROTEIN)
    ("cyclooxygenase-2" . SPARSER::PROTEIN) ("miR-7" . SPARSER::PROTEIN)
    ("activator protein 1" . SPARSER::PROTEIN) ("Raf-1" . SPARSER::PROTEIN)
    ("potential therapeutics" . SPARSER::THERAPEUTICS)
    ("AKTs and their downstream effectors HK2 and PKM2" . SPARSER::COLLECTION)
    ("Bcl-2, Mcl-1, and MMP-2" . SPARSER::COLLECTION)
    ("catabolism" . SPARSER::PROTEIN) ("AKT-HK2/PKM2" . SPARSER::COLLECTION)
    ("HKII" . SPARSER::PROTEIN) ("HK2 and PKM2" . SPARSER::COLLECTION)
    ("a well-documented tumor-suppressing miRNA" . SPARSER::PROTEIN)
    ("PKM2 and HK2" . SPARSER::COLLECTION)
    ("AKT2, AKT3, PKM2 and HK2" . SPARSER::COLLECTION)
    ("analog" . SPARSER::ANALOG) ("AKT2/3, HK2 and PKM2" . SPARSER::COLLECTION)
    ("MK-2206, and GSK690693" . SPARSER::COLLECTION)
    ("parts" . SPARSER::COMPONENT)
    ("miR-29b and simultaneously employed AKT inhibitors"
     . SPARSER::COLLECTION)
    ("AKT2/3" . SPARSER::PROTEIN)
    ("p-AKT2/3, HK2, and PKM2" . SPARSER::COLLECTION)
    ("p-AKT2/3" . SPARSER::PROTEIN-PAIR)
    ("GLUT1 and LDHA" . SPARSER::COLLECTION) ("AO" . SPARSER::PROTEIN)
    ("enzymes, PKM2 and HK2" . SPARSER::COLLECTION)
    ("LDHA and GLUT1" . SPARSER::COLLECTION)
    ("enzymes and miR-29b" . SPARSER::COLLECTION)
    ("enzymes and isozymes" . SPARSER::COLLECTION)
    ("enzymes, GLUT1, HK2, PKM2, and LDHA" . SPARSER::COLLECTION)
    ("LDHA" . SPARSER::PROTEIN) ("AKT1/AKT2/AKT3" . SPARSER::COLLECTION)
    ("the three highly homologous AKT isoforms" . SPARSER::ISOFORM)
    ("onco-protein" . SPARSER::COLLECTION)
    ("miR-29b and AKT2 or AKT3" . SPARSER::COLLECTION)
    ("AKT2 or AKT3" . SPARSER::COLLECTION)
    ("miR-29b or control mimics" . SPARSER::COLLECTION)
    ("RNA or protein" . SPARSER::COLLECTION)
    ("AKTs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("ADR" . SPARSER::PROTEIN)
    ("these four putatively cancer glycolysis-regulating genes"
     . SPARSER::GENE)
    ("AKT2, AKT3, G6PC, and GYS1" . SPARSER::COLLECTION)
    ("PITA" . SPARSER::PROTEIN) ("normoxia/hypoxia" . SPARSER::COLLECTION)
    ("examined miR-29b and its latent downstream targets"
     . SPARSER::COLLECTION)
    ("potential downstream target genes" . SPARSER::GENE)
    ("AKT2 and AKT3" . SPARSER::COLLECTION)
    ("the nearly 2,000 miRNAs" . SPARSER::PROTEIN)
    ("mature miRNAs" . SPARSER::PROTEIN) ("hexokinase" . SPARSER::PROTEIN)
    ("three highly homologous AKT isoforms" . SPARSER::ISOFORM)
    ("AKT1, AKT2, and AKT3" . SPARSER::COLLECTION)
    ("protein kinase B(PKB)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PKB" . SPARSER::PROTEIN) ("FDG" . SPARSER::PROTEIN)
    ("NADH" . SPARSER::MOLECULE) ("lactate" . SPARSER::MOLECULE)
    ("Glucose" . SPARSER::PROTEIN) ("HK2/PKM2" . SPARSER::COLLECTION)
    ("AKT2/AKT3" . SPARSER::COLLECTION) ("small nuclear RNA" . SPARSER::RNA)
    ("N 2" . SPARSER::PROTEIN) ("miR-29" . SPARSER::PROTEIN)
    ("Akt2" . SPARSER::PROTEIN) ("GSK690693" . SPARSER::DRUG)
    ("GLUT1" . SPARSER::PROTEIN) ("CA-125" . SPARSER::PROTEIN)
    ("A 3" . SPARSER::HUMAN-PROTEIN-FAMILY) ("GYS1" . SPARSER::PROTEIN)
    ("G6PC" . SPARSER::PROTEIN)
    ("amino acid synthesis" . SPARSER::PROTEIN-FAMILY)
    ("phosphofructokinase activity" . SPARSER::PROTEIN)
    ("NAD+" . SPARSER::MOLECULE) ("AKT3" . SPARSER::PROTEIN)
    ("AKT2" . SPARSER::PROTEIN) ("Plk4 mitotic kinase" . SPARSER::KINASE)
    ("pro-apoptotic variants" . SPARSER::VARIANT)
    ("Nek2 or SRSF1" . SPARSER::COLLECTION)
    ("Mcl1, Bcl-2 and Bcl-XL" . SPARSER::COLLECTION) ("Mcl" . SPARSER::PROTEIN)
    ("MMTV-ERBB2" . SPARSER::COLLECTION)
    ("E2F1, E2F2 and E2F3" . SPARSER::COLLECTION)
    ("E2F1, E2F2 or E2F3" . SPARSER::COLLECTION) ("MMTV" . SPARSER::PROTEIN)
    ("Plk4" . SPARSER::PROTEIN) ("Plk" . SPARSER::PROTEIN)
    ("larger acini" . SPARSER::PROTEIN) ("smaller acini" . SPARSER::PROTEIN)
    ("acini" . SPARSER::PROTEIN) ("matrigel" . SPARSER::PROTEIN)
    ("ser" . SPARSER::AMINO-ACID) ("condensation" . SPARSER::PROTEIN-FAMILY)
    ("caspase-3 and Bax" . SPARSER::COLLECTION)
    ("phospho-Histone" . SPARSER::PROTEIN)
    ("Ki67 and phospho histone 3" . SPARSER::COLLECTION)
    ("IF" . SPARSER::PROTEIN)
    ("2F3 group and only one tumor" . SPARSER::COLLECTION)
    ("sq" . SPARSER::MOLECULE) ("para" . SPARSER::PROTEIN-FAMILY)
    ("atypical, hyperchromatic or open chromatin" . SPARSER::PROTEIN)
    ("hpf" . SPARSER::PROTEIN) ("Nek2 western blot" . SPARSER::PROTEIN)
    ("pMONO-Hygro-GFP" . SPARSER::COLLECTION)
    ("GFP-Nek2" . SPARSER::COLLECTION) ("Herceptin" . SPARSER::DRUG)
    ("Cdk4 [ xref ] or E2F3 [ xref ]" . SPARSER::COLLECTION)
    ("supranumerary centrosomes" . SPARSER::PROTEIN)
    ("centrosomes" . SPARSER::PROTEIN)
    ("the Nek2 mitotic kinase" . SPARSER::KINASE)
    ("mitotic genes" . SPARSER::GENE)
    ("Cdc2 and cyclin B1" . SPARSER::COLLECTION) ("MEF" . SPARSER::PROTEIN)
    ("E2F1 and E2F2" . SPARSER::COLLECTION)
    ("E2F1 and E2F3" . SPARSER::COLLECTION) ("E2F's" . SPARSER::PROTEIN-FAMILY)
    ("cyclin/Cdks" . SPARSER::COLLECTION)
    ("Cdks" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a mitotic kinase" . SPARSER::KINASE)
    ("Cdk4- or E2F-" . SPARSER::COLLECTION) ("E2F-" . SPARSER::PROTEIN-FAMILY)
    ("Cdk4-" . SPARSER::PROTEIN) ("mammary fat" . SPARSER::PROTEIN)
    ("E2F1 or E2F3" . SPARSER::COLLECTION)
    ("E2F1, E2F2 and E2F3a" . SPARSER::COLLECTION)
    ("Glycine)" . SPARSER::PROTEIN) ("E-Cadherin" . SPARSER::PROTEIN)
    ("γ-H2AX" . SPARSER::PROTEIN) ("histone 3" . SPARSER::PROTEIN)
    ("Rat-1" . SPARSER::PROTEIN) ("Cdc2" . SPARSER::PROTEIN)
    ("Cyclin A" . SPARSER::PROTEIN) ("E2Fs" . SPARSER::PROTEIN-FAMILY)
    ("F3" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Cdk4" . SPARSER::PROTEIN)
    ("Nek2" . SPARSER::PROTEIN)
    ("transcriptional activators" . SPARSER::PROTEIN-FAMILY)
    ("YB-1 and pSTAT3" . SPARSER::COLLECTION)
    ("IL-6 and YB-1" . SPARSER::COLLECTION)
    ("IL-6/STAT3" . SPARSER::COLLECTION)
    ("YB-1 and STAT3" . SPARSER::COLLECTION)
    ("cytokines and chemokines" . SPARSER::COLLECTION)
    ("chemokines" . SPARSER::PROTEIN) ("VEGF, and TGFβ" . SPARSER::COLLECTION)
    ("IL-6 and IL-6R" . SPARSER::COLLECTION)
    ("mRNA and IL-6" . SPARSER::COLLECTION)
    ("IL-6 and some MMPs" . SPARSER::COLLECTION)
    ("extracellular proteinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("YB-1/STAT3" . SPARSER::COLLECTION)
    ("ABCC1 and MVP1" . SPARSER::COLLECTION) ("MVP" . SPARSER::PROTEIN)
    ("transporters" . SPARSER::PROTEIN)
    ("EGF [ xref ] or cytokines" . SPARSER::COLLECTION)
    ("TGFβ or IL-2" . SPARSER::COLLECTION)
    ("Snail1, Twist, and vimentin levels" . SPARSER::COLLECTION)
    ("Snail" . SPARSER::PROTEIN) ("repressors" . SPARSER::REPRESSOR)
    ("cadherin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("YB-1 and E-cadherin" . SPARSER::COLLECTION)
    ("the mesenchymal marker SNAI1" . SPARSER::PROTEIN)
    ("aggressive types" . TYPE) ("a powerful oncoprotein" . SPARSER::PROTEIN)
    ("YB-1 or IL-6" . SPARSER::COLLECTION)
    ("YB-1 and pSTAT3 S727" . SPARSER::COLLECTION)
    ("YB-1 and Stat3" . SPARSER::COLLECTION)
    ("STAT3 or MEK" . SPARSER::COLLECTION)
    ("STAT3 and MEK" . SPARSER::COLLECTION)
    ("STAT3 (S3I-201) and MEK (PD98059)" . SPARSER::COLLECTION)
    ("mRNPs" . SPARSER::BIO-COMPLEX) ("ribonucleoprotein" . SPARSER::PROTEIN)
    ("Cytokine" . SPARSER::PROTEIN) ("IL-6 and TGFβ" . SPARSER::COLLECTION)
    ("YBX1 and SNAI1" . SPARSER::COLLECTION)
    ("YBX1 and STAT3" . SPARSER::COLLECTION) ("dimers" . SPARSER::DIMER)
    ("the mesenchymal marker vimentin and the EMT inducers Snail1"
     . SPARSER::COLLECTION)
    ("the mesenchymal marker vimentin" . SPARSER::PROTEIN)
    ("vimentin" . SPARSER::PROTEIN) ("antibiotic" . SPARSER::DRUG)
    ("pLPCX-YB-1" . SPARSER::COLLECTION)
    ("active YB-1 [ xref , xref ] and IL-6" . SPARSER::COLLECTION)
    ("MEK-ERK" . SPARSER::PROTEIN-PAIR) ("JAK/STAT3" . SPARSER::COLLECTION)
    ("cues" . SPARSER::PROTEIN-FAMILY)
    ("proinflammatory cytokines" . SPARSER::PROTEIN)
    ("the aggressive triple-negative (TNBC) subtypes" . SPARSER::PROTEIN)
    ("YB-1/IL-6" . SPARSER::COLLECTION) ("YB-1 and IL-6" . SPARSER::COLLECTION)
    ("The multifunctional oncoprotein Y-box binding protein-1 (YB-1) and the pleiotropic cytokine interleukin 6 (IL-6)"
     . SPARSER::COLLECTION)
    ("the pleiotropic cytokine interleukin 6" . SPARSER::PROTEIN)
    ("The multifunctional oncoprotein Y-box binding protein-1"
     . SPARSER::PROTEIN)
    ("Growth factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("anti–" . SPARSER::ANTIBODY) ("p60" . SPARSER::PROTEIN)
    ("as 2" . SPARSER::PROTEIN) ("m1" . SPARSER::MOLECULE)
    ("Reverse Transcriptase" . SPARSER::PROTEIN) ("A-3" . SPARSER::PROTEIN)
    ("YB1" . SPARSER::PROTEIN) ("MEK1/2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("penicillin G" . SPARSER::MOLECULE) ("IL-6R" . SPARSER::PROTEIN)
    ("MT1-MMP" . SPARSER::PROTEIN) ("MMP13" . SPARSER::PROTEIN)
    ("MMP2" . SPARSER::PROTEIN) ("IFN-α" . SPARSER::PROTEIN)
    ("ABCC1" . SPARSER::PROTEIN) ("MDR1" . SPARSER::PROTEIN)
    ("PD98059" . SPARSER::MOLECULE) ("Anti–" . SPARSER::ANTIBODY)
    ("gp130" . SPARSER::PROTEIN) ("gp80" . SPARSER::PROTEIN)
    ("IL-6 receptor" . SPARSER::PROTEIN) ("Snail1" . SPARSER::PROTEIN)
    ("MEK1" . SPARSER::PROTEIN) ("ZEB1" . SPARSER::PROTEIN)
    ("SNAI1" . SPARSER::PROTEIN) ("TWIST1" . SPARSER::PROTEIN)
    ("interleukin 6" . SPARSER::PROTEIN)
    ("Y-box binding protein-1" . SPARSER::PROTEIN) ("12/13" . SPARSER::PROTEIN)
    ("KRAS-12/13" . SPARSER::PROTEIN-PAIR)
    ("KRAS, NRAS, and BRAF" . SPARSER::COLLECTION)
    ("EGFR or its ligands" . SPARSER::COLLECTION)
    ("epiregulin (EREG) and amphiregulin (AREG)" . SPARSER::COLLECTION)
    ("EGFR and BRAF" . SPARSER::COLLECTION) ("AREG" . SPARSER::PROTEIN)
    ("amphiregulin" . SPARSER::PROTEIN) ("EREG" . SPARSER::PROTEIN)
    ("epiregulin" . SPARSER::PROTEIN)
    ("Food and Drug Administration (FDA)" . SPARSER::COLLECTION)
    ("irinotecan-" . SPARSER::DRUG) ("FDA" . SPARSER::PROTEIN)
    ("panitumumab" . SPARSER::DRUG) ("Erbitux" . SPARSER::DRUG)
    ("Avastin" . SPARSER::DRUG) ("bevacizumab" . SPARSER::DRUG)
    ("irinotecan" . SPARSER::DRUG) ("Leucovorin" . SPARSER::DRUG)
    ("oxaliplatin" . SPARSER::DRUG) ("UFT" . SPARSER::DRUG)
    ("ftorafur" . SPARSER::DRUG) ("uracil" . SPARSER::DRUG)
    ("capecitabine" . SPARSER::DRUG) ("fluoropyrimidines" . SPARSER::DRUG)
    ("LV" . SPARSER::MOLECULE) ("leucovorin" . SPARSER::DRUG)
    ("the six-oncogenic alleles" . SPARSER::ALLELE)
    ("a random cohort" . SPARSER::MOLECULE) ("CRC-PDXs" . SPARSER::COLLECTION)
    ("PDXs" . SPARSER::PROTEIN) ("MCT" . SPARSER::PROTEIN)
    ("PDX" . SPARSER::PROTEIN) ("mCRC" . SPARSER::PROTEIN)
    ("Cetuximab" . SPARSER::DRUG) ("etc ." . SPARSER::PROTEIN)
    ("PIK3" . SPARSER::PROTEIN) ("ERBB2" . SPARSER::PROTEIN)
    ("5FU" . SPARSER::DRUG) ("5-FU" . SPARSER::PROTEIN)
    ("H/R" . SPARSER::PROTEIN) ("N-RAS" . SPARSER::PROTEIN)
    ("especially PCa harboring mutant p53s" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("mitochondrial-related caspase-9, and -3" . SPARSER::COLLECTION)
    ("caspase-9, and -3" . SPARSER::COLLECTION)
    ("fatostatin-treated PC-3 R248W" . SPARSER::PROTEIN)
    ("Cyclin B1 and Cdk1" . SPARSER::COLLECTION)
    ("cyclin-dependent kinase (Cdk) and cyclin complexes [ xref ]"
     . SPARSER::COLLECTION)
    ("Cdk" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("AR and p53" . SPARSER::COLLECTION)
    ("decrease blood fatty acid and cholesterol and body weight"
     . SPARSER::COLLECTION)
    ("SREBPs, FASN and HMGCR" . SPARSER::COLLECTION)
    ("SREBPs and their downstream genes" . SPARSER::COLLECTION)
    ("the respective vehicle group" . SPARSER::MOLECULE)
    ("FASN and HMGCR" . SPARSER::COLLECTION)
    ("PC-3 and DU145" . SPARSER::COLLECTION)
    ("fatostatin and/or docetaxel" . SPARSER::COLLECTION)
    ("fatostatin (2.5 μM) or docetaxel (5.0 nM)" . SPARSER::COLLECTION)
    ("p21, p53R2, BAX and MDM2" . SPARSER::COLLECTION)
    ("p53R2" . SPARSER::PROTEIN)
    ("SREBP-1, SREBP-2 and FASN" . SPARSER::COLLECTION)
    ("mevalonate kinase (MVK)" . SPARSER::PROTEIN)
    ("SREBPs and their anabolic genes [ xref ]" . SPARSER::COLLECTION)
    ("mevalonate 5-pyrophosphate decarboxylase (MVD) and low-density lipoprotein receptor (LDLR)"
     . SPARSER::COLLECTION)
    ("insulin-induced gene 1 (INSIG1) and SREBP cleavage activating protein (SCAP)"
     . SPARSER::COLLECTION)
    ("insulin-induced gene 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("decarboxylase (MVD)" . SPARSER::PROTEIN)
    ("their anabolic genes" . SPARSER::GENE)
    ("FASN and stearoyl-CoA" . SPARSER::COLLECTION) ("SCAP" . SPARSER::PROTEIN)
    ("chaperones" . SPARSER::PROTEIN) ("LDLR" . SPARSER::PROTEIN)
    ("MVD" . SPARSER::PROTEIN) ("decarboxylase" . SPARSER::PROTEIN)
    ("pyrophosphate" . SPARSER::MOLECULE) ("MVK" . SPARSER::PROTEIN)
    ("CoA" . SPARSER::MOLECULE) ("ACL" . SPARSER::PROTEIN)
    ("caspase-9, caspase-3 and PARP" . SPARSER::COLLECTION)
    ("p-Cdk1" . SPARSER::COLLECTION) ("iodide (PI)" . SPARSER::PROTEIN)
    ("epithelial growth factor receptor (EGFR) and MET (the receptor for hepatocyte growth factor, HGF)"
     . SPARSER::COLLECTION)
    ("receptor (EGFR)" . SPARSER::RECEPTOR) ("MET" . SPARSER::PROTEIN)
    ("Fatostatin" . SPARSER::DRUG)
    ("SREBPs and their target genes (Figure xref )" . SPARSER::COLLECTION)
    ("SREBP-2 and HMGCR" . SPARSER::COLLECTION)
    ("SREBP-1 and FASN" . SPARSER::COLLECTION)
    ("SREBP-2 and their downstream target proteins" . SPARSER::COLLECTION)
    ("HMGCR" . SPARSER::PROTEIN) ("FASN" . SPARSER::PROTEIN)
    ("PC-3 (p53-null) and DU145 (heterozygous p53, P223L and V274F)"
     . SPARSER::COLLECTION)
    ("aggressive PCa" . SPARSER::PROTEIN) ("PCa and PCa" . SPARSER::COLLECTION)
    ("bHLH" . SPARSER::PROTEIN) ("taxane" . SPARSER::DRUG)
    ("GOF" . SPARSER::PROTEIN) ("metastatic PCa" . SPARSER::PROTEIN)
    ("fatostatin and docetaxel" . SPARSER::COLLECTION)
    ("fatostatin" . SPARSER::DRUG) ("SREBP" . SPARSER::PROTEIN-FAMILY)
    ("sterol regulatory element-binding proteins" . SPARSER::PROTEIN)
    ("SREBPs" . SPARSER::PROTEIN-FAMILY) ("Docetaxel" . SPARSER::DRUG)
    ("PCa" . SPARSER::PROTEIN) ("P53R2" . SPARSER::PROTEIN)
    ("P21" . SPARSER::PROTEIN) ("Waf1/Cip1" . SPARSER::PROTEIN)
    ("APR-246" . SPARSER::DRUG)
    ("SREBP cleavage activating protein" . SPARSER::PROTEIN)
    ("INSIG1" . SPARSER::PROTEIN) ("gene 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("low-density lipoprotein receptor" . SPARSER::PROTEIN)
    ("mevalonate kinase" . SPARSER::PROTEIN) ("HMGCS1" . SPARSER::PROTEIN)
    ("SCD-1" . SPARSER::PROTEIN) ("stearoyl-CoA" . SPARSER::MOLECULE)
    ("ATP citrate lyase" . SPARSER::PROTEIN) ("Cdk1" . SPARSER::PROTEIN)
    ("Cyclin B1" . SPARSER::PROTEIN) ("HMG-CoA" . SPARSER::DRUG)
    ("fatty acid synthase" . SPARSER::PROTEIN) ("SREBP-2" . SPARSER::PROTEIN)
    ("SREBP-1" . SPARSER::PROTEIN)
    ("basic helix-loop-helix" . SPARSER::PROTEIN)
    ("p53s" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Guo" . SPARSER::MOLECULE)
    ("ubiquitin and/or SENP3" . SPARSER::COLLECTION)
    ("SUMO1 and SUMO2" . SPARSER::COLLECTION) ("ubiquitin " . SPARSER::PROTEIN)
    ("Sp1 and N-terminally" . SPARSER::COLLECTION) ("cAMP" . SPARSER::PROTEIN)
    ("Han and Kudlow" . SPARSER::COLLECTION)
    ("protein-protein" . SPARSER::COLLECTION)
    ("antagonistic regulators" . SPARSER::REGULATOR)
    ("SENP6 and no other SUMO2/3 specific SENPs" . SPARSER::COLLECTION)
    ("PML" . SPARSER::PROTEIN) ("IB" . SPARSER::DRUG)
    ("survivin" . SPARSER::PROTEIN)
    ("VEGF, cyclin D and Bcl-2" . SPARSER::COLLECTION)
    ("the intact or silenced SENP3" . SPARSER::PROTEIN)
    ("H 2 O 2 and MG132" . SPARSER::COLLECTION)
    ("Sp1 and SENP3" . SPARSER::COLLECTION)
    ("SENP3 and Sp1" . SPARSER::COLLECTION)
    ("RNF4 and Sp1" . SPARSER::COLLECTION) ("FLAG-RNF4" . SPARSER::COLLECTION)
    ("Sp1-RNF4" . SPARSER::COLLECTION) ("SUMO3-Sp1" . SPARSER::COLLECTION)
    ("SENP3 and a STUbL" . SPARSER::COLLECTION)
    ("Ub and SUMO3" . SPARSER::COLLECTION)
    ("ubiquitin, SUMO3 and Sp1" . SPARSER::COLLECTION)
    ("HA-SUMO3" . SPARSER::PROTEIN-PAIR) ("FLAG-Sp1" . SPARSER::COLLECTION)
    ("Sp1-SENP3" . SPARSER::COLLECTION)
    ("the exogenous SENP3" . SPARSER::PROTEIN) ("RH" . SPARSER::MOLECULE)
    ("the existed endogenous Sp1 protein" . SPARSER::PROTEIN)
    ("SENP3 and SUMO2/3" . SPARSER::COLLECTION)
    ("CUL2 and Ku70" . SPARSER::COLLECTION)
    ("CUL1 and CUL3, and XRCC5" . SPARSER::COLLECTION)
    ("CUL3, and XRCC5" . SPARSER::COLLECTION)
    ("available antibodies" . SPARSER::ANTIBODY)
    ("proteins and known cancer-associated proteins (Fig.  xref E, left and middle)"
     . SPARSER::COLLECTION)
    ("known cancer-associated proteins" . SPARSER::PROTEIN)
    ("da" . SPARSER::MOLECULE) ("Component" . SPARSER::COMPONENT)
    ("a nucleolar protein" . SPARSER::PROTEIN)
    ("approximately 100 kDa" . SPARSER::PROTEIN)
    ("run" . SPARSER::PROTEIN-FAMILY)
    ("expressed exogenous ubiquitin and endogenous SUMO2/3"
     . SPARSER::COLLECTION)
    ("expressed exogenous ubiquitin" . SPARSER::PROTEIN)
    ("SUMO3 and SENP3" . SPARSER::COLLECTION) ("Yan" . SPARSER::PROTEIN)
    ("Han" . SPARSER::PROTEIN) ("protease" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Sp1 and the subunit" . SPARSER::COLLECTION)
    ("ubiquitin-proteasomal" . SPARSER::COLLECTION) ("rpt6" . SPARSER::PROTEIN)
    ("a ubiquitously expressed basal transcription factor" . SPARSER::PROTEIN)
    ("Arkadia" . SPARSER::PROTEIN)
    ("the SUMO proteases and the STUbLs" . SPARSER::COLLECTION)
    ("SENP6 and SENP7" . SPARSER::COLLECTION)
    ("Lima and Reverter" . SPARSER::COLLECTION)
    ("SENP5–SENP7" . SPARSER::COLLECTION) ("SENP1–SENP3" . SPARSER::COLLECTION)
    ("Lima" . SPARSER::PROTEIN) ("proteases or SENPs" . SPARSER::COLLECTION)
    ("SUMO1 and SUMO2/3" . SPARSER::COLLECTION)
    ("SUMO2 and SUMO3" . SPARSER::COLLECTION)
    ("SUMO1, SUMO2 and SUMO3" . SPARSER::COLLECTION)
    ("homodimer" . SPARSER::HOMODIMER) ("ligases" . SPARSER::PROTEIN)
    ("modifiers" . SPARSER::MOLECULE) ("Ubiquitin" . SPARSER::PROTEIN)
    ("SENP3 and RNF4" . SPARSER::COLLECTION)
    ("a cancer-associated transcription factor" . SPARSER::PROTEIN)
    ("proteases, SENPs, and RNF4" . SPARSER::COLLECTION)
    ("SUMO" . SPARSER::PROTEIN) ("DCFH-DA" . SPARSER::DRUG)
    ("HCO 3" . SPARSER::MOLECULE) ("Ubi-1" . SPARSER::PROTEIN)
    ("N-acetyl-L-cysteine" . SPARSER::MOLECULE) ("Sp1 " . SPARSER::PROTEIN)
    ("cyclin D" . SPARSER::PROTEIN) ("Ku70" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CUL2" . SPARSER::PROTEIN) ("Ku80" . SPARSER::PROTEIN)
    ("XRCC5" . SPARSER::PROTEIN) ("CUL3" . SPARSER::PROTEIN)
    ("CUL1" . SPARSER::PROTEIN) ("Cullin family" . SPARSER::PROTEIN-FAMILY)
    ("RNF111" . SPARSER::PROTEIN) ("SENP6" . SPARSER::PROTEIN)
    ("SENP7" . SPARSER::PROTEIN) ("SENP5" . SPARSER::PROTEIN)
    ("SENP1" . SPARSER::PROTEIN) ("de-" . SPARSER::MOLECULE)
    ("SUMO3" . SPARSER::PROTEIN) ("SUMO1" . SPARSER::PROTEIN)
    ("De-" . SPARSER::MOLECULE) ("Sp1" . SPARSER::PROTEIN)
    ("SENP3" . SPARSER::PROTEIN) ("SUMO2" . SPARSER::PROTEIN)
    ("RNF4" . SPARSER::PROTEIN) ("catalase" . SPARSER::PROTEIN)
    ("Virulent Ode macrophages" . SPARSER::PROTEIN)
    ("virulent Theileria -transformed macrophages" . SPARSER::PROTEIN)
    ("the same Theileria -transformed macrophages" . SPARSER::PROTEIN)
    ("JAM-L and PI3-K" . SPARSER::COLLECTION)
    ("invasive virulent macrophages" . SPARSER::PROTEIN)
    ("AP-1-driven luciferase" . SPARSER::PROTEIN)
    ("Fos, Fos-B, Fos-L1 and Fos-L2" . SPARSER::COLLECTION)
    ("virulent and attenuated Theileria -transformed macrophages"
     . SPARSER::PROTEIN)
    ("mmp9" . SPARSER::PROTEIN) ("MMP" . SPARSER::PROTEIN)
    ("delta" . SPARSER::PROTEIN)
    ("a dominant-negative mutant" . SPARSER::MUTANT)
    ("PI3-K/AP-1" . SPARSER::COLLECTION) ("CAR" . SPARSER::PROTEIN)
    ("Wortmannin" . SPARSER::PROTEIN)
    ("Grb2 and TGF-RII" . SPARSER::COLLECTION) ("Tyr" . SPARSER::AMINO-ACID)
    ("Grb2 and p85" . SPARSER::COLLECTION) ("GST-Grb2" . SPARSER::COLLECTION)
    ("GST" . SPARSER::PROTEIN)
    ("Grb2 and the p85 subunit" . SPARSER::COLLECTION)
    ("macrophages and protein" . SPARSER::COLLECTION)
    ("exogenous TGF-β2" . SPARSER::PROTEIN)
    ("virulent and attenuated macrophages" . SPARSER::PROTEIN)
    ("virulent disease-causing infected macrophages" . SPARSER::PROTEIN)
    ("Theileria -transformed macrophages" . SPARSER::PROTEIN)
    ("TGF-β2/Grb2/PI3-K/AP-1" . SPARSER::COLLECTION)
    ("Homology" . SPARSER::PROTEIN) ("accessory proteins" . SPARSER::PROTEIN)
    ("a key transcription factor" . SPARSER::PROTEIN)
    ("growth factors and cytokines" . SPARSER::COLLECTION)
    ("the heterodimeric AP-1 transcription factor" . SPARSER::PROTEIN)
    ("Jun and Fos" . SPARSER::COLLECTION)
    ("phosphoinositide" . SPARSER::PROTEIN)
    ("phosphatidylinositol" . SPARSER::PROTEIN) ("inositol" . SPARSER::PROTEIN)
    ("a p110 catalytic subunit and a p85 regulator subunit"
     . SPARSER::COLLECTION)
    ("Smad2 and Smad3" . SPARSER::COLLECTION)
    ("TGF-β1 and TGF-β3" . SPARSER::COLLECTION) ("RI" . SPARSER::MOLECULE)
    ("virulent Theileria -infected macrophages" . SPARSER::PROTEIN)
    ("HF" . SPARSER::PROTEIN) ("transformed macrophages" . SPARSER::PROTEIN)
    ("exogenous growth factors" . SPARSER::GROWTH-FACTOR)
    ("Fos" . SPARSER::HUMAN-PROTEIN-FAMILY) ("TGF-receptor" . SPARSER::DRUG)
    ("TGF" . SPARSER::DRUG) ("virulent macrophages" . SPARSER::PROTEIN)
    ("PI3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY) ("GRP-1" . SPARSER::PROTEIN)
    ("PI3-Kinase" . SPARSER::HUMAN-PROTEIN-FAMILY) ("β-gal" . SPARSER::PROTEIN)
    ("TGFβ" . SPARSER::HUMAN-PROTEIN-FAMILY) ("I-19" . SPARSER::PROTEIN)
    ("Grb-2" . SPARSER::PROTEIN) ("L-Glutamine" . SPARSER::MOLECULE)
    ("TGF-β2 " . SPARSER::PROTEIN)
    ("Matrix MetalloProteinase" . SPARSER::PROTEIN)
    ("Activator Protein 1" . SPARSER::PROTEIN)
    ("colony-stimulating factor" . SPARSER::PROTEIN)
    ("three domains" . SPARSER::PROTEIN)
    ("AP-1 transcription factor" . SPARSER::PROTEIN) ("PIP 3" . SPARSER::PIP3)
    ("PIP 2" . SPARSER::PIP2) ("catalytic subunit" . SPARSER::PROTEIN)
    ("p110" . SPARSER::PROTEIN) ("PI3-kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Class I" . SPARSER::PROTEIN)
    ("Phosphatidylinositol-4, 5-bisphosphate 3-kinases"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Smad4" . SPARSER::PROTEIN) ("TGF-β3" . SPARSER::PROTEIN)
    ("TGF-β1" . SPARSER::PROTEIN) ("TGF-β" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Transforming growth factor" . SPARSER::PROTEIN)
    ("TGF-β2" . SPARSER::PROTEIN) ("GM-CSF" . SPARSER::PROTEIN)
    ("MMP9" . SPARSER::PROTEIN) ("JAM-L" . SPARSER::PROTEIN)
    ("PIP3" . SPARSER::PIP3)
    ("a novel potential therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("DAPK, KLF4 and PER3" . SPARSER::COLLECTION) ("DAPK" . SPARSER::PROTEIN)
    ("MiRNAs" . SPARSER::PROTEIN) ("protein and lipid" . SPARSER::COLLECTION)
    ("PTEN, and GAS5" . SPARSER::COLLECTION) ("si-PTEN" . SPARSER::COLLECTION)
    ("si" . SPARSER::PROTEIN) ("si-GAS5" . SPARSER::COLLECTION)
    ("PTEN and GAS5" . SPARSER::COLLECTION) ("LncRNA" . SPARSER::RNA)
    ("GAS5 and PTEN" . SPARSER::COLLECTION)
    ("homologue (PTEN)" . SPARSER::PROTEIN)
    ("phosphatase and tensin" . SPARSER::COLLECTION)
    ("tensin" . SPARSER::PROTEIN) ("phosphatase" . SPARSER::PHOSPHATASE)
    ("proto-oncogenes (e.g., HOTAIR) or tumor suppressor genes"
     . SPARSER::COLLECTION)
    ("PER3" . SPARSER::PROTEIN) ("KLF4" . SPARSER::PROTEIN)
    ("PI3K-AKT-mTOR" . SPARSER::PROTEIN) ("Annexin-V" . SPARSER::PROTEIN)
    ("TIMP-3" . SPARSER::PROTEIN)
    ("a noncanonical Wnt ligand" . SPARSER::MOLECULE)
    ("Wnt5a" . SPARSER::PROTEIN) ("superoxide" . SPARSER::MOLECULE)
    ("mRNA or protein" . SPARSER::COLLECTION)
    ("Keap1/Nrf2" . SPARSER::COLLECTION)
    ("Nrf2 and NQO1" . SPARSER::COLLECTION)
    ("keratinocytes" . SPARSER::PROTEIN) ("Nrf2 or ROS" . SPARSER::COLLECTION)
    ("osteogenic marker genes" . SPARSER::GENE)
    ("ROS and RANKL" . SPARSER::COLLECTION)
    ("Mature osteoclasts" . SPARSER::PROTEIN) ("RANKL" . SPARSER::PROTEIN)
    ("MAP kinase and NFATc1" . SPARSER::COLLECTION)
    ("Nrf2/Keap1" . SPARSER::COLLECTION) ("The key inducer" . SPARSER::PROTEIN)
    ("functional Nrf2" . SPARSER::PROTEIN)
    ("osteoclasts and osteoblasts" . SPARSER::COLLECTION)
    ("oxidant and antioxidant" . SPARSER::COLLECTION)
    ("oxidant" . SPARSER::PROTEIN)
    ("oxidants and antioxidants" . SPARSER::COLLECTION)
    ("oxidants" . SPARSER::MOLECULE)
    ("enzymes and glutathione" . SPARSER::COLLECTION)
    ("Oxygen" . SPARSER::MOLECULE) ("electrophiles" . SPARSER::MOLECULE)
    ("chemicals" . SPARSER::MOLECULE) ("KO" . SPARSER::PROTEIN)
    ("xenobiotic" . SPARSER::MOLECULE) ("GCLC" . SPARSER::PROTEIN)
    ("GSTs" . SPARSER::PROTEIN) ("glutathione" . SPARSER::DRUG)
    ("cofactors" . SPARSER::PROTEIN)
    ("xenobiotics and oxidative stress" . SPARSER::COLLECTION)
    ("xenobiotics" . SPARSER::MOLECULE)
    ("enzymes and antioxidant" . SPARSER::COLLECTION)
    ("a homodimeric protein" . SPARSER::PROTEIN)
    ("response element (ARE)" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("Maf or Jun" . SPARSER::COLLECTION)
    ("ARE" . SPARSER::ANTI-OXIDANT-RESPONSE-ELEMENT)
    ("Jun" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Maf" . SPARSER::HUMAN-PROTEIN-FAMILY) ("CNC" . SPARSER::PROTEIN)
    ("Nrf1 and Nrf2" . SPARSER::COLLECTION)
    ("a basic leucine zipper protein family" . SPARSER::PROTEIN-FAMILY)
    ("Nrf1, Nrf2, Nrf3 and p45 NF-E2" . SPARSER::COLLECTION)
    ("Nrf1" . SPARSER::PROTEIN) ("Activator" . SPARSER::ACTIVATOR)
    ("Receptor" . SPARSER::RECEPTOR) ("RANK" . SPARSER::PROTEIN)
    ("vitamin D, estrogen, parathyroid hormone and parathyroid hormone-related protein"
     . SPARSER::COLLECTION)
    ("bone morphogenetic proteins" . SPARSER::PROTEIN)
    ("calcitonin" . SPARSER::PROTEIN)
    ("Calcium and phosphate" . SPARSER::COLLECTION)
    ("Calcium" . SPARSER::CALCIUM) ("cytoprotective genes" . SPARSER::GENE)
    ("osteoclasts" . SPARSER::PROTEIN) ("Wnt5" . SPARSER::PROTEIN)
    ("NQO1" . SPARSER::PROTEIN) ("Runx2" . SPARSER::PROTEIN)
    ("NADPH oxidase 4" . SPARSER::PROTEIN) ("NOX4" . SPARSER::PROTEIN)
    ("BMP2" . SPARSER::PROTEIN)
    ("Bone morphogenetic protein 2" . SPARSER::PROTEIN)
    ("Nuclear Factor of Activated T-cells, cytoplasmic 1" . SPARSER::PROTEIN)
    ("filamentous actin" . SPARSER::BIO-COMPLEX) ("NFATc1" . SPARSER::PROTEIN)
    ("MAP kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("pro-oxidant" . SPARSER::MOLECULE)
    ("glutamate-cysteine ligase" . SPARSER::PROTEIN)
    ("quinone oxidoreductase" . SPARSER::PROTEIN)
    ("NAD(P)H" . SPARSER::MOLECULE) ("Rbx1" . SPARSER::PROTEIN)
    ("Cul3" . SPARSER::PROTEIN)
    ("Kelch-like ECH-associated protein 1" . SPARSER::PROTEIN)
    ("Keap1" . SPARSER::PROTEIN) ("NF-E2" . SPARSER::PROTEIN)
    ("p45 NF-E2" . SPARSER::PROTEIN) ("Nrf3" . SPARSER::PROTEIN)
    ("TGF-beta" . SPARSER::PROTEIN) ("vitamin D" . SPARSER::MOLECULE)
    ("insulin-like growth factor-1" . SPARSER::PROTEIN)
    ("parathyroid hormone-related protein" . SPARSER::PROTEIN)
    ("Vitamin D" . SPARSER::MOLECULE)
    ("parathyroid hormone" . SPARSER::PROTEIN)
    ("Nuclear factor erythroid 2-related factor 2" . SPARSER::PROTEIN)
    ("a relevant example" . SPARSER::EXAMPLE)
    ("dominant-negative mutants" . SPARSER::MUTANT)
    ("the DR4 agonistic antibody mapatumumab" . SPARSER::DRUG)
    ("mapatumumab" . SPARSER::DRUG) ("DR5 and DR4" . SPARSER::COLLECTION)
    ("Available FADD and caspase-8" . SPARSER::COLLECTION)
    ("ERK and JNK" . SPARSER::COLLECTION)
    ("anoikis or immunosurveillance" . SPARSER::COLLECTION)
    ("complex (MISC)" . SPARSER::BIO-COMPLEX)
    ("anoikis or TRAIL/DR5-mediated" . SPARSER::COLLECTION)
    ("anoikis" . SPARSER::PROTEIN) ("caspase-8 and DR5" . SPARSER::COLLECTION)
    ("ERK1-" . SPARSER::PROTEIN) ("JNK, ERK or AP-1" . SPARSER::COLLECTION)
    ("c-Jun or Fra1" . SPARSER::COLLECTION)
    ("a secondary signaling complex" . SPARSER::BIO-COMPLEX)
    ("RIP1 and TRAF2" . SPARSER::COLLECTION)
    ("NF-κB, ERK, JNK and p38" . SPARSER::COLLECTION)
    ("DMBA" . SPARSER::MOLECULE) ("caspase-8 and FADD" . SPARSER::COLLECTION)
    ("TRAF2 and FADD" . SPARSER::COLLECTION)
    ("anti-caspase-8 or anti-TRAF2" . SPARSER::COLLECTION)
    ("caspase-8 and TRAF2" . SPARSER::COLLECTION)
    ("Fra-1 and MMP1" . SPARSER::COLLECTION)
    ("DR5 and caspase-8" . SPARSER::COLLECTION)
    ("TRAF2 and MMP1" . SPARSER::COLLECTION)
    ("DR5 and TRAF2" . SPARSER::COLLECTION)
    ("Z-VAD-FMK and Z-IETD-FMK" . SPARSER::COLLECTION)
    ("Z-VAD-FMK (a pan-caspase inhibitor) or Z-IETD-FMK (a caspase-8 inhibitor)"
     . SPARSER::COLLECTION)
    ("Caspase-8, FADD and TRAF2" . SPARSER::COLLECTION)
    ("ERK-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("c-Jun or Fra-1" . SPARSER::COLLECTION)
    ("ERK or JNK" . SPARSER::COLLECTION)
    ("MEK" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TRAF2 and p -ERK1/2" . SPARSER::COLLECTION)
    ("DR5-KO" . SPARSER::PROTEIN-PAIR) ("AP-1 and MMP1" . SPARSER::COLLECTION)
    ("-c-Jun" . SPARSER::COLLECTION) ("-JNK" . SPARSER::COLLECTION)
    ("JNK/AP1" . SPARSER::COLLECTION) ("siRNA or shRNA" . SPARSER::COLLECTION)
    ("PLA" . SPARSER::PROTEIN)
    ("oncogenic K-Ras and its effector" . SPARSER::COLLECTION)
    ("invasion-inducing receptors" . SPARSER::PROTEIN)
    ("Fas and DR5" . SPARSER::COLLECTION) ("Raf1" . SPARSER::PROTEIN)
    ("ROCK" . SPARSER::PROTEIN-FAMILY) ("Raf" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the DR5 agonistic antibody lexatumumab" . SPARSER::DRUG)
    ("lexatumumab" . SPARSER::DRUG)
    ("a potential cancer therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("agonistic antibodies and small molecules [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("recombinant protein, agonistic antibodies and small molecules [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("agonistic antibodies" . SPARSER::ANTIBODY)
    ("TRAIL or DR5" . SPARSER::COLLECTION)
    ("TRAIL-R2 or Killer/DR5" . SPARSER::COLLECTION)
    ("FADD and caspase-8" . SPARSER::COLLECTION)
    ("JNK/AP-1" . SPARSER::COLLECTION)
    ("a well-known cell surface pro-apoptotic protein" . SPARSER::PROTEIN)
    ("pAP1" . SPARSER::PROTEIN) ("Protein-A" . SPARSER::PROTEIN)
    ("Fra1" . SPARSER::PROTEIN) ("RIP1" . SPARSER::PROTEIN)
    ("H-Ras" . SPARSER::PROTEIN) ("Caspase-8" . SPARSER::PROTEIN)
    ("Fra-1" . SPARSER::PROTEIN) ("p -ERK1" . SPARSER::PROTEIN)
    ("K-Ras" . SPARSER::PROTEIN) ("c-myc" . SPARSER::PROTEIN)
    ("TRAIL-R2" . SPARSER::PROTEIN) ("MMP1" . SPARSER::PROTEIN)
    ("matrix metalloproteinase-1" . SPARSER::PROTEIN)
    ("TRAF2" . SPARSER::PROTEIN) ("death receptor 5" . SPARSER::PROTEIN)
    ("Akt, mTORC1 and EGR1" . SPARSER::COLLECTION)
    ("the prosurvival genes" . SPARSER::GENE)
    ("E2F1/POH1" . SPARSER::COLLECTION) ("POH" . SPARSER::DRUG)
    ("K11/K63" . SPARSER::COLLECTION) ("K63-Ub" . SPARSER::COLLECTION)
    ("Ub-K63R" . SPARSER::PROTEIN-PAIR) ("E2F1-K63" . SPARSER::COLLECTION)
    ("Ub" . SPARSER::PROTEIN)
    ("POH1 and its downstream genes Survivin and FOXM1" . SPARSER::COLLECTION)
    ("-Flag" . SPARSER::COLLECTION) ("POH1 and POH1" . SPARSER::COLLECTION)
    ("E2F1, Survivin and FOXM1" . SPARSER::COLLECTION)
    ("POH1(NES)" . SPARSER::PROTEIN) ("NES" . SPARSER::PROTEIN)
    ("POH1 and Flag-tag" . SPARSER::COLLECTION) ("POH1-" . SPARSER::PROTEIN)
    ("E2F1 or Survivin" . SPARSER::COLLECTION)
    ("exogenous POH1" . SPARSER::PROTEIN) ("POH1-E2F1" . SPARSER::COLLECTION)
    ("E2F1 and Ki67" . SPARSER::COLLECTION) ("sh-POH1" . SPARSER::COLLECTION)
    ("the oncogenes-transformed mouse LPCs" . SPARSER::PROTEIN)
    ("LPCs" . SPARSER::PROTEIN) ("ΔJAMM-POH1" . SPARSER::COLLECTION)
    ("JAMM" . SPARSER::PROTEIN-FAMILY)
    ("deubiquitinase" . SPARSER::DEUBIQUITINASE) ("K11-" . SPARSER::PROTEIN)
    ("POH1-Flag" . SPARSER::COLLECTION) ("ubiquitins" . SPARSER::PROTEIN)
    ("His" . SPARSER::AMINO-ACID) ("polyubiquitination" . SPARSER::PROTEIN)
    ("MEFs" . SPARSER::PROTEIN) ("poh1" . SPARSER::PROTEIN)
    ("poh" . SPARSER::DRUG) ("Mx-Cre" . SPARSER::COLLECTION)
    ("recombinase" . SPARSER::PROTEIN) ("E2F1 and POH1" . SPARSER::COLLECTION)
    ("aa" . SPARSER::MOLECULE) ("POH1 and E2F1" . SPARSER::COLLECTION)
    ("exogenous Flag-tagged POH1" . SPARSER::PROTEIN)
    ("E2F2 and E2F3" . SPARSER::COLLECTION)
    ("myristoylated AKT (LPC-Akt) or c-Myc (LPC-c-Myc)" . SPARSER::COLLECTION)
    ("LPC-c-Myc" . SPARSER::COLLECTION) ("LPC-Akt" . SPARSER::COLLECTION)
    ("LPC" . SPARSER::PROTEIN) ("DUB" . SPARSER::PROTEIN)
    ("DUBs" . SPARSER::PROTEIN) ("POH1/rpn11/PSMD14" . SPARSER::COLLECTION)
    ("cullin" . SPARSER::PROTEIN-FAMILY) ("APC" . SPARSER::PROTEIN)
    ("p53 or p14" . SPARSER::COLLECTION)
    ("epidermal growth factor receptor and phosphatidylinositol 3-kinase"
     . SPARSER::COLLECTION)
    ("/Akt" . SPARSER::COLLECTION) ("POH1–E2F1" . SPARSER::COLLECTION)
    ("Survivin and FOXM1" . SPARSER::COLLECTION) ("Poh1" . SPARSER::PROTEIN)
    ("Poh" . SPARSER::DRUG) ("deubiquitylase" . SPARSER::DEUBIQUITYLASE)
    ("MAS 5" . SPARSER::PROTEIN) ("annexin-V" . SPARSER::PROTEIN)
    ("MgCl2" . SPARSER::MOLECULE) ("g −1" . SPARSER::PROTEIN)
    ("interferon-inducible" . SPARSER::PROTEIN) ("RP23" . SPARSER::PROTEIN)
    ("l −1" . SPARSER::PROTEIN) ("si-1" . SPARSER::PROTEIN)
    ("2F1" . SPARSER::PROTEIN) ("α-Tubulin" . SPARSER::PROTEIN)
    ("C-20" . SPARSER::PROTEIN) ("NH 2" . SPARSER::MOLECULE)
    ("K63" . SPARSER::PROTEIN) ("K11" . SPARSER::PROTEIN)
    ("aa1" . SPARSER::PROTEIN) ("PSMD14" . SPARSER::PROTEIN)
    ("rpn11" . SPARSER::PROTEIN) ("SKP2" . SPARSER::PROTEIN)
    ("p14" . SPARSER::PROTEIN) ("transcription factor 1" . SPARSER::PROTEIN)
    ("transcription factor E2F1" . SPARSER::PROTEIN)
    ("FOXM1" . SPARSER::PROTEIN) ("POH1" . SPARSER::PROTEIN)
    ("hnRNPA2 and DAZAP" . SPARSER::COLLECTION)
    ("ASF/SF2" . SPARSER::COLLECTION) ("SF2/ASF-ESE" . SPARSER::COLLECTION)
    ("ESE" . SPARSER::PROTEIN) ("SMN1 and SMN2" . SPARSER::COLLECTION)
    ("ASF-ESE" . SPARSER::PROTEIN-PAIR) ("SMN1/SMN2" . SPARSER::COLLECTION)
    ("hnRNPG and its paralogue RBM" . SPARSER::COLLECTION)
    ("SMN2 and these two proteins" . SPARSER::COLLECTION)
    ("Htra2-β1" . SPARSER::PROTEIN-PAIR) ("RBM" . SPARSER::PROTEIN)
    ("hnRNPG" . SPARSER::PROTEIN) ("tau" . SPARSER::PROTEIN)
    ("-SSNG-3" . SPARSER::COLLECTION) ("-GCUG-3" . SPARSER::COLLECTION)
    ("trans-" . SPARSER::PROTEIN-FAMILY) ("spliceosome" . SPARSER::BIO-COMPLEX)
    ("SRSF5 and SRSF2" . SPARSER::COLLECTION)
    ("SRSF2 and SRSF5" . SPARSER::COLLECTION)
    ("the E9-pSPL3 minigene and mammalian expression constructs encoding SRSF1 (SF2)"
     . SPARSER::COLLECTION)
    ("SRSF5 (SRp40) or SRSF6 (SRp55)" . SPARSER::COLLECTION)
    ("MDD" . SPARSER::PROTEIN) ("strong homology" . SPARSER::PROTEIN)
    ("GGAA" . SPARSER::PROTEIN) ("SRE" . SPARSER::PROTEIN-FAMILY)
    ("dinucleotide" . SPARSER::MOLECULE) ("minigene" . SPARSER::PROTEIN)
    ("minigenes" . SPARSER::PROTEIN)
    ("the potential SREs" . SPARSER::PROTEIN-FAMILY)
    ("hnRNPA1, hnRNPA2 and DAZAP" . SPARSER::COLLECTION)
    ("NF1 and its neighboring genes (5% to 10%)" . SPARSER::COLLECTION)
    ("a classic tumor suppressor gene" . SPARSER::PROTEIN)
    ("neurofibromin" . SPARSER::PROTEIN) ("the gene's" . SPARSER::GENE)
    ("MIM" . SPARSER::PROTEIN)
    ("heterogeneous nuclear ribonucleoproteins" . SPARSER::PROTEIN)
    ("ribonucleoproteins" . SPARSER::PROTEIN)
    ("arginine" . SPARSER::AMINO-ACID)
    ("different auxiliary cis" . SPARSER::PROTEIN)
    ("SREs" . SPARSER::PROTEIN-FAMILY)
    ("alternative-spliced isoforms" . SPARSER::ISOFORM)
    ("a Composite Exon" . SPARSER::PROTEIN) ("CG" . SPARSER::PROTEIN)
    ("the NF1 gene and around 25%" . SPARSER::COLLECTION)
    ("SMN1" . SPARSER::PROTEIN) ("Htra2" . SPARSER::PROTEIN)
    ("SMN2" . SPARSER::PROTEIN) ("pre-mRNAs" . SPARSER::RNA)
    ("SRE1" . SPARSER::PROTEIN) ("P 32" . SPARSER::PROTEIN)
    ("TDP-43" . SPARSER::PROTEIN) ("SRp55" . SPARSER::PROTEIN)
    ("SRSF6" . SPARSER::PROTEIN) ("SRp40" . SPARSER::PROTEIN)
    ("SRSF5" . SPARSER::PROTEIN) ("SRp75" . SPARSER::PROTEIN)
    ("SRSF4" . SPARSER::PROTEIN) ("SRp20" . SPARSER::PROTEIN)
    ("SRSF3" . SPARSER::PROTEIN) ("SC35" . SPARSER::PROTEIN)
    ("DNAse I" . SPARSER::PROTEIN) ("E7" . SPARSER::PROTEIN-FAMILY)
    ("hnRNPA2" . SPARSER::PROTEIN) ("YB-1" . SPARSER::PROTEIN)
    ("chromosome 17" . SPARSER::PROTEIN)
    ("autosomal dominant" . SPARSER::PROTEIN) ("Pre-mRNA" . SPARSER::RNA)
    ("hnRNPA1" . SPARSER::PROTEIN) ("SRSF2" . SPARSER::PROTEIN)
    ("Leu" . SPARSER::AMINO-ACID)
    ("systolic blood pressure (beta" . SPARSER::PROTEIN)
    ("both high diastolic (beta" . SPARSER::PROTEIN)
    ("empirical p" . SPARSER::PROTEIN) ("GSS" . SPARSER::PROTEIN)
    ("sirtuins" . SPARSER::PROTEIN-FAMILY)
    ("a remissive state" . SPARSER::BIO-STATE)
    ("serotonin and dopamine" . SPARSER::COLLECTION)
    ("dopamine" . SPARSER::PROTEIN) ("serotonin" . SPARSER::MOLECULE)
    ("MAOA" . SPARSER::PROTEIN) ("glucose" . SPARSER::PROTEIN)
    ("redox" . SPARSER::PROTEIN) ("-allele" . SPARSER::ALLELE)
    ("type 2 and type 1" . SPARSER::COLLECTION) ("(beta" . SPARSER::PROTEIN)
    ("m 2" . SPARSER::MOLECULE) ("high-density lipoprotein" . SPARSER::PROTEIN)
    ("low-density lipoprotein" . SPARSER::PROTEIN)
    ("monoamine oxidase A" . SPARSER::PROTEIN) ("NHLH2" . SPARSER::PROTEIN)
    ("nescient helix loop helix 2" . SPARSER::PROTEIN)
    ("brain-specific" . SPARSER::PROTEIN)
    ("nicotinamide adenine dinucleotide" . SPARSER::MOLECULE)
    ("deacetylase activity" . SPARSER::PROTEIN)
    ("histone deacetylase" . SPARSER::PROTEIN) ("sirtuin 1" . SPARSER::PROTEIN)
    ("SIRT1" . SPARSER::PROTEIN)
    ("STAT3 and its downstream targets" . SPARSER::COLLECTION)
    ("some natural compounds specifically target E3 ubiquitin ligase"
     . SPARSER::PROTEIN)
    ("TMF" . SPARSER::PROTEIN)
    ("an orally administered bioactive reagent" . SPARSER::MOLECULE)
    ("ubiquitin–STAT3" . SPARSER::COLLECTION) ("CQ" . SPARSER::PROTEIN)
    ("polysaccharide" . SPARSER::POLYSACCHARIDE) ("fucoidan" . SPARSER::DRUG)
    ("polyubiquitin" . SPARSER::PROTEIN)
    ("Newly discovered chemotherapeutic reagents" . SPARSER::MOLECULE)
    ("Dimerized STAT3" . SPARSER::PROTEIN)
    ("receptor-associated kinases" . SPARSER::KINASE)
    ("UPP" . SPARSER::PROTEIN) ("chloroquine" . SPARSER::PROTEIN)
    ("proteasomes" . SPARSER::PROTEIN) ("CHX" . SPARSER::PROTEIN)
    ("cycloheximide (CHX)" . SPARSER::PROTEIN)
    ("total and phosphorylated STAT3" . SPARSER::PROTEIN)
    ("STAT3 and pSTAT3" . SPARSER::COLLECTION)
    ("p53/14-3-3 zeta" . SPARSER::COLLECTION) ("Paeoniflorin" . SPARSER::DRUG)
    ("HIAP-1, Bcl-2, and Survivin" . SPARSER::COLLECTION)
    ("oncoprotein" . SPARSER::PROTEIN) ("lysosomal" . SPARSER::PROTEIN)
    ("U87 and U251" . SPARSER::COLLECTION) ("paeoniflorin" . SPARSER::DRUG)
    ("TRAF6" . SPARSER::PROTEIN) ("ARA160" . SPARSER::PROTEIN)
    ("transforming growth factor" . SPARSER::PROTEIN)
    ("ATP-dependent" . SPARSER::PROTEIN) ("MG132" . SPARSER::PROTEIN)
    ("14-3-3 zeta" . SPARSER::PROTEIN) ("HIAP-1" . SPARSER::PROTEIN)
    ("Signal transducer and activator of transcription 3" . SPARSER::PROTEIN)
    ("U87" . SPARSER::PROTEIN)
    ("the inflammatory mediators and c-Myc" . SPARSER::COLLECTION)
    ("IL-17, IL-20, IL-22, and IL-33" . SPARSER::COLLECTION)
    ("antioxidants" . SPARSER::DRUG) ("IKK" . SPARSER::PROTEIN)
    ("NF- κ B-c-Myc" . SPARSER::COLLECTION)
    ("NF- κ B, AP1, and c-Myc" . SPARSER::COLLECTION)
    ("AP1" . SPARSER::PROTEIN) ("-AP-1-Myc-TNF- α" . SPARSER::COLLECTION)
    ("-NF- κ B-Myc-TNF- α" . SPARSER::COLLECTION)
    ("the hepatoprotective cytokine IL-6" . SPARSER::PROTEIN)
    ("ethanol" . SPARSER::PROTEIN)
    ("Monocyte-derived macrophages" . SPARSER::PROTEIN)
    ("noncholestatic cirrhosis" . SPARSER::PROTEIN)
    ("neutrophil" . SPARSER::PROTEIN)
    ("nonclassical monocytes" . SPARSER::PROTEIN)
    ("Elevated circulating soluble IL-2 receptors" . SPARSER::RECEPTOR)
    ("IL-1, IL-1 β , and c-Myc" . SPARSER::COLLECTION)
    ("ALD" . SPARSER::PROTEIN) ("JNK and c-Jun" . SPARSER::COLLECTION)
    ("diethylnitrosamine (DEN)" . SPARSER::MOLECULE)
    ("The c-Jun NH2-terminal kinase (JNK) and c-Jun" . SPARSER::COLLECTION)
    ("kinase (JNK)" . SPARSER::KINASE) ("HBx" . SPARSER::PROTEIN)
    ("the dominant-negative mutants" . SPARSER::MUTANT)
    ("c-Fos, p38, and Rac1" . SPARSER::COLLECTION) ("LCA" . SPARSER::PROTEIN)
    ("c-Myc and v-Myc" . SPARSER::COLLECTION) ("Sv" . SPARSER::MOLECULE)
    ("p50/p105" . SPARSER::COLLECTION)
    ("diethylnitrosamine" . SPARSER::MOLECULE)
    ("c-Met and c-Myc" . SPARSER::COLLECTION)
    ("p65 and AhR" . SPARSER::COLLECTION)
    ("AhR and RelA" . SPARSER::COLLECTION)
    ("p65 and aryl hydrocarbon receptor" . SPARSER::COLLECTION)
    ("AhR" . SPARSER::PROTEIN) ("NF- κ B/Rel" . SPARSER::COLLECTION)
    ("P65 and p50" . SPARSER::COLLECTION)
    ("gene and mouse" . SPARSER::COLLECTION)
    ("NF- κ B and Myc" . SPARSER::COLLECTION) ("PPAR-" . SPARSER::PROTEIN)
    ("PPAR" . SPARSER::PROTEIN) ("anti-CD40 and LPS" . SPARSER::COLLECTION)
    ("type 1 or type 2" . SPARSER::COLLECTION) ("BAFF" . SPARSER::PROTEIN)
    ("LPS" . SPARSER::PROTEIN) ("p50 and c-Rel" . SPARSER::COLLECTION)
    ("Rel/NF- κ B" . SPARSER::COLLECTION) ("Rel" . SPARSER::PROTEIN)
    ("RelB" . SPARSER::PROTEIN) ("RelA" . SPARSER::PROTEIN)
    ("cyclin D1/cyclin-dependent kinase 4" . SPARSER::COLLECTION)
    ("Smad" . SPARSER::HUMAN-PROTEIN-FAMILY) ("HL60" . SPARSER::PROTEIN)
    ("c-Myc and cyclin D1" . SPARSER::COLLECTION)
    ("c-Myc and c-Fos" . SPARSER::COLLECTION) ("MSCs" . SPARSER::PROTEIN)
    ("c-Myc and p53" . SPARSER::COLLECTION)
    ("TNF- α and its cognate receptors" . SPARSER::COLLECTION)
    ("adipokine" . SPARSER::PROTEIN-FAMILY)
    ("AP-1-Myc-IL-10" . SPARSER::COLLECTION)
    ("NF- κ B-Myc-IL-10" . SPARSER::COLLECTION)
    ("Myc-IL-10" . SPARSER::COLLECTION) ("IL-10 and Myc" . SPARSER::COLLECTION)
    ("mTOR and the transcription factor signal transducer and activator of transcription-1 (STAT1)"
     . SPARSER::COLLECTION)
    ("interferon- γ" . SPARSER::PROTEIN)
    ("IL-10 and c-Myc" . SPARSER::COLLECTION)
    ("NF- κ B-Myc-IL-8" . SPARSER::COLLECTION)
    ("Myc-IL-8" . SPARSER::COLLECTION) ("Nrf2 and c-Myc" . SPARSER::COLLECTION)
    ("c-Myc:Max" . SPARSER::BIO-COMPLEX) ("c-Myc/Max" . SPARSER::COLLECTION)
    ("/HIF-2 α" . SPARSER::COLLECTION) ("HIF" . SPARSER::PROTEIN-FAMILY)
    ("Gene" . SPARSER::GENE) ("IL-6 and IL-8" . SPARSER::COLLECTION)
    ("OV" . SPARSER::MOLECULE)
    ("IL-6, IL-8, TGF- β , TNF- α , and platelet-derived growth factor"
     . SPARSER::COLLECTION)
    ("monocytes-macrophages" . SPARSER::COLLECTION)
    ("neutrophils" . SPARSER::PROTEIN) ("polypeptide" . SPARSER::PROTEIN)
    ("IL-6-NF- κ B-c-Myc" . SPARSER::COLLECTION)
    ("IL-6-AP-1-c-Myc" . SPARSER::COLLECTION)
    ("IL-6-c-Myc" . SPARSER::COLLECTION) ("CEBPA" . SPARSER::PROTEIN)
    ("acute phase proteins" . SPARSER::PROTEIN)
    ("fibrinogen and haptoglobin" . SPARSER::COLLECTION)
    ("haptoglobin" . SPARSER::PROTEIN)
    ("endotoxin and TNF- α" . SPARSER::COLLECTION)
    ("endotoxin" . SPARSER::MOLECULE) ("IL-4-p53-c-Myc" . SPARSER::COLLECTION)
    ("IL-4-NF- κ B-c-Myc" . SPARSER::COLLECTION)
    ("IL-4-c-Myc" . SPARSER::COLLECTION)
    ("primary biliary cirrhosis (PBC)" . SPARSER::PROTEIN)
    ("PBC" . SPARSER::PROTEIN)
    ("tumor-associated macrophages" . SPARSER::PROTEIN)
    ("SHC/Grb2/MAPK" . SPARSER::COLLECTION) ("SHC" . SPARSER::PROTEIN)
    ("synergizes" . SPARSER::PROTEIN) ("IL-4 and IGF-I" . SPARSER::COLLECTION)
    ("transducers and activators" . SPARSER::COLLECTION)
    ("STAT" . SPARSER::PROTEIN) ("activators" . SPARSER::ACTIVATOR)
    ("transducers" . SPARSER::PROTEIN) ("ADP" . SPARSER::PROTEIN)
    ("a multifunctional pleiotropic cytokine" . SPARSER::PROTEIN)
    ("IL-2RA and IL-2" . SPARSER::COLLECTION)
    ("IL-2/IL-2R" . SPARSER::COLLECTION) ("CYP" . SPARSER::PROTEIN)
    ("Genistein" . SPARSER::PROTEIN) ("c-Fos/c-Jun" . SPARSER::COLLECTION)
    ("src" . SPARSER::PROTEIN)
    ("spleen tyrosine kinase and protein" . SPARSER::COLLECTION)
    ("a pleiotropic cytokine" . SPARSER::PROTEIN)
    ("IL-1 β and IL-1" . SPARSER::COLLECTION) ("NB" . SPARSER::PROTEIN)
    ("growth factor (VEGF)" . SPARSER::GROWTH-FACTOR)
    ("TGF- β , TNF- α , angiopoietin-1, IL-6, and vascular endothelial"
     . SPARSER::COLLECTION)
    ("metalloproteinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("matrix" . SPARSER::PROTEIN-FAMILY)
    ("the principal Myc effector" . SPARSER::EFFECTOR)
    ("inflammatory cytokines" . SPARSER::PROTEIN)
    ("Myc and Ras" . SPARSER::COLLECTION) ("Myc" . SPARSER::PROTEIN)
    ("inhibitor (BAMBI)" . SPARSER::INHIBITOR)
    ("fibrogenic tissue inhibitor" . SPARSER::INHIBITOR)
    ("bone morphogenetic protein and activin" . SPARSER::COLLECTION)
    ("BAMBI" . SPARSER::PROTEIN) ("metalloproteinase" . SPARSER::PROTEIN)
    ("HSCs" . SPARSER::PROTEIN)
    ("NOD-like receptors (NLR) or P2X7 receptors [ xref ]"
     . SPARSER::COLLECTION)
    ("receptors (NLR)" . SPARSER::RECEPTOR) ("dipeptide-" . SPARSER::MOLECULE)
    ("NLR" . SPARSER::PROTEIN) ("NOD" . SPARSER::PROTEIN)
    ("dipeptide" . SPARSER::MOLECULE) ("muramyl" . SPARSER::MOLECULE)
    ("TLR" . SPARSER::PROTEIN-FAMILY) ("TLRs" . SPARSER::PROTEIN-FAMILY)
    ("a potent inflammatory cytokine" . SPARSER::PROTEIN)
    ("leukocytes" . SPARSER::PROTEIN)
    ("an important upstream proinflammatory cytokine" . SPARSER::PROTEIN)
    ("CLD" . SPARSER::PROTEIN)
    ("inflammatory mediators and c-Myc" . SPARSER::COLLECTION)
    ("mediators and c-Myc" . SPARSER::COLLECTION)
    ("NF- κ B and AP-1" . SPARSER::COLLECTION) ("AP-1" . SPARSER::PROTEIN)
    ("Max" . SPARSER::PROTEIN) ("Inflammatory cytokines" . SPARSER::PROTEIN)
    ("IL-8, IL-10, TNF- α , and TGF- β" . SPARSER::COLLECTION)
    ("IL-1, IL-2, IL-4, TNF- α , and TGF- β" . SPARSER::COLLECTION)
    ("pro- and anti-inflammatory" . SPARSER::COLLECTION)
    ("pro-" . SPARSER::AMINO-ACID) ("IL-33" . SPARSER::PROTEIN)
    ("IL-22" . SPARSER::PROTEIN) ("IL-20" . SPARSER::PROTEIN)
    ("IL-17" . SPARSER::PROTEIN) ("CD16" . SPARSER::PROTEIN)
    ("p21CIP1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Rac1" . SPARSER::PROTEIN)
    ("ATF2" . SPARSER::PROTEIN) ("p37" . SPARSER::PROTEIN)
    ("v-Myc" . SPARSER::PROTEIN) ("p105" . SPARSER::PROTEIN)
    ("c-Met" . SPARSER::PROTEIN)
    ("aryl hydrocarbon receptor" . SPARSER::PROTEIN) ("P65" . SPARSER::PROTEIN)
    ("PPAR-gamma" . SPARSER::PROTEIN) ("PPAR γ" . SPARSER::PROTEIN)
    ("Peroxisome proliferator-activated receptor gamma" . SPARSER::PROTEIN)
    ("CD40" . SPARSER::PROTEIN) ("CD40L" . SPARSER::PROTEIN)
    ("CD40 ligand" . SPARSER::PROTEIN) ("type 2" . SPARSER::PROTEIN)
    ("type 1" . SPARSER::PROTEIN) ("p52" . SPARSER::PROTEIN)
    ("NF- κ B2" . SPARSER::PROTEIN) ("p50" . SPARSER::PROTEIN)
    ("c-Rel" . SPARSER::PROTEIN) ("Smad2" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase 4" . SPARSER::PROTEIN)
    ("TGF- β 1" . SPARSER::PROTEIN) ("KLF6" . SPARSER::PROTEIN)
    ("E2F1" . SPARSER::PROTEIN) ("Smad3" . SPARSER::PROTEIN)
    ("PP2Ac" . SPARSER::PROTEIN) ("STAT1" . SPARSER::PROTEIN)
    ("signal transducer and activator of transcription-1" . SPARSER::PROTEIN)
    ("IL-10 receptor" . SPARSER::PROTEIN) ("Mxi1" . SPARSER::PROTEIN)
    ("Nrf2" . SPARSER::PROTEIN) ("HIF-2 α" . SPARSER::PROTEIN)
    ("HIF-1 α" . SPARSER::PROTEIN) ("B chain" . SPARSER::PROTEIN)
    ("CCAAT/enhancer binding protein" . SPARSER::PROTEIN)
    ("CD33" . SPARSER::PROTEIN) ("STAT6" . SPARSER::PROTEIN)
    ("Grb2" . SPARSER::PROTEIN) ("PARP14" . SPARSER::PROTEIN)
    ("Th2" . SPARSER::PROTEIN) ("IL-2RA" . SPARSER::PROTEIN)
    ("cytochrome P450" . SPARSER::PROTEIN-FAMILY) ("c-Fos" . SPARSER::PROTEIN)
    ("IL-2 receptor" . SPARSER::PROTEIN) ("IL-2R" . SPARSER::PROTEIN)
    ("spleen tyrosine kinase" . SPARSER::PROTEIN) ("IL-1a" . SPARSER::PROTEIN)
    ("IL-6" . SPARSER::PROTEIN) ("angiopoietin-1" . SPARSER::PROTEIN)
    ("membrane-bound" . SPARSER::PROTEIN)
    ("bone morphogenetic protein" . SPARSER::PROTEIN)
    ("TIMP-1" . SPARSER::PROTEIN) ("P2X7" . SPARSER::PROTEIN)
    ("IL-1 β" . SPARSER::PROTEIN) ("adhesion molecule" . SPARSER::PROTEIN)
    ("NF- κ B" . SPARSER::PROTEIN) ("IL-4" . SPARSER::PROTEIN)
    ("IL-1" . SPARSER::PROTEIN) ("TGF- β" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TNF- α" . SPARSER::PROTEIN) ("IL-10" . SPARSER::PROTEIN)
    ("crizotinib" . SPARSER::DRUG) ("Rocks" . SPARSER::PROTEIN-FAMILY)
    ("ADAM" . SPARSER::PROTEIN) ("a tumor-suppressive gene" . SPARSER::GENE)
    ("specific miRNAs and their targets" . SPARSER::COLLECTION)
    ("ctrl" . SPARSER::PROTEIN) ("MiR-33a" . SPARSER::PROTEIN)
    ("miR-33a" . SPARSER::PROTEIN) ("sh-miR-33a" . SPARSER::PROTEIN-PAIR)
    ("sh" . SPARSER::PROTEIN-FAMILY)
    ("MCF-10A and non-metastatic" . SPARSER::COLLECTION)
    ("PDE8A and UVRAG" . SPARSER::COLLECTION) ("UVRAG" . SPARSER::PROTEIN)
    ("PKA" . SPARSER::PROTEIN) ("an intronic miRNA" . SPARSER::PROTEIN)
    ("sterol" . SPARSER::PROTEIN)
    ("typically 18–22 nucleotides" . SPARSER::NUCLEOTIDE)
    ("Wang and Ouyang" . SPARSER::COLLECTION)
    ("ADAM9 and ROS1" . SPARSER::COLLECTION) ("MicroRNAs" . SPARSER::RNA)
    ("MAP3K1" . SPARSER::PROTEIN) ("CCND1" . SPARSER::PROTEIN)
    ("WNT10B" . SPARSER::PROTEIN) ("EGR3" . SPARSER::PROTEIN)
    ("site 2" . SPARSER::PROTEIN) ("Pim-1" . SPARSER::PROTEIN)
    ("Twist1" . SPARSER::PROTEIN) ("PDE8A" . SPARSER::PROTEIN)
    ("fatty acid" . SPARSER::MOLECULE) ("SREBF2" . SPARSER::PROTEIN)
    ("negative regulator" . SPARSER::NEGATIVE-REGULATOR)
    ("ROS1" . SPARSER::PROTEIN) ("ADAM9" . SPARSER::PROTEIN)
    ("ND1 and COX1" . SPARSER::COLLECTION) ("hnRNP" . SPARSER::PROTEIN)
    ("TNKS2 and ERGIC3" . SPARSER::COLLECTION)
    ("ribosomal proteins" . SPARSER::PROTEIN) ("HuR" . SPARSER::PROTEIN)
    ("polyribosome" . SPARSER::BIO-COMPLEX) ("Sucrose" . SPARSER::MOLECULE)
    ("the biotin-miR-346 loop mutant (B-miR-346 mut) or B-miR-346 loop mutant /hTERT"
     . SPARSER::COLLECTION)
    ("duplex generated obviously shifted complexes" . SPARSER::BIO-COMPLEX)
    ("/hTERT" . SPARSER::COLLECTION)
    ("GRSF1-associated hTERT mRNA" . SPARSER::PROTEIN)
    ("pSilencer-NC" . SPARSER::COLLECTION) ("shR-GRSF1" . SPARSER::COLLECTION)
    ("Flag-GRSF1" . SPARSER::COLLECTION) ("Flag" . SPARSER::PROTEIN-FAMILY)
    ("some cellular and viral mRNAs" . SPARSER::PROTEIN)
    ("Proteins" . SPARSER::PROTEIN) ("ACVR2B and SMAD3" . SPARSER::COLLECTION)
    ("hTERT and pri-miR-346" . SPARSER::COLLECTION) ("RISC" . SPARSER::PROTEIN)
    ("shR-hTERT" . SPARSER::COLLECTION) ("ActD" . SPARSER::MOLECULE)
    ("TRAP" . SPARSER::PROTEIN) ("pEGFP-hTERT" . SPARSER::COLLECTION)
    ("EGFP" . SPARSER::PROTEIN) ("oligomers" . SPARSER::MOLECULE)
    ("polysomes" . SPARSER::BIO-COMPLEX)
    ("cellular and viral mRNAs" . SPARSER::PROTEIN)
    ("polyribosomes" . SPARSER::BIO-COMPLEX) ("NP" . SPARSER::PROTEIN)
    ("nucleoprotein" . SPARSER::PROTEIN)
    ("c-Myc and β-catenin" . SPARSER::COLLECTION)
    ("an essential subunit" . SPARSER::FRAGMENT)
    ("the tankyrase 2 (TNKS2) and the endoplasmic reticulum-Golgi intermediate compartment protein 3 (ERGIC3)"
     . SPARSER::COLLECTION)
    ("AREs" . SPARSER::ANTI-OXIDANT-RESPONSE-ELEMENT)
    ("oncogenes and tumor suppressors xref  xref" . SPARSER::COLLECTION)
    ("IIB" . SPARSER::PROTEIN) ("activin" . SPARSER::PROTEIN)
    ("ribosomes" . SPARSER::BIO-COMPLEX) ("hTERT" . SPARSER::PROTEIN)
    ("NH 4 Cl" . SPARSER::MOLECULE)
    ("glutathione peroxidase 4 " . SPARSER::PROTEIN)
    ("miR-221" . SPARSER::PROTEIN) ("GW182" . SPARSER::PROTEIN)
    ("COX1" . SPARSER::PROTEIN) ("ND1" . SPARSER::PROTEIN)
    ("miR-29b" . SPARSER::MOLECULE) ("miR-1" . SPARSER::PROTEIN)
    ("RIP140" . SPARSER::PROTEIN)
    ("receptor-interacting protein 140" . SPARSER::PROTEIN)
    ("miR-10" . SPARSER::PROTEIN) ("CAT-1" . SPARSER::PROTEIN)
    ("CAT-1 " . SPARSER::PROTEIN) ("SMAD3 " . SPARSER::PROTEIN)
    ("telomerase activity" . SPARSER::PROTEIN)
    ("severe combined immunodeficiency" . SPARSER::PROTEIN)
    ("SMAD3" . SPARSER::PROTEIN) ("SMAD family member 3" . SPARSER::PROTEIN)
    ("hnRNP F" . SPARSER::PROTEIN) ("p65" . SPARSER::PROTEIN)
    ("factor-κB" . SPARSER::PROTEIN) ("c-Myc" . SPARSER::PROTEIN)
    ("telomerase reverse transcriptase" . SPARSER::PROTEIN)
    ("miR-16" . SPARSER::PROTEIN) ("ERGIC3" . SPARSER::PROTEIN)
    ("protein 3" . SPARSER::PROTEIN) ("TNKS2" . SPARSER::PROTEIN)
    ("tankyrase 2" . SPARSER::PROTEIN) ("protein C" . SPARSER::PROTEIN)
    ("ACVR2B" . SPARSER::PROTEIN) ("AGO2" . SPARSER::PROTEIN)
    ("GRSF1" . SPARSER::PROTEIN)
    ("G-rich RNA sequence binding factor 1" . SPARSER::PROTEIN)
    ("larger cohorts" . SPARSER::MOLECULE)
    ("allelic variants" . SPARSER::VARIANT)
    ("tr" . SPARSER::HUMAN-PROTEIN-FAMILY) ("calpain" . SPARSER::PROTEIN)
    ("preoperative serum PSA, and caspase-7" . SPARSER::COLLECTION)
    ("PSA, and caspase-7" . SPARSER::COLLECTION)
    ("preoperative PSA" . SPARSER::PROTEIN)
    ("cleaved caspase-8 and preoperative serum PSA" . SPARSER::COLLECTION)
    ("caspase-7 and Gleason" . SPARSER::COLLECTION)
    ("pro-apoptotic molecules" . SPARSER::MOLECULE)
    ("SMAC/DIABLO" . SPARSER::COLLECTION) ("DIABLO" . SPARSER::PROTEIN)
    ("SMAC" . SPARSER::PROTEIN)
    ("at least one baculoviral IAP" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Survivin and Livin" . SPARSER::COLLECTION) ("BIR" . SPARSER::PROTEIN)
    ("Livin" . SPARSER::PROTEIN) ("BRUCE" . SPARSER::PROTEIN)
    ("ILP" . SPARSER::PROTEIN) ("preoperative serum PSA" . SPARSER::PROTEIN)
    ("IAPs and caspases" . SPARSER::COLLECTION)
    ("caspase-8, procaspase-3 and caspase-7" . SPARSER::COLLECTION)
    ("caspases (procaspase-8, cleaved caspase-8, procaspase-3, cleaved caspase-3, caspase-7 and procaspase-9) and IAPs (cIAP1/2, cIAP2, NAIP, Survivin and XIAP)"
     . SPARSER::COLLECTION)
    ("caspase-3, caspase-7 and procaspase-9" . SPARSER::COLLECTION)
    ("Survivin" . SPARSER::PROTEIN) ("NAIP" . SPARSER::PROTEIN)
    ("caspases and IAPs" . SPARSER::COLLECTION)
    ("caspases and inhibitors" . SPARSER::COLLECTION)
    ("IAPs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ERK 1/2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("p20" . SPARSER::PROTEIN)
    ("ML-IAP" . SPARSER::PROTEIN) ("IAP 1" . SPARSER::PROTEIN)
    ("IAP-like protein" . SPARSER::PROTEIN)
    ("X-linked inhibitor of apoptosis protein" . SPARSER::PROTEIN)
    ("caspase-2" . SPARSER::PROTEIN) ("cIAP2" . SPARSER::PROTEIN)
    ("cIAP1" . SPARSER::PROTEIN) ("caspase-7" . SPARSER::PROTEIN)
    ("FHA and kinase" . SPARSER::COLLECTION)
    ("an essential part" . SPARSER::COMPONENT)
    ("doxorubicin and epirubicin" . SPARSER::COLLECTION)
    ("epirubicin" . SPARSER::DRUG) ("anthracycline" . SPARSER::MOLECULE)
    ("CHEK2 and other DNA repair genes" . SPARSER::COLLECTION)
    ("clearly pathogenic truncating variants" . SPARSER::VARIANT)
    ("the only other known CHEK2 rearrangement variant" . SPARSER::VARIANT)
    ("Slavic population-specific variant" . SPARSER::VARIANT)
    ("hereditary CHEK2 variants" . SPARSER::VARIANT)
    ("clinically meaningful high-penetrant NHL-susceptibility gene"
     . SPARSER::GENE)
    ("cyclophosphamide, doxorubicin, vincristine, and prednisolone"
     . SPARSER::COLLECTION)
    ("heterozygotes" . SPARSER::PROTEIN) ("IPI" . SPARSER::PROTEIN)
    ("PFS" . SPARSER::PROTEIN) ("at least one allele" . SPARSER::ALLELE)
    ("MCL" . SPARSER::PROTEIN) ("delC" . SPARSER::PROTEIN)
    ("stop" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("prone" . SPARSER::PROTEIN-FAMILY) ("barrier" . SPARSER::PROTEIN)
    ("Ser/Thr" . SPARSER::COLLECTION) ("FHA" . SPARSER::PROTEIN-FAMILY)
    ("forkhead" . SPARSER::PROTEIN) ("SCD" . SPARSER::PROTEIN)
    ("TQ" . SPARSER::DRUG) ("SQ" . SPARSER::MOLECULE)
    ("ATM-CHK2-p53" . SPARSER::COLLECTION)
    ("a valuable predictive biomarker" . SPARSER::MOLECULE)
    ("HR-PFS" . SPARSER::PROTEIN-PAIR) ("rituximab" . SPARSER::DRUG)
    ("Identified hereditary variants" . SPARSER::VARIANT)
    ("the entire CHEK2" . SPARSER::PROTEIN) ("OR 2" . SPARSER::MOLECULE)
    ("RNF31" . SPARSER::PROTEIN) ("P190" . SPARSER::PROTEIN)
    ("CHEK2" . SPARSER::PROTEIN) ("checkpoint kinase 2" . SPARSER::PROTEIN)
    ("targets and drugs" . SPARSER::COLLECTION)
    ("classical ERs and GPR30" . SPARSER::COLLECTION)
    ("ERs and GPR30" . SPARSER::COLLECTION)
    ("estradiol/ER" . SPARSER::COLLECTION)
    ("epithelial or stromal AR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the scenario even more complex" . SPARSER::BIO-COMPLEX)
    ("agonist" . SPARSER::AGONIST) ("even synthetic ligands" . SPARSER::LIGAND)
    ("antiestrogens" . SPARSER::DRUG) ("Akt and Erk" . SPARSER::COLLECTION)
    ("Erk" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("estradiol and retinoids" . SPARSER::COLLECTION)
    ("retinoids" . SPARSER::DRUG)
    ("receptor and retinoid X receptor" . SPARSER::COLLECTION)
    ("CD117, Trop2, CD49f and ABCG2" . SPARSER::COLLECTION)
    ("Trop2" . SPARSER::PROTEIN)
    ("epithelial AR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("stromal AR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("traits" . SPARSER::PROTEIN)
    ("the extra-nuclear AR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("extra-nuclear AR-associated signaling effectors or scaffolds"
     . SPARSER::COLLECTION)
    ("effectors or scaffolds" . SPARSER::COLLECTION)
    ("scaffolds" . SPARSER::SCAFFOLD) ("its own androgens" . SPARSER::DRUG)
    ("TMPRSS:ETS" . SPARSER::BIO-COMPLEX)
    ("the AR-responsive TMPRSS2 gene and the erythroblast transformation-specific (ETS) gene"
     . SPARSER::COLLECTION)
    ("TMPRSS2:ETS" . SPARSER::BIO-COMPLEX) ("ETS" . SPARSER::PROTEIN)
    ("cyclin D1b and Slug" . SPARSER::COLLECTION)
    ("cyclin D1b/AR/Slug" . SPARSER::COLLECTION) ("Slug" . SPARSER::PROTEIN)
    ("metastatic PC" . SPARSER::PROTEIN) ("SWI/SNF" . SPARSER::COLLECTION)
    ("subunit" . SPARSER::FRAGMENT) ("SNF" . SPARSER::PROTEIN-FAMILY)
    ("SWI" . SPARSER::PROTEIN)
    ("both primary and metastatic PC" . SPARSER::PROTEIN)
    ("chemokine receptors as well as their ligands [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("chemokine/chemokine receptor" . SPARSER::COLLECTION)
    ("chemokine" . SPARSER::PROTEIN)
    ("bicalutamide and enzalutamide" . SPARSER::COLLECTION)
    ("C4-2, and CWR22Rv1" . SPARSER::COLLECTION) ("rv" . SPARSER::MOLECULE)
    ("MICs" . SPARSER::PROTEIN-FAMILY)
    ("PC and N-methyl-N-nitrosourea" . SPARSER::COLLECTION)
    ("Ras/MAPK" . SPARSER::COLLECTION)
    ("further analysis using new impeded ligands" . SPARSER::LIGAND)
    ("lipid" . SPARSER::LIPID)
    ("dual variable flow-cytometry" . SPARSER::PROTEIN)
    ("CSCS" . SPARSER::PROTEIN) ("SERM" . SPARSER::DRUG)
    ("Raloxifene" . SPARSER::PROTEIN) ("ERα or ERβ" . SPARSER::COLLECTION)
    ("agonists" . SPARSER::AGONIST) ("SERMs" . SPARSER::DRUG)
    ("even more complex" . SPARSER::BIO-COMPLEX)
    ("luminal and castration-resistant basal epithelial cells"
     . SPARSER::COLLECTION)
    ("aromatase" . SPARSER::PROTEIN)
    ("growth factors and their cognate receptors" . SPARSER::COLLECTION)
    ("RIZ" . SPARSER::PROTEIN) ("methyltransferase" . SPARSER::PROTEIN)
    ("Estradiol" . SPARSER::PROTEIN)
    ("estrogens or xeno-estrogens" . SPARSER::COLLECTION)
    ("testosterone and estrogen" . SPARSER::COLLECTION)
    ("fat" . SPARSER::PROTEIN) ("Bisphenol" . SPARSER::MOLECULE)
    ("endocrine" . SPARSER::PROTEIN) ("diethylstilbestrol" . SPARSER::DRUG)
    ("testosterone" . SPARSER::MOLECULE) ("prostatic" . SPARSER::PROTEIN)
    ("Testosterone" . SPARSER::MOLECULE)
    ("estrogens and ERs" . SPARSER::COLLECTION)
    ("estrogens" . SPARSER::MOLECULE) ("ERβ and AR" . SPARSER::COLLECTION)
    ("ER (α or β) and AR" . SPARSER::COLLECTION)
    ("epidermal growth factor (EGF)" . SPARSER::PROTEIN)
    ("ERβ/AR/EGF" . SPARSER::COLLECTION) ("ERα and ERβ" . SPARSER::COLLECTION)
    ("ASC" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("an olefinic amino acid" . SPARSER::AMINO-ACID)
    ("-amide" . SPARSER::MOLECULE) ("Lys" . SPARSER::AMINO-ACID)
    ("amide" . SPARSER::MOLECULE) ("AC" . SPARSER::PROTEIN)
    ("the extranuclear AR/filamin" . SPARSER::COLLECTION)
    ("AR/filamin" . SPARSER::COLLECTION) ("Filamin" . SPARSER::PROTEIN-FAMILY)
    ("PI3-K/Akt" . SPARSER::COLLECTION) ("trigger" . SPARSER::PROTEIN)
    ("filamin" . SPARSER::PROTEIN-FAMILY) ("Androgens" . SPARSER::DRUG)
    ("mitogen-activated protein kinases as well as focal adhesion kinase"
     . SPARSER::COLLECTION)
    ("Ras and Rac 1" . SPARSER::COLLECTION) ("GTP" . SPARSER::NUCLEOTIDE)
    ("bipartite" . SPARSER::PROTEIN) ("KDa" . SPARSER::PROTEIN)
    ("CD133 and CD44" . SPARSER::COLLECTION)
    ("synaptophysin" . SPARSER::PROTEIN) ("chromogranin" . SPARSER::PROTEIN)
    ("p63 and cytokeratin 5" . SPARSER::COLLECTION) ("Luminal" . SPARSER::DRUG)
    ("luminal" . SPARSER::DRUG) ("Estrogens" . SPARSER::MOLECULE)
    ("AR-siRNA" . SPARSER::COLLECTION) ("Casodex" . SPARSER::DRUG)
    ("PCs" . SPARSER::PROTEIN) ("SCs" . SPARSER::PROTEIN)
    ("PC (CRPC)" . SPARSER::PROTEIN) ("androgen/AR" . SPARSER::COLLECTION)
    ("androgens" . SPARSER::DRUG) ("radical" . SPARSER::MOLECULE)
    ("PC" . SPARSER::PROTEIN) ("peptides" . SPARSER::PEPTIDE)
    ("androgen and estradiol" . SPARSER::COLLECTION)
    ("estradiol" . SPARSER::PROTEIN) ("BPH-1" . SPARSER::PROTEIN)
    ("ERβ1" . SPARSER::PROTEIN) ("retinoid X receptor" . SPARSER::PROTEIN)
    ("retinoic acid" . SPARSER::MOLECULE) ("ABCG2" . SPARSER::PROTEIN)
    ("CD49f" . SPARSER::PROTEIN) ("CD117" . SPARSER::PROTEIN)
    ("a 3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Abiraterone acetate" . SPARSER::DRUG)
    ("phosphatase and tensin homolog" . SPARSER::PROTEIN)
    ("SOX9" . SPARSER::PROTEIN) ("TMPRSS2" . SPARSER::PROTEIN)
    ("cyclin D1b" . SPARSER::PROTEIN) ("BAF57" . SPARSER::PROTEIN)
    ("FOXA1" . SPARSER::PROTEIN) ("derived factor-1" . SPARSER::PROTEIN)
    ("CXCR4" . SPARSER::PROTEIN) ("chemokine receptor" . SPARSER::PROTEIN)
    ("C4-2" . SPARSER::PROTEIN) ("anti-androgens" . SPARSER::DRUG)
    ("CCL5" . SPARSER::PROTEIN) ("N-methyl-N-nitrosourea" . SPARSER::MOLECULE)
    ("p85" . SPARSER::PROTEIN) ("Stat3" . SPARSER::PROTEIN)
    ("caveolin 1" . SPARSER::PROTEIN) ("cytokeratin5" . SPARSER::PROTEIN)
    ("anti-estrogen" . SPARSER::DRUG) ("G-1" . SPARSER::PROTEIN)
    ("DU145" . SPARSER::PROTEIN) ("RIZ 1" . SPARSER::PROTEIN)
    ("zinc-finger protein" . SPARSER::PROTEIN) ("ERβ" . SPARSER::PROTEIN)
    ("Mdm-2" . SPARSER::PROTEIN) ("alpha-" . SPARSER::PROTEIN)
    ("S5" . SPARSER::MOLECULE) ("PI3-K" . SPARSER::PROTEIN)
    ("mitogen-activated protein kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Rac 1" . SPARSER::PROTEIN) ("CD44" . SPARSER::PROTEIN)
    ("CD133" . SPARSER::PROTEIN)
    ("prostate stem cell antigen" . SPARSER::PROTEIN)
    ("cytokeratin 5" . SPARSER::PROTEIN) ("p63" . SPARSER::PROTEIN)
    ("anti-estrogens" . SPARSER::DRUG) ("GPR30" . SPARSER::PROTEIN)
    ("a Chinese gastric cancer family" . SPARSER::PROTEIN-FAMILY)
    ("his" . SPARSER::AMINO-ACID)
    ("CDH1 genes or mismatch genes" . SPARSER::COLLECTION)
    ("CDH1 and five Lynch syndrome genes ( EPCAM, MLH1, MSH2, MSH6, PMS2; see xref for the list of 83 genes)"
     . SPARSER::COLLECTION)
    ("EPCAM" . SPARSER::PROTEIN) ("MLH1" . SPARSER::PROTEIN)
    ("a familial gastric cancer family" . SPARSER::PROTEIN-FAMILY)
    ("DNAs" . SPARSER::DNA) ("mismatch" . SPARSER::PROTEIN)
    ("families" . SPARSER::PROTEIN-FAMILY) ("HDGC" . SPARSER::PROTEIN)
    ("few hereditary gastric cancer predisposition genes" . SPARSER::GENE)
    ("2/3" . SPARSER::PROTEIN) ("Loss of heterozygosity" . SPARSER::PROTEIN)
    ("PMS2" . SPARSER::PROTEIN) ("MSH6" . SPARSER::PROTEIN)
    ("MSH2" . SPARSER::PROTEIN) ("I-2" . SPARSER::PROTEIN)
    ("I-1" . SPARSER::PROTEIN)
    ("ataxia telangiectasia mutated" . SPARSER::PROTEIN)
    ("MAP3K6" . SPARSER::PROTEIN) ("CDH1" . SPARSER::PROTEIN)
    ("a useful biomarker and clinical therapy" . SPARSER::COLLECTION)
    ("EGF-EGFR" . SPARSER::COLLECTION)
    ("FGF2 and its receptor" . SPARSER::COLLECTION)
    ("FGFR2 IIIb and PKM1" . SPARSER::COLLECTION)
    ("nPTB/PTB" . SPARSER::COLLECTION)
    ("the PTB-associated splicing factor (PSF)" . SPARSER::PROTEIN)
    ("nPTB/PSF" . SPARSER::COLLECTION) ("PSF" . SPARSER::PROTEIN)
    ("HnRNP A2/B1, PTB, and SRSF1" . SPARSER::COLLECTION)
    ("nPTB/PBT" . SPARSER::COLLECTION) ("PBT" . SPARSER::PROTEIN)
    ("skeletal muscles" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("−exon" . SPARSER::COLLECTION) ("RBM4 or nPTB" . SPARSER::COLLECTION)
    ("nPTB or miR-92a-2" . SPARSER::COLLECTION)
    ("AKT/ERK" . SPARSER::COLLECTION)
    ("nPTB or miR-92a-2 or RBM4" . SPARSER::COLLECTION)
    ("nPTB-KD" . SPARSER::COLLECTION) ("KD" . SPARSER::PROTEIN)
    ("ERK/AKT" . SPARSER::COLLECTION)
    ("the total or phosphorylated ERK and AKT proteins" . SPARSER::PROTEIN)
    ("ERK and AKT" . SPARSER::COLLECTION)
    ("extracellular signal-regulated kinase (ERK)"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Isoform" . SPARSER::ISOFORM)
    ("RBM4, PTB, and nPTB" . SPARSER::COLLECTION)
    ("nPTB, miR-92a-2, PTB or RBM4" . SPARSER::COLLECTION)
    ("FGFR2 , PKM , PTB , and nPTB" . SPARSER::COLLECTION)
    ("RBM4 and the exonic CU-element" . SPARSER::COLLECTION)
    ("mut" . SPARSER::PROTEIN)
    ("recombinant RBM4 and the exonic CU-element" . SPARSER::COLLECTION)
    ("the cassette exon and its flanking intron" . SPARSER::COLLECTION)
    ("ordinary RBM4" . SPARSER::PROTEIN)
    ("the nuclear-localized SA mutant" . SPARSER::MUTANT)
    ("WT RBM4 and nonphosphorylatable S309A protein (SA)"
     . SPARSER::COLLECTION)
    ("nonphosphorylatable S309A protein (SA)" . SPARSER::PROTEIN)
    ("protein (SA)" . SPARSER::PROTEIN)
    ("FLAG-tagged RBM4 and the derived mutants" . SPARSER::COLLECTION)
    ("FLAG" . SPARSER::PROTEIN-FAMILY) ("Protein" . SPARSER::PROTEIN)
    ("nPTB and PTB" . SPARSER::COLLECTION)
    ("nPTB and its paralog" . SPARSER::COLLECTION)
    ("guanosine" . SPARSER::MOLECULE) ("cytosine" . SPARSER::NUCLEOBASE)
    ("adenine" . SPARSER::NUCLEOBASE) ("thymidine" . SPARSER::MOLECULE)
    ("guanine" . SPARSER::PROTEIN) ("-1" . SPARSER::PROTEIN)
    ("miRNA-" . SPARSER::PROTEIN)
    ("differentiating brown adipocytes" . SPARSER::PROTEIN)
    ("adipocytes" . SPARSER::PROTEIN)
    ("CRC-associated miRNA" . SPARSER::PROTEIN)
    ("RBM4 and nPTB" . SPARSER::COLLECTION)
    ("FGFR2 and PKM" . SPARSER::COLLECTION) ("RBM4-nPTB" . SPARSER::COLLECTION)
    ("PKM" . SPARSER::PROTEIN) ("PTB/nPTB" . SPARSER::COLLECTION)
    ("PTB, and nPTB" . SPARSER::COLLECTION)
    ("two paralogous genes" . SPARSER::GENE)
    ("PTB and nPTB" . SPARSER::COLLECTION)
    ("PTB and SRSF1" . SPARSER::COLLECTION)
    ("insulin receptor and MCL-1" . SPARSER::COLLECTION)
    ("protein and its paralog" . SPARSER::COLLECTION)
    ("neuronal (n)PTB" . SPARSER::PROTEIN) ("PTB" . SPARSER::PROTEIN)
    ("pyruvate" . SPARSER::PROTEIN) ("nPTB" . SPARSER::PROTEIN)
    ("S100" . SPARSER::PROTEIN) ("a 20" . SPARSER::PROTEIN)
    ("phospho-ERK" . SPARSER::PROTEIN) ("anti-ERK" . SPARSER::PROTEIN)
    ("green fluorescent" . SPARSER::PROTEIN)
    ("its receptor" . SPARSER::PROTEIN) ("FGF2" . SPARSER::PROTEIN)
    ("FGFR2 IIIb" . SPARSER::PROTEIN) ("splicing factor" . SPARSER::PROTEIN)
    ("HnRNP A2/B1" . SPARSER::PROTEIN) ("SRPK1" . SPARSER::PROTEIN)
    ("ribonucleoprotein complexes" . SPARSER::BIO-COMPLEX)
    ("pre-mRNA" . SPARSER::RNA) ("actinomycin D" . SPARSER::MOLECULE)
    ("MCL-1" . SPARSER::PROTEIN) ("insulin receptor" . SPARSER::PROTEIN)
    ("BCLAF1" . SPARSER::PROTEIN) ("PKM2" . SPARSER::PROTEIN)
    ("FGFR2" . SPARSER::PROTEIN)
    ("fibroblast growth factor receptor" . SPARSER::PROTEIN)
    ("miR-92a" . SPARSER::MOLECULE)
    ("other PI3K inhibitors and mTOR" . SPARSER::COLLECTION)
    ("suppressor (RB)" . SPARSER::SUPPRESSOR) ("cdk4/6" . SPARSER::PROTEIN)
    ("RB" . SPARSER::PROTEIN) ("GDC-0941 or PF-04691502" . SPARSER::COLLECTION)
    ("Cyp" . SPARSER::PROTEIN)
    ("GDC-0941 or PF-04691502 alone efficiently inhibited cell proliferation (Fig. xref ) with inactivation of the PI3K pathway"
     . SPARSER::COLLECTION)
    ("dual PI3K/mTOR inhibitors" . SPARSER::INHIBITOR)
    ("PI3K and mTOR" . SPARSER::COLLECTION)
    ("PI3Kβ inhibitor GSK2636771 (NCT02215096) and pan-PI3K/mTOR inhibitor LY3023414 (NCT02407054)"
     . SPARSER::COLLECTION)
    ("AR and PSA" . SPARSER::COLLECTION)
    ("AR and PI3K/mTOR inhibitors" . SPARSER::COLLECTION)
    ("the AR or PI3K/mTOR inhibitor" . SPARSER::COLLECTION)
    ("AR or PI3K" . SPARSER::COLLECTION)
    ("AR inhibitor and PI3K/mTOR inhibitor" . SPARSER::COLLECTION)
    ("castration-sensitive LNCaP" . SPARSER::PROTEIN)
    ("GDC-0941 and PF-04691502 effectively inhibited the growth of these three cell lines with IC 50 values of 0.06 μM to 0.43 μM (Fig. xref and Table xref )"
     . SPARSER::COLLECTION)
    ("drugs, Enzalutamide and Abiraterone" . SPARSER::COLLECTION)
    ("Enzalutamide and Abiraterone" . SPARSER::COLLECTION)
    ("Abiraterone" . SPARSER::DRUG) ("protein and Akt" . SPARSER::COLLECTION)
    ("FBS" . SPARSER::PROTEIN) ("dextran" . SPARSER::DEXTRAN)
    ("RPMI" . SPARSER::PROTEIN) ("PI3K/Akt" . SPARSER::COLLECTION)
    ("inhibitor and PF-04691502" . SPARSER::COLLECTION)
    ("bicalutamide" . SPARSER::DRUG) ("antiandrogen" . SPARSER::DRUG)
    ("PSA and NKX3.1" . SPARSER::COLLECTION) ("Pten" . SPARSER::PROTEIN)
    ("PHLPP" . SPARSER::PROTEIN) ("PI3K and AR" . SPARSER::COLLECTION)
    ("PI3K/Akt/mTOR" . SPARSER::COLLECTION)
    ("abiraterone acetate (17α-hydroxylase/C17, 20-lyase inhibitor) and enzalutamide (AR inhibitor)"
     . SPARSER::COLLECTION)
    ("enzalutamide" . SPARSER::DRUG) ("lyase" . SPARSER::PROTEIN)
    ("Androgen" . SPARSER::PROTEIN) ("States" . SPARSER::BIO-STATE)
    ("PSA" . SPARSER::PROTEIN) ("Enzalutamide" . SPARSER::DRUG)
    ("LNCaP" . SPARSER::PROTEIN) ("androgen" . SPARSER::PROTEIN)
    ("androgen receptor (AR)" . SPARSER::PROTEIN) ("ddH2" . SPARSER::PROTEIN)
    ("cdk4" . SPARSER::PROTEIN) ("PI3Kα" . SPARSER::PROTEIN)
    ("GSK2636771" . SPARSER::DRUG) ("PI3Kβ" . SPARSER::PROTEIN)
    ("GDC-0980" . SPARSER::DRUG) ("phenol red" . SPARSER::DRUG)
    ("NKX3.1" . SPARSER::PROTEIN)
    ("response element" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("prostate-specific antigen" . SPARSER::PROTEIN)
    ("AZD5363" . SPARSER::DRUG) ("FKBP5" . SPARSER::PROTEIN)
    ("abiraterone acetate" . SPARSER::DRUG) ("MDV3100" . SPARSER::DRUG)
    ("androgen receptor" . SPARSER::PROTEIN)
    ("several chemotherapeutic drugs" . SPARSER::DRUG)
    ("DR4 and DR5" . SPARSER::COLLECTION) ("inducers" . SPARSER::MOLECULE)
    ("Bcl-2, Bcl-xL, and c-FLIPs" . SPARSER::COLLECTION)
    ("FADD or caspase-8" . SPARSER::COLLECTION)
    ("DR4/DR5" . SPARSER::COLLECTION) ("IAP" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Bcl-xL and Mcl-1" . SPARSER::COLLECTION)
    ("DRs and DcRs" . SPARSER::COLLECTION)
    ("ABT-737 and obatoclax" . SPARSER::COLLECTION)
    ("obatoclax" . SPARSER::DRUG) ("Bcl-xL or Mcl-1" . SPARSER::COLLECTION)
    ("docetaxel" . SPARSER::DRUG)
    ("two orally bioavailable Bcl-2 inhibitors" . SPARSER::INHIBITOR)
    ("TRAIL and ABT-737" . SPARSER::COLLECTION)
    ("ABT-263 and TRAIL" . SPARSER::COLLECTION)
    ("DR5 as well as CCAAT/enhancer-binding protein homologue protein (CHOP)"
     . SPARSER::COLLECTION)
    ("protein (CHOP)" . SPARSER::PROTEIN) ("CHOP" . SPARSER::PROTEIN)
    ("homologue" . SPARSER::PROTEIN) ("CCAAT" . SPARSER::PROTEIN)
    ("thapsigargin" . SPARSER::MOLECULE) ("PDTC" . SPARSER::DRUG)
    ("pyrrolidine" . SPARSER::DRUG)
    ("either Bcl-xL siRNA or both Bcl-xL and Bcl-2 siRNA (Figure xref and xref )"
     . SPARSER::COLLECTION)
    ("Bcl-xL and Bcl-2" . SPARSER::COLLECTION)
    ("the respective molecule" . SPARSER::MOLECULE)
    ("Bcl-2 or Bcl-xL" . SPARSER::COLLECTION)
    ("caspase-8, caspase-9, or pan-caspase" . SPARSER::COLLECTION)
    ("Bid" . SPARSER::PROTEIN)
    ("caspase-3 and caspase-8" . SPARSER::COLLECTION)
    ("caspase-3, caspase-8, and caspase-9" . SPARSER::COLLECTION)
    ("TRAIL or ABT-263" . SPARSER::COLLECTION) ("Caspase" . SPARSER::PROTEIN)
    ("ABT-263 and ABT-199" . SPARSER::COLLECTION)
    ("TRAIL and ABT-199" . SPARSER::COLLECTION)
    ("Bcl-2 and Bcl-w, and ABT-263" . SPARSER::COLLECTION)
    ("Bcl-w, and ABT-263" . SPARSER::COLLECTION)
    ("orally bioavailable Bcl-2 inhibitors" . SPARSER::INHIBITOR)
    ("ABT-199 or ABT-263" . SPARSER::COLLECTION)
    ("Bcl-2 and Mcl-1" . SPARSER::COLLECTION)
    ("TRAIL and the Bcl-2 family inhibitors" . SPARSER::COLLECTION)
    ("Bcl-2, Bcl-xL, and Mcl-1" . SPARSER::COLLECTION)
    ("TRAIL and ABT-263" . SPARSER::COLLECTION)
    ("DcR1 and DcR2" . SPARSER::COLLECTION) ("DcR1" . SPARSER::PROTEIN)
    ("orally bioavailable inhibitor" . SPARSER::INHIBITOR)
    ("Bcl-2 and Bcl-w" . SPARSER::COLLECTION)
    ("a clinically approved orally bioavailable inhibitor"
     . SPARSER::INHIBITOR)
    ("Navitoclax" . SPARSER::DRUG)
    ("Bcl-2 and/or Bcl-xL" . SPARSER::COLLECTION)
    ("Bcl-2 and Bcl-xL" . SPARSER::COLLECTION)
    ("the pro-apoptotic proteins Bax and Bak" . SPARSER::COLLECTION)
    ("Bax and Bak" . SPARSER::COLLECTION) ("Bak" . SPARSER::PROTEIN)
    ("Bcl-2, Bcl-xL, Bcl-w, and Mcl-1" . SPARSER::COLLECTION)
    ("TRAIL and its DRs" . SPARSER::COLLECTION) ("DRs" . SPARSER::MOLECULE)
    ("DcRs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("DcR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Fas ligand (FasL) and tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL)"
     . SPARSER::COLLECTION)
    ("FasL" . SPARSER::PROTEIN) ("reagents" . SPARSER::MOLECULE)
    ("ATB" . SPARSER::PROTEIN) ("receptor (DR)" . SPARSER::RECEPTOR)
    ("DR" . SPARSER::MOLECULE)
    ("Bcl-2, Bcl-xL, or c-FLIPs" . SPARSER::COLLECTION)
    ("ABT-263 and ABT-737" . SPARSER::COLLECTION)
    ("Bcl-2, Bcl-xL, and Bcl-w" . SPARSER::COLLECTION)
    ("ligand (TRAIL)" . SPARSER::MOLECULE) ("TRAIL" . SPARSER::PROTEIN)
    ("TNF" . SPARSER::PROTEIN) ("MitoTracker Red" . SPARSER::MOLECULE)
    ("Z-LEHD-FMK" . SPARSER::DRUG) ("Z-IETD-FMK" . SPARSER::DRUG)
    ("Z-VAD-FMK" . SPARSER::DRUG) ("annexin V" . SPARSER::PROTEIN)
    ("alkaline phosphatase" . SPARSER::PROTEIN-FAMILY)
    ("α-tubulin" . SPARSER::PROTEIN) ("Bcl-X" . SPARSER::PROTEIN)
    ("CD264" . SPARSER::PROTEIN) ("CD263" . SPARSER::PROTEIN)
    ("CD262" . SPARSER::PROTEIN) ("CD261" . SPARSER::PROTEIN)
    ("c-FLIP" . SPARSER::PROTEIN) ("CD95" . SPARSER::PROTEIN)
    ("protein can" . SPARSER::PROTEIN) ("DR4" . SPARSER::PROTEIN)
    ("ABT-199" . SPARSER::DRUG) ("Mcl-1" . SPARSER::PROTEIN)
    ("DcR2" . SPARSER::PROTEIN) ("decoy receptor" . SPARSER::PROTEIN)
    ("DR5" . SPARSER::PROTEIN) ("tumor necrosis factor" . SPARSER::PROTEIN)
    ("Fas ligand" . SPARSER::PROTEIN) ("c-FLIPs" . SPARSER::PROTEIN)
    ("Bcl-w" . SPARSER::PROTEIN) ("Bcl-xL" . SPARSER::PROTEIN)
    ("ABT-737" . SPARSER::DRUG) ("ABT-263" . SPARSER::DRUG)
    ("Tumor necrosis factor" . SPARSER::PROTEIN)
    ("CDK1/cyclin" . SPARSER::COLLECTION)
    ("directly target CDK1" . SPARSER::PROTEIN) ("ZFAS1" . SPARSER::PROTEIN)
    ("ZFAS1-miRNA" . SPARSER::PROTEIN-PAIR)
    ("probably other CDKs" . SPARSER::PROTEIN)
    ("CDK1 and CDK2" . SPARSER::COLLECTION)
    ("the predominant kinase" . SPARSER::KINASE)
    ("homologous snoRNA genes" . SPARSER::GENE)
    ("gene and transcript" . SPARSER::COLLECTION)
    ("the exploratory cohort" . SPARSER::MOLECULE)
    ("cyclin B1 and PARP" . SPARSER::COLLECTION)
    ("p53 and cyclin B1" . SPARSER::COLLECTION)
    ("CDK1 and interestingly four algorithms" . SPARSER::COLLECTION)
    ("Cyclin-dependent kinase 1 (CDK1) and Death domain-associated protein 6 (DAXX)"
     . SPARSER::COLLECTION)
    ("Aurora kinase B (AUKB), Cyclin-dependent kinase 9 (CDK9), Cyclin-dependent kinase 1 (CDK1) and Death domain-associated protein 6 (DAXX)"
     . SPARSER::COLLECTION)
    ("DAXX" . SPARSER::PROTEIN) ("biotin–avidin" . SPARSER::COLLECTION)
    ("avidin" . SPARSER::PROTEIN) ("SiRNA" . SPARSER::PROTEIN)
    ("proteins and miRNAs" . SPARSER::COLLECTION)
    ("larger cohort" . SPARSER::MOLECULE)
    ("disease-associated lncRNAs" . SPARSER::RNA)
    ("antisense" . SPARSER::PROTEIN) ("lncRNA" . SPARSER::RNA)
    ("endogenous RNAs (ceRNAs) or natural microRNAs (miRNAs)"
     . SPARSER::COLLECTION)
    ("RNAs and regulators" . SPARSER::COLLECTION)
    ("cis- or trans-regulatory" . SPARSER::COLLECTION)
    ("cis-" . SPARSER::PROTEIN) ("LncRNAs" . SPARSER::RNA)
    ("HOTAIR" . SPARSER::PROTEIN) ("CDK1/cyclin B1" . SPARSER::COLLECTION)
    ("CRC" . SPARSER::PROTEIN) ("lncRNAs" . SPARSER::RNA)
    ("RNAs" . SPARSER::RNA) ("β-tubulin" . SPARSER::PROTEIN)
    ("32 P" . SPARSER::|32P|) ("MiR-150-5p" . SPARSER::MOLECULE)
    ("G2/M" . SPARSER::PROTEIN) ("miR-150-5p" . SPARSER::MOLECULE)
    ("RNA-binding protein" . SPARSER::PROTEIN)
    ("Death domain-associated protein 6" . SPARSER::PROTEIN)
    ("CDK9" . SPARSER::PROTEIN)
    ("Cyclin-dependent kinase 9" . SPARSER::PROTEIN)
    ("Aurora kinase B" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase 1" . SPARSER::PROTEIN)
    ("MALAT1" . SPARSER::PROTEIN) ("cyclin B1" . SPARSER::PROTEIN)
    ("CDK1" . SPARSER::PROTEIN)
    ("Cyclin-dependent kinase 1" . SPARSER::PROTEIN)
    ("DLD-1" . SPARSER::PROTEIN) ("snoRNA" . SPARSER::RNA)
    ("MCF-10A" . SPARSER::PROTEIN) ("light" . SPARSER::PROTEIN)
    ("inducer" . SPARSER::PROTEIN)
    ("The growth-arrest-specific genes family" . SPARSER::PROTEIN-FAMILY)
    ("GAS1, GAS2, GAS3, GAS5, GAS6, GAS7, GAS8 , and GAS9"
     . SPARSER::COLLECTION)
    ("fibronectin/integrin/FAK/N-WASP" . SPARSER::COLLECTION)
    ("ligase" . SPARSER::LIGASE) ("tubulin" . SPARSER::PROTEIN)
    ("β-TrCP/β-catenin" . SPARSER::COLLECTION)
    ("mRNA/protein" . SPARSER::COLLECTION) ("dC" . SPARSER::MOLECULE)
    ("aza" . SPARSER::DRUG) ("CpGs" . SPARSER::PROTEIN)
    ("hot" . SPARSER::PROTEIN) ("bisulfite" . SPARSER::MOLECULE)
    ("N-WASP and hnRNP U" . SPARSER::COLLECTION)
    ("N-WASP or hnRNP U" . SPARSER::COLLECTION)
    ("N-WASP and/or hnRNP U" . SPARSER::COLLECTION)
    ("blot and transwell" . SPARSER::COLLECTION)
    ("β-TrCP and β-catenin" . SPARSER::COLLECTION)
    ("hnRNP U and β-TrCP" . SPARSER::COLLECTION)
    ("GAS7, hnRNP U and β-TrCP" . SPARSER::COLLECTION)
    ("less intense F-actin" . SPARSER::BIO-COMPLEX)
    ("Fibronectin" . SPARSER::PROTEIN) ("Our Western blot" . SPARSER::PROTEIN)
    ("p-paxillin" . SPARSER::COLLECTION) ("p-FAK" . SPARSER::COLLECTION)
    ("paxillin" . SPARSER::PROTEIN) ("pY" . SPARSER::PROTEIN)
    ("protein and GAS7C" . SPARSER::COLLECTION)
    ("the major alterative isoform" . SPARSER::ISOFORM)
    ("hnRNP U/β-TrCP/β-catenin" . SPARSER::COLLECTION)
    ("GAS7 and hnRNP U" . SPARSER::COLLECTION)
    ("p-β-catenin" . SPARSER::COLLECTION)
    ("actin dynamic associated proteins" . SPARSER::PROTEIN)
    ("N-WASP and Arp 2" . SPARSER::COLLECTION)
    ("/N-WASP" . SPARSER::COLLECTION)
    ("several GAS7 WW domain-associated proteins" . SPARSER::PROTEIN)
    ("actin" . SPARSER::PROTEIN) ("polypeptides" . SPARSER::PROTEIN)
    ("Ras and Src" . SPARSER::COLLECTION)
    ("proline-rich ligands and change" . SPARSER::COLLECTION)
    ("proline" . SPARSER::AMINO-ACID) ("FES-CIP4" . SPARSER::COLLECTION)
    ("FCH" . SPARSER::PROTEIN-FAMILY) ("FES" . SPARSER::PROTEIN)
    ("a chromosomally-inserted retrovirus-based lacZ reporter gene"
     . SPARSER::GENE)
    ("Gas7" . SPARSER::PROTEIN) ("lacZ" . SPARSER::PROTEIN)
    ("the growth-arrest-specific 7 ( GAS7 ) gene" . SPARSER::GENE)
    ("hnRNP U/β-TrCP" . SPARSER::COLLECTION)
    ("fibronectin/integrin/FAK" . SPARSER::COLLECTION)
    ("FAK" . SPARSER::PROTEIN) ("- 3" . SPARSER::PROTEIN)
    ("C-R" . SPARSER::PROTEIN)
    ("reverse-transcriptase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Cytokeratin 7" . SPARSER::PROTEIN) ("GAS8" . SPARSER::PROTEIN)
    ("GAS6" . SPARSER::PROTEIN) ("GAS5" . SPARSER::PROTEIN)
    ("GAS3" . SPARSER::PROTEIN) ("GAS2" . SPARSER::PROTEIN)
    ("GAS1" . SPARSER::PROTEIN) ("WD1" . SPARSER::PROTEIN)
    ("cell membrane" . SPARSER::PROTEIN) ("Cdc42" . SPARSER::PROTEIN)
    ("CL1-5" . SPARSER::PROTEIN) ("CL1-0" . SPARSER::PROTEIN)
    ("Arp 2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Arp 2/3" . SPARSER::PROTEIN)
    ("heterogeneous nuclear ribonucleoprotein U" . SPARSER::PROTEIN)
    ("CIP4" . SPARSER::PROTEIN) ("loss of heterozygosity" . SPARSER::PROTEIN)
    ("β-TrCP" . SPARSER::PROTEIN) ("hnRNP U" . SPARSER::PROTEIN)
    ("F-actin" . SPARSER::BIO-COMPLEX) ("N-WASP" . SPARSER::PROTEIN)
    ("GAS7" . SPARSER::PROTEIN) ("binding prometastatic genes" . SPARSER::GENE)
    ("CD47-SIRPα" . SPARSER::COLLECTION)
    ("CD47-signal regulatory protein" . SPARSER::COLLECTION)
    ("chemotaxis" . SPARSER::PROTEIN)
    ("integrin and CD47" . SPARSER::COLLECTION)
    ("cytoskeletal proteins and multiple signaling molecules"
     . SPARSER::COLLECTION)
    ("cytoskeletal proteins" . SPARSER::PROTEIN)
    ("scaffold" . SPARSER::SCAFFOLD)
    ("miR-192-mediated ITGB3" . SPARSER::PROTEIN)
    ("ITGB3 and plectin" . SPARSER::COLLECTION) ("plectin" . SPARSER::PROTEIN)
    ("ITGAV and ITGB3" . SPARSER::COLLECTION)
    ("ZEB2 and E-cadherin" . SPARSER::COLLECTION)
    ("p53-miR" . SPARSER::COLLECTION)
    ("Food and Drug Administration-approved drugs" . SPARSER::COLLECTION)
    ("gemcitabine and pemetrexed" . SPARSER::COLLECTION)
    ("MYC" . SPARSER::PROTEIN) ("Group" . SPARSER::MOLECULE)
    ("Drug" . SPARSER::DRUG) ("Food" . SPARSER::MOLECULE)
    ("BLI" . SPARSER::PROTEIN)
    ("ITGB1 ( P = 1.00) and VIM ( P = 0.08)" . SPARSER::COLLECTION)
    ("ITGB3 ( P <0.01) and CD47 (P <0.01)" . SPARSER::COLLECTION)
    ("ITGAV ( P <0.001), ITGB3 ( P <0.01) and CD47 (P <0.01)"
     . SPARSER::COLLECTION)
    ("the seeding group ( N = 8) and non-seeding group ( N = 10)"
     . SPARSER::COLLECTION)
    ("integrins and integrin-related proteins" . SPARSER::COLLECTION)
    ("integrin" . SPARSER::PROTEIN) ("integrins" . SPARSER::PROTEIN)
    ("‘transporter’" . SPARSER::PROTEIN) ("transporter" . SPARSER::PROTEIN)
    ("ITGAV, ITGB1, ITGB3, and CD47" . SPARSER::COLLECTION)
    ("ECM" . SPARSER::PROTEIN) ("type I and fibrinogen" . SPARSER::COLLECTION)
    ("fibrinogen" . SPARSER::PROTEIN) ("laminin" . SPARSER::PROTEIN)
    ("collagen" . SPARSER::PROTEIN) ("fibronectin" . SPARSER::PROTEIN)
    ("genes and proteins" . SPARSER::COLLECTION)
    ("ZEB2, E-cadherin and VIM" . SPARSER::COLLECTION)
    ("NC-miR" . SPARSER::COLLECTION) ("pReceiver-DHFR" . SPARSER::COLLECTION)
    ("a target of methotrexate and the key enzyme" . SPARSER::COLLECTION)
    ("methotrexate" . SPARSER::DRUG)
    ("the tumor non-seeding group ( N = 20) or the normal cerebellum group (all P values <0.05, Figure xref )"
     . SPARSER::COLLECTION)
    ("a naturally occurring class" . CLASS)
    ("histologic subtypes" . SPARSER::PROTEIN) ("SHH" . SPARSER::PROTEIN)
    ("WNT" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ITGAV, ITGB1, ITGB3 , and CD47" . SPARSER::COLLECTION)
    ("ITGAV" . SPARSER::PROTEIN) ("DHFR" . SPARSER::PROTEIN)
    ("Differentially" . SPARSER::PROTEIN) ("CSF" . SPARSER::PROTEIN)
    ("miRs" . SPARSER::PROTEIN) ("–3" . SPARSER::PROTEIN)
    ("S–S" . SPARSER::PROTEIN) ("Dual-Luciferase" . SPARSER::PROTEIN)
    ("6B" . SPARSER::PROTEIN) ("SIRPα" . SPARSER::PROTEIN)
    ("signal regulatory protein" . SPARSER::PROTEIN)
    ("MED8" . SPARSER::PROTEIN) ("ZEB2" . SPARSER::PROTEIN)
    ("b-5" . SPARSER::PROTEIN) ("miR-21" . SPARSER::PROTEIN)
    ("CD47" . SPARSER::PROTEIN) ("ITGB3" . SPARSER::PROTEIN)
    ("ITGB1" . SPARSER::PROTEIN) ("rpS6 and p-rpS6" . SPARSER::COLLECTION)
    ("PTEN and HIF-1α" . SPARSER::COLLECTION) ("Partial" . SPARSER::PROTEIN)
    ("p-Akt" . SPARSER::COLLECTION) ("Cho" . SPARSER::PROTEIN)
    ("p21 and p57" . SPARSER::COLLECTION) ("Cip" . SPARSER::PROTEIN)
    ("ebp" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p70S6K, HIF1A, and 4E-BP1" . SPARSER::COLLECTION)
    ("mTORC1 and mTORC2" . SPARSER::COLLECTION)
    ("rapamycin derivatives and form" . SPARSER::COLLECTION)
    ("predictive biomarkers" . SPARSER::MOLECULE) ("RpS6" . SPARSER::PROTEIN)
    ("rpS6 and its phosphorylated form" . SPARSER::COLLECTION)
    ("p27-" . SPARSER::PROTEIN) ("rpS6, p27, and 4ebp1" . SPARSER::COLLECTION)
    ("Everolimus or leucine" . SPARSER::COLLECTION)
    ("p-4ebp1" . SPARSER::COLLECTION)
    ("a translational repressor" . SPARSER::REPRESSOR)
    ("Rheb" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("mTOR and rpS6" . SPARSER::COLLECTION) ("GSK3-BAD" . SPARSER::COLLECTION)
    ("BAD" . SPARSER::PROTEIN)
    ("the translational repressor 4EBP1, HIF1A, p27, and Bcl-2"
     . SPARSER::COLLECTION)
    ("4EBP1, HIF1A, p27, and Bcl-2" . SPARSER::COLLECTION)
    ("p70S6K" . SPARSER::PROTEIN) ("repressor" . SPARSER::REPRESSOR)
    ("/AKT" . SPARSER::COLLECTION) ("Temsirolimus" . SPARSER::DRUG)
    ("tyrosine-kinase inhibitors and mammalian target of rapamycin (mTOR) inhibitors"
     . SPARSER::COLLECTION)
    ("p" . SPARSER::PROTEIN)
    ("phosphorylated rpS6 (p-rpS6) and non-phosphorylated rpS6"
     . SPARSER::COLLECTION)
    ("p-rpS6" . SPARSER::COLLECTION) ("4ebp1 or p27" . SPARSER::COLLECTION)
    ("4ebp1" . SPARSER::PROTEIN) ("rpS6" . SPARSER::PROTEIN)
    ("rpS" . SPARSER::PROTEIN) ("everolimus" . SPARSER::DRUG)
    ("Inhibitors" . SPARSER::INHIBITOR) ("H2O2" . SPARSER::DRUG)
    ("G10" . SPARSER::PROTEIN) ("NaVO3" . SPARSER::MOLECULE)
    ("HK-2" . SPARSER::PROTEIN) ("AP23573" . SPARSER::DRUG)
    ("Pdcd4" . SPARSER::PROTEIN) ("p57" . SPARSER::PROTEIN)
    ("tissue type" . SPARSER::PROTEIN) ("mTORC2" . SPARSER::PROTEIN)
    ("FKBP12" . SPARSER::PROTEIN) ("FK506-binding protein" . SPARSER::PROTEIN)
    ("3-2" . SPARSER::PROTEIN) ("1-1" . SPARSER::PROTEIN)
    ("1-2" . SPARSER::PROTEIN) ("mTORC1" . SPARSER::PROTEIN)
    ("a 3D" . SPARSER::PROTEIN) ("HK2" . SPARSER::PROTEIN)
    ("GSK3" . SPARSER::PROTEIN) ("eEF2K" . SPARSER::PROTEIN)
    ("ribosomal protein S6" . SPARSER::PROTEIN) ("HIF1A" . SPARSER::PROTEIN)
    ("4EBP1" . SPARSER::PROTEIN) ("p70S6" . SPARSER::PROTEIN)
    ("ribosomal protein S6 kinase" . SPARSER::PROTEIN)
    ("VEGF-R" . SPARSER::PROTEIN) ("RAD001" . SPARSER::DRUG)
    ("CCI-779" . SPARSER::DRUG)
    ("mammalian target of rapamycin" . SPARSER::PROTEIN)
    ("ebp1" . SPARSER::PROTEIN)
    ("Cyclophosphamide and ifosfamide" . SPARSER::COLLECTION)
    ("Cyclophosphamide" . SPARSER::DRUG)
    ("vincristine, doxorubicin, cyclophosphamide, ifosfamide and etoposide"
     . SPARSER::COLLECTION)
    ("etoposide" . SPARSER::PROTEIN) ("ifosfamide" . SPARSER::DRUG)
    ("cyclophosphamide" . SPARSER::DRUG) ("vincristine" . SPARSER::DRUG)
    ("PARP1 or toxic DSBs" . SPARSER::COLLECTION) ("PC-3" . SPARSER::PROTEIN)
    ("temozolomide, and PARP1" . SPARSER::COLLECTION)
    ("Cisplatin" . SPARSER::DRUG)
    ("protein, and siRNA-mediated" . SPARSER::COLLECTION)
    ("Temozolomide" . SPARSER::DRUG)
    ("temozolomide and 10μM" . SPARSER::COLLECTION)
    ("temozolomide and PARP1" . SPARSER::COLLECTION)
    ("Niraparib" . SPARSER::DRUG)
    ("cisplatin, temozolomide and camptothecin" . SPARSER::COLLECTION)
    ("NCT02044120, NCT01858168 and NCT02116777" . SPARSER::COLLECTION)
    ("niraparib" . SPARSER::DRUG) ("BRCA1 or CtIP" . SPARSER::COLLECTION)
    ("proteins, BRCA1 and CtIP" . SPARSER::COLLECTION)
    ("CtIP" . SPARSER::PROTEIN) ("ATR and ATM" . SPARSER::COLLECTION)
    ("topoisomerase" . SPARSER::PROTEIN) ("RPA" . SPARSER::PROTEIN)
    ("exonuclease" . SPARSER::PROTEIN) ("ATM and ATR" . SPARSER::COLLECTION)
    ("aphidicolin" . SPARSER::PROTEIN) ("palbociclib" . SPARSER::DRUG)
    ("Serine" . SPARSER::AMINO-ACID)
    ("ATM, ATR, 53BP1, CHK1, CHK2, MRE11, BRCA1 and BRCA2"
     . SPARSER::COLLECTION)
    ("MHH-ES-1" . SPARSER::COLLECTION) ("TM" . SPARSER::PROTEIN)
    ("functional DDR and HR" . SPARSER::COLLECTION)
    ("DDR and HR" . SPARSER::COLLECTION)
    ("ATM, ATR, DNA-PK, CHK1 or CHK2" . SPARSER::COLLECTION)
    ("DNA-damage" . SPARSER::DNA) ("DDR" . SPARSER::PROTEIN)
    ("bleomycin, cisplatin, gemcitabine and doxorubicin" . SPARSER::COLLECTION)
    ("doxorubicin" . SPARSER::PROTEIN) ("bleomycin" . SPARSER::DRUG)
    ("analogs" . SPARSER::ANALOG) ("camptothecin" . SPARSER::DRUG)
    ("olaparib and rucaparib" . SPARSER::COLLECTION)
    ("veliparib" . SPARSER::DRUG) ("AG" . SPARSER::PROTEIN)
    ("rucaparib" . SPARSER::DRUG) ("met" . SPARSER::AMINO-ACID)
    ("olaparib" . SPARSER::DRUG) ("trap" . SPARSER::PROTEIN)
    ("ATM, ATR or PTEN" . SPARSER::COLLECTION) ("ATR" . SPARSER::PROTEIN)
    ("ATM" . SPARSER::PROTEIN) ("modulators" . SPARSER::PROTEIN)
    ("-mutant" . SPARSER::MUTANT) ("BRCA" . SPARSER::PROTEIN-FAMILY)
    ("Olaparib" . SPARSER::DRUG)
    ("PARP1 and the related protein PARP2" . SPARSER::COLLECTION)
    ("SSBs" . SPARSER::PROTEIN) ("PARPs" . SPARSER::MOLECULE)
    ("polymerases" . SPARSER::PROTEIN) ("multidrug" . SPARSER::PROTEIN)
    ("EWS-FLI1" . SPARSER::COLLECTION) ("t" . SPARSER::PROTEIN)
    ("EWS" . SPARSER::PROTEIN) ("temozolomide and PARP" . SPARSER::COLLECTION)
    ("temozolomide" . SPARSER::DRUG) ("SSB" . SPARSER::PROTEIN)
    ("siRNA-mediated" . SPARSER::PROTEIN) ("RBBP8" . SPARSER::PROTEIN)
    ("KAP1" . SPARSER::PROTEIN) ("CDK4/6" . SPARSER::PROTEIN)
    ("H2AX" . SPARSER::PROTEIN) ("BRCA2" . SPARSER::PROTEIN)
    ("MRE11" . SPARSER::PROTEIN) ("ES-1" . SPARSER::PROTEIN)
    ("CHK2" . SPARSER::PROTEIN) ("CHK1" . SPARSER::PROTEIN)
    ("DNA-PK" . SPARSER::PROTEIN) ("ABT-888" . SPARSER::DRUG)
    ("18h" . SPARSER::PROTEIN) ("RAD51" . SPARSER::PROTEIN)
    ("a 37" . SPARSER::PROTEIN) ("γH2AX" . SPARSER::PROTEIN)
    ("alkylating agent" . SPARSER::MOLECULE) ("PARP2" . SPARSER::PROTEIN)
    ("NAD +" . SPARSER::MOLECULE) ("ADP-ribosyl" . SPARSER::MOLECULE)
    ("FLI1" . SPARSER::PROTEIN) ("site 1" . SPARSER::PROTEIN)
    ("PARP1" . SPARSER::PROTEIN) ("BRCA1" . SPARSER::PROTEIN)
    ("Rep" . SPARSER::PROTEIN) ("SRT" . SPARSER::PROTEIN)
    ("53BP1 and claspin" . SPARSER::COLLECTION) ("IR" . SPARSER::PROTEIN)
    ("sham" . SPARSER::DRUG) ("mAG" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("iodide" . SPARSER::PROTEIN) ("propidium" . SPARSER::MOLECULE)
    ("claspin" . SPARSER::PROTEIN) ("Bora" . SPARSER::PROTEIN)
    ("TAK" . SPARSER::PROTEIN) ("serine/threonine" . SPARSER::COLLECTION)
    ("threonine" . SPARSER::AMINO-ACID) ("serine" . SPARSER::AMINO-ACID)
    ("anti-β" . SPARSER::PROTEIN) ("S10" . SPARSER::PROTEIN)
    ("BI2536" . SPARSER::DRUG) ("p53 binding protein 1" . SPARSER::PROTEIN)
    ("Cdc25C" . SPARSER::PROTEIN) ("Aurora-A" . SPARSER::PROTEIN)
    ("53BP1" . SPARSER::PROTEIN) ("protein 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("tumor suppressor p53" . SPARSER::PROTEIN) ("RNF8" . SPARSER::PROTEIN)
    ("PLK1" . SPARSER::PROTEIN) ("Polo-like kinase" . SPARSER::PROTEIN)
    ("caspase-3 and caspase-9" . SPARSER::COLLECTION)
    ("ERK1/2, JNK1/2 and P38" . SPARSER::COLLECTION)
    ("MAPK, and extracellular signal-regulated kinase (ERK)"
     . SPARSER::COLLECTION)
    ("MAPK, and extracellular signal-regulated kinase" . SPARSER::COLLECTION)
    ("JNK/SAPKs" . SPARSER::COLLECTION)
    ("kinase/stress activated protein kinases" . SPARSER::COLLECTION)
    ("SAPKs" . SPARSER::PROTEIN)
    ("the released mitochondrial cytochrome" . SPARSER::PROTEIN)
    ("cytochrome" . SPARSER::PROTEIN) ("JNK1/2 and P38" . SPARSER::COLLECTION)
    ("SP600125 and SB202190" . SPARSER::COLLECTION)
    ("U0126 (an ERK inhibitor) or SB202190 (a P38 inhibitor)"
     . SPARSER::COLLECTION)
    ("JNK, ERK and P38" . SPARSER::COLLECTION) ("MAPKs" . SPARSER::PROTEIN)
    ("chemotherapeutic drugs" . SPARSER::DRUG)
    ("MAPK and JNK" . SPARSER::COLLECTION) ("MMPs" . SPARSER::PROTEIN)
    ("PARP, Bcl-2, Bax, NF-κB and P53" . SPARSER::COLLECTION)
    ("P53 and Bax" . SPARSER::COLLECTION)
    ("Annexin V and PI" . SPARSER::COLLECTION) ("PBS" . SPARSER::PROTEIN)
    ("Cytotoxic" . SPARSER::PROTEIN)
    ("JNK, ERK, Bax and P38" . SPARSER::COLLECTION)
    ("Bcl-2 and NF-κB" . SPARSER::COLLECTION) ("lymphoid-" . SPARSER::PROTEIN)
    ("myeloid" . SPARSER::PROTEIN) ("lymphoid" . SPARSER::PROTEIN)
    ("MAPK and JNK1/2" . SPARSER::COLLECTION)
    ("MAPK, ERK1/2 and JNK1/2" . SPARSER::COLLECTION)
    ("Phloretin" . SPARSER::DRUG)
    ("extracellular signal-regulated kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("stress activated protein kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NH2" . SPARSER::MOLECULE) ("c-Jun" . SPARSER::PROTEIN)
    ("NP40" . SPARSER::MOLECULE) ("p-ERK1" . SPARSER::PROTEIN)
    ("p-P38" . SPARSER::PROTEIN) ("JNK1" . SPARSER::PROTEIN)
    ("SB202190" . SPARSER::DRUG) ("U0126" . SPARSER::DRUG)
    ("SP600125" . SPARSER::PROTEIN)
    ("3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide"
     . SPARSER::MOLECULE)
    ("P53" . SPARSER::HUMAN-PROTEIN-FAMILY) ("NF-κB" . SPARSER::PROTEIN)
    ("JNK1/2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("P38" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MTA1 and MICoA" . SPARSER::COLLECTION)
    ("MTA1-IFI16" . SPARSER::COLLECTION) ("MTA1-TFAP2C" . SPARSER::COLLECTION)
    ("MTA1 and MTA1s" . SPARSER::COLLECTION)
    ("ERα and AR" . SPARSER::COLLECTION) ("AR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ERα-SP1" . SPARSER::COLLECTION) ("SP1" . SPARSER::PROTEIN)
    ("tamoxifen" . SPARSER::MOLECULE)
    ("coactivators, corepressors, and chromatin" . SPARSER::COLLECTION)
    ("coactivators" . SPARSER::PROTEIN)
    ("a complex and multistep process that is influenced by coactivator and corepressor proteins"
     . SPARSER::COLLECTION)
    ("STAT3 and IL-1α" . SPARSER::COLLECTION) ("PTPRO" . SPARSER::PROTEIN)
    ("cyclin D1, and Bcl-2" . SPARSER::COLLECTION)
    ("cyclin" . SPARSER::HUMAN-PROTEIN-FAMILY) ("MiR" . SPARSER::PROTEIN)
    ("interleukin-6 and hepatocyte growth factor" . SPARSER::COLLECTION)
    ("CCK-8 and EdU" . SPARSER::COLLECTION)
    ("expressed ERα and ectopically overexpressed MTA1" . SPARSER::COLLECTION)
    ("Matrigel" . SPARSER::PROTEIN) ("ethynyl" . SPARSER::MOLECULE)
    ("protein and mRNA" . SPARSER::COLLECTION)
    ("a wildtype MTA1 promoter fragment and a mutant MTA1 promoter"
     . SPARSER::COLLECTION)
    ("fragment" . SPARSER::FRAGMENT) ("chromatin" . SPARSER::PROTEIN)
    ("corepressors, NCoR and SMRT" . SPARSER::COLLECTION)
    ("ligands" . SPARSER::LIGAND) ("SMRT" . SPARSER::PROTEIN)
    ("NCoR" . SPARSER::PROTEIN) ("Corepressors" . SPARSER::PROTEIN)
    ("-GGATC-3" . SPARSER::COLLECTION) ("estrogen" . SPARSER::MOLECULE)
    ("Ligand" . SPARSER::LIGAND) ("the major ER" . SPARSER::PROTEIN)
    ("ERs" . SPARSER::PROTEIN) ("Estrogen" . SPARSER::MOLECULE)
    ("estrogen receptor (ER)-negative HCC" . SPARSER::PROTEIN)
    ("invasive HBV-associated HCC" . SPARSER::PROTEIN)
    ("HBV-associated HCC" . SPARSER::PROTEIN) ("HCCs" . SPARSER::PROTEIN)
    ("ERα and MTA1" . SPARSER::COLLECTION) ("corepressors" . SPARSER::PROTEIN)
    ("ShRNA and dual-luciferase" . SPARSER::COLLECTION)
    ("MTA1 and ERα" . SPARSER::COLLECTION) ("ShRNA" . SPARSER::PROTEIN)
    ("EdU" . SPARSER::DRUG) ("MTA3" . SPARSER::PROTEIN)
    ("IFI16" . SPARSER::PROTEIN) ("TFAP2C" . SPARSER::PROTEIN)
    ("MTA1s" . SPARSER::PROTEIN) ("FoxA1" . SPARSER::PROTEIN)
    ("TLE3" . SPARSER::PROTEIN) ("NCOR2" . SPARSER::PROTEIN)
    ("Bmi1" . SPARSER::PROTEIN) ("IL-1α" . SPARSER::PROTEIN)
    ("NF-kappaB" . SPARSER::PROTEIN) ("caspase 3" . SPARSER::PROTEIN)
    ("MMP-2" . SPARSER::PROTEIN)
    ("hepatocyte growth factor" . SPARSER::PROTEIN)
    ("interleukin-6" . SPARSER::PROTEIN) ("BMI1" . SPARSER::PROTEIN)
    ("CCK-8" . SPARSER::PROTEIN) ("17β-estradiol" . SPARSER::PROTEIN)
    ("Alkaline Phosphatase" . SPARSER::PROTEIN-FAMILY)
    ("a 2 " . SPARSER::HUMAN-PROTEIN-FAMILY) ("PPARγ" . SPARSER::PROTEIN)
    ("E2" . SPARSER::MOLECULE) ("17 β-estradiol" . SPARSER::PROTEIN)
    ("steroid hormone" . SPARSER::MOLECULE) ("ERα" . SPARSER::PROTEIN)
    ("MTA1" . SPARSER::PROTEIN)
    ("cetuximab or trastuzumab" . SPARSER::COLLECTION)
    ("the dual EGFR/HER2" . SPARSER::COLLECTION)
    ("trastuzumab- or cetuximab-mediated ADCC" . SPARSER::COLLECTION)
    ("gefitinib and erlotinib" . SPARSER::COLLECTION)
    ("heterodimers" . SPARSER::HETERODIMER) ("dimer" . SPARSER::DIMER)
    ("afatinib or lapatinib" . SPARSER::COLLECTION)
    ("weaker" . SPARSER::PROTEIN) ("gefinitib" . SPARSER::DRUG)
    ("the EGFR-TKI gefitinib nor pan-HER TKI afatinib" . SPARSER::COLLECTION)
    ("the EGFR-TKI gefitinib and pan-HER TKI afatinib" . SPARSER::COLLECTION)
    ("dual EGFR/HER2-TKI lapatinib" . SPARSER::DRUG)
    ("EGFR or HER2" . SPARSER::COLLECTION) ("EGFR-" . SPARSER::PROTEIN)
    ("trastuzumab or lapatinib" . SPARSER::COLLECTION)
    ("gefitinib or erlotinib" . SPARSER::COLLECTION)
    ("cetuximab and trastuzumab" . SPARSER::COLLECTION)
    ("trastuzumab or cetuximab" . SPARSER::COLLECTION)
    ("cetuximab-" . SPARSER::DRUG) ("Gefitinib" . SPARSER::DRUG)
    ("afatinib and lapatinib" . SPARSER::COLLECTION)
    ("a dual EGFR/HER2-TKI" . SPARSER::COLLECTION)
    ("Lapatinib and afatinib" . SPARSER::COLLECTION)
    ("EGFR, HER2 and HER3" . SPARSER::COLLECTION)
    ("trastuzumab and/or cetuximab" . SPARSER::COLLECTION)
    ("the EGFR-TKI gefitinib nor the pan-HER-TKI afatinib"
     . SPARSER::COLLECTION)
    ("the dual EGFR/HER2-TKI lapatinib" . SPARSER::DRUG)
    ("EGFR/HER2-TKI" . SPARSER::COLLECTION)
    ("EGFR and HER2" . SPARSER::COLLECTION) ("EGFR-TKIs" . SPARSER::COLLECTION)
    ("EGFR-tyrosine kinase" . SPARSER::COLLECTION)
    ("lapatinib and trastuzumab" . SPARSER::COLLECTION)
    ("both trastuzumab- and cetuximab-mediated ADCC" . SPARSER::COLLECTION)
    ("HER2 and EGFR" . SPARSER::COLLECTION)
    ("receptors and trastuzumab-" . SPARSER::COLLECTION)
    ("trastuzumab-" . SPARSER::DRUG) ("cetuximab" . SPARSER::DRUG)
    ("LDH" . SPARSER::PROTEIN)
    ("gefitinib, afatinib and lapatinib" . SPARSER::COLLECTION)
    ("afatinib" . SPARSER::DRUG) ("gefitinib" . SPARSER::DRUG)
    ("TKIs" . SPARSER::PROTEIN) ("TKI" . SPARSER::PROTEIN)
    ("EGFR/HER2" . SPARSER::COLLECTION) ("MPM" . SPARSER::MOLECULE)
    ("p3" . SPARSER::HUMAN-PROTEIN-FAMILY) ("IL-2" . SPARSER::PROTEIN)
    ("IgG2b" . SPARSER::BIO-COMPLEX) ("L-glutamine" . SPARSER::MOLECULE)
    ("EGFR-TKI" . SPARSER::PROTEIN) ("EBI" . SPARSER::PROTEIN)
    ("a possible new target" . SPARSER::TARGET-PROTEIN)
    ("FOG/GATA1" . SPARSER::COLLECTION)
    ("genes TFDP2 (Transcription Factor DP2) and ATP1B3 (ATPase, Na + /K + Transporting, Beta 3 Polypeptide)"
     . SPARSER::COLLECTION)
    ("Polypeptide" . SPARSER::PEPTIDE) ("ATPase" . SPARSER::PROTEIN)
    ("FOG" . SPARSER::PROTEIN) ("peptidase" . SPARSER::PROTEIN)
    ("imatinib and dasatinib" . SPARSER::COLLECTION)
    ("dasatinib" . SPARSER::DRUG) ("tyrosine" . SPARSER::AMINO-ACID)
    ("gonadal" . SPARSER::PROTEIN-FAMILY) ("GATA" . SPARSER::PROTEIN)
    ("paralogue" . SPARSER::PROTEIN) ("GSEA" . SPARSER::PROTEIN)
    ("GAB2 and USP35" . SPARSER::COLLECTION) ("enhancers" . SPARSER::PROTEIN)
    ("NANOG" . SPARSER::PROTEIN) ("DNase" . SPARSER::PROTEIN)
    ("GERP" . SPARSER::PROTEIN) ("Mapping" . SPARSER::PROTEIN)
    ("ATP1B3, BCAR4, GAB2, GSPT1, RSL1D1 , TFDP2, TNFRSF17, USP35 and ZFPM1"
     . SPARSER::COLLECTION)
    ("sentinel" . SPARSER::DRUG) ("p22" . SPARSER::PROTEIN)
    ("RSL1D1, GSPT1 and TNFRSF17" . SPARSER::COLLECTION)
    ("USP" . SPARSER::PROTEIN) ("maps" . SPARSER::PROTEIN)
    ("TFDP2 and ATP1B3" . SPARSER::COLLECTION) ("UK" . SPARSER::PROTEIN)
    ("mapping" . SPARSER::PROTEIN) ("KIT/KITLG" . SPARSER::COLLECTION)
    ("KITLG" . SPARSER::PROTEIN) ("Family" . SPARSER::PROTEIN-FAMILY)
    ("variant and gene" . SPARSER::COLLECTION) ("H3K4Me3" . SPARSER::PROTEIN)
    ("H3K4" . SPARSER::PROTEIN) ("1–2" . SPARSER::PROTEIN)
    ("Beta 3" . SPARSER::PROTEIN) ("Na + /K + Transporting" . SPARSER::PROTEIN)
    ("DP2" . SPARSER::PROTEIN) ("Transcription Factor" . SPARSER::PROTEIN)
    ("GATA1" . SPARSER::PROTEIN) ("Friend of GATA1" . SPARSER::PROTEIN)
    ("zinc finger protein" . SPARSER::PROTEIN)
    ("proto-oncogene" . SPARSER::PROTEIN) ("top 1" . SPARSER::PROTEIN)
    ("GRB2" . SPARSER::PROTEIN) ("early growth response" . SPARSER::PROTEIN)
    ("TNFRSF17" . SPARSER::PROTEIN) ("RSL1D1" . SPARSER::PROTEIN)
    ("ATP1B3" . SPARSER::PROTEIN) ("ZFPM1" . SPARSER::PROTEIN)
    ("GSPT1" . SPARSER::PROTEIN) ("p13" . SPARSER::PROTEIN)
    ("GAB2" . SPARSER::PROTEIN) ("TFDP2" . SPARSER::PROTEIN)
    ("Nat" . SPARSER::PROTEIN) ("a previously unreported type" . TYPE)
    ("Numb:p53" . SPARSER::BIO-COMPLEX)
    ("p53 and the E3 ubiquitin ligase MDM2" . SPARSER::COLLECTION)
    ("a tripartite complex" . SPARSER::BIO-COMPLEX)
    ("p53 and p21" . SPARSER::COLLECTION)
    ("foetal myogenic" . SPARSER::PROTEIN) ("reagent" . SPARSER::MOLECULE)
    ("Rox" . SPARSER::PROTEIN) ("cysteine (NAC)" . SPARSER::MOLECULE)
    ("DPI and SAβGal" . SPARSER::COLLECTION) ("NAC" . SPARSER::PROTEIN)
    ("cysteine" . SPARSER::AMINO-ACID) ("ROS" . SPARSER::PROTEIN)
    ("oxygen" . SPARSER::MOLECULE) ("p16/p21" . SPARSER::COLLECTION)
    ("p21 or p53" . SPARSER::COLLECTION)
    ("p16 and/or p19" . SPARSER::COLLECTION)
    ("Ink4a/ARF" . SPARSER::COLLECTION)
    ("DPI and 8-week-old" . SPARSER::COLLECTION)
    ("myogenic and macrophage" . SPARSER::COLLECTION)
    ("macrophage" . SPARSER::PROTEIN) ("/Myosin" . SPARSER::COLLECTION)
    ("Myosin" . SPARSER::PROTEIN-FAMILY) ("Collagen" . SPARSER::PROTEIN)
    ("green fluorescent protein (GFP)" . SPARSER::PROTEIN)
    ("the senescence-associated heterochromatin foci" . SPARSER::PROTEIN)
    ("Numb:Numbl:DMD" . SPARSER::BIO-COMPLEX) ("dystrophin" . SPARSER::PROTEIN)
    ("DMD" . SPARSER::PROTEIN) ("dystrophic" . SPARSER::PROTEIN)
    ("Hey1 and HeyL" . SPARSER::COLLECTION) ("HeyL" . SPARSER::PROTEIN)
    ("Von" . SPARSER::PROTEIN) ("calcium" . SPARSER::CALCIUM)
    ("DPI" . SPARSER::PROTEIN) ("cardiotoxin" . SPARSER::PROTEIN)
    ("TA" . SPARSER::PROTEIN) ("Numb:Numbl" . SPARSER::BIO-COMPLEX)
    ("Tg:Pax7CT2" . SPARSER::BIO-COMPLEX)
    ("Tg:Pax7-Cre" . SPARSER::BIO-COMPLEX) ("Cre" . SPARSER::PROTEIN)
    ("Ink4A/ARF" . SPARSER::COLLECTION) ("Numb/Numbl" . SPARSER::COLLECTION)
    ("Numbl" . SPARSER::PROTEIN)
    ("The endocytic adaptor Numb" . SPARSER::PROTEIN)
    ("Shh and Wnt" . SPARSER::COLLECTION)
    ("protein–protein" . SPARSER::COLLECTION) ("Shh" . SPARSER::PROTEIN)
    ("p16, p19, p53 and Rb" . SPARSER::COLLECTION)
    ("p21 and p27" . SPARSER::COLLECTION)
    ("ref" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("senescence-associated heterochromatin foci" . SPARSER::PROTEIN)
    ("foci" . SPARSER::PROTEIN) ("heterochromatin" . SPARSER::PROTEIN)
    ("myoblasts" . SPARSER::PROTEIN) ("differentially" . SPARSER::PROTEIN)
    ("INK4a/ARF" . SPARSER::COLLECTION) ("ARF" . SPARSER::PROTEIN)
    ("myogenic" . SPARSER::PROTEIN)
    ("the endocytic adaptor protein Numb" . SPARSER::PROTEIN)
    ("Numb" . SPARSER::PROTEIN) ("skeletal muscle" . SPARSER::PROTEIN)
    ("Col1a1" . SPARSER::PROTEIN) ("K 4" . SPARSER::PROTEIN)
    ("K 3" . SPARSER::PROTEIN) ("X-gal" . SPARSER::MOLECULE)
    ("βGalactosidase" . SPARSER::PROTEIN) ("H11" . SPARSER::PROTEIN)
    ("C48" . SPARSER::PROTEIN) ("Calcitonin receptor" . SPARSER::PROTEIN)
    ("F11" . SPARSER::PROTEIN) ("F12" . SPARSER::PROTEIN)
    ("muscle)" . SPARSER::PROTEIN) ("ml −1" . SPARSER::PROTEIN)
    ("p38" . SPARSER::HUMAN-PROTEIN-FAMILY) ("MDM2" . SPARSER::PROTEIN)
    ("ubiquitin ligase" . SPARSER::PROTEIN) ("second type" . SPARSER::PROTEIN)
    ("anti-oxidants" . SPARSER::DRUG) ("Ink4a" . SPARSER::PROTEIN)
    ("NG2" . SPARSER::PROTEIN) ("vascular endothelial" . SPARSER::PROTEIN)
    ("Flk-1" . SPARSER::PROTEIN) ("Ki67" . SPARSER::PROTEIN)
    ("Heavy Chain" . SPARSER::PROTEIN) ("IL6" . SPARSER::PROTEIN)
    ("HP1γ" . SPARSER::PROTEIN) ("Hey1" . SPARSER::PROTEIN)
    ("Tcf4" . SPARSER::PROTEIN) ("4-OHT" . SPARSER::DRUG)
    ("4-hydroxytamoxifen" . SPARSER::DRUG) ("CT2" . SPARSER::PROTEIN)
    ("ERT2" . SPARSER::PROTEIN) ("Ink4A" . SPARSER::PROTEIN)
    ("p19" . SPARSER::PROTEIN) ("βGal" . SPARSER::PROTEIN)
    ("β-galactosidase" . SPARSER::PROTEIN) ("Pax7" . SPARSER::PROTEIN)
    ("anti-oxidant" . SPARSER::DRUG) ("INK4a" . SPARSER::PROTEIN)
    ("adaptor protein" . SPARSER::PROTEIN)
    ("a significantly longer TTP" . SPARSER::PROTEIN)
    ("TTP" . SPARSER::PROTEIN) ("responding group" . SPARSER::MOLECULE)
    ("gene and protein" . SPARSER::COLLECTION)
    ("DNA and RNA" . SPARSER::COLLECTION)
    ("purine and pyrimidine" . SPARSER::COLLECTION)
    ("dihydrofolate reductase, and glycinamide" . SPARSER::COLLECTION)
    ("ribonucleotide" . SPARSER::MOLECULE) ("pyrimidine" . SPARSER::DRUG)
    ("purine" . SPARSER::DRUG) ("antimetabolite" . SPARSER::DRUG)
    ("Pemetrexed" . SPARSER::DRUG) ("TTP " . SPARSER::PROTEIN)
    ("pemetrexed" . SPARSER::DRUG) ("antifolate" . SPARSER::MOLECULE)
    ("TYMS" . SPARSER::PROTEIN) ("housekeeping gene" . SPARSER::PROTEIN)
    ("ATP5E" . SPARSER::PROTEIN) ("dihydrofolate reductase" . SPARSER::PROTEIN)
    ("thymidylate synthase" . SPARSER::PROTEIN)
    ("at least ten different HDACIs" . SPARSER::MOLECULE)
    ("II" . SPARSER::PROTEIN) ("HDACI" . SPARSER::MOLECULE)
    ("vorinostat" . SPARSER::DRUG) ("−1" . SPARSER::PROTEIN)
    ("pro-apoptotic proteins Bax, Bad and Bim" . SPARSER::COLLECTION)
    ("Bax, Bad and Bim" . SPARSER::COLLECTION) ("Bim" . SPARSER::PROTEIN)
    ("Bad" . SPARSER::PROTEIN) ("Bax" . SPARSER::PROTEIN)
    ("p16, p27, cyclin E and gelsolin" . SPARSER::COLLECTION)
    ("gelsolin" . SPARSER::PROTEIN) ("cdk" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HDAC-1/HDAC-2/HDAC-4/HDAC-6" . SPARSER::COLLECTION)
    ("HDAC-1/HDAC-2" . SPARSER::COLLECTION) ("thyroid" . SPARSER::PROTEIN)
    ("gemcitabine" . SPARSER::DRUG) ("fluorouracil" . SPARSER::DRUG)
    ("nucleosome" . SPARSER::BIO-COMPLEX)
    ("HATs and HDACs" . SPARSER::COLLECTION) ("homology" . SPARSER::PROTEIN)
    ("histones and histone" . SPARSER::COLLECTION)
    ("lysine" . SPARSER::AMINO-ACID) ("coenzyme" . SPARSER::MOLECULE)
    ("acetyl" . SPARSER::MOLECULE) ("HATs" . SPARSER::PROTEIN)
    ("HDACIs" . SPARSER::MOLECULE) ("HDACs" . SPARSER::PROTEIN)
    ("Bcl-XL" . SPARSER::PROTEIN) ("p21" . SPARSER::PROTEIN)
    ("IgG 2a" . SPARSER::PROTEIN) ("IgG 2b" . SPARSER::BIO-COMPLEX)
    ("A-4" . SPARSER::PROTEIN) ("N1" . SPARSER::PROTEIN)
    ("Rpd3" . SPARSER::PROTEIN) ("−3" . SPARSER::PROTEIN)
    ("S. Cerevisiae" . SPARSER::PROTEIN) ("HDAC-2" . SPARSER::PROTEIN)
    ("HDAC-6" . SPARSER::PROTEIN) ("HDAC-4" . SPARSER::PROTEIN)
    ("−2" . SPARSER::PROTEIN) ("HDAC-1" . SPARSER::PROTEIN)
    ("log-rank" . SPARSER::PROTEIN) ("media" . SPARSER::PROTEIN)
    ("p53 and PTEN" . SPARSER::COLLECTION)
    ("a functional RAS GAP" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PH and BTK" . SPARSER::COLLECTION) ("BTK" . SPARSER::PROTEIN)
    ("PH" . SPARSER::PROTEIN) ("NRAS" . SPARSER::PROTEIN)
    ("RAS-GAP" . SPARSER::COLLECTION) ("Phe" . SPARSER::AMINO-ACID)
    ("Arg" . SPARSER::AMINO-ACID) ("shRNA" . SPARSER::PROTEIN)
    ("RASA2 and NF1" . SPARSER::COLLECTION) ("GDP" . SPARSER::NUCLEOTIDE)
    ("its mutated oncogenic form" . SPARSER::FORM)
    ("GTPase-activating protein (GAP)" . SPARSER::PROTEIN)
    ("GTPase" . SPARSER::GTPASE) ("GAP" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a potential tumor suppressor gene" . SPARSER::PROTEIN)
    ("TP53 , NF1 , ARID2 , CDKN2A , and PTEN" . SPARSER::COLLECTION)
    ("Genes" . SPARSER::GENE) ("A possible solution" . SPARSER::MOLECULE)
    ("solution" . SPARSER::MOLECULE) ("suppressors" . SPARSER::SUPPRESSOR)
    ("GAPs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Ras" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("RAS" . SPARSER::HUMAN-PROTEIN-FAMILY) ("RasGAP" . SPARSER::PROTEIN)
    ("1-4" . SPARSER::PROTEIN) ("1 - 2" . SPARSER::PROTEIN)
    ("Mg 2+" . SPARSER::MOLECULE) ("Ras-GTP" . SPARSER::PROTEIN)
    ("M2" . SPARSER::MOLECULE) ("β-mercaptoethanol" . SPARSER::MOLECULE)
    ("RAS-GTP" . SPARSER::PROTEIN) ("p120GAP" . SPARSER::PROTEIN)
    ("RAS GAP" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("GTPase-activating protein" . SPARSER::PROTEIN)
    ("ARID2" . SPARSER::PROTEIN) ("NF1" . SPARSER::PROTEIN)
    ("RASA2" . SPARSER::PROTEIN) ("HER3 and HER4" . SPARSER::COLLECTION)
    ("HER1/EGFR" . SPARSER::COLLECTION) ("ErbB2" . SPARSER::PROTEIN)
    ("Neu" . SPARSER::PROTEIN) ("HER" . SPARSER::PROTEIN)
    ("STAT3 [ xref ] and HIF-1 [ xref ]" . SPARSER::COLLECTION)
    ("resveratrol" . SPARSER::PROTEIN) ("Jak and Src" . SPARSER::COLLECTION)
    ("Src" . SPARSER::PROTEIN) ("Jak" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("STAT3 and VEGF" . SPARSER::COLLECTION)
    ("pro-apoptotic proteins" . SPARSER::PROTEIN)
    ("BAX, NOXA and PUMA" . SPARSER::COLLECTION) ("PUMA" . SPARSER::PROTEIN)
    ("NOXA" . SPARSER::PROTEIN) ("proteinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("hypoxia and oncogene" . SPARSER::COLLECTION)
    ("substrates" . SPARSER::SUBSTRATE) ("proteases" . SPARSER::PROTEIN)
    ("Caspases" . SPARSER::PROTEIN)
    ("caspase-8 inhibitor Z-IETD- fmk and the caspase-9 inhibitor Z-LEHD -fmk"
     . SPARSER::COLLECTION)
    ("caspases-8, -3, and PARP" . SPARSER::COLLECTION)
    ("Bcl-2 and BAX" . SPARSER::COLLECTION)
    ("HIF-1α and JAK" . SPARSER::COLLECTION)
    ("HIF-1α inhibitor (EF-24) and JAK inhibitor I" . SPARSER::COLLECTION)
    ("JAK" . SPARSER::PROTEIN) ("EF" . SPARSER::PROTEIN)
    ("STAT-3 and VEGF" . SPARSER::COLLECTION)
    ("VEGF and MMP-9" . SPARSER::COLLECTION)
    ("STAT3 and HIF-1α" . SPARSER::COLLECTION) ("p-JAK2" . SPARSER::COLLECTION)
    ("p-JAK1" . SPARSER::COLLECTION) ("kinases" . SPARSER::KINASE)
    ("p-STAT3" . SPARSER::COLLECTION) ("p-p53" . SPARSER::COLLECTION)
    ("FCCP" . SPARSER::MOLECULE) ("DMSO" . SPARSER::MOLECULE)
    ("the monomeric form" . SPARSER::FORM)
    ("JC-1 spontaneously forms complexes" . SPARSER::BIO-COMPLEX)
    ("complexes" . SPARSER::BIO-COMPLEX)
    ("BAX and Bcl-2 " . SPARSER::COLLECTION)
    ("BAX and Bcl-2" . SPARSER::COLLECTION)
    ("caspase-8 and caspase-9" . SPARSER::COLLECTION)
    ("the caspase-8 inhibitor Z-IETD- fmk and the caspase-9 inhibitor Z-LEHD -fmk ( xref B)"
     . SPARSER::COLLECTION)
    ("caspase-8 and caspase-3 " . SPARSER::COLLECTION)
    ("Z-IETD- fmk and Z-LEHD -fmk" . SPARSER::COLLECTION)
    ("caspase-8 and caspase-3" . SPARSER::COLLECTION)
    ("caspase-8, caspase-3 and PARP" . SPARSER::COLLECTION)
    ("apigenin and genistein" . SPARSER::COLLECTION)
    ("genistein" . SPARSER::PROTEIN)
    ("apoptotic molecules and intracellular signalling molecules"
     . SPARSER::COLLECTION)
    ("ATP" . SPARSER::ATP) ("Lapatinib" . SPARSER::DRUG)
    ("Trastuzumab" . SPARSER::DRUG)
    ("trastuzumab (herceptin) and lapatinib (tykerb)" . SPARSER::COLLECTION)
    ("specifically target HER2" . SPARSER::PROTEIN) ("tykerb" . SPARSER::DRUG)
    ("lapatinib" . SPARSER::DRUG) ("herceptin" . SPARSER::DRUG)
    ("trastuzumab" . SPARSER::DRUG) ("caspases" . SPARSER::PROTEIN)
    ("effector" . SPARSER::EFFECTOR) ("apoptosome" . SPARSER::BIO-COMPLEX)
    ("cytochrome c and apoptosis-inducing" . SPARSER::COLLECTION)
    ("AIF" . SPARSER::PROTEIN) ("complex (DISC)" . SPARSER::BIO-COMPLEX)
    ("DISC" . SPARSER::BIO-COMPLEX) ("FADD" . SPARSER::PROTEIN)
    ("receptors (TNFR)" . SPARSER::RECEPTOR)
    ("Fas and tumour necrosis factor" . SPARSER::COLLECTION)
    ("TNFR" . SPARSER::PROTEIN) ("Fas" . SPARSER::PROTEIN) ("types " . TYPE)
    ("a vital component" . SPARSER::COMPONENT) ("chemical" . SPARSER::MOLECULE)
    ("hormone" . SPARSER::MOLECULE) ("substances" . SPARSER::SUBSTANCE)
    ("HIF-1α and VEGF" . SPARSER::COLLECTION) ("JNK" . SPARSER::PROTEIN)
    ("FoxO" . SPARSER::PROTEIN-FAMILY) ("TRAMP" . SPARSER::PROTEIN)
    ("antidepressant" . SPARSER::DRUG) ("antioxidant" . SPARSER::PROTEIN)
    ("wine" . SPARSER::MOLECULE) ("-trihydroxyflavone" . SPARSER::MOLECULE)
    ("trihydroxyflavone" . SPARSER::MOLECULE) ("stilbenes" . SPARSER::MOLECULE)
    ("lignans" . SPARSER::MOLECULE) ("isoflavones" . SPARSER::MOLECULE)
    ("flavones" . SPARSER::DRUG) ("phytoestrogens" . SPARSER::DRUG)
    ("receptor (ER)" . SPARSER::RECEPTOR)
    ("Phytoestrogens" . SPARSER::MOLECULE)
    ("phospho-JAK1, phospho-JAK2 and phospho-STAT3" . SPARSER::COLLECTION)
    ("Bcl-2-associated X protein (BAX)" . SPARSER::PROTEIN)
    ("protein (BAX)" . SPARSER::PROTEIN) ("BAX" . SPARSER::PROTEIN)
    ("polymerase (PARP)" . SPARSER::PROTEIN) ("PARP" . SPARSER::PROTEIN)
    ("polymerase" . SPARSER::PROTEIN) ("apigenin" . SPARSER::DRUG)
    ("Phytoestrogen" . SPARSER::MOLECULE) ("caspase" . SPARSER::PROTEIN)
    ("Apigenin" . SPARSER::DRUG) ("HER4" . SPARSER::PROTEIN)
    ("HER3" . SPARSER::PROTEIN) ("HER1" . SPARSER::PROTEIN)
    ("HIF-1" . SPARSER::PROTEIN) ("growth factor" . SPARSER::GROWTH-FACTOR)
    ("G 2 /M" . SPARSER::PROTEIN) ("caspases-8" . SPARSER::PROTEIN)
    ("STAT-3" . SPARSER::PROTEIN) ("JAK-STAT" . SPARSER::PROTEIN)
    ("STAT3 " . SPARSER::PROTEIN) ("Bcl-2 " . SPARSER::PROTEIN)
    ("mitochondrial)" . SPARSER::PROTEIN) ("caspase-3 " . SPARSER::PROTEIN)
    ("p4" . SPARSER::HUMAN-PROTEIN-FAMILY) ("SO 4" . SPARSER::PROTEIN)
    ("Tween 20" . SPARSER::MOLECULE) ("MMP-9 " . SPARSER::PROTEIN)
    ("MgCl 2" . SPARSER::MOLECULE) ("H 2 O 2" . SPARSER::DRUG)
    ("hydrogen peroxide" . SPARSER::MOLECULE) ("Na 3 VO 4" . SPARSER::MOLECULE)
    ("NP-40" . SPARSER::DRUG) ("FL-2" . SPARSER::PROTEIN)
    ("FL-1" . SPARSER::PROTEIN) ("RNase A" . SPARSER::PROTEIN)
    ("–2 " . SPARSER::PROTEIN) ("S3I-201" . SPARSER::MOLECULE)
    ("Z-LEHD -fmk" . SPARSER::DRUG) ("Z-IETD- fmk" . SPARSER::DRUG)
    ("JC-1" . SPARSER::MOLECULE)
    ("protein kinase domain" . SPARSER::PROTEIN-FAMILY)
    ("Caspase-3" . SPARSER::PROTEIN) ("caspase-9" . SPARSER::PROTEIN)
    ("procaspase-9" . SPARSER::PROTEIN) ("APAF1" . SPARSER::PROTEIN)
    ("Cytochrome c" . SPARSER::PROTEIN)
    ("apoptosis-inducing" . SPARSER::PROTEIN)
    ("Procaspase-8" . SPARSER::PROTEIN) ("procaspase-8" . SPARSER::PROTEIN)
    ("tumour necrosis factor" . SPARSER::PROTEIN)
    ("CoCl 2" . SPARSER::MOLECULE)
    ("signal transducer and activator of transcription 3" . SPARSER::PROTEIN)
    ("JAK2" . SPARSER::PROTEIN) ("JAK1" . SPARSER::PROTEIN)
    ("ADP-ribose" . SPARSER::MOLECULE) ("caspase-3" . SPARSER::PROTEIN)
    ("caspase-8" . SPARSER::PROTEIN) ("STAT3" . SPARSER::PROTEIN)
    ("a possible therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("mitochondria" . SPARSER::PROTEIN)
    ("Bcl-2-beclin 1" . SPARSER::COLLECTION)
    ("Annexin V-PI" . SPARSER::COLLECTION)
    ("LC3-II and beclin 1" . SPARSER::COLLECTION)
    ("the reliable biomarkers" . SPARSER::MOLECULE)
    ("LC3-II, beclin 1 and p62" . SPARSER::COLLECTION)
    ("The two well-studied PI3K inhibitors" . SPARSER::INHIBITOR)
    ("wortmannin and LY294002" . SPARSER::COLLECTION)
    ("AKT and mTOR" . SPARSER::COLLECTION) ("inactive" . SPARSER::INACTIVE)
    ("GSK2126458 and PKI-587" . SPARSER::COLLECTION)
    ("a dual PI3K/mTOR inhibitor" . SPARSER::INHIBITOR)
    ("PI3K/mTOR" . SPARSER::COLLECTION)
    ("PI3K/mechanistic target of rapamycin" . SPARSER::COLLECTION)
    ("NPC" . SPARSER::MOLECULE)
    ("kinase insert domain receptor and platelet-derived growth factor"
     . SPARSER::COLLECTION)
    ("isoforms" . SPARSER::ISOFORM) ("IA" . SPARSER::MOLECULE)
    ("Medicine" . SPARSER::DRUG)
    ("an essential component" . SPARSER::COMPONENT)
    ("siRNA or co-treatment" . SPARSER::COLLECTION)
    ("p-AKT" . SPARSER::COLLECTION)
    ("protein kinase B (AKT)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p-mTOR" . SPARSER::COLLECTION) ("-AKT" . SPARSER::COLLECTION)
    ("monodansylcadaverine (MDC)" . SPARSER::DRUG)
    ("-light chain 3" . SPARSER::COLLECTION) ("electron" . SPARSER::MOLECULE)
    ("punctate" . SPARSER::PROTEIN) ("MDC" . SPARSER::PROTEIN)
    ("monodansylcadaverine" . SPARSER::DRUG)
    ("phosphatidylinositol 3-kinase (PI3K) inhibitors and the mechanisms of inducing autophagy in cancer cells"
     . SPARSER::COLLECTION)
    ("cytochrome c" . SPARSER::PROTEIN) ("Bcl-2" . SPARSER::PROTEIN)
    ("PI3Ks" . SPARSER::PROTEIN) ("LY294002" . SPARSER::MOLECULE)
    ("Beclin 1" . SPARSER::PROTEIN)
    ("Microtubule-associated protein" . SPARSER::PROTEIN)
    ("mM 3" . SPARSER::PROTEIN)
    ("glyceraldehyde 3-phosphate dehydrogenase" . SPARSER::PROTEIN)
    ("polyvinylidene fluoride" . SPARSER::DRUG)
    ("dimethyl sulfoxide" . SPARSER::MOLECULE)
    ("type III" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("type II" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("type I" . SPARSER::HUMAN-PROTEIN-FAMILY) ("PKI-587" . SPARSER::DRUG)
    ("GSK2126458" . SPARSER::DRUG) ("BEZ235" . SPARSER::DRUG)
    ("5–2" . SPARSER::PROTEIN)
    ("derived growth factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("kinase insert domain receptor" . SPARSER::PROTEIN)
    ("p110γ" . SPARSER::PROTEIN) ("p110δ" . SPARSER::PROTEIN)
    ("p110β" . SPARSER::PROTEIN) ("p110α" . SPARSER::PROTEIN)
    ("LC3-II" . SPARSER::PROTEIN) ("GFP-LC3" . SPARSER::PROTEIN)
    ("mechanistic target of rapamycin" . SPARSER::PROTEIN)
    ("protein kinase B" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p62" . SPARSER::PROTEIN) ("LC3" . SPARSER::PROTEIN)
    ("light chain 3" . SPARSER::PROTEIN)
    ("green fluorescent protein" . SPARSER::PROTEIN)
    ("phosphatidylinositol 3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("anti-neoplastic" . SPARSER::DRUG) ("LEF/TCF" . SPARSER::COLLECTION)
    ("TCF" . SPARSER::PROTEIN) ("LEF" . SPARSER::PROTEIN)
    ("component" . SPARSER::COMPONENT) ("/beta-catenin" . SPARSER::COLLECTION)
    ("wnt/β-catenin" . SPARSER::COLLECTION)
    ("wnt" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("C-myc and Cyclin D1" . SPARSER::COLLECTION) ("pCMV" . SPARSER::PROTEIN)
    ("CMV6" . SPARSER::PROTEIN) ("PI and Annexin V-FITC" . SPARSER::COLLECTION)
    ("FITC" . SPARSER::MOLECULE) ("PI" . SPARSER::PROTEIN)
    ("a potential tumor suppressor" . SPARSER::SUPPRESSOR)
    ("CMV6-Klotho" . SPARSER::COLLECTION)
    ("MMP-7 and MMP-9" . SPARSER::COLLECTION)
    ("IGF-I and IGFBP-3" . SPARSER::COLLECTION) ("alcohol" . SPARSER::DRUG)
    ("β-catenin, C-myc, and Cyclin D1" . SPARSER::COLLECTION)
    ("Wnt/β-catenin" . SPARSER::COLLECTION)
    ("Wnt" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("pCMV-Klotho" . SPARSER::PROTEIN-PAIR)
    ("Klotho, β-catenin, C-myc, and Cyclin D1" . SPARSER::COLLECTION)
    ("Klotho" . SPARSER::PROTEIN) ("Beta-catenin" . SPARSER::PROTEIN)
    ("beta-catenin" . SPARSER::PROTEIN) ("lamin B1" . SPARSER::PROTEIN)
    ("beclin 1" . SPARSER::PROTEIN) ("Annexin V" . SPARSER::PROTEIN)
    ("glyceraldehyde-3-phosphate dehydrogenase" . SPARSER::PROTEIN)
    ("reverse transcriptase" . SPARSER::PROTEIN)
    ("myc-tagged" . SPARSER::PROTEIN) ("MMP-9" . SPARSER::PROTEIN)
    ("MMP-7" . SPARSER::PROTEIN) ("N-cadherin" . SPARSER::PROTEIN)
    ("E-cadherin" . SPARSER::PROTEIN) ("IGF-II" . SPARSER::PROTEIN)
    ("IGFBP-3" . SPARSER::PROTEIN) ("IGF-I" . SPARSER::PROTEIN)
    ("membrane protein" . SPARSER::PROTEIN) ("Cyclin D1" . SPARSER::PROTEIN)
    ("C-myc" . SPARSER::PROTEIN) ("β-catenin" . SPARSER::PROTEIN)
    ("NCT" . SPARSER::PROTEIN) ("NEXT" . SPARSER::PROTEIN)
    ("Dr" . SPARSER::MOLECULE) ("mixtures" . SPARSER::MOLECULE)
    ("normal cfDNA" . SPARSER::PROTEIN)
    ("colon cancer and EGFR" . SPARSER::COLLECTION) ("–1" . SPARSER::PROTEIN)
    ("the actual mutant" . SPARSER::MUTANT)
    ("input DNA and actual mutant" . SPARSER::COLLECTION)
    ("actual mutant" . SPARSER::MUTANT) ("copies/~11,000" . SPARSER::PROTEIN)
    ("isogenic wild type (wt) DNA" . SPARSER::DNA)
    ("isogenic reference DNA" . SPARSER::DNA)
    ("histologically either moderately or poorly differentiated type" . TYPE)
    ("erlotinib" . SPARSER::DRUG)
    ("target and biomarker" . SPARSER::COLLECTION)
    ("IGF-1, HGF, and EGF" . SPARSER::COLLECTION) ("EGF" . SPARSER::PROTEIN)
    ("HGF" . SPARSER::PROTEIN)
    ("epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK) inhibitor"
     . SPARSER::COLLECTION)
    ("specific v-raf murine sarcoma viral oncogene homolog B1 (BRAF) inhibitors"
     . SPARSER::INHIBITOR)
    ("v-erb-b2 erythroblastic leukaemia viral oncogene homolog 2"
     . SPARSER::PROTEIN)
    ("v-Ki-ras" . SPARSER::COLLECTION) ("v-raf" . SPARSER::COLLECTION)
    ("raf" . SPARSER::HUMAN-PROTEIN-FAMILY) ("ALK" . SPARSER::PROTEIN)
    ("EGFR" . SPARSER::PROTEIN) ("antibodies" . SPARSER::ANTIBODY)
    ("Examples" . SPARSER::EXAMPLE)
    ("potential therapeutic targets" . SPARSER::TARGET-PROTEIN)
    ("medicine" . SPARSER::DRUG)
    ("metastatic or inoperable BTC" . SPARSER::PROTEIN)
    ("metastatic BTC" . SPARSER::PROTEIN) ("BTC" . SPARSER::PROTEIN)
    ("Type 1" . SPARSER::PROTEIN) ("ml–1" . SPARSER::PROTEIN)
    ("K+" . SPARSER::MOLECULE) ("anti-EGFR" . SPARSER::PROTEIN)
    ("PI3" . SPARSER::PROTEIN) ("IGF-1" . SPARSER::PROTEIN)
    ("phosphoinositide-3 kinase" . SPARSER::PROTEIN)
    ("alpha subunit" . SPARSER::PROTEIN) ("STK11" . SPARSER::PROTEIN)
    ("serine/threonine kinase 11" . SPARSER::PROTEIN)
    ("SMAD4" . SPARSER::PROTEIN) ("SMAD family member 4" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase inhibitor 2A" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Ki-ras" . SPARSER::PROTEIN)
    ("anaplastic lymphoma kinase" . SPARSER::PROTEIN)
    ("epidermal growth factor receptor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("homolog 2" . SPARSER::PROTEIN) ("v-erb" . SPARSER::PROTEIN)
    ("PIK3CA" . SPARSER::PROTEIN) ("NF-kB or CREB" . SPARSER::COLLECTION)
    ("CREB" . SPARSER::HUMAN-PROTEIN-FAMILY) ("FP" . SPARSER::RECEPTOR)
    ("PGE 2 and PGF 2α" . SPARSER::COLLECTION)
    ("growth factors and pro-inflammatory" . SPARSER::COLLECTION)
    ("the possible downstream COX2 effectors" . SPARSER::EFFECTOR)
    ("synthases" . SPARSER::PROTEIN) ("effectors" . SPARSER::EFFECTOR)
    ("PGs/PG" . SPARSER::COLLECTION)
    ("PTGS2 or PTGES and EGR1" . SPARSER::COLLECTION)
    ("PTGS2 and EGR1" . SPARSER::COLLECTION)
    ("PTGES and EGR1" . SPARSER::COLLECTION)
    ("EGR1 and mPGES1" . SPARSER::COLLECTION) ("Luciferase" . SPARSER::PROTEIN)
    ("− 1" . SPARSER::PROTEIN) ("Etoricoxib" . SPARSER::DRUG)
    ("synthases-PG" . SPARSER::COLLECTION) ("COX-PG" . SPARSER::COLLECTION)
    ("PTGES2 , PTGES3 or PGFS" . SPARSER::COLLECTION)
    ("PGFS" . SPARSER::PROTEIN)
    ("the HT29-lucD6 derivatives and evolution" . SPARSER::COLLECTION)
    ("derivatives" . SPARSER::DERIVATIVE) ("PMA" . SPARSER::PROTEIN)
    ("-COX2" . SPARSER::COLLECTION) ("pg" . SPARSER::MOLECULE)
    ("mRNA, and COX2" . SPARSER::COLLECTION) ("ADH" . SPARSER::PROTEIN)
    ("mucin" . SPARSER::PROTEIN) ("mPGES1 and COX2" . SPARSER::COLLECTION)
    ("colorectal tumors PTGS2 , PTGES and PTGER3" . SPARSER::COLLECTION)
    ("PTGS2 , PTGES and PTGER3" . SPARSER::COLLECTION)
    ("the COX-prostaglandin(s)-PG receptor(s) genes" . SPARSER::GENE)
    ("COX-prostaglandin" . SPARSER::COLLECTION)
    ("COX2 and mPGES1" . SPARSER::COLLECTION)
    ("components" . SPARSER::COMPONENT)
    ("COX2 and colon cancer" . SPARSER::COLLECTION)
    ("COX2 or mPGES1" . SPARSER::COLLECTION) ("NSAIDs" . SPARSER::DRUG)
    ("PGF 2α and PGE 2" . SPARSER::COLLECTION)
    ("prostanoids" . SPARSER::MOLECULE)
    ("mPGES-2 and the cytoplasmic cPGES" . SPARSER::COLLECTION)
    ("mPGES1, mPGES-2 and the cytoplasmic cPGES" . SPARSER::COLLECTION)
    ("PTGES , PTGES2 and PTGES3" . SPARSER::COLLECTION)
    ("cPGES" . SPARSER::PROTEIN)
    ("the principal prostanoid" . SPARSER::MOLECULE)
    ("prostanoid" . SPARSER::MOLECULE) ("COX" . SPARSER::PROTEIN)
    ("cyclooxygenases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("novel potential therapeutic targets" . SPARSER::TARGET-PROTEIN)
    ("PGs" . SPARSER::PROTEIN) ("PTGS2 and PTGES" . SPARSER::COLLECTION)
    ("COX2-" . SPARSER::PROTEIN) ("antagonist, or EGR1" . SPARSER::COLLECTION)
    ("antagonist" . SPARSER::MOLECULE)
    ("COX2 and microsomal Prostaglandin E 2 synthase 1 (mPGES1) proteins"
     . SPARSER::COLLECTION)
    ("microsomal Prostaglandin E 2 synthase 1 (mPGES1) proteins"
     . SPARSER::PROTEIN)
    ("PTGS2 (prostaglandin G/H synthase and cyclooxygenase) and PTGES (prostaglandin E synthase)"
     . SPARSER::COLLECTION)
    ("synthase and cyclooxygenase" . SPARSER::COLLECTION)
    ("PTGES" . SPARSER::PROTEIN) ("cyclooxygenase" . SPARSER::PROTEIN)
    ("synthase" . SPARSER::PROTEIN) ("-PG" . SPARSER::COLLECTION)
    ("PG" . SPARSER::PROTEIN) ("prostaglandin" . SPARSER::PROTEIN)
    ("Anti-" . SPARSER::ANTIBODY) ("Triton X-100" . SPARSER::MOLECULE)
    ("HSP90" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Foxn1" . SPARSER::PROTEIN)
    ("PGF2a" . SPARSER::MOLECULE) ("PGH 2" . SPARSER::MOLECULE)
    ("NF-kB" . SPARSER::PROTEIN)
    ("response elements" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("AL8810" . SPARSER::DRUG) ("SW480" . SPARSER::PROTEIN)
    ("PTGER3" . SPARSER::PROTEIN) ("NFκB" . SPARSER::PROTEIN)
    ("zinc finger" . SPARSER::PROTEIN) ("C2H2" . SPARSER::MOLECULE)
    ("transcriptional regulator" . SPARSER::PROTEIN-FAMILY)
    ("Early growth response 1" . SPARSER::PROTEIN)
    ("PTGES3" . SPARSER::PROTEIN) ("PTGES2" . SPARSER::PROTEIN)
    ("mPGES-2" . SPARSER::PROTEIN) ("PGI 2" . SPARSER::PROTEIN)
    ("PGD 2" . SPARSER::PROTEIN) ("PGE 2" . SPARSER::DRUG)
    ("cyclooxygenase 2" . SPARSER::PROTEIN) ("colon cancer" . SPARSER::PROTEIN)
    ("PGF 2α" . SPARSER::MOLECULE) ("EGR1" . SPARSER::PROTEIN)
    ("early growth response 1" . SPARSER::PROTEIN)
    ("mPGES1" . SPARSER::PROTEIN) ("synthase 1" . SPARSER::PROTEIN)
    ("Prostaglandin E 2" . SPARSER::MOLECULE)
    ("prostaglandin E synthase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PTGS2" . SPARSER::PROTEIN) ("COX2" . SPARSER::PROTEIN)
    ("Cyclooxygenase2" . SPARSER::PROTEIN)
    ("SESN1 and SESN2" . SPARSER::COLLECTION)
    ("p53 and p16" . SPARSER::COLLECTION) ("fit" . SPARSER::PROTEIN-FAMILY)
    ("RNA binding protein (RBP)" . SPARSER::PROTEIN) ("RBP" . SPARSER::PROTEIN)
    ("trans" . SPARSER::PROTEIN-FAMILY) ("RBPs" . SPARSER::PROTEIN)
    ("polysomal fraction" . SPARSER::COMPONENT)
    ("the severe hypoxia" . SPARSER::PROTEIN)
    ("phosphorylated eIF4EBP1" . SPARSER::PROTEIN-FAMILY)
    ("c-MYC and mutant" . SPARSER::COLLECTION)
    ("mRNA and protein" . SPARSER::COLLECTION) ("map" . SPARSER::PROTEIN)
    ("the bicistronic mRNA" . SPARSER::PROTEIN)
    ("acceptor" . SPARSER::MOLECULE) ("cis" . SPARSER::PROTEIN)
    ("normoxia and hypoxia" . SPARSER::COLLECTION)
    ("normoxia" . SPARSER::PROTEIN) ("adenosine" . SPARSER::PROTEIN)
    ("NAI" . SPARSER::MOLECULE) ("electrophile" . SPARSER::MOLECULE)
    ("c-MYC and B2M" . SPARSER::COLLECTION)
    ("the YBX1 western blot" . SPARSER::PROTEIN)
    ("c-MYC and p16" . SPARSER::COLLECTION)
    ("p16 and c-MYC" . SPARSER::COLLECTION)
    ("IgG" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("B2M and β-Actin" . SPARSER::COLLECTION)
    ("SRSF10 (FUSIP)" . SPARSER::PROTEIN)
    ("RBM4, YBX1 and SRSF1" . SPARSER::COLLECTION)
    ("SF2/ASF" . SPARSER::COLLECTION) ("RIP" . SPARSER::PROTEIN)
    ("ASF" . SPARSER::PROTEIN) ("HNRNPL" . SPARSER::PROTEIN)
    ("p16 INK4a and p53" . SPARSER::COLLECTION)
    ("Torin1 and Rapamycin" . SPARSER::COLLECTION)
    ("PCNA and ERK1" . SPARSER::COLLECTION)
    ("PCNA (Proliferative Cell Nuclear Antigen) and ERK (Extracellular Regulated Kinase 1)"
     . SPARSER::COLLECTION)
    ("PCNA" . SPARSER::PROTEIN) ("p53 and c-MYC" . SPARSER::COLLECTION)
    ("p16, p53 and c-MYC" . SPARSER::COLLECTION)
    ("subpolysomal and polysomal fractions" . SPARSER::COMPONENT)
    ("p16, c-MYC and p53" . SPARSER::COLLECTION)
    ("Rps20, EEF2 and VIM" . SPARSER::COLLECTION) ("VIM" . SPARSER::PROTEIN)
    ("Rps" . SPARSER::PROTEIN) ("the polysomal fraction" . SPARSER::COMPONENT)
    ("shp" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("derivative" . SPARSER::DERIVATIVE) ("FBL" . SPARSER::PROTEIN)
    ("Fibrillarin" . SPARSER::PROTEIN)
    ("β-actin and β-globin" . SPARSER::COLLECTION) ("eIF2α" . SPARSER::PROTEIN)
    ("eIF4E-BP1" . SPARSER::PROTEIN) ("eIF" . SPARSER::PROTEIN)
    ("Rapamycin and Torin1" . SPARSER::COLLECTION)
    ("Everolimus" . SPARSER::MOLECULE) ("Rapamycin" . SPARSER::DRUG)
    ("Hypoxia and mTOR" . SPARSER::COLLECTION) ("cryptic" . SPARSER::PROTEIN)
    ("the more distal 180 nucleotides" . SPARSER::NUCLEOTIDE)
    ("the proximal 90 nucleotides" . SPARSER::NUCLEOTIDE)
    ("p16 INK4a and c-MYC" . SPARSER::COLLECTION) ("Rluc" . SPARSER::PROTEIN)
    ("fragments" . SPARSER::FRAGMENT) ("Trans" . SPARSER::PROTEIN-FAMILY)
    ("CSD" . SPARSER::PROTEIN) ("Hypoxia" . SPARSER::PROTEIN)
    ("CDK4 and CDK6" . SPARSER::COLLECTION) ("pRB" . SPARSER::PROTEIN)
    ("Growth Factor (VEGF)" . SPARSER::GROWTH-FACTOR)
    ("TP53 and p27" . SPARSER::COLLECTION) ("examples" . SPARSER::EXAMPLE)
    ("XIAP" . SPARSER::PROTEIN) ("VEGF" . SPARSER::PROTEIN)
    ("hypoxia" . SPARSER::PROTEIN) ("subunits" . SPARSER::FRAGMENT)
    ("ribosome" . SPARSER::BIO-COMPLEX) ("Ribosome" . SPARSER::BIO-COMPLEX)
    ("an essential tumor suppressor gene" . SPARSER::PROTEIN)
    ("CDKN2A/p16 INK4a" . SPARSER::COLLECTION) ("PLB1" . SPARSER::PROTEIN)
    ("si-RNA" . SPARSER::RNA) ("miR-34a" . SPARSER::MOLECULE)
    ("SESN2" . SPARSER::PROTEIN) ("SESN1" . SPARSER::PROTEIN)
    ("tumor suppressor protein" . SPARSER::PROTEIN)
    ("RNA binding protein" . SPARSER::PROTEIN)
    ("eIF4EBP" . SPARSER::PROTEIN-FAMILY) ("β-Actin" . SPARSER::PROTEIN)
    ("B2M" . SPARSER::PROTEIN) ("SF2" . SPARSER::PROTEIN)
    ("SRSF1" . SPARSER::PROTEIN) ("RBM4" . SPARSER::PROTEIN)
    ("YT521-B" . SPARSER::PROTEIN) ("YTHDC1" . SPARSER::PROTEIN)
    ("SRSF10" . SPARSER::PROTEIN) ("RNA binding" . SPARSER::PROTEIN)
    ("HIF1α" . SPARSER::PROTEIN)
    ("Extracellular Regulated Kinase" . SPARSER::PROTEIN)
    ("EEF2" . SPARSER::PROTEIN) ("Torin 1" . SPARSER::DRUG)
    ("p53" . SPARSER::HUMAN-PROTEIN-FAMILY) ("β-globin" . SPARSER::PROTEIN)
    ("PP242" . SPARSER::DRUG) ("4E-BP1" . SPARSER::PROTEIN)
    ("Torin1" . SPARSER::DRUG) ("p16 protein" . SPARSER::PROTEIN)
    ("Y-box binding protein 1" . SPARSER::PROTEIN) ("p16" . SPARSER::PROTEIN)
    ("retinoblastoma protein" . SPARSER::PROTEIN) ("CDK4" . SPARSER::PROTEIN)
    ("TP53" . SPARSER::PROTEIN) ("BCL2" . SPARSER::PROTEIN)
    ("c-MYC" . SPARSER::PROTEIN) ("Growth Factor" . SPARSER::GROWTH-FACTOR)
    ("Vascular Endothelial" . SPARSER::PROTEIN) ("YBX1" . SPARSER::PROTEIN)
    ("tumor suppressor gene" . SPARSER::PROTEIN)
    ("p16 INK4a" . SPARSER::PROTEIN) ("CDKN2A" . SPARSER::PROTEIN)
    ("prognostic and predictive biomarkers" . SPARSER::MOLECULE)
    ("minimally invasive biomarkers" . SPARSER::MOLECULE)
    ("EpCAM and CK" . SPARSER::COLLECTION) ("EMT" . SPARSER::PROTEIN)
    ("the mesenchymal marker Zeb1" . SPARSER::PROTEIN)
    ("Zeb1" . SPARSER::PROTEIN) ("Zeb" . SPARSER::PROTEIN)
    ("EpCAM and cytokeratin (CK)" . SPARSER::COLLECTION)
    ("EpCAM and cytokeratin" . SPARSER::COLLECTION) ("CK" . SPARSER::PROTEIN)
    ("cytokeratin" . SPARSER::PROTEIN-FAMILY)
    ("WT DNA or G12R mutant DNA" . SPARSER::COLLECTION)
    ("Mutant" . SPARSER::MUTANT) ("Exon" . SPARSER::PROTEIN)
    ("a HR 2.9" . SPARSER::PROTEIN) ("KRAS and 7/12" . SPARSER::COLLECTION)
    ("HR" . SPARSER::PROTEIN)
    ("the corresponding positive control G12D mutant DNA and WT DNA"
     . SPARSER::COLLECTION)
    ("spiked and non-spiked" . SPARSER::COLLECTION)
    ("example" . SPARSER::EXAMPLE) ("spike" . SPARSER::PROTEIN)
    ("spiked" . SPARSER::PROTEIN) ("cohorts" . SPARSER::MOLECULE)
    ("LA" . SPARSER::PROTEIN) ("male and 21 female" . SPARSER::COLLECTION)
    ("male" . SPARSER::MOLECULE) ("prognostic biomarkers" . SPARSER::MOLECULE)
    ("states" . SPARSER::BIO-STATE)
    ("the marker EpCAM and/or Cytokeratins" . SPARSER::COLLECTION)
    ("Cytokeratins" . SPARSER::PROTEIN) ("EpCAM" . SPARSER::PROTEIN)
    ("IV" . SPARSER::PROTEIN)
    ("new diagnostic and predictive biomarkers" . SPARSER::MOLECULE)
    ("complement" . SPARSER::PROTEIN) ("carbohydrate" . SPARSER::MOLECULE)
    ("a larger patient cohort" . SPARSER::MOLECULE)
    ("cfDNA" . SPARSER::PROTEIN) ("KRAS" . SPARSER::PROTEIN)
    ("a novel minimally invasive biomarker" . SPARSER::MOLECULE)
    ("PDAC" . SPARSER::MOLECULE) ("HR 2" . SPARSER::PROTEIN)
    ("S2" . SPARSER::MOLECULE) ("per 1" . SPARSER::PROTEIN)
    ("ammonium chloride" . SPARSER::MOLECULE) ("RPP30" . SPARSER::PROTEIN)
    ("of 45" . SPARSER::PROTEIN) ("amino acids" . SPARSER::AMINO-ACID)
    ("class" . CLASS) ("folate" . SPARSER::MOLECULE)
    ("VEGFR" . SPARSER::PROTEIN) ("variants" . SPARSER::VARIANT)
    ("microRNA" . SPARSER::RNA) ("adjuvant" . SPARSER::DRUG)
    ("stem cell factor (SCF)" . SPARSER::PROTEIN)
    ("a predictive biomarker" . SPARSER::MOLECULE)
    ("se" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("KIT or PDGFRA" . SPARSER::COLLECTION)
    ("a constitutional SNP variant" . SPARSER::VARIANT)
    ("seven" . SPARSER::PROTEIN) ("HPF" . SPARSER::PROTEIN)
    ("rank" . SPARSER::PROTEIN) ("RFS" . SPARSER::PROTEIN)
    ("the mutated forms" . SPARSER::FORM)
    ("AKT and ERK1" . SPARSER::COLLECTION)
    ("particular ERK2" . SPARSER::PROTEIN)
    ("ERK" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("RAF, ERK1 and ERK2" . SPARSER::COLLECTION) ("MAPK" . SPARSER::PROTEIN)
    ("RAF" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("both mature and immature KIT" . SPARSER::PROTEIN)
    ("only membrane mature KIT" . SPARSER::PROTEIN)
    ("The immature 125-kDa form" . SPARSER::FORM)
    ("tyrosines" . SPARSER::AMINO-ACID) ("SCF" . SPARSER::PROTEIN)
    ("form" . SPARSER::FORM)
    ("125 kDa (immature) and 145 kDa (mature)" . SPARSER::COLLECTION)
    ("the receptor, 125 kDa (immature) and 145 kDa (mature)"
     . SPARSER::COLLECTION)
    ("kDa" . SPARSER::PROTEIN) ("MIGR" . SPARSER::PROTEIN)
    ("chronic eosinophilic leukemia" . SPARSER::PROTEIN)
    ("chronic myelogenous leukemia (CML)" . SPARSER::PROTEIN)
    ("the mature KIT protein" . SPARSER::PROTEIN) ("AF" . SPARSER::PROTEIN)
    ("leucine" . SPARSER::AMINO-ACID) ("methionine" . SPARSER::AMINO-ACID)
    ("nucleotide" . SPARSER::NUCLEOTIDE)
    ("KIT and PDGFR-α" . SPARSER::COLLECTION)
    ("KIT and PDGFRA" . SPARSER::COLLECTION) ("receptors" . SPARSER::RECEPTOR)
    ("variety" . SPARSER::VARIETY)
    ("the proto-oncogenes KIT (75-80 %) and PDGFRA (5–10 %)"
     . SPARSER::COLLECTION)
    ("ligand" . SPARSER::MOLECULE) ("PDGFRA" . SPARSER::PROTEIN)
    ("imatinib" . SPARSER::DRUG)
    ("the classical mutated forms" . SPARSER::FORM)
    ("AKT and ERK1/2" . SPARSER::COLLECTION) ("receptor" . SPARSER::RECEPTOR)
    ("variant" . SPARSER::VARIANT) ("exon" . SPARSER::PROTEIN)
    ("KIT" . SPARSER::PROTEIN) ("SPP1" . SPARSER::PROTEIN)
    ("IGF1R" . SPARSER::PROTEIN)
    ("receptor tyrosine kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CYP1B1" . SPARSER::PROTEIN) ("etc." . SPARSER::PROTEIN)
    ("stem cell factor" . SPARSER::PROTEIN)
    ("tyrosine kinase" . SPARSER::PROTEIN) ("ERK2" . SPARSER::PROTEIN)
    ("ERK1" . SPARSER::PROTEIN) ("PI3K-AKT" . SPARSER::COLLECTION)
    ("Chi-2" . SPARSER::PROTEIN) ("DNA polymerase" . SPARSER::PROTEIN)
    ("TG-3" . SPARSER::PROTEIN) ("Stem Cell Factor" . SPARSER::PROTEIN)
    ("G418" . SPARSER::MOLECULE) ("CO2" . SPARSER::PROTEIN)
    ("full-length" . SPARSER::PROTEIN) ("PDGFR-α" . SPARSER::PROTEIN)
    ("tyrosine kinase receptor" . SPARSER::PROTEIN)
    ("ERK1/2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("pAKT/SOX2" . SPARSER::COLLECTION) ("AKT or PI3K" . SPARSER::COLLECTION)
    ("GCD" . SPARSER::PROTEIN) ("Akt" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("leptomycin B (LMB)" . SPARSER::MOLECULE) ("LMB" . SPARSER::MOLECULE)
    ("Ala" . SPARSER::AMINO-ACID) ("iPS" . SPARSER::PROTEIN)
    ("Wang and co-workers" . SPARSER::COLLECTION) ("Ube2s" . SPARSER::PROTEIN)
    ("ubiquitin" . SPARSER::PROTEIN) ("Wang" . SPARSER::PROTEIN)
    ("PI3K or AKT" . SPARSER::COLLECTION)
    ("PI3K or loss-of-function" . SPARSER::COLLECTION)
    ("classical disease-defining genes" . SPARSER::GENE)
    ("PI3K/AKT/mTOR" . SPARSER::COLLECTION) ("HER2/neu" . SPARSER::COLLECTION)
    ("forms" . SPARSER::FORM) ("neu" . SPARSER::PROTEIN)
    ("MDA-MB468" . SPARSER::PROTEIN) ("oncogene" . SPARSER::ONCOGENE)
    ("The pluripotency-associated protein SOX2" . SPARSER::PROTEIN)
    ("MK-2206 and bortezomib" . SPARSER::COLLECTION)
    ("bortezomib" . SPARSER::DRUG) ("versa" . SPARSER::PROTEIN)
    ("leptomycin B and MK-2206" . SPARSER::COLLECTION)
    ("leptomycin B and AKT" . SPARSER::COLLECTION)
    ("bright" . SPARSER::PROTEIN) ("Proteasomal" . SPARSER::PROTEIN)
    ("cycloheximide" . SPARSER::PROTEIN)
    ("an inducible heterologous promoter" . SPARSER::PROMOTER)
    ("promoter" . SPARSER::PROMOTER) ("peptide" . SPARSER::PEPTIDE)
    ("GAPDH and RPS6" . SPARSER::COLLECTION) ("SDS" . SPARSER::PROTEIN)
    ("GAPDH" . SPARSER::PROTEIN) ("SOX2 and AKT" . SPARSER::COLLECTION)
    ("substrate" . SPARSER::SUBSTRATE) ("enzyme" . SPARSER::ENZYME)
    ("fractions" . SPARSER::COMPONENT) ("fish" . SPARSER::PROTEIN)
    ("AKT and SOX2" . SPARSER::COLLECTION)
    ("cyclin D1, cyclin E, and CDK2" . SPARSER::COLLECTION)
    ("AKT/pAKT" . SPARSER::COLLECTION) ("mCherry-SOX2" . SPARSER::COLLECTION)
    ("an immediate upstream regulator" . SPARSER::REGULATOR)
    ("rapamycin" . SPARSER::DRUG) ("mTOR" . SPARSER::PROTEIN)
    ("wortmannin and GDC-0941" . SPARSER::COLLECTION)
    ("Akti" . SPARSER::PROTEIN) ("wortmannin" . SPARSER::PROTEIN)
    ("myristoylated" . SPARSER::PROTEIN)
    ("pAKT and SOX2" . SPARSER::COLLECTION) ("fraction" . SPARSER::COMPONENT)
    ("paclitaxel" . SPARSER::DRUG) ("cisplatin" . SPARSER::DRUG)
    ("SRR" . SPARSER::PROTEIN) ("3D-" . SPARSER::PROTEIN-FAMILY)
    ("pSer" . SPARSER::PROTEIN) ("puromycine" . SPARSER::DRUG)
    ("ON" . SPARSER::PROTEIN) ("Tet" . SPARSER::PROTEIN)
    ("doxycycline" . SPARSER::DRUG) ("mCherry" . SPARSER::PROTEIN)
    ("fused" . SPARSER::PROTEIN) ("GFP" . SPARSER::PROTEIN)
    ("shRNAs" . SPARSER::RNA) ("MCF7" . SPARSER::PROTEIN)
    ("mRNA" . SPARSER::PROTEIN) ("active" . SPARSER::ACTIVE)
    ("perifosine" . SPARSER::PROTEIN) ("PI3K/AKT" . SPARSER::COLLECTION)
    ("subtypes" . SPARSER::PROTEIN)
    ("a pluripotent stem cell state" . SPARSER::BIO-STATE)
    ("Pluripotency-associated proteins" . SPARSER::PROTEIN)
    ("SOX2 and OCT4" . SPARSER::COLLECTION) ("state" . SPARSER::BIO-STATE)
    ("AKT/SOX2" . SPARSER::COLLECTION) ("proteasomal" . SPARSER::PROTEIN)
    ("SOX2 and pAKT" . SPARSER::COLLECTION) ("pAKT" . SPARSER::PROTEIN-FAMILY)
    ("AKT" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Thr" . SPARSER::AMINO-ACID)
    ("Ser" . SPARSER::AMINO-ACID) ("regulator" . SPARSER::REGULATOR)
    ("E3" . SPARSER::MOLECULE) ("Protein A" . SPARSER::PROTEIN)
    ("lamin A/C" . SPARSER::PROTEIN) ("T-3" . SPARSER::PROTEIN)
    ("beta-Actin" . SPARSER::PROTEIN) ("For 3" . SPARSER::PROTEIN)
    ("B-27" . SPARSER::PROTEIN) ("amino acid" . SPARSER::AMINO-ACID)
    ("p27" . SPARSER::PROTEIN) ("FoxO1" . SPARSER::PROTEIN)
    ("Sox2" . SPARSER::PROTEIN) ("2–4" . SPARSER::PROTEIN)
    ("HER2" . SPARSER::PROTEIN) ("estrogen receptor" . SPARSER::PROTEIN)
    ("BRCA-1" . SPARSER::PROTEIN) ("leptomycin B" . SPARSER::MOLECULE)
    ("cyclin D3" . SPARSER::PROTEIN) ("cyclin E" . SPARSER::PROTEIN)
    ("cyclin D1" . SPARSER::PROTEIN) ("RPS6" . SPARSER::PROTEIN)
    ("GDC-0941" . SPARSER::DRUG) ("AKT1" . SPARSER::PROTEIN)
    ("MK-2206" . SPARSER::MOLECULE) ("N-terminally" . SPARSER::PROTEIN)
    ("3D" . SPARSER::PROTEIN-FAMILY) ("kinase activity" . SPARSER::PROTEIN)
    (NIL . SPARSER::PROTEIN) ("PI3K" . SPARSER::PROTEIN-FAMILY)
    ("OCT4" . SPARSER::PROTEIN) ("SOX2" . SPARSER::PROTEIN)
    ("transcription factor" . SPARSER::PROTEIN)
    ("HDAC2/GCR" . SPARSER::COLLECTION)
    ("prednisolone and theophylline" . SPARSER::COLLECTION)
    ("prednisolone and/or very low dose cyclosporine" . SPARSER::COLLECTION)
    ("propionate" . SPARSER::MOLECULE) ("fluticasone" . SPARSER::DRUG)
    ("IBD" . SPARSER::PROTEIN) ("GC" . SPARSER::PROTEIN)
    ("an age-related or senescent-specific HDAC" . SPARSER::PROTEIN)
    ("these pro-inflammatory cytokines" . SPARSER::PROTEIN)
    ("pro-inflammatory cytokines, IFNγ and TNFα" . SPARSER::COLLECTION)
    ("mediators, perforin and granzyme" . SPARSER::COLLECTION)
    ("histones" . SPARSER::PROTEIN) ("the relevant isoform" . SPARSER::ISOFORM)
    ("isoform" . SPARSER::ISOFORM)
    ("pro-inflammatory cytokines IFNγ and TNFα" . SPARSER::COLLECTION)
    ("monocytes" . SPARSER::PROTEIN) ("GCR" . SPARSER::PROTEIN)
    ("HDAC2 and IFNγ" . SPARSER::COLLECTION)
    ("theophylline and MP" . SPARSER::COLLECTION)
    ("trichostatin" . SPARSER::MOLECULE)
    ("theophylline, and MP or CsA" . SPARSER::COLLECTION)
    ("MP or CsA" . SPARSER::COLLECTION) ("HDAC2 or IFNγ" . SPARSER::COLLECTION)
    ("MP" . SPARSER::PROTEIN) ("methylprednisolone" . SPARSER::DRUG)
    ("drugs" . SPARSER::DRUG) ("FEV" . SPARSER::PROTEIN)
    ("CD28−" . SPARSER::PROTEIN) ("Western Blot" . SPARSER::PROTEIN)
    ("Blot" . SPARSER::PROTEIN)
    ("IFNγ (Fig.  xref ) and TNFα (data not shown)" . SPARSER::COLLECTION)
    ("pro-inflammatory cytokine" . SPARSER::PROTEIN)
    ("HDAC2 or HAT" . SPARSER::COLLECTION)
    ("group and TNFα" . SPARSER::COLLECTION)
    ("HAT, HDAC2 and IFNγ and TNFα" . SPARSER::COLLECTION)
    ("IFNγ and TNFα" . SPARSER::COLLECTION) ("HAT " . SPARSER::PROTEIN)
    ("perforin or granzyme" . SPARSER::COLLECTION) ("CD8−" . SPARSER::PROTEIN)
    ("perforin and granzyme" . SPARSER::COLLECTION)
    ("Granzyme" . SPARSER::PROTEIN-FAMILY)
    ("HDAC2 and HAT" . SPARSER::COLLECTION)
    ("theophylline and immunosuppressant" . SPARSER::COLLECTION)
    ("cytokine" . SPARSER::PROTEIN)
    ("mediators or pro-inflammatory" . SPARSER::COLLECTION)
    ("glucocorticoid receptor (GCR)" . SPARSER::PROTEIN)
    ("drug" . SPARSER::DRUG) ("BAL" . SPARSER::PROTEIN)
    ("therapeutics" . SPARSER::THERAPEUTICS)
    ("pro-inflammatory cytokines" . SPARSER::PROTEIN)
    ("perforin" . SPARSER::PROTEIN) ("granzyme" . SPARSER::PROTEIN-FAMILY)
    ("mediators" . SPARSER::PROTEIN) ("cytotoxic" . SPARSER::PROTEIN)
    ("CsA" . SPARSER::PROTEIN) ("theophylline " . SPARSER::DRUG)
    ("IFNγ or TNFα" . SPARSER::COLLECTION)
    ("Intracellular pro-inflammatory cytokines, IFNγ and TNFα"
     . SPARSER::COLLECTION)
    ("cytokines, IFNγ and TNFα" . SPARSER::COLLECTION)
    ("CD28, HDAC2 and HAT" . SPARSER::COLLECTION)
    ("immunosuppressant" . SPARSER::DRUG) ("cyclosporine" . SPARSER::DRUG)
    ("prednisolone" . SPARSER::DRUG) ("activator" . SPARSER::ACTIVATOR)
    ("theophylline" . SPARSER::DRUG) ("cytokines" . SPARSER::PROTEIN)
    ("NKT" . SPARSER::PROTEIN) ("COPD" . SPARSER::PROTEIN)
    ("macrophages" . SPARSER::PROTEIN)
    ("Histone acetyltransferases (HAT) and histone deacetylases (HDAC)"
     . SPARSER::COLLECTION)
    ("deacetylases (HDAC)" . SPARSER::PROTEIN)
    ("acetyltransferases (HAT)" . SPARSER::PROTEIN)
    ("pro" . SPARSER::AMINO-ACID) ("enzymes" . SPARSER::ENZYME)
    ("HDAC" . SPARSER::PROTEIN) ("deacetylases" . SPARSER::PROTEIN)
    ("histone" . SPARSER::PROTEIN) ("HAT" . SPARSER::PROTEIN)
    ("acetyltransferases" . SPARSER::PROTEIN) ("Histone" . SPARSER::PROTEIN)
    ("HDAC1" . SPARSER::PROTEIN) ("IL-8" . SPARSER::PROTEIN)
    ("55kD" . SPARSER::PROTEIN) ("IFNγ " . SPARSER::PROTEIN)
    ("CD28 " . SPARSER::PROTEIN) ("β-actin" . SPARSER::PROTEIN)
    ("Bis-Tris" . SPARSER::MOLECULE) ("Cyclosporin A" . SPARSER::MOLECULE)
    ("serum albumin" . SPARSER::PROTEIN) ("CO 2" . SPARSER::PROTEIN)
    ("brefeldin A" . SPARSER::MOLECULE) ("CD3 " . SPARSER::PROTEIN)
    ("CD45" . SPARSER::HUMAN-PROTEIN-FAMILY) ("granzyme B" . SPARSER::PROTEIN)
    ("CD56" . SPARSER::PROTEIN) ("CD3" . SPARSER::PROTEIN)
    ("IgG1" . SPARSER::BIO-COMPLEX)
    ("glucocorticoid receptor" . SPARSER::PROTEIN) ("Pgp-1" . SPARSER::PROTEIN)
    ("CD8 " . SPARSER::PROTEIN) ("or 2" . SPARSER::MOLECULE)
    ("T-cell" . SPARSER::PROTEIN) ("TNFα" . SPARSER::PROTEIN)
    ("IFNγ" . SPARSER::PROTEIN) ("CD8" . SPARSER::PROTEIN)
    ("CD28" . SPARSER::PROTEIN) ("HDAC2" . SPARSER::PROTEIN)
    ("a reasonable candidate biomarker" . SPARSER::MOLECULE)
    ("biomarkers" . SPARSER::MOLECULE) ("hepatocytes" . SPARSER::PROTEIN)
    ("E2F2, CDK6, and CDK3" . SPARSER::COLLECTION)
    ("leukemia" . SPARSER::PROTEIN) ("family" . SPARSER::PROTEIN-FAMILY)
    ("attractive therapeutic targets" . SPARSER::TARGET-PROTEIN)
    ("HCC and other cancer types" . SPARSER::COLLECTION)
    ("the differential biologic" . SPARSER::DRUG) ("types" . TYPE)
    ("a tumor-suppressive miRNA" . SPARSER::PROTEIN)
    ("proteins" . SPARSER::PROTEIN)
    ("compelling biologic as well as clinical evidence" . SPARSER::COLLECTION)
    ("biologic" . SPARSER::DRUG) ("ER" . SPARSER::PROTEIN)
    ("PTEN" . SPARSER::PROTEIN) ("miR-199a/199a" . SPARSER::COLLECTION)
    ("molecule" . SPARSER::MOLECULE)
    ("a new tumor-suppressive miRNA" . SPARSER::PROTEIN)
    ("promoters" . SPARSER::PROMOTER) ("gene" . SPARSER::GENE)
    ("inhibitor and tumor" . SPARSER::COLLECTION)
    ("Western blot" . SPARSER::PROTEIN) ("group" . SPARSER::MOLECULE)
    ("siRNA" . SPARSER::PROTEIN) ("siRNAs" . SPARSER::PROTEIN)
    ("E2F2, CDK3, or CDK6" . SPARSER::COLLECTION)
    ("cytometry" . SPARSER::PROTEIN) ("nucleotides" . SPARSER::NUCLEOTIDE)
    ("CDK6-3" . SPARSER::COLLECTION) ("pGL3-E2F2" . SPARSER::COLLECTION)
    ("luciferase" . SPARSER::PROTEIN) ("western blot" . SPARSER::PROTEIN)
    ("blot" . SPARSER::PROTEIN) ("Target" . SPARSER::TARGET-PROTEIN)
    ("target" . SPARSER::TARGET-PROTEIN) ("199a" . SPARSER::PROTEIN)
    ("CDK3, CDK6 and E2F2" . SPARSER::COLLECTION)
    ("antagonists" . SPARSER::MOLECULE) ("NC" . SPARSER::PROTEIN)
    ("oligonucleotides" . SPARSER::MOLECULE) ("DNA" . SPARSER::DNA)
    ("MTT" . SPARSER::MOLECULE) ("a prognostic biomarker" . SPARSER::MOLECULE)
    ("biomarker" . SPARSER::MOLECULE) ("TNM" . SPARSER::MOLECULE)
    ("miR-199a" . SPARSER::COLLECTION) ("cirrhosis" . SPARSER::PROTEIN)
    ("suppressor" . SPARSER::SUPPRESSOR) ("regulators" . SPARSER::REGULATOR)
    ("mRNAs" . SPARSER::PROTEIN) ("miRNA" . SPARSER::PROTEIN)
    ("miRNAs" . SPARSER::PROTEIN) ("microRNAs" . SPARSER::RNA)
    ("cyclins and CDKs" . SPARSER::COLLECTION) ("CDKs" . SPARSER::PROTEIN)
    ("mitogens and growth factors" . SPARSER::COLLECTION)
    ("mitogens" . SPARSER::MITOGEN) ("Cyclin E/CDK2" . SPARSER::COLLECTION)
    ("Cyclin D-CDK6" . SPARSER::COLLECTION) ("protein" . SPARSER::PROTEIN)
    ("complex" . SPARSER::BIO-COMPLEX)
    ("cyclins and cyclin-dependent kinases (CDK)" . SPARSER::COLLECTION)
    ("cyclins and cyclin-dependent kinases" . SPARSER::COLLECTION)
    ("cyclins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("molecules" . SPARSER::MOLECULE) ("classes" . CLASS)
    ("genes" . SPARSER::GENE) ("oncogenes" . SPARSER::ONCOGENE)
    ("targets" . SPARSER::TARGET-PROTEIN)
    ("E2F2, CDK3 and CDK6" . SPARSER::COLLECTION) ("RNA" . SPARSER::RNA)
    ("E2F2, CDK3, and CDK6" . SPARSER::COLLECTION)
    ("CDK" . SPARSER::HUMAN-PROTEIN-FAMILY) ("HCC" . SPARSER::PROTEIN)
    ("miR" . SPARSER::PROTEIN) ("Aims" . SPARSER::PROTEIN)
    ("a 2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("-2" . SPARSER::PROTEIN)
    ("c-nu" . SPARSER::PROTEIN) ("monoclonal antibody" . SPARSER::DRUG)
    ("p-Rb" . SPARSER::PROTEIN) ("U6" . SPARSER::PROTEIN)
    ("epidermal growth factor" . SPARSER::PROTEIN)
    ("proto-oncogenes" . SPARSER::PROTO-ONCOGENE) ("DDR1" . SPARSER::PROTEIN)
    ("E2F3" . SPARSER::PROTEIN) ("HIF-1α" . SPARSER::PROTEIN)
    ("-3" . SPARSER::PROTEIN) ("pGL3" . SPARSER::PROTEIN)
    ("anti-" . SPARSER::ANTIBODY)
    ("negative regulators" . SPARSER::NEGATIVE-REGULATOR)
    ("growth factors" . SPARSER::GROWTH-FACTOR)
    ("transcriptional activator" . SPARSER::PROTEIN-FAMILY)
    ("E2F" . SPARSER::PROTEIN-FAMILY) ("CDK2" . SPARSER::PROTEIN)
    ("Cyclin E" . SPARSER::PROTEIN) ("Cyclin D" . SPARSER::PROTEIN)
    ("cyclin-dependent kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("dual-luciferase" . SPARSER::PROTEIN) ("CDK3" . SPARSER::PROTEIN)
    ("CDK6" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("E2F2" . SPARSER::PROTEIN) ("melting" . SPARSER::DRUG)
    ("antibody" . SPARSER::ANTIBODY) ("mutants" . SPARSER::MUTANT)
    ("type and frequency" . SPARSER::COLLECTION) ("type" . TYPE)
    ("part" . SPARSER::COMPONENT) ("CR and PR" . SPARSER::COLLECTION)
    ("MR" . SPARSER::PROTEIN) ("SD" . SPARSER::PROTEIN)
    ("PR" . SPARSER::HUMAN-PROTEIN-FAMILY) ("partial" . SPARSER::PROTEIN)
    ("CR" . SPARSER::PROTEIN) ("cohort" . SPARSER::MOLECULE)
    ("the BRAF inhibitors vemurafenib ( n = 67) or dabrafenib ( n = 9)"
     . SPARSER::COLLECTION)
    ("mutated alleles" . SPARSER::ALLELE)
    ("mutated BRAFV600 alleles" . SPARSER::ALLELE) ("BRAFV" . SPARSER::PROTEIN)
    ("GT" . SPARSER::PROTEIN)
    ("vemurafenib and dabrafenib" . SPARSER::COLLECTION)
    ("dabrafenib" . SPARSER::DRUG) ("vemurafenib" . SPARSER::DRUG)
    ("kinase" . SPARSER::KINASE)
    ("mutated BRAF V600 alleles" . SPARSER::ALLELE) ("AA-" . SPARSER::MOLECULE)
    ("AA" . SPARSER::MOLECULE) ("TG" . SPARSER::PROTEIN)
    ("allele" . SPARSER::ALLELE) ("inhibitors" . SPARSER::INHIBITOR)
    ("formalin" . SPARSER::MOLECULE) ("Allele" . SPARSER::ALLELE)
    ("alleles" . SPARSER::ALLELE) ("mutant" . SPARSER::MUTANT)
    ("inhibitor" . SPARSER::INHIBITOR) ("BRAF" . SPARSER::PROTEIN)))